Citrus Sinensis ID: 018614
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 353 | 2.2.26 [Sep-21-2011] | |||||||
| Q54H46 | 642 | Probable serine/threonine | yes | no | 0.711 | 0.390 | 0.367 | 3e-39 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.722 | 0.105 | 0.372 | 1e-38 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.705 | 0.360 | 0.369 | 4e-38 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.674 | 0.610 | 0.375 | 7e-38 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.677 | 0.144 | 0.337 | 2e-37 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.688 | 0.149 | 0.354 | 3e-37 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.674 | 0.317 | 0.357 | 3e-37 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.719 | 0.388 | 0.338 | 5e-37 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.747 | 0.282 | 0.367 | 1e-36 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.691 | 0.266 | 0.348 | 1e-36 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 162 bits (411), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 103/280 (36%), Positives = 157/280 (56%), Gaps = 29/280 (10%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
+ID H++ V I KG + L WRG QVAVKKL I +++ ++ F E+ L++
Sbjct: 368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 424
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 159
+RHPNV+QFLG+ + I TEY+P+G L + L + L+ S ++ +D A+G+
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T T C + +PE
Sbjct: 485 YLHNSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 540
Query: 220 VFKNEEYDTKVDVFSFALILQEMIE------GCPPFTMKHDNEVPKAYAARQRPPF--KA 271
V +++ Y K DV+SF +IL E G PPF + + RPP
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQV-----IFAVGREGMRPPVPQNG 595
Query: 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311
P K +L+ +C NE P+ RPT Q + RLESI++S
Sbjct: 596 PPKYI-----QLLIDCLNENPSHRPTMEQCLERLESIDSS 630
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 160 bits (405), Expect = 1e-38, Method: Composition-based stats.
Identities = 111/298 (37%), Positives = 154/298 (51%), Gaps = 43/298 (14%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 98
EYEID +EL+F + I KG F +WR VA+K + + + F++E+ +
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164
Query: 99 LQKIRHPNVVQFLGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGAL---KPSTAVRFALD 153
L K+RHPNVVQFLGA T IVTE++ G LR FL L P ++ ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRD---DSGN----------LKVADFGVSKLLTV 200
IA+GMNYLH P PI+HRDL NIL D D N K++DFG+S+L
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM- 2282
Query: 201 KEDRPLTCQDTSC-RYVAPEVFKNEEYDTKVDVFSFALILQEMI------EGCPPFTMKH 253
E Q C Y+APEVFK + K DV+S+ ++L E++ + P M H
Sbjct: 2283 -EQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 254 DNEVPKAYAARQRP-PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310
AY + + P P +K KE++ +CW+ P RPTF+QII L+ + +
Sbjct: 2342 ----LAAYESYRPPIPLTTSSK-----WKEILTQCWDSNPDSRPTFKQIIVHLKEMED 2390
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (401), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 102/276 (36%), Positives = 152/276 (55%), Gaps = 27/276 (9%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
+ID ++ V I KG F L WRG QVAVKKL I +++ ++ F E+ L++
Sbjct: 385 DIDTQQIKI--GVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 441
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 159
+RHPNV+QFLG+ S + I TEY+P+G L + L K + S R +D A+G+
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGII 501
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T T C + +PE
Sbjct: 502 YLHGSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 557
Query: 220 VFKNEEYDTKVDVFSFALILQEMIE------GCPPFTMKHDNEVPKAYAARQRPPFKAPA 273
V +++ Y K DV+SF +IL E G PPF + A R + P
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPF---------QVIFAVGREGMRPPT 608
Query: 274 KLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESI 308
Y +L+++C NE P++RPT Q + LESI
Sbjct: 609 PKYGPPKYIQLLKDCLNENPSQRPTMEQCLEILESI 644
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 7e-38, Method: Compositional matrix adjust.
Identities = 96/256 (37%), Positives = 143/256 (55%), Gaps = 18/256 (7%)
Query: 67 FWRGI----QVAVKKLGEEVISDDDRVR---AFRDELALLQKIRHPNVVQFLGAVTQSSP 119
+RGI VAVK + ++ R + F+ E+ALL ++ HPN+VQF+ A +
Sbjct: 100 IYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 159
Query: 120 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
I+TEY+ +G+LR +L +K +L T +R ALDI+RGM YLH +IHRDL+ +
Sbjct: 160 YCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQG---VIHRDLKSN 216
Query: 178 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 237
N+L +D +KVADFG S L T + R + R++APE+ K + Y KVDV+SF +
Sbjct: 217 NLLLNDEMRVKVADFGTSCLET--QCREAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 274
Query: 238 ILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRP 296
+L E+ PF + A A + +RPP A + L LI+ CW+E P+KRP
Sbjct: 275 VLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQ---PALAHLIKRCWSENPSKRP 331
Query: 297 TFRQIITRLESINNSI 312
F I+ LE + +
Sbjct: 332 DFSNIVAVLEKYDECV 347
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 156 bits (395), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 86/255 (33%), Positives = 151/255 (59%), Gaps = 16/255 (6%)
Query: 57 EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 113
+I G++ + + W+ + VA+KK ++ I D++ + R+E+A L+K+ HPN++ +GA
Sbjct: 1404 QIGLGSYGVVYRGKWKNVDVAIKKFIKQKI-DENHLLGIREEIAFLKKLHHPNIITMVGA 1462
Query: 114 VTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 172
+ + IVTEY+ KG+LR ++ L+ ++ ++IA+G++YLH P PIIHR
Sbjct: 1463 SLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHSFDP-PIIHR 1521
Query: 173 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 232
D++PSNIL D++ N+K+ADFG ++ +KE+ + + + + APE+ +N+ YD KVDV
Sbjct: 1522 DIKPSNILIDENWNVKIADFGFAR---IKEENAIMTRCGTPCWTAPEIIRNDIYDEKVDV 1578
Query: 233 FSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--PFKAPAKLYARGLKELIEECWNE 290
FSF +++ E++ PF + ++ RP P P + +L+ +CW+
Sbjct: 1579 FSFGIVMWEVLTCKEPFIGANFMKITMDILEDVRPKIPQDCPEE-----FAKLMRKCWHA 1633
Query: 291 KPAKRPTFRQIITRL 305
K KRPT +I L
Sbjct: 1634 KSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 156 bits (394), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 96/271 (35%), Positives = 154/271 (56%), Gaps = 28/271 (10%)
Query: 57 EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 113
+I G++ + F W+G+ VAVKK ++ +S+ ++ FR E+A L +++H N+V F+GA
Sbjct: 1369 QIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSET-QLLEFRAEMAFLSELKHSNIVTFIGA 1427
Query: 114 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA------LDIARGMNYLHENKPV 167
+ + IVTEY+ G+LR LK P + FA A G++YLH + P+
Sbjct: 1428 CIKKPNICIVTEYMRMGNLRDVLKN-----PDIKITFANKLKLLYGAAMGIDYLHSSNPM 1482
Query: 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEY 226
I+HRD++P+NIL D+ N+K+ADFG ++ +KED +T T C + APEV + E+Y
Sbjct: 1483 -IVHRDIKPANILVDEHFNVKIADFGFAR---IKEDNTTMTRCGTPC-WTAPEVIRGEKY 1537
Query: 227 DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--PFKAPAKLYARGLKELI 284
K DVFSF +++ E++ G PF + +V RP P P + +LI
Sbjct: 1538 CEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDILEGGRPIIPSDCPHE-----FAKLI 1592
Query: 285 EECWNEKPAKRPTFRQIITRLESINNSINHK 315
++CW+ K KRPT +++ +L I +HK
Sbjct: 1593 KKCWHAKAHKRPTMTEVVQQLMLITEQFDHK 1623
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (393), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 93/260 (35%), Positives = 141/260 (54%), Gaps = 22/260 (8%)
Query: 57 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116
E+ GT WRGI VA+KK D+D + E ++ ++RHPN+ QFLG
Sbjct: 504 EVFTGT-----WRGIIVAIKKAKLLNEDDEDFLNELAQEATIMSQLRHPNICQFLGTCNN 558
Query: 117 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF------ALDIARGMNYLHENKPVPII 170
++IV EY+P G L L PS ++ + ALDIA+GMNYLH P+ +I
Sbjct: 559 PPEILIVMEYMPLGSLYRILH-----DPSISLDWPRMKSMALDIAKGMNYLHCCDPI-VI 612
Query: 171 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDT 228
HRDL+ N+L D+ +K++DFG+S D+ +T T C + APEV +N+ Y
Sbjct: 613 HRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPC-WTAPEVLRNDPYTE 671
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288
K DVFSFA++L E++ P+ ++ + + P P + LI ECW
Sbjct: 672 KADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQ--VSAPFTRLITECW 729
Query: 289 NEKPAKRPTFRQIITRLESI 308
+E P +RP+F++I+ RLE++
Sbjct: 730 SEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (392), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 93/275 (33%), Positives = 155/275 (56%), Gaps = 21/275 (7%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 95
E+ +EID +E+ + ++ G F + RG +VA+KKL + V +++ + F+ E
Sbjct: 161 EIIRWEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVF-EENTMNEFKKE 219
Query: 96 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 155
++L+ K+R+P+++ F+GA T + IVTE +PKG + + L+ K + A+ IA
Sbjct: 220 VSLMAKLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIA 279
Query: 156 R----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
R GM +LH + I+H DL+P+N+L D + +KVADFG+SK + L Q
Sbjct: 280 RDTVLGMTWLHASN---ILHLDLKPANLLVDQNWVVKVADFGLSKYMKPDSKDKLLGQAG 336
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAYAARQRP- 267
S Y+APE+ N+ YD KVDVFSF+++L E++ P+ + + V + RP
Sbjct: 337 SPLYMAPEMLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPI 396
Query: 268 -PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
P P + LK+L+ CW+ P++RP+F +I
Sbjct: 397 IPDYFPTR-----LKDLLARCWDHYPSRRPSFAEI 426
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (388), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 101/275 (36%), Positives = 157/275 (57%), Gaps = 11/275 (4%)
Query: 39 EVPEYEIDPHELDFTNSVEI-TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 97
+V E EI ++L + + + G A W G +VAVKK ++ S + FR E+
Sbjct: 658 DVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGA-ALAEFRSEVR 716
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIAR 156
+++++RHPNVV FLGAVT+ + IVTE+LP+G L L R K + ++ ALD+A
Sbjct: 717 IMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAM 776
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--R 214
GMN LH + P I+HRDL+ N+L D++ N+KV DFG+S+L K + L+ + T+
Sbjct: 777 GMNCLHTSTPT-IVHRDLKTPNLLVDNNWNVKVGDFGLSRL---KHNTFLSSKSTAGTPE 832
Query: 215 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274
++APEV +NE + K DV+SF +IL E+ P+ + +V A + R + P +
Sbjct: 833 WMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNR-RLEIPKE 891
Query: 275 LYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309
L + +I ECW P RP+F Q+ L+ +N
Sbjct: 892 LDPV-VGRIILECWQTDPNLRPSFAQLTEVLKPLN 925
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (388), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 91/261 (34%), Positives = 147/261 (56%), Gaps = 17/261 (6%)
Query: 55 SVEITKGTFILAF---WRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 109
S ++ +GTF + + WRG VA+K K+ E+V ++ + FR EL +L ++RHPN+V
Sbjct: 665 SSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDV--NNQVLEEFRKELTILSRLRHPNIVL 722
Query: 110 FLGAVTQSSPMMIVTEYLPKGDLR-AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 168
+ A T + +TEYLP G L A +K + + A+ IA+GMNYLH +
Sbjct: 723 LMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHLSG--- 779
Query: 169 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 228
+IHRD++ N+L D+ N+K+ DFG+SKL + + +T S +++PE+ E+Y
Sbjct: 780 VIHRDIKSLNLLLDEHMNVKICDFGLSKLKS--KSTEMTKSIGSPIWMSPELLMGEDYTE 837
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEEC 287
KVDV++F +IL E+ G P++ ++ A + RPP + L LI+ C
Sbjct: 838 KVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPI---PNAWPYQLSHLIQAC 894
Query: 288 WNEKPAKRPTFRQIITRLESI 308
W++ P KRP+F +I+ L I
Sbjct: 895 WHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 353 | ||||||
| 255562560 | 466 | protein kinase, putative [Ricinus commun | 0.869 | 0.658 | 0.866 | 1e-158 | |
| 356555470 | 456 | PREDICTED: probable serine/threonine-pro | 0.875 | 0.677 | 0.841 | 1e-157 | |
| 356549162 | 455 | PREDICTED: probable serine/threonine-pro | 0.872 | 0.676 | 0.844 | 1e-156 | |
| 224076914 | 423 | predicted protein [Populus trichocarpa] | 0.855 | 0.713 | 0.837 | 1e-151 | |
| 225443668 | 462 | PREDICTED: dual specificity protein kina | 0.875 | 0.668 | 0.811 | 1e-150 | |
| 449459316 | 458 | PREDICTED: serine/threonine-protein kina | 0.875 | 0.674 | 0.792 | 1e-145 | |
| 449500828 | 352 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.875 | 0.877 | 0.789 | 1e-143 | |
| 356499380 | 454 | PREDICTED: dual specificity protein kina | 0.883 | 0.687 | 0.765 | 1e-140 | |
| 356553484 | 453 | PREDICTED: serine/threonine-protein kina | 0.883 | 0.688 | 0.753 | 1e-138 | |
| 449433589 | 460 | PREDICTED: probable serine/threonine-pro | 0.872 | 0.669 | 0.782 | 1e-137 |
| >gi|255562560|ref|XP_002522286.1| protein kinase, putative [Ricinus communis] gi|223538539|gb|EEF40144.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 562 bits (1449), Expect = e-158, Method: Compositional matrix adjust.
Identities = 267/308 (86%), Positives = 287/308 (93%), Gaps = 1/308 (0%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
MAPMHV HAREVPEYEI+PHELDFTNSVEITKGTF LA WRGIQVAVKKLGE+VISD+D+
Sbjct: 145 MAPMHVNHAREVPEYEINPHELDFTNSVEITKGTFHLASWRGIQVAVKKLGEDVISDEDK 204
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
VRAF DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL KGDLRAFLK+KGAL+P TAV
Sbjct: 205 VRAFSDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLHKGDLRAFLKKKGALRPGTAV 264
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208
RF LDIARG+NYLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVSKLLTVKED+PLTC
Sbjct: 265 RFGLDIARGLNYLHENKP-PIIHRDLEPSNILRDDSGHLKVADFGVSKLLTVKEDKPLTC 323
Query: 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268
QDTSCRYVAPEVFK+EEYDTKVDVFSFALILQEMIEGCPPF+ K D EVPK+YAA++RPP
Sbjct: 324 QDTSCRYVAPEVFKHEEYDTKVDVFSFALILQEMIEGCPPFSAKQDLEVPKSYAAKERPP 383
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHN 328
F+AP K Y GLK+LI+ECWNE PAKRPTFRQIIT+LESI NSI HKRRWK+R +KCF N
Sbjct: 384 FRAPTKHYPHGLKDLIQECWNENPAKRPTFRQIITKLESIYNSIGHKRRWKVRPLKCFQN 443
Query: 329 LEAMLKKD 336
EAMLKKD
Sbjct: 444 FEAMLKKD 451
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555470|ref|XP_003546054.1| PREDICTED: probable serine/threonine-protein kinase drkB-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 260/309 (84%), Positives = 286/309 (92%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
MAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF A WRG +VAVKKLGE+VISD+++
Sbjct: 131 MAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCSALWRGTKVAVKKLGEDVISDEEK 190
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F+KRKGALKPSTAV
Sbjct: 191 VKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDFMKRKGALKPSTAV 250
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208
RFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVSKLL VKED+PLTC
Sbjct: 251 RFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVSKLLAVKEDKPLTC 310
Query: 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268
QDTSCRYVAPEVF+ EEYDTKVDVFSFALILQEMIEGCPPF+ K D+EVPK YAA++RPP
Sbjct: 311 QDTSCRYVAPEVFRQEEYDTKVDVFSFALILQEMIEGCPPFSAKQDDEVPKVYAAKERPP 370
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHN 328
F+APAK Y+ G++ELIEECWNE PAKRPTFRQIIT+LESI N+I HKR WK+R +KCF N
Sbjct: 371 FQAPAKRYSHGIRELIEECWNENPAKRPTFRQIITKLESIYNTIGHKRHWKVRPLKCFQN 430
Query: 329 LEAMLKKDH 337
LEA+LK+DH
Sbjct: 431 LEALLKRDH 439
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549162|ref|XP_003542966.1| PREDICTED: probable serine/threonine-protein kinase drkA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1434), Expect = e-156, Method: Compositional matrix adjust.
Identities = 261/309 (84%), Positives = 287/309 (92%), Gaps = 1/309 (0%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
MAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF +A WRG +VAVKKLGE+VISD+++
Sbjct: 131 MAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCIALWRGTEVAVKKLGEDVISDEEK 190
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR FLKRKGALKPSTAV
Sbjct: 191 VKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDFLKRKGALKPSTAV 250
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208
RFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVSKLL VKED+PLTC
Sbjct: 251 RFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVSKLLAVKEDKPLTC 310
Query: 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268
DTSCRYVAPEVF+ +EYDTKVDVFSFALILQEMIEGCPPF+ K DNEVPK YAA++RPP
Sbjct: 311 HDTSCRYVAPEVFR-QEYDTKVDVFSFALILQEMIEGCPPFSAKQDNEVPKVYAAKERPP 369
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHN 328
F+APAK Y+ G++ELIEECWNE PAKRPTFRQIITRLESI N+I+HKR WK+R +KCF N
Sbjct: 370 FRAPAKHYSYGIRELIEECWNENPAKRPTFRQIITRLESIYNTISHKRHWKVRPLKCFQN 429
Query: 329 LEAMLKKDH 337
LEA+LK+DH
Sbjct: 430 LEALLKRDH 438
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076914|ref|XP_002305047.1| predicted protein [Populus trichocarpa] gi|222848011|gb|EEE85558.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1389), Expect = e-151, Method: Compositional matrix adjust.
Identities = 253/302 (83%), Positives = 278/302 (92%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
MAPMHVKHAREVPEYEI+P ELDFTNSVE+TKGTF +A WRGIQVAVKKLGEEV+SD+D+
Sbjct: 122 MAPMHVKHAREVPEYEINPDELDFTNSVELTKGTFCVALWRGIQVAVKKLGEEVLSDEDK 181
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE+LPKGD AFLKRKGALKP AV
Sbjct: 182 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEFLPKGDFCAFLKRKGALKPIAAV 241
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208
R ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG+LKVADFG+SKLLTVKE++PL
Sbjct: 242 RLALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGHLKVADFGISKLLTVKEEKPLIS 301
Query: 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268
D S RYVAPEVFKNEEYDTKVD+FSFALILQEMIEGCPPF+ K ++EVP AYAA++RPP
Sbjct: 302 LDNSWRYVAPEVFKNEEYDTKVDIFSFALILQEMIEGCPPFSAKQEHEVPSAYAAKERPP 361
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHN 328
F+AP K YA GLKELI+ECW+E PAKRPTFRQI+TRL++I NSI HKRRWK+R +KCF N
Sbjct: 362 FRAPTKSYAHGLKELIQECWHENPAKRPTFRQILTRLDAIQNSIGHKRRWKVRPLKCFQN 421
Query: 329 LE 330
LE
Sbjct: 422 LE 423
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225443668|ref|XP_002263226.1| PREDICTED: dual specificity protein kinase shkB [Vitis vinifera] gi|297740576|emb|CBI30758.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 536 bits (1380), Expect = e-150, Method: Compositional matrix adjust.
Identities = 254/313 (81%), Positives = 282/313 (90%), Gaps = 4/313 (1%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
MAPMHV +AREVPEYEIDP ELDFTNSV+ITKGT+ +A WRGIQVAVK+LG+EVI D+D+
Sbjct: 136 MAPMHVNNAREVPEYEIDPKELDFTNSVDITKGTYRIASWRGIQVAVKRLGDEVIIDEDK 195
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V+AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL AFLKRKGALK +TAV
Sbjct: 196 VKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLHAFLKRKGALKTATAV 255
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL----TVKEDR 204
+FALDIARGMNYLHE++P IIHRDLEPSNILRDDSG+LKVADFGVSKLL TVKED
Sbjct: 256 KFALDIARGMNYLHEHRPEAIIHRDLEPSNILRDDSGHLKVADFGVSKLLKVANTVKEDY 315
Query: 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 264
PL CQ+TSCRY+APEVFKNE YDTKVDVFSFALILQEMIEGCPPF+ K +NEVPK YAA+
Sbjct: 316 PLICQETSCRYLAPEVFKNEAYDTKVDVFSFALILQEMIEGCPPFSAKPENEVPKVYAAQ 375
Query: 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMK 324
+RPPF+AP+KLY+ GLKELIEECWNE P KRPTF QI+TRL+ I N + KRRWK+R +K
Sbjct: 376 ERPPFRAPSKLYSHGLKELIEECWNENPTKRPTFGQILTRLDRIYNHLGQKRRWKVRPLK 435
Query: 325 CFHNLEAMLKKDH 337
CF NLEAM KKDH
Sbjct: 436 CFQNLEAMWKKDH 448
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449459316|ref|XP_004147392.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 245/309 (79%), Positives = 277/309 (89%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
MAPMHVKHAREVPEYEIDP E DFTNSV +TKGTF LA WRGIQVAVK+L E+VIS++D+
Sbjct: 135 MAPMHVKHAREVPEYEIDPKEFDFTNSVNLTKGTFHLASWRGIQVAVKELPEDVISEEDK 194
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL L +KG LKP AV
Sbjct: 195 VNAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCQLLHKKGPLKPIVAV 254
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208
+FALDIARGMNYLHENKP PIIHRDLEPSNILRDD+GNLKVADFGVSKLLTVKED+PLTC
Sbjct: 255 KFALDIARGMNYLHENKPAPIIHRDLEPSNILRDDTGNLKVADFGVSKLLTVKEDKPLTC 314
Query: 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268
QDT+CRYVAPEVFKN YDTKVDVFSFALILQEMIEG PPF+ K +N + K YAA RPP
Sbjct: 315 QDTACRYVAPEVFKNNGYDTKVDVFSFALILQEMIEGQPPFSNKKENAICKGYAAGMRPP 374
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHN 328
FKAPAK YA G+KELIE CW+E+P+KRPTFRQIITRLE+I++S++H+RRWK+ T++CF +
Sbjct: 375 FKAPAKCYAHGIKELIEACWDERPSKRPTFRQIITRLETIHHSLSHRRRWKLPTLRCFQD 434
Query: 329 LEAMLKKDH 337
+A +++DH
Sbjct: 435 PDAKIRRDH 443
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449500828|ref|XP_004161205.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1325), Expect = e-143, Method: Compositional matrix adjust.
Identities = 244/309 (78%), Positives = 275/309 (88%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
MAPMHVKHAREVPEYEIDP E DFTNSV +TKGTF LA WRGIQVAVK+L E+VIS++D+
Sbjct: 29 MAPMHVKHAREVPEYEIDPKEFDFTNSVNLTKGTFHLASWRGIQVAVKELPEDVISEEDK 88
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL L +KG LKP AV
Sbjct: 89 VNAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCQLLHKKGPLKPIVAV 148
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208
+FALDIARGMNYLHENKP PIIHRDLEPSNILRDD+GNLKVADFGVSKLLTVKED+PLTC
Sbjct: 149 KFALDIARGMNYLHENKPAPIIHRDLEPSNILRDDTGNLKVADFGVSKLLTVKEDKPLTC 208
Query: 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268
QDT+CRYVAPEVFKN YDTKVDVFSFALILQEMIEG PPF+ K + K YAA RPP
Sbjct: 209 QDTACRYVAPEVFKNNGYDTKVDVFSFALILQEMIEGQPPFSNKKKMXICKGYAAGMRPP 268
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHN 328
FKAPAK YA G+KELIE CW+E+P+KRPTFRQIITRLE+I++S++H+RRWK+ T++CF +
Sbjct: 269 FKAPAKCYAHGIKELIEACWDERPSKRPTFRQIITRLETIHHSLSHRRRWKLPTLRCFQD 328
Query: 329 LEAMLKKDH 337
+A +++DH
Sbjct: 329 PDAKIRRDH 337
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499380|ref|XP_003518519.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 504 bits (1299), Expect = e-140, Method: Compositional matrix adjust.
Identities = 242/316 (76%), Positives = 272/316 (86%), Gaps = 4/316 (1%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRG QVAVK LGEE+ +DDD+
Sbjct: 129 MAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGTQVAVKTLGEELFTDDDK 188
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V+AF DEL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDLRA+LKRKGALKP TAV
Sbjct: 189 VKAFHDELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLRAYLKRKGALKPVTAV 248
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL----TVKEDR 204
+FALDIARGMNYLHE+KP IIHRDLEPSNILRDDSG+LKVADFGVSKLL TVKED+
Sbjct: 249 KFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKLLKVAKTVKEDK 308
Query: 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 264
P+T DTS RYVAPEV+KNEEYDTKVDVFSFALILQEMIEGCPPF K +NEVPKAY
Sbjct: 309 PVTSLDTSWRYVAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFYEKPENEVPKAYVEN 368
Query: 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMK 324
+RPPF+A KLYA GLK+LIEECW+EKP +RPTFRQII RLE I + KRRWK+R
Sbjct: 369 ERPPFRASPKLYAYGLKQLIEECWDEKPYRRPTFRQIIGRLEDIYYHLAQKRRWKVRAPG 428
Query: 325 CFHNLEAMLKKDHSSP 340
CF NLE + + + ++P
Sbjct: 429 CFQNLEVIFRGNRTNP 444
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553484|ref|XP_003545086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1276), Expect = e-138, Method: Compositional matrix adjust.
Identities = 238/316 (75%), Positives = 269/316 (85%), Gaps = 4/316 (1%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRGIQVAVK LGEE+ +DDD+
Sbjct: 128 MAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGIQVAVKTLGEELFTDDDK 187
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V+AF EL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDL A+LKRKGALKP TAV
Sbjct: 188 VKAFHYELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLGAYLKRKGALKPVTAV 247
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL----TVKEDR 204
+FALDIARGMNYLHE+KP IIHRDLEPSNILRDDSG+LKVADFGVSKLL VKED+
Sbjct: 248 KFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKLLKVAKMVKEDK 307
Query: 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 264
P+ DTS RYVAPEV++NEEYDT VDVFSFALILQEMIEGCPPF K +NEVPKAY
Sbjct: 308 PVASLDTSWRYVAPEVYRNEEYDTNVDVFSFALILQEMIEGCPPFFAKPENEVPKAYVEN 367
Query: 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMK 324
+RPPF+A KLYA GLK+LIEECW+EKP +RPTFRQII RLE I + KR WK+RT
Sbjct: 368 ERPPFRASPKLYAYGLKQLIEECWDEKPYRRPTFRQIIGRLEDIYYHLAQKRGWKVRTPG 427
Query: 325 CFHNLEAMLKKDHSSP 340
CF NLEA+ + + ++P
Sbjct: 428 CFQNLEAIFRGNRTNP 443
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433589|ref|XP_004134580.1| PREDICTED: probable serine/threonine-protein kinase drkD-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 494 bits (1272), Expect = e-137, Method: Compositional matrix adjust.
Identities = 241/308 (78%), Positives = 265/308 (86%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
+APM VK+AREVP+YEIDP ELDFTNSV ITKGTF A WRG +VAVK+LGE++ +D+++
Sbjct: 135 VAPMLVKNAREVPDYEIDPKELDFTNSVNITKGTFRRASWRGTEVAVKELGEDLFTDEEK 194
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
VRAFRDELALLQKIRHPNVVQFLGAVTQS PMMIVTEYLPKGDL A L RK +K + V
Sbjct: 195 VRAFRDELALLQKIRHPNVVQFLGAVTQSWPMMIVTEYLPKGDLGALLSRKREIKTMSVV 254
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208
R ALDIARGMNYLHENKP PIIHR+LEPSNILRDDSG+LKVADFGVSKLLTVKED+ TC
Sbjct: 255 RLALDIARGMNYLHENKPAPIIHRNLEPSNILRDDSGHLKVADFGVSKLLTVKEDKFSTC 314
Query: 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268
+TS RY APEVFKNEEYDTKVDVFSFALILQEM+EGC PF K D+EVPK YAA +RPP
Sbjct: 315 SETSRRYQAPEVFKNEEYDTKVDVFSFALILQEMLEGCSPFPDKADSEVPKLYAAGERPP 374
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHN 328
F A K YA GLKELIEECWNEKP KRPTFRQIIT+LE I N HKRRWK+R +KCF N
Sbjct: 375 FGALIKRYANGLKELIEECWNEKPNKRPTFRQIITQLEFIYNRFCHKRRWKVRPLKCFQN 434
Query: 329 LEAMLKKD 336
+EAMLKKD
Sbjct: 435 IEAMLKKD 442
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 353 | ||||||
| TAIR|locus:2117129 | 459 | AT4G18950 [Arabidopsis thalian | 0.920 | 0.708 | 0.718 | 3.9e-124 | |
| TAIR|locus:2098999 | 471 | AT3G58760 [Arabidopsis thalian | 0.875 | 0.656 | 0.684 | 5.3e-111 | |
| TAIR|locus:2044034 | 479 | AT2G43850 [Arabidopsis thalian | 0.818 | 0.603 | 0.494 | 1.1e-71 | |
| TAIR|locus:2045258 | 476 | AT2G31800 [Arabidopsis thalian | 0.818 | 0.607 | 0.484 | 2.4e-69 | |
| TAIR|locus:2080517 | 477 | AT3G59830 [Arabidopsis thalian | 0.818 | 0.605 | 0.488 | 2.4e-67 | |
| TAIR|locus:2014849 | 438 | VIK "VH1-interacting kinase" [ | 0.784 | 0.632 | 0.5 | 1.2e-65 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.804 | 0.498 | 0.359 | 1.7e-43 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.747 | 0.483 | 0.372 | 2.2e-43 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.733 | 0.338 | 0.365 | 4.7e-38 | |
| DICTYBASE|DDB_G0289791 | 642 | drkA "DRK subfamily protein ki | 0.725 | 0.398 | 0.374 | 6.8e-38 |
| TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1220 (434.5 bits), Expect = 3.9e-124, P = 3.9e-124
Identities = 235/327 (71%), Positives = 269/327 (82%)
Query: 11 YKELCVCTVSSYCELIFQMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRG 70
YK + V + MAPMHVK AREVPEYEI+P ELDFT S EITKGT+ +A WRG
Sbjct: 119 YKNIDVIKILEIHGAKHPMAPMHVKTAREVPEYEINPSELDFTQSKEITKGTYCMAMWRG 178
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
IQVAVKKL +EV+SDDD+VR F DELALLQ++RHPN+VQFLGAVTQS+PMMIVTEYLP+G
Sbjct: 179 IQVAVKKLDDEVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRG 238
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
DLR LKRKG LKP+TAVR+ALDIARGM+YLHE K PIIHRDLEPSNILRDDSG+LKVA
Sbjct: 239 DLRELLKRKGQLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPSNILRDDSGHLKVA 298
Query: 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
DFGVSKL+TVKED+P TCQD SCRY+APEVF +EEYDTK DVFSFALI+QEMIEG PF
Sbjct: 299 DFGVSKLVTVKEDKPFTCQDISCRYIAPEVFTSEEYDTKADVFSFALIVQEMIEGRMPFA 358
Query: 251 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310
K D+E +AYA + RP FKAP+K Y GLK LIEECW+EKPAKRPTFR+II RLESI +
Sbjct: 359 EKEDSEASEAYAGKHRPLFKAPSKNYPHGLKTLIEECWHEKPAKRPTFREIIKRLESILH 418
Query: 311 SINHKRRWKIRTMKCFHNLEAMLKKDH 337
+ HKR+W++R + CF N E KK H
Sbjct: 419 HMGHKRQWRMRPLTCFQNFEH--KKKH 443
|
|
| TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1096 (390.9 bits), Expect = 5.3e-111, P = 5.3e-111
Identities = 215/314 (68%), Positives = 252/314 (80%)
Query: 29 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 88
+APMHV +EVPEYEI P ELDF+NSV+I+KGTF A WRGI VAVK GEE+ +D+D+
Sbjct: 143 IAPMHVLTDKEVPEYEIHPTELDFSNSVKISKGTFNKASWRGIDVAVKTFGEEMFTDEDK 202
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V AFRDELALLQKIRHPNVVQFLGAVTQS+PMMIVTEYLPKGDLR +L RKG L P+ AV
Sbjct: 203 VNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRQYLDRKGPLMPAHAV 262
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL----TVKEDR 204
+FAL+IARGMNYLHE+KP IIH DLEP NILRDDSG+LKVADFGVSKLL TVK+DR
Sbjct: 263 KFALEIARGMNYLHEHKPEAIIHCDLEPPNILRDDSGHLKVADFGVSKLLVVKKTVKKDR 322
Query: 205 PL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 263
P+ TC D+S RY+APEV++NEEYDTKVDVFSFALILQEMIEGC PF D EVPKAY
Sbjct: 323 PVVTCLDSSWRYMAPEVYRNEEYDTKVDVFSFALILQEMIEGCEPFHEIEDREVPKAYIE 382
Query: 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTM 323
+RPPF AP K Y GL+ELI++CW+++ +KRPTFR II+ LE I++ I KR WK+
Sbjct: 383 DERPPFNAPTKSYPFGLQELIQDCWDKEASKRPTFRVIISTLELISDRIARKRSWKVMLG 442
Query: 324 KCFHNLEAMLKKDH 337
+C K+D+
Sbjct: 443 RCLPRFRLFTKRDY 456
|
|
| TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 725 (260.3 bits), Expect = 1.1e-71, P = 1.1e-71
Identities = 146/295 (49%), Positives = 197/295 (66%)
Query: 31 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVR 90
PM V + REVPEYE++P E+ S I+KG + +A W G +V+VK L ++ SD +R+
Sbjct: 177 PMTVSNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTRVSVKILDKDSYSDPERIN 236
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 150
AFR EL LL+K+RHPNV+QF+GAVTQ+ PMMIV EY PKGDL +L++KG L PS A+RF
Sbjct: 237 AFRHELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYLQKKGRLSPSKALRF 296
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ- 209
ALDIARGMNYLHE KP PIIH DL+P NIL D G LK++ FG+ +L + +D+
Sbjct: 297 ALDIARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFGMIRLSKISQDKAKVANH 356
Query: 210 ----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR- 264
D S Y+APEV+K+E +D +VD SF +IL E+ EG P F + EV +
Sbjct: 357 KAHIDLSNYYIAPEVYKDEIFDLRVDAHSFGVILYEITEGVPVFHPRPPEEVARMMCLEG 416
Query: 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWK 319
+RP FK ++ Y +KELIE+CW+ + RPTF +II RL+ I + + + WK
Sbjct: 417 KRPVFKTKSRSYPPDIKELIEKCWHPEAGIRPTFSEIIIRLDKIVANCSKQGWWK 471
|
|
| TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 703 (252.5 bits), Expect = 2.4e-69, P = 2.4e-69
Identities = 143/295 (48%), Positives = 193/295 (65%)
Query: 31 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVR 90
PM V + REVPEYE++P EL + I+KG + +A W G +V+VK L +++ D D +
Sbjct: 174 PMVVANPREVPEYELNPQELQVRKADGISKGIYQVAKWNGTKVSVKILDKDLYKDSDTIN 233
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 150
AF+ EL L +K+RHPNVVQF+GAVTQ+ PMMIV+EY PKGDL ++L++KG L P+ +RF
Sbjct: 234 AFKHELTLFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQKKGRLSPAKVLRF 293
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ- 209
ALDIARGMNYLHE KP P+IH DL+P NI+ D G+LKVA FG+ + D+
Sbjct: 294 ALDIARGMNYLHECKPEPVIHCDLKPKNIMLDSGGHLKVAGFGLISFAKLSSDKSKILNH 353
Query: 210 ----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR- 264
D S +APEV+K+E +D VD +SF ++L EMIEG PF K E K
Sbjct: 354 GAHIDPSNYCMAPEVYKDEIFDRSVDSYSFGVVLYEMIEGVQPFHPKPPEEAVKLMCLEG 413
Query: 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWK 319
+RP FKA +K + ++ELIEECW+ + RPTF +II RL+ I + + WK
Sbjct: 414 RRPSFKAKSKSCPQEMRELIEECWDTETFVRPTFSEIIVRLDKIFVHCSKQGWWK 468
|
|
| TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 684 (245.8 bits), Expect = 2.4e-67, P = 2.4e-67
Identities = 144/295 (48%), Positives = 190/295 (64%)
Query: 31 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVR 90
PM V + +EVPEYE++P EL I+KGT+ +A W G +V+VK ++ SD +RV
Sbjct: 175 PMTVGNPKEVPEYELNPLELQVRKVDGISKGTYQVAKWNGTRVSVKIFDKDSYSDPERVN 234
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 150
AF +EL LL K RHPN+VQF+GAVTQ+ PMMIV E PKGDL +L++KG L PS A+RF
Sbjct: 235 AFTNELTLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQKKGRLSPSKALRF 294
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ- 209
ALDIARGMNYLHE KP PIIH +L P NIL D G LK++ FG+ KL + ED
Sbjct: 295 ALDIARGMNYLHECKPDPIIHCELMPKNILLDRGGQLKISGFGLIKLSKIGEDSAKVVNH 354
Query: 210 ----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR- 264
D S Y+APE++K+E +D + DV SF +IL E+ EG F K EV ++
Sbjct: 355 EAQIDKSNYYIAPEIYKDEVFDKRADVHSFGVILYELTEGVSLFHPKPPEEVAESICIEG 414
Query: 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWK 319
+RP + +K Y LKELIEECW+ + + RP F +II RL+ I + + + WK
Sbjct: 415 KRPTIRTKSKSYPPELKELIEECWHPEISVRPIFSEIIIRLDKIVTNCSKQGWWK 469
|
|
| TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 1.2e-65, P = 1.2e-65
Identities = 145/290 (50%), Positives = 192/290 (66%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRV-RAFRDELA 97
++EI+P ELDF+N+ I KG+F + A+WRG VAVK++ +SDD V + FR E+
Sbjct: 152 DWEIEPAELDFSNAAMIGKGSFGEIVKAYWRGTPVAVKRILPS-LSDDRLVIQDFRHEVD 210
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 157
LL K+RHPN+VQFLGAVT+ P+M++TEYL GDL +LK KG L P+TAV FALDIARG
Sbjct: 211 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHQYLKEKGGLTPTTAVNFALDIARG 270
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVKEDRP---LTCQDTS 212
M YLH N+P IIHRDL+P N+L +S +LKV DFG+SKL+ V+ +T + S
Sbjct: 271 MTYLH-NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 329
Query: 213 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 272
RY+APEVFK+ YD KVDVFSFA+IL EM+EG PPF E K + RP F++
Sbjct: 330 YRYMAPEVFKHRRYDKKVDVFSFAMILYEMLEGEPPFANHEPYEAAKHVSDGHRPTFRS- 388
Query: 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRT 322
K L+ELI +CW+ +RP+F I+ RLE I ++ W + T
Sbjct: 389 -KGCTPDLRELIVKCWDADMNQRPSFLDILKRLEKIKETLPSDHHWGLFT 437
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 459 (166.6 bits), Expect = 1.7e-43, P = 1.7e-43
Identities = 107/298 (35%), Positives = 172/298 (57%)
Query: 42 EYEIDPHELDFTNSVEI-TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
E+EID +L V + G + +VA+K L E ++ + +R F E+ +++
Sbjct: 284 EWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILKPERVNAE-MLREFSQEVYIMR 342
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 159
K+RH NVVQF+GA T+S + IVTE++ +G + FL K KG K + ++ ALD+++GMN
Sbjct: 343 KVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMN 402
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YLH+N IIHRDL+ +N+L D+ +KVADFGV+++ T E +T + + R++APE
Sbjct: 403 YLHQNN---IIHRDLKTANLLMDEHEVVKVADFGVARVQT--ESGVMTAETGTYRWMAPE 457
Query: 220 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279
V +++ YD + DVFS+A++L E++ G P++ + + P K P + + +
Sbjct: 458 VIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRP-KIPKETHPK- 515
Query: 280 LKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDH 337
L EL+E+CW + PA RP F +II L + + R K + F L KK H
Sbjct: 516 LTELLEKCWQQDPALRPNFAEIIEMLNQLIREVGDDERHKDKHGGYFSGL----KKGH 569
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 458 (166.3 bits), Expect = 2.2e-43, P = 2.2e-43
Identities = 102/274 (37%), Positives = 167/274 (60%)
Query: 42 EYEIDPHELDFTNSVEI-TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
E+EID +L V + G + +VA+K L + ++++ +R F E+ +++
Sbjct: 278 EWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLKPDRVNNE-MLREFSQEVFIMR 336
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 159
K+RH NVVQFLGA T+S + IVTE++ +G + FL K+K A K T ++ ALD+A+GM+
Sbjct: 337 KVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKGMS 396
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YLH+N IIHRDL+ +N+L D+ G +KVADFGV+++ E +T + + R++APE
Sbjct: 397 YLHQNN---IIHRDLKTANLLMDEHGLVKVADFGVARVQI--ESGVMTAETGTYRWMAPE 451
Query: 220 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279
V +++ Y+ K DVFS+A++L E++ G P+ + + P K P K + +
Sbjct: 452 VIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRP-KIPKKTHPK- 509
Query: 280 LKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313
+K L+E CW++ P +RP F +II L+ I +N
Sbjct: 510 VKGLLERCWHQDPEQRPLFEEIIEMLQQIMKEVN 543
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 415 (151.1 bits), Expect = 4.7e-38, P = 4.7e-38
Identities = 99/271 (36%), Positives = 158/271 (58%)
Query: 42 EYEIDPHELDFTNSV-EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
+YEI +L + + + GT W G VAVK ++ S++ + +F+ E++L++
Sbjct: 479 DYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEI-ITSFKQEVSLMK 537
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMN 159
++RHPNV+ F+GAV + IVTE+LP+G L L+R K L + A DIARGMN
Sbjct: 538 RLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGMN 597
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-RYVAP 218
YLH P PIIHRDL+ SN+L D + +KVADFG+S+ +K + LT +++AP
Sbjct: 598 YLHHCSP-PIIHRDLKSSNLLVDRNWTVKVADFGLSR---IKHETYLTTNGRGTPQWMAP 653
Query: 219 EVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYA 277
EV +NE D K DV+SF ++L E++ P+ + +V A QR + P +
Sbjct: 654 EVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQR--LEVPKDVDP 711
Query: 278 RGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ + L+E CW+ +P RP+F++++ +L +
Sbjct: 712 QWIA-LMESCWHSEPQCRPSFQELMDKLREL 741
|
|
| DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 410 (149.4 bits), Expect = 6.8e-38, P = 6.8e-38
Identities = 103/275 (37%), Positives = 157/275 (57%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
+ID H++ V I KG + L WRG QVAVKKL I+++ ++ F E+ L++
Sbjct: 368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENI-LKEFHREINLMK 424
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMN 159
+RHPNV+QFLG+ + I TEY+P+G L + L + L+ S ++ +D A+G+
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T T C + +PE
Sbjct: 485 YLHNSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 540
Query: 220 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPF--KAPAKLY 276
V +++ Y K DV+SF +IL E P+ +V A RPP P K Y
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPK-Y 599
Query: 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311
+L+ +C NE P+ RPT Q + RLESI++S
Sbjct: 600 I----QLLIDCLNENPSHRPTMEQCLERLESIDSS 630
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.IV.2537.1 | hypothetical protein (423 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 353 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-67 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-65 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-64 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-63 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-63 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-48 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-46 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-42 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-42 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-40 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-38 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-38 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-37 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-37 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-37 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-37 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-36 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-36 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-35 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-35 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-34 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-34 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-33 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-33 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-32 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-32 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-32 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-31 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-31 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-31 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-31 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-30 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-30 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-30 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-30 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-30 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-30 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-30 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-30 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-29 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-29 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-29 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-29 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-28 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-28 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-27 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-27 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-27 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-27 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-26 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-26 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-25 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-25 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-25 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-24 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-24 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-23 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-23 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-23 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-23 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-23 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-22 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-22 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-20 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-20 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-20 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-19 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-18 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-18 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-17 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-14 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-14 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-14 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-12 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 1e-67
Identities = 82/266 (30%), Positives = 136/266 (51%), Gaps = 30/266 (11%)
Query: 57 EITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 107
++ +G F +G +VAVK L E + ++ F +E ++++K+ HPN+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLSHPNI 63
Query: 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKP 166
V+ LG TQ P+ IVTEY+P GDL FL++ G L ++ AL IA+GM YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN- 122
Query: 167 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFK 222
+HRDL N L ++ +K++DFG+S+ + + + +++APE K
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY---YRKRGGGKLPIKWMAPESLK 177
Query: 223 NEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARG 279
+ ++ +K DV+SF ++L E+ P+ + EV + R P P +LY
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELY--- 234
Query: 280 LKELIEECWNEKPAKRPTFRQIITRL 305
EL+ +CW P RPTF +++ L
Sbjct: 235 --ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 4e-65
Identities = 82/253 (32%), Positives = 129/253 (50%), Gaps = 36/253 (14%)
Query: 68 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127
+ ++VAVK L E+ + + ++ F E +++K+ HPNVV+ LG T+ P+ IV EY+
Sbjct: 26 KKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYM 83
Query: 128 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
GDL ++L K + L S + FAL IARGM YL IHRDL N L ++
Sbjct: 84 EGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLV 140
Query: 187 LKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239
+K++DFG+S+ L + P+ R++APE K ++ +K DV+SF ++L
Sbjct: 141 VKISDFGLSRDLYDDDYYRKRGGKLPI-------RWMAPESLKEGKFTSKSDVWSFGVLL 193
Query: 240 QEMI-------EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 292
E+ G + + Y R P P +LY +L+ +CW E P
Sbjct: 194 WEIFTLGEQPYPGMSNEEVLEY--LKNGY--RLPQPPNCPPELY-----DLMLQCWAEDP 244
Query: 293 AKRPTFRQIITRL 305
RPTF +++ L
Sbjct: 245 EDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 203 bits (520), Expect = 4e-64
Identities = 86/267 (32%), Positives = 133/267 (49%), Gaps = 43/267 (16%)
Query: 61 GTFILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 114
G +G ++VAVK L E+ + + ++ F E +++K+ HPN+V+ LG
Sbjct: 13 GEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIVKLLGVC 70
Query: 115 TQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 172
T+ P+MIV EY+P GDL +L+ R L S + FAL IARGM YL IHR
Sbjct: 71 TEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHR 127
Query: 173 DLEPSNILRDDSGNLKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEE 225
DL N L ++ +K++DFG+S+ L + P+ R++APE K +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI-------RWMAPESLKEGK 180
Query: 226 YDTKVDVFSFALILQEMI-------EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278
+ +K DV+SF ++L E+ G + + K Y R P P +LY
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY--LKKGY--RLPKPPNCPPELY-- 234
Query: 279 GLKELIEECWNEKPAKRPTFRQIITRL 305
+L+ +CW E P RPTF +++ L
Sbjct: 235 ---KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 202 bits (517), Expect = 1e-63
Identities = 84/266 (31%), Positives = 134/266 (50%), Gaps = 29/266 (10%)
Query: 57 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116
E+ KG + +VAVK L E+ + ++ + F E +++K+ HPNVV+ LG T+
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE 67
Query: 117 SSPMMIVTEYLPKGDLRAFLKR---------KGALKPSTAVRFALDIARGMNYLHENKPV 167
P+ +V EY+ GDL +L++ K L + FA+ IA+GM YL K
Sbjct: 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-- 125
Query: 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKN 223
+HRDL N L + +K++DFG+S+ + + + T R++APE K+
Sbjct: 126 -FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWMAPESLKD 181
Query: 224 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGL 280
+ +K DV+SF ++L E+ G P+ + EV + R P P +LY
Sbjct: 182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY---- 237
Query: 281 KELIEECWNEKPAKRPTFRQIITRLE 306
EL+ CW P RPTF +++ RLE
Sbjct: 238 -ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 2e-63
Identities = 92/259 (35%), Positives = 138/259 (53%), Gaps = 14/259 (5%)
Query: 52 FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 106
+ ++ G+F A + G VAVK L + A R E+ +L+++ HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 107 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKP 166
+V+ + A + +V EY GDL +L R G L A + AL I RG+ YLH N
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 167 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEE 225
IIHRDL+P NIL D++G +K+ADFG++K L K LT + Y+APEV
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 226 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG---LKE 282
Y KVDV+S +IL E++ G PPF+ ++ + + PP + ++ G K+
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 283 LIEECWNEKPAKRPTFRQI 301
LI++C N+ P+KRPT +I
Sbjct: 236 LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 1e-60
Identities = 79/255 (30%), Positives = 129/255 (50%), Gaps = 22/255 (8%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
++ +G+F LA + G VA+K + ++ I D E+ +L+K++HPN+V+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNIVRLY 63
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ +V EY GDL LK++G L A + I + YLH I+H
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVH 120
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 228
RDL+P NIL D+ G++K+ADFG+++ L E T Y+APEV + Y
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKL-----TTFVGTPEYMAPEVLLGKGYGK 175
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEE 286
VD++S +IL E++ G PPF D+++ + + + +PPF P + K+LI +
Sbjct: 176 AVDIWSLGVILYELLTGKPPF--PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233
Query: 287 CWNEKPAKRPTFRQI 301
+ P KR T +
Sbjct: 234 LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 7e-54
Identities = 79/256 (30%), Positives = 118/256 (46%), Gaps = 49/256 (19%)
Query: 58 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 112
+ +G F LA + G +VA+K + + + E+ +L+K+ HPN+V+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 113 AVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ + +V EY G L+ LK L +R L I G+ YLH N IIH
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115
Query: 172 RDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTK 229
RDL+P NIL D+G +K+ADFG+SKLLT + T T Y+APEV + Y K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP-AYMAPEVLLGKGYYSEK 174
Query: 230 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289
D++S +IL E+ E LK+LI +
Sbjct: 175 SDIWSLGVILYELPE-----------------------------------LKDLIRKMLQ 199
Query: 290 EKPAKRPTFRQIITRL 305
+ P KRP+ ++I+ L
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 16/232 (6%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM--IVTEYLPKG 130
+AVK + E ++ + A E+ +L ++HPN+V++ G+ I EY+ G
Sbjct: 28 MAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
L + LK+ G L ++ I G+ YLH N I+HRD++ +NIL D G +K+A
Sbjct: 87 SLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLA 143
Query: 191 DFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 248
DFG +K L + + + T ++APEV + EEY D++S + EM G PP
Sbjct: 144 DFGCAKRLGDIETGEGTGSVRGTP-YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
Query: 249 FTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 297
++ N + Y + + P P L K+ + +C P KRPT
Sbjct: 203 WSE-LGNPMAALYKIGSSGEPPEI--PEHLSE-EAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-46
Identities = 94/279 (33%), Positives = 149/279 (53%), Gaps = 36/279 (12%)
Query: 43 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 99
+ I+ EL + I KG F +L +RG +VAVK L ++ + +AF E +++
Sbjct: 1 WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVKCLKDDSTA----AQAFLAEASVM 54
Query: 100 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARG 157
+RHPN+VQ LG V Q +P+ IVTEY+ KG L +L+ +G + + + FALD+ G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CR 214
M YL E +HRDL N+L + KV+DFG++K + QD+ +
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-------QDSGKLPVK 164
Query: 215 YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPF 269
+ APE + +++ TK DV+SF ++L E+ G P+ +V K Y R P
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY--RMEAPE 222
Query: 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
P ++Y +++++CW PAKRPTF+Q+ +L I
Sbjct: 223 GCPPEVY-----KVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-44
Identities = 95/271 (35%), Positives = 147/271 (54%), Gaps = 26/271 (9%)
Query: 45 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
IDP EL F E+ G F L WRG I VA+K + E +S+DD F +E ++
Sbjct: 1 IDPSELTFLK--ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD----FIEEAKVMM 54
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 159
K+ HPN+VQ G T+ P+ IVTEY+ G L +L+ RKG L + D+ M
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS--CRYVA 217
YL N IHRDL N L + +KV+DFG+++ V +D+ + Q T ++
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP 169
Query: 218 PEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAK 274
PEVF + +K DV+SF +++ E+ EG P+ ++EV ++ +A R P AP +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTE 229
Query: 275 LYARGLKELIEECWNEKPAKRPTFRQIITRL 305
+Y ++ CW+EKP RP F++++++L
Sbjct: 230 VY-----TIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 78/259 (30%), Positives = 128/259 (49%), Gaps = 27/259 (10%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
F +I KG F A + G +VA+K + E +++ E+ +L+K +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHEN 164
N+V++ G+ + + IV E+ G L+ LK L S ++ +G+ YLH N
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 165 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF 221
IIHRD++ +NIL G +K+ DFG+S L+ + R +T ++APEV
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-----NTMVGTPYWMAPEVI 169
Query: 222 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA--YAARQRPP-FKAPAKLYAR 278
+ YD K D++S + E+ EG PP+ + KA A PP + P K ++
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEK-WSD 225
Query: 279 GLKELIEECWNEKPAKRPT 297
K+ +++C + P KRPT
Sbjct: 226 EFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 6e-42
Identities = 91/266 (34%), Positives = 139/266 (52%), Gaps = 22/266 (8%)
Query: 45 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
I+P EL F E+ G F L WR I+VA+K + E +S++D F +E ++
Sbjct: 1 INPSELTFMK--ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----FIEEAKVMM 54
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 159
K+ HP +VQ G TQ P+ IVTE++ G L +L+ R+G L + D+ GM
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YL N IHRDL N L +G +KV+DFG+++ + E + ++ PE
Sbjct: 115 YLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPE 171
Query: 220 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 276
VF +Y +K DV+SF +++ E+ EG PF K + EV + + R P A +Y
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVY 231
Query: 277 ARGLKELIEECWNEKPAKRPTFRQII 302
E++ CW+EKP RPTF +++
Sbjct: 232 -----EVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 85/270 (31%), Positives = 141/270 (52%), Gaps = 24/270 (8%)
Query: 45 IDPHELDFTNSVEITKGTFILAFWRGI-----QVAVKKLGEEVISDDDRVRAFRDELALL 99
I P EL EI G F L W G +VA+K + E +S++D F +E ++
Sbjct: 1 IHPSELTL--VQEIGSGQFGLV-WLGYWLEKRKVAIKTIREGAMSEED----FIEEAQVM 53
Query: 100 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 158
K+ HP +VQ G T+ SP+ +V E++ G L +L+ ++G T + LD+ GM
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 159 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 218
YL + +IHRDL N L ++ +KV+DFG+++ + + T ++ +P
Sbjct: 114 AYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
Query: 219 EVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKL 275
EVF +Y +K DV+SF +++ E+ EG P+ + ++EV + A R P A +
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSV 230
Query: 276 YARGLKELIEECWNEKPAKRPTFRQIITRL 305
Y EL++ CW E+P RP+F ++ +L
Sbjct: 231 Y-----ELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 4e-39
Identities = 79/244 (32%), Positives = 129/244 (52%), Gaps = 23/244 (9%)
Query: 68 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127
+ G +VAVK I D +AF +E A++ K+ H N+V+ LG + + + IV E +
Sbjct: 27 YTGQKVAVK-----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80
Query: 128 PKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185
KG+L FL+ +G S ++F+LD+A GM YL K ++HRDL NIL + G
Sbjct: 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDG 137
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 244
KV+DFG++++ + ++ APE K++++ +K DV+S+ ++L E+
Sbjct: 138 VAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193
Query: 245 GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
G P+ EV + R PP PA +Y L+ CW +P KRP+F ++
Sbjct: 194 GRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV-----LMTSCWETEPKKRPSFHKLR 248
Query: 303 TRLE 306
+LE
Sbjct: 249 EKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 67/239 (28%), Positives = 119/239 (49%), Gaps = 12/239 (5%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G +K++ +S+ +R A E+ +L+K+ HPN++++ + + + IV EY
Sbjct: 25 GKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83
Query: 130 GDLRAFLKRKGALKPSTAVRFALD----IARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185
GDL +K++ LD + + YLH K I+HRD++P NI +G
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNG 140
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 245
+K+ DFG+SK+L+ D T T Y++PE+ +N+ Y+ K D++S +L E+
Sbjct: 141 LVKLGDFGISKVLSSTVDLAKTVVGTPY-YLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199
Query: 246 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304
PF ++ E+ Q PP + Y+ L+ L+ + P +RP+ QI+
Sbjct: 200 KHPFEGENLLELALKILKGQYPPIPSQ---YSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 84/258 (32%), Positives = 124/258 (48%), Gaps = 23/258 (8%)
Query: 57 EITKGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 115
E+ GT W G +VAVK L +S AF E +++K+RH +VQ +
Sbjct: 21 EVWMGT-----WNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 116 QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173
+ P+ IVTEY+ KG L FLK L+ V A IA GM YL IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRD 128
Query: 174 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 233
L NIL ++ K+ADFG+++L+ E ++ APE + K DV+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 234 SFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA--PAKLYARGLKELIEECWNE 290
SF ++L E++ G P+ + EV + R P P +LY +L+ +CW++
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY-----DLMLQCWDK 243
Query: 291 KPAKRPTFRQIITRLESI 308
P +RPTF + + LE
Sbjct: 244 DPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 8e-38
Identities = 88/257 (34%), Positives = 130/257 (50%), Gaps = 19/257 (7%)
Query: 57 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116
E+ +G L + I VA+K L + SD R F E +++ + HPN+++ G VT+
Sbjct: 19 EVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQR-LDFLTEASIMGQFDHPNIIRLEGVVTK 76
Query: 117 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 175
S P+MI+TEY+ G L FL+ G V IA GM YL E V HRDL
Sbjct: 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV---HRDLA 133
Query: 176 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFS 234
NIL + + KV+DFG+S+ L E T R+ APE ++ + DV+S
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWS 193
Query: 235 FALILQE-MIEGCPPFTMKHDNEVPKA----YAARQRPPFKAPAKLYARGLKELIEECWN 289
F +++ E M G P+ + +V KA Y R PP P+ LY +L+ +CW
Sbjct: 194 FGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY--RLPPPMDCPSALY-----QLMLDCWQ 246
Query: 290 EKPAKRPTFRQIITRLE 306
+ +RPTF QI++ L+
Sbjct: 247 KDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-37
Identities = 71/229 (31%), Positives = 112/229 (48%), Gaps = 14/229 (6%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L ++ I V E +L +I HP +V+ A + +V EY P G+L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
+ L ++G A +A +I + YLH II+RDL+P NIL D G++K+ DFG
Sbjct: 82 SHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFG 138
Query: 194 VSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
++K L+ + R +T C Y+APEV + Y VD +S ++L EM+ G PPF
Sbjct: 139 LAKELSSEGSRT----NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF- 193
Query: 251 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299
+ + + Y + P + P L + ++LI + P KR
Sbjct: 194 --YAEDRKEIYEKILKDPLRFPEFL-SPEARDLISGLLQKDPTKRLGSG 239
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-37
Identities = 76/253 (30%), Positives = 123/253 (48%), Gaps = 24/253 (9%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
+VA+K + E S +R F +E +++++ +VV+ LG V+ P ++V E +
Sbjct: 35 PETRVAIKTVNENA-SMRER-IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92
Query: 129 KGDLRAFLKRK-------GALKPSTAVRF---ALDIARGMNYLHENKPVPIIHRDLEPSN 178
KGDL+++L+ + L P T +F A +IA GM YL K +HRDL N
Sbjct: 93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARN 149
Query: 179 ILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 237
+ + +K+ DFG+++ + + R R++APE K+ + TK DV+SF +
Sbjct: 150 CMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGV 209
Query: 238 ILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKPAK 294
+L EM P+ + EV K P P KL EL+ CW P
Sbjct: 210 VLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLL-----ELMRMCWQYNPKM 264
Query: 295 RPTFRQIITRLES 307
RPTF +I++ L+
Sbjct: 265 RPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 8e-37
Identities = 87/270 (32%), Positives = 139/270 (51%), Gaps = 22/270 (8%)
Query: 45 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
IDP +L F E+ G F WRG VA+K + E +S+D+ F +E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 159
K+ H +VQ G T+ P+ IVTEY+ G L +L+ G +PS + D+ GM
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA 114
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YL + IHRDL N L DD G +KV+DFG+S+ + E R+ PE
Sbjct: 115 YLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 220 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 276
V ++ +K DV++F +++ E+ G P+ +++E + + R P A K+Y
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231
Query: 277 ARGLKELIEECWNEKPAKRPTFRQIITRLE 306
A ++ CW+EK +RPTF+Q+++ +E
Sbjct: 232 A-----IMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-37
Identities = 86/275 (31%), Positives = 143/275 (52%), Gaps = 30/275 (10%)
Query: 47 PHELDFTNSVEITKGTFILAF---WRG-IQVAVKKLGEEVISDDDRVRA--FRDELALLQ 100
P E +FT ++ G F + W+ ++VA+K ++ DD ++ F+ E+ L+
Sbjct: 4 PRE-EFTLERKLGSGYFGEVWEGLWKNRVRVAIK-----ILKSDDLLKQQDFQKEVQALK 57
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGM 158
++RH +++ + P+ I+TE + KG L AFL+ L ++ + A +A GM
Sbjct: 58 RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 159 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYV 216
YL E IHRDL NIL + KVADFG+++L+ KED L+ D ++
Sbjct: 118 AYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLS-SDKKIPYKWT 171
Query: 217 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA--RQRPPFKAPA 273
APE + + TK DV+SF ++L EM G P+ +++EV A R P K P
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ 231
Query: 274 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
++Y +++ ECW +P RP+F+ + L++I
Sbjct: 232 EIY-----KIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 78/255 (30%), Positives = 126/255 (49%), Gaps = 29/255 (11%)
Query: 66 AFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123
W+ + VAVK L E+ + V F E A++++I+HPN+VQ LG T+ P I+
Sbjct: 25 GVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80
Query: 124 TEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 181
TE++ G+L +L+ + + + A I+ M YL + IHRDL N L
Sbjct: 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLV 137
Query: 182 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALI 238
++ +KVADFG+S+L+T T + ++ APE ++ K DV++F ++
Sbjct: 138 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 194
Query: 239 LQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 293
L E+ G P+ ++V K Y R P P K+Y EL+ CW P+
Sbjct: 195 LWEIATYGMSPYPGIDLSQVYELLEKGY--RMERPEGCPPKVY-----ELMRACWQWNPS 247
Query: 294 KRPTFRQIITRLESI 308
RP+F +I E++
Sbjct: 248 DRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-36
Identities = 85/262 (32%), Positives = 128/262 (48%), Gaps = 40/262 (15%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
VA+K L E ++ + FR E L+ ++HPN+V LG T+ P ++ EYL G
Sbjct: 36 TSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHG 93
Query: 131 DLRAFLKR----------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 174
DL FL R K +L S + A+ IA GM YL + +HRDL
Sbjct: 94 DLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDL 150
Query: 175 EPSNILRDDSGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 228
N L + +K++DFG+S+ + V+ L R++ PE ++ T
Sbjct: 151 AARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-----PVRWMPPEAILYGKFTT 205
Query: 229 KVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIE 285
+ D++SF ++L E+ G P+ + EV + +RQ P PA++YA L+
Sbjct: 206 ESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYA-----LMI 260
Query: 286 ECWNEKPAKRPTFRQIITRLES 307
ECWNE PA+RP F+ I TRL S
Sbjct: 261 ECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 8e-36
Identities = 85/263 (32%), Positives = 138/263 (52%), Gaps = 32/263 (12%)
Query: 58 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA- 113
I KG F +L +RG +VAVK I +D +AF E +++ ++RH N+VQ LG
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 114 VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
V + + IVTEY+ KG L +L+ +G L ++F+LD+ M YL N +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDT 228
RDL N+L + KV+DFG++K + + QDT ++ APE + +++ T
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFST 178
Query: 229 KVDVFSFALILQEMIE-GCPPFTMKHDNEV-PKAYAA-RQRPPFKAPAKLYARGLKELIE 285
K DV+SF ++L E+ G P+ +V P+ + P P +Y ++++
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY-----DVMK 233
Query: 286 ECWNEKPAKRPTFRQIITRLESI 308
+CW+ A RP+F Q+ +LE I
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 71/245 (28%), Positives = 122/245 (49%), Gaps = 23/245 (9%)
Query: 70 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127
G ++AVK++ + S + + V A E+ LL+ ++H +VQ+ G + + I EY+
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
P G ++ LK GAL + ++ I G+ YLH N I+HRD++ +NILRD +GN+
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNV 143
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQ 240
K+ DFG SK L + + T + +++PEV E Y K DV+S +
Sbjct: 144 KLGDFGASKRL-----QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVV 198
Query: 241 EMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 298
EM+ PP+ + E A A Q + P+ + + + + + E KRP+
Sbjct: 199 EMLTEKPPWA---EFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLRRTFVENAKKRPSA 254
Query: 299 RQIIT 303
+++
Sbjct: 255 EELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-35
Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 16/266 (6%)
Query: 48 HELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 107
EL N + KG +++ + ++VAVK L +E I+ + F E +++ ++ HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 167
V+ +G V + P+M+V E P G L +LK++ + S A +A GM YL V
Sbjct: 59 VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEE 225
HRDL N+L + K++DFG+S+ L D R T ++ APE +
Sbjct: 118 ---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 226 YDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKE 282
+ +K DV+S+ + L E G P+ EV + +R P + P ++Y+
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYS----- 229
Query: 283 LIEECWNEKPAKRPTFRQIITRLESI 308
++ CW +P RPTF ++ +
Sbjct: 230 IMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-35
Identities = 76/251 (30%), Positives = 116/251 (46%), Gaps = 26/251 (10%)
Query: 68 WRGI-----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122
W G+ VAVK L + D F E +++K+RHP ++Q T P+ I
Sbjct: 23 WEGLWNNTTPVAVKTLKPGTMDPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78
Query: 123 VTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180
VTE + G L +L+ ALK + A +A GM YL IHRDL N+L
Sbjct: 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVL 135
Query: 181 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 240
++ KVADFG+++++ ++ APE + K DV+SF ++L
Sbjct: 136 VGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLT 195
Query: 241 EMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
E++ G P+ + EV + Y R P P +LY +++ +CW E P R
Sbjct: 196 EIVTYGRMPYPGMTNAEVLQQVDQGY--RMPCPPGCPKELY-----DIMLDCWKEDPDDR 248
Query: 296 PTFRQIITRLE 306
PTF + +LE
Sbjct: 249 PTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 50/270 (18%)
Query: 70 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIV 123
G QVAVK L E+ SD F E+ +L+ + H N+V++ G + + ++
Sbjct: 33 GEQVAVKSLNHSGEEQHRSD------FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86
Query: 124 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 182
EYLP G LR +L+R + + + F+ I +GM+YL + IHRDL NIL +
Sbjct: 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVE 143
Query: 183 DSGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 235
+K++DFG++K+L VKE ++ + APE + ++ + DV+SF
Sbjct: 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPG-----ESPIFWYAPECLRTSKFSSASDVWSF 198
Query: 236 ALILQEMIEGC-----PP--FTMKHDNEVPKAYAAR--------QR--PPFKAPAKLYAR 278
+ L E+ PP F + R +R P P ++Y
Sbjct: 199 GVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY-- 256
Query: 279 GLKELIEECWNEKPAKRPTFRQIITRLESI 308
+L++ CW +P RP+F +I ++ +
Sbjct: 257 ---DLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 75/240 (31%), Positives = 115/240 (47%), Gaps = 12/240 (5%)
Query: 68 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127
G A+KK+ V D++ + EL L+ P VV+ GA + + IV EY+
Sbjct: 24 PTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81
Query: 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
G L LK+ G + A I +G++YLH + IIHRD++PSN+L + G +
Sbjct: 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEV 139
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 247
K+ADFG+SK+L D+ T T Y++PE + E Y D++S L L E G
Sbjct: 140 KIADFGISKVLENTLDQCNTFVGT-VTYMSPERIQGESYSYAADIWSLGLTLLECALGKF 198
Query: 248 PFTMKHDNEVPK----AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
PF P A PP PA+ ++ ++ I C + P KRP+ +++
Sbjct: 199 PFL---PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (323), Expect = 1e-34
Identities = 67/186 (36%), Positives = 102/186 (54%), Gaps = 16/186 (8%)
Query: 70 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125
G VA+KK+ EE I A R E++LL++++HPN+V+ L + + +V E
Sbjct: 24 GEIVALKKIRLDNEEEGIP----STALR-EISLLKELKHPNIVKLLDVIHTERKLYLVFE 78
Query: 126 YLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
Y DL+ +L KR G L P+ + RG+ Y H ++ I+HRDL+P NIL +
Sbjct: 79 YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRD 134
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 243
G LK+ADFG+++ + R T + + Y APE+ ++ Y T VD++S I EMI
Sbjct: 135 GVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193
Query: 244 EGCPPF 249
G P F
Sbjct: 194 TGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 76/248 (30%), Positives = 116/248 (46%), Gaps = 25/248 (10%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
+VAVK + D R F E +L++ HPN+V+ +G Q P+ IV E +P
Sbjct: 19 NTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76
Query: 130 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
G L FL++K L ++ +LD A GM YL E+K IHRDL N L ++ LK
Sbjct: 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ESKNC--IHRDLAARNCLVGENNVLK 133
Query: 189 VADFGVSKLLTVKEDRPLTCQD----TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 244
++DFG+S+ +E T D ++ APE Y ++ DV+S+ ++L E
Sbjct: 134 ISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190
Query: 245 G--CPPFTMKHD---NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299
P M + + Y R P P ++Y L+ +CW P RP+F
Sbjct: 191 LGDTPYPGMSNQQTRERIESGY--RMPAPQLCPEEIY-----RLMLQCWAYDPENRPSFS 243
Query: 300 QIITRLES 307
+I L+
Sbjct: 244 EIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 18/234 (7%)
Query: 74 AVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
AVK E I D+D ++ DE+ +L+ ++HPN+V++ G + I EY G
Sbjct: 29 AVK---EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85
Query: 132 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
L L+ L + L + G+ YLH + I+HRD++P+NI D +G +K+ D
Sbjct: 86 LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGD 142
Query: 192 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTK---VDVFSFALILQEMIEG 245
FG + L + + Y+APEV + D++S ++ EM G
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
Query: 246 CPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 297
P++ + DNE + A +PP +L G K+ ++ C P KRPT
Sbjct: 203 KRPWS-ELDNEFQIMFHVGAGHKPPIPDSLQLSPEG-KDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 14/233 (6%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K++ +S +R A +E+ +L + HPN++ + A + + IV EY P GDL
Sbjct: 29 ALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS 87
Query: 134 AFLKRKGALK---PSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
+ ++ + P + R + + RG+ LHE K I+HRDL+ +NIL + +K+
Sbjct: 88 KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKI 144
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
D G+SK+L Q + Y+APEV+K Y K D++S +L EM PPF
Sbjct: 145 GDLGISKVLK---KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
Query: 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
+ ++ + PP +Y++ L+ I KP RP +I+
Sbjct: 202 EARSMQDLRYKVQRGKYPPIPP---IYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 72/259 (27%), Positives = 131/259 (50%), Gaps = 21/259 (8%)
Query: 51 DFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRH 104
++ I +G F ++G+ VA+K++ E I ++ +++ E+ LL+ ++H
Sbjct: 1 NYQLGDLIGRGAFG-VVYKGLNLETGDFVAIKQISLEKIKEEA-LKSIMQEIDLLKNLKH 58
Query: 105 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 164
PN+V+++G++ S + I+ EY G LR +K+ G S + + +G+ YLHE
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 165 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 224
+IHRD++ +NIL G +K+ADFGV+ L + T ++APEV +
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTP-YWMAPEVIEMS 174
Query: 225 EYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYA--ARQRPPFKAPAKLYARGLK 281
T D++S + E++ G PP+ +D N + + PP P + LK
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPY---YDLNPMAALFRIVQDDHPPL--PEGISPE-LK 228
Query: 282 ELIEECWNEKPAKRPTFRQ 300
+ + +C+ + P RPT +Q
Sbjct: 229 DFLMQCFQKDPNLRPTAKQ 247
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 84/261 (32%), Positives = 133/261 (50%), Gaps = 22/261 (8%)
Query: 57 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116
E+ G L R I VA+K L + + + R F E +++ + HPN++ G VT+
Sbjct: 19 EVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 117 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 175
S P+MIVTEY+ G L AFL++ G V IA GM YL + + +HRDL
Sbjct: 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 133
Query: 176 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 230
NIL + + KV+DFG+S++L ED P T R+ APE ++ +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190
Query: 231 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 287
DV+S+ +++ E++ G P+ + +V KA R P PA L+ +L+ +C
Sbjct: 191 DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH-----QLMLDC 245
Query: 288 WNEKPAKRPTFRQIITRLESI 308
W + +RP F QI++ L+ +
Sbjct: 246 WQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 42/270 (15%)
Query: 52 FTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
FT I KG+F + + I VA+K + E +D + + E+ L + R P
Sbjct: 3 FTLLECIGKGSFGEVY-KAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSP 59
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 165
+ ++ G+ + S + I+ EY G LK G L + ++ G+ YLHE
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEG 118
Query: 166 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------YV 216
IHRD++ +NIL + G++K+ADFGVS LT T + ++
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLT----------STMSKRNTFVGTPFWM 165
Query: 217 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT----MKHDNEVPKAYAARQRPPFKAP 272
APEV K YD K D++S + E+ +G PP + M+ +PK P
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------NNPPSLE 219
Query: 273 AKLYARGLKELIEECWNEKPAKRPTFRQII 302
+++ K+ + C N+ P +RP+ ++++
Sbjct: 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 77/271 (28%), Positives = 124/271 (45%), Gaps = 55/271 (20%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129
VAVK L ++ D + E+ +++ I +H N++ LG TQ P+ +V EY
Sbjct: 43 STVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100
Query: 130 GDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173
G+LR FL+ + L V FA +ARGM +L K IHRD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRD 157
Query: 174 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TSCR----YVAPEVFKNE 224
L N+L + +K+ADFG++ R + D T+ R ++APE +
Sbjct: 158 LAARNVLVTEDHVMKIADFGLA--------RDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209
Query: 225 EYDTKVDVFSFALILQEMIE--GCPPFTMKHDNEVPKAYA-----ARQRPPFKAPAKLYA 277
Y + DV+SF ++L E+ G P + V + + R P +LY
Sbjct: 210 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEELFKLLKEGYRMEKPQNCTQELYH 265
Query: 278 RGLKELIEECWNEKPAKRPTFRQIITRLESI 308
L+ +CW+E P++RPTF+Q++ L+ +
Sbjct: 266 -----LMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 68/239 (28%), Positives = 108/239 (45%), Gaps = 18/239 (7%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A+K + + + ++V E +L + + P VV+ + + +V EYLP GDL
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
+ L+ G+L A + +I + YLH N IIHRDL+P NIL D +G+LK+ DF
Sbjct: 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDF 137
Query: 193 GVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEMIEG 245
G+SK+ V+ L + + Y+APEV + + VD +S IL E + G
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
Query: 246 CPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
PPF H + + + + +LI + P KR + I
Sbjct: 198 IPPF---HGETPEEIFQNILNGKIEWPEDVEVSDE--AIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 73/236 (30%), Positives = 116/236 (49%), Gaps = 18/236 (7%)
Query: 74 AVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
AVK L ++ + + V+ E+ALL K++HPN+VQ+LG + + I E +P G
Sbjct: 29 AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88
Query: 132 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
L LK+ G+ + I G+ YLH+ +HRD++ +NIL D +G +K+AD
Sbjct: 89 LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLAD 145
Query: 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFT 250
FG++K V E S ++APEV + Y D++S + EM G PP+
Sbjct: 146 FGMAK--QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW- 202
Query: 251 MKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
E V K +++ PP P L K+ I +C P+ RPT +++
Sbjct: 203 --SQLEGVAAVFKIGRSKELPPI--PDHLSDEA-KDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 69/225 (30%), Positives = 119/225 (52%), Gaps = 14/225 (6%)
Query: 86 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS 145
++ V A R E+ L+ ++ HP++++ LGA + S + E++ G + L + GA K +
Sbjct: 44 EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA 103
Query: 146 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKEDR 204
+ + + RG++YLHEN+ IIHRD++ +N+L D +G L++ADFG + L K
Sbjct: 104 VIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160
Query: 205 PLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVP-- 258
Q + ++APEV + E+Y DV+S ++ EM PP+ KH N +
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
Query: 259 -KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
K +A P P L + GL+++ C +P RP R+++
Sbjct: 221 FKIASATTAPSI--PEHL-SPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 87/261 (33%), Positives = 134/261 (51%), Gaps = 22/261 (8%)
Query: 61 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSS 118
GT I + + I AVK L I+D + V F E +++ HPNV+ LG ++ S
Sbjct: 14 GTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71
Query: 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEP 176
P+ +V Y+ GDLR F+ R P+ + F L +A+GM YL K +HRDL
Sbjct: 72 PL-VVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAA 126
Query: 177 SNILRDDSGNLKVADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 233
N + D+S +KVADFG+++ + KE T +++A E + +++ TK DV+
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVW 186
Query: 234 SFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 290
SF ++L E M G PP+ D V R P P LY E++ CW+
Sbjct: 187 SFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY-----EVMLSCWHP 241
Query: 291 KPAKRPTFRQIITRLESINNS 311
KP RPTF ++++R+E I ++
Sbjct: 242 KPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 65/256 (25%), Positives = 124/256 (48%), Gaps = 15/256 (5%)
Query: 57 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116
++ +G ++ I VAVK + F E ++++ HP++V+ +G +T+
Sbjct: 21 DVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78
Query: 117 SSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 175
+ P+ IV E P G+LR++L K +L ++ + ++ ++ + YL + V HRD+
Sbjct: 79 N-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV---HRDIA 134
Query: 176 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 235
N+L +K+ DFG+S+ L + + +++APE + + DV+ F
Sbjct: 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 194
Query: 236 ALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKP 292
+ + E ++ G PF +N+V +R P P LY+ L+ +CW P
Sbjct: 195 GVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-----LMTKCWAYDP 249
Query: 293 AKRPTFRQIITRLESI 308
+KRP F ++ +L I
Sbjct: 250 SKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 86/264 (32%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 54 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 113
N E+ KGT VAVK E+ + + +++ F E +L++ HPN+V+ +G
Sbjct: 7 NFGEVFKGTL----KDKTPVAVKTCKED-LPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 114 VTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 172
TQ P+ IV E +P GD +FL K+K LK V+FALD A GM YL IHR
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 173 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDT 228
DL N L ++ LK++DFG+S+ +ED + + ++ APE Y +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 229 KVDVFSFALILQEMIE--GCPPFTMKHDN---EVPKAYAARQRPPFKAPAKLYARGLKEL 283
+ DV+S+ ++L E CP M + +V K Y R P K P +Y ++
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--RMSCPQKCPDDVY-----KV 226
Query: 284 IEECWNEKPAKRPTFRQIITRLES 307
++ CW+ KP RP F ++ L +
Sbjct: 227 MQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 71/193 (36%), Positives = 106/193 (54%), Gaps = 18/193 (9%)
Query: 70 GIQVAVKK--LGEEVISDDDRVRAFRD----ELALLQKIRHPNVVQFLGAVTQSSPMMIV 123
G +AVK+ L S DR R+ D E+ALL++++H N+VQ+LG+ + + I
Sbjct: 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
EY+P G + A L GA + + F I +G+NYLH IIHRD++ +NIL D+
Sbjct: 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDN 141
Query: 184 SGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 236
G +K++DFG+SK L RP + Q S ++APEV K Y K D++S
Sbjct: 142 KGGIKISDFGISKKLEANSLSTKTNGARP-SLQG-SVFWMAPEVVKQTSYTRKADIWSLG 199
Query: 237 LILQEMIEGCPPF 249
++ EM+ G PF
Sbjct: 200 CLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 65/239 (27%), Positives = 119/239 (49%), Gaps = 18/239 (7%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G +VA+KK + +E+ +++ +HPN+V + + + +V EY+
Sbjct: 44 GKEVAIKK----MRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99
Query: 130 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
G L + + + ++ +G+ YLH +IHRD++ NIL G++K
Sbjct: 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVK 156
Query: 189 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 248
+ADFG + LT ++ + + T ++APEV K ++Y KVD++S ++ EM EG PP
Sbjct: 157 LADFGFAAQLTKEKSKRNSVVGTP-YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
Query: 249 FTMKHDNEVP-KA-YAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
+ E P +A + + PP K P K + K+ + +C + P KRP+ +++
Sbjct: 216 ----YLREPPLRALFLITTKGIPPLKNPEKW-SPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 81/245 (33%), Positives = 127/245 (51%), Gaps = 28/245 (11%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
+VA+K L + +S + AF E L+++++HP +V+ VTQ P+ I+TEY+ G
Sbjct: 32 KVAIKSLKQGSMSPE----AFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGS 86
Query: 132 LRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
L FLK L + + A IA GM ++ IHRDL +NIL ++ K+
Sbjct: 87 LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKI 143
Query: 190 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 245
ADFG+++L+ ED T ++ + ++ APE + K DV+SF ++L E++ G
Sbjct: 144 ADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG 200
Query: 246 CPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
P+ + EV + Y R P P +LY EL+ CW EKP +RPTF +
Sbjct: 201 RIPYPGMTNPEVIQNLERGY--RMPRPDNCPEELY-----ELMRLCWKEKPEERPTFEYL 253
Query: 302 ITRLE 306
+ LE
Sbjct: 254 RSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 85/291 (29%), Positives = 141/291 (48%), Gaps = 31/291 (10%)
Query: 46 DPHELDFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALL 99
DP EL FT I KG+F F +GI VA+K + E +D + + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVF-KGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVL 56
Query: 100 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 159
+ P V ++ G+ + + + I+ EYL G L R G +I +G++
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLD 115
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YLH K IHRD++ +N+L + G++K+ADFGV+ LT + + T T ++APE
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPE 171
Query: 220 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL--YA 277
V + YD+K D++S + E+ +G PP + H V P P ++
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFLIPKNNPPTLTGEFS 226
Query: 278 RGLKELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRRWK 319
+ KE I+ C N+ P+ RPT ++++ + N+ I+ +RWK
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFKRWK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 4e-31
Identities = 77/243 (31%), Positives = 128/243 (52%), Gaps = 23/243 (9%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
+VAVK L +S V+AF +E L++ ++H +V+ VT+ P+ I+TEY+ KG
Sbjct: 32 KVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87
Query: 132 LRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
L FLK G + + F+ IA GM Y+ IHRDL +N+L +S K+
Sbjct: 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKI 144
Query: 190 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 245
ADFG+++++ ED T ++ + ++ APE + K DV+SF ++L E++ G
Sbjct: 145 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYG 201
Query: 246 CPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
P+ +++V A R P P +LY ++++ CW EK +RPTF + +
Sbjct: 202 KIPYPGMSNSDVMSALQRGYRMPRMENCPDELY-----DIMKTCWKEKAEERPTFDYLQS 256
Query: 304 RLE 306
L+
Sbjct: 257 VLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 5e-31
Identities = 85/287 (29%), Positives = 144/287 (50%), Gaps = 23/287 (8%)
Query: 46 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 101
DP EL FT +I KG+F F +GI +K+ I D +D + + E+ +L +
Sbjct: 1 DPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58
Query: 102 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 161
P V ++ G+ + + + I+ EYL G L+ G L + +I +G++YL
Sbjct: 59 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYL 117
Query: 162 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 221
H K IHRD++ +N+L + G +K+ADFGV+ LT + + T T ++APEV
Sbjct: 118 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 222 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281
K YD+K D++S + E+ +G PP + H +V P + Y++ LK
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGN---YSKPLK 230
Query: 282 ELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRRWK 319
E +E C N++P+ RPT ++++ + + I+ +RWK
Sbjct: 231 EFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELIDRYKRWK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 71/246 (28%), Positives = 127/246 (51%), Gaps = 16/246 (6%)
Query: 58 ITKGTFILAFWRGIQVAVKK-LGEEVI---SDDDRVRAFRDELALLQKIRH---PNVVQF 110
I +G + A +RG V + + ++I + DD V + E+ALL ++R PN+ ++
Sbjct: 9 IGRGAY-GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 111 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 170
G+ + + I+ EY G +R L + G + ++ + Y+H+ V +I
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK---VGVI 123
Query: 171 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTK 229
HRD++ +NIL ++GN+K+ DFGV+ LL + T T ++APEV + YDTK
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP-YWMAPEVITEGKYYDTK 182
Query: 230 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289
D++S + + EM G PP++ D + +PP + Y++ L+E + C +
Sbjct: 183 ADIWSLGITIYEMATGNPPYS-DVDAFRAMMLIPKSKPP-RLEDNGYSKLLREFVAACLD 240
Query: 290 EKPAKR 295
E+P +R
Sbjct: 241 EEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 82/263 (31%), Positives = 130/263 (49%), Gaps = 24/263 (9%)
Query: 57 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116
E+ +G L R I VA+K L + + + R F E +++ + HPN++ G VT+
Sbjct: 19 EVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 117 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 175
S P+MI+TE++ G L +FL++ G V IA GM YL E + +HRDL
Sbjct: 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLA 133
Query: 176 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-------RYVAPEVFKNEEYDT 228
NIL + + KV+DFG+S+ L ED TS R+ APE ++ +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS 190
Query: 229 KVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIE 285
DV+S+ +++ E M G P+ + +V A R PP P L+ +L+
Sbjct: 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALH-----QLML 245
Query: 286 ECWNEKPAKRPTFRQIITRLESI 308
+CW + RP F QI++ L+ +
Sbjct: 246 DCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 77/253 (30%), Positives = 110/253 (43%), Gaps = 39/253 (15%)
Query: 71 IQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
I VAVK L + +SD DD F E A++ + H N+++ G V P+M+VTE P
Sbjct: 24 IPVAVKCLKSDKLSDIMDD----FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78
Query: 129 KGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
G L L+ G ST +A+ IA GM YL + IHRDL NIL
Sbjct: 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDK 135
Query: 187 LKVADFGVSKLLTVKEDR---------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 237
+K+ DFG+ + L ED P + APE + + DV+ F +
Sbjct: 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFA-------WCAPESLRTRTFSHASDVWMFGV 188
Query: 238 ILQEMIE-GCPPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKP 292
L EM G P+ +++ K +RP P +Y ++ +CW P
Sbjct: 189 TLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA-CPQDIY-----NVMLQCWAHNP 242
Query: 293 AKRPTFRQIITRL 305
A RPTF + L
Sbjct: 243 ADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 77/256 (30%), Positives = 127/256 (49%), Gaps = 31/256 (12%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VA+K L + I++ + F+ E +L+ ++ HPN+V LG VTQ P+ ++ EYL +GDL
Sbjct: 37 VAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 133 RAFL-----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 175
FL K +L + A+ IA GM YL + +H+DL
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLA 151
Query: 176 PSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 234
NIL + ++K++D G+S+ + + R R++ PE ++ + D++S
Sbjct: 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 235 FALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK--APAKLYARGLKELIEECWNEK 291
F ++L E+ G P+ + EV + RQ P P ++Y+ L+ ECW E
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYS-----LMTECWQEG 266
Query: 292 PAKRPTFRQIITRLES 307
P++RP F+ I TRL S
Sbjct: 267 PSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 79/263 (30%), Positives = 114/263 (43%), Gaps = 45/263 (17%)
Query: 72 QVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
VAVK L + D R F E+ +L ++ PN+ + LG T P+ ++ EY+ G
Sbjct: 48 LVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 131 DLRAFLKR-----------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179
DL FL++ +L ST + A IA GM YL V HRDL N
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLATRNC 161
Query: 180 LRDDSGNLKVADFGVSKLLTVK-----EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 234
L + +K+ADFG+S+ L + R R++A E ++ TK DV++
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP----LPIRWMAWESVLLGKFTTKSDVWA 217
Query: 235 FALILQEMIEGC--PPFTMKHDNEV----------PKAYAARQRPPFKAPAKLYARGLKE 282
F + L E++ C P+ D +V RPP P +Y E
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPP-NCPKDIY-----E 271
Query: 283 LIEECWNEKPAKRPTFRQIITRL 305
L+ ECW RPTFR+I L
Sbjct: 272 LMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-30
Identities = 85/287 (29%), Positives = 141/287 (49%), Gaps = 23/287 (8%)
Query: 46 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 101
DP EL FT I KG+F ++GI K++ I D +D + + E+ +L +
Sbjct: 1 DPEEL-FTKLERIGKGSF-GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58
Query: 102 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 161
P + ++ G+ + + + I+ EYL G LK G L+ + +I +G++YL
Sbjct: 59 CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYL 117
Query: 162 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 221
H + IHRD++ +N+L + G++K+ADFGV+ LT + + T T ++APEV
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 222 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281
K YD K D++S + E+ +G PP + H V P + Y++ K
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ---YSKPFK 230
Query: 282 ELIEECWNEKPAKRPTFRQI-----ITRLES----INNSINHKRRWK 319
E +E C N+ P RPT +++ ITR + I+ +RWK
Sbjct: 231 EFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWK 277
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-30
Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 57 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116
E+ +G + + + VA+K L + ++ R F E +++ + H N+++ G VT+
Sbjct: 20 EVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQD-FLSEASIMGQFSHHNIIRLEGVVTK 77
Query: 117 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 175
P MI+TEY+ G L +L+ G V IA GM YL + + +HRDL
Sbjct: 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLA 134
Query: 176 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 230
NIL + + KV+DFG+S++L ED P TS R+ APE ++ +
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS 191
Query: 231 DVFSFALILQE-MIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 287
DV+SF +++ E M G P+ ++EV KA R P P+ +Y +L+ +C
Sbjct: 192 DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY-----QLMLQC 246
Query: 288 WNEKPAKRPTFRQIITRLESI 308
W + A+RP F I+ L+ +
Sbjct: 247 WQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 75/250 (30%), Positives = 120/250 (48%), Gaps = 24/250 (9%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
+QVAVK L E S+ D F E ++ K H N+V+ +G + P I+ E + G
Sbjct: 37 LQVAVKTL-PESCSEQDESD-FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGG 94
Query: 131 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
DL++FL+ R +PS+ + A D+A+G YL EN IHRD+ N L
Sbjct: 95 DLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTC 151
Query: 184 SGN---LKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239
G K+ADFG+++ + R +++ PE F + + +K DV+SF ++L
Sbjct: 152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211
Query: 240 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 296
E+ G P+ + + EV + R PP P +Y ++ +CW P RP
Sbjct: 212 WEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVY-----RIMTDCWQHTPEDRP 266
Query: 297 TFRQIITRLE 306
F I+ R++
Sbjct: 267 NFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 6e-30
Identities = 88/257 (34%), Positives = 132/257 (51%), Gaps = 29/257 (11%)
Query: 61 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119
G + W G +VAVK L +S + +F +E +++K+RH +VQ L AV P
Sbjct: 20 GEVWMGTWNGNTKVAVKTLKPGTMSPE----SFLEEAQIMKKLRHDKLVQ-LYAVVSEEP 74
Query: 120 MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
+ IVTEY+ KG L FLK ALK V A +A GM Y+ + IHRDL +
Sbjct: 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 131
Query: 178 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 234
NIL D K+ADFG+++L+ ED T + + ++ APE + K DV+S
Sbjct: 132 NILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 235 FALILQEMI-EGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289
F ++L E++ +G P+ ++ E V + Y R P P L+ EL+ +CW
Sbjct: 189 FGILLTELVTKGRVPYPGMNNREVLEQVERGY--RMPCPQDCPISLH-----ELMLQCWK 241
Query: 290 EKPAKRPTFRQIITRLE 306
+ P +RPTF + + LE
Sbjct: 242 KDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 6e-30
Identities = 81/286 (28%), Positives = 132/286 (46%), Gaps = 48/286 (16%)
Query: 57 EITKGT-FILAFWRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 114
++ K T F L G VAVK L E + +R E LL+++ HP+V++ GA
Sbjct: 15 KVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVNHPHVIKLYGAC 72
Query: 115 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPS------------------------TAVRF 150
+Q P++++ EY G LR+FL+ + PS + F
Sbjct: 73 SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210
A I+RGM YL E K ++HRDL N+L + +K++DFG+S+ + ++ +
Sbjct: 133 AWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG 189
Query: 211 -TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-------GCPPFTMKHDNEVPKAYA 262
+++A E + Y T+ DV+SF ++L E++ G P + N + Y
Sbjct: 190 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF--NLLKTGY- 246
Query: 263 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
R P ++Y L+ CW ++P KRPTF I LE +
Sbjct: 247 -RMERPENCSEEMYN-----LMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 78/247 (31%), Positives = 122/247 (49%), Gaps = 23/247 (9%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
V VK L + D++ FR EL + +K+ H NVV+ LG ++ P ++ EY GDL
Sbjct: 38 VLVKALQK--TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 133 RAFL----KRKGALKP---STAVRFAL--DIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
+ FL + LKP ST + AL IA GM++L + +HRDL N L
Sbjct: 96 KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSS 152
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
+KV+ +SK + E L R++APE + +++ TK DV+SF +++ E+
Sbjct: 153 QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
Query: 244 -EGCPPFTMKHDNEV---PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299
+G PF D EV +A P P++LY +L+ CW P RP+F
Sbjct: 213 TQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY-----KLMTRCWAVNPKDRPSFS 267
Query: 300 QIITRLE 306
++++ L
Sbjct: 268 ELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 14/218 (6%)
Query: 94 DELALLQKIRHPNVVQFLG--AVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTA 147
E+ +L++++HPN+V++ + + IV EY GDL +++ + ++
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 148 VRFALDIARGMNYLH---ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204
R + + H + ++HRDL+P+NI D + N+K+ DFG++K+L
Sbjct: 108 WRILTQLLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 264
T T Y++PE + YD K D++S ++ E+ PPFT ++ ++
Sbjct: 167 AKTYVGTP-YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG 225
Query: 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
+ Y+ L E+I+ N P KRP+ +++
Sbjct: 226 KFRRIPY---RYSSELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 76/255 (29%), Positives = 122/255 (47%), Gaps = 25/255 (9%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 123
+VAVK L ++ S D + F E A +++ HPNV++ +G +S M++
Sbjct: 27 FQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 124 TEYLPKGDLRAFL--KRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
++ GDL FL R G L T VRF +DIA GM YL IHRDL
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAAR 142
Query: 178 NILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 236
N + +++ + VADFG+S K+ + R +++A E + Y T DV++F
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG 202
Query: 237 LILQE-MIEGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPA 293
+ + E M G P+ ++E+ R + P +Y EL+ +CW+ +P
Sbjct: 203 VTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVY-----ELMCQCWSPEPK 257
Query: 294 KRPTFRQIITRLESI 308
RP+F+ + +LE I
Sbjct: 258 CRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 62/190 (32%), Positives = 102/190 (53%), Gaps = 7/190 (3%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
G VA+KK+ + +A R E+ LQ +HP VV+ L S ++V EY+P
Sbjct: 24 TGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP 82
Query: 129 KGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
DL L+ + L + + + +G+ Y+H N I+HRDL+P+N+L G L
Sbjct: 83 -SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVL 138
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGC 246
K+ADFG+++L + +E R + Q + Y APE+ + +YD VD+++ I E++ G
Sbjct: 139 KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
Query: 247 PPFTMKHDNE 256
P F ++D E
Sbjct: 199 PLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-29
Identities = 82/254 (32%), Positives = 125/254 (49%), Gaps = 35/254 (13%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A K+ +E S++D R F EL +L K+ HPN++ LGA + I EY P G+L
Sbjct: 32 AAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL 90
Query: 133 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 176
FL++ L+ A ++FA D+A GM YL E + IHRDL
Sbjct: 91 LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAA 147
Query: 177 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 236
N+L ++ K+ADFG+S+ V + T R++A E Y TK DV+SF
Sbjct: 148 RNVLVGENLASKIADFGLSRGEEVYVKK--TMGRLPVRWMAIESLNYSVYTTKSDVWSFG 205
Query: 237 LILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 291
++L E++ G P M + ++P+ Y R P ++Y EL+ +CW ++
Sbjct: 206 VLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RMEKPRNCDDEVY-----ELMRQCWRDR 258
Query: 292 PAKRPTFRQIITRL 305
P +RP F QI +L
Sbjct: 259 PYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-29
Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 27/276 (9%)
Query: 51 DFTNSVEITKGTFILAF--WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NV 107
+ ++ +G+F + VA+K L +++ S V F E+ +L + HP N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFALDIARGMNYLHEN 164
V+ + +V EY+ G L LK RKG L S A+ I + YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 165 KPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLT-----VKEDRPLTCQDTSCRYVAP 218
IIHRD++P NIL D G +K+ DFG++KLL + + Y+AP
Sbjct: 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 219 EVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA---------YAARQR 266
EV + D++S + L E++ G PPF + ++ +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
P + +L ++ +L+++ + P R + +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-29
Identities = 67/240 (27%), Positives = 117/240 (48%), Gaps = 16/240 (6%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
I VA+K L EE + + DE ++ + HP+VV+ LG + SS + ++T+ +P G
Sbjct: 37 IPVAIKVLREE--TSPKANKEILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLG 93
Query: 131 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
L +++ K + + + + IA+GM+YL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKI 150
Query: 190 ADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCP 247
DFG++KLL V E +++A E + Y K DV+S+ + + E M G
Sbjct: 151 TDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
Query: 248 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
P+ E+P +R P +Y ++ +CW RPTF+++I
Sbjct: 211 PYEGIPAVEIPDLLEKGERLPQPPICTIDVYM-----VLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 82/257 (31%), Positives = 128/257 (49%), Gaps = 36/257 (14%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129
+ A+K++ E DD R F EL +L K+ HPN++ LGA + + EY P
Sbjct: 35 MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92
Query: 130 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 173
G+L FL++ L+ P+ A+ FA D+ARGM+YL + + IHRD
Sbjct: 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 149
Query: 174 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 233
L NIL ++ K+ADFG+S+ V + T R++A E Y T DV+
Sbjct: 150 LAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVW 207
Query: 234 SFALILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288
S+ ++L E++ G P M + ++P+ Y R P ++Y +L+ +CW
Sbjct: 208 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY-----DLMRQCW 260
Query: 289 NEKPAKRPTFRQIITRL 305
EKP +RP+F QI+ L
Sbjct: 261 REKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 87/261 (33%), Positives = 133/261 (50%), Gaps = 34/261 (13%)
Query: 57 EITKGTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 115
E+ GT W G +VA+K L +S + AF E +++K+RH +VQ L AV
Sbjct: 21 EVWMGT-----WNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-LYAVV 70
Query: 116 QSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173
P+ IVTEY+ KG L FLK + L+ V A IA GM Y+ + +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127
Query: 174 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKV 230
L +NIL ++ KVADFG+++L+ ED T + + ++ APE + K
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 231 DVFSFALILQEM-IEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIE 285
DV+SF ++L E+ +G P+ + E V + Y R P + P L+ +L+
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCPPECPESLH-----DLMC 237
Query: 286 ECWNEKPAKRPTFRQIITRLE 306
+CW ++P +RPTF + LE
Sbjct: 238 QCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 6/192 (3%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K + ++ + VR +E +LQ++ HP +V + M +V + L GDLR
Sbjct: 29 AMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR 88
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
L +K + +I + YLH IIHRD++P NIL D+ G++ + DF
Sbjct: 89 YHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFN 145
Query: 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 253
++ +T D T + Y+APEV + Y VD +S + E + G P+ H
Sbjct: 146 IATKVT--PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR-GH 202
Query: 254 DNEVPKAYAARQ 265
+ A+Q
Sbjct: 203 SRTIRDQIRAKQ 214
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-28
Identities = 82/254 (32%), Positives = 124/254 (48%), Gaps = 35/254 (13%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A K +E S DD R F EL +L K+ HPN++ LGA + + EY P G+L
Sbjct: 25 AAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 83
Query: 133 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 176
FL++ L+ A + FA D+ARGM+YL + + IHRDL
Sbjct: 84 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAA 140
Query: 177 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 236
NIL ++ K+ADFG+S+ V + T R++A E Y T DV+S+
Sbjct: 141 RNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYG 198
Query: 237 LILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 291
++L E++ G P M + ++P+ Y R P ++Y +L+ +CW EK
Sbjct: 199 VLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY-----DLMRQCWREK 251
Query: 292 PAKRPTFRQIITRL 305
P +RP+F QI+ L
Sbjct: 252 PYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 76/260 (29%), Positives = 128/260 (49%), Gaps = 36/260 (13%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---PMMIVTEYLPK 129
VAVKKL S + +R F E+ +L+ ++H N+V++ G V S+ + +V EYLP
Sbjct: 36 VAVKKLQH---STAEHLRDFEREIEILKSLQHDNIVKYKG-VCYSAGRRNLRLVMEYLPY 91
Query: 130 GDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
G LR +L K + L + +A I +GM YL + +HRDL NIL + +K
Sbjct: 92 GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVK 148
Query: 189 VADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
+ DFG++K+L ++ + ++ + APE ++ DV+SF ++L E+
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS 208
Query: 247 -----PP--FTMKHDNEVPKAYAA-----------RQRPPFKAPAKLYARGLKELIEECW 288
PP F N+ R P PA++YA +++ECW
Sbjct: 209 DKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYA-----IMKECW 263
Query: 289 NEKPAKRPTFRQIITRLESI 308
N P++RP+F ++ ++E+I
Sbjct: 264 NNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 20/223 (8%)
Query: 95 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 152
EL + + + P +V++ GA SS + I EY G L + K+ +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 153 DIA----RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208
IA +G++YLH K IIHRD++PSNIL G +K+ DFGVS L T
Sbjct: 109 KIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK----AYAAR 264
TS Y+APE + + Y DV+S L L E+ + PF + + + +Y
Sbjct: 165 -GTS-FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222
Query: 265 QRPP-FKAPAKL---YARGLKELIEECWNEKPAKRPTFRQIIT 303
P K ++ K+ I++C + P +RPT ++
Sbjct: 223 MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 82/277 (29%), Positives = 135/277 (48%), Gaps = 38/277 (13%)
Query: 48 HELDFTNS---VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL 99
+E ++ + V + KGT+ + + +++A+K++ E D V+ +E+AL
Sbjct: 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALH 59
Query: 100 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKP--STAVRFALDIAR 156
++H N+VQ+LG+ +++ I E +P G L A L+ K G LK T + + I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDT-SCR 214
G+ YLH+N+ I+HRD++ N+L + SG +K++DFG SK L P T T + +
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQ 174
Query: 215 YVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-------RQ 265
Y+APEV Y D++S + EM G PPF E+ + AA +
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI-----ELGEPQAAMFKVGMFKI 229
Query: 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
P P L A K I C+ P KR + ++
Sbjct: 230 HPEI--PESLSAEA-KNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 7/177 (3%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A+K L + I +V +E +LQ IRHP +V G+ S + +V EY+P G+L
Sbjct: 29 YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
+ L++ G A +A + + YLH I++RDL+P N+L D G +K+ DF
Sbjct: 89 FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDF 145
Query: 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G +K + + R T T Y+APE+ ++ Y VD ++ +++ EM+ G PPF
Sbjct: 146 GFAKRV---KGRTYTLCGT-PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 74/249 (29%), Positives = 121/249 (48%), Gaps = 26/249 (10%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129
++VAVK L + A EL ++ + H N+V LGA T P++++TEY
Sbjct: 66 MKVAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCY 123
Query: 130 GDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
GDL FL+RK L + F+ +A+GM +L IHRDL N+L +
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIV 180
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 244
K+ DFG+++ + D + + +++APE N Y + DV+S+ ++L E+
Sbjct: 181 KICDFGLAR--DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
Query: 245 --GCP----PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 298
P P K + + Y R P APA++Y ++++ CW+ P KRPTF
Sbjct: 239 LGSNPYPGMPVDSKFYKLIKEGY--RMAQPEHAPAEIY-----DIMKTCWDADPLKRPTF 291
Query: 299 RQIITRLES 307
+QI+ +
Sbjct: 292 KQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 54/184 (29%), Positives = 96/184 (52%), Gaps = 8/184 (4%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VA+KK+ S+ A R E+ LL+++ HPN+++ L + +V E++ DL
Sbjct: 27 VAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDL 84
Query: 133 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
+K + P + ++ + + +G+ + H + I+HRDL+P N+L + G LK+AD
Sbjct: 85 YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLAD 141
Query: 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
FG+++ RP T + Y APE+ ++ Y T VD++S I E++ P F
Sbjct: 142 FGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200
Query: 251 MKHD 254
K +
Sbjct: 201 GKSE 204
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 72/248 (29%), Positives = 115/248 (46%), Gaps = 34/248 (13%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
+VA+K++ E V R E+ + + HPNVV++ + + +V YL
Sbjct: 25 NNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82
Query: 129 KGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185
G L +K G L + ++ +G+ YLH N IHRD++ NIL + G
Sbjct: 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDG 139
Query: 186 NLKVADFGVSKLLTVKEDRPL----TCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQ 240
++K+ADFGVS L DR T T C ++APEV + YD K D++SF +
Sbjct: 140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPC-WMAPEVMEQVHGYDFKADIWSFGITAI 198
Query: 241 EMIEGCPPF-----------TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289
E+ G P+ T+++D P + A K Y++ +++I C
Sbjct: 199 ELATGAAPYSKYPPMKVLMLTLQND---PPSL------ETGADYKKYSKSFRKMISLCLQ 249
Query: 290 EKPAKRPT 297
+ P+KRPT
Sbjct: 250 KDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 16/225 (7%)
Query: 87 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 146
D V+A R E+ L+ + H N+VQ+LG T + I EY+P G + + L+ G +
Sbjct: 50 DMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109
Query: 147 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206
F + G+ YLH I+HRDL+ N+L D G K++DFG+SK +D
Sbjct: 110 VRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYD 163
Query: 207 TCQDTSCR----YVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPK 259
Q+ S + ++APEV + Y KVD++S ++ EM G P+ + + K
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
Query: 260 AYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
R PP L L + + C+ P RPT R+++
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVAL-DFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 77/244 (31%), Positives = 118/244 (48%), Gaps = 23/244 (9%)
Query: 73 VAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
VAVK E + D ++A F E +L++ HPN+V+ +G TQ P+ IV E + GD
Sbjct: 23 VAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79
Query: 132 LRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
FL+ +G LK ++ + A GM YL E+K IHRDL N L + LK++
Sbjct: 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYL-ESKHC--IHRDLAARNCLVTEKNVLKIS 136
Query: 191 DFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 245
DFG+S+ +ED + ++ APE Y ++ DV+SF ++L E G
Sbjct: 137 DFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLG 193
Query: 246 CPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
P+ + + +A R P P +Y L+E CW P +RP+F +
Sbjct: 194 AVPYANLSNQQTREAIEQGVRLPCPELCPDAVY-----RLMERCWEYDPGQRPSFSTVHQ 248
Query: 304 RLES 307
L+S
Sbjct: 249 ELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 67/231 (29%), Positives = 112/231 (48%), Gaps = 15/231 (6%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G VA+K + V D + E+++L++ P +V++ G+ +++ + IV EY
Sbjct: 28 GQVVAIKVV--PVEEDLQEII---KEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82
Query: 130 GDLRAFLKRKGALKPSTAVRFAL---DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
G + +K K T A +G+ YLH NK IHRD++ NIL ++ G
Sbjct: 83 GSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQ 137
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
K+ADFGVS LT + T T ++APEV + Y+ K D++S + EM EG
Sbjct: 138 AKLADFGVSGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
Query: 247 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 297
PP++ H + P P K ++ + +++C + P +RP+
Sbjct: 197 PPYSDIHPMRAIFMIPNKPPPTLSDPEK-WSPEFNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 11/214 (5%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 153
EL +L K P +V F GA + + I EY+ G L LK +G + + A+
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 213
+ +G+ YLHE IIHRD++PSNIL + G +K+ DFGVS L T
Sbjct: 109 VLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKT--FVGT 162
Query: 214 R-YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEVPKAYAARQRPPF 269
Y+APE + +Y K D++S L L E+ G PP D PP
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222
Query: 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
+ P+ ++ ++ + C + P +RP++++++
Sbjct: 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 84/253 (33%), Positives = 125/253 (49%), Gaps = 21/253 (8%)
Query: 61 GTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119
G + W G +VA+K L + + AF E +++K+RH +V L AV P
Sbjct: 20 GEVWMGTWNGTTKVAIKTLKPGTMMPE----AFLQEAQIMKKLRHDKLVP-LYAVVSEEP 74
Query: 120 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
+ IVTE++ KG L FLK LK V A IA GM Y+ + IHRDL +
Sbjct: 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAA 131
Query: 178 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 234
NIL D+ K+ADFG+++L+ ED T + + ++ APE + K DV+S
Sbjct: 132 NILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 235 FALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 293
F ++L E++ +G P+ + EV + R P L EL++ CW + P
Sbjct: 189 FGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC---PESLHELMKLCWKKDPD 245
Query: 294 KRPTFRQIITRLE 306
+RPTF I + LE
Sbjct: 246 ERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 5/178 (2%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VA+KK E +D + A R E+ +L+++RH N+V A + + +V EY+ + L
Sbjct: 29 VAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
G L P + + + + Y H + IIHRD++P NIL +SG LK+ DF
Sbjct: 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDF 144
Query: 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 249
G ++ L + PLT + Y APE+ + Y VDV++ I+ E+++G P F
Sbjct: 145 GFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 60/185 (32%), Positives = 94/185 (50%), Gaps = 17/185 (9%)
Query: 73 VAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEY 126
VA+KK + ++++ + A R E+ LLQK+RHPN+V+ VT + +V EY
Sbjct: 27 VALKK----IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81
Query: 127 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185
+ DL L S + + G+ YLH N I+HRD++ SNIL ++ G
Sbjct: 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDG 137
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIE 244
LK+ADFG+++ T + T + + Y PE+ Y +VD++S IL E+
Sbjct: 138 VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197
Query: 245 GCPPF 249
G P F
Sbjct: 198 GKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 74/259 (28%), Positives = 115/259 (44%), Gaps = 38/259 (14%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
VAVK L E + +D + F E LL +H N+V+F G T+ P ++V EY+ G
Sbjct: 36 ELVAVKTLKE--TASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93
Query: 131 DLRAFLKR--------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176
DL FL+ G L S ++ A+ IA GM YL V HRDL
Sbjct: 94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLAT 150
Query: 177 SNILRDDSGNLKVADFGVSK------LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 230
N L +K+ DFG+S+ V L R++ PE ++ T+
Sbjct: 151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML-----PIRWMPPESIMYRKFTTES 205
Query: 231 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEEC 287
DV+SF ++L E+ G P+ + EV + + + P P+++Y +++ C
Sbjct: 206 DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVY-----DIMLGC 260
Query: 288 WNEKPAKRPTFRQIITRLE 306
W P +R + I RL+
Sbjct: 261 WKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 77/243 (31%), Positives = 127/243 (52%), Gaps = 24/243 (9%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
+VAVK + +S V AF E +++ ++H +V+ L AV P+ I+TE++ KG
Sbjct: 32 KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 86
Query: 132 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
L FLK +G+ +P + F+ IA GM ++ + IHRDL +NIL S K+
Sbjct: 87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 143
Query: 190 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 245
ADFG+++++ ED T ++ + ++ APE + K DV+SF ++L E++ G
Sbjct: 144 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 200
Query: 246 CPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
P+ + EV +A R P P +LY ++ CW +P +RPTF I +
Sbjct: 201 RIPYPGMSNPEVIRALERGYRMPRPENCPEELY-----NIMMRCWKNRPEERPTFEYIQS 255
Query: 304 RLE 306
L+
Sbjct: 256 VLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 76/263 (28%), Positives = 118/263 (44%), Gaps = 42/263 (15%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VAVK L EE + D F+ E AL+ + HPN+V+ LG PM ++ EY+ GDL
Sbjct: 38 VAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95
Query: 133 RAFLKRKGALKPSTAVR----------------------FALDIARGMNYLHENKPVPII 170
FL+ + + A +A GM YL E K +
Sbjct: 96 NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FV 152
Query: 171 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTK 229
HRDL N L ++ +K+ADFG+S+ + + + D R++ PE Y T+
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 230 VDVFSFALILQEMIE-GCPP-FTMKHDNEVPKAYAARQ----RPPFKAPAKLYARGLKEL 283
DV+++ ++L E+ G P + M H+ + Y R P P +LY L
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVI---YYVRDGNVLSCPDNCPLELYN-----L 264
Query: 284 IEECWNEKPAKRPTFRQIITRLE 306
+ CW++ P+ RP+F I L+
Sbjct: 265 MRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 70/246 (28%), Positives = 112/246 (45%), Gaps = 21/246 (8%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VA+K++ + ++ + VR E +L + +V+ L A + + EY+P GD
Sbjct: 29 VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
R L G L A + ++ ++ LHE + IHRDL+P N L D SG++K+ DF
Sbjct: 89 RTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDF 145
Query: 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 252
G+SK + + + D Y+APEV + + YD VD +S +L E + G PPF+
Sbjct: 146 GLSKGIVTYANSVVGSPD----YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201
Query: 253 HDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
NE QRP + P + +LI + N+ R S+
Sbjct: 202 TPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPS----------RRFGSL 251
Query: 309 NNSINH 314
+ NH
Sbjct: 252 EDIKNH 257
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 70/253 (27%), Positives = 119/253 (47%), Gaps = 15/253 (5%)
Query: 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
DF +I KG+F + F A+K++ ++ +R A DE +L K+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 163
++++ + + IV EY GDL LK R L RF + I G+ +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 164 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 223
K I+HRD++ N+ D N+K+ D GV+KLL+ + T T Y++PE+ ++
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP-YYLSPELCED 175
Query: 224 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283
+ Y+ K DV++ ++L E G PF + + PP Y++ L +L
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM---YSQQLAQL 232
Query: 284 IEECWNEKPAKRP 296
I++C + +RP
Sbjct: 233 IDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 69/272 (25%), Positives = 130/272 (47%), Gaps = 19/272 (6%)
Query: 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRH 104
+F +I KG F + + G VA+KK+ E++ R + E+ LL+++ H
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDH 61
Query: 105 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAV-RFALDIARGMNY 160
PNV+++L + +++ + IV E GDL +K ++ L P + ++ + + + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 161 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 220
+H + I+HRD++P+N+ +G +K+ D G+ + + K + T Y++PE
Sbjct: 122 MHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPER 177
Query: 221 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYAR 278
Y+ K D++S +L EM PF N + K PP PA Y+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL--PADHYSE 235
Query: 279 GLKELIEECWNEKPAKRPTFRQIITRLESINN 310
L++L+ C N P KRP ++ + ++
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-26
Identities = 60/170 (35%), Positives = 91/170 (53%), Gaps = 17/170 (10%)
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALKPST 146
V A E+ LL+ ++H +VQ+ G + + + I EY+P G ++ LK GAL S
Sbjct: 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107
Query: 147 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206
++ I GM+YLH N I+HRD++ +NILRD +GN+K+ DFG SK L + +
Sbjct: 108 TRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTI 159
Query: 207 TCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
T R +++PEV E Y K DV+S + EM+ PP+
Sbjct: 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 16/220 (7%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 154
EL ++ + R P +V F GA + + + E++ G L K+ G + + A+ +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSC 213
G+ YL+ I+HRD++PSNIL + G +K+ DFGVS +L+ D T TS
Sbjct: 113 VEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD---TFVGTST 167
Query: 214 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------- 264
Y++PE + +Y K DV+S + + E+ G PF + ++ +
Sbjct: 168 -YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226
Query: 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304
Q PP + P+ + L++ ++ C + P +RPT +Q+
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 69/255 (27%), Positives = 120/255 (47%), Gaps = 30/255 (11%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VA+K L ++ + F+ E + +++HPN+V LG VT+ P+ ++ Y DL
Sbjct: 38 VAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 133 RAFL----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176
FL K L+P+ V IA GM +L + ++H+DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152
Query: 177 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 235
N+L D N+K++D G+ + + + L R+++PE ++ D++S+
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 236 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKP 292
++L E+ G P+ + +V + RQ P PA +Y L+ ECWNE P
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYT-----LMLECWNEFP 267
Query: 293 AKRPTFRQIITRLES 307
++RP F+ I +RL +
Sbjct: 268 SRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 73/244 (29%), Positives = 114/244 (46%), Gaps = 40/244 (16%)
Query: 73 VAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
VA+K VI D + E+++L++ RHPN+V + G+ + + IV EY G
Sbjct: 31 VAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85
Query: 131 DLRAFLKR-KGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
L+ + +G L + R L +G+ YLHE IHRD++ +NIL + G+
Sbjct: 86 SLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETG---KIHRDIKGANILLTEDGD 139
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMI 243
+K+ADFGVS LT + + T ++APEV E YD K D+++ + E+
Sbjct: 140 VKLADFGVSAQLTATIAKRKSFIGTP-YWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198
Query: 244 EGCPP----------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 293
E PP F + N P P K K ++ + I++C + P
Sbjct: 199 ELQPPMFDLHPMRALFLISKSNFPP--------PKLKDKEK-WSPVFHDFIKKCLTKDPK 249
Query: 294 KRPT 297
KRPT
Sbjct: 250 KRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 74/261 (28%), Positives = 126/261 (48%), Gaps = 31/261 (11%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 127
+ + VAVK L ++ D + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 43 KPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100
Query: 128 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
KG+LR +L+ + L V A +ARGM YL K IH
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157
Query: 172 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 230
RDL N+L + +K+ADFG+++ + + + T +++APE + Y +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 217
Query: 231 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 287
DV+SF ++L E+ G P+ E+ K R P +LY ++ EC
Sbjct: 218 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYM-----IMREC 272
Query: 288 WNEKPAKRPTFRQIITRLESI 308
W+ P++RPTF+Q++ L+ +
Sbjct: 273 WHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 27/255 (10%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVT 124
++VAVK + ++ + + + F E A ++ HPNV++ +G ++S + M++
Sbjct: 28 LKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVIL 86
Query: 125 EYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 178
++ GDL +FL R G L T ++F +DIA GM YL IHRDL N
Sbjct: 87 PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARN 143
Query: 179 ILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 236
+ + + VADFG+SK + D R +++A E + Y +K DV++F
Sbjct: 144 CMLREDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202
Query: 237 LILQE-MIEGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 293
+ + E G P+ ++E+ + R + P +LY +L+ CW P
Sbjct: 203 VTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELY-----DLMYSCWRADPK 257
Query: 294 KRPTFRQIITRLESI 308
RPTF ++ LE+I
Sbjct: 258 DRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 66/234 (28%), Positives = 122/234 (52%), Gaps = 12/234 (5%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
V +K++ E ++ D+R+ A ++E +L+ + HPN++++ + +MIV EY P G L
Sbjct: 28 VIIKQIPVEQMTKDERLAA-QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86
Query: 133 RAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKV 189
+++++ L T + F + I ++++H I+HRDL+ NIL D +K+
Sbjct: 87 AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKI 143
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
DFG+SK+L+ K + T T C Y++PE+ + + Y+ K D+++ +L E+ F
Sbjct: 144 GDFGISKILSSKS-KAYTVVGTPC-YISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201
Query: 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
+ +P F + Y+ L++LI N P+KRP QI+
Sbjct: 202 EAAN---LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 58/166 (34%), Positives = 91/166 (54%), Gaps = 7/166 (4%)
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPST 146
V A E+ LL+ +RH +VQ+ G + + + I EY+P G ++ LK GAL +
Sbjct: 48 VNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV 107
Query: 147 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV--KEDR 204
R+ I +G++YLH N I+HRD++ +NILRD +GN+K+ DFG SK +
Sbjct: 108 TRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164
Query: 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
+ + +++PEV E Y K DV+S A + EM+ PP+
Sbjct: 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 65/184 (35%), Positives = 98/184 (53%), Gaps = 13/184 (7%)
Query: 70 GIQVAVKK--LGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125
G VA+KK LGE + D + A R E+ LLQ+++HPN++ L S + +V E
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFT-ALR-EIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82
Query: 126 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
++ DL +K K L P+ + L RG+ YLH N I+HRDL+P+N+L
Sbjct: 83 FME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASD 138
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 243
G LK+ADFG+++ +R +T Q + Y APE+ F Y VD++S I E++
Sbjct: 139 GVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELL 197
Query: 244 EGCP 247
P
Sbjct: 198 LRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 76/267 (28%), Positives = 131/267 (49%), Gaps = 44/267 (16%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYL 127
G QVAVK L E S + + + E+ +L+ + H N+V++ G T+ + + ++ E+L
Sbjct: 33 GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 128 PKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
P G L+ +L R K + +++A+ I +GM+YL + +HRDL N+L +
Sbjct: 91 PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 147
Query: 187 LKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239
+K+ DFG++K + TVK+D D+ + APE ++ DV+SF + L
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDL-----DSPVFWYAPECLIQSKFYIASDVWSFGVTL 202
Query: 240 QEMIEGC----PPFTM-------KHDN-------EVPKAYAARQRPPFKAPAKLYARGLK 281
E++ C P T+ H V + RPP P ++Y
Sbjct: 203 YELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPP-NCPEEVY----- 256
Query: 282 ELIEECWNEKPAKRPTFRQIITRLESI 308
+L+ +CW +P+KR TF+ +I E+I
Sbjct: 257 QLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 72/259 (27%), Positives = 125/259 (48%), Gaps = 31/259 (11%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129
+ VAVK L ++ D + E+ +++ I +H N++ LGA TQ P+ ++ EY K
Sbjct: 48 VTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105
Query: 130 GDLRAFLKRKGALK----------PSTAVRF------ALDIARGMNYLHENKPVPIIHRD 173
G+LR +L+ + P + F +ARGM YL K IHRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRD 162
Query: 174 LEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 232
L N+L ++ +K+ADFG+++ + + + T +++APE + Y + DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 233 FSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWN 289
+SF +++ E+ G P+ E+ K R P +LY ++ +CW+
Sbjct: 223 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCWH 277
Query: 290 EKPAKRPTFRQIITRLESI 308
P+ RPTF+Q++ L+ I
Sbjct: 278 AIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 31/270 (11%)
Query: 57 EITKGTF--ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 113
E+ +GT IL G I+VAVK L + D + F E L+ HPN+V+ LG
Sbjct: 10 EVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGV 67
Query: 114 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA-------VRFALDIARGMNYLHENKP 166
+ P I+ E + GDL ++L+ + + LD+A+G YL +
Sbjct: 68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH- 126
Query: 167 VPIIHRDLEPSNILRDDSGN-----LKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPE 219
IHRDL N L + G +K+ DFG+++ + K D R R++APE
Sbjct: 127 --FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLPVRWMAPE 183
Query: 220 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLY 276
+ ++ T+ DV+SF +++ E++ G P+ ++ EV + A R + P P K+Y
Sbjct: 184 SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIY 243
Query: 277 ARGLKELIEECWNEKPAKRPTFRQIITRLE 306
+L+ CW + P++RPTF +I L+
Sbjct: 244 -----QLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 73/266 (27%), Positives = 127/266 (47%), Gaps = 31/266 (11%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 127
+ + VAVK L + + D + E+ L++ I +H N++ LG TQ P+ ++ EY
Sbjct: 43 QTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100
Query: 128 PKGDLRAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIH 171
KG+LR FL+ + P V A +ARGM YL + IH
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIH 157
Query: 172 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 230
RDL N+L + +K+ADFG+++ + + + + +++APE + Y +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217
Query: 231 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 287
DV+SF +++ E+ G P+ E+ K R P +LY L+ EC
Sbjct: 218 DVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYM-----LMREC 272
Query: 288 WNEKPAKRPTFRQIITRLESINNSIN 313
W+ P +RPTF+Q++ L+ + +++
Sbjct: 273 WHAVPTQRPTFKQLVEALDKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 74/236 (31%), Positives = 118/236 (50%), Gaps = 11/236 (4%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-IVTEYLP 128
G Q +KKL S +R +A E LL +++HPN+V + + ++ IV +
Sbjct: 25 GKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 129 KGDLRAFLK-RKGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
GDL LK +KG L P + V + + IA + YLHE I+HRDL+ N+ +
Sbjct: 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNI 140
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
+KV D G++++L + D T T Y++PE+F N+ Y+ K DV++ + EM
Sbjct: 141 IKVGDLGIARVLENQCDMASTLIGTP-YYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
Query: 247 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
F K N + + PP K Y+ L ELI +++P KRP+ + I+
Sbjct: 200 HAFNAKDMNSLVYRIIEGKLPPM---PKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 31/261 (11%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 127
R +VAVK L + D + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 49 RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106
Query: 128 PKGDLRAFL--KRKGALK----PSTA----------VRFALDIARGMNYLHENKPVPIIH 171
KG+LR +L +R ++ P+ V A +ARGM YL K IH
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIH 163
Query: 172 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 230
RDL N+L + +K+ADFG+++ + + + T +++APE + Y +
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223
Query: 231 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 287
DV+SF ++L E+ G P+ E+ K R P +LY ++ +C
Sbjct: 224 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 278
Query: 288 WNEKPAKRPTFRQIITRLESI 308
W+ P++RPTF+Q++ L+ I
Sbjct: 279 WHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 25/233 (10%)
Query: 83 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KG 140
I ++ + F E+ +L + +HPN+V A + + I+ E+ G L + + +G
Sbjct: 40 IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG 99
Query: 141 ALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS-KL 197
+P R L+ +N+LH +K +IHRDL+ NIL G++K+ADFGVS K
Sbjct: 100 LTEPQIRYVCRQMLE---ALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153
Query: 198 LTVKEDRPLTCQDT---SCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPF 249
+ + R DT + ++APEV FK+ YD K D++S + L E+ + PP
Sbjct: 154 KSTLQKR-----DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH 208
Query: 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
+ V + P P+K ++ + ++ C + P RPT +++
Sbjct: 209 HELNPMRVLLKILKSEPPTLDQPSK-WSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 71/251 (28%), Positives = 112/251 (44%), Gaps = 33/251 (13%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP------MMIVTE 125
VA+K + +D ++E +L+K HPN+ F GA + +P + +V E
Sbjct: 34 VAIKIMD----IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89
Query: 126 YLPKG---DL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 181
G DL + K+ LK + RG+ YLHENK +IHRD++ NIL
Sbjct: 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILL 146
Query: 182 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVFSFA 236
+ +K+ DFGVS L R T T ++APEV +E YD + DV+S
Sbjct: 147 TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY-WMAPEVIACDEQPDASYDARSDVWSLG 205
Query: 237 LILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 292
+ E+ +G PP H +P R PP + +++ + I EC +
Sbjct: 206 ITAIELADGKPPLCDMHPMRALFKIP-----RNPPPTLKSPENWSKKFNDFISECLIKNY 260
Query: 293 AKRPTFRQIIT 303
+RP +++
Sbjct: 261 EQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 58 ITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFL 111
+ KG+F +LA +G AVK L ++VI DD V E +L +HP + Q
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ V EY+ GDL ++R G A +A +I G+ +LHE II+
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIY 119
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 231
RDL+ N+L D G++K+ADFG+ K + T T Y+APE+ + Y VD
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP-DYIAPEILSYQPYGPAVD 178
Query: 232 VFSFALILQEMIEGCPPFTMKHDNEV 257
++ ++L EM+ G PF ++E+
Sbjct: 179 WWALGVLLYEMLAGQSPFEGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-24
Identities = 51/156 (32%), Positives = 91/156 (58%), Gaps = 7/156 (4%)
Query: 94 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 153
+E +L+++ HP +++ + ++ EY+P G+L ++L+ G ST + +A +
Sbjct: 50 NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 213
I + YLH + I++RDL+P NIL D G++K+ DFG +K L DR T T
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWTLCGTP- 162
Query: 214 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
Y+APEV +++ ++ VD ++ +++ EM+ G PPF
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 5e-24
Identities = 59/186 (31%), Positives = 95/186 (51%), Gaps = 9/186 (4%)
Query: 70 GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTE 125
G ++AVK++ E V A E+ LL+ + H +VQ+ G + + I E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185
++P G ++ LK GAL + ++ I G++YLH N I+HRD++ +NILRD G
Sbjct: 87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVG 143
Query: 186 NLKVADFGVSKLLTV--KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
N+K+ DFG SK L + + +++PEV E Y K D++S + EM+
Sbjct: 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203
Query: 244 EGCPPF 249
PP+
Sbjct: 204 TEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 51/166 (30%), Positives = 98/166 (59%), Gaps = 9/166 (5%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFA 151
E++L+++++H N+V+ + + +M+V EY+ K DL+ ++ +GAL P+T F
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
+ +G+ + HEN+ ++HRDL+P N+L + G LK+ADFG+++ + + + +
Sbjct: 107 YQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV 162
Query: 212 SCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 256
+ Y AP+V + Y T +D++S I+ EMI G P F ++ +
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-23
Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 14/238 (5%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
V K++ +S+ +R R +E+ +L ++HPN++ + + ++I EY G
Sbjct: 27 LVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85
Query: 132 L-RAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
L +++KG L V + L I ++Y+H+ I+HRD++ NI +G +K+
Sbjct: 86 LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
DFG+SK+L + T T Y++PE+ + +Y+ K D+++ +L E++
Sbjct: 143 GDFGISKILGSEYSMAETVVGTP-YYMSPELCQGVKYNFKSDIWALGCVLYELL--TLKR 199
Query: 250 TMKHDN--EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
T N + P + Y+ L L+ + P KRPT +++ +
Sbjct: 200 TFDATNPLNLVVKIVQGNYTPVVSV---YSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-23
Identities = 72/254 (28%), Positives = 116/254 (45%), Gaps = 24/254 (9%)
Query: 57 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116
E+ +G L R + VA+ L SD R R F E L + H N+V+ G +T+
Sbjct: 20 ELCRGCLKLPSKRELPVAIHTL-RAGCSDKQR-RGFLAEALTLGQFDHSNIVRLEGVITR 77
Query: 117 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 175
+ MMIVTEY+ G L +FL++ +G L + +A GM YL E + +H+ L
Sbjct: 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLA 134
Query: 176 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKV 230
+L + K++ F ++ED+ T + APE + + +
Sbjct: 135 AHKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189
Query: 231 DVFSFALILQE-MIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 287
DV+SF +++ E M G P+ +V KA R P P L+ +L+ +C
Sbjct: 190 DVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH-----QLMLDC 244
Query: 288 WNEKPAKRPTFRQI 301
W ++ +RP F QI
Sbjct: 245 WQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-23
Identities = 76/253 (30%), Positives = 118/253 (46%), Gaps = 23/253 (9%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-------SPMMIV 123
++VAVK + + I + F E +++ HPNV++ +G Q+ SP++I+
Sbjct: 27 LKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL 85
Query: 124 TEYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
++ GDL +FL R G L V+F DIA GM YL IHRDL
Sbjct: 86 P-FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAAR 141
Query: 178 NILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 236
N + +++ N+ VADFG+SK + + R +++A E + Y TK DV+SF
Sbjct: 142 NCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG 201
Query: 237 LILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
+ + E+ G P+ ++E+ RQ K P GL L+ CW P R
Sbjct: 202 VTMWEIATRGQTPYPGVENSEIYDYL--RQGNRLKQPPDCL-DGLYSLMSSCWLLNPKDR 258
Query: 296 PTFRQIITRLESI 308
P+F + LE
Sbjct: 259 PSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 6e-23
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 18/252 (7%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL-GAVTQSSPMMIVTEYLP 128
G +VA+K L + ++ + FR E AL ++ HPN+V L + V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 185
LR L GAL R L + + H I+HRDL+P NI+
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRP 119
Query: 186 NLKVADFGVSKLLT-VKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVDVFSFALIL 239
+ KV DFG+ LL V++ T T + Y APE + E D++++ LI
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 240 QEMIEGCPPFTMKHDNEVPKAYAARQRP-PFKAPAKLYARGLKELIEECWNEKPAKRP-T 297
E + G E+ + P P + L +++ + N+ P +R +
Sbjct: 180 LECLTGQRVVQGASVAEI---LYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAAS 236
Query: 298 FRQIITRLESIN 309
+ R ++
Sbjct: 237 APALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 6e-23
Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 14/215 (6%)
Query: 51 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 102
DF + + KG+F +LA +G A+K L ++VI DD V E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK- 59
Query: 103 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 162
P + Q + V EY+ GDL +++ G K AV +A +IA G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 163 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 222
II+RDL+ N++ D G++K+ADFG+ K T T Y+APE+
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP-DYIAPEIIA 174
Query: 223 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 257
+ Y VD ++F ++L EM+ G PPF + ++E+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 7e-23
Identities = 60/182 (32%), Positives = 101/182 (55%), Gaps = 13/182 (7%)
Query: 73 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
VA+KK+ E ++D+ V A R E++LL+++ HPN+V+ L V + + +V E+L
Sbjct: 27 VALKKIRLE--TEDEGVPSTAIR-EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL- 82
Query: 131 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
DL+ ++ L P + + +G+ Y H ++ ++HRDL+P N+L D G LK
Sbjct: 83 DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALK 139
Query: 189 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 247
+ADFG+++ V R T + + Y APE+ + +Y T VD++S I EM+ P
Sbjct: 140 LADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198
Query: 248 PF 249
F
Sbjct: 199 LF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 7e-23
Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 23/200 (11%)
Query: 70 GIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
+ A+K L + + + +V+ ++ L + HP +++ + V EY P
Sbjct: 26 NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85
Query: 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
G+L ++++ G+L +A +I + YLH IIHRDL+P NIL D ++K
Sbjct: 86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIK 142
Query: 189 VADFGVSKLL---------------TVKEDRPLTCQDTS----CRYVAPEVFKNEEYDTK 229
+ DFG +K+L + + S YV+PE+ +
Sbjct: 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS 202
Query: 230 VDVFSFALILQEMIEGCPPF 249
D+++ I+ +M+ G PPF
Sbjct: 203 SDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 8e-23
Identities = 65/244 (26%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G Q +K++ +S +R + R E+A+L ++HPN+VQ+ + ++ + IV +Y
Sbjct: 25 GKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 130 GDLRAFL-KRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
GDL + ++G L P + + + I + ++H+ K I+HRD++ NI G +
Sbjct: 84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTI 140
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 247
K+ DFG++++L + TC T Y++PE+ +N Y+ K D+++ +L EM
Sbjct: 141 KLGDFGIARVLNSTVELARTCIGTP-YYLSPEICENRPYNNKSDIWALGCVLYEMC---- 195
Query: 248 PFTMKH-------DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
T+KH N V K R + + Y+ L+ L+ + + P RP+
Sbjct: 196 --TLKHAFEAGNMKNLVLKII----RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNS 249
Query: 301 IITR 304
I+ +
Sbjct: 250 ILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 60 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAF---RDELALLQKIRHPNVVQFL 111
KG+F +LA +G A+K L ++V+ +DD V R LAL + HP +
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFLTHLF 62
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ V EYL GDL ++ G + A +A +I G+ +LH+ II+
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIY 119
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 228
RDL+ N+L D G++K+ADFG+ K E + T C Y+APE+ K ++Y+
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK----ASTFCGTPDYIAPEILKGQKYNE 175
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEV 257
VD +SF ++L EM+ G PF + ++E+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 60/182 (32%), Positives = 95/182 (52%), Gaps = 10/182 (5%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPK 129
VA+KK+ + D + + R E+ LL +RHPN+V+ V + +V EY +
Sbjct: 34 IVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92
Query: 130 GDLRAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
DL + L + V+ L + RG+ YLHEN IIHRDL+ SN+L D G LK
Sbjct: 93 -DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLK 148
Query: 189 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 247
+ADFG+++ + +P+T + + Y APE+ Y T +D+++ IL E++ P
Sbjct: 149 IADFGLARTYGLP-AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207
Query: 248 PF 249
Sbjct: 208 LL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 65/195 (33%), Positives = 94/195 (48%), Gaps = 27/195 (13%)
Query: 70 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIV 123
G +VA+KK+ V D D R R E+ LL+ +RH N++ L + SP IV
Sbjct: 25 GRKVAIKKI-SNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
TE + DL +K L F I RG+ YLH +IHRDL+PSNIL +
Sbjct: 83 TELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNS 138
Query: 184 SGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEVFKN-EEYDTKVDVFS 234
+ +LK+ DFG+++ + ED LT YV APE+ + Y +D++S
Sbjct: 139 NCDLKICDFGLARGVDPDEDEKGFLT------EYVVTRWYRAPELLLSSSRYTKAIDIWS 192
Query: 235 FALILQEMIEGCPPF 249
I E++ P F
Sbjct: 193 VGCIFAELLTRKPLF 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 63/191 (32%), Positives = 102/191 (53%), Gaps = 13/191 (6%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA-VTQSSPMMIVTEYL 127
G VA+KK+ + + R +R EL LL+ +RH N++ ++ + VTE L
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92
Query: 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
DL L L+ F I RG+ Y+H ++HRDL+PSNIL +++ +L
Sbjct: 93 GT-DLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDL 147
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGC 246
K+ DFG++++ +D +T ++ Y APE+ ++YD +VD++S I EM+EG
Sbjct: 148 KICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
Query: 247 PPFTMK-HDNE 256
P F K H N+
Sbjct: 204 PLFPGKDHVNQ 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 57/182 (31%), Positives = 96/182 (52%), Gaps = 21/182 (11%)
Query: 73 VAVKKLGEEVISDDDRVRAF--RDELALLQKIR---HPNVVQFLG-----AVTQSSPMMI 122
VA+KK+ V ++ + R E+ALL+++ HPN+V+ L + + +
Sbjct: 27 VALKKV--RVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83
Query: 123 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180
V E++ + DL +L + K L P T + RG+++LH ++ I+HRDL+P NIL
Sbjct: 84 VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNIL 139
Query: 181 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 240
G +K+ADFG++++ + + LT + Y APEV Y T VD++S I
Sbjct: 140 VTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197
Query: 241 EM 242
E+
Sbjct: 198 EL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 42/267 (15%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIVTEYL 127
G VAVK L E ++ E+ +L+ + H N+V++ G ++ + ++ EY+
Sbjct: 33 GEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
P G LR +L + L + + FA I GM YLH IHRDL N+L D+ +
Sbjct: 91 PLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146
Query: 188 KVADFGVSKLLT-------VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 240
K+ DFG++K + V+ED D+ + A E K ++ DV+SF + L
Sbjct: 147 KIGDFGLAKAVPEGHEYYRVRED-----GDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201
Query: 241 EMIEGCPPF-------------TMKHDNEVP--KAYAARQRPPF--KAPAKLYARGLKEL 283
E++ C V + R P P ++Y L
Sbjct: 202 ELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVY-----IL 256
Query: 284 IEECWNEKPAKRPTFRQIITRLESINN 310
++ CW + RPTFR +I L+ +++
Sbjct: 257 MKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 65/252 (25%), Positives = 120/252 (47%), Gaps = 24/252 (9%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
+ + VAVK L +V F E+ ++ ++++PN+++ LG P+ ++TEY+
Sbjct: 43 QPVLVAVKMLRADVTKTARN--DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100
Query: 129 KGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176
GDL FL ++ ++ + + A+ IA GM YL + +HRDL
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157
Query: 177 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 235
N L + +K+ADFG+S+ L + + + R++A E ++ T DV++F
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217
Query: 236 ALILQEMIEGCP--PFTMKHDNEVPKA----YAARQRPPFKAPAKLYARGLKELIEECWN 289
+ L EM C P+++ D +V + + + R + + L + +L+ CW+
Sbjct: 218 GVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWS 277
Query: 290 EKPAKRPTFRQI 301
RPTF +I
Sbjct: 278 RDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 5/177 (2%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K + + I + + E +L++ HP +V+ + ++ EY G+L
Sbjct: 22 ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
L+ +G TA + + YLH II+RDL+P N+L D +G +K+ DFG
Sbjct: 82 TILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFG 138
Query: 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
+K L + + T T YVAPE+ N+ YD VD +S ++L E++ G PPF
Sbjct: 139 FAKKLKSGQ-KTWTFCGTP-EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 45/211 (21%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L + + +++ R E +L P +V+ + + +V EY+P GDL
Sbjct: 30 AMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM 89
Query: 134 AFLKRKGALKPSTAVRF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
L RK TA RF ALD + + IHRD++P NIL D G+
Sbjct: 90 NLLIRKDVFPEETA-RFYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGH 139
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDT----------------------------SCRYVAP 218
+K+ADFG+ K + +DR D+ + Y+AP
Sbjct: 140 IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199
Query: 219 EVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
EV + Y + D +S +IL EM+ G PPF
Sbjct: 200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-22
Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 5/185 (2%)
Query: 74 AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
AVK L ++ I + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 24 AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL 83
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
L+R+ + A +A +IA + YLH II+RDL+P NIL D G++ + DF
Sbjct: 84 FFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDF 140
Query: 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 252
G+ K T T Y+APEV + + YD VD + +L EM+ G PPF +
Sbjct: 141 GLCKEGIEHSKTTSTFCGTP-EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
Query: 253 HDNEV 257
E+
Sbjct: 200 DTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 5e-22
Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 11/227 (4%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
G A+K L + I +V+ E ++L ++ HP +V + + + + + E++
Sbjct: 42 TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101
Query: 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
G+L L++ G A + ++ YLH II+RDL+P N+L D+ G++K
Sbjct: 102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158
Query: 189 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 248
V DFG +K + DR T T Y+APEV +++ + VD ++ ++L E I G PP
Sbjct: 159 VTDFGFAKKVP---DRTFTLCGTP-EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
Query: 249 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
F D+ + Y K P R ++L++ KR
Sbjct: 215 F---FDDTPFRIYEKILAGRLKFPNWFDGRA-RDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-22
Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 11/215 (5%)
Query: 93 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPS-TAVRF 150
R E LL K++HPN+V F + + IV EY GDL +K ++G L P T +++
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210
+ + G+ ++HE + ++HRD++ NI +G +K+ DFG ++LLT T
Sbjct: 106 FVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG 162
Query: 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH-DNEVPKAYAARQRPPF 269
T YV PE+++N Y+ K D++S IL E+ PF N + K +P
Sbjct: 163 TP-YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-- 219
Query: 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304
P+ Y+ L+ LI++ + P RP+ I++R
Sbjct: 220 -LPSH-YSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 6e-22
Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 20/218 (9%)
Query: 51 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 102
DF + + KG+F +LA +G A+K L ++V+ DD V E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK- 59
Query: 103 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 162
P + Q + V EY+ GDL +++ G K AV +A +I+ G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 163 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPE 219
II+RDL+ N++ D G++K+ADFG+ K V T C Y+APE
Sbjct: 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAPE 171
Query: 220 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 257
+ + Y VD +++ ++L EM+ G PPF + ++E+
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-22
Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 10/217 (4%)
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL-KPSTAV 148
A + E+ LL K++HPN+V F + ++ + IV EY GDL + R +G L +
Sbjct: 45 ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL 104
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLT 207
+ + I+ G+ ++H+ K I+HRD++ NI +G + K+ DFG+++ L + T
Sbjct: 105 SWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161
Query: 208 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 267
C T Y++PE+ +N Y+ K D++S +L E+ PF N + + +
Sbjct: 162 CVGTP-YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF---EGNNLHQLVLKICQG 217
Query: 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304
F + ++R L+ LI + + P RP+ I+ R
Sbjct: 218 YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-22
Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 11/190 (5%)
Query: 69 RGIQVAVKKLG---EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125
+G +AVK++ V++ + ++E+ LL+ ++H N+VQ+LG + + I E
Sbjct: 23 QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82
Query: 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185
++P G + + L R G L ++ I G+ YLH N ++HRD++ +N++ +G
Sbjct: 83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNG 139
Query: 186 NLKVADFGVSKLL-----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 240
+K+ DFG ++ L L + ++APEV Y K D++S +
Sbjct: 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199
Query: 241 EMIEGCPPFT 250
EM G PP
Sbjct: 200 EMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 23/266 (8%)
Query: 46 DPHELDFTNSVEI---TKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
DP N V+I + G +A + G QVAVKK+ + R +E+ +++
Sbjct: 16 DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMR 71
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 160
+HPN+V+ + + +V E+L G L + + A L + + +++
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSF 130
Query: 161 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 220
LH +IHRD++ +IL G +K++DFG ++ + R + T ++APEV
Sbjct: 131 LHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTP-YWMAPEV 186
Query: 221 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----PPFKAPAKLY 276
Y T+VD++S +++ EM++G PP+ NE P R R P K K+
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYF----NEPPLQAMKRIRDNLPPKLKNLHKVS 242
Query: 277 ARGLKELIEECWNEKPAKRPTFRQII 302
R L+ ++ PA+R T +++
Sbjct: 243 PR-LRSFLDRMLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 66/244 (27%), Positives = 117/244 (47%), Gaps = 23/244 (9%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
VAVK ++ +D+ A +DEL ++Q++ +P +V+ +G + ++ M+V E
Sbjct: 25 VAVK-----ILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG-ICEAESWMLVMELAE 78
Query: 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
G L FL++ + ++ GM YL E +HRDL N+L K
Sbjct: 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAK 135
Query: 189 VADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 245
++DFG+SK L E+ + T ++ APE ++ +K DV+SF +++ E G
Sbjct: 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYG 195
Query: 246 CPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
P+ NEV + + +R P + P ++Y +L++ CW +RP F +
Sbjct: 196 QKPYKGMKGNEVTQMIESGERMECPQRCPPEMY-----DLMKLCWTYGVDERPGFAVVEL 250
Query: 304 RLES 307
RL +
Sbjct: 251 RLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 43/235 (18%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVR-- 149
E LL + H N++ L + P ++ Y+ G+L+ FL+ R G A+
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 150 ----FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK--------L 197
A+ IA GM+YLH+ +IH+D+ N + D+ +K+ D +S+
Sbjct: 118 QLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 198 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCP-----PFT 250
L E+RP+ +++A E N+EY + DV+SF ++L E++ P PF
Sbjct: 175 LGDNENRPV-------KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227
Query: 251 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
M + Y Q P P +L+A ++ CW P +RP+F Q++ L
Sbjct: 228 MAA--YLKDGYRLAQ--PINCPDELFA-----VMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 110
I+KG F LA R G A+K L + + ++V + E A++ P V +
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 111 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 170
+ + +V EYL GD + +K G L A ++ ++ G+ LH+ II
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119
Query: 171 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 230
HRD++P N+L D +G+LK+ DFG+S+ + T Y+APE D
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-----YLAPETILGVGDDKMS 174
Query: 231 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 264
D +S ++ E + G PPF E P A
Sbjct: 175 DWWSLGCVIFEFLFGYPPF----HAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-21
Identities = 60/236 (25%), Positives = 117/236 (49%), Gaps = 13/236 (5%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G +VA+K++ + + +E+ ++++ +HPN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G L + + + + + + +LH N+ +IHRD++ NIL G++K+
Sbjct: 101 GSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
DFG +T ++ + T T ++APEV + Y KVD++S ++ EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 250 TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
++N + Y A P + P KL A ++ + C KR + ++++
Sbjct: 216 L--NENPLRALYLIATNGTPELQNPEKLSA-IFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-21
Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 30/256 (11%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
I VAVK L + + D+ + F E LL ++H ++V+F G + P+++V EY+ G
Sbjct: 36 ILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 131 DLRAFLKRKGA-------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
DL FL+ G L S + A IA GM YL +HRDL
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR 149
Query: 178 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 236
N L ++ +K+ DFG+S+ + + R R++ PE ++ T+ DV+S
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 209
Query: 237 LILQEMIE-GCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKP 292
++L E+ G P+ +NEV + QRP P ++Y +L+ CW +P
Sbjct: 210 VVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR-TCPKEVY-----DLMLGCWQREP 263
Query: 293 AKRPTFRQIITRLESI 308
R ++I + L+++
Sbjct: 264 HMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-21
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 74 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
AVK L ++ I + + + A R+ LL+ ++HP +V + + + V +Y+ G
Sbjct: 24 AVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
+L L+R+ A +A ++A + YLH + II+RDL+P NIL D G++ +
Sbjct: 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLT 138
Query: 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
DFG+ K E+ T T Y+APEV + E YD VD + +L EM+ G PPF
Sbjct: 139 DFGLCKEGVEPEETTSTFCGTP-EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF- 196
Query: 251 MKHDNEVPKAYAARQRPPFKAP 272
+ +V + Y P + P
Sbjct: 197 --YSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-21
Identities = 67/249 (26%), Positives = 121/249 (48%), Gaps = 21/249 (8%)
Query: 57 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGA 113
E+ + T +L G+ VA+KK+ I D +A D E+ LL+++ HPNV+++ +
Sbjct: 17 EVYRATCLL---DGVPVALKKVQ---IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70
Query: 114 VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 169
+ + + IV E GDL + F K+K + T ++ + + + ++H + +
Sbjct: 71 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---V 127
Query: 170 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 229
+HRD++P+N+ +G +K+ D G+ + + K + T Y++PE Y+ K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPERIHENGYNFK 186
Query: 230 VDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARGLKELIEEC 287
D++S +L EM PF N + K PP P+ Y+ L++L+ C
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSEELRQLVNMC 244
Query: 288 WNEKPAKRP 296
N P KRP
Sbjct: 245 INPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 67/210 (31%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIR 103
D+T +I +GT+ + + G VA+KK+ E S+++ V A R E++LL++++
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIR-EISLLKELQ 57
Query: 104 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFAL-DIARGMNY 160
HPN+V + Q S + ++ E+L DL+ +L KG + V+ L I +G+ +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 161 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 220
H + ++HRDL+P N+L D+ G +K+ADFG+++ + R T + + Y APEV
Sbjct: 117 CHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEV 172
Query: 221 F-KNEEYDTKVDVFSFALILQEMIEGCPPF 249
+ Y T VD++S I EM P F
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 7e-21
Identities = 68/244 (27%), Positives = 116/244 (47%), Gaps = 20/244 (8%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G+ +A+K++ E+ D+ + EL +L K P +V F GA + + EY+
Sbjct: 26 GVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83
Query: 130 GDLRAFLKRKGAL--KPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
G L A P +R + +G+ +L E IIHRD++P+N+L + +G
Sbjct: 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQ 141
Query: 187 LKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALIL 239
+K+ DFGVS L+ + CQ Y+APE K+ Y + DV+S L +
Sbjct: 142 VKLCDFGVSGNLVASLAKTNIGCQS----YMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197
Query: 240 QEMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 298
EM G P+ + + N + A P P+ Y+ ++ + +C N+ P +RPT+
Sbjct: 198 LEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG-YSDDAQDFVAKCLNKIPNRRPTY 256
Query: 299 RQII 302
Q++
Sbjct: 257 AQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 67/252 (26%), Positives = 125/252 (49%), Gaps = 30/252 (11%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
+VA+K + E S +R+ F +E +++++ +VV+ LG V+Q P +++ E + +GD
Sbjct: 38 RVAIKTVNEAA-SMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 95
Query: 132 LRAFLKRKGALKPSTA-------------VRFALDIARGMNYLHENKPVPIIHRDLEPSN 178
L+++L+ +L+P ++ A +IA GM YL+ NK +HRDL N
Sbjct: 96 LKSYLR---SLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARN 149
Query: 179 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 237
+ + +K+ DFG+++ + R R+++PE K+ + T DV+SF +
Sbjct: 150 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209
Query: 238 ILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 294
+L E+ P+ + +V + P P L+ EL+ CW P
Sbjct: 210 VLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKM 264
Query: 295 RPTFRQIITRLE 306
RP+F +II+ ++
Sbjct: 265 RPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 17/232 (7%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYL 127
+G AVK L ++V+ DD V E +L +P + + V E+L
Sbjct: 19 KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78
Query: 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
GDL ++ KG A +A +I G+ +LH II+RDL+ N++ D G++
Sbjct: 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHI 135
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 247
K+ADFG+ K ++R T T Y+APE+ + +Y VD +SF ++L EM+ G
Sbjct: 136 KIADFGMCKENVFGDNRASTFCGTP-DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194
Query: 248 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL----KELIEECWNEKPAKR 295
PF ++E+ + + R P Y R + K+++E+ + P +R
Sbjct: 195 PFHGDDEDELFE--SIRVDTPH------YPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 27/246 (10%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G +AVK++ V S + + R D ++ + P V F GA+ + + I E +
Sbjct: 26 GTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VMD 83
Query: 130 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185
L F K+ KG P + + A+ I + + YLH V IHRD++PSN+L + +G
Sbjct: 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNG 141
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVF----KNEEYDTKVDVFSFALILQ 240
+K+ DFG+S L D D C+ Y+APE + YD K DV+S + +
Sbjct: 142 QVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198
Query: 241 EMIEGCPPFTMKHD-----NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
E+ G P+ +V + P + PA+ ++ ++ + +C + +R
Sbjct: 199 ELATGRFPYDSWKTPFQQLKQVVEE------PSPQLPAEKFSPEFQDFVNKCLKKNYKER 252
Query: 296 PTFRQI 301
P + ++
Sbjct: 253 PNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 81/295 (27%), Positives = 134/295 (45%), Gaps = 48/295 (16%)
Query: 39 EVPEYEID-PHEL---DFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 94
EV E+ P +L F +V KG R + VAVK L + ++ + F
Sbjct: 20 EVHLCEVVNPQDLPTLQFPFNVR--KG-------RPLLVAVKILRPD--ANKNARNDFLK 68
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------- 140
E+ +L +++ PN+++ LG P+ ++TEY+ GDL FL
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 141 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195
A+ S+ + AL IA GM YL + +HRDL N L ++ +K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 196 KLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC--PPFTMK 252
+ L + + + R++A E ++ T DV++F + L E++ C P+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 253 HDNEVPKAYA------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
D +V + RQ F+ P +GL EL+ +CW+ +RP+F I
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPP--CPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-20
Identities = 57/189 (30%), Positives = 100/189 (52%), Gaps = 11/189 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A+K + +E+++DD+ + + E + Q HP +V S + V EY+ GDL
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 140
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K + RP T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 141 GMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 250 TMKHDNEVP 258
+ ++ P
Sbjct: 197 DIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 54/189 (28%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A+K + +E+++DD+ + + E + HP +V S + V E++ GDL
Sbjct: 24 AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL 83
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
++R+ L A ++ +I+ +N+LHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 140
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K + RP T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 141 GMCK----EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 250 TMKHDNEVP 258
+ ++ P
Sbjct: 197 DIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-20
Identities = 57/186 (30%), Positives = 98/186 (52%), Gaps = 11/186 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A+K + +E++ DD+ + + E + Q +P +V +S + +V EY+ GDL
Sbjct: 24 AMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
++R+ L A +A +I +N+LHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDY 140
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K + P T C Y+APE+ + EEY VD ++ +++ EM+ G PF
Sbjct: 141 GMCK----EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 250 TMKHDN 255
+ DN
Sbjct: 197 DIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-20
Identities = 61/254 (24%), Positives = 110/254 (43%), Gaps = 32/254 (12%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
+V VK+L + D F E+ +++ HPNV+Q LG +S P ++V E+ P
Sbjct: 21 SKARVVVKEL--RASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78
Query: 129 KGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
GDL+ +L+ + R A ++A G+ +LH+ IH DL N
Sbjct: 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTA 135
Query: 184 SGNLKVADFGVSKLLTVKEDRPLT--CQDTSCRYVAPEVFKNEEYDTKV-------DVFS 234
++K+ D+G++ L ED +T C R++APE+ + D +++S
Sbjct: 136 DLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194
Query: 235 FALILQEMIE-GCPPFTMKHDNEVPKAYAARQR------PPFKAPAKLYARGLKELIEEC 287
+ + E+ P+ +E R++ P Y+ E+++ C
Sbjct: 195 LGVTMWELFTAADQPYP-DLSDEQVLKQVVREQDIKLPKPQLDLK---YSDRWYEVMQFC 250
Query: 288 WNEKPAKRPTFRQI 301
W + P RPT ++
Sbjct: 251 WLD-PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-20
Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 19/233 (8%)
Query: 78 LGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYL---PKGDLR 133
G++ D + E+ ++ +++RHPN+V++ ++ + IV + + P G+
Sbjct: 41 FGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF 100
Query: 134 AFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
LK K + + + + YLH+ K I+HRDL P+NI+ + + + DF
Sbjct: 101 NSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158
Query: 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 252
G++K + + LT + Y PE+ KNE Y K DV++F IL +M PPF
Sbjct: 159 GLAK--QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF--- 213
Query: 253 HDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
+ + K A P P +Y+ + ++I C RP Q+
Sbjct: 214 YSTNMLSLATKIVEAVYEP---LPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-20
Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 13/231 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A KKL ++ + + +E +L+K+ +V A + +V + GDL+
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81
Query: 134 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
+ G + A+ +A I G+ +LH+ + I++RDL+P N+L DD GN++++D
Sbjct: 82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISD 138
Query: 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 251
G++ + +K + + + + Y+APEV + E YD VD F+ L EMI G PF
Sbjct: 139 LGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196
Query: 252 ---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299
K + E K + P K ++ K+L E + P KR R
Sbjct: 197 RKEKVEKEELKRRTLEM--AVEYPDK-FSPEAKDLCEALLQKDPEKRLGCR 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 8e-20
Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 150
E LL K+ HP +V+F + + I+TEY DL L + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209
+ + G++Y+H+ + I+HRDL+ NI L+++ LK+ DFGVS+LL D T
Sbjct: 112 FIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFT 166
Query: 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 269
T Y++PE K++ YD+K D++S IL EM C + N + + P
Sbjct: 167 GTP-YYMSPEALKHQGYDSKSDIWSLGCILYEMC--CLAHAFEGQNFLSVVLRIVEGPTP 223
Query: 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
P Y+R L +++ N+ P+ RP+ +I+
Sbjct: 224 SLPET-YSRQLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 58 ITKGTF---ILAFWRGIQV--AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFL 111
I KG+F +LA + + AVK L ++ I + E LL+ ++HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ + + V +Y+ G+L L+R+ A +A +IA + YLH + I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVY 119
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 228
RDL+P NIL D G++ + DFG+ K + T C Y+APEV + YD
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEV 257
VD + +L EM+ G PPF ++ E+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 60 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFL 111
KG+F +LA +G A+K L ++VI DD V E LAL K HP +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTALH 62
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ V EY+ GDL ++R + +A ++ + +LH + +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIY 119
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 231
RDL+ NIL D G+ K+ADFG+ K + T T Y+APE+ + EY VD
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP-DYIAPEILQELEYGPSVD 178
Query: 232 VFSFALILQEMIEGCPPFTMKHDNE 256
++ +++ EM+ G PPF + DNE
Sbjct: 179 WWALGVLMYEMMAGQPPF--EADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-19
Identities = 64/239 (26%), Positives = 113/239 (47%), Gaps = 22/239 (9%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127
I VA+K I D + F+ D + + + H +V+ LG +S + +VT+
Sbjct: 37 IPVAIK-----TIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLS 90
Query: 128 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
P G L + + + +L P + + + IA+GM YL E++ ++HR+L NIL
Sbjct: 91 PLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSI 147
Query: 187 LKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 244
+++ADFGV+ LL + + + T +++A E Y + DV+S+ + + EM+
Sbjct: 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207
Query: 245 GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
G P+ +EVP +R P +Y +K CW RPTF+++
Sbjct: 208 GAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVK-----CWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 62/188 (32%), Positives = 94/188 (50%), Gaps = 19/188 (10%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 123
G +VA+KKL S R +R EL LL+ + H NV+ L T +S + +V
Sbjct: 40 GRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRD 182
T L DL +K + L ++F + I RG+ Y+H IIHRDL+PSNI +
Sbjct: 99 TH-LMGADLNNIVKCQ-KLSDDH-IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVN 152
Query: 183 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQE 241
+ LK+ DFG+++ D +T + Y APE+ N Y+ VD++S I+ E
Sbjct: 153 EDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
Query: 242 MIEGCPPF 249
++ G F
Sbjct: 209 LLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 150
E+ LL+++ HPNV+++L + + + + IV E GDL + F K+K + T ++
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210
+ + + ++H + ++HRD++P+N+ +G +K+ D G+ + + K +
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPP 268
T Y++PE Y+ K D++S +L EM PF N Q PP
Sbjct: 169 TP-YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRP 296
P + Y+ L+EL+ C P +RP
Sbjct: 228 L--PTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 121
G VA+KK+ D + A R E+ +L+K++HPNVV + + +
Sbjct: 33 GRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91
Query: 122 IVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180
+VT Y+ DL L+ L S + L + G+NYLHEN I+HRD++ +NIL
Sbjct: 92 MVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANIL 147
Query: 181 RDDSGNLKVADFGVSKLLTVKEDRP------LTCQDTSC---R-YVAPEVFKNE-EYDTK 229
D+ G LK+ADFG+++ P T + T+ R Y PE+ E Y T
Sbjct: 148 IDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207
Query: 230 VDVFSFALILQEMIEGCPPFTMKHD 254
VD++ + EM P K D
Sbjct: 208 VDIWGIGCVFAEMFTRRPILQGKSD 232
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-19
Identities = 56/233 (24%), Positives = 115/233 (49%), Gaps = 9/233 (3%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G +VA+K++ + + +E+ +++++++PN+V FL + + +V EYL
Sbjct: 44 GQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G L + + + + + + +LH N+ +IHRD++ N+L G++K+
Sbjct: 101 GSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKL 156
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
DFG +T ++ + T T ++APEV + Y KVD++S ++ EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
++ A P + P KL + ++ + C KR + ++++
Sbjct: 216 LNENPLRALYLIATNGTPELQNPEKL-SPIFRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-19
Identities = 67/254 (26%), Positives = 123/254 (48%), Gaps = 28/254 (11%)
Query: 68 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 119
++G V +L + D D + E+ +L+K H N+ + GA + +P
Sbjct: 23 YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82
Query: 120 -MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176
+ +V E+ G + +K + LK +I RG+++LH++K +IHRD++
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKG 139
Query: 177 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEE-----YDT 228
N+L ++ +K+ DFGVS L DR + ++T + ++APEV +E YD
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF 195
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288
K D++S + EM EG PP H + + + P + +K +++ + IE C
Sbjct: 196 KSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPAPRLKSKKWSKKFQSFIESCL 253
Query: 289 NEKPAKRPTFRQII 302
+ ++RPT Q++
Sbjct: 254 VKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 57/187 (30%), Positives = 98/187 (52%), Gaps = 9/187 (4%)
Query: 74 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
AVK L ++++ + + A R+ LL+ ++HP +V + + + V +++ G
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
+L L+R+ + A +A +IA + YLH + I++RDL+P NIL D G++ +
Sbjct: 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLT 138
Query: 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
DFG+ K + D T T Y+APEV + + YD VD + +L EM+ G PPF
Sbjct: 139 DFGLCKEGIAQSDTTTTFCGTP-EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197
Query: 251 MKHDNEV 257
+ E+
Sbjct: 198 CRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 60/187 (32%), Positives = 87/187 (46%), Gaps = 8/187 (4%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQ---KIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
A+K L + I D V + E + + RHP +V + V EY G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
DL + +P AV +A + G+ YLHENK I++RDL+ N+L D G +K+A
Sbjct: 88 DLMMHIHTDVFSEPR-AVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIA 143
Query: 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
DFG+ K DR T T ++APEV Y VD + +++ EM+ G PF
Sbjct: 144 DFGLCKEGMGFGDRTSTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
Query: 251 MKHDNEV 257
+ EV
Sbjct: 203 GDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 51/183 (27%), Positives = 95/183 (51%), Gaps = 18/183 (9%)
Query: 73 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
VA+K++ + DD+ V A R E+ LL++++H N+V+ + + +V EY +
Sbjct: 28 VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ- 83
Query: 131 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
DL+ + G + P F + +G+ + H + ++HRDL+P N+L + +G LK+
Sbjct: 84 DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKL 140
Query: 190 ADFGVSKLLTVKEDRPLTC---QDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEG 245
ADFG+++ + P+ C + + Y P+V F + Y T +D++S I E+
Sbjct: 141 ADFGLARAFGI----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
Query: 246 CPP 248
P
Sbjct: 197 GRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 59/184 (32%), Positives = 97/184 (52%), Gaps = 7/184 (3%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L + + DRVR + E +L ++ HP +V+ A + ++ ++L GDL
Sbjct: 28 AMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 86
Query: 134 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
L K + V+F L ++A +++LH + II+RDL+P NIL D+ G++K+ DF
Sbjct: 87 TRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDF 142
Query: 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 252
G+SK E + + T Y+APEV + D +SF +++ EM+ G PF K
Sbjct: 143 GLSKESIDHEKKAYSFCGT-VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201
Query: 253 HDNE 256
E
Sbjct: 202 DRKE 205
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 39/243 (16%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 154
EL +L + P +V F GA + I E++ G L LK+ G + + + ++ +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 214
RG+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 163
Query: 215 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMK------------------- 252
Y++PE + Y + D++S L L EM G PP K
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223
Query: 253 -----HDNEVPKAYAARQ-------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
H + P+ A + PP K P+ ++ ++ +++C + P +R ++
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283
Query: 301 IIT 303
+
Sbjct: 284 LTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 51 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
DF + + KG+F +LA +G A+K L ++V+ DD V E +L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 106 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 164
+ L + Q+ + V EY+ GDL +++ G K AV +A +IA G+ +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 165 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL-----LTVKEDRPLTCQDTSC---RYV 216
II+RDL+ N++ D G++K+ADFG+ K +T K T C Y+
Sbjct: 121 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK---------TFCGTPDYI 168
Query: 217 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 257
APE+ + Y VD ++F ++L EM+ G PF + ++E+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-19
Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 86 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKP 144
++ + + E+ +L HPN+V+ L A + + I+ E+ G + A L+ + L
Sbjct: 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE 102
Query: 145 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204
+NYLHENK IIHRDL+ NIL G++K+ADFGVS K R
Sbjct: 103 PQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTR 155
Query: 205 PLTCQDT---SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 256
+ +D+ + ++APEV K+ YD K DV+S + L EM + PP +
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215
Query: 257 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
V A + P P++ ++ K+ +++C + R T Q++
Sbjct: 216 VLLKIAKSEPPTLAQPSR-WSSEFKDFLKKCLEKNVDARWTTTQLL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 10/192 (5%)
Query: 61 GTFILAFWRGIQ---VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 117
G ILA ++ VA+K+ + I +V E +L I HP V G+
Sbjct: 44 GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103
Query: 118 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
S + +V E++ G+ FL+R +A I YL + + I++RDL+P
Sbjct: 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPE 160
Query: 178 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 237
N+L D G +K+ DFG +K++ + R T T Y+APE+ N + D ++ +
Sbjct: 161 NLLLDKDGFIKMTDFGFAKVV---DTRTYTLCGTP-EYIAPEILLNVGHGKAADWWTLGI 216
Query: 238 ILQEMIEGCPPF 249
+ E++ GCPPF
Sbjct: 217 FIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 154
E +L ++ P +V + + +V ++ G+L L+R+G S A + ++
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 213
+ LH+ +I+RDL+P NIL D G++ + DFG+ KL +D+ +T C
Sbjct: 103 LCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK----TNTFCG 155
Query: 214 --RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 271
Y+APE+ Y VD ++ ++L EM+ G PPF +D V + Y + P +
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF---YDENVNEMYRKILQEPLRF 212
Query: 272 PAKLYARGLKELIEECWNEKPAKR 295
P R K+L+ + P +R
Sbjct: 213 PDGF-DRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 74/258 (28%), Positives = 120/258 (46%), Gaps = 24/258 (9%)
Query: 60 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGA 113
KG+F LA +G A+K L ++V+ DD V E +L HP +
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64
Query: 114 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173
+ V EYL GDL ++ A +A +I G+ +LH I++RD
Sbjct: 65 FQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRD 121
Query: 174 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 233
L+ NIL D G++K+ADFG+ K + + + T T Y+APE+ ++Y+T VD +
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP-DYIAPEILLGQKYNTSVDWW 180
Query: 234 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 293
SF ++L EM+ G PF + E+ + R P + R K+++ + + +P
Sbjct: 181 SFGVLLYEMLIGQSPFHGHDEEEL--FQSIRMDNPCY--PRWLTREAKDILVKLFVREPE 236
Query: 294 KR----------PTFRQI 301
+R P FR+I
Sbjct: 237 RRLGVKGDIRQHPFFREI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 52/157 (33%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 153
E++LL+ ++H N+V + + +V EYL DL+ +L G L V+ F
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 213
+ RG++Y H+ K I+HRDL+P N+L ++ G LK+ADFG+++ +V + + + +
Sbjct: 112 LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVVTL 167
Query: 214 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 249
Y P+V + EY T +D++ IL EM G P F
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-19
Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 43 YEIDPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELA 97
++ DP +L FT+ EI G+F + F R ++ VA+KK+ +++ + E+
Sbjct: 19 FKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 157
LQ+I+HPN +++ G + +V EY K L+ +G
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 217
+ YLH + +IHRD++ NIL + G +K+ADFG + + + P + ++A
Sbjct: 138 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMA 189
Query: 218 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPA 273
PEV +YD KVDV+S + E+ E PP F M N + Y Q +
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPTLQS 246
Query: 274 KLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
++ + ++ C + P RPT +++ +
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-19
Identities = 71/254 (27%), Positives = 123/254 (48%), Gaps = 28/254 (11%)
Query: 68 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 119
++G V +L + D +D + E+ +L+K H N+ + GA + SP
Sbjct: 33 YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92
Query: 120 -MMIVTEYLPKGDLRAFLKR-KG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176
+ +V E+ G + +K KG ALK +I RG+ +LH +K +IHRD++
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKG 149
Query: 177 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEE-----YDT 228
N+L ++ +K+ DFGVS L DR + ++T + ++APEV +E YD
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDY 205
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288
+ D++S + EM EG PP H + + + PP K +K +++ + IE C
Sbjct: 206 RSDIWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCL 263
Query: 289 NEKPAKRPTFRQII 302
+ RP+ Q++
Sbjct: 264 VKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-19
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 18/219 (8%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 130 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
GDL+ + G + AV +A +I G+ LH+ + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHI 141
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 247
+++D G++ + V E + + + + Y+APEV KNE Y D ++ +L EMI G
Sbjct: 142 RISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
Query: 248 PFTMKHD-----------NEVPKAYAARQRPPFKAPAKL 275
PF + EV + Y+ + P ++ K+
Sbjct: 200 PFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 30/253 (11%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
+VAVK + E S +R+ F +E ++++ +VV+ LG V++ P ++V E + G
Sbjct: 37 TRVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94
Query: 131 DLRAFLK--------RKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180
DL+++L+ G P+ ++ A +IA GM YL+ K +HRDL N +
Sbjct: 95 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 151
Query: 181 RDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239
+K+ DFG+++ + R R++APE K+ + T D++SF ++L
Sbjct: 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211
Query: 240 QEMIE-GCPPFTMKHDNEVPK-----AYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 293
E+ P+ + +V K Y + P P ++ +L+ CW P
Sbjct: 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ---PDNCPERVT-----DLMRMCWQFNPK 263
Query: 294 KRPTFRQIITRLE 306
RPTF +I+ L+
Sbjct: 264 MRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 21/261 (8%)
Query: 46 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 100
DP +L F++ EI G+F + F R ++ VA+KK+ +++ + E+ LQ
Sbjct: 12 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 160
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 161 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 220
LH + +IHRD++ NIL + G +K+ DFG + ++ P + ++APEV
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEV 182
Query: 221 ---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPAKLY 276
+YD KVDV+S + E+ E PP F M N + Y Q + +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPALQSGHW 239
Query: 277 ARGLKELIEECWNEKPAKRPT 297
+ + ++ C + P RPT
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 52/161 (32%), Positives = 87/161 (54%), Gaps = 10/161 (6%)
Query: 93 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 152
+ E +L+ ++HP +V + A + ++ EYL G+L L+R+G TA +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 212
+I+ + +LH+ II+RDL+P NIL D G++K+ DFG+ K ++ E T T
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEG---TVTHTF 160
Query: 213 C---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
C Y+APE+ + VD +S ++ +M+ G PPFT
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 2e-18
Identities = 55/233 (23%), Positives = 114/233 (48%), Gaps = 9/233 (3%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G +VA+K++ + + +E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G L + + + + +++LH N+ +IHRD++ NIL G++K+
Sbjct: 101 GSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
DFG +T ++ + T T ++APEV + Y KVD++S ++ EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
++ A P + P +L A ++ + C +R + ++++
Sbjct: 216 LNENPLRALYLIATNGTPELQNPERLSAV-FRDFLNRCLEMDVDRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 19/228 (8%)
Query: 85 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGAL 142
++ + + E+ +L HP +V+ LGA + I+ E+ P G + A + +G
Sbjct: 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT 108
Query: 143 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202
+P V + + YLH K IIHRDL+ N+L G++K+ADFGVS K
Sbjct: 109 EPQIQV-ICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVS----AKN 160
Query: 203 DRPLTCQDT---SCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 254
+ L +D+ + ++APEV K+ YD K D++S + L EM + PP +
Sbjct: 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220
Query: 255 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
V A + P P+K ++ ++ ++ ++ P RP+ Q++
Sbjct: 221 MRVLLKIAKSEPPTLSQPSK-WSMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-18
Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFAL 152
E +L+K+ P +V A + + +V + GDL+ + G L+ + ++
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 212
I G+ +LH + I++RD++P N+L DD GN +++D G++ + +K+ + +T + +
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGT 157
Query: 213 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------- 264
Y+APE+ K E Y VD F+ + EM+ G PF H +V K R
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK-DHKEKVAKEELKRRTLEDEVK 216
Query: 265 -QRPPFKAPAKLYAR-GLKELIEE-----CWNEKPAKRPTFRQI-ITRLES 307
+ F +K R L + E+ N+ P K F+ I RLE+
Sbjct: 217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-18
Identities = 57/233 (24%), Positives = 114/233 (48%), Gaps = 9/233 (3%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G +VA++++ + + +E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 45 GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G L + + + + + +LH N+ +IHRD++ NIL G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
DFG +T ++ + T T ++APEV + Y KVD++S ++ EMIEG PP+
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
Query: 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
++ A P + P KL A ++ + C + KR + ++++
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLDMDVEKRGSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 35/268 (13%)
Query: 58 ITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 112
I KGT+ +L G + AVK L + + D+ + A + L L HPNVV+F G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSD--HPNVVKFYG 82
Query: 113 A-----VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHE 163
V + +V E G + + FLKR ++ + G+ +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 164 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 223
NK IHRD++ +NIL G +K+ DFGVS LT R T T ++APEV
Sbjct: 143 NK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIAC 198
Query: 224 EE-----YDTKVDVFSFALILQEMIEGCPPFT----MKHDNEVPKAYAARQRPPFKAPAK 274
E+ YD + DV+S + E+ +G PP M+ ++P R PP +
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP-----RNPPPTLHQPE 253
Query: 275 LYARGLKELIEECWNEKPAKRPTFRQII 302
L++ + I +C + KRPT ++
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 30/254 (11%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VAVK L E S+ R + F+ E LL ++H ++V+F G T+ P+++V EY+ GDL
Sbjct: 38 VAVKALKE--ASESAR-QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL 94
Query: 133 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
FL+ G L + A IA GM YL + +HRDL
Sbjct: 95 NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATR 151
Query: 178 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 236
N L +K+ DFG+S+ + + R R++ PE ++ T+ D++SF
Sbjct: 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211
Query: 237 LILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKPA 293
++L E+ G P+ + E + + P P ++YA +++ CW +P
Sbjct: 212 VVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYA-----IMQGCWQREPQ 266
Query: 294 KRPTFRQIITRLES 307
+R + I +RL++
Sbjct: 267 QRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 31/272 (11%)
Query: 46 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 100
DP +L FT+ EI G+F + F R ++ VA+KK+ +++ + E+ LQ
Sbjct: 12 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYL--PKGDLRAFLKRKGALKPSTAVRFA---LDIA 155
++RHPN +++ G + +V EY D+ K KP V A
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAICHGAL 125
Query: 156 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 215
+G+ YLH ++ IHRD++ NIL + G +K+ADFG + L++ P + +
Sbjct: 126 QGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYW 177
Query: 216 VAPEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKA 271
+APEV +YD KVDV+S + E+ E PP F M N + Y Q
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNDSPTL 234
Query: 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
+ ++ + ++ C + P RP+ +++
Sbjct: 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 27/227 (11%)
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 150
AF + +L+ ++ H ++V+ G V ++V EY+ G L FL R+ S +
Sbjct: 47 AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKN-NVSLHWKL 104
Query: 151 --ALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGN---LKVADFGVSKLLTVK 201
A +A ++YL + K ++H ++ NIL + G +K++D G+ + +
Sbjct: 105 DVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161
Query: 202 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVP 258
E+R ++APE +N + D +SF L E+ P + +E
Sbjct: 162 EERVERIP-----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216
Query: 259 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
+ Y + R P A+L LI +CW P KRP+FR I+ L
Sbjct: 217 RFYQDQHRLPMPDCAELA-----NLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K + + V+ + V F +E +L P + Q A + +V EY P GDL
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 134 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
+ L R +F L ++ ++ +H+ + +HRD++P N+L D +G++K+ADF
Sbjct: 90 SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADF 146
Query: 193 GVSKLLT----VKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEM 242
G + LT V P+ D Y+APEV Y + D +S +I EM
Sbjct: 147 GSAARLTANKMVNSKLPVGTPD----YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202
Query: 243 IEGCPPFT 250
I G PF
Sbjct: 203 IYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 74/251 (29%), Positives = 111/251 (44%), Gaps = 30/251 (11%)
Query: 70 GIQVAVKKLGEEVISD-DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-----PMMI 122
G AVK L + ISD D+ + A E +LQ + HPNVV+F G ++ + +
Sbjct: 47 GSLAAVKIL--DPISDVDEEIEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101
Query: 123 VTEYLPKGD----LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 178
V E G ++ L L + G+ +LH N+ IIHRD++ +N
Sbjct: 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNN 158
Query: 179 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVF 233
IL G +K+ DFGVS LT R T T ++APEV E+ YD + DV+
Sbjct: 159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIACEQQYDYSYDARCDVW 217
Query: 234 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP--FKAPAKLYARGLKELIEECWNEK 291
S + E+ +G PP H V + + PP P K + R I +C +
Sbjct: 218 SLGITAIELGDGDPPLFDMH--PVKTLFKIPRNPPPTLLHPEK-WCRSFNHFISQCLIKD 274
Query: 292 PAKRPTFRQII 302
RP+ ++
Sbjct: 275 FEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-18
Identities = 67/251 (26%), Positives = 119/251 (47%), Gaps = 23/251 (9%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VAVK L E+ ++ + F E+ ++ +++ PN+++ L S P+ ++TEY+ GDL
Sbjct: 49 VAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 133 RAFLKRKGALKP-----------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 181
FL R + ST + A IA GM YL + +HRDL N L
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 182 DDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSFALILQ 240
+ +K+ADFG+S+ L + + + R+++ E ++ T DV++F + L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 241 EMIEGCP--PFTMKHDNEVPKA----YAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 294
E++ C P++ D +V + + + R + L L +L+ CW +
Sbjct: 224 EILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKE 283
Query: 295 RPTFRQIITRL 305
RP+F++I L
Sbjct: 284 RPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-18
Identities = 51/177 (28%), Positives = 96/177 (54%), Gaps = 9/177 (5%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G VA+KK+ + ++ A R E++LL+++ HPN+V+ L + + + +V E+L +
Sbjct: 25 GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 83
Query: 130 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
DL+ F+ + + + +G+ + H ++ ++HRDL+P N+L + G +
Sbjct: 84 -DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAI 139
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMI 243
K+ADFG+++ V R T + + Y APE+ + Y T VD++S I EM+
Sbjct: 140 KLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-18
Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 22/267 (8%)
Query: 49 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 106
EL N + KG + + + I VA+K K E D+ +R E ++ ++ +P
Sbjct: 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMR----EAEIMHQLDNPY 56
Query: 107 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENK 165
+V+ +G V ++ +M+V E G L FL +K + S V ++ GM YL
Sbjct: 57 IVRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 166 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN 223
+HRDL N+L + K++DFG+SK L + + + ++ APE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 224 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGL 280
++ ++ DV+S+ + + E G P+ EV R P + P ++YA
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA--- 229
Query: 281 KELIEECWNEKPAKRPTFRQIITRLES 307
L+++CW K RP F ++ R+ +
Sbjct: 230 --LMKDCWIYKWEDRPNFAKVEERMRT 254
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-18
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 7/182 (3%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 130 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
GDL+ + G AV +A +I G+ LH + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHI 141
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 247
+++D G++ + + E + + + Y+APEV KNE Y D + ++ EMIEG
Sbjct: 142 RISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 248 PF 249
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-18
Identities = 69/250 (27%), Positives = 114/250 (45%), Gaps = 33/250 (13%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VAVK L + ++ + F+ E LL ++H ++V+F G P+++V EY+ GDL
Sbjct: 38 VAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94
Query: 133 RAFLK----------------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176
FL+ KG L S + A IA GM YL +HRDL
Sbjct: 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLAT 151
Query: 177 SNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 235
N L + +K+ DFG+S+ + + R R++ PE ++ T+ DV+SF
Sbjct: 152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 236 ALILQEMIE-GCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEK 291
+IL E+ G P+ + EV + +RP P ++Y +++ CW +
Sbjct: 212 GVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV-CPKEVY-----DIMLGCWQRE 265
Query: 292 PAKRPTFRQI 301
P +R ++I
Sbjct: 266 PQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-18
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 10/231 (4%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A KKL ++ + E +L K+ +V A + + +V + GDLR
Sbjct: 22 ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR 81
Query: 134 AFL----KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
+ + A + I G+ +LH+ + II+RDL+P N+L D+ GN+++
Sbjct: 82 YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRI 138
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
+D G++ L + + T ++APE+ + EEYD VD F+ + L EMI PF
Sbjct: 139 SDLGLAVELKDGQSKTKGYAGTP-GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
Query: 250 TMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299
+ + K R P K ++ K E + P KR FR
Sbjct: 198 RARGEKVENKELKQRILNDSVTYPDK-FSPASKSFCEALLAKDPEKRLGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 7/157 (4%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 153
E++LL+ ++H N+V + + +V EYL K DL+ +L G V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 213
+ RG+NY H K ++HRDL+P N+L ++ G LK+ADFG+++ ++ + + + +
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTL 168
Query: 214 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 249
Y P++ + +Y T++D++ I EM G P F
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 85 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 144
+D R E+ +L+ + HPNVV+ + + ++ E++ G L A +
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THIADEQ 168
Query: 145 STAVRFALDIAR----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200
A D+AR G+ YLH I+HRD++PSN+L + + N+K+ADFGVS++L
Sbjct: 169 FLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220
Query: 201 KEDRPLTCQDTSCRYVAPEVFKNE----EYDTKV-DVFSFALILQEMIEGCPPFTMKHDN 255
D P + Y++PE + YD D++S + + E G PF +
Sbjct: 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG 279
Query: 256 EVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
+ A +PP +APA +R + I C +PAKR + Q++
Sbjct: 280 DWASLMCAICMSQPP-EAPATA-SREFRHFISCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 1e-17
Identities = 77/283 (27%), Positives = 135/283 (47%), Gaps = 56/283 (19%)
Query: 59 TKGTFILAFWR--GIQVAVKKLGEEVISDDD--RVRAFRDELALLQKI-RHPNVVQFLGA 113
T G+ LA + G VA+KK+ ++ S ++ +R E+ L+K+ HPN+V+
Sbjct: 11 TFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR----EVKSLRKLNEHPNIVKLKEV 66
Query: 114 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIH 171
++ + V EY+ +G+L +K RKG + +R + I +G+ ++H++ H
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFH 122
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCR-YVAPEVF-KNEEYDT 228
RDL+P N+L +K+ADFG+++ ++ P T D S R Y APE+ ++ Y +
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYT--DYVSTRWYRAPEILLRSTSYSS 178
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEV------------------PKAYA-ARQ---R 266
VD+++ I+ E+ P F +E+ P+ Y A + R
Sbjct: 179 PVDIWALGCIMAELYTLRPLF--PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236
Query: 267 PPFKAPAKLY------ARGLKELIEEC--WNEKPAKRPTFRQI 301
P AP L+ + +LI++ W+ P KRPT Q
Sbjct: 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWD--PKKRPTASQA 277
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 51/157 (32%), Positives = 86/157 (54%), Gaps = 7/157 (4%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 153
E++LL+ ++H N+V V + +V EYL K DL+ ++ G + V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 213
I RG+ Y H K ++HRDL+P N+L ++ G LK+ADFG+++ +V + + + +
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTL 168
Query: 214 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 249
Y P+V + EY T++D++ I EM G P F
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 47/250 (18%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 154
EL +L + P +V F GA + I E++ G L LK+ G + + ++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 214
+G+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 113 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 167
Query: 215 YVAPEVFKNEEYDTKVDVFSFALILQEM-----------------IEGCPPFTMKHDNEV 257
Y++PE + Y + D++S L L EM + GCP ++E
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227
Query: 258 P----------KAYAARQRPPF---------------KAPAKLYARGLKELIEECWNEKP 292
+Y RPP K P+ ++ ++ + +C + P
Sbjct: 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNP 287
Query: 293 AKRPTFRQII 302
A+R +Q++
Sbjct: 288 AERADLKQLM 297
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 26/249 (10%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEY-- 126
G +AVK++ D+ + +L ++ + P +V+F GA+ + I E
Sbjct: 29 GTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86
Query: 127 --LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
L K + K + + A+ + +NYL E + IIHRD++PSNIL D +
Sbjct: 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRN 144
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE---VFKNEEYDTKVDVFSFALILQ 240
GN+K+ DFG+S L D +D CR Y+APE + YD + DV+S + L
Sbjct: 145 GNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY 201
Query: 241 EMIEGCPPFTMKHDN------EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 294
E+ G P+ K ++ +V K + + ++ I C + +K
Sbjct: 202 EVATGKFPYP-KWNSVFDQLTQVVKGDPPILSN---SEEREFSPSFVNFINLCLIKDESK 257
Query: 295 RPTFRQIIT 303
RP +++++
Sbjct: 258 RPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-17
Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 5/156 (3%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 154
E +LL+ ++H N+V + + +V EY+ + K G L P F +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 214
RG++Y+H+ I+HRDL+P N+L D+G LK+ADFG+++ +V + + +
Sbjct: 113 LRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLW 168
Query: 215 YVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 249
Y P+V + EY T +D++ I EMI+G F
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 11/191 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
AVK L ++VI DD V E +L R HP + Q + V E++ GDL
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL 83
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
+++ + A +A +I + +LH+ II+RDL+ N+L D G+ K+ADF
Sbjct: 84 MFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 140
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K + T C Y+APE+ + Y VD ++ ++L EM+ G PF
Sbjct: 141 GMCK----EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
Query: 250 TMKHDNEVPKA 260
++++++ +A
Sbjct: 197 EAENEDDLFEA 207
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 11/181 (6%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI---VTEY 126
G +VA+KK+ R R EL +L+ +H N++ + V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88
Query: 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
L + DL + L F + RG+ Y+H +IHRDL+PSN+L ++
Sbjct: 89 LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCE 145
Query: 187 LKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEM 242
L++ DFG+++ L+ + +T + Y APE+ EY T +D++S I EM
Sbjct: 146 LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
Query: 243 I 243
+
Sbjct: 206 L 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 56/182 (30%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 73 VAVKKLGEEVISDDDRVR--AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
VA+KK E DD V+ A R E+ +L+++RH N+V + + + +V E++
Sbjct: 29 VAIKKFLES--EDDKMVKKIAMR-EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
L K L S ++ I RG+ + H + IIHRD++P NIL SG +K+
Sbjct: 86 VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLC 142
Query: 191 DFGVSKLLTVKEDRPLTCQD-TSCR-YVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCP 247
DFG ++ L + D + R Y APE + + +Y VD+++ ++ EM+ G P
Sbjct: 143 DFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199
Query: 248 PF 249
F
Sbjct: 200 LF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-17
Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 32/251 (12%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
QV VK+L + F +E + ++H N++Q LG T+ +P ++V E+ P GD
Sbjct: 24 QVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81
Query: 132 LRAFLK--RKGAL---KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
L+ +L+ RK L P+T R A +IA G+ +LH+N IH DL N L
Sbjct: 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLT 138
Query: 187 LKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKV-------DVFSFAL 237
+K+ D+G+S KED +T R++APE+ + V +V+S +
Sbjct: 139 VKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGV 197
Query: 238 ILQEMIE-GCPPFTMKHDNEVPKAYAARQ------RPPFKAPAKLYARGLKELIEECWNE 290
+ E+ E G P+ D +V Y R+ +P K P + E+++ CW
Sbjct: 198 TIWELFELGSQPYRHLSDEQV-LTYTVREQQLKLPKPRLKLP---LSDRWYEVMQFCW-L 252
Query: 291 KPAKRPTFRQI 301
+P +RP+ ++
Sbjct: 253 QPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-17
Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 17/190 (8%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+KK+ ++ + ++++ E +L +P VV + + +V EY+ GD
Sbjct: 30 AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
LK GAL A + + + YLH I+HRDL+P N+L G++K+ DFG
Sbjct: 90 TLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG 146
Query: 194 VSKL----LTV--------KEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALIL 239
+SK+ LT K+ R + + Y+APEV + Y VD ++ +IL
Sbjct: 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206
Query: 240 QEMIEGCPPF 249
E + GC PF
Sbjct: 207 YEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-17
Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 21/264 (7%)
Query: 43 YEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAFRDELA 97
Y+ DP E+ F EI G+F ++ VAVKK+ +++ + E+
Sbjct: 15 YKDDPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 157
LQ+++HPN +++ G + +V EY K L+ +G
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 217
+ YLH + +IHRD++ NIL + G +K+ADFG + + P + ++A
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMA 185
Query: 218 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPA 273
PEV +YD KVDV+S + E+ E PP F M N + Y Q +
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNDSPTLQS 242
Query: 274 KLYARGLKELIEECWNEKPAKRPT 297
+ + ++ C + P +RP
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 7e-17
Identities = 57/181 (31%), Positives = 96/181 (53%), Gaps = 10/181 (5%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKG 130
VA+KKL E + + + R E+ +L K++HPN+V V S+ + +V EY+ +
Sbjct: 33 VALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-EH 90
Query: 131 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
DL++ ++ K S L + G+ +LH+N I+HRDL+ SN+L ++ G LK+
Sbjct: 91 DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKI 147
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPP 248
DFG+++ +P T + Y APE+ EY T +D++S I E++ P
Sbjct: 148 CDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPL 206
Query: 249 F 249
F
Sbjct: 207 F 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 19/274 (6%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTFILAF--WRGIQVAVKKLGEEVISDDDRVRAF-RDE 95
EVPE +P E + + + + AF RG K + + V+ +D+R A+ R E
Sbjct: 57 EVPE-SNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSE 115
Query: 96 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFA 151
L L H +V+ ++++ EY GDL + LK +
Sbjct: 116 LHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLF 175
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
I ++ +H K ++HRDL+ +NI +G +K+ DFG SK + + L +
Sbjct: 176 YQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS--DSVSLDVASS 230
Query: 212 SC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268
C Y+APE+++ + Y K D++S +IL E++ PF E+ + + P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
F P + G+K L++ ++ PA RPT +Q++
Sbjct: 291 FPCPV---SSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 9e-17
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 9/195 (4%)
Query: 60 KGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 114
KGTF IL + G A+K L +EVI D V E +LQ RHP + A
Sbjct: 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 64
Query: 115 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 174
+ V EY G+L L R+ A + +I + YLH +++RD+
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 121
Query: 175 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 234
+ N++ D G++K+ DFG+ K T T Y+APEV ++ +Y VD +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWG 180
Query: 235 FALILQEMIEGCPPF 249
+++ EM+ G PF
Sbjct: 181 LGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 61/235 (25%), Positives = 117/235 (49%), Gaps = 12/235 (5%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
I VA+K+L E ++ DE ++ + +P+V + LG + +S + ++T+ +P G
Sbjct: 37 IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 93
Query: 131 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
L +++ K + + + + IA+GMNYL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKI 150
Query: 190 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCP 247
DFG++KLL E + +++A E + Y + DV+S+ + + E M G
Sbjct: 151 TDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 210
Query: 248 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
P+ +E+ +R P + P + + ++ +CW RP FR++I
Sbjct: 211 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 3/176 (1%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
L R+ A + +I ++YLH K V ++RDL+ N++ D G++K+ DFG
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFG 141
Query: 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
+ K +K+ + + Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 142 LCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 60/254 (23%), Positives = 112/254 (44%), Gaps = 39/254 (15%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI-VTEYLPKGDL 132
A+K L ++ + ++V+ E +L + HP + L A Q+ + V +Y P G+L
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT-LYASFQTETYLCLVMDYCPGGEL 88
Query: 133 RAFL-KRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
L ++ G RF A ++ + YLH I++RDL+P NIL +SG++ ++
Sbjct: 89 FRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLS 145
Query: 191 DFGVSKLLTVK--------------------EDRPLTCQDT----SC----RYVAPEVFK 222
DF +SK V+ + + + S Y+APEV
Sbjct: 146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS 205
Query: 223 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-YARGLK 281
+ + + VD ++ ++L EM+ G PF + +E ++ + P + +
Sbjct: 206 GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET---FSNILKKEVTFPGSPPVSSSAR 262
Query: 282 ELIEECWNEKPAKR 295
+LI + + P+KR
Sbjct: 263 DLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 90 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR 149
+ EL +L K P ++ F GA + + I TE++ G L + + R
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGR 99
Query: 150 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209
A+ + +G+ YL K I+HRD++PSN+L + G +K+ DFGVS L +
Sbjct: 100 IAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT 156
Query: 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAY---AA 263
+ Y+APE E+Y DV+S + E+ G P+ N+ +P
Sbjct: 157 NA---YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV 213
Query: 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 297
+ PP P ++ I +C ++P +RP
Sbjct: 214 DEDPP-VLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 93 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 151
R E +L+ +R P +V A + + ++ +Y+ G+L L ++ S +
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQD 210
+I +++LH+ II+RD++ NIL D G++ + DFG+SK L +E+R +
Sbjct: 112 AEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168
Query: 211 TSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---Q 265
T Y+APEV + +D VD +S ++ E++ G PFT+ + + R
Sbjct: 169 T-IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS 227
Query: 266 RPPFKAPAKLYARGLKELIEECWNEKPAKR 295
+PPF P + A ++ I++ + P KR
Sbjct: 228 KPPF--PKTMSAEA-RDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 99 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 151
L+ HPNVV+ T S + + +V E++ + DL +L + + + T
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 116
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
+ RG+++LH ++ ++HRDL+P NIL SG +K+ADFG++++ + + LT
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVV 171
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 254
+ Y APEV Y T VD++S I EM P F D
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 154
EL +L + P +V F GA + I E++ G L LK + + ++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 214
RG+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 167
Query: 215 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEV------------PK 259
Y++PE + Y + D++S L L E+ G PP K + P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227
Query: 260 AYAARQRPPFKAPAKLY------ARGLKELIEECWNEKPAKRP 296
+ + R RPP + P + A + EL++ NE P K P
Sbjct: 228 SISPRPRPPGR-PVSGHGMDSRPAMAIFELLDYIVNEPPPKLP 269
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 59/241 (24%), Positives = 117/241 (48%), Gaps = 12/241 (4%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
I VA+K L E ++ DE ++ + P V + LG + +S + +VT+ +P G
Sbjct: 37 IPVAIKVLRENTSPKANK--EILDEAYVMAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYG 93
Query: 131 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
L +++ K + + + + IA+GM+YL E V ++HRDL N+L ++K+
Sbjct: 94 CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKI 150
Query: 190 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 247
DFG+++LL + E + +++A E + + + DV+S+ + + E++ G
Sbjct: 151 TDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAK 210
Query: 248 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 307
P+ E+P +R P + P + + ++ +CW RP FR+++
Sbjct: 211 PYDGIPAREIPDLLEKGERLP-QPP--ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267
Query: 308 I 308
+
Sbjct: 268 M 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 7/157 (4%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 153
E +LL+ ++H N+V + + +V EYL DL+ ++ G L F
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 213
+ RG+ Y H+ + ++HRDL+P N+L + G LK+ADFG+++ +V + + + +
Sbjct: 112 LLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVVTL 167
Query: 214 RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 249
Y P+V + EY T +D++ I EM G P F
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 20/177 (11%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 154
EL ++ +I+H N++ + + + +V + + DL+ + RK L S L I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV-------------SKLLTVK 201
G+N LH+ +HRDL P+NI + G K+ADFG+ SK T++
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 202 EDRPLTCQDTSCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 257
+T + + Y APE + E+Y VD++S I E++ G P F +NE+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP--GENEI 240
|
Length = 335 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 105 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE 163
P +V+ G S + I E L L LKR +G + + + I + ++YL E
Sbjct: 74 PYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 164 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-- 221
V IHRD++PSNIL D SGN+K+ DFG+S L + + T Y+APE
Sbjct: 133 KHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRSAGCAAYMAPERIDP 188
Query: 222 --KNEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPPFKAPAKLYAR 278
N +YD + DV+S + L E+ G P+ K + EV ++ PP P + ++
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-LTKILQEEPPSLPPNEGFSP 247
Query: 279 GLKELIEECWNEKPAKRPTFRQI-----ITRLESINNSI 312
++ C + KRP +R++ I R E+ +
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 73 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRH-PNVVQFLGA--VTQSSP---MMIVT 124
VA+KK E D++ + A R E++LLQ + +V+ L V + + + +V
Sbjct: 29 VALKKTRLE--MDEEGIPPTALR-EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85
Query: 125 EYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179
EYL DL+ F+ G L T F + +G+ + H++ ++HRDL+P N+
Sbjct: 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNL 141
Query: 180 LRDDSGN-LKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEV-FKNEEYDTKVDVFS 234
L D LK+AD G+ + ++ P+ T + + Y APEV + Y T VD++S
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSI----PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197
Query: 235 FALILQEMIEGCPPF 249
I EM P F
Sbjct: 198 VGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 4/180 (2%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G A+K L +EVI D V E +L+ RHP + + + V EY+
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G+L L R+ + +I ++YLH K I++RDL+ N++ D G++K+
Sbjct: 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKI 136
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
DFG+ K + + + + Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 137 TDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 7/182 (3%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G A K+L ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84
Query: 130 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
GDL+ + G + A+ +A +I G+ LH ++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHI 141
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 247
+++D G++ + + E + + + Y+APEV N+ Y D + ++ EMIEG
Sbjct: 142 RISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
Query: 248 PF 249
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 60 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 114
KGTF IL + A+K L +EVI D V E +LQ RHP + +
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF 64
Query: 115 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 174
+ V EY G+L L R+ A + +I + YLH +++RDL
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDL 121
Query: 175 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C---RYVAPEVFKNEEYDT 228
+ N++ D G++K+ DFG+ KE ++ T C Y+APEV ++ +Y
Sbjct: 122 KLENLMLDKDGHIKITDFGL-----CKEG--ISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEV 257
VD + +++ EM+ G PF + D+E
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQ-DHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 62/236 (26%), Positives = 112/236 (47%), Gaps = 15/236 (6%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G QVAVKK+ + R +E+ +++ H NVV + + +V E+L
Sbjct: 47 GKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G L + + A L + R ++YLH +IHRD++ +IL G +K+
Sbjct: 104 GALTDIVTHTRMNEEQIAT-VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
+DFG ++ + + + T ++APEV Y T+VD++S +++ EMI+G PP+
Sbjct: 160 SDFGFCAQVSKEVPKRKSLVGTP-YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
Query: 250 TMKHDNEVPKAYAARQR---PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
NE P R R PP + + L+ ++ +P++R T ++++
Sbjct: 219 F----NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 23/197 (11%)
Query: 69 RGIQVAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVTQSS-----P 119
G++VA+KK IS + R R E+ +L++ +H N++ L + S
Sbjct: 29 TGVKVAIKK-----ISPFEHQTFCQRTLR-EIKILRRFKHENIIGILDIIRPPSFESFND 82
Query: 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179
+ IV E + DL +K + L F I RG+ Y+H ++HRDL+PSN+
Sbjct: 83 VYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNL 137
Query: 180 LRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFA 236
L + + +LK+ DFG++++ + D LT + Y APE+ N + Y +D++S
Sbjct: 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVG 197
Query: 237 LILQEMIEGCPPFTMKH 253
IL EM+ P F K
Sbjct: 198 CILAEMLSNRPLFPGKD 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 7e-16
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 39/203 (19%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G VA+KK+ + + + A R E+ +L+++ H N+V IVT+ K
Sbjct: 32 GELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNL---------KEIVTD---K 78
Query: 130 GDLRAFLKRKGA--------------LKPSTAVRFALD--------IARGMNYLHENKPV 167
D F K KGA L S V F+ D + G+NY H+
Sbjct: 79 QDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN-- 136
Query: 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-Y 226
+HRD++ SNIL ++ G +K+ADFG+++L +E RP T + + Y PE+ EE Y
Sbjct: 137 -FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 195
Query: 227 DTKVDVFSFALILQEMIEGCPPF 249
+DV+S IL E+ P F
Sbjct: 196 GPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 153
E +LL+ ++H N+V + + V EY+ DL ++ + G L P F
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 213
+ RG+ Y+H I+HRDL+P N+L G LK+ADFG+++ + + Q S
Sbjct: 112 LLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSS 162
Query: 214 R-----YVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 249
Y P+V +Y + +D++ I EM++G P F
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 16/165 (9%)
Query: 95 ELALLQKIR---HPNVVQFLGAVT-----QSSPMMIVTEYLPKGDLRAFLKRKGA--LKP 144
E+ALL+++ HPN+V+ + + + + +V E++ + DLR +L + L
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA 107
Query: 145 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204
T RG+++LH N I+HRDL+P NIL G +K+ADFG++++ + +
Sbjct: 108 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--M 162
Query: 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
LT + Y APEV Y T VD++S I EM P F
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 57/205 (27%)
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
VRA RD LA + +P VV+ + + + ++ EYLP GD+ L +K
Sbjct: 48 VRAERDILA---EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET- 103
Query: 149 RF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL--- 198
RF A+D + Y IHRD++P N+L D G++K++DFG+ L
Sbjct: 104 RFYIAETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154
Query: 199 -------TVKEDRPLTCQDTSCR---------------------------YVAPEVFKNE 224
+ P D + Y+APEVF
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214
Query: 225 EYDTKVDVFSFALILQEMIEGCPPF 249
Y+ + D +S +I+ EM+ G PPF
Sbjct: 215 GYNKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 8/180 (4%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
A+K L ++ I V E +L + P +V + S + +VT+Y+ G
Sbjct: 22 AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG 81
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
+L L+++G A + ++ + +LH+ I++RDL+P NIL D +G++ +
Sbjct: 82 ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALC 138
Query: 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPF 249
DFG+SK T T+ Y+APEV +E+ Y VD +S +++ EM G PF
Sbjct: 139 DFGLSKANLTDNKTTNTFCGTT-EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 60/234 (25%), Positives = 115/234 (49%), Gaps = 12/234 (5%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
I VA+K L E + F DE ++ + HP++V+ LG V S + +VT+ +P G
Sbjct: 37 IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 93
Query: 131 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
L ++ + K + + + + IA+GM YL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 150
Query: 190 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 247
DFG+++LL E + +++A E ++ + DV+S+ + + E++ G
Sbjct: 151 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 210
Query: 248 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
P+ E+P +R P + P + + ++ +CW RP F+++
Sbjct: 211 PYDGIPTREIPDLLEKGERLP-QPP--ICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 59/183 (32%), Positives = 96/183 (52%), Gaps = 14/183 (7%)
Query: 73 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
+A+KK+ E +D+ V A R E++LL++++H N+V+ V + +V EYL
Sbjct: 30 IALKKIRLE--QEDEGVPSTAIR-EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL- 85
Query: 131 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-L 187
DL+ + A P + I RG+ Y H ++ ++HRDL+P N+L D N L
Sbjct: 86 DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNAL 142
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGC 246
K+ADFG+++ + R T + + Y APE+ + Y T VD++S I EM+
Sbjct: 143 KLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
Query: 247 PPF 249
P F
Sbjct: 202 PLF 204
|
Length = 294 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 23/228 (10%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY--- 126
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T + ++
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98
Query: 127 LP--KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
+P DL +K + L + +G+ Y+H IIHRDL+P N+ ++
Sbjct: 99 MPFMGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNED 154
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 243
LK+ DFG+++ + D +T + Y APEV N Y VD++S I+ EM+
Sbjct: 155 CELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
Query: 244 EGCPPFT-MKHDNEVPKAYAARQRPPFKAPAKL-------YARGLKEL 283
G P F H +++ + P + KL Y + L
Sbjct: 211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF 258
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 10/215 (4%)
Query: 93 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 152
+ E+ +++ +H N+V + G+ + + I E+ G L+ G L S +
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR 113
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 212
+ +G+ YLH +HRD++ +NIL D+G++K+ADFGVS +T + + T
Sbjct: 114 ETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 213 CRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV--PKAYAARQRP 267
++APEV E Y+ D+++ + E+ E PP H + Q P
Sbjct: 171 -YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229
Query: 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
K K ++ ++ + P KRPT +++
Sbjct: 230 KLKDKMK-WSNSFHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-15
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFL-KRKGALKPSTAVRFA 151
E LLQ + HP+V++ + + +V LP DL +L KR L A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
I G+ YLH + IIHRD++ NI +D + + D G ++ V L T
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLAGT 219
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
APEV ++Y++K D++S ++L EM+
Sbjct: 220 -VETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 62/253 (24%), Positives = 113/253 (44%), Gaps = 12/253 (4%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84
Query: 130 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
GDL+ + G A+ +A ++ G+ L + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHI 141
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 247
+++D G++ + + E + + + Y+APEV NE+Y D + ++ EMI+G
Sbjct: 142 RISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
Query: 248 PFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ---IIT 303
PF K V + R+ + + ++ ++ K + + P +R R
Sbjct: 200 PFR-KRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV 258
Query: 304 RLESINNSINHKR 316
+ I +IN KR
Sbjct: 259 KQHPIFKNINFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 17/185 (9%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 121
G +VA+KK+ + R FR EL +L +H NV L A+ P +
Sbjct: 25 GKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNV---LSALDILQPPHIDPFEEIY 80
Query: 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 181
+VTE L + DL + L F I RG+ YLH I+HRD++P N+L
Sbjct: 81 VVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLV 136
Query: 182 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQ 240
+ + LK+ DFG++++ E + +T + + Y APE+ + Y + VD++S I
Sbjct: 137 NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196
Query: 241 EMIEG 245
E++
Sbjct: 197 ELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 64/194 (32%), Positives = 101/194 (52%), Gaps = 30/194 (15%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM---IVTEYLP 128
VA+KK+ + + D R FR E+ LQ++ HPN+V+ L V ++ +V EY+
Sbjct: 35 VALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYM- 91
Query: 129 KGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
+ DL A + R L+ R+ + + + + Y+H +IHRDL+PSNIL + +
Sbjct: 92 ETDLHAVI-RANILED-VHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRV 146
Query: 188 KVADFGVSKLLTVKEDRP----LTCQDTSCRYVA------PEV-FKNEEYDTKVDVFSFA 236
K+ADFG+++ L+ E+ P LT YVA PE+ + Y VD++S
Sbjct: 147 KLADFGLARSLSELEENPENPVLT------DYVATRWYRAPEILLGSTRYTKGVDMWSVG 200
Query: 237 LILQEMIEGCPPFT 250
IL EM+ G P F
Sbjct: 201 CILGEMLLGKPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 58/183 (31%), Positives = 93/183 (50%), Gaps = 17/183 (9%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 124
G++VAVKKL S R +R EL LL+ ++H NV+ L T + + + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 125 EYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
+L DL +K + V+F + I RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 101 THLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEM 242
LK+ DFG+++ D +T + Y APE+ N Y+ VD++S I+ E+
Sbjct: 156 DCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211
Query: 243 IEG 245
+ G
Sbjct: 212 LTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 46/177 (25%), Positives = 88/177 (49%), Gaps = 4/177 (2%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VA+KK + +++ + R EL +L+ ++ N+V+ A + + +V EY+ K L
Sbjct: 29 VAIKKFKDSEENEEVKETTLR-ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
+ + P + + + +++ H+N I+HRD++P N+L + LK+ DF
Sbjct: 88 ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDF 144
Query: 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G ++ L+ + T + Y +PE+ Y VD++S IL E+ +G P F
Sbjct: 145 GFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 93 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 151
R E +L+ IR P +V A + + ++ +Y+ G+L L ++ K ++
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
+I + +LH+ + II+RD++ NIL D +G++ + DFG+SK E
Sbjct: 112 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168
Query: 212 SCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR 266
+ Y+AP++ + + +D VD +S +++ E++ G PFT+ + + R
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228
Query: 267 PPFKAPAKLYARGLKELIEECWNEKPAKR 295
PP+ P ++ A K++I+ + P KR
Sbjct: 229 PPY--PQEMSALA-KDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 17/173 (9%)
Query: 141 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200
AL + F+ +A+GM++L IHRDL NIL K+ DFG+++ +
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR--DI 264
Query: 201 KEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDN 255
+ D + + +++APE N Y + DV+S+ ++L E+ G P+ M D+
Sbjct: 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
Query: 256 EVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306
+ K R P AP+++Y ++++ CW+ P KRPTF+QI+ +E
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMY-----DIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 56/184 (30%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-----QSSPMMIVTEY 126
+VA+KK+ + D R R E+ LL+ + H NV+ + + + IV E
Sbjct: 32 KVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE- 89
Query: 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
L DL ++ L F + RG+ Y+H ++HRDL+PSN+L + + +
Sbjct: 90 LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCD 146
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 245
LK+ DFG+++ + K D +T + Y APE+ N EY T +DV+S I E++
Sbjct: 147 LKICDFGLARTTSEKGDF-MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR 205
Query: 246 CPPF 249
P F
Sbjct: 206 KPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 69/264 (26%), Positives = 122/264 (46%), Gaps = 19/264 (7%)
Query: 46 DPHELDFTNSVEITKG-TFILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
DP L N ++I +G T I+ R G QVAVK + + R +E+ +++
Sbjct: 18 DPRSL-LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 73
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 160
+H NVV+ + + ++ E+L G L + + L + + + Y
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCY 132
Query: 161 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY-VAPE 219
LH +IHRD++ +IL G +K++DFG + +D P Y +APE
Sbjct: 133 LHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPE 187
Query: 220 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP-AKLYAR 278
V Y T+VD++S +++ EM++G PP+ D+ V R PP K A +
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRLRDSPPPKLKNAHKISP 245
Query: 279 GLKELIEECWNEKPAKRPTFRQII 302
L++ +E +P +R T ++++
Sbjct: 246 VLRDFLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 8/223 (3%)
Query: 87 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 146
D + E+ ++++ +H N+V + G+ + I EY G L+ G L
Sbjct: 48 DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ 107
Query: 147 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206
+ +G+ YLH +HRD++ +NIL D+G++K+ADFGV+ +T +
Sbjct: 108 IAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164
Query: 207 TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 263
+ T ++APEV KN Y+ D+++ + E+ E PP H +
Sbjct: 165 SFIGTP-YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK 223
Query: 264 RQRPPFKAPAKL-YARGLKELIEECWNEKPAKRPTFRQIITRL 305
P K K ++ ++ + P KRPT +++T L
Sbjct: 224 SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 27/168 (16%)
Query: 150 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----- 204
++ +A+GM +L K IHRDL NIL ++ +K+ DFG+++ + D
Sbjct: 184 YSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 205 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPK 259
PL +++APE + Y + DV+SF ++L E+ G P+ +K D E +
Sbjct: 241 ARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 293
Query: 260 AY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
R R P ++Y L +CW+ +P++RPTF +++ L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTML-----DCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 73 VAVKKLGEEVISDDD---RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
VA+KK E S+DD + A R E+ +L++++HPN+V + + + +V EY
Sbjct: 29 VAIKKFVE---SEDDPVIKKIALR-EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
L K + + + +N+ H++ IHRD++P NIL G +K+
Sbjct: 85 TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKL 141
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCP 247
DFG +++LT D T Y APE+ + +Y VDV++ + E++ G P
Sbjct: 142 CDFGFARILTGPGDDYTDYVATRW-YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 43/123 (34%), Positives = 71/123 (57%), Gaps = 9/123 (7%)
Query: 88 RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 147
+V+A RD LAL + P +V ++ ++ + +V EYL GD+++ L G A
Sbjct: 50 QVQAERDALAL---SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA 106
Query: 148 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 207
V++ ++A ++YLH + IIHRDL+P N+L + G++K+ DFG+SK V +R L
Sbjct: 107 VKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK---VTLNRELN 160
Query: 208 CQD 210
D
Sbjct: 161 MMD 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 23/193 (11%)
Query: 127 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
+++ L G+ L + F +ARGM +L V HRDL N+L
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQG 273
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQE 241
+K+ DFG+++ + D + ++ +++APE + Y T DV+S+ ++L E
Sbjct: 274 KIVKICDFGLAR--DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331
Query: 242 MIE--GCPPFTMKHD----NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
+ G P M D N++ Y R P A ++Y +++ +CWN +P KR
Sbjct: 332 IFSLGGTPYPGMIVDSTFYNKIKSGY--RMAKPDHATQEVY-----DIMVKCWNSEPEKR 384
Query: 296 PTFRQIITRLESI 308
P+F + +ES+
Sbjct: 385 PSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 24/170 (14%)
Query: 92 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 146
F +E ++ P VVQ A + +V EY+P GDL + K A +
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149
Query: 147 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206
V ALD M + IHRD++P N+L D SG+LK+ADFG + + ++ +
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV 198
Query: 207 TCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 249
C DT+ Y++PEV K++ Y + D +S + L EM+ G PF
Sbjct: 199 RC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 26/198 (13%)
Query: 70 GIQVAVKKLGE--EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----MMI 122
G +VA+KK+ + E +SD R+ R E+ LL+ +RHP++V+ + S + +
Sbjct: 25 GEKVAIKKINDVFEHVSDATRI--LR-EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81
Query: 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 182
V E L + DL +K L P F + R + Y+H + HRDL+P NIL +
Sbjct: 82 VFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILAN 137
Query: 183 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--------YDTKVDVFS 234
LK+ DFG++++ D P T YVA ++ E Y +D++S
Sbjct: 138 ADCKLKICDFGLARVAF--NDTPTAIFWTD--YVATRWYRAPELCGSFFSKYTPAIDIWS 193
Query: 235 FALILQEMIEGCPPFTMK 252
I E++ G P F K
Sbjct: 194 IGCIFAEVLTGKPLFPGK 211
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY----- 126
+VAVKKL S R +R EL LL+ ++H NV+ L T ++ + E
Sbjct: 42 KVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100
Query: 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
L DL +K + L + RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 101 LMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCE 156
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 245
L++ DFG+++ + D +T + Y APE+ N Y+ VD++S I+ E+++G
Sbjct: 157 LRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 58/186 (31%), Positives = 87/186 (46%), Gaps = 23/186 (12%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
GI VAVKKL + RA+R EL LL+ + H N++ L T P + E+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKSLEEF--- 98
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNI 179
D+ ++ A + LD R G+ +LH IIHRDL+PSNI
Sbjct: 99 QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 154
Query: 180 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239
+ LK+ DFG+++ T + +T + Y APEV Y VD++S I+
Sbjct: 155 VVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212
Query: 240 QEMIEG 245
E+++G
Sbjct: 213 GELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 26/203 (12%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF--------------LGAVTQS 117
+VAVKK+ V++D V+ E+ +++++ H N+V+ +G++T+
Sbjct: 32 RVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88
Query: 118 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
+ + IV EY+ + DL L+ +G L A F + RG+ Y+H ++HRDL+P+
Sbjct: 89 NSVYIVQEYM-ETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143
Query: 178 NIL-RDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE-VFKNEEYDTKVDVF 233
N+ + LK+ DFG+++++ L+ + Y +P + Y +D++
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 203
Query: 234 SFALILQEMIEGCPPFTMKHDNE 256
+ I EM+ G P F H+ E
Sbjct: 204 AAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 27/168 (16%)
Query: 150 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----- 204
++ +ARGM +L K IHRDL NIL ++ +K+ DFG+++ + D
Sbjct: 178 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 205 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPK 259
PL +++APE ++ Y T+ DV+SF ++L E+ G P+ ++ D E +
Sbjct: 235 ARLPL-------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287
Query: 260 AY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
R R P A ++Y+ L +CW+ P RPTF +++ L
Sbjct: 288 RLKEGTRMRAPEYATPEIYSIML-----DCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G VAVKK+ + R +E+ +++ +H NVV+ + + +V E+L
Sbjct: 45 GKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G L + + A L + + ++ LH +IHRD++ +IL G +K+
Sbjct: 102 GALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 157
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
+DFG ++ + R + T ++APE+ Y +VD++S +++ EM++G PP+
Sbjct: 158 SDFGFCAQVSKEVPRRKSLVGTP-YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
Query: 250 ---------TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
M DN PK + P LK ++ PA+R T +
Sbjct: 217 FNEPPLKAMKMIRDNLPPKLKNLHKVSPS----------LKGFLDRLLVRDPAQRATAAE 266
Query: 301 II 302
++
Sbjct: 267 LL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 59/188 (31%), Positives = 83/188 (44%), Gaps = 25/188 (13%)
Query: 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 127
G VA+KKL + RA+R EL L++ + H N++ L T Q S YL
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98
Query: 128 PKGDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPS 177
+ A L ++ LD R G+ +LH IIHRDL+PS
Sbjct: 99 VMELMDANL--------CQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 147
Query: 178 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 237
NI+ LK+ DFG+++ T +T + Y APEV Y VD++S
Sbjct: 148 NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205
Query: 238 ILQEMIEG 245
I+ EMI G
Sbjct: 206 IMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 92 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF- 150
F +E ++ P VVQ A + +V EY+P GDL + P +F
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFY 147
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210
++ ++ +H + +IHRD++P N+L D G+LK+ADFG + + E + C D
Sbjct: 148 TAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRC-D 201
Query: 211 TSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 249
T+ Y++PEV K++ Y + D +S + L EM+ G PF
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 34/199 (17%)
Query: 70 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 124
VA+KK+ +++++ RA R EL LL+ R H N+ M IV
Sbjct: 27 EETVAIKKITNVFSKKILAK----RALR-ELKLLRHFRGHKNITCLYD-------MDIVF 74
Query: 125 ----------EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 174
E L + DL ++ L + F I G+ Y+H ++HRDL
Sbjct: 75 PGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDL 131
Query: 175 EPSNILRDDSGNLKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKV 230
+P N+L + LK+ DFG+++ + + +T + Y APE+ + Y +
Sbjct: 132 KPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI 191
Query: 231 DVFSFALILQEMIEGCPPF 249
DV+S IL E++ P F
Sbjct: 192 DVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 7e-13
Identities = 58/184 (31%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 123
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T + +V
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRD 182
Y+ + DL+ K G V++ + + G+ Y+H IIHRDL+P N+ +
Sbjct: 99 MPYM-QTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151
Query: 183 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQE 241
+ LK+ DFG+++ D +T + Y APEV N Y+ VD++S I+ E
Sbjct: 152 EDCELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAE 207
Query: 242 MIEG 245
M+ G
Sbjct: 208 MLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 19/161 (11%)
Query: 150 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209
++ +ARGM +L K IHRDL NIL ++ +K+ DFG+++ + +D P +
Sbjct: 179 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR--DIYKD-PDYVR 232
Query: 210 DTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPKAY-- 261
S R ++APE ++ Y T+ DV+SF ++L E+ G P+ ++ + E +
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292
Query: 262 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
R R P A ++Y ++ CW P +RPTF ++
Sbjct: 293 GTRMRAPENATPEIY-----RIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 34/191 (17%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM---------IV 123
VA+KK+ E + + A R E+ +LQ ++H NVV L + ++ +V
Sbjct: 40 VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN-LIEICRTKATPYNRYKGSFYLV 97
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIAR-------GMNYLHENKPVPIIHRDLE 175
E+ DL L K V+F L +I + G+ Y+H NK I+HRD++
Sbjct: 98 FEFCEH-DLAGLLSNK-------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMK 146
Query: 176 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNE-EYDTKVD 231
+NIL G LK+ADFG+++ ++ ++ + Y PE+ E +Y +D
Sbjct: 147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPID 206
Query: 232 VFSFALILQEM 242
++ I+ EM
Sbjct: 207 MWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 113 AVTQSSPMMI-VTEYLP----KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 167
A +SS +YLP + + AL V F+ +A GM +L V
Sbjct: 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261
Query: 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNE 224
HRDL N+L + +K+ DFG+++ + D + ++ +++APE N
Sbjct: 262 ---HRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 225 EYDTKVDVFSFALILQEM--IEGCP----PFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278
Y T DV+SF ++L E+ + G P P + N + + Y R P A ++Y
Sbjct: 317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY--RMAKPAHASDEIY-- 372
Query: 279 GLKELIEECWNEKPAKRPTFRQIITRLESI 308
E++++CW EK RP F Q++ + +
Sbjct: 373 ---EIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 24/157 (15%)
Query: 105 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMN 159
+VQ A + +V EY+P GDL + K A + V ALD M
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYV 216
+ IHRD++P N+L D SG+LK+ADFG + + + + C DT+ Y+
Sbjct: 163 F---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRC-DTAVGTPDYI 210
Query: 217 APEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 249
+PEV K++ Y + D +S + L EM+ G PF
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 102 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV----RFALDIARG 157
++HPN++Q LG ++ P ++V EY GDL+++L ++ + ++ + R A +IA G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---R 214
+ ++H++ +H DL N +KV D+G+ KED + +D C R
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDY-IETEDDKCVPLR 166
Query: 215 YVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV-PKAYAARQ 265
++APE+ E +V++ + L E+ E P++ D EV +Q
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ 226
Query: 266 RPPFKAPAKL-YARGLKELIEECWNEKPAKRPTFRQI 301
FK +L Y+ E+++ CW P KR T ++
Sbjct: 227 VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 37/210 (17%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L + + + ++V R E +L + VV+ + + ++ E+LP GD+
Sbjct: 30 AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMM 89
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
L +K L + + ++ +H+ + IHRD++P N+L D G++K++DFG
Sbjct: 90 TLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFG 146
Query: 194 V--------------------------------SKLLTVKEDRPLTCQDT--SCRYVAPE 219
+ K T K++R T + Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206
Query: 220 VFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
VF Y+ D +S +I+ EM+ G PPF
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 60/279 (21%), Positives = 122/279 (43%), Gaps = 33/279 (11%)
Query: 45 IDPHELDFTNSVEITKGTFILAFWRGI----QVAVKKLGEEVISDDDRVRAFRDELALLQ 100
I+ ++D SV I + + ++GI +V ++ + + +E+ L+
Sbjct: 15 IESDDIDKYTSVLIKEND-QNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLR 73
Query: 101 KIRHPNVVQFLG---AVTQSSP-MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 156
+I N+++ G + P + ++ EY +G LR L ++ L T + A+D +
Sbjct: 74 RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCK 133
Query: 157 GMNYLHE--NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 214
G+ L++ NKP +++L + L ++ LK+ G+ K+L+ P
Sbjct: 134 GLYNLYKYTNKP----YKNLTSVSFLVTENYKLKIICHGLEKILSS----PPFKNVNFMV 185
Query: 215 YVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPF-----TMKHDNEVPKAYAARQRP 267
Y + ++ + EY K D++S ++L E+ G PF +D + K + +
Sbjct: 186 YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS--LKL 243
Query: 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306
P P +K ++E C + KRP ++I+ L
Sbjct: 244 PLDCP-----LEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 51/209 (24%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 93 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 151
R E +L+ +R P +V A + + ++ +Y+ G++ L ++ ++
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQD 210
+I + +LH+ + I++RD++ NIL D G++ + DFG+SK L+ +++R +
Sbjct: 112 GEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG 168
Query: 211 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR 266
T Y+APE+ + + K VD +S +++ E++ G PFT++ + + R
Sbjct: 169 TI-EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD 227
Query: 267 PPFKAPAKLYARGLKELIEECWNEKPAKR 295
PPF + A+ +L+ + + P KR
Sbjct: 228 PPFPSFIGPEAQ---DLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 46/243 (18%)
Query: 120 MMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 175
+ +V +Y GDLR +K + + A + + ++++H +IHRD++
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIK 170
Query: 176 PSNILRDDSGNLKVADFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 233
+NIL +G +K+ DFG SK+ TV +D T T YVAPE+++ + Y K D+F
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP-YYVAPEIWRRKPYSKKADMF 229
Query: 234 SFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRP--------------------PFKAP 272
S ++L E++ PF ++ EV K A R P P + P
Sbjct: 230 SLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRP 289
Query: 273 A----------KLYARGLKELIEECWNEKPAKRPTFRQIITR-LESINNSINHKRRWKIR 321
+ KL+ GL E+++ +P R I+R ++ + +RR +R
Sbjct: 290 SSSKLLNMPICKLFISGLLEIVQ----TQPGFSGPLRDTISRQIQQTKQLLQVERRRIVR 345
Query: 322 TMK 324
M+
Sbjct: 346 QME 348
|
Length = 496 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L + + + ++V R E +L + VV+ + + ++ E+LP GD+
Sbjct: 30 AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
L +K L + + ++ +H+ + IHRD++P N+L D G++K++DFG
Sbjct: 90 TLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFG 146
Query: 194 V--------------------------------SKLLTVKEDRPLTCQDT--SCRYVAPE 219
+ K T K +R T + Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206
Query: 220 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 259
VF Y+ D +S +I+ EM+ G PPF + E K
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYK 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKGDLRAFLK-----RKGALKPSTA 147
E+ALL++++H NVV + + + + + +Y + DL +K ++ ++ PS
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 148 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLTVKED 203
I G++YLH N ++HRDL+P+NIL + G +K+ D G+++L
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPL 166
Query: 204 RPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPF 249
+PL D + Y APE+ + TK +D+++ I E++ P F
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 48/203 (23%)
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V+A RD LA + + VV+ + + V +Y+P GD+ + L R G + A
Sbjct: 48 VKAERDILA---EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR 104
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV-------------- 194
+ ++ + +H+ + IHRD++P NIL D G++K+ DFG+
Sbjct: 105 FYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 195 ------------SKLLTVKEDRPLTC-------QDTSCR---------YVAPEVFKNEEY 226
S+ + + L Q C Y+APEV Y
Sbjct: 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221
Query: 227 DTKVDVFSFALILQEMIEGCPPF 249
D +S +IL EM+ G PPF
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 27/171 (15%)
Query: 148 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL------TVK 201
+RF+ +A+GM++L IHRD+ N+L D K+ DFG+++ + VK
Sbjct: 215 LRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF-----TMKHDN 255
+ L +++APE + Y + DV+S+ ++L E+ G P+ K
Sbjct: 272 GNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
Query: 256 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306
V + Y RP F AP ++Y+ +++ CWN +P +RPTF QI ++
Sbjct: 327 MVKRGYQM-SRPDF-APPEIYS-----IMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 40/121 (33%), Positives = 68/121 (56%), Gaps = 7/121 (5%)
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
GDL L + G + +A +I G+ ++H N+ V ++RDL+P+NIL D+ G++++
Sbjct: 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-NRFV--VYRDLKPANILLDEHGHVRI 138
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPP 248
+D G++ + K +P T Y+APEV K YD+ D FS +L +++ G P
Sbjct: 139 SDLGLACDFSKK--KPHASVGTH-GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
Query: 249 F 249
F
Sbjct: 196 F 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 93 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 152
R L+L+ P +V A + + + + GDL L + G +A
Sbjct: 45 RIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT 104
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 212
+I G+ ++H +++RDL+P+NIL D+ G+++++D G++ + K +P T
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTH 159
Query: 213 CRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 249
Y+APEV K YD+ D FS +L +++ G PF
Sbjct: 160 -GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFLKRKGALKPSTAVRFAL 152
E +L+ I HP+++Q G T + ++ LP K DL +L K + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL-LTVKEDRPLTCQDT 211
+ R + YLHEN+ IIHRD++ NI + G++ + DFG + + + ++ T
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 245
APE+ + Y VD++S ++L EM
Sbjct: 247 IATN-APELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 6e-11
Identities = 56/184 (30%), Positives = 85/184 (46%), Gaps = 23/184 (12%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
VA+KKL + RA+R EL L++ + H N++ L T P + E+ D
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QD 103
Query: 132 LRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILR 181
+ ++ A ++ LD R G+ +LH IIHRDL+PSNI+
Sbjct: 104 VYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVV 159
Query: 182 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 241
LK+ DFG+++ T +T + Y APEV Y VD++S I+ E
Sbjct: 160 KSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 242 MIEG 245
MI+G
Sbjct: 218 MIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 46/214 (21%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 153
E+ +L+ I H ++ + A S + M++ +Y K DL ++ R G L A+
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYVDRSGPLPLEQAITIQRR 193
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL------T 207
+ + YLH IIHRD++ NI D+ N + DFG + L D P T
Sbjct: 194 LLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 208 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM-IEGCPPFTMK-------------- 252
+ S PE+ + Y K D++S L+L EM ++ F +
Sbjct: 251 LETNS-----PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305
Query: 253 ---HDNEVP-----------KAYAARQRPPFKAP 272
H E P K YA RPP+ P
Sbjct: 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIP 339
|
Length = 392 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VA+KKL + RA+R EL L++ + H N++ L T P + E+ D+
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKSLEEF---QDV 97
Query: 133 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 182
++ A ++ LD R G+ +LH IIHRDL+PSNI+
Sbjct: 98 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 153
Query: 183 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 242
LK+ DFG+++ T +T + Y APEV Y VD++S I+ EM
Sbjct: 154 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 243 I 243
+
Sbjct: 212 V 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 18/190 (9%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VAVKK+ + + ++ + E+ ++++HPN++ ++ + S + +V+ + G
Sbjct: 28 VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86
Query: 133 RAFLKR--KGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
LK L P A+ F L D+ ++Y+H IHR ++ S+IL G + +
Sbjct: 87 EDLLKTHFPEGL-PELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVL 142
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRY-------VAPEVFKN--EEYDTKVDVFSFALILQ 240
+ S + +K + + ++PEV + + Y+ K D++S +
Sbjct: 143 SGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201
Query: 241 EMIEGCPPFT 250
E+ G PF
Sbjct: 202 ELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 52/207 (25%)
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V+A RD LA + P VV + + + ++ E+LP GDL L +
Sbjct: 48 VKAERDVLA---ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR 104
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS------------- 195
+ + + +H+ + IHRD++P NIL D G++K++DFG+S
Sbjct: 105 FYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 196 KLLTVKEDRP----------------LTCQDT-----------------SCRYVAPEVFK 222
KLL K ++ ++ +D + Y+APE+F
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221
Query: 223 NEEYDTKVDVFSFALILQEMIEGCPPF 249
+ Y + D +S I+ E + G PPF
Sbjct: 222 QQGYGQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 52/207 (25%)
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
V+A RD LA + + VV+ + + V +Y+P GD+ + L R G A
Sbjct: 48 VKAERDILA---EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLAR 104
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV---------SKLLT 199
+ ++ + +H+ + IHRD++P NIL D G++K+ DFG+ SK
Sbjct: 105 FYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 200 ----VKEDR---------PLTC---------------QDTSC---------RYVAPEVFK 222
V++D P C Q C Y+APEV
Sbjct: 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL 221
Query: 223 NEEYDTKVDVFSFALILQEMIEGCPPF 249
Y D +S +IL EM+ G PPF
Sbjct: 222 RTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 49/222 (22%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L ++ + + ++V + E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
+ L R A + ++ + +H+ + IHRD++P NIL D G++K+ DFG
Sbjct: 90 SLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFG 146
Query: 194 V-------------SKLLTVKED--RPLTCQD--TSCR---------------------- 214
+ K +++D P D ++CR
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206
Query: 215 -------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
Y+APEV + Y D +S +IL EM+ G PPF
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 23/232 (9%)
Query: 84 SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL 142
S D AF + +L+ ++ H ++ G + S ++V E++ G L L++ KG +
Sbjct: 55 SHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV 114
Query: 143 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFGVS 195
+ + A +A ++YL E+K ++H ++ NIL G +K++D GVS
Sbjct: 115 PVAWKITVAQQLASALSYL-EDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171
Query: 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEM-IEGCPPFTMKH 253
+E+R ++APE T D +SF L E+ +G P +
Sbjct: 172 FTALSREERV-----ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226
Query: 254 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
+E + Y + R P P+ + L LI +C +P +RP+FR I+ L
Sbjct: 227 PSEKERFYEKKHRLP--EPS---CKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 92 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 151
FR+E +L + + A + + +V +Y GDL L + P RF
Sbjct: 48 FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107
Query: 152 L-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210
L ++ ++ +H+ + +HRD++P NIL D +G++++ADFG L + ED T Q
Sbjct: 108 LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDG--TVQS 160
Query: 211 T----SCRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKA 260
+ + Y++PE+ + E Y + D +S + + EM+ G PF + E K
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
Query: 261 YAARQRPPFKAPAKLYARGLKELI 284
++R F A + K+LI
Sbjct: 221 MNHKERFQFPAQVTDVSEDAKDLI 244
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 38/239 (15%)
Query: 95 ELALLQKIRHPNVVQ----FLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPST 146
E+ ++++++H N+V+ FL Q + I+ E+ GDL + K G ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQK--LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119
Query: 147 AVRFALDIARGMNYLHENKPVP----IIHRDLEPSNI-----------LRDDSGNL---- 187
V + + Y H K P ++HRDL+P NI + + NL
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 188 --KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMI 243
K+ DFG+SK + + E +C T Y +PE+ +E YD K D+++ I+ E+
Sbjct: 180 IAKIGDFGLSKNIGI-ESMAHSCVGTP-YYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 244 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
G PF N + + +R P P K ++ L LI+ N +RP+ Q +
Sbjct: 238 SGKTPF--HKANNFSQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 24/180 (13%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 144
E+ALL++++HPNV+ S + ++ +Y + DL +K A K P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106
Query: 145 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLT 199
+ V+ L I G++YLH N ++HRDL+P+NIL + G +K+AD G ++L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 200 VKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDN 255
+PL D + Y APE+ + TK +D+++ I E++ P F + ++
Sbjct: 164 -SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 4e-09
Identities = 42/174 (24%), Positives = 83/174 (47%), Gaps = 10/174 (5%)
Query: 104 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 163
+PN ++ +VT +++ +Y+ GDL LK++G L + + + +N LH+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 164 NKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 222
+ IIH D++ N+L D + + + D+G+ K++ +C D + Y +PE K
Sbjct: 128 HN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIK 179
Query: 223 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKL 275
YD D ++ ++ E++ G PF D E+ ++ RQ+ +
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233
|
Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 51/180 (28%), Positives = 89/180 (49%), Gaps = 24/180 (13%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 144
E+ALL++++HPNV+ + + ++ +Y + DL +K A K P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106
Query: 145 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLT 199
V+ L I G++YLH N ++HRDL+P+NIL + G +K+AD G ++L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 200 VKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDN 255
+PL D + Y APE+ + TK +D+++ I E++ P F + ++
Sbjct: 164 -SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 27/70 (38%), Positives = 41/70 (58%), Gaps = 3/70 (4%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129
++VAVK L + + D A EL +L + +H N+V LGA T P++++TEY
Sbjct: 69 LRVAVKML--KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126
Query: 130 GDLRAFLKRK 139
GDL FL++K
Sbjct: 127 GDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 29/194 (14%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV-----QFLGAVTQSSP---MMIV 123
+VA+KK V+ D + EL +++ + H N++ + ++ + +V
Sbjct: 93 KVAIKK----VLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 124 TEYLPKGDLRAFLK---RKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 179
E++P+ + ++K R P V+ ++ + R + Y+H I HRDL+P N+
Sbjct: 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNL 201
Query: 180 LRD-DSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFA 236
L D ++ LK+ DFG +K LL + C S Y APE+ Y T +D++S
Sbjct: 202 LIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFYRAPELMLGATNYTTHIDLWSLG 258
Query: 237 LILQEMIEGCPPFT 250
I+ EMI G P F+
Sbjct: 259 CIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 38/140 (27%), Positives = 71/140 (50%), Gaps = 17/140 (12%)
Query: 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSN 178
+ +V +Y GDL L + P RF + ++ ++ +H+ V HRD++P N
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV---HRDIKPDN 132
Query: 179 ILRDDSGNLKVADFG----VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTK 229
+L D +G++++ADFG +++ TV+ + D Y++PE+ + E Y +
Sbjct: 133 VLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD----YISPEILQAMEDGMGKYGPE 188
Query: 230 VDVFSFALILQEMIEGCPPF 249
D +S + + EM+ G PF
Sbjct: 189 CDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 40/138 (28%), Positives = 72/138 (52%), Gaps = 17/138 (12%)
Query: 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL 180
+V +Y GDL L + P RF L ++ ++ +H+ + +HRD++P N+L
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVL 134
Query: 181 RDDSGNLKVADFGVS-KLL---TVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVD 231
D +G++++ADFG +LL TV+ + + D Y++PE+ + E Y + D
Sbjct: 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD----YISPEILQAMEDGKGRYGPECD 190
Query: 232 VFSFALILQEMIEGCPPF 249
+S + + EM+ G PF
Sbjct: 191 WWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 60 KGTFILAFWRGIQVAVKKLGE----EVI------SDDDRVRAFRDELALLQKIRHPNVVQ 109
+GTF F +GI+ V GE EV+ S + +F + +++ ++ H ++V
Sbjct: 5 QGTFTKIF-KGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVL 63
Query: 110 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-AVRFALDIARGMNYLHENKPVP 168
G ++V EY+ G L +LK+ L + + A +A +++L +
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--- 120
Query: 169 IIHRDLEPSNIL-----RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 220
+ H ++ N+L +GN +K++D G+S +TV L +V PE
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILL---ERIPWVPPEC 175
Query: 221 FKN-EEYDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278
+N + D +SF L E+ G P + + + Y R + PA +
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH----QLPAPKWTE 231
Query: 279 GLKELIEECWNEKPAKRPTFRQIITRL 305
L LI +C + +P RP+FR II L
Sbjct: 232 -LANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 18/191 (9%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--MMIVTEYLPK 129
A+K + ++ ++V R E+ L+++ HPN+++ + + + +V E L
Sbjct: 27 YAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE-LMD 83
Query: 130 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
+L +K RK L + + + ++++H N I HRD++P NIL D LK
Sbjct: 84 MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILK 139
Query: 189 VADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE-VFKNEEYDTKVDVFSFALILQEMIEGC 246
+ADFG + + P T + S R Y APE + + Y K+D+++ + E++
Sbjct: 140 LADFGSCR--GIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196
Query: 247 PPFTMKHDNEV 257
P F NE+
Sbjct: 197 PLFPGT--NEL 205
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 61/245 (24%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
I+V +K L S D AF + ++++++ H ++V G + ++V E++ G
Sbjct: 33 IKVILKVLDP---SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89
Query: 131 DLRAFLKRKGALKPSTAVRF--ALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGN 186
L F+ RK + +T +F A +A ++YL + ++H ++ NIL R+
Sbjct: 90 PLDLFMHRKSDVL-TTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDG 145
Query: 187 -----LKVADFGVSKLLTVKEDRPLTCQDTSCR--YVAPEVFKNEE-YDTKVDVFSFALI 238
+K++D G+ +TV L+ Q+ R ++APE ++ + D +SF
Sbjct: 146 ECGPFIKLSDPGIP--ITV-----LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTT 198
Query: 239 LQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 297
L E+ G P K E + Y + P+ + L +L+ C N P +RP
Sbjct: 199 LWEICYNGEIPLKDKTLAEKERFYEGQCML--VTPS---CKELADLMTHCMNYDPNQRPF 253
Query: 298 FRQII 302
FR I+
Sbjct: 254 FRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 18/192 (9%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G V V+ E +++ ++A ++E+ L RHPN++ T S + +++ ++
Sbjct: 25 GTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 130 GDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
G + LK S A+ RG+NYLH+N IHR+++ S+IL G +
Sbjct: 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLV 140
Query: 188 KVADFGVSKL--LTVKEDRPLTCQD-----TSCR-YVAPEVFKNE--EYDTKVDVFSFAL 237
++ G+S L L + D TS +++PE+ + + Y+ K D++S +
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 238 ILQEMIEGCPPF 249
E+ G PF
Sbjct: 199 TACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-07
Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 9/142 (6%)
Query: 105 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 164
PN+V + + +V ++ G L + + + + R+A ++ ++ LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 165 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKN 223
I+ RDL P+NIL DD G++++ F E + Y APEV
Sbjct: 105 G---IVCRDLNPNNILLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGI 156
Query: 224 EEYDTKVDVFSFALILQEMIEG 245
E D +S IL E++ G
Sbjct: 157 SEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 28/185 (15%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G+Q VK+ I+D + + + E+A + K++HPN+V+ +G ++ EY+
Sbjct: 715 GMQFVVKE-----INDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNL 187
+L L+ L + A+ IA+ + +LH ++ +L P I+ D D +L
Sbjct: 768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEMI 243
+++ G L C DT C YVAPE + ++ K D++ F LIL E++
Sbjct: 825 RLSLPG------------LLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL 872
Query: 244 EGCPP 248
G P
Sbjct: 873 TGKSP 877
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 28/163 (17%)
Query: 45 IDPHELDFTNSVEITKGTFIL-------AFWR--------------GIQVAVKKLGEEVI 83
+DP +L + ++ E+ + +L AF R ++VAVK L
Sbjct: 21 VDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR 80
Query: 84 SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 142
S + + A EL ++ + H N+V LGA T+ P+ I+TEY GDL +L R
Sbjct: 81 SSEKQ--ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR---- 134
Query: 143 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185
T +++ LD R L P+ R S D G
Sbjct: 135 NKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGG 177
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 58/262 (22%), Positives = 103/262 (39%), Gaps = 51/262 (19%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
+VA+KK+ E++ + + F E + + HP +V + P+ Y+
Sbjct: 29 RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88
Query: 132 LRAFLKR-------KGALKPSTAVRFALDI----ARGMNYLHENKPVPIIHRDLEPSNIL 180
L++ LK L T+V L I + Y+H ++HRDL+P NIL
Sbjct: 89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNIL 145
Query: 181 RDDSGNLKVADFGVSKLLTVKEDRPLTC---QDTSC--------------RYVAPEVFKN 223
G + + D+G + ++E+ L + C Y+APE
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205
Query: 224 EEYDTKVDVFSFALILQEMIEGCPPF--------TMKHDNEVPKAYAA-RQRPPF----- 269
D+++ +IL +M+ P+ + + P A R+ PPF
Sbjct: 206 VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIA 265
Query: 270 -KA----PAKLYARGLKELIEE 286
KA PA+ Y ++EL ++
Sbjct: 266 MKALAVDPAERY-SSVQELKQD 286
|
Length = 932 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 3/68 (4%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
VAVK L + A EL +L + H N+V LGA T P +++TEY GD
Sbjct: 68 VAVKMLKPSAHLTERE--ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGD 125
Query: 132 LRAFLKRK 139
L FL+RK
Sbjct: 126 LLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK--GDLRAFL-KRKGALKPSTAVRFA 151
E LL+++ HP V+ L +V LPK DL +L R L + A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT---- 207
+ ++Y+H IIHRD++ N+L + ++ + DFG + P
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 208 -CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 241
DT+ APEV + Y VD++S L++ E
Sbjct: 324 GTVDTN----APEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 27/69 (39%), Positives = 39/69 (56%), Gaps = 4/69 (5%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 130
VAVK L E + + + A EL +L I H NVV LGA T+ + P+M++ E+ G
Sbjct: 40 VAVKMLKEGATASEHK--ALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYG 97
Query: 131 DLRAFLKRK 139
+L FL+ K
Sbjct: 98 NLSNFLRAK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 3/69 (4%)
Query: 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129
++VAVK L S + + A EL ++ + H N+V LGA T+S P+ I+TEY
Sbjct: 68 MKVAVKMLKPTARSSEKQ--ALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFY 125
Query: 130 GDLRAFLKR 138
GDL +L +
Sbjct: 126 GDLVNYLHK 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 29/155 (18%), Positives = 53/155 (34%), Gaps = 27/155 (17%)
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210
L + LH + NIL + + + G T ++ RP D
Sbjct: 23 CLQCLGALRELHRQA---------KSGNIL--LTWDGLLKLDGSVAFKTPEQSRP----D 67
Query: 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-------AA 263
++APEV + + Y K D++S + L E ++ P+ + E+ A
Sbjct: 68 PY--FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN--EERELSAILEILLNGMPA 123
Query: 264 RQRPPFKAPAK-LYARGLKELIEECWNEKPAKRPT 297
AR ++ + C + P +R
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.003
Identities = 22/85 (25%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179
+IV EY+ L+ + G + + + + LH IIH DL SN+
Sbjct: 74 FIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGK----LHSAG---IIHGDLTTSNM 126
Query: 180 LRDDSGNLKVADFGVSKLLTVKEDR 204
+ G + + DFG+++ EDR
Sbjct: 127 ILSG-GKIYLIDFGLAEFSKDLEDR 150
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 353 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.51 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.38 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.37 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.22 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.15 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.15 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.02 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.78 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.7 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.37 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.37 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.35 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.16 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.12 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.08 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.06 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.92 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.83 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.7 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.56 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.37 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.99 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.85 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.3 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.94 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.67 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.41 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.13 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.01 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.93 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.61 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.85 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.81 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.33 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.87 | |
| PLN02236 | 344 | choline kinase | 91.68 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 90.83 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.61 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 90.15 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-53 Score=391.36 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=231.4
Q ss_pred CCCcccCccCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEE
Q 018614 40 VPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 114 (353)
Q Consensus 40 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 114 (353)
+|+.-.++....|..++.||+|+|..+| ..|+.||+|++.+..+.+....+.+.+|+++.++|+|||||+++++|
T Consensus 8 ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 8 IPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred CCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence 3444455556789999999999998887 36899999999998888888889999999999999999999999999
Q ss_pred EecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 115 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 115 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
++...+|||+|+|..++|.+++++++.+++..++.++.||+.||.|||+++ |+|||||.+|+|++++.+|||+||||
T Consensus 88 EDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 88 EDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred ecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccce
Confidence 999999999999999999999998889999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchh
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
|.....+..+..+ .-|||.|.|||++....++..+||||+||+||.|+.|++||...+..+....+......- +.
T Consensus 165 At~le~~~Erk~T-lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~----P~ 239 (592)
T KOG0575|consen 165 ATQLEYDGERKKT-LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM----PS 239 (592)
T ss_pred eeeecCcccccce-ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc----cc
Confidence 9998765444333 558999999999999999999999999999999999999999888777777775554322 23
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.++.+.++||.++|+.||.+|||+++++.|
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 688999999999999999999999999987
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=363.63 Aligned_cols=244 Identities=28% Similarity=0.467 Sum_probs=212.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc-eEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~iv~ 124 (353)
+.+....||+|..|.|++ +++.+|+|++... .+.+..+++.+|+++++..+|||||+++|.|.+++. +.|+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 566778999999998873 6899999999543 356777889999999999999999999999999995 99999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||++|+|++++...+.+++....+++.++++||.|||. ++ ||||||||+|+|++..|.|||||||.+..+...
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999988889999999999999999999996 66 999999999999999999999999999887644
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC--CCCch---HHHHHhcCCCCCCCchhhhHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK--HDNEV---PKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~ 278 (353)
....+.||..|||||.+.+..|+.++||||||++++|+++|+.||... ..... ...|..+..+.++ ...+++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP--~~~fS~ 309 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLP--EGEFSP 309 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCC--cccCCH
Confidence 334577999999999999999999999999999999999999999874 22233 3334333333332 225999
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++++||..||++||.+||+++++++|
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999988
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-52 Score=380.11 Aligned_cols=259 Identities=34% Similarity=0.589 Sum_probs=230.6
Q ss_pred CCcccCccCcCcccceeeecceEEEEE---EcCe-EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAF---WRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~---~~g~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 116 (353)
..|+++.+. ++..+.||+|.||.|+ |+|. .||+|.++...... ++|.+|+++|++|+|++||++++++..
T Consensus 199 d~wei~r~~--l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 199 DPWEIPREE--LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred CCeeecHHH--HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 346665554 4556789999999886 6666 99999998754433 467899999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
++.+||||||++.|+|.++|+. ...+...+.+.++.||++||+||++++ +|||||.+.||||+++..+||+||||
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccc
Confidence 8899999999999999999986 445999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCch
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 273 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 273 (353)
|+...+...........+..|.|||.+....++.+||||||||+|||++| |+.||.+++..++.+.+..+.+.+- +
T Consensus 350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---P 426 (468)
T KOG0197|consen 350 ARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---P 426 (468)
T ss_pred ccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---C
Confidence 99766665555666667889999999999999999999999999999999 9999999999999999988888775 5
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
..||.++.++|..||..+|++|||++.+...|+++...
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 56899999999999999999999999999999988653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=370.55 Aligned_cols=274 Identities=42% Similarity=0.730 Sum_probs=233.7
Q ss_pred CCCCCcccCccCcCcccceeeecceEEEEE---EcCeE-EEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeE
Q 018614 38 REVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 113 (353)
Q Consensus 38 ~~~~~~~i~~~~~~~~~~~~ig~G~~~~v~---~~g~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 113 (353)
...++|.+++..+.+.. .||.|+||.|| |.|.. ||||++......... ...|.+|+.+|.+++|||||+++|+
T Consensus 31 ~~~~~~~i~~~~l~~~~--~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 31 DELPEEEIDPDELPIEE--VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred ccccceecChHHhhhhh--hcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 44567788777655444 49999999987 67888 999999876554444 7789999999999999999999999
Q ss_pred EEecC-ceEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEE
Q 018614 114 VTQSS-PMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKV 189 (353)
Q Consensus 114 ~~~~~-~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl 189 (353)
+.+.. ..+|||||+++|+|.+++.. ...++...++.++.||+.||.|||++++ ||||||||+|||++.++ ++||
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEE
Confidence 99887 79999999999999999987 5679999999999999999999999984 89999999999999998 9999
Q ss_pred eecccccccccCCCCCcccCCCCCcccCccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-C
Q 018614 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R 266 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~ 266 (353)
+|||+++...... ...+...||+.|||||++. ...++.|+||||||+++|||+||+.||.+.....+...+..+. +
T Consensus 186 ~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 186 ADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR 264 (362)
T ss_pred CCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9999998765432 3334467899999999999 5699999999999999999999999999998866666665444 4
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhccccce
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKI 320 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~ 320 (353)
+.++ ..+++.+..||..||..||+.||++.+++..|+.+...+.....+..
T Consensus 265 p~~p---~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~~ 315 (362)
T KOG0192|consen 265 PPIP---KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPEDS 315 (362)
T ss_pred CCCC---ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcccc
Confidence 4443 33788999999999999999999999999999999887765555443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=363.55 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=219.8
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHH----HHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 49 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
...|...+.||+|+||.|. .+|..||||++++....... ......+|+++|+.|+|||||+++++|.....
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3458889999999999886 47999999999875443311 22335799999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC---CCEEEeeccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSK 196 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~---~~vkl~Dfg~a~ 196 (353)
.||||||++||.|.+.+-.++.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ -.+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999999999888999999999999999999999999 9999999999999977 469999999999
Q ss_pred ccccCCCCCcccCCCCCcccCccccCCCCC---CCchhHHHHHHHHHHHHcCCCCCCCCCCCc-hHHHHHhcCCCCCCCc
Q 018614 197 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEY---DTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAP 272 (353)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 272 (353)
..... ......-||+.|.|||++.+... ..+.|+|||||++|-+++|.+||.+..... ..+++.++...-.+..
T Consensus 328 ~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 328 VSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred ccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 98633 23334568999999999977643 347899999999999999999999887777 7777777776666677
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
+..++.+..+||.+||..||++|||+.++|+|-+-
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 88899999999999999999999999999998543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=349.73 Aligned_cols=252 Identities=27% Similarity=0.481 Sum_probs=216.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceee-EEEecCc-eEEE
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSSP-MMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~~~-~~iv 123 (353)
+|++.++||+|+||.|| ++|..||.|.+.-. ..+.+..+....|+.+|++|+|||||++++ .|.++.. ++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 69999999999999988 47999999999844 346677788999999999999999999998 5554444 8999
Q ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 124 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPV-PIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~-~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
||+|++|+|...++. ...+++..+|+++.|++.||..+|+.-+. -|+||||||.|||++.+|.|||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999973 34599999999999999999999993221 2999999999999999999999999999998
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
..... ...+..|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+....++..+|..+..+++ +...+|.
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~--p~~~YS~ 255 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL--PDEHYST 255 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC--cHHHhhh
Confidence 65432 23567899999999999999999999999999999999999999999988888888877755544 3378999
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
++..||..|+..||+.||+...++..+.
T Consensus 256 ~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 9999999999999999999655554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-50 Score=351.84 Aligned_cols=247 Identities=30% Similarity=0.483 Sum_probs=221.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.|+. .++.+|+|++++..+......+....|..+|..++||+||+++..|++.+.+|+|+|
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence 688999999999999873 588999999998887777777889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+.||.|..+|++.+.|++..+..++..|+.||.|||++| ||||||||+|||+|.+|+++|+|||+++..-......
T Consensus 106 ~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 106 YLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred ccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999998654443333
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
....||+.|||||++.+..|+..+|+||||+++|+|++|.+||...+..+..+.+..+..+. .+..++.+.+++++
T Consensus 183 -~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~---~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 183 -RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL---PPGYLSEEARDLLK 258 (357)
T ss_pred -ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC---CCccCCHHHHHHHH
Confidence 33678999999999999999999999999999999999999999999888888887766333 34557889999999
Q ss_pred HHcccCCCCCC----CHHHHHHH
Q 018614 286 ECWNEKPAKRP----TFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rp----s~~~ll~~ 304 (353)
.+|..||++|. ++.+|.+|
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcC
Confidence 99999999995 56666544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=345.83 Aligned_cols=249 Identities=31% Similarity=0.530 Sum_probs=216.9
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|...++||.|+|++||. ++..||||.+..... ..+..+.+..|+.+|+.++|||||++++++...+.+|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 34788888999999999983 688999999987654 456667788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC------CCEEEeecccccc
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKL 197 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~------~~vkl~Dfg~a~~ 197 (353)
||||.||+|.+++.+.+.+++..++.++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999999999999999999999999999999999 9999999999999875 4589999999999
Q ss_pred cccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
+... ......-|++.|||||++..+.|+.|+|+||+|+++|+|++|+.||...+..+....+.++. ...+..+...+
T Consensus 165 L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~-~~~~~~~~~~s 241 (429)
T KOG0595|consen 165 LQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN-EIVPVLPAELS 241 (429)
T ss_pred CCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc-cccCchhhhcc
Confidence 8733 22234568899999999999999999999999999999999999999988888877664444 33333455567
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..+.+++...+..+|..|.++.+.+.+
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhh
Confidence 778899999999999999888877665
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=358.85 Aligned_cols=248 Identities=27% Similarity=0.484 Sum_probs=223.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
+|..++.||.|+|..|+ ..+..+|||++.+..+..+....-+..|-..|.+| .||+|++++-.|+|...+|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 79999999999999887 36889999999888777666666677899999999 7999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++|+|.++++..+.|++.-++.++.||+.||+|||+.| ||||||||+|||+|++|+++|+|||.|+.+......
T Consensus 154 e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999988643221
Q ss_pred ------------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCc
Q 018614 205 ------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 272 (353)
Q Consensus 205 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
....+.||..|.+||++.....+..+|+|+|||++|+|+.|.+||...+..-+.+.|......-
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f---- 306 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF---- 306 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC----
Confidence 1245889999999999999999999999999999999999999999998888888886655332
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+..+++.+.+||+++|..||.+|++.++|.+|.
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 345778899999999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=343.32 Aligned_cols=252 Identities=27% Similarity=0.496 Sum_probs=208.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC--ceE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 121 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 121 (353)
..+|...+.||+|+||.|+. +|+..|||.+.... .. ..+.+.+|+.+|++++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--ch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 45688899999999999983 37899999987652 12 2567899999999999999999999854444 689
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-CCCEEEeecccccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT 199 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-~~~vkl~Dfg~a~~~~ 199 (353)
|.|||+++|+|.+++.+.+ .+++..+..+++|+++||+|||++| ++||||||+|||++. ++.+||+|||+++...
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999876 7999999999999999999999999 999999999999999 7999999999998876
Q ss_pred c--CCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCC-CCCchHHHHHhcCCCCCCCchhh
Q 018614 200 V--KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKL 275 (353)
Q Consensus 200 ~--~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 275 (353)
. ..........||+.|||||++.++ ....++|||||||++.||+||+.||... ...+....+.... ..+..+..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~~ 247 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPDS 247 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCcc
Confidence 4 222233457799999999999853 3445999999999999999999999874 3333333332222 22244566
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 276 YARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 276 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
++.+.++|+.+||..||++|||++++|+|.-.-
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 899999999999999999999999999996554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=328.09 Aligned_cols=249 Identities=21% Similarity=0.398 Sum_probs=206.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|+...++|+|+||+|++ +|+.||||++.... .++...+-.++|+++|++++|+|+|.++++|...+.+++|+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 478888999999999984 68999999997542 234444556899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
||+..-|+++=.....++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+.. +...
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 9977555544444445999999999999999999999999 99999999999999999999999999998875 3445
Q ss_pred cccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC-----------------
Q 018614 206 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP----------------- 267 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------- 267 (353)
.+.+..|.+|.|||.+.| ..|+...||||+||++.||++|.+.|++..+-+....|......
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 566788999999999988 68999999999999999999999999998876655444321110
Q ss_pred ----------CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ----------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ----------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++......+.-+.+|++.||..||++|++.++++.|
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0000112345678899999999999999999999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=322.64 Aligned_cols=235 Identities=26% Similarity=0.485 Sum_probs=214.3
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||.|+||.|- .+|..+|+|++....+-...+.+...+|..+|+.+.||+++++++.+.+...+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 478899999999999875 368899999999887777778888999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||.+||.|..++++.++|++..++.++.||+.||+|||+.+ +++|||||+|||+|++|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999987532
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
....-|||.|+|||++....++.++|+||||+++|||+.|.+||.......+.++|..+...- +..++.++++|+
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~f----P~~fs~~~kdLl 272 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKF----PSYFSSDAKDLL 272 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccC----CcccCHHHHHHH
Confidence 333558999999999999999999999999999999999999999998888888886665322 356788999999
Q ss_pred HHHcccCCCCC
Q 018614 285 EECWNEKPAKR 295 (353)
Q Consensus 285 ~~cl~~dp~~R 295 (353)
+.+|+.|-.+|
T Consensus 273 ~~LL~vD~t~R 283 (355)
T KOG0616|consen 273 KKLLQVDLTKR 283 (355)
T ss_pred HHHHhhhhHhh
Confidence 99999999988
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=345.13 Aligned_cols=247 Identities=29% Similarity=0.500 Sum_probs=222.3
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
...|+..+.||+|.||.||+ .++.||+|++..+.. .+.++.+++|+.++.+++++||.++++.+..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 34588889999999999984 578999999988754 34557889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||||.||++.++++....+.+..+.-++++++.||.|||.++ .+|||||+.|||+..+|.|||+|||.+-.......
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999999988777789999999999999999999999 99999999999999999999999999988876655
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
.. ..+.||+.|||||++.+..|+.++||||||++++||++|.+||....+..+...|.+...|.+. ..+++.+++|
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~kEF 242 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPFKEF 242 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHHHHH
Confidence 55 4578999999999999999999999999999999999999999999987777776555555543 3789999999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~ 304 (353)
|..||.+||+.||+|.+|++|
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhh
Confidence 999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=348.27 Aligned_cols=245 Identities=24% Similarity=0.473 Sum_probs=220.9
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|....+||+|.-|.|| ..++.||||.+....... .+-+.+|+.+|+..+|+|||.+++.|.-.+.+|+|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 58888899999998887 367889999997654333 3457899999999999999999999998899999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|++||+|.|.+.... +++.++..|...+++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+.....++
T Consensus 351 ym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred ecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 999999999997653 999999999999999999999999 9999999999999999999999999998887655443
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
....||+.|||||+.....|+++.||||||++++||+.|.+||-..+.......+...+.+.+... ..+++++++|+.
T Consensus 427 -~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~-~klS~~~kdFL~ 504 (550)
T KOG0578|consen 427 -STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNP-EKLSPELKDFLD 504 (550)
T ss_pred -ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCc-cccCHHHHHHHH
Confidence 346789999999999999999999999999999999999999998888888888888888887664 568999999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~ 304 (353)
+||+.|+++|+++.+||+|
T Consensus 505 ~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHhhcchhcCCCHHHHhcC
Confidence 9999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=340.27 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=213.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 122 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~i 122 (353)
..|+..++||+|+||.||+ +|..||+|+++.+... ++...-..+|+.+|++|+||||+++.+...+. +.+|+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3688999999999999994 6889999999876533 33344567899999999999999999998876 78999
Q ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
|+|||+. +|.-++...+ .|++.++..++.||+.||+|+|++| ++|||||.+|||||++|.+||+|||||+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999965 8999987744 5999999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCC----------
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK---------- 270 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 270 (353)
.....+....|.+|.|||++.|. .|+...|+||.||||.||++|++.|++.+..+....|-+....+-.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 77778888899999999998876 7999999999999999999999999998876666555432211100
Q ss_pred -----C----------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 271 -----A----------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 271 -----~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+ ....++....+|+..+|..||.+|.|+.++|..
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 012456778899999999999999999999865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=340.82 Aligned_cols=250 Identities=28% Similarity=0.464 Sum_probs=212.9
Q ss_pred ccCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCH--HHHHHHHHHHHHHhcCC-CCcccceeeEEEecC
Q 018614 47 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS 118 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 118 (353)
....+|..++.||.|+||.|+ .+|..||+|++........ ...+.+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345589999999999999987 3689999998766422211 23455678999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC-CCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~-~~vkl~Dfg~a~~ 197 (353)
.+|+||||+.||+|.+++.+.+++.+..+..+++|++.|++|||++| |+||||||+|+|++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999999888999999999999999999999999 9999999999999999 9999999999998
Q ss_pred cccCCCCCcccCCCCCcccCccccCCCC-CC-CchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhh
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKNEE-YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 275 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (353)
.. ..........|++.|+|||++.+.. |+ .++||||+|+++|.|++|..||...+...+...+..+.. .+ +..
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-~~---p~~ 245 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-KI---PSY 245 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-cC---CCC
Confidence 74 2233344566899999999999977 85 789999999999999999999998766666666544332 22 233
Q ss_pred h-HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 276 Y-ARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 276 ~-~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+ +.++++|+.+||..||.+|+++.+++.+
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 4 8899999999999999999999999955
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=327.94 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=214.8
Q ss_pred cCccCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 45 IDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 45 i~~~~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
....-..|+..+.||.|.-+.|+ ..++.||||++..+..... +..+++|+..++.++||||++++..|..+..
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 33445579999999999877776 3689999999988765433 6789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
+|+||+||.+|++.++++..- .+++..+..|++++++||.|||.+| .||||||+.||||+++|.|||+|||..-.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeee
Confidence 999999999999999998632 3999999999999999999999999 99999999999999999999999997765
Q ss_pred cccCCCCCc---ccCCCCCcccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCC--
Q 018614 198 LTVKEDRPL---TCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK-- 270 (353)
Q Consensus 198 ~~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 270 (353)
+.....+.. ....|+++|||||++.. ..|+.|+||||||+++.||.+|+.||......++.-....+..+...
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 543222111 45679999999999644 47899999999999999999999999998887776555444443111
Q ss_pred ----CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 271 ----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 271 ----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.....+++.++.++..||.+||++|||+.+++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1234677899999999999999999999999965
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=338.95 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=222.6
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
...+|+..+.||+|+||.|+. +|..+|+|++++..+.....+..++.|-.+|....+|+||+++..|++...+|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 345799999999999999983 689999999999888888888999999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC-
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK- 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~- 201 (353)
||||++||++..+|.+.+.+++..+..++.+++.|++.||..| +|||||||+|+|||..|++||+||||+.-+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999999999999999999999999999999999999999 999999999999999999999999999533210
Q ss_pred ---------------------CCC-----Cc-------------------ccCCCCCcccCccccCCCCCCCchhHHHHH
Q 018614 202 ---------------------EDR-----PL-------------------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 236 (353)
Q Consensus 202 ---------------------~~~-----~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 236 (353)
... .. .+..|||.|+|||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 000 00 124689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 018614 237 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 304 (353)
Q Consensus 237 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 304 (353)
||||||+.|-+||...+..+....+.........+.....+.+..|||.+||. ||++|.- ++||.+|
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 99999999999999999999998887766444444455677999999999999 9999975 6666655
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=338.88 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=207.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecC-ceE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS-PMM 121 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~~ 121 (353)
..+|+..++||.|+||.|+. .|+.||||.++.....-++. . -.+|+..|++++ ||||+++.+++.++. .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~-nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-M-NLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-H-HHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34799999999999999984 68899999998865443332 2 257999999998 999999999998887 899
Q ss_pred EEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
+||||| ..+|.++++.+++ |++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..|||+|||+|+....
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 999999 6799999987654 999999999999999999999999 99999999999999989999999999998754
Q ss_pred CCCCCcccCCCCCcccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CC-----------
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP----------- 267 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~----------- 267 (353)
. .+.+.+..|.+|+|||++. .+-|+.+.||||+||+++|+.+-++.|++.+..+...++.... .|
T Consensus 163 k--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 K--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred C--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 3 3456678899999999875 5578999999999999999999999999877655444442211 11
Q ss_pred ---------CCCC-----chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ---------PFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ---------~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.... ....++.++.++|.+|++.||++||||++++++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1100 112367889999999999999999999999987
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=326.21 Aligned_cols=257 Identities=19% Similarity=0.317 Sum_probs=215.6
Q ss_pred cccCccCcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe---
Q 018614 43 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--- 116 (353)
Q Consensus 43 ~~i~~~~~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 116 (353)
..++..+++......||+|+++.|| .+|+.||||.++..........+.+.+|+.++++++||||+++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 3455666666666789999998876 5799999999987654455556778899999999999999999999876
Q ss_pred -cCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 117 -SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 117 -~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~-~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
....++||||+++|+|.+++.....+++...+.++.|++.||.|||.. + ++||||||+||++++++.+||+|||+
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccch
Confidence 346899999999999999998877899999999999999999999985 6 88999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCC
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKA 271 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~ 271 (353)
+....... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.... ....
T Consensus 170 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 243 (283)
T PHA02988 170 EKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL-- 243 (283)
T ss_pred Hhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--
Confidence 88654322 12346778999999976 688999999999999999999999999877666655554333 2222
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
+..++.++.+|+.+||+.||++|||++++++.|+.+.
T Consensus 244 -~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 -PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2346889999999999999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=356.46 Aligned_cols=253 Identities=31% Similarity=0.549 Sum_probs=222.0
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
+....++||+|.||.||. ....||||.++... +.+..++|++|++++..++|||||+++|+|..+++.
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344567899999999983 34689999998763 455778999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC
Q 018614 121 MIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
|+|+|||..|+|.++|.... +++..+.+.|+.||+.||+||.++. +|||||.++|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999997421 2778899999999999999999998 999999999999999999
Q ss_pred EEEeecccccccccCCCCCc-ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhc
Q 018614 187 LKVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 264 (353)
Q Consensus 187 vkl~Dfg~a~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 264 (353)
|||+|||+++..-..+.... ....-+.+|||||.+..++|+++|||||+||+|||+++ |+.||.+..+.++.+.+..+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999987644333222 23345789999999999999999999999999999998 99999999999999999777
Q ss_pred CCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 265 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
...+ .+..+|.++.+||..||+.+|++||++++|-..|+.....
T Consensus 722 ~lL~---~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 722 QLLS---CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred Cccc---CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 7533 4678999999999999999999999999999999988553
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=343.93 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=214.9
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
-|+.++.||+|+.|.|. .+|+.+|||++....-..+.....+.+|+-+|+.+.||||+++++++.+...+|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 46778999999999886 5799999999987644444555678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|++||-|.+++..++++++..+.++++||+.|+.|+|..+ |+|||+||+|+|+|..+++||+|||+|.....+ ..
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--kl 167 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KL 167 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC--cc
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999875432 33
Q ss_pred cccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
....-|.+.|++||++.|..| +.++||||.|||||.|++|+.||++.+-..+..++..+. +.. +..++.++++||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~---f~M-Ps~Is~eaQdLL 243 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV---FEM-PSNISSEAQDLL 243 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc---ccC-CCcCCHHHHHHH
Confidence 334457889999999999988 579999999999999999999998665555555554444 222 366889999999
Q ss_pred HHHcccCCCCCCCHHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.+||..||++|.|.++|++|-.
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHhccCccccccHHHHhhCch
Confidence 9999999999999999999853
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=339.84 Aligned_cols=272 Identities=28% Similarity=0.541 Sum_probs=233.5
Q ss_pred ccCCCCCCCcccCccCcCcccceeeecceEEEEEE------cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC
Q 018614 34 VKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW------RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH 104 (353)
Q Consensus 34 ~~~~~~~~~~~i~~~~~~~~~~~~ig~G~~~~v~~------~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h 104 (353)
...+...+.|++..++..+. ++||+|.||.|+. ++ ..||||..+.+.....+...++.+|++++++++|
T Consensus 143 L~~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H 220 (474)
T KOG0194|consen 143 LKRPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH 220 (474)
T ss_pred ecccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC
Confidence 34556667899998888777 8999999999873 12 2389999886444567888999999999999999
Q ss_pred CcccceeeEEEecCceEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC
Q 018614 105 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183 (353)
Q Consensus 105 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~ 183 (353)
|||++++|+..+..++++|||+|.||+|.++|+..+. ++..+...++.+.+.||+|||+++ +|||||.++|+|++.
T Consensus 221 ~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 221 PNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSK 297 (474)
T ss_pred CCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecC
Confidence 9999999999999999999999999999999998764 999999999999999999999999 999999999999999
Q ss_pred CCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHH
Q 018614 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 262 (353)
Q Consensus 184 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 262 (353)
++.+||+|||+++........ .....-+.+|+|||.+..+.++.++|||||||++||+++ |..||.+....++...+.
T Consensus 298 ~~~vKISDFGLs~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~ 376 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV 376 (474)
T ss_pred CCeEEeCccccccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence 999999999998876421111 112245779999999999999999999999999999998 899999999988888884
Q ss_pred h-cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhh
Q 018614 263 A-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314 (353)
Q Consensus 263 ~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~ 314 (353)
. +.+.+.+ ...|.++..++.+||..+|+.||++.++.+.|+.+......
T Consensus 377 ~~~~r~~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 377 KNGYRMPIP---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred hcCccCCCC---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 4 4444443 25678899999999999999999999999999999776553
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=324.55 Aligned_cols=247 Identities=26% Similarity=0.458 Sum_probs=223.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.|. ..|+.||||.++++.+.+++.+-.+++|++++..|+||||++++++|.+...+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 79999999999999886 4699999999999999998888899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|..+|.|.||+..++.+++..++.+++||+.|+.|+|.++ ++|||||.+|||+|+++++||+|||++-.+... +.
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kf 208 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KF 208 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc--cH
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999887543 33
Q ss_pred cccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
...+-|++-|.+||++.|..| ++..|-||||+++|.|..|..||++.+...+..++..+....... |....-||
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-----PSdA~gLI 283 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-----PSDASGLI 283 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-----CchHHHHH
Confidence 445668889999999999988 679999999999999999999999999888888887666433222 33456899
Q ss_pred HHHcccCCCCCCCHHHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
+.||..||++|.|+.++..|.+-
T Consensus 284 RwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred HHHHhcCcccchhHHHHhhhhee
Confidence 99999999999999999999854
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=305.42 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=209.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|...+.+|+|+||.||+ +|+.||||+++.....+.-. ....+|+..|+.++|+||+.++++|.+...+.+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 688889999999999984 68999999998765443323 345689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|++ .+|...+++.. .++..++..++.++++|++|||+++ |+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 994 59999998654 4899999999999999999999999 999999999999999999999999999998765443
Q ss_pred CcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCC--------------
Q 018614 205 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP-------------- 268 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~-------------- 268 (353)
. +....|.+|.|||.+.|. .|+...|+||.||++.||+-|.+-|++.++-+....+-... .|.
T Consensus 158 ~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 Q-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred c-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 3 334678999999998765 78999999999999999999999998877655444432211 111
Q ss_pred ---------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 269 ---------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 269 ---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
........+.++.+|+..+|..||.+|+++.|++++ ..+..
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~-~yf~~ 286 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH-PYFKS 286 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc-hhhhc
Confidence 111112345678899999999999999999999988 44433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=336.23 Aligned_cols=244 Identities=27% Similarity=0.508 Sum_probs=213.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|.+.+.||+|+||.||+ +.+.||+|.+.+.. ..++.+..+.+|+++++.++||||+.++++|+....+|+|.|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578889999999999994 56789999987653 345667789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+.| +|..++...+.++++.+..++.|++.||.|||+.+ |+|||+||.|||++..|.+|++|||+|+.+... ...
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence 9955 99999999999999999999999999999999999 999999999999999999999999999987643 334
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.+...|||.|||||...++.|+..+|+|||||++||+++|++||....-....+.|.+....+ +...+..+.+|++
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----PSTASSSFVNFLQ 232 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC----cccccHHHHHHHH
Confidence 456789999999999999999999999999999999999999997655444444443332222 3467888999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~ 304 (353)
.+|.+||..|.+..+++.|
T Consensus 233 gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHhhcChhhcccHHHHhcC
Confidence 9999999999999999976
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=328.03 Aligned_cols=244 Identities=24% Similarity=0.404 Sum_probs=208.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||+|++........+..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 588889999999999873 478999999865433333445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++...+.+++..++.++.|++.||.|||++| ++||||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--- 155 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--- 155 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc---
Confidence 9999999999998888999999999999999999999999 9999999999999999999999999987654321
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..... .+ +..++..+++||+
T Consensus 156 -~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~---~~~~~~~~~~li~ 230 (291)
T cd05612 156 -WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-EF---PRHLDLYAKDLIK 230 (291)
T ss_pred -ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-CC---CccCCHHHHHHHH
Confidence 224578899999999998999999999999999999999999988766555555544332 21 2345788999999
Q ss_pred HHcccCCCCCCC-----HHHHHHHH
Q 018614 286 ECWNEKPAKRPT-----FRQIITRL 305 (353)
Q Consensus 286 ~cl~~dp~~Rps-----~~~ll~~l 305 (353)
+||+.||.+||+ ++++++|-
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCc
Confidence 999999999995 88888773
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=332.03 Aligned_cols=241 Identities=25% Similarity=0.400 Sum_probs=204.8
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 130 (353)
+.||+|+||.||. +|+.||+|++.............+.+|+.++++++||||+++++.+..+...|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999883 57899999987654434445567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 018614 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210 (353)
Q Consensus 131 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 210 (353)
+|.+++...+.+++..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccccee
Confidence 99999988888999999999999999999999999 9999999999999999999999999987543221 1222345
Q ss_pred CCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHccc
Q 018614 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 290 (353)
Q Consensus 211 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 290 (353)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... ..+ +..+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~---p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRF---PRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCC---CCCCCHHHHHHHHHHccC
Confidence 7899999999999999999999999999999999999998766555554443322 222 345788899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 018614 291 KPAKRP-----TFRQIITR 304 (353)
Q Consensus 291 dp~~Rp-----s~~~ll~~ 304 (353)
||++|| ++.++++|
T Consensus 233 dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CHHHcCCCCCCCHHHHHcC
Confidence 999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=327.83 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=204.9
Q ss_pred cCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec-
Q 018614 50 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS- 117 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~- 117 (353)
.+|+..+.||+|+||.||.. +..||||++.... ..+....+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 46888899999999999742 3579999987542 234456788999999999 899999999988754
Q ss_pred CceEEEEecCCCCCHHHHHHhc----------------------------------------------------------
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------- 139 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~---------------------------------------------------------- 139 (353)
..++++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999999742
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCc
Q 018614 140 ----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCR 214 (353)
Q Consensus 140 ----~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~ 214 (353)
..+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23677888999999999999999999 999999999999999999999999999865432221 1122345678
Q ss_pred ccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCC
Q 018614 215 YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 293 (353)
Q Consensus 215 y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 293 (353)
|+|||++.+..++.++||||||+++|||++ |..||......+............ ..+..+++++.+|+.+||+.||+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHccCChh
Confidence 999999999899999999999999999997 999998765544333322222111 12345678899999999999999
Q ss_pred CCCCHHHHHHHHHHHHH
Q 018614 294 KRPTFRQIITRLESINN 310 (353)
Q Consensus 294 ~Rps~~~ll~~l~~~~~ 310 (353)
+|||+.++++.|+++..
T Consensus 320 ~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 320 ERPTFSALVEILGDLLQ 336 (338)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=322.18 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=204.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|+..+.||+|+||.||. +|+.||+|.+.............+.+|+.++++++|++|+++++.+.++...++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999873 578999999876544333344567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++|+|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888643 35899999999999999999999999 9999999999999999999999999997754221
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+..............++.++.+|
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 235 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 2223457889999999999999999999999999999999999998765543333332222222222234578899999
Q ss_pred HHHHcccCCCCCCC-----HHHHHHH
Q 018614 284 IEECWNEKPAKRPT-----FRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps-----~~~ll~~ 304 (353)
+++||+.||++||+ ++++++|
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 236 CRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999999997 7888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=331.02 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=210.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++.............+.+|+.++.+++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 688899999999999883 478999999876544334455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++...+.+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..... .
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999976543 2
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC----CCCCCchhhhHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----PPFKAPAKLYARGLK 281 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~ 281 (353)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..... +........++.++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 2234578899999999999999999999999999999999999987766555554433221 111111124678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+||.+||..+|++||+++++++|
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=331.79 Aligned_cols=244 Identities=24% Similarity=0.411 Sum_probs=209.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||+|++.............+.+|+.++++++||||+++++.+.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 4788999999999999873 57899999987654333445567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 99999999999998888999999999999999999999999 9999999999999999999999999998654321
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
....|++.|+|||++.+..++.++|||||||++|+|++|..||......+....+.... ..+ +..++..+++||
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~---p~~~~~~~~~li 246 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKF---PNWFDGRARDLV 246 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCC---CCCCCHHHHHHH
Confidence 22457889999999999999999999999999999999999998766555545443332 222 234678899999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 018614 285 EECWNEKPAKRPT-----FRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps-----~~~ll~~ 304 (353)
.+||+.||++||+ +++++.|
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999997 7888877
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=335.20 Aligned_cols=264 Identities=28% Similarity=0.517 Sum_probs=217.2
Q ss_pred CCcccCccCcCcccceeeecceEEEEEEc--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
.+|+|.+++ ...+..||+|.||.||.. ..+||||+++.... .++..++|++|+.++++-+|.||+-+.|++....
T Consensus 385 ~~WeIp~~e--v~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEE--VLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHH--hhccceeccccccceeecccccceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 567776654 556778999999999832 23899999998765 4568899999999999999999999999998877
Q ss_pred ceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
. .||+.+|+|-+|..++... .+|.....+.|++|+++|+.|||.++ |||+|||..|||+.+++.|||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 6 9999999999999999743 35888999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCC-CCcccCCCCCcccCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCc
Q 018614 198 LTVKED-RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAP 272 (353)
Q Consensus 198 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~ 272 (353)
-..-.. .......+...|||||++..+ +|+..+||||||+++|||++|..||.....+.+...+-.+. .+.....
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 543211 122233466789999998643 68899999999999999999999999655555444332332 2333344
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
...+++++++|+..||..++++||.+.+|+..|+.+...
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 567889999999999999999999999999999888553
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=326.61 Aligned_cols=241 Identities=24% Similarity=0.386 Sum_probs=204.6
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 130 (353)
+.||+|+||.||. +|..||+|++.............+.+|+.+++.++||||+++++.+..+...|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999983 57899999987654434455567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 018614 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210 (353)
Q Consensus 131 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 210 (353)
+|.+++.....+++..++.++.||+.||.|||++| ++||||||+|||++.++.++|+|||++....... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccccc
Confidence 99999988778999999999999999999999999 9999999999999999999999999987532221 1222345
Q ss_pred CCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHccc
Q 018614 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 290 (353)
Q Consensus 211 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 290 (353)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... . .+..+++++.++|.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~-~---~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-R---FPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-C---CCCCCCHHHHHHHHHHccC
Confidence 78899999999999999999999999999999999999987766555554433221 1 1345788899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 018614 291 KPAKRP-----TFRQIITR 304 (353)
Q Consensus 291 dp~~Rp-----s~~~ll~~ 304 (353)
||++|+ ++.++++|
T Consensus 233 dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHhCCCCCCCHHHHHcC
Confidence 999998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.01 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=209.5
Q ss_pred CcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 49 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
..+|+..+.||+|+||.||. .+..||+|.+.... .......+.+|+..+++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34688889999999999863 25689999987643 234456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999764 46899999999999999999999999 9999999999999999999999999876543
Q ss_pred cCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
...........++..|+|||.+.+..++.++|||||||++|++++ |..||......+....+......+ .+..++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 235 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRNCPN 235 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCH
Confidence 221111112234568999999999999999999999999999885 999998877666555554443322 2455788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.+.+++.+||+.+|++||++++|++.|.++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=299.54 Aligned_cols=246 Identities=26% Similarity=0.420 Sum_probs=218.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+.++.||+|-||.|| .++-.||+|++.++.+.......++.+|+++-.+|+||||++++++|.+...+|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 68889999999999998 3577899999988766666666789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|.++|.|...+. ....+++...+.++.|++.||.|+|..+ +|||||||+|+|++..|.+|++|||.+...+.
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~--- 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 176 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC---
Confidence 999999999998 4456999999999999999999999999 99999999999999999999999999877552
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......-||..|.+||+..+..++...|+|++|++.||++.|.+||......+....+.+..... +..++.+++|+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~----p~~is~~a~dl 252 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKF----PSTISGGAADL 252 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccC----CcccChhHHHH
Confidence 22233558999999999999999999999999999999999999999988888887776544322 25678899999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
|.+|+.++|.+|....+++.|-.
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHhccCccccccHHHHhhhHH
Confidence 99999999999999999998854
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=328.77 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=209.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|..||+|+++.......+....+.+|+.+++.++|+||+++++.+.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 588899999999999883 578999999976544344556678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999875 56999999999999999999999999 999999999999999999999999999876543322
Q ss_pred CcccCCCCCcccCccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 205 PLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
......+++.|+|||++. +..++.++|||||||++|+|++|+.||...........+.........+....++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223345788999999986 45678899999999999999999999987766555555543332111112234678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.+|+..||. +|.+||+++++++|
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 89999999998 99999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=327.87 Aligned_cols=247 Identities=26% Similarity=0.474 Sum_probs=219.5
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc-eEEE
Q 018614 50 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~iv 123 (353)
.+|...+.+|+|.||.++ .++..+++|.+......+.+. +...+|+.++++++|||||.+.+.|..++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 478899999999999765 356789999998876655544 366789999999999999999999998888 9999
Q ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 124 TEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
|+||+||+|.+.+++.. .|++..+..|+.|++.|+.|||++. |+|||||+.|||++.++.|+|+|||+|+.....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998654 4999999999999999999999888 999999999999999999999999999998755
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.. ......||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+.......+.... +.+.+..++.+++
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~ 235 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---YSPLPSMYSSELR 235 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc---CCCCCccccHHHH
Confidence 42 2334779999999999999999999999999999999999999999888878777776665 3344678999999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+|+.||..+|..||++.+||.+
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999999987
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=326.19 Aligned_cols=241 Identities=25% Similarity=0.398 Sum_probs=204.1
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 130 (353)
+.||+|+||.||. +|..||+|++........+....+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999983 57899999997654444455567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 018614 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210 (353)
Q Consensus 131 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 210 (353)
+|.+++.....+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++....... .......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccccc
Confidence 99999988778999999999999999999999999 9999999999999999999999999987543221 1222345
Q ss_pred CCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHccc
Q 018614 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 290 (353)
Q Consensus 211 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 290 (353)
|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.... .. .+..++.++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~---~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IK---FPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-cc---CCCCCCHHHHHHHHHHcCC
Confidence 7889999999999999999999999999999999999998766555444432222 11 2345788899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 018614 291 KPAKRP-----TFRQIITR 304 (353)
Q Consensus 291 dp~~Rp-----s~~~ll~~ 304 (353)
||++|+ ++.++++|
T Consensus 233 dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 999997 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=329.20 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=206.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||+|++........+....+..|+.++.+++|+||+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 588899999999999873 478999999876543344555678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~- 204 (353)
|+++|+|.+++...+.+++..+..++.|++.||+|||+.| ++||||||+|||++.++.++|+|||+++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998754321100
Q ss_pred ---------------------------------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 018614 205 ---------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 251 (353)
Q Consensus 205 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 251 (353)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 01124588999999999999999999999999999999999999987
Q ss_pred CCCCchHHHHHhcCC-CCCCCchhhhHHHHHHHHHHHcc--cCCCCCCCHHHHHHH
Q 018614 252 KHDNEVPKAYAARQR-PPFKAPAKLYARGLKELIEECWN--EKPAKRPTFRQIITR 304 (353)
Q Consensus 252 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rps~~~ll~~ 304 (353)
....+....+..... ..++ ....++++++++|.+++. .++..||+++++++|
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFP-PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHcCcCcccCC-CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 766665555544322 2222 122467889999998765 233356899999988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=331.74 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=211.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|...+.||+|+||.||. +|+.||||++.............+.+|+.+++.++|+||+++++++.++...|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 588899999999999883 478999999876544333455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC---
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--- 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~--- 202 (353)
|+++++|.+++...+.+++..++.++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999988878999999999999999999999999 9999999999999999999999999998765433
Q ss_pred -------------------------CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch
Q 018614 203 -------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 257 (353)
Q Consensus 203 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 257 (353)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 1112334578899999999999999999999999999999999999988775555
Q ss_pred HHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCC-HHHHHHH
Q 018614 258 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT-FRQIITR 304 (353)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~ll~~ 304 (353)
...+.........+....+++++.+||.+||. ||.+||+ ++++++|
T Consensus 239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 55554321111111122368899999999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=331.53 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=208.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++.............+.+|+.+++.++||||+++++.+.++...|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 688899999999999883 578999999976543344555678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~- 204 (353)
|+++|+|.+++...+.+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999988878999999999999999999999999 999999999999999999999999998764321100
Q ss_pred ------------------------------------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCC
Q 018614 205 ------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 248 (353)
Q Consensus 205 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 248 (353)
......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00123478999999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 018614 249 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 304 (353)
Q Consensus 249 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 304 (353)
|......+....+.........+....+++++.+||.+|+. +|.+|++ +.++++|
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 98776555544443322211111223467889999999997 8999998 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=327.35 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=208.7
Q ss_pred CcCcccceeeecceEEEEEE---c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 49 ELDFTNSVEITKGTFILAFW---R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~---~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
..+|+..+.||+|+||.||. . +..||+|.+.............+.+|+.+++.++||||+++++++.+....|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 34688999999999999873 1 25799999876544344455678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||||+++|+|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999999999988888999999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... . .+..+++.+.+
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~---~p~~~~~~~~~ 257 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-Y---FPKFLDNNCKH 257 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C---CCCCCCHHHHH
Confidence 1234578899999999998899999999999999999999999987765555555443321 1 12346778999
Q ss_pred HHHHHcccCCCCCC-----CHHHHHHH
Q 018614 283 LIEECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
+|++||+.||++|+ +++++++|
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999995 89999987
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=331.24 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=206.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|+..+.||+|+||.||. ++..||||++........+....+.+|+.++++++|+||+++++.+.+....|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999983 578999999976554455566778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-- 203 (353)
|+++|+|.+++...+.+++..+..++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999988878999999999999999999999999 99999999999999999999999999764321000
Q ss_pred --------------------------------------------CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHH
Q 018614 204 --------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239 (353)
Q Consensus 204 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 239 (353)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 000124588999999999998999999999999999
Q ss_pred HHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHc--ccCCCCCCCHHHHHHH
Q 018614 240 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW--NEKPAKRPTFRQIITR 304 (353)
Q Consensus 240 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dp~~Rps~~~ll~~ 304 (353)
|||++|..||......+....+.........+....+++++.+||.+++ ..+|..|+++.++++|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999877655544444332211111223357889999999955 5566669999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=333.95 Aligned_cols=241 Identities=26% Similarity=0.407 Sum_probs=214.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~i 122 (353)
..+|...+.||+|.||.|.. +++.+|||++++..+...+.++..+.|.+++.... ||.++.++..|+...++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 34788899999999999873 57899999999998888888899999999999885 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||||+.||++..+. ..+.|++..+..++..++.||.|||++| |||||||.+|||+|..|.+||+|||+++......
T Consensus 447 vmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 99999999954443 4456999999999999999999999999 9999999999999999999999999999876444
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.. ...+-||+.|+|||++.+..|+...|+|||||+||||+.|..||.+.+.+++...|....... +..++.+..+
T Consensus 523 ~~-TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y----P~~ls~ea~~ 597 (694)
T KOG0694|consen 523 DR-TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY----PRFLSKEAIA 597 (694)
T ss_pred Cc-cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC----CCcccHHHHH
Confidence 43 344668999999999999999999999999999999999999999999999998886554222 4567899999
Q ss_pred HHHHHcccCCCCCCCH
Q 018614 283 LIEECWNEKPAKRPTF 298 (353)
Q Consensus 283 li~~cl~~dp~~Rps~ 298 (353)
+++++|.+||++|...
T Consensus 598 il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHhccCcccccCC
Confidence 9999999999999765
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=323.88 Aligned_cols=239 Identities=25% Similarity=0.390 Sum_probs=201.1
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCH
Q 018614 58 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132 (353)
Q Consensus 58 ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 132 (353)
||+|+||.||. ++..||+|++.............+.+|+.++++++||||+++++.+.+....|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999883 4778999998764433445556788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCC
Q 018614 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 212 (353)
Q Consensus 133 ~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~ 212 (353)
.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ......|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccCC
Confidence 999988878999999999999999999999999 99999999999999999999999999876432221 12234578
Q ss_pred CcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCC
Q 018614 213 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 292 (353)
Q Consensus 213 ~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 292 (353)
+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.... .. .+..+++++.+||.+||..||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LR---FPDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CC---CCCcCCHHHHHHHHHHcCCCH
Confidence 89999999999999999999999999999999999998766555544443322 11 234577889999999999999
Q ss_pred CCCCC---HHHHHHH
Q 018614 293 AKRPT---FRQIITR 304 (353)
Q Consensus 293 ~~Rps---~~~ll~~ 304 (353)
++||+ +.+++.|
T Consensus 233 ~~R~~~~~~~e~l~h 247 (312)
T cd05585 233 TRRLGYNGAQEIKNH 247 (312)
T ss_pred HHcCCCCCHHHHHcC
Confidence 99975 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=325.49 Aligned_cols=248 Identities=21% Similarity=0.382 Sum_probs=203.5
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 120 (353)
+|+..+.||+|+||.||. .|..||+|++...... .......+..|+.+++++ +|++|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999883 4788999998653321 233345678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999988778999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHH---hcCCCCCCCchhhh
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLY 276 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 276 (353)
..........|++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+. ....+. .+..+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 234 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP---FPSFI 234 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC---CCCCC
Confidence 333333345688999999999865 47889999999999999999999997544332222221 112222 23457
Q ss_pred HHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
+..+.+++.+||+.||++|| +++++++|
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 78899999999999999999 78899877
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=304.92 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=221.6
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
+.+|+.-+.||+|.|..|+ -+|+.+|+|+++...+... ..+.+.+|+.+-+.|+||||+++.+.+...+..|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3468888999999998776 4788899998877655433 457889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC---CCEEEeeccccccccc
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTV 200 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~---~~vkl~Dfg~a~~~~~ 200 (353)
+|+++|++|-.-+-.+..+++..+...++||++||.|+|.++ |||||+||.|+++.+. .-+||+|||+|....
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999999766655556899999999999999999999999 9999999999999743 349999999999887
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
.........|||.|+|||++....++..+|||+.|+++|-|+.|.+||.+.+...+.+.+..+...-..+..+.++++.
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 3445566789999999999999999999999999999999999999999988888999987777555555678899999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
++|+++||..||.+|.|+.|.|+|-+
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCch
Confidence 99999999999999999999997743
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=350.33 Aligned_cols=253 Identities=34% Similarity=0.574 Sum_probs=220.2
Q ss_pred CcccceeeecceEEEEEE------cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFW------RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~------~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
+.+....||+|.||.||. .| ..||||.++.. .+.+....|.+|+.+++.++||||++++|++.+.+..
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 455677899999999983 23 35888988753 4677788999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc------C-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 121 MIVTEYLPKGDLRAFLKRK------G-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~------~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
+|++|||+||+|..+|++. . .++..+.+.++.||++|+.||++++ +|||||.++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999865 2 3888999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCc-ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 194 VSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 194 ~a~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
+|+.+-....... ....-+.+|||||.+..+.++.|+|||||||++||++| |..||+..++.++...+..+.+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~--- 924 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD--- 924 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC---
Confidence 9995443333222 22345679999999999999999999999999999999 999999999999998777777444
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
.+..||..+.++|.+||+.+|++||++..|++.+.++...
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 3567889999999999999999999999999988887654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=322.60 Aligned_cols=262 Identities=34% Similarity=0.541 Sum_probs=207.9
Q ss_pred ccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC-
Q 018614 44 EIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 118 (353)
Q Consensus 44 ~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 118 (353)
++...+.+|.....||+|+||.||+ +|..||||.+....... ..+|.+|+.++.+++|||+++++|+|.+.+
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence 3444556899999999999999983 45899999887654321 345999999999999999999999999988
Q ss_pred ceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
..++|+||++.|+|.+++.... .++|..+.+|+.+++.||+|||.....+|||||||++|||+|.+...||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 4999999999999999997654 78999999999999999999999876679999999999999999999999999997
Q ss_pred ccccCCCCCcccC-CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--Cc-hHH----HHHhcC---
Q 018614 197 LLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NE-VPK----AYAARQ--- 265 (353)
Q Consensus 197 ~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~--~~-~~~----~~~~~~--- 265 (353)
..... ....... .||.+|+|||+...+..+.|+||||||+++.||++|+.|...... .. ... .+....
T Consensus 226 ~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~e 304 (361)
T KOG1187|consen 226 LGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLRE 304 (361)
T ss_pred cCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhh
Confidence 65431 1111112 789999999999999999999999999999999999988875431 11 111 111111
Q ss_pred --CCCCC--Cchh-hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 266 --RPPFK--APAK-LYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 266 --~~~~~--~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
.+.+. .... ..-..+..+...|++.+|.+||++.++++.|+.+.
T Consensus 305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 11111 1110 22344778889999999999999999988885553
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=316.81 Aligned_cols=250 Identities=21% Similarity=0.354 Sum_probs=201.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +++.||+|++..... .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 588899999999998873 477899999875432 22334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|++++.+..+......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9988777666555556999999999999999999999999 9999999999999999999999999998765433323
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC-------------------
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------------- 266 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------- 266 (353)
.....+++.|+|||++.+..++.++|||||||++|+|++|++||......+....+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 3334578899999999998999999999999999999999999987654332222211000
Q ss_pred --CCCCC-------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 --PPFKA-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 --~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.... ....++.++.+||++||+.||++|||++++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 012357789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=320.66 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=205.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCC-----------HHHHHHHHHHHHHHhcCCCCcccceeeEE
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISD-----------DDRVRAFRDELALLQKIRHPNVVQFLGAV 114 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 114 (353)
+|+..+.||+|.||.|. .+++.||||++.+..... ...++...+|+.+|+++.|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 69999999999999986 368899999987643221 11235788999999999999999999998
Q ss_pred Eec--CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeec
Q 018614 115 TQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192 (353)
Q Consensus 115 ~~~--~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Df 192 (353)
.+. ..+|||+|||..|.+...=.....+++.++++++.+++.||+|||.+| ||||||||+|+||+++|+|||+||
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecc
Confidence 654 679999999988877654333333899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCC----cccCCCCCcccCccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhc
Q 018614 193 GVSKLLTVKEDRP----LTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 264 (353)
Q Consensus 193 g~a~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 264 (353)
|.+.......... .....|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+....+...+|...
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 9998764332211 13367999999999987743 356899999999999999999999887777777766443
Q ss_pred CCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 265 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
- ..++. .....+.+++||.++|.+||+.|.+..+|..|...-
T Consensus 335 p-L~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 335 P-LEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred c-ccCCC-cccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 3 22222 224568899999999999999999999999987654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=319.78 Aligned_cols=248 Identities=25% Similarity=0.445 Sum_probs=205.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.|+. +|..+|+|.+.... ..+....+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 45799999999999999873 57889999987542 344556789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++++|.+++.....+++..+..++.|++.||.|||+.+ +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999999988778999999999999999999999863 29999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHH---------------------
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA--------------------- 262 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~--------------------- 262 (353)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 223457889999999999999999999999999999999999997654333221110
Q ss_pred -------------------------hcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 263 -------------------------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 263 -------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
....+. .....++.++++||.+||+.||++|||++++++|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000 01124678899999999999999999999999884
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=330.83 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=205.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++........+....+.+|+.++++++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 588889999999999983 578999999865433334455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-- 203 (353)
|+++|+|.+++...+.+++..++.++.|++.||+|||+.| ++||||||+|||++.++.++|+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999988778999999999999999999999999 99999999999999999999999999864321100
Q ss_pred -----------C---------------------------------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHH
Q 018614 204 -----------R---------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239 (353)
Q Consensus 204 -----------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 239 (353)
. ......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00123588899999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCC---CCHHHHHHHH
Q 018614 240 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR---PTFRQIITRL 305 (353)
Q Consensus 240 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~ll~~l 305 (353)
|||++|..||......+....+.........+....++.++.+||.+||. +|.+| +++.+++.|-
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 99999999998766555444443322111111223467889999999997 67665 5999999873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=328.07 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=208.4
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|..||+|.+.............+.+|+.+++.++||||+++++++.++...|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 34789999999999999883 5789999998654333333445678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++|+|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999998764 5889999999999999999999999 99999999999999999999999999987643322
Q ss_pred CCcccCCCCCcccCccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.........+....++.+
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 222335588999999998653 4788999999999999999999999887665555555443322111222357889
Q ss_pred HHHHHHHHcccCCCC--CCCHHHHHHHH
Q 018614 280 LKELIEECWNEKPAK--RPTFRQIITRL 305 (353)
Q Consensus 280 l~~li~~cl~~dp~~--Rps~~~ll~~l 305 (353)
+.+||.+||..+|++ |+++.++++|-
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 999999999999988 99999999883
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=324.41 Aligned_cols=241 Identities=25% Similarity=0.404 Sum_probs=203.5
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 130 (353)
+.||+|+||.||. +|..||+|++.............+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999983 57899999997654444445567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 131 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
+|.+++.....+++..++.++.||+.||.|||+ .+ ++||||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 999999887789999999999999999999997 67 99999999999999999999999999875432211 12234
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ..+ +..+++++.+||.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRF---PRTLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-CCC---CCCCCHHHHHHHHHHhh
Confidence 57889999999999999999999999999999999999998776655554443322 111 23467889999999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 018614 290 EKPAKRP-----TFRQIITR 304 (353)
Q Consensus 290 ~dp~~Rp-----s~~~ll~~ 304 (353)
.||++|+ ++.++++|
T Consensus 233 ~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcC
Confidence 9999996 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=329.23 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=205.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|+..+.||+|+||.||. ++..||+|++.............+.+|+.++++++|+||+++++.+.++...|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 488899999999999983 578899999876544344556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-- 203 (353)
|+++|+|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999988778999999999999999999999999 99999999999999999999999999753311000
Q ss_pred --------------------------------------------CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHH
Q 018614 204 --------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239 (353)
Q Consensus 204 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 239 (353)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 000123578999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 018614 240 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 304 (353)
Q Consensus 240 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 304 (353)
|||++|+.||...+..+....+.........+....+++++.++|.+|+ .+|.+|++ +.++++|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999999877655544444333222222223457888999999976 59999997 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=330.88 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=205.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++.............+.+|+.+++.++|+||+++++.+.+++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 588899999999999983 478999999865433333445668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-- 203 (353)
|+++|+|.+++...+.+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999988878999999999999999999999999 99999999999999999999999999753311000
Q ss_pred ----------------------------------------CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHH
Q 018614 204 ----------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243 (353)
Q Consensus 204 ----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ell 243 (353)
.......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0001235889999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCC---CHHHHHHH
Q 018614 244 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP---TFRQIITR 304 (353)
Q Consensus 244 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~ll~~ 304 (353)
+|+.||......+....+.........+....+++++.++|.+|+ .+|.+|+ ++.++++|
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999877655544444332211111222356788999999976 5999999 99999988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=320.69 Aligned_cols=241 Identities=24% Similarity=0.415 Sum_probs=201.9
Q ss_pred eeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 56 VEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 56 ~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+.||+|+||.||. .|+.||+|++...... .......+.+|+.+++.++||||+++++.+..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999873 4678999998654321 223345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 206 (353)
+++++|.+++...+.+.+..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++........ ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence 999999999988888899999999999999999999999 99999999999999999999999999875432221 22
Q ss_pred ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 286 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 286 (353)
....|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+..... . .+..+++++.+||.+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-N---LPPYLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C---CCCCCCHHHHHHHHH
Confidence 234578899999999998899999999999999999999999987665554444433321 2 133467889999999
Q ss_pred HcccCCCCCC-----CHHHHHHH
Q 018614 287 CWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 287 cl~~dp~~Rp-----s~~~ll~~ 304 (353)
||+.||++|| +++++++|
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcC
Confidence 9999999999 89999886
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=310.65 Aligned_cols=249 Identities=33% Similarity=0.556 Sum_probs=209.3
Q ss_pred CcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
+|+..+.||+|+||.||.. +..||+|.+.... .......+.+|+.++++++||||+++++++.+....
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 5788899999999988731 2579999987542 345556789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC
Q 018614 121 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~ 184 (353)
+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 9999999999999999754 34788899999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHH
Q 018614 185 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 262 (353)
Q Consensus 185 ~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 262 (353)
+.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876533221 11222345678999999998899999999999999999998 999998877666665554
Q ss_pred hcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 018614 263 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
...... .+..++.++.+|+.+||+.||.+||++++++++|+.
T Consensus 241 ~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 SRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 443332 245688999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=321.40 Aligned_cols=241 Identities=25% Similarity=0.404 Sum_probs=201.6
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. +++.||||++.............+..|..++..+ +||||+++++++.+...+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999883 4788999998765433344456677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|.+++.....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++....... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987543221 122234
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..... . .+..++.++.+|+++||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~---~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-V---YPTWLSQDAVDILKAFMT 232 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-C---CCCCCCHHHHHHHHHHcc
Confidence 578899999999999999999999999999999999999988776666555543322 1 133467889999999999
Q ss_pred cCCCCCCCH------HHHHHH
Q 018614 290 EKPAKRPTF------RQIITR 304 (353)
Q Consensus 290 ~dp~~Rps~------~~ll~~ 304 (353)
.||++||++ ++++.|
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcC
Confidence 999999998 666655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=329.03 Aligned_cols=244 Identities=25% Similarity=0.470 Sum_probs=218.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..|+..+.||.|+||.||. +.+.||||++.-......+..+.+.+|+.+|+++.|||++.+.|+|..+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3588889999999999984 57899999998877667777789999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||| -|+-.|++.- +.++-+..+..|..+.++||+|||+.+ .||||||+.|||+++.|.|||+|||.|....+.
T Consensus 106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 999 7799999875 345889999999999999999999999 999999999999999999999999998775433
Q ss_pred CCcccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
.++.|||.|||||++. .+.|+-++||||||++..||...++|+-.++.......|..+..|.+. .+.++..+
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~eWS~~F 254 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSDYF 254 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--CchhHHHH
Confidence 3477999999999875 568999999999999999999999999999888888888777766664 46789999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++|+..||++-|.+|||.++++.|
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhc
Confidence 999999999999999999999876
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=305.96 Aligned_cols=248 Identities=29% Similarity=0.516 Sum_probs=207.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|...+.||.|+||.|+. .+..||+|.+... ......+.+|+.++++++|+||+++++++..+...+++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 477778999999998863 4788999998643 2234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999997543 4889999999999999999999999 99999999999999999999999999987654322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
........+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....... .+..++.++.+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 236 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME---RPEGCPPKVYE 236 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHH
Confidence 22222234567999999999899999999999999999998 999998776655555443332222 23457889999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
++.+||..||++||++.++++.|+.+
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=319.28 Aligned_cols=244 Identities=26% Similarity=0.402 Sum_probs=200.7
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH---hcCCCCcccceeeEEEecCceEEE
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL---QKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
|+..+.||+|+||.||. +|+.||||++........+..+.+..|+.++ +.++||||+++++++.+....|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56778999999999883 4789999998765433334445666676655 566799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++++|..++.. +.+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999988864 45999999999999999999999999 99999999999999999999999999875432221
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+...... .+..++.++.++
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~l 231 (324)
T cd05589 157 -RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR----YPRFLSREAISI 231 (324)
T ss_pred -cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCCCCCHHHHHH
Confidence 222345788999999999999999999999999999999999999877665555555443321 123467889999
Q ss_pred HHHHcccCCCCCC-----CHHHHHHH
Q 018614 284 IEECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
|.+||..||++|| ++.+++++
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 9999999999999 67788776
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=319.15 Aligned_cols=246 Identities=28% Similarity=0.440 Sum_probs=205.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC-cccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~iv~ 124 (353)
+|+..+.||+|+||.||. +++.||||++...........+.+..|..+++.+.|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478889999999999983 4678999998765443444556788899999999764 6888999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++++|.+++.....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++....... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-K 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-C
Confidence 99999999999988888999999999999999999999999 9999999999999999999999999986532221 1
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..+ +..++.++.+++
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~---~~~~~~~~~~li 232 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSY---PKSLSKEAVSIC 232 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCC---CCCCCHHHHHHH
Confidence 2223457889999999999999999999999999999999999998776655555554332 222 345778899999
Q ss_pred HHHcccCCCCCCCH-----HHHHHH
Q 018614 285 EECWNEKPAKRPTF-----RQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~-----~~ll~~ 304 (353)
.+||..||.+|++. +++++|
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999986 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=303.21 Aligned_cols=248 Identities=28% Similarity=0.411 Sum_probs=204.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceEEE
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~iv 123 (353)
+|+....|+.|+||.|| .+++.||+|+++.+.-...-- -...+|+.+|.+++|||||.+-++.... +.+|||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP-ItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP-ITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc-chhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 68889999999999999 368899999998764211111 1246899999999999999999887643 569999
Q ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||||+. +|..++.+-+ +|...++.-+..|++.|++|||.++ |+||||||+|+|+++.|.+||+|||+|+.+..+
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 999965 9999998744 7999999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC-------CCCc--
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-------FKAP-- 272 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------~~~~-- 272 (353)
....+....|.+|.|||.+.+. .|+...|+||+|||+.||+++++.|++.........+......+ +...
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 3445567789999999998775 68999999999999999999999999887766555553322111 1000
Q ss_pred -------------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 273 -------------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 273 -------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...++..-.+|+..+|..||.+|.|+++.|+|
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 01145778899999999999999999999988
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=312.48 Aligned_cols=252 Identities=28% Similarity=0.469 Sum_probs=202.4
Q ss_pred cCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccc
Q 018614 50 LDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 108 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 108 (353)
.+|+..+.||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3688889999999999873 23469999987542 344556789999999999999999
Q ss_pred ceeeEEEecCceEEEEecCCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCE
Q 018614 109 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------------ALKPSTAVRFALDIARGMNYLHENKPVPI 169 (353)
Q Consensus 109 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~i 169 (353)
++++++.+....++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ +
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 99999999999999999999999999986531 2567889999999999999999999 9
Q ss_pred EecCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc--CC
Q 018614 170 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GC 246 (353)
Q Consensus 170 iH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~ 246 (353)
+||||||+|||++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999999765432211 1122334678999999988899999999999999999986 67
Q ss_pred CCCCCCCCCchHHHHHh----cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 247 PPFTMKHDNEVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 247 ~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.||......+....... .........+..++..+.+|+.+||..||++|||+.+|.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 78887665544433221 1111111123356788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=322.42 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=206.2
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 117 (353)
..+|+..+.||+|+||.||. ++..||+|++.... ..+....+.+|+.+++.+ +|+||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34688899999999999873 12479999997543 234456788999999999 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhc----------------------------------------------------------
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------- 139 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~---------------------------------------------------------- 139 (353)
...++||||+++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999998542
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-Cc
Q 018614 140 ------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PL 206 (353)
Q Consensus 140 ------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~ 206 (353)
..+++..++.++.|++.||.|||+++ ++||||||+||++++++.++|+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 13677889999999999999999999 999999999999999999999999999765432211 11
Q ss_pred ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||.................... .+...++++.+++.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 349 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMK 349 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHH
Confidence 12234567999999998899999999999999999997 9999987665444333333322111 12345788999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
+||+.||++|||+.++++.|+++.
T Consensus 350 ~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 350 MCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=318.66 Aligned_cols=241 Identities=29% Similarity=0.478 Sum_probs=198.6
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. +++.||+|+++..........+.+..|..++... +||||+++++++..+...|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999983 4678999998765433334445556677777654 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999997643322 222334
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. ..+.+ +..++.++.+|+.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DRPHF---PRWISKEAKDCLSKLFE 232 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCHHHHHHHHHHcc
Confidence 578899999999999999999999999999999999999988766555555433 22222 34567889999999999
Q ss_pred cCCCCCCCHH-HHHHH
Q 018614 290 EKPAKRPTFR-QIITR 304 (353)
Q Consensus 290 ~dp~~Rps~~-~ll~~ 304 (353)
.||++||++. ++++|
T Consensus 233 ~~P~~R~~~~~~l~~h 248 (316)
T cd05592 233 RDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCHHHcCCChHHHHcC
Confidence 9999999875 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=321.19 Aligned_cols=252 Identities=28% Similarity=0.462 Sum_probs=204.1
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecC
Q 018614 50 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 118 (353)
.+|+..+.||+|+||.||. .+..||||+++.... ....+.+.+|+.+++.+ +||||+++++++.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 3688899999999999863 245899999875432 23345788999999999 8999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcC----------------------------------------------------------
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG---------------------------------------------------------- 140 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~---------------------------------------------------------- 140 (353)
..++||||+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999986421
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 141 -----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 141 -----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
.+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 3677888999999999999999999 99999999999999999999999999986643322
Q ss_pred CC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 204 RP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 204 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.................... .+...+.++.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 347 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEMY 347 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHHH
Confidence 11 122334567999999999999999999999999999998 8999987654433333333222111 1234577899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+|+.+||+.||++||++.++++.|++.
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=319.24 Aligned_cols=241 Identities=27% Similarity=0.421 Sum_probs=196.7
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. +|+.||+|++.............+..|.. +++.++||||+++++.+.+....|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999873 57899999987543322333344445544 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|.+++.....+++..+..++.||+.||.|||++| ++||||||+|||++.++.+||+|||++....... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccccc
Confidence 999999988878999999999999999999999999 9999999999999999999999999987543221 122234
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..... .. ...++.++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~---~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RL---KPNISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CC---CCCCCHHHHHHHHHHhh
Confidence 578899999999999999999999999999999999999987765555555433321 11 23457889999999999
Q ss_pred cCCCCCCCHH----HHHHH
Q 018614 290 EKPAKRPTFR----QIITR 304 (353)
Q Consensus 290 ~dp~~Rps~~----~ll~~ 304 (353)
.||++||++. ++++|
T Consensus 233 ~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred cCHHhCCCCCCCHHHHHcC
Confidence 9999999984 66554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.90 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=207.1
Q ss_pred CcCcccceeeecceEEEEEE-----c-CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
...|...+.||+|+||.||. + +..||+|.+... .......+.+|+.+++.++||||+++++++..++..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34589999999999998873 2 567888876433 34445667889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 123 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
||||+++|+|.+++.. ..++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 9999999999988753 345899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 199 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 199 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+......+. +..++
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~s 296 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPVS 296 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccCC
Confidence 533221 12334578999999999999999999999999999999999999987766555555544443332 34577
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.++.+||.+||..||++||++.+++.+
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 889999999999999999999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=312.22 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=204.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +++.||+|.+.............+.+|+.++++++||||+++++.+..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999873 478999999876544333444567789999999999999999999999899999999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999988653 35899999999999999999999999 9999999999999999999999999987654222
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......++..|+|||.+.+..++.++||||+|+++|+|++|..||...........+...........+..++..+.+|
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence 1123457889999999998899999999999999999999999998765543333322211111112234578889999
Q ss_pred HHHHcccCCCCCC-----CHHHHHHH
Q 018614 284 IEECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
+.+||..||++|| +++++++|
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999 88899877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=319.81 Aligned_cols=241 Identities=24% Similarity=0.383 Sum_probs=202.8
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. .|+.||+|++........+....+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999883 4678999998765443445556677888888866 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|.+++.....+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++........ .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccccc
Confidence 999999988878999999999999999999999999 99999999999999999999999999875432221 22234
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..... . .+..++.++.+++.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~---~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-L---YPVWLSKEAVSILKAFMT 232 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C---CCCCCCHHHHHHHHHHhc
Confidence 578899999999999999999999999999999999999988766665555543321 1 123467889999999999
Q ss_pred cCCCCCC-------CHHHHHHH
Q 018614 290 EKPAKRP-------TFRQIITR 304 (353)
Q Consensus 290 ~dp~~Rp-------s~~~ll~~ 304 (353)
.||++|| +++++++|
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcC
Confidence 9999999 88888877
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=310.95 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=198.3
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCH
Q 018614 58 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132 (353)
Q Consensus 58 ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 132 (353)
||+|+||.||. +|+.||+|.+.............+..|+.+++.++|+||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999883 5789999998765443444456678899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 018614 133 RAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208 (353)
Q Consensus 133 ~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 208 (353)
.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988743 335899999999999999999999999 999999999999999999999999999765433222 223
Q ss_pred CCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHc
Q 018614 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288 (353)
Q Consensus 209 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 288 (353)
..+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......................+..++.++.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 45788999999999999999999999999999999999999865443222222221111111223457889999999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 018614 289 NEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 289 ~~dp~~Rp-----s~~~ll~~ 304 (353)
+.||++|| +++++++|
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=303.91 Aligned_cols=252 Identities=24% Similarity=0.459 Sum_probs=208.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.|| .+|..||||.+......+.+....+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 68889999999999887 2578999998865444455666778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 126 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 126 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999998853 334789999999999999999999999 999999999999999999999999998776432
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--chHHHHHhcCCCCCCCchhhhHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.. ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... .....+.....++ .....++..
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP--LPTEHYSEK 236 (267)
T ss_pred hH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC--CChhhcCHH
Confidence 21 112345677899999999888999999999999999999999999654332 2222222222222 123456788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+.+++.+||..+|++||+++++++.++++
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 99999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=317.21 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=224.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~i 122 (353)
...|+..+.||+|.||.|+. +|+.+|+|.+.+...........+.+|+.+|++++ ||||+.+.++|.+...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 44689999999999999883 58999999998876655555678899999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC----CCEEEeeccccccc
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLL 198 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~----~~vkl~Dfg~a~~~ 198 (353)
|||++.||.|.+.+... .+++..+..++.|++.|+.|||+.| ++||||||+|+|+... +.++++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999876 4999999999999999999999999 9999999999998743 47999999999988
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
.. ........||+.|+|||++.+..++..+||||+|+++|.|++|..||...+.......+..+...-.......++.
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 76 3444557799999999999999999999999999999999999999999988888887776665444556677899
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
.+++||+.+|..||.+|+++.++|+|-
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 999999999999999999999999984
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=307.18 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=205.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-----cCce
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-----SSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 120 (353)
.|...+.||+|.||.|. .+|+.||||++... +...-..+...+|+.+|++++|+||+.+.+++.. -..+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45557899999999875 36899999998753 3344555677889999999999999999998864 3568
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
|+|+|+| +.+|...++.+..+++.++..++.|++.||.|+|+.+ ++||||||+|+|++.+..+||+|||+|+....
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccc
Confidence 9999999 7799999998878999999999999999999999999 99999999999999999999999999998864
Q ss_pred CCC-CCcccCCCCCcccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC------------
Q 018614 201 KED-RPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------ 266 (353)
Q Consensus 201 ~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------ 266 (353)
... ...+.+..|.+|.|||++. ...|+...||||+||++.||++|++.|++.+.......+.....
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 322 2235677899999999875 55899999999999999999999999998876444433322111
Q ss_pred ---------------CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 ---------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ---------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.++.......++...+|+++||..||.+|+|++++|+|
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111123456789999999999999999999999987
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=306.45 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=214.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|+..+.||+|..|.||. .+..+|+|++.+..+...+...+...|.++|+.++||.++.++..|..+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 477788999999999983 347899999998877777777888899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC-
Q 018614 126 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE- 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~- 202 (353)
||+||+|..+.+.+. .|++..++.++..++.||+|||..| ||+|||||+||||-++|+|-|+||.|+......+
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999998754 4999999999999999999999999 9999999999999999999999999885432100
Q ss_pred --------------------------------C----------------------CCcccCCCCCcccCccccCCCCCCC
Q 018614 203 --------------------------------D----------------------RPLTCQDTSCRYVAPEVFKNEEYDT 228 (353)
Q Consensus 203 --------------------------------~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 228 (353)
. ....++.||-.|+|||++.|..++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0112356888899999999999999
Q ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCC----HHHHHHH
Q 018614 229 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT----FRQIITR 304 (353)
Q Consensus 229 ~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~ll~~ 304 (353)
+.|+|+|||++|||+.|..||.+.+..+....+.... ..++..+ .++..++|||+++|.+||++|.. +.+|.+|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP-LKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC-CcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 9999999999999999999999999999888875443 3333222 57788999999999999999998 7777765
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=304.95 Aligned_cols=248 Identities=30% Similarity=0.531 Sum_probs=207.3
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|+..++||+|+||.||. ++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+....+++|||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 588889999999998873 45679999876532 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 127 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 127 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999753 34788999999999999999999998 999999999999999999999999999876533222
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+......+ ....++.++.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 236 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP---RMENCPDELYDI 236 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHH
Confidence 2222335667999999988889999999999999999998 999998766655555554433222 223577889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+.+||..+|++||+++++++.|+++
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=324.18 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=206.0
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +++.+|+|++.............+.+|+.+++.++||||+++++.+.++...|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 34799999999999999883 4778999998654333334445678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++|+|.+++... .+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999999999999764 5899999999999999999999999 99999999999999999999999999987643322
Q ss_pred CCcccCCCCCcccCccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.........+....++..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 222345689999999998754 3778999999999999999999999877655555555443322111222346788
Q ss_pred HHHHHHHHcccCCCC--CCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAK--RPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~--Rps~~~ll~~ 304 (353)
+++++..||..++.+ |+++.++++|
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcC
Confidence 999999999865544 8999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=314.19 Aligned_cols=246 Identities=27% Similarity=0.488 Sum_probs=203.3
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|..+|+|.+.... .......+.+|++++++++|+||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 35799999999999999884 57789999886542 344556788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~-~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||+++++|.+++...+.+++..+..++.|++.||.|||+. + ++|+||||+|||+++++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999999998877899999999999999999999985 5 9999999999999999999999999987653321
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHH--------------------
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-------------------- 262 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~-------------------- 262 (353)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 123457889999999999899999999999999999999999997654322221110
Q ss_pred ------------------------hcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 263 ------------------------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 263 ------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+.. ....++.++++||.+||+.||++|||+.+++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000 112356789999999999999999999999977
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=318.12 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=196.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec-----Cce
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 120 (353)
+|+..+.||+|+||.||. +|..||||.+..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 488889999999998873 578999999865322 223335678999999999999999999988543 247
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
|+||||+ +++|.+++.....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999999 5799999988778999999999999999999999999 99999999999999999999999999976532
Q ss_pred CCCC--CcccCCCCCcccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHh-------------
Q 018614 201 KEDR--PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA------------- 263 (353)
Q Consensus 201 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~------------- 263 (353)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 2211 1233467889999999866 6788999999999999999999999976543222111100
Q ss_pred --------------cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 264 --------------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 264 --------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....++......+++++.+++.+||..||++||+++++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000112356778999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=316.72 Aligned_cols=241 Identities=27% Similarity=0.452 Sum_probs=198.2
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. +|..||+|.+.............+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999873 5789999998765332223345566788887755 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|.+++.....+++..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence 999999988778999999999999999999999999 9999999999999999999999999987532221 122334
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... .+.+ +..++.+++++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHY---PRWITKESKDILEKLFE 232 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCC---CCCCCHHHHHHHHHHcc
Confidence 5788999999999999999999999999999999999999876655555444322 2222 23467889999999999
Q ss_pred cCCCCCCCHH-HHHHH
Q 018614 290 EKPAKRPTFR-QIITR 304 (353)
Q Consensus 290 ~dp~~Rps~~-~ll~~ 304 (353)
.||++||++. ++++|
T Consensus 233 ~dP~~R~~~~~~~~~h 248 (316)
T cd05620 233 RDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCHHHcCCChHHHHcC
Confidence 9999999984 66644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=316.90 Aligned_cols=246 Identities=27% Similarity=0.417 Sum_probs=204.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
+|...+.||+|+||.||. ++..||+|++.............+..|..++..+ .|++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999983 4678999998765433344445667788888877 5889999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence 99999999999988778999999999999999999999999 99999999999999999999999999875432211
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .+ +..++.++.+++
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~---p~~~s~~~~~li 232 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AY---PKSMSKEAVAIC 232 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC---CCcCCHHHHHHH
Confidence 22234578899999999999999999999999999999999999988766655555543322 11 235678899999
Q ss_pred HHHcccCCCCCCCH-----HHHHHH
Q 018614 285 EECWNEKPAKRPTF-----RQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~-----~~ll~~ 304 (353)
.+||+.||++|++. .++++|
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcC
Confidence 99999999999985 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=316.81 Aligned_cols=241 Identities=27% Similarity=0.436 Sum_probs=201.9
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. ++..||||++........+....+..|..+++.+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999873 4778999998765443444456677888999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++........ .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccce
Confidence 999999988878999999999999999999999999 99999999999999999999999999865322211 12223
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... .. .+..++.++.+||.+||.
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~~---~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VR---YPRWLSKEAKSILKSFLT 232 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CC---CCCcCCHHHHHHHHHHcc
Confidence 47889999999999999999999999999999999999998766555544443322 11 123567889999999999
Q ss_pred cCCCCCCCH-----HHHHHH
Q 018614 290 EKPAKRPTF-----RQIITR 304 (353)
Q Consensus 290 ~dp~~Rps~-----~~ll~~ 304 (353)
.||++||++ .+++++
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcC
Confidence 999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=317.66 Aligned_cols=242 Identities=24% Similarity=0.409 Sum_probs=198.5
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. ++..||+|+++.......+....+..|..+++.+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999873 5789999999875544455566788999999998 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|.+++...+.+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccccc
Confidence 999999988778999999999999999999999999 9999999999999999999999999987532211 122234
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc--------hHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--------VPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.|++.|+|||++.+..++.++|+|||||++|+|++|+.||....... ............ .+..++.++.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~ 233 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---IPRSLSVKAS 233 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC---CCCCCCHHHH
Confidence 57889999999999999999999999999999999999996422111 111111222222 2345678899
Q ss_pred HHHHHHcccCCCCCCC------HHHHHHH
Q 018614 282 ELIEECWNEKPAKRPT------FRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps------~~~ll~~ 304 (353)
++|.+||+.||.+|++ ++++++|
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999997 6777766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=317.44 Aligned_cols=236 Identities=27% Similarity=0.399 Sum_probs=192.6
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. +|..||+|++.............+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999883 47889999987543323333344555544 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|..++.....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-ccccc
Confidence 999999988777999999999999999999999999 99999999999999999999999999875322221 22234
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.... ..+ +...+.++.+++.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~---~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQL---PGGKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCC---CCCCCHHHHHHHHHHcc
Confidence 57889999999999899999999999999999999999998776544444443322 111 23457789999999999
Q ss_pred cCCCCCCCHH
Q 018614 290 EKPAKRPTFR 299 (353)
Q Consensus 290 ~dp~~Rps~~ 299 (353)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (321)
T cd05603 233 KDQRRRLGAK 242 (321)
T ss_pred CCHhhcCCCC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.68 Aligned_cols=245 Identities=33% Similarity=0.583 Sum_probs=204.2
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|+..+.||+|+||.||. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 467788999999998873 3558999987654321 24678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+++++|.+++... +.+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999753 45899999999999999999999999 9999999999999999999999999987654322222
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+........ +...+.++.+++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~li 234 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTVYEVM 234 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHH
Confidence 222334567999999998889999999999999999999 9999988776666666655443322 234567899999
Q ss_pred HHHcccCCCCCCCHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l 305 (353)
.+||+.+|++||++.++++.|
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=310.82 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=198.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||.|+||.||. ++..||+|.+...... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3688899999999999984 5789999998654321 12245678999999999999999999999988999999
Q ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||++ ++|.+++...+ .+++..+..++.||+.||+|||++| ++||||||+|||++.++.+||+|||++........
T Consensus 83 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 83 EYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred eCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 9996 59999887654 4789999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC--------------
Q 018614 204 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-------------- 268 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------- 268 (353)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+..+....+......+
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1223456789999999865 468899999999999999999999998766544433332111000
Q ss_pred ----CC--------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 ----FK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ----~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++ .....++.++.+||.+||..||.+|||++++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0012356789999999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=322.50 Aligned_cols=242 Identities=23% Similarity=0.304 Sum_probs=195.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. .++.||+|.... ..+.+|+.++++++||||+++++++..+...++|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 4699999999999999873 578999997432 24678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|++ +++|.+++.....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.........
T Consensus 163 e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 163 PRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred ecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 999 5799999988778999999999999999999999999 999999999999999999999999999764332222
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-------chHHHHHh-cC-----------
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------EVPKAYAA-RQ----------- 265 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-------~~~~~~~~-~~----------- 265 (353)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.. .+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 233456899999999999999999999999999999999999877543210 00111100 00
Q ss_pred ----------------CCCCCC---chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 ----------------RPPFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 ----------------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+...+ .....+.++.+||.+||+.||++|||++++++|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 112346789999999999999999999999976
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=302.08 Aligned_cols=250 Identities=32% Similarity=0.529 Sum_probs=210.0
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
+|+..+.||+|+||.||. +...||+|.+.... .......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 588889999999999873 13479999986543 34445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
+|||+++++|.+++... +.+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999764 46899999999999999999999999 999999999999999999999999999887522
Q ss_pred CCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 202 EDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 202 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......+. +..++..
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 236 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---PMDCPSA 236 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHH
Confidence 211 1112234568999999999999999999999999999998 9999987766666555544333222 3456888
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+.+++.+||+.+|++||++++++++|+++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=296.35 Aligned_cols=250 Identities=25% Similarity=0.420 Sum_probs=215.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCc
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 119 (353)
+|...+.||+|+-..|. ..|...|+|++...... ..+..++-.+|+.+|+++ .||+|+++.++|..+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 57788899999886553 56788899987542211 133456667899999999 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
.++|+|.|+.|.|.|++...-.+++...++|+.|+++|++|||.++ |+||||||+|||++++.+++|+|||+++.+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999998878999999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCcccCCCCCcccCccccCC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCch
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 273 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 273 (353)
.+. .....-|||+|+|||.+.. ..|+...|+|++|++||.|+.|.+||--..+.-+...+..++..--.+.+
T Consensus 175 ~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 175 PGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred Cch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 543 3344568999999999853 46788999999999999999999999665555666777777766666778
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
.+++.+.++||.+||+.||++|.|++++|.|-
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 88999999999999999999999999999884
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=307.87 Aligned_cols=244 Identities=36% Similarity=0.681 Sum_probs=199.2
Q ss_pred cceeeecceEEEEEE---c------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 54 NSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 54 ~~~~ig~G~~~~v~~---~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..+.||.|.||.|+. . +..|+||.++.. ...+....+.+|++.+++++||||++++|++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 457899999998873 3 578999999653 24455678999999999999999999999999888899999
Q ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 125 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 125 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+++||++++++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999999886 56999999999999999999999999 9999999999999999999999999998763221
Q ss_pred C-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 203 D-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 203 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
. ...........|+|||.+.+..++.++||||||+++||+++ |+.||......+....+....... .+..++..+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPKDI 234 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhHHH
Confidence 1 11122335668999999998889999999999999999999 789998887666666664444433 244578889
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
.++|.+||..||++||++.++++.|
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=305.27 Aligned_cols=253 Identities=28% Similarity=0.501 Sum_probs=210.9
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.+|...+.||+|+||.||. ++..+|+|.+... .......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 4688889999999999873 1346889988643 24445678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
.++||||+++++|.+++...+ .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999999997543 3899999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhc
Q 018614 187 LKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 264 (353)
Q Consensus 187 vkl~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 264 (353)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+...
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876543221 11122334668999999998899999999999999999998 99999877666665555444
Q ss_pred CCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 265 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
..... ...++.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 239 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 43222 334678899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=323.53 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=206.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.|+. +|+.||+|++........+....+..|+.++.+++|++|+++++.+.+....|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 578889999999999873 578999999875443344556678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-- 203 (353)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.| ++||||||+|||++.+|.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999875432110
Q ss_pred --------------------------------CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 018614 204 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 251 (353)
Q Consensus 204 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 251 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001124588999999999999999999999999999999999999988
Q ss_pred CCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 018614 252 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 304 (353)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 304 (353)
.........+.........+....++.++++||.+++. ||.+|++ +.++++|
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 77666555554322111111122367889999999774 9999985 6788776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=301.99 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=207.4
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 50 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.+|+..+.||+|++|.||. .+..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3588889999999998873 456899999875432 23467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
++++++|.+++.... .+++..+..++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999997644 5899999999999999999999999 99999999999999999999999999987653222
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
........+..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+......+ ....++..+.+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 235 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP---CPPGCPKELYD 235 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCHHHHH
Confidence 21122223457999999999899999999999999999999 999998776655555554333222 23456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
++.+||+.+|++||++.++++.|+++
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=321.28 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=206.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +++.||+|++.............+.+|+.+++.++||||+++++.+.++...|+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 35799999999999999873 5778999998653333334445678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++++|.+++... .+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999999764 4899999999999999999999999 99999999999999999999999999987653322
Q ss_pred CCcccCCCCCcccCccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.........+....++.+
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 222345688999999998754 3788999999999999999999999876655555555443322111223457889
Q ss_pred HHHHHHHHcccCCCC--CCCHHHHHHHH
Q 018614 280 LKELIEECWNEKPAK--RPTFRQIITRL 305 (353)
Q Consensus 280 l~~li~~cl~~dp~~--Rps~~~ll~~l 305 (353)
++++|..||..++.+ |++++++++|.
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 999999999844433 78999999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=314.54 Aligned_cols=241 Identities=27% Similarity=0.450 Sum_probs=198.1
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. ++..||||++.............+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999883 4678999998765332223344566777777764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
|+|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++........ .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeee
Confidence 999999988777999999999999999999999999 99999999999999999999999999875432211 12234
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... +.+ +..++.++.+|+.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~---~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCY---PRWLTREAKDILVKLFV 232 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC---CccCCHHHHHHHHHHhc
Confidence 57889999999999899999999999999999999999998776655555543322 222 23467889999999999
Q ss_pred cCCCCCCCHH-HHHHH
Q 018614 290 EKPAKRPTFR-QIITR 304 (353)
Q Consensus 290 ~dp~~Rps~~-~ll~~ 304 (353)
.||++||++. ++++|
T Consensus 233 ~~P~~R~~~~~~l~~h 248 (316)
T cd05619 233 REPERRLGVKGDIRQH 248 (316)
T ss_pred cCHhhcCCChHHHHcC
Confidence 9999999997 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=315.70 Aligned_cols=242 Identities=24% Similarity=0.406 Sum_probs=197.1
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. +++.||+|++.............+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999873 5778999999876544555556778899988877 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|..++.....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccccc
Confidence 999999988778999999999999999999999999 99999999999999999999999999875432211 22234
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-----ch---HHHHHhcCCCCCCCchhhhHHHHH
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-----EV---PKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-----~~---~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .. ........... .+..++..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---~p~~~~~~~~ 233 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IPRSLSVKAA 233 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---CCCCCCHHHH
Confidence 5788999999999999999999999999999999999999532111 11 11111222222 2345678899
Q ss_pred HHHHHHcccCCCCCCCH------HHHHHH
Q 018614 282 ELIEECWNEKPAKRPTF------RQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~------~~ll~~ 304 (353)
++|.+||+.||++||++ .++++|
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999999984 677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=322.95 Aligned_cols=248 Identities=35% Similarity=0.551 Sum_probs=209.4
Q ss_pred CcccCccCcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
.|+|..+.+ ...+-||.|..|.|| ..++.||||+++.- -..+++-|++|+||||+.|.|+|...-
T Consensus 118 ~WeiPFe~I--sELeWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEI--SELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHh--hhhhhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 466654432 234558999999888 46899999987532 125788899999999999999999998
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
-+|||||||+.|.|.++|+....+.......|..+|+.|+.|||.+. |||||||.-||||..+..|||+|||.++..
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999999999989999999999999999999999999 999999999999999999999999999877
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
... ...-.+.||..|||||++.+...+.|.|||||||+||||+||..||.+.+...+...+-.+.. -.+.+..+|+
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL--~LpvPstcP~ 338 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSL--HLPVPSTCPD 338 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcc--cccCcccCch
Confidence 544 223356789999999999999999999999999999999999999988766555443322221 1123567889
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.++-||++||+-.|..||+|.+++.||.=+
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 999999999999999999999999998543
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=299.81 Aligned_cols=245 Identities=26% Similarity=0.432 Sum_probs=204.6
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 57 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 57 ~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+||+|+||.||. ++..+|+|++.... .+....+.+.+|+.+++.++|+||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999998873 46789999986543 234455778899999999999999999998864 567899999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC--cc
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LT 207 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~--~~ 207 (353)
++|.+++.....+++..++.++.|++.||+|||+++ ++|+||||+||++++++.++|+|||++.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999987777999999999999999999999999 9999999999999999999999999998764332211 11
Q ss_pred cCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHH
Q 018614 208 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 286 (353)
Q Consensus 208 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 286 (353)
...++..|+|||.+.+..++.++|+||||+++|||++ |..||......+....+.....++. +..++.++.++|.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~ 233 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC---PQRCPPEMYDLMKL 233 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHHHH
Confidence 1223568999999988889999999999999999998 9999987766666666654443332 34578899999999
Q ss_pred HcccCCCCCCCHHHHHHHHHHHH
Q 018614 287 CWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 287 cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
||+.||++||++.+|.+.|+++.
T Consensus 234 ~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 234 CWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred HhccCchhCcCHHHHHHHHhccc
Confidence 99999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.12 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=196.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++.... .......+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 577888999999999883 47899999986432 34455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+. ....+..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||++........ .
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 9999998653 23567888899999999999999999 99999999999999999999999999987643221 1
Q ss_pred cccCCCCCcccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
.....|+..|+|||.+.. ...+.++|||||||++|+|++|+.||..........................++.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 223457889999998743 234568999999999999999999998544444333322221111122234578889
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++||.+||..||++||++.++++|
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999987
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=313.27 Aligned_cols=246 Identities=27% Similarity=0.423 Sum_probs=203.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~ 124 (353)
+|+..+.||+|+||.||. +|..||+|++.............+..|..+++.+. |++|+++++++.+....|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367788999999999983 57899999987654333444566778889988886 577888999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++||||||+|||++.++.++|+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 99999999999988888999999999999999999999999 99999999999999999999999999875432221
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... . .+..++.++.+++
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~---~p~~~~~~~~~li 232 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-S---YPKSLSKEAVSIC 232 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C---CCccCCHHHHHHH
Confidence 12234578899999999998999999999999999999999999988766555555543322 1 1245678899999
Q ss_pred HHHcccCCCCCCCH-----HHHHHH
Q 018614 285 EECWNEKPAKRPTF-----RQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~-----~~ll~~ 304 (353)
.+||..+|.+|++. +++++|
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcC
Confidence 99999999999984 455554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=314.10 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=204.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.|+. +++.||+|++...........+.+.+|..++..++|+||+++++++.++...|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 588899999999999873 478999999875433334445668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+++++|.+++.. ...+++..+..++.||+.||+|||+++ ++||||||+|||++.++.++|+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999976 446899999999999999999999999 999999999999999999999999998765433322
Q ss_pred CcccCCCCCcccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHH
Q 018614 205 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 278 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 278 (353)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.... ...+......++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2223457889999999863 457889999999999999999999998765555544443322 2222233344788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAK--RPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~--Rps~~~ll~~ 304 (353)
++++++++||..++++ |++++++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999988654443 7899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=299.58 Aligned_cols=250 Identities=27% Similarity=0.471 Sum_probs=206.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
+|+..+.||.|++|.||. ++..||+|.+....... ......+.+|+.++++++||||+++++++.++...++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 588899999999998873 47899999886543211 22345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
+|++++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999999988778999999999999999999999999 99999999999999999999999999876543222
Q ss_pred CCc--ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 204 RPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 204 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||................. ....+..++..+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPQLPSHVSPDAR 237 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC--CCCCCccCCHHHH
Confidence 111 223466789999999998899999999999999999999999977654443333322221 1223345788899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+++.+||..+|++||++.+++++.
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhCC
Confidence 999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=303.20 Aligned_cols=249 Identities=29% Similarity=0.489 Sum_probs=207.7
Q ss_pred cCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.+|...+.||+|+||.||.. +..||+|.+.... ..+..+.+.+|+++++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 35788899999999998731 3679999987542 34455788999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~ 185 (353)
.++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence 999999999999999997542 3678899999999999999999999 99999999999999999
Q ss_pred CEEEeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHh
Q 018614 186 NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 263 (353)
Q Consensus 186 ~vkl~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 263 (353)
.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 999999999876432211 11122334678999999999999999999999999999998 9999987776666655543
Q ss_pred cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
+.... .+..++..+.+++.+||+.||++||++.++++.|+
T Consensus 240 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 GRLLQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCcCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 33222 23457888999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=300.51 Aligned_cols=246 Identities=30% Similarity=0.546 Sum_probs=203.7
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|+..+.||+|+||.||. .+..+|+|.+...... ...+.+|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 477788999999998873 2346999988754322 24678899999999999999999999988899999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999764 35899999999999999999999999 9999999999999999999999999987654332222
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+........ +...+..+.+++
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 234 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVYAIM 234 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHHHHH
Confidence 222334567999999988889999999999999999998 9999987766555555544433322 234578899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.+||..+|++||++.++++.|+
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHcCCCcccCCCHHHHHHhhC
Confidence 9999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=318.72 Aligned_cols=257 Identities=30% Similarity=0.522 Sum_probs=226.5
Q ss_pred CcccCccCcCcccceeeecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 116 (353)
.|+++ .-+.+...+||.|.||.|| | ..-.||||.++.+. -.+.+|++|+.+++.++|||+|+++|+|..
T Consensus 261 kWEme--RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 261 KWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred hhhcc--chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 35543 2345667899999999887 3 24579999987653 345789999999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
+..+|||+|||..|+|.+||.++.+ ++.-..+.++.||..||+||..++ +|||||.+.|+|+.++..||++|||+
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999999986543 777888899999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCch
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 273 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 273 (353)
++++..+..........++.|.|||-+....++.|+|||+||++|||+.| |--||++.+...+...+.++-++.- +
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~---P 488 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG---P 488 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC---C
Confidence 99998777766666677889999999999999999999999999999998 9999999988888888877776653 5
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
..|++.+..||++||+.+|.+||++.++-+.++.++.
T Consensus 489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 6789999999999999999999999999999987754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=304.10 Aligned_cols=243 Identities=25% Similarity=0.384 Sum_probs=194.8
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCH
Q 018614 58 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132 (353)
Q Consensus 58 ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 132 (353)
||+|+||.||. +|+.||+|.+.............+..|++++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999873 4889999998654333222334556799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 018614 133 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210 (353)
Q Consensus 133 ~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 210 (353)
.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 99886543 4888999999999999999999999 9999999999999999999999999987664321 222345
Q ss_pred CCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHHHHHHHHHHHcc
Q 018614 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 211 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ..........++.++++|+.+||+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence 7889999999999899999999999999999999999997654322222221111 111222234578899999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 018614 290 EKPAKRPTFRQIITRL 305 (353)
Q Consensus 290 ~dp~~Rps~~~ll~~l 305 (353)
.||++||+++++++.+
T Consensus 236 ~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 236 KKPEDRLGSREKNDDP 251 (277)
T ss_pred cCHhhCCCCccchhhh
Confidence 9999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=316.71 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=199.5
Q ss_pred eeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecC
Q 018614 56 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127 (353)
Q Consensus 56 ~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 127 (353)
+.||+|+||.||. .|+.||+|++...... ......+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999998872 4789999998754322 222345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcc
Q 018614 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 207 (353)
Q Consensus 128 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 207 (353)
++++|.+++.....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 99999999988778999999999999999999999999 99999999999999999999999999876543221 222
Q ss_pred cCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHH
Q 018614 208 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 287 (353)
Q Consensus 208 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 287 (353)
...|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..... . .+..+++++.+||++|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-~---~p~~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-G---MPQFLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-C---CCCCCCHHHHHHHHHH
Confidence 34578899999999988899999999999999999999999987665555544433221 1 1234678899999999
Q ss_pred cccCCCCCCCH-----HHHHHH
Q 018614 288 WNEKPAKRPTF-----RQIITR 304 (353)
Q Consensus 288 l~~dp~~Rps~-----~~ll~~ 304 (353)
|+.||++||++ .+++.+
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCC
Confidence 99999999994 556544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=302.64 Aligned_cols=249 Identities=30% Similarity=0.521 Sum_probs=205.4
Q ss_pred CcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceE
Q 018614 51 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 121 (353)
+|+..+.||+|+||.||. .+..|++|.+.... ..+....+.+|+.++++++||||+++++++......|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 477778999999999874 34689999987532 3444567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC
Q 018614 122 IVTEYLPKGDLRAFLKRK-----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~ 184 (353)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 999999999999998532 13678889999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHH
Q 018614 185 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 262 (353)
Q Consensus 185 ~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 262 (353)
+.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999976543221 11222334567999999988889999999999999999998 999998766555555544
Q ss_pred hcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 018614 263 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
.....+ .+..++..+.+++.+||+.||++||++.+++++|+.
T Consensus 241 ~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 433332 234577889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=302.25 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=204.2
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 49 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
..+|+..+.||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++..+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34688899999999998873 24679999885432 2334456889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEE
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vk 188 (353)
..++||||+++++|.+++.... .++...++.++.|++.||.|||+.+ ++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999997532 2467788999999999999999999 99999999999999999999
Q ss_pred EeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCC
Q 018614 189 VADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 189 l~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 266 (353)
|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999987653322111 112234668999999998899999999999999999999 7899987766555554444333
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
... +..++..+.+++.+||+.||++||++.++++.|+
T Consensus 240 ~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 LDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 222 3456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.94 Aligned_cols=252 Identities=27% Similarity=0.484 Sum_probs=209.1
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
+|...+.||+|+||.||. ++..+++|.+.... ......+.+|+.++++++|+||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 577788999999998873 23468889886542 34445688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC
Q 018614 121 MIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~ 184 (353)
++||||+++++|.+++...+ .+++..++.++.||+.||+|||+++ ++|+||||+||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999997532 3788999999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHH
Q 018614 185 GNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 262 (353)
Q Consensus 185 ~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 262 (353)
+.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 99999999999765432211 1122345678999999999899999999999999999998 999998776666555544
Q ss_pred hcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 263 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
...... ....++..+.+++.+||+.+|++||+++++++.|+++.+.
T Consensus 240 ~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 QGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 433322 2334678899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=299.13 Aligned_cols=245 Identities=31% Similarity=0.562 Sum_probs=203.0
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|+..+.||+|+||.||. .+..+|+|.+...... ...+.+|+.++++++|+||+++++++......++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 477889999999998873 3457999998654322 13577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999763 45899999999999999999999999 9999999999999999999999999987654322221
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+........ +..++.++.+++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 234 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---PKLAPTEVYTIM 234 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHH
Confidence 122223457999999999899999999999999999999 8999987766555555543332222 234788999999
Q ss_pred HHHcccCCCCCCCHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l 305 (353)
.+||..+|++||++.++++.|
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=303.26 Aligned_cols=244 Identities=27% Similarity=0.450 Sum_probs=211.7
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|.+..+||+|+||.|+ .+|..||||.+..+ ..++++.+|+.++++++.|+||++||.+..+..+||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 7778899999999886 47999999998654 3457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|.-|++.+++.. +..+++..+..++...++||+|||... -||||||+.|||++.+|..||+|||.|-.+...-...
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 988999999975 446999999999999999999999988 7999999999999999999999999998876543333
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
. ...||+.|||||++..-.|+.++||||||++..||..|++||.+-.......-+..+-.+.+. .+..++.++.+|++
T Consensus 187 N-TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~-KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 187 N-TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK-KPEEWSSEFNDFIR 264 (502)
T ss_pred C-ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC-ChHhhhhHHHHHHH
Confidence 3 356899999999999999999999999999999999999999887765544434333333333 35679999999999
Q ss_pred HHcccCCCCCCCHHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~l 305 (353)
.||.++|++|.|+.+|++|-
T Consensus 265 ~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred HHhcCCHHHHHHHHHHhhhh
Confidence 99999999999999999873
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=325.36 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=208.9
Q ss_pred CccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC--
Q 018614 46 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-- 118 (353)
Q Consensus 46 ~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 118 (353)
.....+|+..+.||+|+||.||. +|+.||||++..... .......+.+|+.++..++|+|++++.+.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 34456899999999999999873 588999999876544 3445567889999999999999999888765332
Q ss_pred ------ceEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEE
Q 018614 119 ------PMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188 (353)
Q Consensus 119 ------~~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vk 188 (353)
.+++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 368999999999999999652 35899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC
Q 018614 189 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 267 (353)
Q Consensus 189 l~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 267 (353)
|+|||+++.+...... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+......
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~ 263 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 9999999876432211 123345788999999999999999999999999999999999999876655555555444333
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+ .+..+++++.+++.+||+.||++||++.+++++
T Consensus 264 ~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 P---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 3 234578899999999999999999999999876
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=305.37 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=194.7
Q ss_pred CcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeeEEE-----e
Q 018614 51 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT-----Q 116 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~-----~ 116 (353)
+|+..+.||+|+||.||. .|..||+|.+....... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 688899999999999873 35789999886543222 1223455677777665 6999999999885 2
Q ss_pred cCceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
....++|||+++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 6999999753 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCC----
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK---- 270 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---- 270 (353)
+...... .......+++.|+|||.+.+..++.++|||||||++|+|++|++||......+....+......+..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9765433 2223345788999999999889999999999999999999999999877655444444322110000
Q ss_pred -------------------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 271 -------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 271 -------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.....++..+.+|+.+||+.||++|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0012356778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=299.34 Aligned_cols=252 Identities=25% Similarity=0.486 Sum_probs=208.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|..+|||.+......+......+.+|+.+++.++|+||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 578889999999998873 678999998866444445556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 126 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 126 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999863 345899999999999999999999999 999999999999999999999999998766433
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--chHHHHHhcCCCCCCCchhhhHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... +....+.....++. ....++.+
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSEE 236 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC--CcccccHH
Confidence 221 12345677899999999888999999999999999999999999754332 22222222222221 23457889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+.+++.+||..||++|||+.++++.++++
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 99999999999999999999999998876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=300.28 Aligned_cols=249 Identities=30% Similarity=0.525 Sum_probs=210.0
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 50 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.+|+..+.||.|+||.||. .+..+++|.+.... ......+..|+.+++.++|+||+++++++.+....++|||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 4688899999999998873 46789999987543 2334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999753 34889999999999999999999999 99999999999999999999999999977643322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+. +..+++++.+
T Consensus 160 ~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 235 (261)
T cd05148 160 LS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC---PAKCPQEIYK 235 (261)
T ss_pred cc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC---CCCCCHHHHH
Confidence 21 23345668999999988899999999999999999998 8999987776666655544333322 3456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
++.+||+.||++|||++++++.|+.+
T Consensus 236 ~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 236 IMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=304.49 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=202.1
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|+..+.||+|+||.||. .++.||+|.+.............+.+|+.++++++|++++++++.+.++...++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67778999999999874 5789999998765444444445677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 127 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 127 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999986433 4899999999999999999999999 9999999999999999999999999987653222
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......++..|+|||.+.+..++.++||||+|+++|+|++|+.||..........................+++++.+|+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 11234578899999999999999999999999999999999999986544322221111111111112345678899999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 018614 285 EECWNEKPAKRPT-----FRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps-----~~~ll~~ 304 (353)
.+||+.||++||| ++++++|
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcC
Confidence 9999999999999 8899986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=304.61 Aligned_cols=262 Identities=29% Similarity=0.517 Sum_probs=212.3
Q ss_pred CCCcccCccCcCcccceeeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCc
Q 018614 40 VPEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN 106 (353)
Q Consensus 40 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 106 (353)
.|.|++.. .+|...+.||+|+||.||.. +..+|+|.+.... .......+..|+.+++.+ +|+|
T Consensus 10 ~~~~~~~~--~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 10 DPRWEVPR--DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred CCcceeeh--HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCC
Confidence 44565543 46899999999999998732 2469999987542 233446688899999999 7999
Q ss_pred ccceeeEEEecCceEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEE
Q 018614 107 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPII 170 (353)
Q Consensus 107 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~ii 170 (353)
|+++++++......|+||||+++++|.+++.... .+++..++.++.|++.||+|||+.| ++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~ 162 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CI 162 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999999997532 3788899999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCC
Q 018614 171 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 248 (353)
Q Consensus 171 H~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 248 (353)
|+||||+||+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 163 H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p 242 (307)
T cd05098 163 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242 (307)
T ss_pred cccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999987654322111 111223467999999998899999999999999999998 8999
Q ss_pred CCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 249 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 249 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
|......+....+....... .+..++.++.+|+.+||..+|++||++.++++.|+++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 243 YPGVPVEELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CCcCCHHHHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 97765545554443333222 2345678899999999999999999999999999998665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.14 Aligned_cols=252 Identities=29% Similarity=0.526 Sum_probs=207.4
Q ss_pred CcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
+|+..+.||+|+||.||.. ...+++|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4778899999999998741 2468888886543 234456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCC
Q 018614 121 MIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp 176 (353)
++++||+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence 9999999999999998642 23678899999999999999999999 99999999
Q ss_pred CCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 018614 177 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 254 (353)
Q Consensus 177 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 254 (353)
+||++++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++++|++ |..||.....
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999998765332211 1122334568999999988889999999999999999998 9999987766
Q ss_pred CchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 255 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.++...+....... .+..++.++.+|+..||+.+|++||++.++++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 55555443333222 234567889999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=296.80 Aligned_cols=243 Identities=30% Similarity=0.537 Sum_probs=200.1
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 130 (353)
+.||+|+||.||. +|..||+|.+.... ..+....+.+|++++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3689999998873 57889999876432 3445567899999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc-cc
Q 018614 131 DLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TC 208 (353)
Q Consensus 131 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~-~~ 208 (353)
+|.+++...+ .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........... ..
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9999997644 5899999999999999999999999 99999999999999999999999999876442211111 11
Q ss_pred CCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHH
Q 018614 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 287 (353)
Q Consensus 209 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 287 (353)
...+..|+|||.+.++.++.++||||||+++|+|++ |..||...........+....... .+..++..+.+|+.+|
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~ 232 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP---CPELCPDAVYRLMERC 232 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC---CcccCCHHHHHHHHHH
Confidence 123456999999999899999999999999999997 999997765544444443332222 2345678899999999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 018614 288 WNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 288 l~~dp~~Rps~~~ll~~l~ 306 (353)
|+.+|++||++.++++.|+
T Consensus 233 l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 233 WEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCChhhCcCHHHHHHHHh
Confidence 9999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.03 Aligned_cols=239 Identities=26% Similarity=0.405 Sum_probs=194.3
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHH-HHHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. ++..||+|++.............+..|. .+++.++||||+++++.+...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999873 4678999998754322222223444444 457888999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|.+++.....+++..+..++.||+.||.|||+.| ++||||||+|||++.++.++|+|||++........ .....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccccc
Confidence 999999988778999999999999999999999999 99999999999999999999999999875432221 22334
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.|++.|+|||++.+..++.++|||||||++|+|++|..||......+....+..... .. ...++..+.+++.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~---~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QL---KPNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-CC---CCCCCHHHHHHHHHHcc
Confidence 578899999999999999999999999999999999999987665555554433221 11 23567889999999999
Q ss_pred cCCCCCCCHHHHH
Q 018614 290 EKPAKRPTFRQII 302 (353)
Q Consensus 290 ~dp~~Rps~~~ll 302 (353)
.||.+||++.+.+
T Consensus 233 ~~p~~R~~~~~~~ 245 (325)
T cd05602 233 KDRTKRLGAKDDF 245 (325)
T ss_pred cCHHHCCCCCCCH
Confidence 9999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=307.43 Aligned_cols=260 Identities=30% Similarity=0.542 Sum_probs=212.4
Q ss_pred CCcccCccCcCcccceeeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcc
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV 107 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 107 (353)
|+|++.. .+|++.+.||+|+||.||.. +..||+|.+.... .......+.+|+.+++++ +||||
T Consensus 5 ~~~~~~~--~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 5 PKWELSR--TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred cccccCH--hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCe
Confidence 5677653 46889999999999988731 2368999886532 344557788999999999 79999
Q ss_pred cceeeEEEecCceEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEe
Q 018614 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 171 (353)
Q Consensus 108 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH 171 (353)
+++++++......++++||+++++|.+++.... .++...++.++.|++.||.|||+.| ++|
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH 157 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 999999999999999999999999999997532 3677888999999999999999999 999
Q ss_pred cCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 018614 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 249 (353)
Q Consensus 172 ~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf 249 (353)
|||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999765432211 1122233457999999999999999999999999999998 89999
Q ss_pred CCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
......+....+........ +..++.++.+++.+||+.+|++||++.++++.|+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 238 PGIPVEELFKLLKEGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 87766555555543333222 23467789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=316.25 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=201.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC-----ce
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 120 (353)
+|+..+.||+|+||.||. +|+.||||.+.... ........+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 477889999999999883 57899999986532 23334467889999999999999999999998766 78
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
|+|+||+. ++|.+++.....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999994 689998887777999999999999999999999999 99999999999999999999999999987644
Q ss_pred CCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhc---------------
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------------- 264 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------------- 264 (353)
..........++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 333333334567889999998774 4788999999999999999999999876544333222110
Q ss_pred --------C-CCCCC----CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 265 --------Q-RPPFK----APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 265 --------~-~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
. .++.. ......++++.+||.+||+.||++|||+.++++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 0 00000 01123467899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=307.33 Aligned_cols=248 Identities=25% Similarity=0.451 Sum_probs=194.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||.|+||.||. +|..||||++..... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 4689999999999999873 578999999875432 112235678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||+ .++|.+++... +.+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 83 EYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred ECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 999 56888887654 45899999999999999999999999 9999999999999999999999999987543322
Q ss_pred CCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-hHHHHHhc-CCC------------C
Q 018614 204 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAAR-QRP------------P 268 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~~~~~-~~~------------~ 268 (353)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+... ..+ .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12233456889999999865 457889999999999999999999998654321 11111100 000 0
Q ss_pred CC--------C-------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 FK--------A-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ~~--------~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+. . ....+++.+.+|+.+||+.||++|||++++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 0 001234678899999999999999999999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.43 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=204.4
Q ss_pred CcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEe-cC
Q 018614 51 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SS 118 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~ 118 (353)
+|+..+.||+|+||.||.. ++.||+|++.... ..+....+..|+.+++++ +|+||+++++++.. +.
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 6888999999999999842 3679999987543 234446678899999999 79999999998764 45
Q ss_pred ceEEEEecCCCCCHHHHHHhc-----------------------------------------------------------
Q 018614 119 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 139 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~----------------------------------------------------------- 139 (353)
.++++|||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCccc
Q 018614 140 --GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYV 216 (353)
Q Consensus 140 --~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~ 216 (353)
..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..+...... ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 24788899999999999999999999 999999999999999999999999999876433221 122234566799
Q ss_pred CccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCC
Q 018614 217 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295 (353)
Q Consensus 217 aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 295 (353)
|||++.+..++.++|||||||++|+|++ |..||......+............. .+..+++++.+++.+||+.+|++|
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p~~R 320 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNPEDR 320 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC--CCccCCHHHHHHHHHHccCChhhC
Confidence 9999999999999999999999999998 9999987554443333322222111 223567889999999999999999
Q ss_pred CCHHHHHHHHHHHHH
Q 018614 296 PTFRQIITRLESINN 310 (353)
Q Consensus 296 ps~~~ll~~l~~~~~ 310 (353)
|++.+++++|+++..
T Consensus 321 Ps~~ell~~l~~~~~ 335 (337)
T cd05054 321 PTFSELVEILGDLLQ 335 (337)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=311.58 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=204.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. .++.||+|++.............+.+|..++..++|++|+++++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 688899999999998873 567899999865433333444567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999986 456899999999999999999999999 999999999999999999999999999776433222
Q ss_pred CcccCCCCCcccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHH
Q 018614 205 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 278 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 278 (353)
......|++.|+|||++.+ +.++.++||||||+++|+|++|+.||......+....+.... ...++.....++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2223458899999999875 467889999999999999999999998766555554443322 2223333345688
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAK--RPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~--Rps~~~ll~~ 304 (353)
++++++.+||..++++ |++++++++|
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999999999876554 4688888877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.82 Aligned_cols=246 Identities=33% Similarity=0.539 Sum_probs=204.4
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|+..+.||+|+||.||. .+..+|+|.+...... ...+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 588889999999998872 4567999998764332 246889999999999999999999875 4568999999
Q ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 127 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 127 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999753 34899999999999999999999999 999999999999999999999999999776433222
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+......+. +...+..+.+|
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 235 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC---PQDCPISLHEL 235 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHHH
Confidence 2222334567999999988889999999999999999999 9999988766666665544333322 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
+.+||..+|++|||+.++.+.|++
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=312.55 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=204.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.|+. .+..+|+|++.............+.+|+.++..++|++|+++++.+.+....|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 588889999999999873 467899999865333333444567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999976 456899999999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHH
Q 018614 205 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 278 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 278 (353)
......|++.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+.... ...++.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223345889999999986 3467889999999999999999999998776655555554333 2223333345788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAK--RPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~--Rps~~~ll~~ 304 (353)
++++|+++|+..++++ |+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 9999999999665544 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=302.40 Aligned_cols=253 Identities=29% Similarity=0.459 Sum_probs=206.4
Q ss_pred CcCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc
Q 018614 49 ELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 107 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 107 (353)
..+|+..+.||+|+||.|+. .+..||+|.+.... .......+.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence 34688899999999998873 22568999987543 23455778899999999999999
Q ss_pred cceeeEEEecCceEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCC
Q 018614 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176 (353)
Q Consensus 108 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp 176 (353)
+++++++..+...+++||++++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence 999999999999999999999999999997655 5899999999999999999999999 99999999
Q ss_pred CCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCC
Q 018614 177 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKH 253 (353)
Q Consensus 177 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~ 253 (353)
+||++++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 9999999999999999998765332211 1223345678999999988889999999999999999998 778887765
Q ss_pred CCchHHHHHhc----CCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 254 DNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 254 ~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
........... ........+..++.++.+++.+||+.||++|||+.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 54444443322 111112223456788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=300.68 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=202.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|..||+|++.... ......+.+|+.++++++||||+++++.+......++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 4699999999999998873 57889999986542 223346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999999999987778999999999999999999999999 99999999999999999999999999986643221
Q ss_pred CcccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGL 280 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 280 (353)
......++..|+|||.+. ...++.++|+||+|+++|+|++|..||...........+.... .++.......++.++
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 122345677899999874 3457789999999999999999999996554333222221111 111111223467899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
.+|+.+||..+|++||+++++++++
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.64 Aligned_cols=248 Identities=27% Similarity=0.513 Sum_probs=218.1
Q ss_pred cceeeecceEEEEEE-------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 54 NSVEITKGTFILAFW-------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 54 ~~~~ig~G~~~~v~~-------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..+.||.|.||-||. .| ..||||+.+.+.. .+..+.|..|+.++++++||||++++|++.+ .+.||||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 356799999998872 23 4689999887543 3446789999999999999999999999986 5789999
Q ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|.++.|.|..+++.+. .++......++.||+.||+|||+.. +|||||.+.|||+.....|||+|||+++.+.....
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999999998654 4888899999999999999999999 99999999999999999999999999999876655
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.......-+..|||||.+.-..++.++|||.||++|||++. |..||.+..+.++.-.+.++.+.+. +..||+.+..
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~---P~nCPp~LYs 623 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC---PPNCPPALYS 623 (974)
T ss_pred hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---CCCCChHHHH
Confidence 44444445778999999999999999999999999999997 9999999998888888888887775 4568899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
|+.+||+.+|.+||.+.+|...|.++..
T Consensus 624 lmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999998865
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=302.61 Aligned_cols=261 Identities=28% Similarity=0.528 Sum_probs=213.2
Q ss_pred CCcccCccCcCcccceeeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcc
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV 107 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 107 (353)
|.|++ ...+|...+.||+|+||.||.. +..||+|.+.... .......+.+|+.+++.+ +||||
T Consensus 8 ~~~~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 8 PRWEF--SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred Ccccc--cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCc
Confidence 34543 3557888899999999998722 3479999886542 234456788999999999 79999
Q ss_pred cceeeEEEecCceEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEe
Q 018614 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 171 (353)
Q Consensus 108 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH 171 (353)
+++++++......+++|||+++++|.+++.... .++...++.++.|++.||.|||++| ++|
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH 160 (304)
T cd05101 84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIH 160 (304)
T ss_pred hheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 999999999999999999999999999997532 3677889999999999999999999 999
Q ss_pred cCCCCCCEEEcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 018614 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 249 (353)
Q Consensus 172 ~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf 249 (353)
+||||+||++++++.++|+|||++.......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 161 ~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred cccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999998764332221 122334567999999998889999999999999999998 88999
Q ss_pred CCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
......+....+........ +..++.++.+|+.+||..+|++||++.++++.|+++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 241 PGIPVEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ccCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 87766665555543333222 345778899999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.59 Aligned_cols=245 Identities=34% Similarity=0.615 Sum_probs=207.6
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 50 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
.+|+..+.||.|+||.|| ..|+.||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 367888999999999887 468899999987553 1456788999999999999999999999988999999999
Q ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 127 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 127 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999998765 5899999999999999999999999 99999999999999999999999999987632221
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
....+..|+|||.+.+..++.++||||||++++++++ |..||...........+....... .+..+++++.++
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 231 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME---APEGCPPEVYKV 231 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC---CccCCCHHHHHH
Confidence 2234557999999988889999999999999999997 999998776555544443332222 234567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+.+||..+|++||++.++++.|+++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHhccChhhCcCHHHHHHHHhcC
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=295.21 Aligned_cols=244 Identities=28% Similarity=0.511 Sum_probs=202.6
Q ss_pred eeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecC
Q 018614 56 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127 (353)
Q Consensus 56 ~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 127 (353)
++||+|+||.|+. .+..+|+|.+...... .....+.+|+.++++++|+||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 4699999998863 1268999998765432 34467889999999999999999999876 45689999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc-
Q 018614 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL- 206 (353)
Q Consensus 128 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~- 206 (353)
++++|.+++.....+++..++.++.|++.||+|||..+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999999988778999999999999999999999999 99999999999999999999999999987643322111
Q ss_pred -ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 207 -TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 207 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+....... .+..++..+.+++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 231 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---RPEECPQEIYSIM 231 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHH
Confidence 11223457999999998899999999999999999998 999998776655555554433222 2345778899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.+||..+|++||++.++++.|+++
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=314.07 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=206.0
Q ss_pred CcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 117 (353)
..+|+..+.||+|+||.||.. +..||||++.... .....+.+.+|+.+++++. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 446888899999999999731 2369999986543 3344567899999999996 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhc----------------------------------------------------------
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------- 139 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~---------------------------------------------------------- 139 (353)
...|+||||+++|+|.+++...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999988642
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE
Q 018614 140 --------------------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 181 (353)
Q Consensus 140 --------------------------------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill 181 (353)
..+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 12667788899999999999999999 9999999999999
Q ss_pred cCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHH
Q 018614 182 DDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 259 (353)
Q Consensus 182 ~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 259 (353)
++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 99999999999999865432221 1122345678999999998899999999999999999997 999998765444333
Q ss_pred HHHhcC-CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 260 AYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 260 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
...... ... .+..++.++.+++.+||+.||++||++.++.+.|+++.
T Consensus 351 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 NKIKSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHhcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 322222 222 23457788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=302.86 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=203.2
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|+..+.||+|+||.||. +|+.||+|.+.............+.+|+.++++++|+||+++.+.+..+...+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67778999999999874 5789999998765444444445677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 127 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 127 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999888653 35899999999999999999999999 9999999999999999999999999987653221
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..............++.++.+|+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 11234578899999999988999999999999999999999999987654433333322221111122345678899999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 018614 285 EECWNEKPAKRPT-----FRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps-----~~~ll~~ 304 (353)
..||+.||++||+ +.+++.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcC
Confidence 9999999999999 7777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=311.21 Aligned_cols=242 Identities=24% Similarity=0.410 Sum_probs=198.4
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.|+. ++..||+|++........+....+.+|+.++.++ +||||+++++++.+...+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999873 5688999999876554555567788999999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|..++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 999999988778999999999999999999999999 9999999999999999999999999987532221 122234
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC------chHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN------EVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
.|++.|+|||++.+..++.++||||||+++|+|++|..||...... +............ .+..++..+.++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~l 233 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR---IPRFLSVKASHV 233 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC---CCCCCCHHHHHH
Confidence 5788999999999999999999999999999999999999643221 1112222222212 234467889999
Q ss_pred HHHHcccCCCCCCCH------HHHHHH
Q 018614 284 IEECWNEKPAKRPTF------RQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~------~~ll~~ 304 (353)
+.+||+.||++|+++ .++++|
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 999999999999984 577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=299.65 Aligned_cols=248 Identities=27% Similarity=0.486 Sum_probs=204.9
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.++...++||+|+||.||. ++..+|+|.+... .......+.+|+++++.++|+||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 3577788999999999874 2457889987643 24445678999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG---------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~ 184 (353)
.+++|||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCC
Confidence 999999999999999997542 3788999999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHH
Q 018614 185 GNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 262 (353)
Q Consensus 185 ~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 262 (353)
+.++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 99999999998765322211 1112234578999999999999999999999999999998 999997766555555544
Q ss_pred hcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 263 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
...... .+..+++.+.+|+.+||+.||++||+++++++.|+
T Consensus 239 ~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 QGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 433222 22456788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=297.01 Aligned_cols=249 Identities=32% Similarity=0.513 Sum_probs=204.8
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 50 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.+|+..++||+|+||.||. ++..||+|.+...... ...+.+|+.++++++|+||+++++.+.. ...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 3588999999999998873 3357999998754321 2467889999999999999999998754 56799999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999999753 34789999999999999999999999 99999999999999999999999999976654332
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.......++..|+|||...+..++.++||||||+++|+|++ |..||......+....+......+. ...++..+.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~ 234 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLHD 234 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC---ccccCHHHHH
Confidence 22223345667999999988899999999999999999999 8999987765555544433322222 3457788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
|+.+||+.||++||++.++++.|+.++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=305.11 Aligned_cols=254 Identities=24% Similarity=0.483 Sum_probs=207.0
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
.+|+..+.||+|+||.||. +|. .||+|.+... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 4689999999999999874 233 4899998643 2344556788999999999999999999998764 56
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++++||+++|+|.+++.... .++...++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 89999999999999998643 5889999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 200 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 200 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
...... ......+..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+......+. +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICT 237 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCC
Confidence 432211 112233567999999999999999999999999999998 9999987655444443333333222 23467
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
.++.+++.+||..+|++||++.+++..+..+....
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 78999999999999999999999999998885543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=302.33 Aligned_cols=249 Identities=27% Similarity=0.488 Sum_probs=206.8
Q ss_pred CcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
+|...+.||+|+||.||.. +..||+|++.... .......+.+|+.++..++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4777889999999988742 4679999987542 334456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC
Q 018614 121 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~ 184 (353)
++++||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 9999999999999998532 23778889999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHH
Q 018614 185 GNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 262 (353)
Q Consensus 185 ~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 262 (353)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999998765432221 1122335678999999988889999999999999999998 899998776666665555
Q ss_pred hcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 018614 263 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
.....+ .+..++..+.+|+.+||+.+|++||++++|+..|+.
T Consensus 241 ~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 444333 235678889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=296.86 Aligned_cols=248 Identities=31% Similarity=0.526 Sum_probs=205.5
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 50 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.+|+..++||+|+||.||. ++..||+|.+...... ...+.+|+.++++++|+||+++++++. ....+++||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 3588889999999998873 5788999998764332 246788999999999999999999875 456899999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
++++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999998753 34889999999999999999999999 99999999999999999999999999877653222
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.......++..|+|||.+.+..++.++||||||+++|++++ |+.||...+..+....+......+ .+..++.++.+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 234 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP---RPDNCPEELYE 234 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---CCCCCCHHHHH
Confidence 22223345678999999998889999999999999999998 999998776655555543332222 23456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
++.+||+.+|++||++++++..|+++
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHccCChhhCCCHHHHHHHhhcC
Confidence 99999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=297.86 Aligned_cols=249 Identities=27% Similarity=0.477 Sum_probs=199.4
Q ss_pred cccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--Cce
Q 018614 52 FTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 120 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 120 (353)
|+..+.||+|+||.|+. ++..||+|.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 48889999999999852 46789999987542 233446788999999999999999999987653 457
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
+++|||+++++|.+++... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999999764 4999999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch---------------HHHHHh
Q 018614 201 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------------PKAYAA 263 (353)
Q Consensus 201 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~---------------~~~~~~ 263 (353)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 3221 11222345679999999988899999999999999999999999865432100 000001
Q ss_pred cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
.... +.+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 240 ~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111 123456789999999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=294.98 Aligned_cols=246 Identities=27% Similarity=0.463 Sum_probs=207.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|++|.+|. +|..|++|.+...... ......+.+|+.++++++||||+++++.+.+....++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 477788999999998873 5788999998654333 4455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999999764 45899999999999999999999999 99999999999999999999999999887654322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
. .....+++.|+|||++.+..++.++|+||||+++++|++|+.||...........+.....+.. ...++.++.++
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQLAQL 232 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence 1 1223467789999999998999999999999999999999999987765444444444333332 33678889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+||+.+|++||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHccCCcccCcCHHHHhhC
Confidence 999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=293.93 Aligned_cols=254 Identities=26% Similarity=0.493 Sum_probs=208.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|..||+|.++.....+......+.+|+.++++++|+|++++++.+......++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 3688899999999998873 58899999887544444555677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 125 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 125 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999864 234889999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--chHHHHHhcCCCCCCCchhhhHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... +....+.....++. +...++.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL--PADHYSE 235 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC--ChhhcCH
Confidence 3221 12234677899999999889999999999999999999999999654321 12222222222222 2235778
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
.+.++|.+||..+|++||++.+|++.|+++.
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 8999999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=302.47 Aligned_cols=256 Identities=29% Similarity=0.521 Sum_probs=210.2
Q ss_pred cCcccceeeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEe
Q 018614 50 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 116 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 116 (353)
.+|...+.||+|+||.||.. +..+|+|.+.... .......+.+|+.+++++ +||||+++++++.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 46888999999999988742 3468999987542 234456788999999999 69999999999999
Q ss_pred cCceEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEE
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nil 180 (353)
.+..+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 99999999999999999999753 23788889999999999999999999 999999999999
Q ss_pred EcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchH
Q 018614 181 RDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 258 (353)
Q Consensus 181 l~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 258 (353)
+++++.++|+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998664322111 111223457999999998899999999999999999999 89999876655555
Q ss_pred HHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 259 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
..+........ +..++.++.+++.+||..+|++||++.++++.|+++.....
T Consensus 247 ~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 247 KLLREGHRMDK---PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHHcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 55544333222 34567789999999999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=312.33 Aligned_cols=236 Identities=26% Similarity=0.406 Sum_probs=194.0
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||+|+||.||. +|..||+|++.............+..|.. +++.++||||+++++.+......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999883 57899999987543333333344555554 56778999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|..++.....+++..+..++.||+.||.|||+.| ++||||||+|||+++++.++|+|||++....... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987543221 122334
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..... .. ....+..+.+++.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VL---RPGASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cC---CCCCCHHHHHHHHHHhc
Confidence 578899999999999999999999999999999999999987765555555433221 11 12367789999999999
Q ss_pred cCCCCCCCHH
Q 018614 290 EKPAKRPTFR 299 (353)
Q Consensus 290 ~dp~~Rps~~ 299 (353)
.+|++||++.
T Consensus 233 ~~p~~R~~~~ 242 (325)
T cd05604 233 KDRQRRLGAK 242 (325)
T ss_pred cCHHhcCCCC
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=294.21 Aligned_cols=244 Identities=25% Similarity=0.441 Sum_probs=201.3
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 57 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 57 ~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
.||+|+||.||. .+..||+|++.... .....+.+.+|+.++++++|+||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 489999998873 24569999986542 3344567889999999999999999999885 4578999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC--c
Q 018614 130 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--L 206 (353)
Q Consensus 130 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~--~ 206 (353)
++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......... .
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999999975 445899999999999999999999999 9999999999999999999999999997654332211 1
Q ss_pred ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
....++..|+|||.+.+..++.++||||||+++|++++ |..||......+....+..+..... +..++.++.+++.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~ 232 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PAECPPEMYALMK 232 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHHH
Confidence 12223568999999988889999999999999999996 9999988776666555544444332 3456789999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
+||..+|++||++.++.+.|+.+.
T Consensus 233 ~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 233 DCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHcCCChhhCcCHHHHHHHHhhhc
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=298.08 Aligned_cols=249 Identities=28% Similarity=0.471 Sum_probs=203.8
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.+|+..+.||+|+||.||. .+..|++|.+.... .......+.+|+.+++.++|+||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4688889999999998872 34678999876432 23444568889999999999999999999998889
Q ss_pred eEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC---CEEE
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV 189 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~---~vkl 189 (353)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .++|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999997643 3788999999999999999999999 99999999999998765 5999
Q ss_pred eecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCC
Q 018614 190 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 267 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 267 (353)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999998763221111 111223457999999998899999999999999999997 99999877666655554433332
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.. +..++..+.+++.+||+.+|++||++.+++++|+
T Consensus 241 ~~---~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 DP---PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 22 3456788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=301.31 Aligned_cols=258 Identities=30% Similarity=0.542 Sum_probs=211.0
Q ss_pred CcccCccCcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccce
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 110 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~ 110 (353)
.|++. ..+|+..+.||+|+||.|+.. ...+|+|.+.... ..+....+.+|+.+++++ +|+||+++
T Consensus 6 ~~~~~--~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 6 EWELP--RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred ccccC--HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 34443 446888899999999988732 2578999987542 234446688999999999 79999999
Q ss_pred eeEEEecCceEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCC
Q 018614 111 LGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 174 (353)
Q Consensus 111 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dl 174 (353)
++++..++..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dl 158 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDL 158 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 99999999999999999999999999642 34788999999999999999999999 999999
Q ss_pred CCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 018614 175 EPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMK 252 (353)
Q Consensus 175 kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 252 (353)
||+||++++++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999999999999999999999876433211 1122234567999999988899999999999999999997 99999877
Q ss_pred CCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 253 HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
...+....+........ +..++.++.+|+.+||..||++|||++++++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PVEELFKLLKEGYRMEK---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 66666655544433222 2345778999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=298.15 Aligned_cols=249 Identities=28% Similarity=0.476 Sum_probs=206.4
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.+|+....||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++.....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3688889999999999873 13679999986542 23444678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEE
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl 189 (353)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999996532 2577889999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCC
Q 018614 190 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 267 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 267 (353)
+|||+++........ ......++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 999998765433211 1122335678999999988889999999999999999998 99999877766666655533333
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.. +..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 241 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 241 DL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 32 3346888999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=295.37 Aligned_cols=248 Identities=29% Similarity=0.502 Sum_probs=204.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC------HHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
+|.....||+|+||.||. ++..+|+|.+....... .+....+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477788999999998873 46889999886543221 2234568899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
.+++|||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999988778999999999999999999999999 9999999999999999999999999988765
Q ss_pred cCCCC-----CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchh
Q 018614 200 VKEDR-----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 200 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+. .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 234 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IPS 234 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc---CCc
Confidence 22111 1112346778999999999889999999999999999999999998765433333332222222 234
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.++..+.++|++||+.||++||++.+++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 577889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=291.27 Aligned_cols=242 Identities=31% Similarity=0.541 Sum_probs=200.4
Q ss_pred eeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCH
Q 018614 57 EITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132 (353)
Q Consensus 57 ~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 132 (353)
.||+|+||.||. ++..+|+|.+.... ..+....+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 689999999873 46789999987543 344445788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCC
Q 018614 133 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211 (353)
Q Consensus 133 ~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 211 (353)
.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...............+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9998754 35789999999999999999999999 9999999999999999999999999987644322222222234
Q ss_pred CCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHccc
Q 018614 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 290 (353)
Q Consensus 212 ~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 290 (353)
+..|+|||++.+..++.++||||||+++|++++ |..||...........+........ +..++..+.+|+.+||+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~ 233 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC---PQKCPDDVYKVMQRCWDY 233 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHccc
Confidence 567999999998889999999999999999998 9999987765555544433322222 234678899999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 018614 291 KPAKRPTFRQIITRLE 306 (353)
Q Consensus 291 dp~~Rps~~~ll~~l~ 306 (353)
+|++||++.++++.|.
T Consensus 234 ~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 234 KPENRPKFSELQKELA 249 (250)
T ss_pred CcccCCCHHHHHHHhc
Confidence 9999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=294.76 Aligned_cols=247 Identities=32% Similarity=0.523 Sum_probs=202.4
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|.....||.|+||.||. .+..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence 478888999999998873 345799998765432 22467889999999999999999998754 568999999
Q ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 127 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 127 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999997643 3789999999999999999999999 999999999999999999999999999776433222
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......++..|+|||...+..++.++||||||+++|+|++ |..||......+....+......+ .+...+..+.++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 235 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP---CPQGCPESLHEL 235 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHH
Confidence 2222345667999999998899999999999999999999 999998766555555443332222 234567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+.+||+.||++||+++++++.|+++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred HHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=296.57 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=209.7
Q ss_pred ccCcCcccceeeecceEEEEEE----c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-
Q 018614 47 PHELDFTNSVEITKGTFILAFW----R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ- 116 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~----~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 116 (353)
....+|+..+.||+|+||.||. . +..|++|.+... ........+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3455788899999999998872 2 578999988643 244556778899999999999999999998765
Q ss_pred cCceEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEE
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vk 188 (353)
+...++++|++++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEE
Confidence 46789999999999999999753 34889999999999999999999999 99999999999999999999
Q ss_pred EeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCC
Q 018614 189 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 189 l~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 266 (353)
|+|||+++.+...... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||......+....+.....
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 237 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence 9999999865432211 1112334667999999998889999999999999999998 9999987655554444433322
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
.. ....++.++.+++.+||..||++|||+.++++.|+++.+.
T Consensus 238 ~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 LA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 22 1234678899999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=298.62 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=206.9
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 117 (353)
..+|...+.||+|+||.|+. .+..||+|.++... .....+.+.+|+.+++++ +|+||+++++.+...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34688899999999998863 23479999887542 234456788999999999 799999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
+..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999997543 2899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCch
Q 018614 196 KLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 273 (353)
Q Consensus 196 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 273 (353)
......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+............ ..+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 266 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--AQP 266 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--CCC
Confidence 866433211 1122335678999999999899999999999999999998 999998766544433332222111 122
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
...+.++.+|+.+||..+|++||++.++++.|+++
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 34578899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=295.29 Aligned_cols=250 Identities=24% Similarity=0.466 Sum_probs=205.9
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
+|+..+.||+|+||.||. +|+.+|+|.+...... .......+.+|+.++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999874 5778999988654221 233346688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC-
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE- 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~- 202 (353)
+||+++++|.+++.+...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999988778999999999999999999999999 9999999999999999999999999987653211
Q ss_pred ----CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 203 ----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 203 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
........++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... .......+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-RGLMPRLPDSFSA 236 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-cCCCCCCCCCCCH
Confidence 11112345778899999999988999999999999999999999999866544333222222 1122223456788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.+++++||..+|++||++.+++++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=304.70 Aligned_cols=244 Identities=24% Similarity=0.460 Sum_probs=212.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
-|...+.||+|-|.+|. ..|+.||||++.+..+. .-....+.+|++.++.++|||||++|++......+|+|+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 37788899999998875 58999999999887654 3344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE-cCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill-~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
+-++|+|.||+-... .+++..+.+++.||+.|+.|+|... +|||||||+||.+ ..-|.|||.|||++-.+...
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-- 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-- 172 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence 999999999997644 4999999999999999999999998 9999999999765 57789999999999776544
Q ss_pred CCcccCCCCCcccCccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
......-|...|.|||++.|..|+ ++.||||||+|+|-|.+|++||...++.+....|..-+... +..++.++++
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv----PshvS~eCrd 248 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV----PSHVSKECRD 248 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC----chhhhHHHHH
Confidence 333345578899999999999996 58999999999999999999999988888877765544332 5789999999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||..||..||.+|.+.++|..+
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHhcCchhhccHHHHhcc
Confidence 9999999999999999999854
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=293.98 Aligned_cols=253 Identities=26% Similarity=0.488 Sum_probs=208.0
Q ss_pred CcCcccceeeecceEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 49 ELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
..+|...+.||+|+||.||.. ...|+||...... ..+..+.+.+|+.++++++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 345788899999999998731 1368899876442 24455678999999999999999999998875 457
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 89999999999999997644 4899999999999999999999999 9999999999999999999999999987764
Q ss_pred cCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
...........++..|+|||.+.+..++.++||||||+++|++++ |..||......+....+......+. +..++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~ 235 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM---PPNCPP 235 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCH
Confidence 432222222234567999999988889999999999999999986 9999987776655555544433332 345678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
++.+++.+||..+|++|||+.++++.|+++..
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=294.20 Aligned_cols=250 Identities=32% Similarity=0.542 Sum_probs=207.3
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
+|+..+.||+|+||.||. .+..+|+|.+.... .......+.+|+.++++++||||+++++++.+++..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 577889999999998873 13379999986543 23445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||||+++++|.+++... +.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999764 35899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcc--cCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 202 EDRPLT--CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 202 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
...... ...++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+......+. ...++.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 236 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA---PMDCPA 236 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC---CCCCCH
Confidence 221111 1223457999999998899999999999999999987 9999987766555555544332222 235678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.+.+++.+||+.+|++||++.++++.|+++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.02 Aligned_cols=259 Identities=22% Similarity=0.385 Sum_probs=209.9
Q ss_pred cCccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeE-EEe-
Q 018614 45 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGA-VTQ- 116 (353)
Q Consensus 45 i~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~-~~~- 116 (353)
+.....++++.+.|.+|||+.||. .|..+|+|++-. .++..++.+.+|+.+|+.|+ |+|||.+++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 333455788889999999999983 348999999854 37888899999999999996 9999999993 321
Q ss_pred ---c--CceEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEE
Q 018614 117 ---S--SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189 (353)
Q Consensus 117 ---~--~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl 189 (353)
+ -.++|.||||.||.|-|+++. ...|++.++++|+.|++.|+.+||... -++||||||-+||||+.+|..||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence 1 246899999999999999985 335999999999999999999999987 46999999999999999999999
Q ss_pred eecccccccccCCCCCc--------ccCCCCCcccCcccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchH
Q 018614 190 ADFGVSKLLTVKEDRPL--------TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 258 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~~~~--------~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 258 (353)
||||.|........... .....|+.|+|||++ .+...+.|+|||+|||+||.|+....||.......+.
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl 267 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL 267 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE
Confidence 99999976543331111 123468899999986 5778999999999999999999999999876443332
Q ss_pred HHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 259 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
... -.+++ ...++..+++||+.||+.||++||++-+++.++..+...-.
T Consensus 268 ----ng~-Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 268 ----NGN-YSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ----ecc-ccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 222 11222 25689999999999999999999999999999998865433
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=294.03 Aligned_cols=245 Identities=27% Similarity=0.452 Sum_probs=204.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|+||.|+ .++..+|+|.++... .....+.+.+|+.+++.++|+||+++++.+.++...|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 47888999999999886 257889999986532 23345677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999988653 34889999999999999999999999 99999999999999999999999999876643221
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......++..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+......+. +..++..+.+|
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 231 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYELRSL 231 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHHHHH
Confidence 12234577889999999998999999999999999999999999987655444444433333322 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+||+.||++||++.+++..
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=315.31 Aligned_cols=242 Identities=29% Similarity=0.375 Sum_probs=197.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-C-----CcccceeeEEEecCc
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H-----PNVVQFLGAVTQSSP 119 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~i~~~~~~~~~~~~ 119 (353)
+|++.+.||+|+||.|. .+++.||||+++.. .....+-..|+.+|..|+ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 57888999999999876 36899999999764 445566678999999996 3 389999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC--CEEEeecccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVS 195 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~--~vkl~Dfg~a 195 (353)
+|||+|.+ +.+|.++++.+. .++...++.++.||+.||.+||..+ |||+||||+||||.+.+ .|||+|||.+
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999 779999998764 4899999999999999999999999 99999999999998654 5999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC----------
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---------- 265 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---------- 265 (353)
++...... .+.-+..|.|||++.|..|+.+.||||||||++||++|.+.|++.+..+....+....
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 98653322 3444668999999999999999999999999999999999998766533332221100
Q ss_pred --------------------------------------------CC-CCCCc----hhhhHHHHHHHHHHHcccCCCCCC
Q 018614 266 --------------------------------------------RP-PFKAP----AKLYARGLKELIEECWNEKPAKRP 296 (353)
Q Consensus 266 --------------------------------------------~~-~~~~~----~~~~~~~l~~li~~cl~~dp~~Rp 296 (353)
.+ ..... ...-...+.+||++||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 00 00000 001235689999999999999999
Q ss_pred CHHHHHHH
Q 018614 297 TFRQIITR 304 (353)
Q Consensus 297 s~~~ll~~ 304 (353)
|+.+.++|
T Consensus 495 tp~qal~H 502 (586)
T KOG0667|consen 495 TPAQALNH 502 (586)
T ss_pred CHHHHhcC
Confidence 99999998
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=294.43 Aligned_cols=250 Identities=32% Similarity=0.515 Sum_probs=206.7
Q ss_pred CcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..+|+..+.||.|+||.||. ++..||||.+...... ...+.+|+.++++++|+||+++++++......++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 34688889999999998873 3467999998754321 246788999999999999999999999888999999
Q ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 125 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|++++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999997643 5899999999999999999999999 9999999999999999999999999987764322
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.........+..|+|||.+.+..++.++|+||||+++++|++ |+.||...........+......+. +...+.++.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNCPEELY 234 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHH
Confidence 111122234567999999998899999999999999999998 9999987765555555543322222 234578899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+++.+||..+|++||+++++++.|+.+
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 235 DLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=294.50 Aligned_cols=250 Identities=27% Similarity=0.467 Sum_probs=204.6
Q ss_pred cccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc----
Q 018614 52 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 119 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 119 (353)
|+..+.||+|+||.|+. .+..||+|.+..... .......+.+|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 46678899999999873 136799999876433 33445678899999999999999999998865443
Q ss_pred --eEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 120 --MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 120 --~~iv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
.++++||+++++|..++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence 79999999999999998542 24889999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCC
Q 018614 192 FGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 269 (353)
Q Consensus 192 fg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 269 (353)
||+++......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||......+....+.......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~- 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK- 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 99998664332211 112234567999999988899999999999999999999 999998776666555554433322
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.+..++.++.+++.+||+.||++||++.+++++|+++
T Consensus 236 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 --QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2345788999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=301.83 Aligned_cols=251 Identities=32% Similarity=0.548 Sum_probs=202.8
Q ss_pred CcccceeeecceEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~i 122 (353)
+|+..+.||+|+||.||. +|. .+++|.+... ........+.+|+.++.++ +|+||+++++++..++..|+
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 678889999999998873 233 4577776532 2344556788999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC
Q 018614 123 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
||||+++++|.+++.... .+++..++.++.|++.||+|||+.| ++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997532 3788899999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcC
Q 018614 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 265 (353)
Q Consensus 187 vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 265 (353)
++|+|||++........ ......+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+....
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 99999999864321111 111223567999999988889999999999999999998 999998766655544442221
Q ss_pred CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 266 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
... .+..++.++.+|+.+||+.+|++||++.+++..|+++...
T Consensus 241 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 241 RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 1234677899999999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=297.42 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=205.8
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.+|++.+.||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++.+...
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3688899999999999884 13479999886542 23334567889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEE
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl 189 (353)
.++||||+++|+|.+++.... ..+...++.++.|++.||.|||+++ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997522 2456788899999999999999999 999999999999999999999
Q ss_pred eecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCC
Q 018614 190 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 267 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 267 (353)
+|||+++......... .....++..|+|||.+.++.++.++|||||||++|+|++ |..||......+....+......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999987654322111 111234567999999998899999999999999999998 89999877666655555443333
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.. +...+..+.+++.+||+.||++|||+.++++.|++...
T Consensus 241 ~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 241 DQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 22 23456889999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.73 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=202.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.+|. ++..||+|.++... ......+.+|+.+++.++||||+++++.+......++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 3688889999999998873 57899999986542 233356778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 99999999999988888999999999999999999999999 99999999999999999999999999876543221
Q ss_pred CcccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC-CCCCCchhhhHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PPFKAPAKLYARGL 280 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 280 (353)
......++..|+|||.+. ...++.++|+|||||++|+|++|..||................. ++.......++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 223345788999999874 45688899999999999999999999976554333322222221 11111122467789
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+++.+||+.+|++||++++++++
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcC
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=309.44 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=195.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 118 (353)
.+|+..+.||+|+||.||. .|..||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4799999999999999873 478999999875432 3344566789999999999999999999986443
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++...
T Consensus 100 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCC-cCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 4799999995 567776643 4888999999999999999999999 999999999999999999999999999764
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-------------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------- 265 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------- 265 (353)
... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 174 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 174 CTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 322 12233457889999999999999999999999999999999999998765432211111100
Q ss_pred --------CCCCC-----------------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 266 --------RPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 266 --------~~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
.+... ......+.++++||.+||..||++|||+.++++|-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000 00112356789999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=324.30 Aligned_cols=254 Identities=31% Similarity=0.533 Sum_probs=224.0
Q ss_pred cccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 52 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+.+.||.|.||.|+. ....||||.++... .+.+...|+.|+.+|-|++||||+++.|+........||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34567899999999973 34689999998764 456668899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
+|||++|+|+.+|+. .+.|..-++..+++.|+.||.||.+.+ +|||||.+.|||++.+-..|++|||+++.+.++.
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999999975 456999999999999999999999999 9999999999999999999999999999886555
Q ss_pred CCCcccC--CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 203 DRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 203 ~~~~~~~--~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
....+.. .-+.+|.|||.+...+++.++||||+|++|||.++ |..||=++.+-++.+.+..+-+.+. +.++|..
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp---PmDCP~a 862 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP---PMDCPAA 862 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC---CCCCcHH
Confidence 3333323 34678999999999999999999999999999997 9999999999999999877766553 4568999
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
|.+|+..||++|-.+||.+.+|+..|.++..+.+
T Consensus 863 L~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 863 LYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 9999999999999999999999999999865544
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=312.07 Aligned_cols=240 Identities=25% Similarity=0.395 Sum_probs=195.5
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeeEEEecCceEEEEecCCC
Q 018614 58 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 58 ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
||+|+||.||. +|..||||++................|..++... .||||+++++.+.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999983 4789999998654333333344555677776655 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|.+++...+.+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++........ .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccCc
Confidence 999999988888999999999999999999999999 99999999999999999999999999875432221 12234
Q ss_pred CCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHc
Q 018614 210 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 288 (353)
.|+..|+|||++.+. .++.++|||||||++|+|++|..||......+....+..... . .....++.++.+|+.+||
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~--~~~~~~~~~~~~li~~~L 233 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-R--FPKNVLSDEGRQFVKGLL 233 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-C--CCCccCCHHHHHHHHHHc
Confidence 578899999998765 478999999999999999999999987765555555433322 1 122346788999999999
Q ss_pred ccCCCCCC----CHHHHHHH
Q 018614 289 NEKPAKRP----TFRQIITR 304 (353)
Q Consensus 289 ~~dp~~Rp----s~~~ll~~ 304 (353)
+.||++|| ++.++++|
T Consensus 234 ~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCHHHCCCCCCCHHHHhcC
Confidence 99999998 67777765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=291.88 Aligned_cols=247 Identities=22% Similarity=0.393 Sum_probs=208.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|+||.++ .+|..+++|.+...... ......+.+|+.++++++|+||+++++++.+....+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 48889999999998665 35788999998654432 3445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999999764 35899999999999999999999999 99999999999999999999999999987644332
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......++..|+|||.+.+..++.++||||||+++|+|++|..||......+....+......+ ....++.++.++
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---VVSVYSSELISL 232 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHHHHHH
Confidence 1223456789999999988889999999999999999999999998766655555554433322 235577889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~l 305 (353)
+.+||..+|++||++.++++++
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCc
Confidence 9999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=298.17 Aligned_cols=252 Identities=27% Similarity=0.464 Sum_probs=203.0
Q ss_pred cCcccceeeecceEEEEEEc-------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccce
Q 018614 50 LDFTNSVEITKGTFILAFWR-------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF 110 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~~-------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 110 (353)
.+|+..+.||+|+||.||.. ...||+|.+.... .......+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 46888899999999998731 1258999987542 34455678899999999999999999
Q ss_pred eeEEEecCceEEEEecCCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCC
Q 018614 111 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 178 (353)
Q Consensus 111 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~N 178 (353)
++++......++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 999999999999999999999999996432 3678889999999999999999999 9999999999
Q ss_pred EEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCC
Q 018614 179 ILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDN 255 (353)
Q Consensus 179 ill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~ 255 (353)
|++++++.+||+|||++......... ......++..|+|||.+.++.++.++||||||+++|+|++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999998765432211 1122334678999999998899999999999999999998 67888776654
Q ss_pred chHHHHHh----cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 256 EVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 256 ~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
+....+.. ............++..+.+|+.+||+.||++||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 44433221 1121222223446788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=294.07 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=201.1
Q ss_pred ccceeeecceEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------Cc
Q 018614 53 TNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 119 (353)
Q Consensus 53 ~~~~~ig~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~ 119 (353)
...+.||+|+||.||. .+ ..||+|.++... ......+.+.+|+.+++.++|+||+++++.+... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999883 22 268999887643 2345567788999999999999999999986432 24
Q ss_pred eEEEEecCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 120 MMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
.+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998842 123789999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 194 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 194 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
++......... .......++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 235 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ-- 235 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 99876432211 1122335668999999999999999999999999999999 8999987666555555544433222
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
...++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 -PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 235678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=292.65 Aligned_cols=244 Identities=30% Similarity=0.561 Sum_probs=202.1
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEE-ecCceEEEEe
Q 018614 50 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTE 125 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~iv~e 125 (353)
.+|+..+.||+|+||.+| ..|..||+|.+.... ..+.+.+|+.++++++|+|++++++++. .+...+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 368888999999998877 468889999886432 2356889999999999999999999764 4567899999
Q ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999997644 3788999999999999999999999 9999999999999999999999999987653322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.....+..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.....+. ....+++.+.+
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPVVYD 230 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHH
Confidence 12233557999999998899999999999999999997 999998765555544443332222 23457888999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
++.+||..+|++|||+.++++.|+.+
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=292.09 Aligned_cols=248 Identities=29% Similarity=0.507 Sum_probs=204.2
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 50 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.+|+..+.||+|+||.||. .+..+++|.+... ......+.+|+.+++.++|+||+++++.+.+ ...+++||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4688899999999999873 4567999987643 2334678899999999999999999999887 77899999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++++|.+++... ..++...+..++.|++.||.|||+.+ ++|+||+|+||+++..+.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999763 24788889999999999999999998 99999999999999999999999999876543322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.......++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+.......+......+ .....+.++.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 234 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---RPENCPEELYN 234 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC---CcccCCHHHHH
Confidence 22222334567999999998889999999999999999998 999998766555554443332222 23456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
++.+||..+|++||++.++++.|+++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=292.95 Aligned_cols=243 Identities=33% Similarity=0.606 Sum_probs=205.8
Q ss_pred eeeecceEEEEEE-----c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecC
Q 018614 56 VEITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 127 (353)
+.||+|+||.|+. . +..|++|.+..... ......+.+|+..++.++|+||+++++++......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 3689999998873 2 77899999876532 224577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 128 PKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 128 ~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccc
Confidence 999999999875 66999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 199 TVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 199 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....... .+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 232 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP---KPEYC 232 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCccC
Confidence 54321 11223446778999999988889999999999999999999 699998886666666555433322 23456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
+.++.+++.+||..+|++||++.+++++|+
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 233 PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=282.64 Aligned_cols=259 Identities=23% Similarity=0.393 Sum_probs=206.0
Q ss_pred ccCccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 44 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 44 ~i~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
.+-..+.+|.+.+.+|.|||..|+. ++..+|+|++... ..+..+..++|++..+.++||||++++++...+.
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 3445567899999999999988873 5788999998655 3455677889999999999999999998765443
Q ss_pred -----ceEEEEecCCCCCHHHHHHhc---C-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEE
Q 018614 119 -----PMMIVTEYLPKGDLRAFLKRK---G-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189 (353)
Q Consensus 119 -----~~~iv~e~~~~~~L~~~l~~~---~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl 189 (353)
..|++++|...|+|.+.++.. + .+++.+++.|+.+++.||.+||+... +++||||||.|||+.+.+.++|
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEE
Confidence 489999999999999999752 2 58999999999999999999999874 5999999999999999999999
Q ss_pred eecccccccccCCCCC--------cccCCCCCcccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--Cc
Q 018614 190 ADFGVSKLLTVKEDRP--------LTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NE 256 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~--~~ 256 (353)
.|||.++...-.-... ......|..|.|||.+.- ...+.++|||||||++|+|+.|.-||..... ..
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 9999998764322111 123346788999999854 4567899999999999999999999964321 11
Q ss_pred hHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 257 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+...+...+ ..++ ....+|+.+.+||+.||+.||.+||++.+++.++.++
T Consensus 251 laLAv~n~q-~s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 251 LALAVQNAQ-ISIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EEEeeeccc-cccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111111111 1111 2334899999999999999999999999999999876
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=299.35 Aligned_cols=243 Identities=28% Similarity=0.475 Sum_probs=206.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. .++.||+|++........+....+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 588889999999998872 578999999876544444556678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998876433
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...........+... ...+ +..++..+++++.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~---~~~~~~~l~~li~ 230 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRF---PSFFSPDAKDLIR 230 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccC---CccCCHHHHHHHH
Confidence 12234678899999998888899999999999999999999999876644444444322 2222 2345788999999
Q ss_pred HHcccCCCCCC-----CHHHHHHH
Q 018614 286 ECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
+||..||++|+ +++++++|
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcC
Confidence 99999999999 88888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.57 Aligned_cols=250 Identities=30% Similarity=0.536 Sum_probs=207.3
Q ss_pred CcccceeeecceEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
+|+..+.||+|+||.||. .+ ..+|+|.+.... .....+.+.+|+.++++++|+||+++++++.+....++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 677889999999998872 22 379999886542 23445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||||+++++|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999764 46899999999999999999999999 999999999999999999999999998766433
Q ss_pred CCCCcc--cCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 202 EDRPLT--CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 202 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
...... ....+..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+ ....++.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~ 237 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---APMDCPS 237 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---CCCCCCH
Confidence 222111 1223457999999998889999999999999999997 999998776655555554433222 2334678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
++.+++.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=299.44 Aligned_cols=248 Identities=27% Similarity=0.467 Sum_probs=202.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.|+. +|..+|+|.+.... ..+....+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 588899999999999873 47789999886542 34455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+++++|.+++...+.+++..+..++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999999887789999999999999999999998 47 9999999999999999999999999987653221
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC------------------
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------------ 266 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------ 266 (353)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 1234567899999999888899999999999999999999999965443222211111000
Q ss_pred ----------------CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 267 ----------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 267 ----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.....+...++.++++|+.+||..+|++||++++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000011236778999999999999999999999998843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=302.30 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=198.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|...+.||+|+||.||. ++..||+|.+...... .....+.+|+.++++++||||+++++++..+...++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 3688899999999999984 5778999998754321 22235678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||++ ++|.+++...+ .++...+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++........
T Consensus 84 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 84 EYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred eCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 9996 58888887644 4789999999999999999999999 99999999999999999999999999876543222
Q ss_pred CCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC----------------
Q 018614 204 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---------------- 266 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------- 266 (353)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+.....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1222346788999998865 4678999999999999999999999987665444333322110
Q ss_pred -----CCCC-----CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 -----PPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 -----~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+... .....++.++.+||.+||..||.+|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000 0112357789999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=297.89 Aligned_cols=252 Identities=32% Similarity=0.533 Sum_probs=205.2
Q ss_pred CcccceeeecceEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~i 122 (353)
+|+..+.||+|+||.|+. +| ..+++|.++.. ......+.+.+|+.+++++ +||||+++++++......++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 578888999999998873 23 24688887632 2334456788999999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC
Q 018614 123 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
++||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence 999999999999997532 3778899999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcC
Q 018614 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 265 (353)
Q Consensus 187 vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 265 (353)
+||+|||++........ ......+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....
T Consensus 158 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EEECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999999864322111 111223457999999998889999999999999999997 999998776655555543332
Q ss_pred CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 266 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
... .+..++.++.+|+.+||..+|.+||+++++++.|+++....
T Consensus 236 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 236 RME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 222 23457788999999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=296.80 Aligned_cols=251 Identities=30% Similarity=0.488 Sum_probs=205.9
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 49 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
..+|+..+.||+|+||.|+. .+..||+|.+.... ..+....+.+|+.++++++||||+++++++.++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 34688889999999998874 35789999987542 2344567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCC
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp 176 (353)
..+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence 9999999999999999997431 3677888999999999999999999 99999999
Q ss_pred CCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 018614 177 SNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 254 (353)
Q Consensus 177 ~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 254 (353)
+||++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876532211 11112233567999999998899999999999999999997 8899987666
Q ss_pred CchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 018614 255 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
.+....+......+ .+..++.++.+|+.+||+.+|++||++.++++.|++
T Consensus 239 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 55555554333322 234567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.82 Aligned_cols=252 Identities=23% Similarity=0.469 Sum_probs=204.0
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
.+|+..+.||+|+||.||. .|. .+++|.+.... .......+..|+..+++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 3677889999999999873 233 47888875332 23444677888889999999999999998764 557
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++++||+++|+|.+++... +.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 8899999999999999764 45899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 200 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 200 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
..... ......++..|+|||.+.+..++.++||||||+++||+++ |..||.+.........+..+..... +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQICT 237 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCCCC
Confidence 32221 1223345678999999998899999999999999999998 9999987765555555443333322 23456
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.++.+++.+||..||++|||+.++++.|..+..
T Consensus 238 ~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 238 IDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 778999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.26 Aligned_cols=252 Identities=23% Similarity=0.481 Sum_probs=206.5
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
.+|+..+.||+|+||.||. +|. .||+|.+.... .......+.+|+.+++.++|+||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 3688889999999999874 333 48999986542 34445678899999999999999999999875 457
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++++|++++|+|.+++... +.+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 8999999999999999764 45899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 200 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 200 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...........+......+. +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPICT 237 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CccCC
Confidence 322211 112234567999999999899999999999999999998 9999987666555555544333332 34567
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.++.+++.+||..||++||++.++++.|+.+..
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 889999999999999999999999999887744
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=296.61 Aligned_cols=253 Identities=27% Similarity=0.469 Sum_probs=202.9
Q ss_pred cCcccceeeecceEEEEEEc---------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccc
Q 018614 50 LDFTNSVEITKGTFILAFWR---------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 108 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~~---------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 108 (353)
.+|+..+.||+|+||.||.. +..||+|.+.... .......+.+|+.+++.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 35888999999999999842 3468999987542 344456788999999999999999
Q ss_pred ceeeEEEecCceEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCC
Q 018614 109 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177 (353)
Q Consensus 109 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~ 177 (353)
++++++......+++|||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 99999999999999999999999999997532 2567789999999999999999999 999999999
Q ss_pred CEEEcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCC
Q 018614 178 NILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHD 254 (353)
Q Consensus 178 Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~ 254 (353)
||++++++.++|+|||++.......... .....++..|++||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999987653322111 112234568999999888889999999999999999998 7889976655
Q ss_pred CchHHHHHh----cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 018614 255 NEVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 255 ~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
.+....... .......+.+..++..+.+|+.+||..||++||++.++++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 443332211 11111122234567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.85 Aligned_cols=248 Identities=29% Similarity=0.463 Sum_probs=205.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||.|+||.++. ++..+++|.+.... .+....+.+|+.++++++||||+++++.+.+...+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 3688889999999998873 46789999986543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999999999765 67999999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCcccCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARG 279 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 279 (353)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.... .+........++.+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 12234567789999999776 78899999999999999999999998765444333333321 11222233457888
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+|+.+||..+|.+||++.+++.+
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=290.64 Aligned_cols=245 Identities=31% Similarity=0.602 Sum_probs=203.9
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|+..+.||+|+||.||. .+..+|+|.+....... ..+.+|++++++++|||++++++++......++||||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 567778999999998874 37789999987543322 3578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+++++|.+++... +.+++..++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999764 45899999999999999999999999 9999999999999999999999999987654332222
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+........ +...+..+.+|+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 234 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQSVYELM 234 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCHHHHHHH
Confidence 222334568999999998899999999999999999998 9999987666555555543332221 233578899999
Q ss_pred HHHcccCCCCCCCHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l 305 (353)
.+||+.+|++||++.++++.|
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.56 Aligned_cols=250 Identities=30% Similarity=0.536 Sum_probs=205.6
Q ss_pred CcccceeeecceEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
.|...+.||+|+||.||. ++ ..||||.+.... .......+..|+.++++++||||+++++++.++...++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 467789999999998873 12 369999986542 34556789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||||+++++|.+++... +.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999764 45899999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCc--ccCC--CCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 202 EDRPL--TCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 202 ~~~~~--~~~~--~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
..... .... .+..|+|||.+.+..++.++||||||+++||+++ |..||......+....+......+. +..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~ 236 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP---PMDC 236 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC---cccC
Confidence 22111 1111 2347999999999899999999999999999986 9999987665555555533322221 2456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+..+.+++.+||+.+|++||++++++..|+++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 78899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=299.38 Aligned_cols=248 Identities=28% Similarity=0.547 Sum_probs=200.2
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|+..+.||+|+||.||. +++.+|+|.+....... .......+|+.++++++||||+++++++.+....++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 67789999999999984 56789999997654322 2222345699999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 206 (353)
+++++|.+++.....+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+.... ......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~ 155 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF 155 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence 988899999997778999999999999999999999999 9999999999999999999999999987641 112233
Q ss_pred ccCCCCCcccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCC---CchhhhHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK---APAKLYARGLKE 282 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 282 (353)
....++..|+|||.+. +..++.++||||||+++++|++|..||...........+......... ......+.++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 3455788999999998 888999999999999999999999999876322222222211111100 011112478999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+|.+||+.||++||++.+++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.41 Aligned_cols=257 Identities=20% Similarity=0.298 Sum_probs=205.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. .|+.||+|++.............+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 3688999999999999984 47899999997654444555677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 125 EYLPKGDLRAFLKRK-----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 125 e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
||++|++|.+++.+. ...+...++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998641 12456678899999999999999999 9999999999999999999999999
Q ss_pred cccccccCCC-----------------CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 018614 194 VSKLLTVKED-----------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 256 (353)
Q Consensus 194 ~a~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 256 (353)
++........ .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 00112358899999999999999999999999999999999999997754433
Q ss_pred hHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHHHH
Q 018614 257 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP-TFRQIITRLESINN 310 (353)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~l~~~~~ 310 (353)
....... ..+........+++.+.+++.+||..||++|| +++++++.|+.+..
T Consensus 239 i~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 3222111 11111112235678899999999999999995 56677777777644
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=297.53 Aligned_cols=243 Identities=27% Similarity=0.424 Sum_probs=196.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC-----
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----- 118 (353)
+..|...+.+|.|+||.||. .++.||||++-.+.- --.+|+++|+.++|||||++..+|....
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 45788899999999999984 578999998754321 1136999999999999999999886432
Q ss_pred ceEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC-CCEEEeecc
Q 018614 119 PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFG 193 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~-~~vkl~Dfg 193 (353)
...+||||++ .+|.++++. +..++.-.+.-+.+||+.||.|||+.| |+||||||.|+|+|.+ |.+||||||
T Consensus 96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCC
Confidence 3468999996 499988874 456888899999999999999999999 9999999999999954 999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC----
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP---- 268 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---- 268 (353)
.|+.+..... ..++..+..|+|||.+.|. .|+.+.||||.||++.||+-|++.|++.+.......+.+....+
T Consensus 172 SAK~L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 172 SAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred cceeeccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998865433 3456678899999998775 78999999999999999999999999877655544443311110
Q ss_pred ---------------CC------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 ---------------FK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ---------------~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+. ......+++..+|+.++|..+|++|.++.+++.|
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00 0123467889999999999999999999999966
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=293.74 Aligned_cols=252 Identities=26% Similarity=0.518 Sum_probs=201.2
Q ss_pred CcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--
Q 018614 49 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-- 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 117 (353)
...|+..+.||+|+||.||. .+..||+|.+.... .......+.+|+.++++++||||+++.+++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 34578899999999999862 36789999986542 344456789999999999999999999998765
Q ss_pred CceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++||||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 56899999999999999997643 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----------C--c---hHH
Q 018614 197 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD----------N--E---VPK 259 (353)
Q Consensus 197 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~----------~--~---~~~ 259 (353)
........ ......++..|+|||.+.+..++.++||||||+++|+|++++.|+..... . . ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76433221 11234456679999999888899999999999999999998766432110 0 0 011
Q ss_pred HHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 260 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.+......+ .+..++..+.+|+.+||+.||++||+++++++.|+++
T Consensus 238 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111111 2345788899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=298.70 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=204.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+|+.||. .++.|++|.+.............+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999998873 467899999876543334455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~- 204 (353)
|++|++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999988642111000
Q ss_pred -------------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 205 -------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 205 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+........... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-WPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-CCC
Confidence 001234677899999999889999999999999999999999999876655555544333222 122
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
....++.++.+||.+||+.||++||+..++++.|+
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 22357888999999999999999999654444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=292.44 Aligned_cols=245 Identities=29% Similarity=0.497 Sum_probs=205.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|+..+.||.|+||.+|. .+..||+|.+.... .......+.+|+.+++++.|+||+++++.+.++...++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 477888999999998873 47789999886542 23445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++.. +++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 9999999999865 46899999999999999999999999 99999999999999999999999999976643322 1
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+ .....++..+.+++.
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~ 234 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP---TLTGEFSKPFKEFID 234 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC---CCchhhhHHHHHHHH
Confidence 22234677899999999888999999999999999999999999876655444433222222 223457888999999
Q ss_pred HHcccCCCCCCCHHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~l 305 (353)
+||..+|++||++.+++++-
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred HHcccCcccCcCHHHHHhCh
Confidence 99999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.03 Aligned_cols=252 Identities=28% Similarity=0.484 Sum_probs=201.9
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec-C
Q 018614 51 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 118 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~ 118 (353)
+|+..+.||+|+||.||. .++.||||.++... .......+.+|+.++.++ +|+||+++++++... .
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 699999999999999873 35789999987543 233456788999999999 689999999987654 5
Q ss_pred ceEEEEecCCCCCHHHHHHhcC----------------------------------------------------------
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG---------------------------------------------------------- 140 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~---------------------------------------------------------- 140 (353)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6799999999999999986421
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCC
Q 018614 141 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQD 210 (353)
Q Consensus 141 ---------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~ 210 (353)
.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 2567788899999999999999999 999999999999999999999999998765332211 112233
Q ss_pred CCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHH-hcCCCCCCCchhhhHHHHHHHHHHHc
Q 018614 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECW 288 (353)
Q Consensus 211 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl 288 (353)
++..|+|||.+.+..++.++||||||+++|+|++ |..||............. ....... +..+++++.+++..||
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~cl 319 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCW 319 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC---CCCCCHHHHHHHHHHc
Confidence 4567999999988899999999999999999997 999998765443332222 2222221 2335678999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHH
Q 018614 289 NEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 289 ~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
+.||++||++.+++++|+.+..
T Consensus 320 ~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 320 HGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred cCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=291.09 Aligned_cols=249 Identities=29% Similarity=0.505 Sum_probs=207.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|+||.+|. ++..+++|++...... .....+.+|+..++.++|+||+++++.+......++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 688899999999998872 5678999998654332 245678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
++++++|.+++... ..+++..+..++.|++.||+|||+.| ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999763 35899999999999999999999999 9999999999999999999999999987765433
Q ss_pred CC---CcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCch--hhh
Q 018614 203 DR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA--KLY 276 (353)
Q Consensus 203 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 276 (353)
.. ......++..|+|||.+... .++.++|+||||+++++|++|+.||......+..........+.+.... ..+
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence 22 11233567889999998777 7889999999999999999999999877665555444443333232222 367
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+..+.+++.+||..||++||+++++++|
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 7889999999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=314.82 Aligned_cols=243 Identities=24% Similarity=0.357 Sum_probs=190.3
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------ 117 (353)
..+|+..+.||+|+||.||. .++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 34799999999999999983 57899999875431 1234799999999999999999877432
Q ss_pred --CceEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEe
Q 018614 118 --SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVA 190 (353)
Q Consensus 118 --~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~ 190 (353)
..+++||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence 24679999995 578777652 445899999999999999999999999 99999999999999665 69999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC-C-
Q 018614 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-P- 267 (353)
Q Consensus 191 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~- 267 (353)
|||+++...... ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+..... +
T Consensus 214 DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 214 DFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred ccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998764322 22234568899999998664 689999999999999999999999987655443333322110 0
Q ss_pred -----------------CCCC------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 -----------------PFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 -----------------~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.... .+...+.++.+||.+||..||.+|||+.++++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 012356789999999999999999999999977
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.10 Aligned_cols=241 Identities=31% Similarity=0.540 Sum_probs=202.5
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 130 (353)
-.||+|+||.||. +...+|||.+... +....+-+.+|+.+.+++.|.|||+++|.+..++.+-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 4699999999993 3567899988654 2344466889999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc-CCCCEEEeecccccccccCCCCCc
Q 018614 131 DLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPL 206 (353)
Q Consensus 131 ~L~~~l~~~-~~~--~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~ 206 (353)
+|.+++... +++ ++..+-.+..||++||.|||.+. |||||||-+||||+ -.|.+||.|||.++.+...+. ..
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~T 733 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CT 733 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-cc
Confidence 999999864 455 78889999999999999999999 99999999999998 578999999999988765433 33
Q ss_pred ccCCCCCcccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
..+.||..|||||++..+ .|+.++|||||||++.||.||++||.........-.. .+....-++.+..++.+.+.||
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-VGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-VGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-hcceecCCCCcHHHHHHHHHHH
Confidence 457789999999999765 6889999999999999999999999877665543222 2222223334677899999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+|+.+||..||+++++|..
T Consensus 813 lrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHcCCCcccCccHHHhccC
Confidence 99999999999999999853
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=288.93 Aligned_cols=246 Identities=28% Similarity=0.439 Sum_probs=202.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-cCceEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~ 124 (353)
+|+..+.||+|++|.|+. +++.||+|.+..... .......+.+|+.++++++|+|++++++.+.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 478889999999998872 467899999865432 23445668889999999999999999998764 44679999
Q ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 125 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 125 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||+++++|.+++... ..+++..++.++.|++.|+.+||+.| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999763 34899999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
. ......+++.|+|||.+.+..++.++||||||+++++|++|+.||...+.......+.....+. .+..+++++.+
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGE 232 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHH
Confidence 2 2223456788999999999999999999999999999999999998665444444443333322 23457889999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.+||+.||++||++.+++++
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcC
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=306.96 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=196.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------C
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 118 (353)
.+|+..+.||+|+||.|+. .++.||||++..... .......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4799999999999999873 478899999876432 334445678899999999999999999987543 3
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 5799999995 578887754 3788999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC----------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP---------- 268 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---------- 268 (353)
.... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+
T Consensus 177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 4321 2233457889999999999999999999999999999999999998766544333322111100
Q ss_pred -----------CC-----------------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -----------FK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -----------~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+. ......+.++++||.+||..||.+|||+.++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0011124578999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=289.34 Aligned_cols=250 Identities=24% Similarity=0.435 Sum_probs=205.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+|+.++. ++..|++|.+...... .+..+.+..|+.+++.++|+||+++++.+......++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 578889999999998863 5788999998765432 4566789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999988777899999999999999999999999 9999999999999999999999999988765433221
Q ss_pred c---ccCCCCCcccCccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 206 L---TCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 206 ~---~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
. ....++..|+|||.+.+.. ++.++||||||++++++++|..||..................+..+....++..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE 236 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHH
Confidence 1 1244677899999998766 888999999999999999999999765433222222222222222222345788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+++.+||+.+|++||++.+++.+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.19 Aligned_cols=252 Identities=21% Similarity=0.434 Sum_probs=206.4
Q ss_pred ccCccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 44 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 44 ~i~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
.+.....+|+..+.||+|+||.||. +|..|++|.+..... .....+.+|+.+++.+.|+||+++++.+..+.
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 3444456899999999999998873 478999998865432 22356889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|+||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred EEEEeecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 999999999999999998654 5889999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.................+.. ..+..++.
T Consensus 167 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 244 (296)
T cd06654 167 TPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSA 244 (296)
T ss_pred cccccc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCC-CCccccCH
Confidence 432211 1234577889999999988899999999999999999999999976554333222222222222 22345778
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+.+++.+||..+|++||++.+++++
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 245 IFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 89999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.81 Aligned_cols=251 Identities=22% Similarity=0.452 Sum_probs=208.4
Q ss_pred cCccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 45 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 45 i~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
+.....+|+..+.||.|+||.||. +|+.|++|.+..... .....+.+|+.+++.++||||+++++.+.....
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 344456799999999999998873 578999998865432 223567889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
.++|+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 99999999999999998754 5899999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.....+.. ..+..++..
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (296)
T cd06655 167 PEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSPI 244 (296)
T ss_pred ccccc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCccc-CCcccCCHH
Confidence 33221 1223567789999999988899999999999999999999999987665444433333332222 223457788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+||.+||..||++||++.+++++
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhC
Confidence 9999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.30 Aligned_cols=247 Identities=26% Similarity=0.463 Sum_probs=201.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. .|..||+|.+.... .......+.+|+.++++++|+||+++++.+...+..++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 578889999999998873 57899999886532 33445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 126 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 126 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
|+++++|..++... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999998763 368999999999999999999997 47 999999999999999999999999998765322
Q ss_pred CCCCcccCCCCCcccCccccCCCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhh
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 275 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (353)
. .....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+...........+..
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 157 L---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred c---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 1 12234677899999986543 47899999999999999999999976555444433322221111222344
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 276 YARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 276 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
++.++.+||.+||..+|++||++++++.+-
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 789999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=316.31 Aligned_cols=244 Identities=20% Similarity=0.237 Sum_probs=188.9
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC------CCcccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~ 117 (353)
..+|+..+.||+|+||.||. .++.||||+++... ........|+.+++.+. |.+++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 45799999999999999984 47789999986421 22233455666666654 45688888888754
Q ss_pred -CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCC----------
Q 018614 118 -SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG---------- 185 (353)
Q Consensus 118 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~---------- 185 (353)
...|+|||++ +++|.+++...+.+++..+..++.||+.||.|||+ .| ||||||||+|||++..+
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccc
Confidence 5689999998 78999999887789999999999999999999998 48 99999999999998765
Q ss_pred ------CEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHH
Q 018614 186 ------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 259 (353)
Q Consensus 186 ------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 259 (353)
.+||+|||.+..... ......+|+.|+|||++.+..++.++|||||||++|||++|++||...+..+...
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred cCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 499999998764321 2234567899999999999999999999999999999999999998766543333
Q ss_pred HHHhcCC--------------------------CCCCC------------chhhhHHHHHHHHHHHcccCCCCCCCHHHH
Q 018614 260 AYAARQR--------------------------PPFKA------------PAKLYARGLKELIEECWNEKPAKRPTFRQI 301 (353)
Q Consensus 260 ~~~~~~~--------------------------~~~~~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~l 301 (353)
.+..... +.... ......+.+.+||.+||..||++|||++++
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 2221100 00000 000113557899999999999999999999
Q ss_pred HHH
Q 018614 302 ITR 304 (353)
Q Consensus 302 l~~ 304 (353)
++|
T Consensus 436 L~H 438 (467)
T PTZ00284 436 TTH 438 (467)
T ss_pred hcC
Confidence 987
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=308.65 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=197.6
Q ss_pred cCcccceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 50 LDFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
.+|+..+.||+|+||.||. .+..||+|.+.... ...+|+.++++++||||+++++++......|+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 4699999999999999883 24679999875431 34579999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
+||++ +++|.+++.....+++..++.++.||+.||.|||+.| ++||||||+|||++.++.++|+|||++.......
T Consensus 164 v~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred Eehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99999 5789999977778999999999999999999999999 9999999999999999999999999997665432
Q ss_pred CC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH---Hh---------------
Q 018614 203 DR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AA--------------- 263 (353)
Q Consensus 203 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~---~~--------------- 263 (353)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+ ..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 22 222356889999999999999999999999999999999999999765433211111 00
Q ss_pred -----------cCCCCCCCc----hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 264 -----------RQRPPFKAP----AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 264 -----------~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...++.... ...++.++.++|.+||..||++||++.+++.|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001111100 12346678999999999999999999999998
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.04 Aligned_cols=245 Identities=28% Similarity=0.488 Sum_probs=206.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|+||.||. +|..||+|.+.... .......+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 578889999999998873 57899999986543 23344568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK- 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccccc-
Confidence 99999999999765 6899999999999999999999999 999999999999999999999999999877543222
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.....+.... ..++.++.+++.
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~ 232 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG--NKFSKPFKDFVS 232 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc--cccCHHHHHHHH
Confidence 223456778999999998889999999999999999999999998766544444443333322221 227888999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~ 304 (353)
+||..+|++||++++++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 233 LCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHhhCChhhCcCHHHHhhC
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=288.07 Aligned_cols=246 Identities=34% Similarity=0.602 Sum_probs=205.1
Q ss_pred cccceeeecceEEEEEE-----c----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 52 FTNSVEITKGTFILAFW-----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
++..+.||.|+||.|+. . +..||+|.+.... ..+....+..|+.+++.++|+||+++++.+.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 35568899999998872 2 3789999986553 23355678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 123 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
+||++++++|.+++..... +++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999999976544 899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
..........+++.|+|||.+.+..++.++||||||+++++|++ |..||...........+........ ...++.+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPE 232 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHH
Confidence 32222112235678999999988889999999999999999998 8999987666555555544443332 3347889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+.+++.+||..||++|||+.++++.|
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=305.57 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=195.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------C
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 118 (353)
.+|+..+.||+|+||.|+. .+..||||.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 4799999999999999873 478899999876432 334456678899999999999999999988643 3
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.| ++||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 4799999995 577777754 4889999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-------------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------- 265 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------- 265 (353)
.... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 4321 1223457889999999999999999999999999999999999997655322221111100
Q ss_pred --------CCCC-----------------CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 --------RPPF-----------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 --------~~~~-----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+.. .......+.++++||.+||..||++|||+.++++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 00111235678999999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=306.01 Aligned_cols=257 Identities=28% Similarity=0.468 Sum_probs=206.9
Q ss_pred cccCccCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCccccee
Q 018614 43 YEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFL 111 (353)
Q Consensus 43 ~~i~~~~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~ 111 (353)
|++... +|...+.||+|+||.||. .+..||+|++.... .....+.+.+|+.++.++. ||||++++
T Consensus 32 ~~~~~~--~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 32 WEMPRD--NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred ceecHH--HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 554433 577789999999999973 13579999997643 2333457889999999997 99999999
Q ss_pred eEEEecCceEEEEecCCCCCHHHHHHhcC---------------------------------------------------
Q 018614 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------------------------------------------------- 140 (353)
Q Consensus 112 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--------------------------------------------------- 140 (353)
+++...+..++||||+++|+|.+++...+
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 99999999999999999999999996431
Q ss_pred -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecC
Q 018614 141 -----------------------------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173 (353)
Q Consensus 141 -----------------------------------------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~d 173 (353)
.+++..++.++.|++.||.|||+.+ ++|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCccc
Confidence 2566678889999999999999998 99999
Q ss_pred CCCCCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 018614 174 LEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 251 (353)
Q Consensus 174 lkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~ 251 (353)
|||+|||+++++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999986532221 11122345678999999998889999999999999999998 8999987
Q ss_pred CCCCchHHHHHhcC-CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 252 KHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 252 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
....+......... .+. .+..++.++.+|+.+||..+|++||++++|+..|+++.
T Consensus 345 ~~~~~~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 345 LPMNEQFYNAIKRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCchHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 65544433332222 222 23346788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=291.32 Aligned_cols=249 Identities=28% Similarity=0.454 Sum_probs=201.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc-ccceeeEEEecC-----
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSS----- 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~----- 118 (353)
..|+..++||+|+||.||. +|..||+|+++.+.-. +..-....+|+.+++.++|+| |+++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3588888999999999984 6889999999875421 111123468999999999999 999999998776
Q ss_pred -ceEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 119 -PMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 119 -~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
.+++|+||+ .-+|..++.... .++...+..++.||+.||+|||+++ |+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 789999999 669999998755 4777899999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCC---
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP--- 268 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~--- 268 (353)
+|+....+. +..+...+|.+|.|||++.+. .|+...||||+||+++||+++++.|++....+....+-... .+.
T Consensus 166 lAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 999765432 234456678899999999887 78999999999999999999999998877644444432211 110
Q ss_pred -------------CCCc--h-------hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -------------FKAP--A-------KLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -------------~~~~--~-------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+... + +...++..+++.+||+.+|.+|.|++.++.|
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000 1 1112478899999999999999999999998
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=291.30 Aligned_cols=250 Identities=29% Similarity=0.492 Sum_probs=205.8
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.+|+....||.|+||.||. ....|++|.+.... .......+.+|+.++++++|+||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 4688889999999999873 23578999875432 23355678999999999999999999999999899
Q ss_pred eEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEe
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~ 190 (353)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence 999999999999999998655 5899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCC
Q 018614 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 269 (353)
Q Consensus 191 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 269 (353)
|||++...............++..|+|||.+.+..++.++||||||+++|++++ |..||...........+...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~-~ 238 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-L 238 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC-C
Confidence 999987543322222222344667999999988888999999999999999998 88999776655555544322211 1
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.....++..+.+++.+||+.+|++||++.++++.|+
T Consensus 239 -~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 -PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 123457788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=290.37 Aligned_cols=251 Identities=26% Similarity=0.523 Sum_probs=204.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
+|+..+.||+|+||.+|. +|..||+|.+...... .......+.+|+.++++++|+||+++++++.+....++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999998873 5788999998653311 12345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~Dfg~a~~~~~~ 201 (353)
|+||+++++|.+++.+.+.+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999988778999999999999999999999999 99999999999998776 5999999998776533
Q ss_pred CCCC---cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhH
Q 018614 202 EDRP---LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYA 277 (353)
Q Consensus 202 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 277 (353)
.... .....++..|+|||.+.+..++.++|+||||+++++|++|..||...........+.... .......+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1111 112346778999999988889999999999999999999999997654433333222111 111122344578
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++.+++.+||..+|++||++.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 889999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=292.81 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=201.5
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|+..+.||+|+||.||. .+..+++|.+... .......+.+|+.+++.++||||+++++.+......++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 67778899999999874 4678899988543 344556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+++++|..++.+ ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 999999998865 456899999999999999999999999 99999999999999999999999999876543221 1
Q ss_pred cccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 206 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
.....++..|+|||++. +..++.++||||+||++|+|++|.+||......+....+.....+.. ..+..++.++
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSEF 238 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCccccCHHH
Confidence 22345778899999874 44577899999999999999999999987654444334333222221 2234578899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
.+||.+||+.||++||++.+++++-
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCC
Confidence 9999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=286.77 Aligned_cols=243 Identities=30% Similarity=0.534 Sum_probs=200.7
Q ss_pred eeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCC
Q 018614 56 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131 (353)
Q Consensus 56 ~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 131 (353)
+.||+|+||.||. .+..||+|.+..... .+....+.+|++++++++|+||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 3689999988762 378999999876543 2455678999999999999999999999999999999999999999
Q ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc-ccC
Q 018614 132 LRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQ 209 (353)
Q Consensus 132 L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~-~~~ 209 (353)
|.+++... ..++...++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99999653 45889999999999999999999999 99999999999999999999999999876542211111 112
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 288 (353)
..+..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+....... .+..++.++.+++.+||
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l 232 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP---APQLCPEEIYRLMLQCW 232 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHh
Confidence 23456999999988899999999999999999999 899998776655555543332222 23456788999999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 018614 289 NEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 289 ~~dp~~Rps~~~ll~~l~ 306 (353)
..+|++||++.++++.|+
T Consensus 233 ~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 233 AYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccChhhCcCHHHHHHHhh
Confidence 999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=291.09 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=198.7
Q ss_pred CcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe--c
Q 018614 49 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--S 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 117 (353)
+..|+..+.||+|+||.||. .+..||+|.+... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 44688889999999999874 4678999998654 34445678899999999999999999998743 3
Q ss_pred CceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||||+||++++++.++|+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 4689999999999999999764 45899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCC--cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch------------HH---
Q 018614 197 LLTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV------------PK--- 259 (353)
Q Consensus 197 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~------------~~--- 259 (353)
......... .....++..|+|||.+.+..++.++||||||++++||++|..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 764332211 1112234469999999988999999999999999999998776643321100 00
Q ss_pred HHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 260 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
...... ........++.++.+|+.+||..+|++|||++++++.|+.+
T Consensus 237 ~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNN--GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcC--CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000111 11112345678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=290.23 Aligned_cols=254 Identities=26% Similarity=0.508 Sum_probs=209.6
Q ss_pred cCcccceeeecceEEEEEE-----cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 50 LDFTNSVEITKGTFILAFW-----RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
.+|+..+.||+|+||.||. +| ..+|+|...... .......+.+|+.+++.++|+||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 4688889999999998874 22 258999886553 24455678899999999999999999999887 788
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999999764 45899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCc-ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 200 VKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 200 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
....... ....++..|+|||.+....++.++|+||||+++|++++ |+.||......+....+......+. +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ---PPICT 237 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCC
Confidence 3222111 11223567999999988889999999999999999998 9999988766666655544333222 23466
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
..+.+++.+||..||++||++.++++.|+++....
T Consensus 238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 238 IDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 78999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=287.60 Aligned_cols=247 Identities=31% Similarity=0.554 Sum_probs=196.9
Q ss_pred eeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEE-ecCceEEEEec
Q 018614 56 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY 126 (353)
Q Consensus 56 ~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~iv~e~ 126 (353)
+.||+|+||.||. .+..||+|.+... ........+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 3689999998873 1347999987532 23445567889999999999999999999765 45668999999
Q ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 018614 127 LPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 203 (353)
Q Consensus 127 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-- 203 (353)
+.+++|.+++.... ..+...+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999997643 3677888899999999999999998 99999999999999999999999999876533211
Q ss_pred -CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 204 -RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 204 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.......++..|+|||.+.+..++.++||||||+++|||++ |.+||......+....+.....+.. +..++..+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPLY 232 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHHH
Confidence 11112335668999999988899999999999999999999 5777776554444444433322221 234677899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
+++.+||..+|++||++.++++.|+++..
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=297.30 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=206.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. ++..||+|.+.............+.+|+.+++.++|+||+++++.+.++...|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 588889999999998873 478999999977655444456678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999754 45899999999999999999999999 99999999999999999999999999876532211
Q ss_pred C----------------------------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 018614 204 R----------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 255 (353)
Q Consensus 204 ~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 255 (353)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011234677899999999988999999999999999999999999877655
Q ss_pred chHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCC----HHHHHHH
Q 018614 256 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT----FRQIITR 304 (353)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~ll~~ 304 (353)
.....+.... ..... ....+.++.+++.+||..||++||+ +++++.+
T Consensus 239 ~~~~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSNILKKE-VTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHhcCC-ccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 5444433222 11111 2236888999999999999999999 8888876
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.33 Aligned_cols=241 Identities=32% Similarity=0.599 Sum_probs=201.5
Q ss_pred CcccceeeecceEEEEEE---cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecC
Q 018614 51 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 127 (353)
+|+..+.||+|+||.|+. .+..||+|.+.... ....+.+|+.++++++|||++++++++..+. .+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence 588889999999998874 67889999986532 2356889999999999999999999987654 79999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 128 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 128 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999999997643 4789999999999999999999999 9999999999999999999999999987643221
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+....+.....+. ....++.++.+++
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 230 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PPEGCPADVYVLM 230 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC---CCCcCCHHHHHHH
Confidence 11223457999999998899999999999999999997 999998776655555544433222 2345788899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
.+||+.+|++||+++++++.|+.
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 231 TSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHcCCChhhCcCHHHHHHHHcc
Confidence 99999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=292.79 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=202.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..|+..+.||+|+||.||. .+..|++|.+... ..+....+.+|+.+++.++|+||+++++.+..++..++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 3588999999999999883 4789999998654 3455677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||+++++|..++.+ ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999999988765 445899999999999999999999999 99999999999999999999999998876432211
Q ss_pred CCcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 204 RPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
......++..|+|||.+. ...++.++||||||+++|+|++|..||......+....+.....+. ...+..++.
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 243 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPSKWSM 243 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCcccCH
Confidence 112334677899999985 3456789999999999999999999997765444333332222222 222345778
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.+++.+||..||++||++++++++
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 89999999999999999999999876
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.44 Aligned_cols=246 Identities=24% Similarity=0.462 Sum_probs=206.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.++. +|..||+|.+...... ......+.+|+.+++.++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 488899999999998774 6789999998654332 3344578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999999997643 4789999999999999999999999 99999999999999999999999999976643221
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
. .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||......+....+..+..+. .+..++.++.++
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 232 (256)
T cd08218 157 L-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNL 232 (256)
T ss_pred h-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHH
Confidence 1 122346778999999999899999999999999999999999998765555554444443332 234567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~ 304 (353)
|.+||+.+|++||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhC
Confidence 999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=291.86 Aligned_cols=246 Identities=27% Similarity=0.389 Sum_probs=218.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|...+.||+|+||.|. ..|+.+|+|+++++.+...+....-..|-++|+...||.+..+...|+...++|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 57778899999999886 3688999999999988888888888999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|..||.|.-++.+...+++...+.+...|+.||.|||+++ ||+||||.+|.++|.+|++||+|||+++..-.....
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t- 324 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT- 324 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccce-
Confidence 9999999999988888999999999999999999999999 999999999999999999999999999865433222
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
...+-|||.|+|||++....|+...|+|.+|++||||++|+.||...+++.+...+......- +..++++.+.|+.
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF----Pr~ls~eAktLLs 400 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF----PRTLSPEAKTLLS 400 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC----CccCCHHHHHHHH
Confidence 334668999999999999999999999999999999999999999999999988875544221 3557889999999
Q ss_pred HHcccCCCCCC-----CHHHHHHH
Q 018614 286 ECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
.+|.+||.+|. ++.++..|
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHhh
Confidence 99999999994 46666654
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=291.75 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=206.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|+|+.||. ++..||+|.+.............+.+|++++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 588899999999988772 478999999976554444556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+.+++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 9999999999988777999999999999999999999999 9999999999999999999999999987764332 1
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ..........+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-AKQETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-HHhccccccCcccCcHHHHHHHH
Confidence 22344677899999999888999999999999999999999999877643222211 11111222233457789999999
Q ss_pred HHcccCCCCCCCH--HHHHHH
Q 018614 286 ECWNEKPAKRPTF--RQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rps~--~~ll~~ 304 (353)
+||..||.+||++ ++++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HHccCChhHcCCccHHHHhcC
Confidence 9999999999999 666543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.55 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=191.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeeEEEec-----
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQS----- 117 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~----- 117 (353)
+|+..+.||+|+||.||. +|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 488889999999999873 57889999987543221 1112345666666655 799999999988642
Q ss_pred CceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
...+++||+++ ++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 45799999996 58999887643 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC--------
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP-------- 267 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------- 267 (353)
....... ......++..|+|||++.+..++.++|||||||++|+|++|++||...........+......
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 8764321 122345678899999999989999999999999999999999999766544333322211000
Q ss_pred -------CC--------CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 -------PF--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 -------~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+ ......++..+.+++.+||+.||++|||+.+++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00112456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=293.52 Aligned_cols=246 Identities=24% Similarity=0.415 Sum_probs=204.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|+||.||. ++..+|+|.+... .....+.+..|+.+++.++|+||+++++.+..+...|+|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 588899999999998873 4788999998643 34555678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999999764 45899999999999999999999999 999999999999999999999999988765432221
Q ss_pred CcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 205 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.....++..|+|||.+. +..++.++|+||||+++|+|++|+.||...........+.....+.+. .+..++.+
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 237 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-QPSKWSSS 237 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-CcccCCHH
Confidence 22344678899999874 345678999999999999999999999877655544444333322222 23457889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+++.+||..+|++||++.+++++
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcC
Confidence 9999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=288.52 Aligned_cols=249 Identities=27% Similarity=0.479 Sum_probs=201.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--Cce
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 120 (353)
.+|+..+.||+|+||.+|. .|..|++|.+...... ..+....+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688999999999998873 4788999988654321 223446688999999999999999999988753 567
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
++++||+++++|.+++.+...+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999988777999999999999999999999999 99999999999999999999999999876542
Q ss_pred CCC--CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 201 KED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 201 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||......+.......... ....+..+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--NPQLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC--CCCCchhcCH
Confidence 211 111224467889999999998899999999999999999999999987654443333322211 1122345677
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+++++ .||..+|++||+++++++|
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 888998 6888899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=311.33 Aligned_cols=246 Identities=25% Similarity=0.415 Sum_probs=210.7
Q ss_pred cccceeeecceEEEEEEc-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|.+...||.|.||.||+. +...|.|++. ....+.++.|.-|+.+|..++||+|+++++.|..++.+||+.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 777889999999999842 3334556653 34678889999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+||.++.++..- ..+.+.++.-+..|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+...... ...
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence 9999999988764 35999999999999999999999999 999999999999999999999999987554322 223
Q ss_pred cccCCCCCcccCcccc-----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 206 LTCQDTSCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
...+.|||.|||||+. ...+|+.++||||||+++.||..+.+|........+.-.+.+.. |+....+..++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-PPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-CCcccCcchhhhHH
Confidence 3567899999999986 45689999999999999999999999999888777776665544 44444567899999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
.||+..||.+||..||++.+|++|-
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCc
Confidence 9999999999999999999999873
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=287.77 Aligned_cols=243 Identities=30% Similarity=0.516 Sum_probs=201.1
Q ss_pred eeeecceEEEEEE------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecC
Q 018614 56 VEITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127 (353)
Q Consensus 56 ~~ig~G~~~~v~~------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 127 (353)
+.||+|++|.||. .+ ..||||.+...... +..+.+.+|+.++++++||||+++++.+.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 3689999998873 12 36899999876532 556788999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-
Q 018614 128 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 204 (353)
Q Consensus 128 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~- 204 (353)
++++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999997754 5899999999999999999999999 999999999999999999999999999876432211
Q ss_pred -CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 205 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 205 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+...... ...+..++..+.+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 232 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER--LERPEACPQDIYN 232 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc--CCCCccCCHHHHH
Confidence 1122345678999999998899999999999999999998 99999876655555554432211 1123456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
++.+||+.+|++||++.++++.|.
T Consensus 233 li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 233 VMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=297.79 Aligned_cols=247 Identities=17% Similarity=0.348 Sum_probs=191.7
Q ss_pred cceeeecc--eEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 54 NSVEITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 54 ~~~~ig~G--~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
....||+| +|+.|+ .+|+.||+|.+..... ..+....+.+|+.+++.++||||+++++++..+...++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 35679999 566665 3578999999876533 234456778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 127 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 127 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+++.||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999999753 34899999999999999999999999 999999999999999999999999865443211110
Q ss_pred ------CcccCCCCCcccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC--------
Q 018614 205 ------PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-------- 268 (353)
Q Consensus 205 ------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------- 268 (353)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.................+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0111235567999999876 468899999999999999999999997654333222211111000
Q ss_pred ----------------------------------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 ----------------------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ----------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.......+++++.+|+.+||+.||++|||++++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000112356789999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=286.91 Aligned_cols=247 Identities=27% Similarity=0.462 Sum_probs=205.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
+|+..+.||+|+||.||. ++..|++|.+..... ...+....+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 477788999999998873 578999998765321 2244567789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
+||+++++|.+++.+...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999988777899999999999999999999999 9999999999999999999999999987754332
Q ss_pred CCcccCCCCCcccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...........+... ......+..+++.+.+
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS--KELPPIPDHLSDEAKD 233 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc--ccCCCcCCCcCHHHHH
Confidence 122345678899999987766 899999999999999999999999876543333333221 1222233457788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.+||..+|++||++.+++.+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcC
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=290.15 Aligned_cols=241 Identities=25% Similarity=0.438 Sum_probs=197.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. ++..||+|.+.... ..+....+.+|+.++++++||||+++++.+......++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 477788999999998873 57889999986542 23445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 80 FMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred cCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99999997652 4788899999999999999999999 9999999999999999999999999987654321
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-------hHHHHHhcCCCCCCCchhhhHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-------VPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ....+.....+. .....++.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 227 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV--LPVGQFSE 227 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC--CCCCcCCH
Confidence 223457789999999999899999999999999999999999997543221 111111111111 12234677
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
++.+|+.+||..+|++||++++++++-
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=289.83 Aligned_cols=234 Identities=25% Similarity=0.434 Sum_probs=188.0
Q ss_pred eeecceEEEEEEcC-----------------------------eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc
Q 018614 57 EITKGTFILAFWRG-----------------------------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 107 (353)
Q Consensus 57 ~ig~G~~~~v~~~g-----------------------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 107 (353)
.||+|+||.||... ..|++|.+... ..+....+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 58999999888321 35888988643 23344678889999999999999
Q ss_pred cceeeEEEecCceEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-
Q 018614 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 185 (353)
Q Consensus 108 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~- 185 (353)
+++++++.++...++||||+++++|..++.. .+.+++..+..++.|++.||.|||+++ ++||||||+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999999975 456899999999999999999999998 99999999999998654
Q ss_pred ------CEEEeecccccccccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCch
Q 018614 186 ------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV 257 (353)
Q Consensus 186 ------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~pf~~~~~~~~ 257 (353)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|+++ +|..||......+.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999987654221 11235667999998865 56889999999999999995 69999987655444
Q ss_pred HHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 258 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
......... . +...++.+.++|.+||+.+|++|||+.++++.|+
T Consensus 231 ~~~~~~~~~--~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFYEKKHR--L---PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHhccC--C---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 333222211 1 1223467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=287.11 Aligned_cols=245 Identities=26% Similarity=0.459 Sum_probs=204.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||.|+||.++. ++..+++|.+.... ..+.+.+|+.+++.++|+||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 4688889999999998773 36889999986532 1567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|++++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999999975 345899999999999999999999999 99999999999999999999999999887654322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+........ .....++.++.++
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL-SDPEKWSPEFNDF 232 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCC-CchhhcCHHHHHH
Confidence 12223467789999999998999999999999999999999999987655443333322222222 2234577889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+||+.||++||++.+++++
T Consensus 233 i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcC
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=304.86 Aligned_cols=253 Identities=28% Similarity=0.470 Sum_probs=213.5
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
.....++||+|.||.|.. .+..||||+++.... .....+|.+|+++|.+++||||+.++|+|..++.+++++||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 355678899999998762 348999999987653 44567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 127 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 127 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
++.|+|.+++.... .+......+|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+|||+++.+-.....
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999998763 2455677789999999999999999 999999999999999999999999999965444332
Q ss_pred -CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCCchHHHHHh----cCCCCCCCchhhhH
Q 018614 205 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDNEVPKAYAA----RQRPPFKAPAKLYA 277 (353)
Q Consensus 205 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 277 (353)
......-+.+|||||.+.-++++.++|+|+||+++||+++ ...||....++.+.+.... .........+..++
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 2233445789999999999999999999999999999975 7899999888776655422 22223334466789
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.++.++|..||..+-++||+++++..+|++.
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 9999999999999999999999999999875
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=289.11 Aligned_cols=251 Identities=28% Similarity=0.485 Sum_probs=202.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-------CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
+|...+.||.|+||.||. +|+.||+|.+...... .....+.+.+|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578889999999999873 5789999987542211 1123456788999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999988778999999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCC-CcccCCCCCcccCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCC-Cch
Q 018614 199 TVKEDR-PLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK-APA 273 (353)
Q Consensus 199 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~-~~~ 273 (353)
...... ......++..|+|||.+.+.. ++.++|+||||+++|++++|..||......+....+.... ...+. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 432211 122344677899999987654 7889999999999999999999997554433222222221 22211 122
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..++.++.+++.+||..+|++||+++++++|
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3567899999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=291.58 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=196.9
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCH
Q 018614 58 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132 (353)
Q Consensus 58 ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 132 (353)
||+|+||.||. +|+.||+|.+.............+..|+.++++++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999998873 4789999998764433334445667899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 018614 133 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210 (353)
Q Consensus 133 ~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 210 (353)
.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 99997655 6899999999999999999999999 999999999999999999999999998765432 1222344
Q ss_pred CCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHccc
Q 018614 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 290 (353)
Q Consensus 211 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 290 (353)
++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+...........+..+++.+.++|.+||+.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence 67789999999888899999999999999999999999977655333333322222111122345688899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 018614 291 KPAKRP-----TFRQIITR 304 (353)
Q Consensus 291 dp~~Rp-----s~~~ll~~ 304 (353)
||++|| ++.+++.|
T Consensus 236 ~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 236 DPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ChhHccCCCcccHHHHHhC
Confidence 999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=288.09 Aligned_cols=243 Identities=33% Similarity=0.558 Sum_probs=197.0
Q ss_pred eeecceEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCC
Q 018614 57 EITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 57 ~ig~G~~~~v~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
.||+|+||.||. +|. .+++|.+.... ..+..+.+.+|+.++.++ +||||+++++++...+..++||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 589999998873 232 46888876432 334456788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeec
Q 018614 129 KGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192 (353)
Q Consensus 129 ~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Df 192 (353)
+++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999997532 3678899999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 193 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
|++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+........
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 232 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-- 232 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCC--
Confidence 9986432111 1111223557999999988889999999999999999997 9999987665555554433322222
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
+..++.++.+++.+||..||.+||++.++++.|+++.
T Consensus 233 -~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 233 -PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2345678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=294.96 Aligned_cols=251 Identities=21% Similarity=0.435 Sum_probs=206.2
Q ss_pred cCccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 45 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 45 i~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
+.....+|+..+.||.|+||.||. +|..||+|.+..... ...+.+.+|+.+++.++|+||+++++.+..+..
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence 344456899999999999998873 578999999865432 223567889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
.++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EEEeecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999999998653 5889999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
..... .....+++.|+|||.+.+..++.++|+||||+++|++++|..||...+.......+.....+.. ..+..++..
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (297)
T cd06656 167 PEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPERLSAV 244 (297)
T ss_pred CCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCC-CCccccCHH
Confidence 33221 2234567789999999998899999999999999999999999976554333222222222222 123456788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+|+.+||..+|++||++.+++++
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=294.75 Aligned_cols=248 Identities=23% Similarity=0.409 Sum_probs=196.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||.|+||.||. ++..||+|.+...... .....+.+|+.+++.++||||+++++++......++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 3688899999999999873 4788999998654321 12235678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||++ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 9995 6898888754 45889999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC----------------
Q 018614 204 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---------------- 266 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------- 266 (353)
......+++.|+|||.+.+. .++.++||||||+++|+|++|++||...+..+....+.....
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 11223457789999988654 578899999999999999999999987654333222211100
Q ss_pred -----CCCC-----CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 -----PPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 -----~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+... .....+++.+++||.+||..||.+|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 0112457789999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=284.44 Aligned_cols=245 Identities=26% Similarity=0.461 Sum_probs=204.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.+|. ++..+|+|.+...... .+....+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 588889999999998873 5788999998765443 3445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~Dfg~a~~~~~~~ 202 (353)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||++++++ .++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999997642 4889999999999999999999999 99999999999998654 58999999998764332
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+....... .+..++.++.+
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~ 231 (256)
T cd08220 157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQ 231 (256)
T ss_pred c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHH
Confidence 1 122346778999999998889999999999999999999999998776555544443333222 23447788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.+||..+|++|||+.+++++
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhC
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=286.83 Aligned_cols=240 Identities=25% Similarity=0.410 Sum_probs=199.3
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCH
Q 018614 58 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132 (353)
Q Consensus 58 ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 132 (353)
||.|+||.+|. .+..|++|++...........+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68899987762 3789999998765544445557789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCC
Q 018614 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 212 (353)
Q Consensus 133 ~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~ 212 (353)
.+++.+...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 999988777899999999999999999999999 9999999999999999999999999998765432 11223467
Q ss_pred CcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHccc
Q 018614 213 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 290 (353)
Q Consensus 213 ~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 290 (353)
..|++||.+.+..++.++|+||||+++|+|++|..||..... .+....+..... . ...+...+.++.++|.+||..
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-K-LEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-C-CCCCcccCHHHHHHHHHHccC
Confidence 789999999888899999999999999999999999987663 223333322111 1 112233478899999999999
Q ss_pred CCCCCCC-----HHHHHHH
Q 018614 291 KPAKRPT-----FRQIITR 304 (353)
Q Consensus 291 dp~~Rps-----~~~ll~~ 304 (353)
+|++||+ ++++++|
T Consensus 234 ~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 234 NPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred ChhhCcCCcccCHHHHhcC
Confidence 9999999 8888875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=291.02 Aligned_cols=245 Identities=29% Similarity=0.496 Sum_probs=203.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|+..+.||+|+||.||. .|..||+|.+.... .......+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 367778899999998873 46789999886543 23445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 9999999998865 45899999999999999999999999 99999999999999999999999999876543221 1
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+. ....++.++.+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~ 234 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT---LEGQYSKPFKEFVE 234 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC---CCcccCHHHHHHHH
Confidence 122346778999999999899999999999999999999999998665544443332222222 22346788999999
Q ss_pred HHcccCCCCCCCHHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~l 305 (353)
+||..+|++||++.+++++-
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred HHccCCcccCcCHHHHHHhH
Confidence 99999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=292.33 Aligned_cols=249 Identities=24% Similarity=0.442 Sum_probs=204.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|..||+|++.... ..+....+.+|+++++.++||||+++++.+.....+++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4688889999999999873 47889999876532 2344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||+++++|.+++...+.+++..+..++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 999999999999887789999999999999999999997 56 99999999999999999999999999865432211
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-----------chHHHHHhcCCCCCCCc
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-----------EVPKAYAARQRPPFKAP 272 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~ 272 (353)
....++..|+|||++.+..++.++|+|||||++|++++|..||...... +....+.....+.+ .
T Consensus 160 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 234 (284)
T cd06620 160 ---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL--P 234 (284)
T ss_pred ---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC--C
Confidence 2245788999999998889999999999999999999999999865432 11112211111111 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
...++.++.+|+.+||..||++||++.+++++..-+
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 233678899999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=291.67 Aligned_cols=249 Identities=23% Similarity=0.391 Sum_probs=199.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+....||+|+||.||. +|..||+|++..... .....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 588889999999998874 478999998864321 12223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|++++.|..++.....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 9999888888776667999999999999999999999999 99999999999999999999999999987654322 1
Q ss_pred cccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-------------------
Q 018614 206 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------- 265 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------------- 265 (353)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 223346778999999876 457889999999999999999999998765543332221100
Q ss_pred --CCCCC------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 --RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 --~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+... .....++..+.+|+.+||..+|++||++.+++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 0012456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.43 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=191.2
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 57 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 57 ~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
.||+|+||.||. .+..+|+|.++.... ......+.+|+.++++++||||+++++.+.+....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 589999999873 235689998865432 23335688899999999999999999999998899999999999
Q ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 130 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 130 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
++|.+++.... ..++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999997532 2566778899999999999999999 999999999999999999999999998754322111
Q ss_pred -CcccCCCCCcccCccccCCC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCC--Cch
Q 018614 205 -PLTCQDTSCRYVAPEVFKNE-------EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK--APA 273 (353)
Q Consensus 205 -~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~ 273 (353)
......++..|+|||++.+. .++.++||||||+++|+|++ |..||......+.............. ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence 11223456789999988642 35789999999999999996 99999877655544333332222111 112
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
...++.+.+++..|| .+|++|||+++|+..|+
T Consensus 237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 345678999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=284.64 Aligned_cols=248 Identities=26% Similarity=0.446 Sum_probs=200.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 121 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 121 (353)
+|+..+.||+|+||.||. +|..||||.+.... .........+.+|+.+++++.||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 578889999999999873 47899999875432 12234456788999999999999999999988763 4678
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
++|||+++++|.+++.+...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999999988777899999999999999999999999 999999999999999999999999998765422
Q ss_pred CC--CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 202 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 202 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|+.||............... +.....+..++..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVLPPHVSDH 237 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC--CCCCCCchhhCHH
Confidence 11 1112234677899999998888999999999999999999999999765443333322221 1122234456788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+++.+|+. +|++||++++++++
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 9999999995 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=301.40 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=194.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------C
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 118 (353)
.+|+..+.||+|+||.||. ++..||||.+..... .......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 3699999999999999873 467899999875432 223345677899999999999999999987543 3
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999998 7899988864 45999999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC----------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP---------- 267 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------- 267 (353)
... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus 169 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred CCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 432 223457889999999877 56889999999999999999999999765543322222111000
Q ss_pred ------------CCCC-----chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ------------PFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ------------~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.... .....++.+.+|+.+||..||++|||+.++++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 011234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=285.16 Aligned_cols=246 Identities=24% Similarity=0.443 Sum_probs=204.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe--cCceEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 123 (353)
+|+..+.||.|+||.||. +|..||+|.+..... .....+.+..|+.+++.++|+||+++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 477889999999998873 568899999876543 34445678899999999999999999998754 4557999
Q ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 124 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLH-----ENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh-----~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
|||+++++|.+++.. ...+++..++.++.|++.||.||| +.+ ++|+||+|+||++++++.++|+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999999975 346899999999999999999999 777 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchh
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
+......... .....++..|+|||.+.+..++.++|+||||+++++|++|+.||...+.......+.....+ ..+.
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 232 (265)
T cd08217 157 AKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---RIPY 232 (265)
T ss_pred cccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC---CCcc
Confidence 9876543321 22245678899999999988999999999999999999999999887655544444333322 2344
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.++..+.+++.+||..+|++||++++++++
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 677889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=289.25 Aligned_cols=247 Identities=26% Similarity=0.433 Sum_probs=197.2
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec----
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS---- 117 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~---- 117 (353)
.+..|+..+.||+|+||.||. .++.||+|.+.... .....+.+|+.+++++ +|+||+++++.+...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 345688889999999999873 46789999986542 1224677899999998 699999999998753
Q ss_pred --CceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 118 --SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 118 --~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
...|++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 3579999999999999999863 34899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 268 (353)
++........ ......++..|+|||++. +..++.++||||+||++|+|++|..||...................
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 235 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence 9876543221 222345778899999986 3457889999999999999999999997654433332222221111
Q ss_pred CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.....++.++.+|+.+||..||++||++.++++|
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 236 --LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1233567889999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=288.03 Aligned_cols=243 Identities=29% Similarity=0.517 Sum_probs=197.1
Q ss_pred eeecceEEEEEEc-----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 57 EITKGTFILAFWR-----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 57 ~ig~G~~~~v~~~-----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.||+|+||.||.. +..+|+|.+.... .......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999998731 1578999876432 22345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-----CEEEeecc
Q 018614 126 YLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFG 193 (353)
Q Consensus 126 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-----~vkl~Dfg 193 (353)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999742 23788999999999999999999998 99999999999999887 89999999
Q ss_pred cccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 194 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 194 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--- 233 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ--- 233 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC---
Confidence 98765432211 1112234568999999999999999999999999999998 999998765545444443322222
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
.+..++..+.+++.+||..+|++||++.++++.|++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 234 KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 234567889999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=284.86 Aligned_cols=248 Identities=28% Similarity=0.459 Sum_probs=206.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|+++.++. +|..|++|.+..... ......+.+|+..+..++|+|++++++++......++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 577889999999998763 488999999876532 2445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+++++|.+++.....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999887789999999999999999999999 98 999999999999999999999999998876533222
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhh-hHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-YARGLKEL 283 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 283 (353)
. ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......................... ++..+.++
T Consensus 157 ~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 C-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred c-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 1 234467789999999998899999999999999999999999987753222222222222222222333 78899999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+||..+|++||++.+++++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=334.22 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=211.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+.+.+||.|.||.||. +|+..|+|.++..... ......+.+|..++..++|||+|+++|+=.+.+..+|.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 45799999999999999983 6888999987654332 44556678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||||++|+|.+++.-.+-.++.....+..|++.|+.|||.+| ||||||||.||+++.+|.+|++|||.|..+.....
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999999987665667777778899999999999999 99999999999999999999999999988765431
Q ss_pred C---CcccCCCCCcccCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHhcCCCCCCCchhhh
Q 018614 204 R---PLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 204 ~---~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 276 (353)
. ......||+.|||||++.+. ....++|||||||++.||+||+.||...+.+ .+...+..+..|.+ +..+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~---P~~l 1466 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI---PERL 1466 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC---chhh
Confidence 1 12456799999999999764 4667999999999999999999999988764 34455555556665 3448
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+-++||.+||..||+.|+++.||+++
T Consensus 1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 9999999999999999999999998876
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.10 Aligned_cols=244 Identities=26% Similarity=0.446 Sum_probs=191.6
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 57 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 57 ~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+||+|+||.||. ....+++|.+.... .......+.+|+.+++.++|+||+++++.+.+....++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 589999999873 23468888775432 334446688899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC-
Q 018614 130 GDLRAFLKRKGA-----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 203 (353)
Q Consensus 130 ~~L~~~l~~~~~-----~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~- 203 (353)
++|.+++..... .++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999976432 457788899999999999999999 99999999999999999999999999865432211
Q ss_pred CCcccCCCCCcccCccccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCC--CCch
Q 018614 204 RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPA 273 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~ 273 (353)
.......++..|+|||++.. ..++.++||||||+++|+|++ |..||......+............. ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 11122334667999998643 356789999999999999998 8899987665554444433332222 1223
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
..++..+.+++..|| .||++||+++++++.|.
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 457788899999999 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=322.58 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=197.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 122 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~i 122 (353)
.+|++.+.||+|+||.||. .+..||+|.+..... .......+..|+.++++++||||++++++|.+. ..+||
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 4799999999999999983 467899999876543 334456788999999999999999999988653 56899
Q ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCEEecCCCCCCEEEcC-----------
Q 018614 123 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP----VPIIHRDLEPSNILRDD----------- 183 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~----~~iiH~dlkp~Nill~~----------- 183 (353)
||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.+. .+|||+||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999999999999975 2469999999999999999999998431 23999999999999964
Q ss_pred ------CCCEEEeecccccccccCCCCCcccCCCCCcccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 018614 184 ------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 255 (353)
Q Consensus 184 ------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 255 (353)
.+.+||+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 3358999999998764322 1223457899999999854 45789999999999999999999999765433
Q ss_pred chHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 256 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
......... .+.+ +...++.++.+||..||..+|.+||++.+++.+
T Consensus 250 ~qli~~lk~-~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 250 SQLISELKR-GPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHHhc-CCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 222222111 1211 123467889999999999999999999999964
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=294.07 Aligned_cols=241 Identities=23% Similarity=0.384 Sum_probs=182.5
Q ss_pred ceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe--cCceEEEEe
Q 018614 55 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 125 (353)
Q Consensus 55 ~~~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e 125 (353)
+++||+|+||.||. .+..||+|.+..... ...+.+|+.++++++||||+++++++.. +...|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 46899999999983 346899999865432 1346789999999999999999998854 456899999
Q ss_pred cCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE----cCCCCEEEeec
Q 018614 126 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 192 (353)
Q Consensus 126 ~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill----~~~~~vkl~Df 192 (353)
|+ +++|.+++... ..+++..+..++.||+.||.|||+.| ++||||||+|||+ +.++.+||+||
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 99 56898887532 13888999999999999999999999 9999999999999 45678999999
Q ss_pred ccccccccCCC--CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc---------hHHH
Q 018614 193 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---------VPKA 260 (353)
Q Consensus 193 g~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~---------~~~~ 260 (353)
|++........ .......+|+.|+|||++.+. .++.++||||+||++|+|++|++||....... ....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 99987643221 122335678899999998774 57899999999999999999999996543211 0011
Q ss_pred HHhc-CCCC------------------------CC---------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 261 YAAR-QRPP------------------------FK---------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 261 ~~~~-~~~~------------------------~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+... ..+. .. ......+.++.+||.+||+.||++|||++++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1000 0000 00 0000123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=284.36 Aligned_cols=234 Identities=24% Similarity=0.405 Sum_probs=187.9
Q ss_pred eeeecceEEEEEEc-----------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 56 VEITKGTFILAFWR-----------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 56 ~~ig~G~~~~v~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
+.||+|+||.||.. ...|++|.+... ..+....+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 35899999988732 225888987653 2344457888999999999999999999999988
Q ss_pred ceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC-------EEEe
Q 018614 119 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-------LKVA 190 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~-------vkl~ 190 (353)
..++||||+++++|..++... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++. ++++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999999988753 45899999999999999999999999 999999999999987664 8999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCccccC-CCCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCchHHHHHhcCCCC
Q 018614 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPP 268 (353)
Q Consensus 191 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~ 268 (353)
|||++...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+..... ......
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~~~ 228 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQCML 228 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcCccC
Confidence 99988654321 1234567899999886 467889999999999999998 589998765544433222 222111
Q ss_pred CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 269 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
....+.++.+||.+||+.||++||++.+|+.++
T Consensus 229 ----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 229 ----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 122356799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=288.24 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=200.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|+||.+|. +|..||+|++...... ......+.+|+.++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 478889999999998874 5789999998765432 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+ +++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99 99999998653 45899999999999999999999999 999999999999999999999999999876544322
Q ss_pred CcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC---------------
Q 018614 205 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP--------------- 268 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------------- 268 (353)
......++..|+|||.+.+. .++.++||||||+++++|++|.+||......+....+......+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 23334578889999998654 46889999999999999999988887655433322222111000
Q ss_pred -----------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -----------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
........+.++.++|.+||..+|++||++++++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000012346889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=292.68 Aligned_cols=245 Identities=23% Similarity=0.423 Sum_probs=201.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|.....||+|+||.|+. ++..||||.+... .......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 355567899999998873 4788999987543 23445668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++.. +.+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~- 174 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK- 174 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-
Confidence 9999999998854 45899999999999999999999999 999999999999999999999999998765432221
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...........+....... ......++..+.+++.
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 253 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-VKDSHKVSSVLRGFLD 253 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-cccccccCHHHHHHHH
Confidence 123456788999999988889999999999999999999999998765544433332222222 1223346778999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~ 304 (353)
+||..||++|||+++++++
T Consensus 254 ~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 254 LMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHccCChhHCcCHHHHhhC
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=287.30 Aligned_cols=244 Identities=29% Similarity=0.526 Sum_probs=201.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|+||.|+. +++.+++|.+..... .+....+.+|++++++++||||+++++.+......++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 577788999999998873 478899999876532 3455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
++++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99989999999875 678999999999999999999999 88 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CchHHHH---HhcCCCCCCCchhhhHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAY---AARQRPPFKAPAKLYAR 278 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~ 278 (353)
.. ..++..|+|||.+.+..++.++||||||+++++|++|..||..... ....... .....+.. ....++.
T Consensus 157 ~~---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (265)
T cd06605 157 KT---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL--PSGKFSP 231 (265)
T ss_pred hc---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC--ChhhcCH
Confidence 11 4567789999999998999999999999999999999999976531 1222222 11212121 1223788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.++|.+||..||++|||+.+++.+
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 89999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=289.78 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=195.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|++|.||. +|..||+|.+..... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 477889999999998874 578899999865432 22233567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 996 6898888642 35899999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC----------------
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---------------- 265 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---------------- 265 (353)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||................
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112223457789999988654 56889999999999999999999997654322111110000
Q ss_pred ---------CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 ---------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 ---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..........+++++.++|.+||..||++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000001122367889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=286.69 Aligned_cols=254 Identities=25% Similarity=0.465 Sum_probs=201.9
Q ss_pred cCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe--cC
Q 018614 50 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SS 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 118 (353)
..|+..+.||+|+||.||. .+..+|||.+..... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 3577789999999998873 257899999876532 2345678999999999999999999999877 55
Q ss_pred ceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
..+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 7899999999999999997654 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCC--cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch-----------HHHHHh-
Q 018614 198 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-----------PKAYAA- 263 (353)
Q Consensus 198 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-----------~~~~~~- 263 (353)
........ ......+..|+|||.+.+..++.++||||||+++++|++|..|+........ ...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65322211 1122344569999999888999999999999999999999999865432210 111110
Q ss_pred cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.........+..++.++.+|+.+||..+|++||++.++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 001111112345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=283.10 Aligned_cols=248 Identities=28% Similarity=0.480 Sum_probs=196.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..++.....||+|+||.||. ++..|++|.+.... ....+.+.+|+.++++++|+||+++++++..+...+++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 33455557899999999873 45689999876542 34456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-CCCEEEeecccccccc
Q 018614 124 TEYLPKGDLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT 199 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~-~~~--~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-~~~vkl~Dfg~a~~~~ 199 (353)
+||+++++|.+++... ..+ ++..+..++.|++.||.|||+.+ ++|+||||+||+++. .+.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999764 345 78889999999999999999999 999999999999986 6789999999987654
Q ss_pred cCCCCCcccCCCCCcccCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
.... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||............ ..........+..++
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLS 238 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccC
Confidence 3221 122345678999999986643 788999999999999999999999765432221111 111111111234577
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++.+|+.+||..+|++||++.+++.|
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 889999999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=290.15 Aligned_cols=254 Identities=23% Similarity=0.483 Sum_probs=205.1
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
.+|+..+.||+|+||.||. .|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 4677888999999999884 233 57889886542 233345688999999999999999999998654 56
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++++||+++|+|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 79999999999999997644 5889999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 200 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 200 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+......+. +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ---PPICT 237 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCC
Confidence 33221 1122334568999999998899999999999999999997 9999987655444444433333322 23456
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
..+.+++..||..+|++||+++++++.|+.+....
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 78999999999999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.10 Aligned_cols=246 Identities=28% Similarity=0.514 Sum_probs=211.3
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
+....++||+|.||.|.. +...||||.++..... .....|.+|+.+|.+|+|+|++++||++.+ ....+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 456678899999999872 2357999999876532 266789999999999999999999999987 78899
Q ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 123 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
|||+++.|+|.+.|.. +..|.....-.++.||+.||.||.+++ +|||||.+.|+|+.....|||+|||+.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999986 334888888999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 201 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 201 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
.... .......+..|+|||.+....++.++|||++||++|||++ |..||.+.....+.+.+..+.+.+ .++.|+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp---RPk~cs 341 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP---RPKYCS 341 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC---CCCCCh
Confidence 4332 1122345678999999999999999999999999999998 999999999888888887554433 256789
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+.+.++++.||+.+|++||+|..|.+.+
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhH
Confidence 9999999999999999999999998544
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=287.52 Aligned_cols=245 Identities=24% Similarity=0.443 Sum_probs=202.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|...+.||.|++|.++. ++..+++|.+... .....+.+.+|+.+++.++|+||+++++++......++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 466678999999998873 4678999987543 23334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++.. ..++...+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 9999999999987 56899999999999999999999999 999999999999999999999999988755432211
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.... ++.......++..+.+|+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCCcccccCCHHHHHHHH
Confidence 122446788999999988889999999999999999999999998765544444443332 2222222336788999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~ 304 (353)
+||..+|++||++.+++++
T Consensus 251 ~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 251 RMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHcccChhhCcCHHHHccC
Confidence 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=299.10 Aligned_cols=282 Identities=23% Similarity=0.364 Sum_probs=232.8
Q ss_pred cchhhhHHHHHHhhcCCcccCCCCCCCcccCccCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHH
Q 018614 16 VCTVSSYCELIFQMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVR 90 (353)
Q Consensus 16 ~~~~~~~c~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~ 90 (353)
.+..+..|..+........+.+...+ +........|.....||+|.|+.|. .+|..||||.+.+... +....+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~s~~-~~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~ 100 (596)
T KOG0586|consen 23 PSIGDTHEKAIIDENGSEDKSPASLE-TDDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQ 100 (596)
T ss_pred CcccchhhhhhhccCcccccCccccc-ccccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHH
Confidence 44555666666544444444444443 3334556689999999999999886 3689999999987654 445556
Q ss_pred HHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEE
Q 018614 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 170 (353)
Q Consensus 91 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~ii 170 (353)
.+.+|+++++.++||||++++.+......+|+||||+.+|.+.+++.+.+...+..+..++.|++.|++|||+++ ++
T Consensus 101 k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---iv 177 (596)
T KOG0586|consen 101 KLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IV 177 (596)
T ss_pred HHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---ee
Confidence 689999999999999999999999999999999999999999999999999888999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCC
Q 018614 171 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPF 249 (353)
Q Consensus 171 H~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf 249 (353)
|||||++|+|++.+.++||+|||++.++... .......|++.|+|||++.+..+ ++.+|+||+|+++|.|+.|.+||
T Consensus 178 HrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF 255 (596)
T KOG0586|consen 178 HRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF 255 (596)
T ss_pred ccccchhhcccccccceeeeccccceeeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence 9999999999999999999999999988733 33344668899999999999877 57999999999999999999999
Q ss_pred CCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.+..-.+.......++..- +-.++.++.++|+++|..+|.+|++.+++.++-+..
T Consensus 256 DG~~lk~Lr~rvl~gk~rI----p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 256 DGQNLKELRPRVLRGKYRI----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred CCcccccccchheeeeecc----cceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 9887766665554444221 223566788999999999999999999999886554
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=287.81 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=197.3
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEE-----e
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT-----Q 116 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-----~ 116 (353)
...+|+..+.||+|+||.||. .|..+|+|.+.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 445799999999999998873 57889999875432 1224577899999999 6999999999874 3
Q ss_pred cCceEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeec
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Df 192 (353)
+...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccC
Confidence 4568999999999999998753 245888999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC
Q 018614 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 267 (353)
Q Consensus 193 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 267 (353)
|++........ ......+++.|+|||++.. ..++.++|||||||++|+|++|+.||.................+
T Consensus 169 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 169 GVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred CceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 99877643221 1223457889999998753 45788999999999999999999999766543332222222111
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
. ...+..++..+.+|+.+||+.||++||++.+++++.
T Consensus 248 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 248 T-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred c-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1 112344677899999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.70 Aligned_cols=248 Identities=27% Similarity=0.428 Sum_probs=199.8
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecC---
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS--- 118 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~--- 118 (353)
...+|+..+.||+|++|.+|. +++.+++|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 346799999999999998873 46789999986542 2335688999999999 6999999999997654
Q ss_pred ---ceEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 119 ---PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 119 ---~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECC
Confidence 48999999999999999875 346899999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCcccCCCCCcccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC
Q 018614 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 192 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 266 (353)
||++........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...........+.....
T Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 235 (275)
T cd06608 157 FGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP 235 (275)
T ss_pred Cccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence 999876543221 1223446788999998753 3467889999999999999999999976554444444333322
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.. .....++.++.+|+.+||..||++|||+.+++++
T Consensus 236 ~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 236 PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 222 2233477899999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=292.07 Aligned_cols=244 Identities=23% Similarity=0.412 Sum_probs=200.4
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|.....||+|+||.|+. ++..||+|.+.... ......+.+|+.+++.++||||+++++.+..+...++++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 44556899999998862 57899999986532 22335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 206 (353)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 999999998765 45899999999999999999999999 99999999999999999999999999875543221 12
Q ss_pred ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 286 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 286 (353)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||......+....+..... ........++..+.++|.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-CCccccCCCCHHHHHHHHH
Confidence 234577899999999988899999999999999999999999986654444433322221 1122234567889999999
Q ss_pred HcccCCCCCCCHHHHHHH
Q 018614 287 CWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 287 cl~~dp~~Rps~~~ll~~ 304 (353)
||+.+|++||++++++++
T Consensus 254 ~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 254 MLTREPQERATAQELLDH 271 (297)
T ss_pred HhcCCcccCcCHHHHhhC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=283.73 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=200.7
Q ss_pred cccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC-----
Q 018614 52 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 118 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----- 118 (353)
|...+.||+|+||.||. .+..||||.+..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 55678899999998873 367899999876533 3445567889999999999999999999886432
Q ss_pred -ceEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 119 -PMMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 119 -~~~iv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
..++++||+.+++|.+++... ..++...++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence 247889999999999887532 13788899999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCC
Q 018614 192 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 269 (353)
Q Consensus 192 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 269 (353)
||++......... ......++..|++||.+.+..++.++||||||+++|+|++ |+.||...+..+....+........
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 9998865432211 1112234567999999998889999999999999999999 8999987665555554443332221
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
...++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 237 ---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 237 ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=284.07 Aligned_cols=241 Identities=26% Similarity=0.378 Sum_probs=193.7
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.||.|+||.||. .|+.||+|.+.............+..|..+ ....+|+|++++++.+..+...|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999998873 578999999865433222333344455444 4455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 209 (353)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 999999988778999999999999999999999999 99999999999999999999999999876432 1123
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
.++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..............+++++.+++.+||+
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence 46778999999988888999999999999999999999998776655554443333221112233578899999999999
Q ss_pred cCCCCCCCH---HHHHHH
Q 018614 290 EKPAKRPTF---RQIITR 304 (353)
Q Consensus 290 ~dp~~Rps~---~~ll~~ 304 (353)
.+|++||++ +++++|
T Consensus 234 ~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 234 MDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CCHHHccCCCcHHHHHcC
Confidence 999999966 455554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=288.56 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=200.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.+|. +++.||+|.+..... ..+....+.+|++++++++|+||+++++++..+...+++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 588899999999998874 477899998865432 23344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|++++.+..+......+++..++.++.|++.||.|||..+ ++|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9988777766666666999999999999999999999999 9999999999999999999999999998765543323
Q ss_pred cccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-------------------
Q 018614 206 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------- 265 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------------- 265 (353)
.....++..|+|||.+.+. .++.++||||||+++|+|++|++||......+....+....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3334567789999999888 88899999999999999999999997654322221111100
Q ss_pred --CCCCCC-------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 --RPPFKA-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 --~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+.... .+..++.++.+||++||..+|++||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 112247889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=275.27 Aligned_cols=245 Identities=26% Similarity=0.477 Sum_probs=200.7
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEe
Q 018614 52 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.+....||.|+-|.|. ..|...|||.+.... ..+....+...+.+.... +.|+||+.+|+|..+..++|.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3345568999888775 367899999998753 456667777788877666 48999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
.| ...++.++.. .+++++..+-++...+++||.||..+. +|+|||+||+|||+|+.|++||||||.+-.+-.. .
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--k 246 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--K 246 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--c
Confidence 99 5577777765 456999999999999999999999865 4999999999999999999999999998776533 3
Q ss_pred CcccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHhcCCCCCCCchhhhHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
..+...|.+.|||||.+. ...|+.++||||||++++||.||+.||.+.+.+ ++...+.. ..++..+....+++.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCHHH
Confidence 334455778899999985 447899999999999999999999999985543 44445544 4444444445599999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+|+..||.+|+.+||.+.+|++|
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcC
Confidence 999999999999999999999987
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=289.15 Aligned_cols=249 Identities=28% Similarity=0.446 Sum_probs=198.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
+|+..+.||+|+||.||. +|+.||||.+...... .......+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999998873 4789999999765433 122335567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||+ +++|.+++.... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999998765 6999999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC-------------
Q 018614 203 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP------------- 268 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------- 268 (353)
.. .....++..|+|||.+.+ ..++.++||||||+++|+|++|.+||......+....+......+
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 RK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred cc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 21 122345678999998855 457889999999999999999988887655433332221110000
Q ss_pred -----------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -----------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
........+..+.++|.+||..||++||++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000112346789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.93 Aligned_cols=243 Identities=21% Similarity=0.277 Sum_probs=191.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
...|...+.||+|+||.||. .++.||||.... ..+.+|+.++++++|+||+++++++..++..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 44799999999999999984 467899996422 2356899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||++ .++|.+++... ..+++..++.++.|++.||.|||+.| |+||||||+|||++.++.++|+|||+++......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999 57898888654 45999999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--------CchHHHHHhcCC--CCCC-
Q 018614 203 DRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--------NEVPKAYAARQR--PPFK- 270 (353)
Q Consensus 203 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~--------~~~~~~~~~~~~--~~~~- 270 (353)
... .....||..|+|||++.+..++.++|||||||++|||++|..|+-.... ..+...+..... ..+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 211 1234588999999999999999999999999999999997655422111 111122211110 0000
Q ss_pred ---------------------------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 271 ---------------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 271 ---------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.....++.++.+||.+||+.||.+|||+.|+|+|
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0001234578999999999999999999999987
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=284.34 Aligned_cols=243 Identities=30% Similarity=0.531 Sum_probs=203.2
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|+..+.||.|+||.||. ++..||+|...... .......+.+|+.++++++||||+++++.+..+...++||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 67788999999999873 46789999876442 233446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 206 (353)
+++++|.+++.. ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++......... .
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 158 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-R 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh-h
Confidence 999999999865 35899999999999999999999999 999999999999999999999999998765432211 1
Q ss_pred ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 286 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 286 (353)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+. ....++.++.+++.+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~ 235 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKEFVEA 235 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcccCHHHHHHHHH
Confidence 22346778999999988889999999999999999999999998765544444443332222 234567889999999
Q ss_pred HcccCCCCCCCHHHHHHH
Q 018614 287 CWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 287 cl~~dp~~Rps~~~ll~~ 304 (353)
||..+|++||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=286.67 Aligned_cols=242 Identities=22% Similarity=0.350 Sum_probs=190.5
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh---cCCCCcccceeeEEEecCceEEEEecCC
Q 018614 57 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ---KIRHPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 57 ~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
.||+|+||.||. +|..+|+|.+.............+.+|..+++ ...|++|+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999883 47899999987654333322233344544443 3479999999999998899999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 018614 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208 (353)
Q Consensus 129 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 208 (353)
+++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....... ...
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 154 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccC
Confidence 9999999988878999999999999999999999999 9999999999999999999999999987554321 122
Q ss_pred CCCCCcccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHH
Q 018614 209 QDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 287 (353)
Q Consensus 209 ~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 287 (353)
..++..|+|||.+. +..++.++||||+||++|+|++|..||.......... +...........+..++.++.++|.+|
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhhcCCcCCccccCHHHHHHHHHH
Confidence 35788999999986 4568899999999999999999999997654333222 111111111112345788999999999
Q ss_pred cccCCCCCC-----CHHHHHHHH
Q 018614 288 WNEKPAKRP-----TFRQIITRL 305 (353)
Q Consensus 288 l~~dp~~Rp-----s~~~ll~~l 305 (353)
|..||++|| +++++++|-
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCc
Confidence 999999999 699998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=290.25 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=198.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. .|..||+|.+...... ......+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 578889999999998873 4788999998654322 2334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|++++.|.++......+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 9999899888776666999999999999999999999999 9999999999999999999999999987754332 22
Q ss_pred cccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-------------------
Q 018614 206 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------- 265 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------------- 265 (353)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|++||......+....+....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 223446778999999865 356789999999999999999999997554322211111100
Q ss_pred --CCCCC------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 --RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 --~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+... .....++..+.+|+.+||..+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 0012456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=288.46 Aligned_cols=246 Identities=26% Similarity=0.458 Sum_probs=202.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..|...+.||+|+||.||. +|..||+|.+........+....+.+|+.+++.++||||+++.+++.+....++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588899999999998873 57899999986554444555667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||++ ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9995 678777764 446899999999999999999999999 999999999999999999999999998765322
Q ss_pred CCcccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
....++..|+|||.+. ...++.++||||||+++|+|++|..||...........+.....+.. ....++.++
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 243 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--SSNDWSDYF 243 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--CchhhCHHH
Confidence 1234677899999874 45678899999999999999999999976654443333322222222 234577889
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.+++.+||..+|++||++.+++.+..
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChh
Confidence 99999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=285.79 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=199.1
Q ss_pred CccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec--
Q 018614 46 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-- 117 (353)
Q Consensus 46 ~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-- 117 (353)
.....+|+..+.||+|+||.||. +|..+|+|.+.... .....+.+|+.+++.+ +|||++++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 34456899999999999998873 57889999986432 1224567889999998 799999999998653
Q ss_pred ---CceEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEe
Q 018614 118 ---SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190 (353)
Q Consensus 118 ---~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~ 190 (353)
...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 358999999999999998863 345899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC
Q 018614 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 265 (353)
Q Consensus 191 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 265 (353)
|||++.......... ....++..|+|||.+... .++.++||||||+++|+|++|+.||......+....+....
T Consensus 171 dfg~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 171 DFGVSAQLTSTRLRR-NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred ecccchhcccccccc-cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 999987654322211 223467789999987543 36789999999999999999999998765444333333322
Q ss_pred CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+... .+..++.++.++|.+||+.+|++||++.++++|
T Consensus 250 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 250 PPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 22222 223466789999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.17 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=199.7
Q ss_pred ccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceE
Q 018614 47 PHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 121 (353)
.....|++.++||+||-..||+ +.+.+|+|.+.... .+.+.+..|.+|+.+|..|+ |.+|++++++-..++.+|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3455799999999999988874 34678888776543 35677889999999999995 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
+|||+- ..+|..+|+.... .+...+..+..||+.|+.++|.+| |||.||||.|+|+-+ |.+||+|||.|..+..
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 999987 6799999987665 444588889999999999999999 999999999999877 7999999999998876
Q ss_pred CCCCC-cccCCCCCcccCccccCCC-----------CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC-
Q 018614 201 KEDRP-LTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP- 267 (353)
Q Consensus 201 ~~~~~-~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 267 (353)
+.... .....||+.||+||.+... +.++++||||||||+|+|+.|+.||..... ...++.....+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAITDPN 589 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhhcCCC
Confidence 54432 3567899999999998543 356799999999999999999999975431 11222222222
Q ss_pred ---CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ---PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++..+.. .++.++++.||+.||++||+..+||+|
T Consensus 590 ~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 590 HEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22222222 338999999999999999999999976
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=290.14 Aligned_cols=248 Identities=22% Similarity=0.416 Sum_probs=193.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|..||+|.+..... .......+.+|+.++++++|+||+++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 478889999999998873 588999999865432 22223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|++ ++|.+++.. .+.+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 995 588888765 456899999999999999999999999 99999999999999999999999999876543221
Q ss_pred CcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC-CchHHHHHhcC-----------------
Q 018614 205 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQ----------------- 265 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~----------------- 265 (353)
......++..|+|||.+.+. .++.++||||||+++|+|++|..|+..... .+....+....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12233467789999998765 468899999999999999998887543222 22111111100
Q ss_pred --CCCCC------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 --RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 --~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+... .....+++++.+||.+||+.||.+|||++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 0112357889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=278.33 Aligned_cols=245 Identities=29% Similarity=0.517 Sum_probs=205.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|++|.+|. +|..+++|++..... +....+.+|+.+++.++|+|++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 477788999999998873 478899999876532 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+++++|.+++... ..+++..++.++.|++.||.+||..+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999999999875 56899999999999999999999998 99999999999999999999999999887654332
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....++..|+|||.+.+..++.++|+||||+++++|++|..||...+.............+.. .....++..+.+++
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i 231 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL-RNPEKWSDEFKDFL 231 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc-CcccccCHHHHHHH
Confidence 2234567789999999888899999999999999999999999987654444433333222222 12233478899999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+||..||++|||+.+++++
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHccCChhhCCCHHHHhcC
Confidence 99999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=285.38 Aligned_cols=245 Identities=26% Similarity=0.500 Sum_probs=200.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~i 122 (353)
.|+..+.||.|+||.+|. +|..||+|.+.... .......+.+|+.+++.++ |||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 477788999999998873 57899999986542 2334456788999999986 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999998654 6899999999999999999999999 9999999999999999999999999988765433
Q ss_pred CCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.. .....++..|+|||.+.++ .++.++|+||||+++|+|++|..||...........+.....+.+ ....++.++.
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRL--EDNGYSKLLR 232 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCC--CcccCCHHHH
Confidence 22 2234577889999988654 568899999999999999999999986654433322222211221 1223678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++.+||..||++||++.+++.+
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhC
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=286.71 Aligned_cols=248 Identities=26% Similarity=0.432 Sum_probs=197.7
Q ss_pred ccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEe----
Q 018614 47 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ---- 116 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---- 116 (353)
.....|+..+.||.|+||.||. .++.+|+|.+... ......+..|+.+++++ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 3445788899999999998873 5788999987543 23335678899999998 69999999999853
Q ss_pred --cCceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeec
Q 018614 117 --SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192 (353)
Q Consensus 117 --~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Df 192 (353)
....|++|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeC
Confidence 45689999999999999999753 34788889999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC
Q 018614 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 267 (353)
Q Consensus 193 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 267 (353)
|++........ ......++..|+|||.+. +..++.++||||||+++|+|++|..||...........+.. ..
T Consensus 166 g~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--~~ 242 (282)
T cd06636 166 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--NP 242 (282)
T ss_pred cchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh--CC
Confidence 99876543221 122345778899999876 34678899999999999999999999976543332222211 11
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
........++.++.+||.+||..||.+||++.+|+++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 2222334578899999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=296.22 Aligned_cols=241 Identities=23% Similarity=0.324 Sum_probs=188.0
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. .+..||+|+.... ....|+.++++++|+||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34799999999999999883 4568999985433 234689999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||++ .++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 136 ~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9999 5688888865 345899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCc----------hHHHHHhcCC--CCC
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNE----------VPKAYAARQR--PPF 269 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~----------~~~~~~~~~~--~~~ 269 (353)
......|++.|+|||++.+..++.++|||||||++|+|+++ ..+|....... ....+..... ..+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 12234578899999999999999999999999999999984 44444322210 0011100000 000
Q ss_pred C-----------------------C----chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 270 K-----------------------A----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 270 ~-----------------------~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
. . ....++.++.+||.+||+.||++|||+.++++|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 0 001345567789999999999999999999987
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=286.41 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=199.7
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 120 (353)
+|+..+.||+|+||.||. +|..||+|++...... .......+.+|+.+++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999998872 5788999998653221 122335678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999999988778999999999999999999999999 99999999999999999999999999987644
Q ss_pred CCCCCcccCCCCCcccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
..........++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+...........+..++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 332222234577889999998753 467899999999999999999999975433222222222111111112344778
Q ss_pred HHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
.+.+++.+||..||++|| ++++++++
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 899999999999999997 77888766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=281.14 Aligned_cols=248 Identities=28% Similarity=0.483 Sum_probs=201.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 121 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 121 (353)
+|...+.||+|+||.+|. +|..||+|.+.... ....+....+.+|+.++++++|+||+++++.+.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 688899999999998873 57899999875321 11234556788999999999999999999998764 4588
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
+++||+++++|.+++...+.+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999999988777899999999999999999999999 999999999999999999999999999865432
Q ss_pred CC--CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 202 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 202 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.. .+.....+..++++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~ 237 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPMLPDGVSDA 237 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCCCcccCHH
Confidence 11 111234577889999999988899999999999999999999999986644443333222 11222234567888
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+++.+||. +|..||++.+++.|
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhcC
Confidence 9999999999 57999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=287.83 Aligned_cols=247 Identities=22% Similarity=0.451 Sum_probs=203.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|...+.||.|+||.||. ++..|++|.+.... ....+.+.+|+.+++.++||||+++++.+......|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 35789999999999998873 46789999985432 23345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
+||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999999998754 4789999999999999999999999 99999999999999999999999998876543322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
. .....+++.|+|||.+.+..++.++|+||||+++|++++|+.||...........+.....+... ....++..++++
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 248 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIFRDF 248 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCC-CccccCHHHHHH
Confidence 1 22345777899999998888999999999999999999999999766543332222222222222 234467789999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+||..+|++||++.+++.|
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=280.99 Aligned_cols=244 Identities=28% Similarity=0.487 Sum_probs=206.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|+|+.++. +|..+++|.+...... ......+.+|+.++++++|+||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 477889999999988763 5788999998764432 3445677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 126 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 126 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||++++++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999999876 345899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
......++..|+|||.+.+..++.++|+||||+++++|++|+.||...+..+....+.....+. ....++.++.
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP---IPPIYSQDLQ 230 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---CchhhCHHHH
Confidence 1222346778999999999899999999999999999999999998776555555444433333 2346788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++.+||..+|++||++.+++++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcC
Confidence 99999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=282.00 Aligned_cols=249 Identities=23% Similarity=0.452 Sum_probs=203.1
Q ss_pred CcccceeeecceEEEEEE------cCeEEEEEEcCccc-------CCCHHHHHHHHHHHHHHhc-CCCCcccceeeEEEe
Q 018614 51 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEV-------ISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ 116 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~------~g~~vavK~~~~~~-------~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~ 116 (353)
+|+..+.||+|+||.||. .+..+|+|.+.... .........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 478889999999998873 35789999875422 1223445667788888865 799999999999999
Q ss_pred cCceEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
++..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998843 3358999999999999999999996 56 99999999999999999999999
Q ss_pred cccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 192 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+......+.
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 99998765432 22334567789999999988899999999999999999999999976655444444433332222
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
....++.++.+++.+||+.||++||++.++..+++
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 22356788999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=279.90 Aligned_cols=232 Identities=27% Similarity=0.505 Sum_probs=187.4
Q ss_pred eeeecceEEEEEE-----cC----------eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 56 VEITKGTFILAFW-----RG----------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 56 ~~ig~G~~~~v~~-----~g----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
+.||+|+||.||. .+ ..+++|.+.... .. ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 3689999998872 12 247778765432 11 4678899999999999999999999988 778
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-------CEEEeec
Q 018614 121 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADF 192 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-------~vkl~Df 192 (353)
++||||+++++|.+++.... .++...+..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+||
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999999998765 6899999999999999999999999 99999999999999888 7999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCccccCCC--CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCC
Q 018614 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 269 (353)
Q Consensus 193 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 269 (353)
|++...... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||......+...........+.
T Consensus 153 g~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 227 (259)
T cd05037 153 GIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM 227 (259)
T ss_pred Ccccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCC
Confidence 998875431 122345679999998876 78899999999999999999 6888877654443333322221111
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
. ....+.+++.+||..+|++||++.++++.|
T Consensus 228 ~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 228 P-----DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred C-----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1 126789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=280.61 Aligned_cols=244 Identities=25% Similarity=0.405 Sum_probs=188.6
Q ss_pred eeecceEEEEEEc----C---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 57 EITKGTFILAFWR----G---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 57 ~ig~G~~~~v~~~----g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+||+|+||.||.. + ..+++|.+.... .......+.+|+.+++.++||||+++++.+.+....|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5899999998742 2 245667665432 234456789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC-C
Q 018614 130 GDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 204 (353)
Q Consensus 130 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~ 204 (353)
++|.+++.+.. ..+...++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999997532 3566778899999999999999999 99999999999999999999999999764321111 1
Q ss_pred CcccCCCCCcccCccccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCC--CCchh
Q 018614 205 PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPAK 274 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 274 (353)
......++..|+|||++.. ..++.++||||||+++|+|++ |..||......+....+........ +....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 1123346778999998753 245779999999999999997 6789876655444444433322211 11233
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.+++.+.+++..|| .+|++||+++++++.|.
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 47788999999999 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.70 Aligned_cols=247 Identities=25% Similarity=0.456 Sum_probs=208.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~ 124 (353)
+|...+.||+|+||.||. +|..||+|++.............+.+|+.++++++ |+||+++++++.+....++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 588889999999998873 57899999987654444455567889999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC-
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~- 203 (353)
|++++++|.+++...+.+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999998878999999999999999999999999 99999999999999999999999999887653321
Q ss_pred ------------------CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC
Q 018614 204 ------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 265 (353)
Q Consensus 204 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 265 (353)
.......++..|+|||...+..++.++|+||||++++++++|..||...........+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 11122346778999999988889999999999999999999999998776544444443222
Q ss_pred CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCH----HHHHHH
Q 018614 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTF----RQIITR 304 (353)
Q Consensus 266 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~~ll~~ 304 (353)
.. .+..+++.+.+|+.+||..+|++||++ +++++|
T Consensus 239 ~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 239 YS----FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CC----CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11 223457889999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=277.63 Aligned_cols=246 Identities=28% Similarity=0.533 Sum_probs=208.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|++|.+|. .+..|++|.+...... ......+.+|++++++++|+|++++++++.+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 477889999999998874 5778999999776432 3456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
++++++|.+++.....+++..++.++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999988778999999999999999999999999 999999999999999999999999999877543322
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....++..|+|||...+..++.++|||+||+++++|++|..||.................+. .+..++..+.+++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP---LPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC---CCCCCCHHHHHHHH
Confidence 122346778999999988888999999999999999999999998765444333333332222 23456788999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~ 304 (353)
+||..+|++||++.+++.+
T Consensus 233 ~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHhCChhhCcCHHHHhcC
Confidence 9999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=284.01 Aligned_cols=248 Identities=25% Similarity=0.482 Sum_probs=206.8
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
...+|+....||.|++|.+|. ++..|++|++..... ....+.+|+..++.++|+||+++++.+......++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 345688889999999998873 478899999865421 34568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
++||+++++|.+++.... .++...++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999999998876 7999999999999999999999999 999999999999999999999999988765432
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+... ....++.++.
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~ 247 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK-NPEKWSPEFK 247 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-chhhCCHHHH
Confidence 22 112234667899999999888999999999999999999999999876554444444333333322 2334788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++|.+||+.+|.+||++.+++.+
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhC
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=283.20 Aligned_cols=241 Identities=30% Similarity=0.434 Sum_probs=198.8
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCH
Q 018614 58 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132 (353)
Q Consensus 58 ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 132 (353)
||.|+||.+|. +|..+++|.+.............+.+|++++++++|+||+++++.+..+...|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 58899988773 4889999998765443445567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-------C
Q 018614 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-------P 205 (353)
Q Consensus 133 ~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-------~ 205 (353)
.+++.+.+.+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......... .
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999988778999999999999999999999999 999999999999999999999999998765433111 1
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....++..|+|||...+...+.++||||||+++|+|++|..||......+....+....... . ....++..+.+++.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW-P-EDVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCC-C-ccccCCHHHHHHHH
Confidence 223346678999999988889999999999999999999999998777666555554422221 1 11124788999999
Q ss_pred HHcccCCCCCCCHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIIT 303 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~ 303 (353)
+||+.+|++||++..+.+
T Consensus 236 ~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred HHhcCCHhhcCCCccHHH
Confidence 999999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=283.08 Aligned_cols=247 Identities=27% Similarity=0.448 Sum_probs=197.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~iv 123 (353)
+|...+.||.|++|.||. .++.+|+|.+.... .......+.+|++++++++||||+++++++.+. ..+++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 577889999999998872 57889999987542 234456788999999999999999999998654 468999
Q ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 124 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999998753 334889999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-----CchHHHHHhcCCCCCCCc--
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-----NEVPKAYAARQRPPFKAP-- 272 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~-- 272 (353)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|..||..... .+....+.....+.+...
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 2221 123456789999999999999999999999999999999999976532 122222222121211111
Q ss_pred -hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 273 -AKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 273 -~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
...+++.+.+|+.+||..+|++|||+.+++++-
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 124678899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=286.41 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=200.2
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 120 (353)
+|+..+.||+|+||.||. ++..||||+++..... .......+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999998873 4578999998653221 223345678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999999987777999999999999999999999998 99999999999999999999999999877543
Q ss_pred CCCCCcccCCCCCcccCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
..........++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+...........+..++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 3222222334678899999987765 78899999999999999999999965433222222211111111122344678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
++.+++.+||+.||++|||+.++.+.|+.
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 89999999999999999998766655544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=278.05 Aligned_cols=246 Identities=26% Similarity=0.486 Sum_probs=207.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|...+.||.|+||.++. ++..+++|.+..... ..+....+.+|+++++.++|+|++++.+.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 477889999999998772 478999999876533 23455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 126 YLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 126 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
++++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999864 56999999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.. ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||......+............ .+..++..+.
T Consensus 157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (258)
T cd08215 157 VD-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELR 232 (258)
T ss_pred cc-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence 21 1222346778999999988889999999999999999999999998776555555544433333 2346788899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++.+||..+|++||++.+++++
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=276.21 Aligned_cols=249 Identities=28% Similarity=0.502 Sum_probs=206.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~iv 123 (353)
+|...+.||+|++|.+|. ++..|++|.+...... ....+.+.+|+..+++++|+||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 477789999999998873 4788999998765432 35567889999999999999999999999988 889999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
+|++++++|.+++.+...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999999988778999999999999999999999998 99999999999999999999999999987765432
Q ss_pred C-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 R-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
. ......++..|+|||.+.+...+.++||||||+++++|++|..||........ ..............+...+..+.+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-ALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHhccccCCCcCCCcccCHHHHH
Confidence 1 12234567789999999988899999999999999999999999987652111 111111111222234456889999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.+||..||++||++.+++.+
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhC
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=285.63 Aligned_cols=247 Identities=26% Similarity=0.479 Sum_probs=204.7
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|...+.||+|+||.++. +|..||+|.+........+....+.+|+.+++.++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 88889999999998873 5788999998765444455567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+. |+|.+++.. ..++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 96 578777754 456899999999999999999999999 999999999999999999999999988654322
Q ss_pred cccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
....++..|+|||.+. ++.++.++||||||+++|+|++|..||...........+.....+.. ....+++.+.+
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 255 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDYFRN 255 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHHHHH
Confidence 1234677899999974 45688899999999999999999999987655554444444433332 23456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
|+.+||+.+|.+||++.++++++..+.
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhc
Confidence 999999999999999999999876653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=281.81 Aligned_cols=244 Identities=25% Similarity=0.483 Sum_probs=192.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HhcCCCCcccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
+|+..+.||+|+||.||. +|..||+|.+...... ... ..+..|+.. ++.++||||+++++++..+...|++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 588889999999999884 5889999998765322 222 344455554 66678999999999999999999999
Q ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 125 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 125 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~-~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
||++ ++|.+++.. ...+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9995 688888764 23589999999999999999999997 7 9999999999999999999999999987654
Q ss_pred cCCCCCcccCCCCCcccCccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHhcCCCCCCCchh
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 274 (353)
.... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... +..........+.. ...
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 231 (283)
T cd06617 156 DSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL--PAE 231 (283)
T ss_pred cccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC--Ccc
Confidence 3211 122346778999998865 34688999999999999999999999754322 22222222222222 234
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.++.++.++|.+||..+|++||++++++++
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 578899999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=287.31 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=181.5
Q ss_pred ceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe--cCceEEEEe
Q 018614 55 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 125 (353)
Q Consensus 55 ~~~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e 125 (353)
+.+||+|+||.||. .+..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 46899999999983 246799998865422 1356789999999999999999998853 456899999
Q ss_pred cCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE----cCCCCEEEeec
Q 018614 126 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 192 (353)
Q Consensus 126 ~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill----~~~~~vkl~Df 192 (353)
|++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 994 5888887521 23788999999999999999999999 9999999999999 56678999999
Q ss_pred ccccccccCCC--CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch---------HHH
Q 018614 193 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------PKA 260 (353)
Q Consensus 193 g~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~---------~~~ 260 (353)
|+++....... .......+++.|+|||.+.+. .++.++|||||||++|+|++|++||........ ...
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 99987643322 122334578899999998764 578999999999999999999999975432110 000
Q ss_pred HHhc-C------------CCCCC---------------------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 261 YAAR-Q------------RPPFK---------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 261 ~~~~-~------------~~~~~---------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+... . .+.+. ......+..+.+|+.+||..||.+|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 0 00000 0001123558899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=279.37 Aligned_cols=246 Identities=24% Similarity=0.453 Sum_probs=202.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.+|. +|..+|+|.+....... .....+.+|+.+++.++|+||+++++.+......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 477889999999998873 57889999986643222 233567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC-EEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~-vkl~Dfg~a~~~~~~~ 202 (353)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++. ++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999997643 3789999999999999999999999 999999999999998864 6999999987764322
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
. ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+....+....... ....++.++.+
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRS 232 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHH
Confidence 1 1222457788999999988889999999999999999999999997665444444333332222 23356788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.+||..+|++||++++++++
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=292.38 Aligned_cols=246 Identities=25% Similarity=0.368 Sum_probs=195.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------C
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 118 (353)
.+|+..+.||+|+||.|+. +|..||+|.+..... ..+....+.+|+.++++++|+||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4699999999999998873 678999999865432 333445677899999999999999999988643 3
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|+||||+ .++|.+.+... ++...+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++...
T Consensus 95 ~~~lv~e~~-~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELM-DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEecc-CCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 579999999 46898888654 889999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC------------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------ 266 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------ 266 (353)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.....
T Consensus 169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 169 GTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 43221 2223467789999999999999999999999999999999999976553222222111000
Q ss_pred ---------CCC------------------CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 ---------PPF------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ---------~~~------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.. .......+.++.++|.+||..||++||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00012346678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=283.76 Aligned_cols=248 Identities=24% Similarity=0.446 Sum_probs=195.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|++|.||. +|..||||.+..... .......+.+|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 478889999999998873 578999998865432 22233567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+. ++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 995 6899988653 45899999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCcccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC--------------
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-------------- 268 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------- 268 (353)
......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+......+
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 122234567899999887644 5889999999999999999999997654332222221111000
Q ss_pred -----------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -----------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+......++.++.++|.+||+.||++||+++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000012356778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=281.27 Aligned_cols=234 Identities=24% Similarity=0.393 Sum_probs=186.0
Q ss_pred eeeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 56 VEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 56 ~~ig~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
+.||.|+||.||.. ...|++|.+... .....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 36899999988742 224777877543 233446788899999999999999999999998999999
Q ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC--------EEEeeccc
Q 018614 124 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LKVADFGV 194 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~--------vkl~Dfg~ 194 (353)
|||+++|+|.+++...+ .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++. ++++|||+
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999999997654 4899999999999999999999999 999999999999987765 69999998
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCchHHHHHhcCCCCCCCc
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQRPPFKAP 272 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
+...... ....++..|+|||.+.+. .++.++||||||+++|+|++| ..||...+......... ....+
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~--- 224 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE--DRHQL--- 224 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH--ccccC---
Confidence 8654321 123466789999999764 578899999999999999998 56666544333222221 11221
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+...+.++.+|+.+||+.||++|||++++++.|
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 123456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=284.51 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=196.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~iv 123 (353)
+|+..+.||.|+||.||. ++..+++|.++..... ......+.+|+.++++++||||+++++++... ...|+|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 688889999999998873 4788999998754332 22233567899999999999999999998877 889999
Q ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||++ ++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99995 59999987644 4899999999999999999999999 9999999999999999999999999988765432
Q ss_pred CCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC--------------
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP-------------- 267 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------------- 267 (353)
. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+......
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 12223457789999998765 4688999999999999999999999866543333322111000
Q ss_pred ---------CC---CC-chhh-hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ---------PF---KA-PAKL-YARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ---------~~---~~-~~~~-~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.. .. .+.. +++.+.++|++||+.+|++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 00 0111 47779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=286.47 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=196.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 122 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~i 122 (353)
.+|+..+.||.|+||.||. +|+.||+|.+....... .....+.+|+.++++++|+||+++++++.+. ...++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 3688899999999998873 48899999986543221 2223456799999999999999999998755 45899
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||||+. ++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999995 589888875 355899999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC------------
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP------------ 268 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------ 268 (353)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+..+....+......+
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 21 1222334678999999865 457899999999999999999999998766544444333211100
Q ss_pred ----CCC----------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 ----FKA----------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ----~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.. .....++++.++|.+||..||++|||+++++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 001247788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=291.97 Aligned_cols=244 Identities=28% Similarity=0.425 Sum_probs=207.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|..-+.||+|+||.|+ .+|.-+|.|.+.+..+.......-..+|-.+|..++.+.||.+-.+|.....+|+|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 57778899999999876 4688899998877776666665667889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
.|.||+|.-+|-+-+ .|++..++.++.+|+.||++||+.+ ||+||+||+|||+|+.|+|+|+|+|+|..+...
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-- 340 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-- 340 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC--
Confidence 999999999887755 6999999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
.......||.+|||||++.+..|+...|+|||||++|+|+.|+-||.....-.-.+.+...........+..+++++++|
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 44555689999999999999999999999999999999999999997654332222232222222223347789999999
Q ss_pred HHHHcccCCCCCCCHH
Q 018614 284 IEECWNEKPAKRPTFR 299 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~ 299 (353)
.+.+|.+||.+|....
T Consensus 421 c~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHccCHHHhccCC
Confidence 9999999999996543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=283.64 Aligned_cols=244 Identities=28% Similarity=0.462 Sum_probs=193.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~ 124 (353)
+|+....||+|+||.||. .|..||+|.+..... ......+.+|+.++.++. |+||+++++++......+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 466678899999999873 578999999875432 244567889999999996 999999999999989999999
Q ss_pred ecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 125 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 125 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~Lh~~-~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
|++. +++.++.. ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9984 56665543 235689999999999999999999985 7 999999999999999999999999998765
Q ss_pred ccCCCCCcccCCCCCcccCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHh---cCCCCCCC-
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---RQRPPFKA- 271 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~~~~~- 271 (353)
..... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.... .....+.. ...+....
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 159 VDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred ccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcCCCc
Confidence 43221 1223467789999998776 68899999999999999999999997654 22222211 11111111
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....++.++.+|+.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123478889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.46 Aligned_cols=239 Identities=22% Similarity=0.357 Sum_probs=189.4
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHH---HHHhcCCCCcccceeeEEEecCceEEEEecCC
Q 018614 57 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL---ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 57 ~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
.||+|+||.||. .|+.||+|.+.............+..|. ..++...||+|+++++.+......++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 379999999872 4789999998765433222222233343 34455679999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 018614 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208 (353)
Q Consensus 129 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 208 (353)
|++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~~ 154 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HA 154 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---cC
Confidence 9999999988778999999999999999999999999 99999999999999999999999999876542211 22
Q ss_pred CCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH--HhcCCCCCCCchhhhHHHHHHHHH
Q 018614 209 QDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 209 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
..++..|+|||.+.++ .++.++||||+|+++|+|++|+.||............ ....... .+..++.++.+++.
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~ 231 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE---LPDSFSPELRSLLE 231 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC---CCCcCCHHHHHHHH
Confidence 3578899999998754 6889999999999999999999999876432222211 1111122 22346788999999
Q ss_pred HHcccCCCCCC-----CHHHHHHH
Q 018614 286 ECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
+||..+|.+|| ++.+++++
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhC
Confidence 99999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=304.99 Aligned_cols=251 Identities=16% Similarity=0.222 Sum_probs=184.7
Q ss_pred cCcccceeeecceEEEEEEc------CeEEEEE--------------EcCcccCCCHHHHHHHHHHHHHHhcCCCCcccc
Q 018614 50 LDFTNSVEITKGTFILAFWR------GIQVAVK--------------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 109 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~~------g~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 109 (353)
.+|+..+.||+|+||.||.. +..++.| .+.............+.+|+.++++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 36999999999999999831 1111111 111111112234456789999999999999999
Q ss_pred eeeEEEecCceEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC
Q 018614 110 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184 (353)
Q Consensus 110 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~ 184 (353)
+++++.+....|+|+|++ +++|.+++.... ......++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 999999999999999999 567887775421 2345677889999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCC-CCCCCCCCchH---HH
Q 018614 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVP---KA 260 (353)
Q Consensus 185 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-pf~~~~~~~~~---~~ 260 (353)
+.+||+|||++..+............|+..|+|||++.+..++.++|||||||++|||++|.. ||......... ..
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999998765433322333568899999999999999999999999999999999765 45433221111 11
Q ss_pred HHhcC--CCCCCC-------------------------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 261 YAARQ--RPPFKA-------------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 261 ~~~~~--~~~~~~-------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.... ...++. .....+..+.++|.+||+.||++|||+.+++.|
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 10000 000000 011234567888999999999999999999986
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.70 Aligned_cols=244 Identities=23% Similarity=0.373 Sum_probs=203.1
Q ss_pred ceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEEecCC
Q 018614 55 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 55 ~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
.+.||.|.|+.|- ++|..+|||++.+. .......+.+|++++.+++ |+||++++++|.++..+|+|||.+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 4579999998664 68999999999765 3445567889999999995 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC---EEEeecccccccccCCC--
Q 018614 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVKED-- 203 (353)
Q Consensus 129 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~---vkl~Dfg~a~~~~~~~~-- 203 (353)
||+|..++.++..|++..+.+++.+|+.||.|||.+| |.|||+||+|||..+... |||+||.+..-......
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999999999888999999999999999999999999 999999999999887664 89999998765432221
Q ss_pred ----CCcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------------chHH
Q 018614 204 ----RPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------------EVPK 259 (353)
Q Consensus 204 ----~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~---------------~~~~ 259 (353)
.......|+..|||||+.. ...|+.+.|.||||+++|-|++|.+||.+.-.. .+.+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 1223456788899999763 336889999999999999999999999775431 2334
Q ss_pred HHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 260 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.|..+...-....+.+++.+.++++..+|..|+..|.++.+++.|
T Consensus 317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 454444444444567889999999999999999999999999985
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.81 Aligned_cols=247 Identities=25% Similarity=0.469 Sum_probs=196.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||.|++|.+|. +|..||||.+..... ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 588899999999998873 578899999876432 2223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|++ ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 996 58988887543 4899999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCC------------
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF------------ 269 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------ 269 (353)
. ......++..|++||.+.+. .++.++||||||+++|+|++|+.||...+..+....+......+.
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 11223457789999988654 568899999999999999999999987765544333322111000
Q ss_pred -----CC--------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 270 -----KA--------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 270 -----~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.. .....+..+.+++.+||+.||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 012346778999999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=280.91 Aligned_cols=254 Identities=15% Similarity=0.149 Sum_probs=186.4
Q ss_pred cCcCcccceeeecceEEEEEEc--------CeEEEEEEcCcccCCC--HHH------HHHHHHHHHHHhcCCCCccccee
Q 018614 48 HELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISD--DDR------VRAFRDELALLQKIRHPNVVQFL 111 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~~--------g~~vavK~~~~~~~~~--~~~------~~~~~~E~~~l~~l~h~~i~~~~ 111 (353)
...+|+..+.||+|+||.||.. +..+|+|+........ +.. ......+...+..++|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 3457999999999999999841 3456666543221100 000 01122334455667899999999
Q ss_pred eEEEecC----ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCE
Q 018614 112 GAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187 (353)
Q Consensus 112 ~~~~~~~----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~v 187 (353)
+.+.... ..++++|++ ..++.+.+......++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 8765443 347888887 5578888776555788889999999999999999999 9999999999999999999
Q ss_pred EEeecccccccccCCC------CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch-HHH
Q 018614 188 KVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKA 260 (353)
Q Consensus 188 kl~Dfg~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-~~~ 260 (353)
+|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999999987642211 111234588999999999999999999999999999999999999987643222 111
Q ss_pred HHh---cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 261 YAA---RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 261 ~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
... ............+++++.++++.||..+|++||++.+|++.|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 100 000001111234578899999999999999999999999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=281.01 Aligned_cols=248 Identities=29% Similarity=0.435 Sum_probs=198.0
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceEEEE
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 124 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~ 124 (353)
|+..+.||.|+||.||. .|..+|+|.+.... ...+....+.+|+.++++++|+|++++++++.+. +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 56778999999998874 46899999997653 2233445678899999999999999999999888 7899999
Q ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||++ ++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9996 5899988765 46899999999999999999999999 99999999999999999999999999987755433
Q ss_pred CCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC-------C------
Q 018614 204 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-------F------ 269 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------~------ 269 (353)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......+ .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22333445678999998765 457889999999999999999999998766443333322211000 0
Q ss_pred ------CC-------c-hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 270 ------KA-------P-AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 270 ------~~-------~-~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.. . ...++..+.+++.+||..+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 0 01137789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=281.82 Aligned_cols=244 Identities=23% Similarity=0.411 Sum_probs=200.3
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|+....||+|+||.||. +|..||||.+... .......+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 44457899999998873 5789999987543 233446688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 206 (353)
+++++|.+++.. ..+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~ 173 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 173 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cc
Confidence 999999998754 45899999999999999999999999 99999999999999999999999998876543221 12
Q ss_pred ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 286 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 286 (353)
....++..|+|||.+.+..++.++|+||+|+++|+|++|..||......+....+.......+. ....++..+.+++.+
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~ 252 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLK-NLHKVSPSLKGFLDR 252 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccC-CcccCCHHHHHHHHH
Confidence 2345678899999998888999999999999999999999999866554443333222222222 223467789999999
Q ss_pred HcccCCCCCCCHHHHHHH
Q 018614 287 CWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 287 cl~~dp~~Rps~~~ll~~ 304 (353)
||..+|.+||++.+++.+
T Consensus 253 ~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 253 LLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHhCCcccCcCHHHHhcC
Confidence 999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=297.19 Aligned_cols=253 Identities=25% Similarity=0.516 Sum_probs=205.6
Q ss_pred ccCccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCc-ccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec
Q 018614 44 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 117 (353)
Q Consensus 44 ~i~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 117 (353)
+.++...-......||+|+|-.||+ .|..||=-.++. +.....+..+.|..|+.+|+.|+||||+++++++.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 3334443344567899999999984 455565221111 2334567778999999999999999999999999876
Q ss_pred Cc--eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc-CCCCEEEeeccc
Q 018614 118 SP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGV 194 (353)
Q Consensus 118 ~~--~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~-~~~~vkl~Dfg~ 194 (353)
.. +-+|+|.+..|+|..|+++.+..+...+..|++||++||.|||++.+ +|||||||.+||||+ ..|.|||+|+||
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhH
Confidence 55 78899999999999999999999999999999999999999999985 699999999999998 568999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-CchHHHHHhcCCCCCCCch
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPPFKAPA 273 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 273 (353)
|......... ...|||.|||||+.. ..|+...||||||++|+||.|+.+||..-.+ .++.+++..+..|..-.
T Consensus 193 Atl~r~s~ak---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~-- 266 (632)
T KOG0584|consen 193 ATLLRKSHAK---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS-- 266 (632)
T ss_pred HHHhhccccc---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh--
Confidence 9987644333 357999999999987 6899999999999999999999999986544 45666665555443211
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..-.+++++||.+||.. .++|||+.+||++
T Consensus 267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 12257899999999999 9999999999965
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=281.53 Aligned_cols=242 Identities=26% Similarity=0.465 Sum_probs=199.0
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|...+.||+|+||.||. .|..|++|.+.............+.+|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999874 5788999998765444455556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+. ++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||++++++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence 95 578877765 445899999999999999999999999 999999999999999999999999988643211
Q ss_pred cccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
....++..|+|||.+. +..++.++||||||+++|+|++|..||...........+.....+.. ....++..+++
T Consensus 175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 251 (313)
T cd06633 175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--QSNEWTDSFRG 251 (313)
T ss_pred -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CccccCHHHHH
Confidence 2234677899999984 45678899999999999999999999987665444444433322222 22346678999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
|+.+||+.+|++||++.+++.+
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=274.62 Aligned_cols=239 Identities=29% Similarity=0.459 Sum_probs=200.4
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCH
Q 018614 58 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132 (353)
Q Consensus 58 ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 132 (353)
||+|+||.+|. .++.+++|.+.............+..|+.++++++|+||+++++.+..+...++|||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999988773 4789999998876555555667788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCC
Q 018614 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 212 (353)
Q Consensus 133 ~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~ 212 (353)
.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCcCC
Confidence 999988777999999999999999999999999 99999999999999999999999999877644321 22334567
Q ss_pred CcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCC
Q 018614 213 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 292 (353)
Q Consensus 213 ~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 292 (353)
..|+|||.+.+...+.++|+||||+++|++++|..||...+.......+.. .... .+...+..+.+++++||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLR---FPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCC---CCCCCCHHHHHHHHHHhcCCH
Confidence 789999999888889999999999999999999999977655444444433 1122 233457889999999999999
Q ss_pred CCCCCH---HHHHHH
Q 018614 293 AKRPTF---RQIITR 304 (353)
Q Consensus 293 ~~Rps~---~~ll~~ 304 (353)
++||++ +++++|
T Consensus 233 ~~R~~~~~~~~l~~~ 247 (250)
T cd05123 233 TKRLGSGGAEEIKAH 247 (250)
T ss_pred hhCCCcccHHHHHhC
Confidence 999999 566554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.76 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=195.7
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|+..+.||.|++|.||. +|..||+|++...... ......+.+|+.+++.++|+|++++++++.+....+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 56778999999998873 5889999998754322 22234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 127 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 127 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
+ +++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 9 569999998765 5899999999999999999999998 99999999999999999999999999876543211
Q ss_pred CcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC------------------
Q 018614 205 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------ 265 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------------ 265 (353)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 11223457789999987664 56889999999999999999999997654322221111100
Q ss_pred -------CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 -------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 -------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..........++..+.+++.+||+.||++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 001111123456789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=276.50 Aligned_cols=236 Identities=22% Similarity=0.386 Sum_probs=187.6
Q ss_pred ccccee--eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 52 FTNSVE--ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 52 ~~~~~~--ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
|+..+. +|.|+||.|+. +|..+|+|.+........ |+.....+ +|+||+++++.+......++|
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 444444 59999998873 577899999865432211 22222222 699999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~Dfg~a~~~~~~~ 202 (353)
|||+++++|.+++.....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 999999999999988778999999999999999999999999 99999999999999998 9999999998765422
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchH-HHHHhcCCCCCCCchhhhHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
....++..|+|||++.+..++.++||||+|+++|+|++|..||......... ..+.... .........+++.+.
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNAN 238 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHH
Confidence 1234678899999999989999999999999999999999999865443321 1221112 111122346788999
Q ss_pred HHHHHHcccCCCCCCC-HHHHHHH
Q 018614 282 ELIEECWNEKPAKRPT-FRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps-~~~ll~~ 304 (353)
+||.+||+.+|.+||+ ++++++|
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcC
Confidence 9999999999999996 6999865
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=281.22 Aligned_cols=248 Identities=24% Similarity=0.410 Sum_probs=191.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||.|++|.||. +|+.||+|.+...... .....+.+|+.++++++|+||+++++++.++...++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 4688899999999999873 5789999998654321 11234568999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 83 EYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred ecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9996 5999988764 35899999999999999999999999 99999999999999999999999999875432211
Q ss_pred CCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-CchHHHHHhcCCC--------------
Q 018614 204 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRP-------------- 267 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~-------------- 267 (353)
......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||..... .+....+......
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122235678999999865 4578899999999999999999999976542 1111111100000
Q ss_pred -------CCCC-----chhhhH--HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 -------PFKA-----PAKLYA--RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 -------~~~~-----~~~~~~--~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.... .....+ .++.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 001122 678899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=281.75 Aligned_cols=251 Identities=18% Similarity=0.327 Sum_probs=196.1
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecC
Q 018614 51 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 127 (353)
.+..++.+|.|+++.++ .+|..||||++..... ..+....+.+|+.+++.++|+||+++++++.+....+++|||+
T Consensus 3 ~~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 35556667777776655 3688999999876532 3445677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-
Q 018614 128 PKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 204 (353)
Q Consensus 128 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~- 204 (353)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 999999999763 34889999999999999999999999 999999999999999999999999988755322111
Q ss_pred -----CcccCCCCCcccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC----------
Q 018614 205 -----PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP---------- 267 (353)
Q Consensus 205 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------- 267 (353)
......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||..............+..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 1122345668999999876 35788999999999999999999999865433221111110000
Q ss_pred --------------------CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 268 --------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 268 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
........++.++.+|+.+||..||++|||+++++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00011234567899999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=278.34 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=190.6
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEec--CceEEE
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMIV 123 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~iv 123 (353)
|+..+.||+|+||.||. ++..||+|.+..... ..+. ....+|+..++++. |+||+++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 56778999999998873 578899999875432 2222 23457888888885 99999999999887 889999
Q ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||++ ++|.+.+... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99995 5888888753 45899999999999999999999999 999999999999999 999999999998764322
Q ss_pred CCCcccCCCCCcccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC---------------C
Q 018614 203 DRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---------------R 266 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---------------~ 266 (353)
. .....++..|+|||.+. +..++.++|||||||++|+|++|..||...+..+....+.... .
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 12234677899999764 4557889999999999999999999998765433322221100 0
Q ss_pred CCCC----------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 PPFK----------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ~~~~----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..+. .....++.++.++|.+||..+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 0012457889999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=315.96 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=217.2
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
-+|.+.+.||+|+||.|. .++..+|+|++++..+.......-|+.|-.+|..-+.+=|++++..|+|+.++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 379999999999999765 357899999998866555555567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||++||+|..++.+.+++++..++.++..|+.||..||+.| +|||||||+|||||..|++||+|||.+-.+......
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999888765555
Q ss_pred CcccCCCCCcccCccccC----C-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHH
Q 018614 205 PLTCQDTSCRYVAPEVFK----N-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 278 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 278 (353)
......|||.|.+||++. + +.|++.+|+||+||++|||+.|..||......+....|...+ ...++ ....+|+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP-~~~~VSe 310 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP-DETDVSE 310 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-cccccCH
Confidence 556678999999999984 3 578999999999999999999999998777667777776544 33343 2345899
Q ss_pred HHHHHHHHHcccCCCCCCC---HHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPT---FRQIITRL 305 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps---~~~ll~~l 305 (353)
+.++||.+.+.. |+.|.. ++++..|-
T Consensus 311 eakdLI~~ll~~-~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 311 EAKDLIEALLCD-REVRLGRNGIEDIKNHP 339 (1317)
T ss_pred HHHHHHHHHhcC-hhhhcccccHHHHHhCc
Confidence 999999988764 788888 88888773
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=287.63 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=198.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec-----Cc
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 119 (353)
.+|...+.||+|+||.||. +|..||||.+..... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3688999999999998873 578999999865432 222334567899999999999999999987644 34
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
.|+|+||+ +++|.+++...+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 79999999 5799999988778999999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhc--------------
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------- 264 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-------------- 264 (353)
... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 332 11223346778999998765 46889999999999999999999999765432211111100
Q ss_pred -------------CCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHH
Q 018614 265 -------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESI 308 (353)
Q Consensus 265 -------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--l~~~ 308 (353)
...........+++++.++|++||+.+|++||+++++++| ++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000111123467889999999999999999999999998 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=287.18 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=195.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec-----Cc
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 119 (353)
.+|+..+.||+|+||.||. +|..||+|.+... ........+.+|+.++++++|+||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4799999999999998873 5789999998642 1233445678899999999999999999987644 34
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
.++++|+++ ++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 799999995 588888854 45899999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCCC--cccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC----------
Q 018614 200 VKEDRP--LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---------- 266 (353)
Q Consensus 200 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------- 266 (353)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 322211 122456788999998654 4688999999999999999999999976543221111110000
Q ss_pred -----------CCCC------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHH
Q 018614 267 -----------PPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESI 308 (353)
Q Consensus 267 -----------~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--l~~~ 308 (353)
.+.. ......+.++.++|.+||+.+|++||++.++++| ++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000 0012346779999999999999999999999998 4444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=281.61 Aligned_cols=248 Identities=26% Similarity=0.455 Sum_probs=202.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..|+..+.||+|+||.+|. ++..+|+|.+.............+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3488888999999998872 56789999886543334455567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9995 688887754 445899999999999999999999999 999999999999999999999999998765422
Q ss_pred CCcccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
....++..|+|||.+. ...++.++||||||+++|+|++|..||......+....+.....+.. ....++..+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 243 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYF 243 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHHH
Confidence 1234677899999874 34678899999999999999999999977655444444433333222 234577889
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.+||.+||..+|++||++.+++++....
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred HHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 9999999999999999999999885544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=286.96 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=202.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC-----ce
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 120 (353)
+|+..+.||.|++|.|+. .|..||||.+.... ......+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 478889999999998873 47899999987542 22344467889999999999999999999987765 78
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
|++|||++ ++|.+++.+...+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999995 589999987778999999999999999999999999 99999999999999999999999999987754
Q ss_pred CCC--CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCC--------
Q 018614 201 KED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF-------- 269 (353)
Q Consensus 201 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------- 269 (353)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|++||......+....+......+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 431 112334567789999999887 789999999999999999999999987665443333322111000
Q ss_pred -------------------CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 270 -------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 270 -------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
......++.++.++|.+||+.+|++||++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00012356789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=283.32 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=193.0
Q ss_pred CcccceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceE
Q 018614 51 DFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 121 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 121 (353)
+|...+.||+|+||.||. .|..||+|.+.............+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 477888999999998873 5789999998764322233335677899999999999999999999888 7899
Q ss_pred EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC----CCCEEEeec
Q 018614 122 IVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD----SGNLKVADF 192 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~----~~~vkl~Df 192 (353)
+||||++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999995 5787777532 25889999999999999999999999 999999999999999 999999999
Q ss_pred ccccccccCCCC--CcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc---------hHHH
Q 018614 193 GVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---------VPKA 260 (353)
Q Consensus 193 g~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~---------~~~~ 260 (353)
|++......... ......++..|+|||.+.+. .++.++||||||+++++|++|++||....... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 999876433221 11223467789999987664 57899999999999999999999997655432 0000
Q ss_pred HH-------------------------hcCCCCCC--Cchh------hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 261 YA-------------------------ARQRPPFK--APAK------LYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 261 ~~-------------------------~~~~~~~~--~~~~------~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+. ........ .... ..+.++.+++.+||..||++|||+.++++|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 00001111 0000 345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=281.58 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=192.6
Q ss_pred ccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC---
Q 018614 47 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--- 118 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 118 (353)
..-.+|+..+.||+|+||.||. +|..||||.+....... .....+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 3344799999999999998873 57899999886543221 22234567999999999999999999886543
Q ss_pred -----ceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeec
Q 018614 119 -----PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192 (353)
Q Consensus 119 -----~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Df 192 (353)
..++||||+. ++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 88 NRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred cCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 3599999994 58888887543 5899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCC---CcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC--
Q 018614 193 GVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-- 266 (353)
Q Consensus 193 g~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-- 266 (353)
|++......... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866433221 11223457789999988664 468899999999999999999999976554332222211100
Q ss_pred C-C---------------CCC----------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 P-P---------------FKA----------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ~-~---------------~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+ . +.. .....+..+.+||.+||..||++|||++++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 0 000 000124567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=303.75 Aligned_cols=259 Identities=31% Similarity=0.525 Sum_probs=217.0
Q ss_pred CcccCccCcCcccceeeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCccc
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVV 108 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~ 108 (353)
.|+++.+.+. ..+.+|.|.||.|++. ...||||.++..... ...+.+..|+.+++.+ .|+||+
T Consensus 290 ~~e~~~~~l~--~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLK--LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhcc--ccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchh
Confidence 6777777664 4449999999987621 457999999876533 5567899999999999 599999
Q ss_pred ceeeEEEecCceEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEec
Q 018614 109 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 172 (353)
Q Consensus 109 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~ 172 (353)
.++|++...+..++|+||+..|+|.+++...+ .++..+.+.++.||+.|++||++.. +|||
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 99999999999999999999999999998665 3788999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC--CCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 018614 173 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 249 (353)
Q Consensus 173 dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf 249 (353)
||.+.|||+.++..+||+|||+++.............. -+..|||||.+....|+.++||||+|+++||+++ |..||
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 99999999999999999999999965544333222111 3567999999999999999999999999999998 99999
Q ss_pred CCCC-CCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 250 TMKH-DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 250 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.+.. ..++.+.+..+.+... +..++.++.++|+.||+.+|++||++.++.+.+.....
T Consensus 523 p~~~~~~~l~~~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 9855 4455555555555443 45678999999999999999999999999999999543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.40 Aligned_cols=251 Identities=23% Similarity=0.365 Sum_probs=197.5
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe----cCce
Q 018614 50 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~ 120 (353)
.+|+..+.||.|+||.|| .+|..||+|++..... .......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 578888999999999887 3588999999875432 22334567789999999999999999988753 3468
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
++||||+ +++|.+++.....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehh-hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999999 5699999987777999999999999999999999999 99999999999999999999999999976643
Q ss_pred CCCCC---cccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhc------------
Q 018614 201 KEDRP---LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR------------ 264 (353)
Q Consensus 201 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~------------ 264 (353)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 32211 122356778999999865 46789999999999999999999999765533222111110
Q ss_pred ------------C-CCCCC--CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 265 ------------Q-RPPFK--APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 265 ------------~-~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
. ..... ......+.++.++|.+||+.+|++||++.+++.+-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0 00000 00123578899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=279.17 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=193.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|++|.+|. +|+.||+|.+..... .......+.+|+.++++++|+||+++++++.+....++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 588899999999998873 578899999865432 22333567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-CCCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~ 202 (353)
|++ ++|.+++..... +++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 588888865443 578888999999999999999999 999999999999985 4579999999997654321
Q ss_pred CCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CC-------------
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP------------- 267 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~------------- 267 (353)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|.+||......+....+.... .+
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112233457789999988664 57889999999999999999999997655433322221110 00
Q ss_pred ------CCCC-----chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ------PFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ------~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.... ....++.++.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 012356789999999999999999999999975
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=271.88 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=200.7
Q ss_pred Ccccc-eeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec----Cc
Q 018614 51 DFTNS-VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----SP 119 (353)
Q Consensus 51 ~~~~~-~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~----~~ 119 (353)
+|.+. ..||-|.-|.|. .+|+.+|+|++... +..++|+++.-.. .|||||.++++|.+. .-
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45543 468888887664 46889999998643 2456788876555 699999999998643 34
Q ss_pred eEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC---CCEEEeeccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGV 194 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~---~~vkl~Dfg~ 194 (353)
+.||||.++||.|...+++++. |++..+..|+.||..|+.|||+.+ |.||||||+|+|...+ ..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 7899999999999999998765 999999999999999999999999 9999999999999854 4699999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC----chHHHHHhcCCCCCC
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN----EVPKAYAARQRPPFK 270 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~ 270 (353)
|+...... .....-.|+.|.|||++...+|+...|+||+|++||-|++|.+||...... .+...|..+...-..
T Consensus 211 AK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 211 AKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 99866432 223344688999999999999999999999999999999999999876653 345566666655555
Q ss_pred CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 271 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+.+..+|+..+++|+.+|..+|++|.|++++++|-
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 66788999999999999999999999999999764
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=279.37 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=192.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCc-----
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP----- 119 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~----- 119 (353)
+|+..+.||.|+||.||. +|..||+|.+..... .......+.+|+.+++.+. |+||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 588889999999999873 578999998765432 1222346778999999995 6999999999877665
Q ss_pred eEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-CCCEEEeecc
Q 018614 120 MMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFG 193 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-~~~vkl~Dfg 193 (353)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999965 898888642 24799999999999999999999999 999999999999998 8899999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CC----
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP---- 267 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~---- 267 (353)
++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.... .+
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 98765432211 122345678999998865 457899999999999999999999998654433222221110 00
Q ss_pred --------------CCC-----CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 --------------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 --------------~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
... .....++.++.+||.+||..||++||++++++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0012467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=278.30 Aligned_cols=248 Identities=23% Similarity=0.394 Sum_probs=190.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|...+.||+|+||.||. +|..||+|.+...... .....+.+|+.+++.++|+||+++.+++.++...|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4688899999999999874 4789999998654321 11234678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 677776654 345788889999999999999999999 99999999999999999999999999876433221
Q ss_pred CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-hHHHHHh-cCC------------C-
Q 018614 204 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAA-RQR------------P- 267 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~~~~-~~~------------~- 267 (353)
. .....++..|+|||.+.+. .++.++||||||+++|+|++|..||....... ....... ... +
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 T-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred C-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1 1223457789999998764 57889999999999999999999997554311 1000000 000 0
Q ss_pred ---C----C-CCc------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ---P----F-KAP------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ---~----~-~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
. . ... ....+.++.+++.+|+..||.+|||+++++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 0 000 00124678899999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=282.86 Aligned_cols=247 Identities=21% Similarity=0.398 Sum_probs=191.1
Q ss_pred eeeecc--eEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCC
Q 018614 56 VEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 56 ~~ig~G--~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
..||+| +|+.||. .|+.||+|++..... ..+..+.+.+|+.+++.++||||+++++++..+...++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456766 7777762 588999999876433 34455788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC-
Q 018614 129 KGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP- 205 (353)
Q Consensus 129 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~- 205 (353)
+++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999998643 4889999999999999999999999 9999999999999999999999998654322111100
Q ss_pred -----cccCCCCCcccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC------------
Q 018614 206 -----LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------ 266 (353)
Q Consensus 206 -----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------ 266 (353)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||.................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0112245569999998764 478899999999999999999999976654332221111100
Q ss_pred -------------------------------CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 267 -------------------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 267 -------------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.........++..+.+|+++||..||++|||+.++++|-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0000112346788999999999999999999999997743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=291.73 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=218.6
Q ss_pred CcccceeeecceEEEEE---EcCeE--EEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAF---WRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~---~~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+++....||-|+||.|. ..++. +|+|++++..+-+....+.+..|-++|..+..|+||++|..|.++..+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 67778899999999865 34444 78999988878788888899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
-|-||.|+..+..++.|++..+..++..+++|++|||++| ||+|||||+|.+++.+|.+||.|||+|+.+.... .
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--K 575 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--K 575 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC--c
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999986442 2
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
...+-||+.|.|||++.+..++.++|.||||+++|||++|++||.+.++....+.+.++....- .+..+++...++|+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~--~Pr~I~k~a~~Lik 653 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE--FPRRITKTATDLIK 653 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh--cccccchhHHHHHH
Confidence 3346689999999999999999999999999999999999999999999888888866553221 23567888999999
Q ss_pred HHcccCCCCCCC-----HHHHHHHH
Q 018614 286 ECWNEKPAKRPT-----FRQIITRL 305 (353)
Q Consensus 286 ~cl~~dp~~Rps-----~~~ll~~l 305 (353)
++...+|.+|.. ..+|.+|-
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhh
Confidence 999999999965 45555553
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=282.33 Aligned_cols=239 Identities=29% Similarity=0.432 Sum_probs=210.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~ 124 (353)
+|.....||+|+||.|.. +.+.+|||+++++.+..++..+--+.|-++|.... -|.++++...|+.-+++|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 566778999999998863 35679999999988777666666678888888884 678999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+.||+|-..+++-+++.+..+..++..|+-||-+||++| ||+||||.+||++|.+|++||+|||+++.--.. ..
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~~ 505 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-GV 505 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC-Cc
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999764333 23
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
....+-||+.|+|||++..++|+...|+||+|+++|||+.|++||.+.+.+++...+...... .+..+|.+..++.
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs----yPKslSkEAv~ic 581 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS----YPKSLSKEAVAIC 581 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc----CcccccHHHHHHH
Confidence 334566899999999999999999999999999999999999999999999988888554422 2567899999999
Q ss_pred HHHcccCCCCCCC
Q 018614 285 EECWNEKPAKRPT 297 (353)
Q Consensus 285 ~~cl~~dp~~Rps 297 (353)
+..|.+.|.+|..
T Consensus 582 kg~ltK~P~kRLG 594 (683)
T KOG0696|consen 582 KGLLTKHPGKRLG 594 (683)
T ss_pred HHHhhcCCccccC
Confidence 9999999999953
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=276.05 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=199.0
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|+..+.||.|++|.+|. +|..+++|.+...... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 56678999999998873 5788999998765432 23445778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 80 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 80 MD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred cC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 96 5888888763 46899999999999999999999999 9999999999999999999999999987765433 12
Q ss_pred cccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC-----------------
Q 018614 206 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP----------------- 267 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------- 267 (353)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2234467789999998876 7889999999999999999999999776653333222211100
Q ss_pred ---------CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ---------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
........++.++.+||.+||..||++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0001123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=276.10 Aligned_cols=248 Identities=28% Similarity=0.469 Sum_probs=194.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.|+. .|..||||.+..... ......+..|+.++... .|+||+++++++.+....|++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4688899999999998873 388999999875432 23334556677766666 599999999999999999999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 124 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|||++......
T Consensus 93 ~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9998 5588887765 4468999999999999999999997 47 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHhcCCCCCCCchhhh
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 276 (353)
... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... +....+.....+.. .....+
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 245 (296)
T cd06618 169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGF 245 (296)
T ss_pred Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCC
Confidence 221 2234567899999987654 788999999999999999999999754322 22222222222222 122347
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
+.++.+|+.+||..||++||++++++.+-.
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 788999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=279.94 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=194.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 118 (353)
.+|+..+.||+|+||.||. +|+.||+|.+...... ......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 4688889999999998873 4788999998654321 222245678999999999999999999887654
Q ss_pred ----ceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 119 ----PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 119 ----~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
.+++|+||+++ ++.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999965 777777653 35899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC----
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP---- 268 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---- 268 (353)
++...............++..|+|||.+.+ ..++.++||||||+++++|++|++||......+....+......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 998765433222222334668999998765 356889999999999999999999997655433332222211000
Q ss_pred ---C-------------------CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 ---F-------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ---~-------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
. ......++..+.+++.+||..||++||++++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00112357889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=273.63 Aligned_cols=246 Identities=27% Similarity=0.438 Sum_probs=193.9
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeeEEEecCc----
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSP---- 119 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~---- 119 (353)
|+..+.||+|+||.+|. +|..||+|.+..... .......+.+|+.+++++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 56788999999998872 478999999875432 222234566787777666 59999999999988776
Q ss_pred -eEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 120 -MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 120 -~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
.+++||++. ++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999995 58999887643 4899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC----------
Q 018614 197 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---------- 266 (353)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------- 266 (353)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|++||......+....+.....
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 7643321 1223467789999999998999999999999999999999999987655443333321100
Q ss_pred -------------CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 -------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 -------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..........+..+.+++.+||+.||++||++.+++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000112356778999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=286.26 Aligned_cols=243 Identities=24% Similarity=0.385 Sum_probs=210.6
Q ss_pred ceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 55 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 55 ~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
.+.||.|.||.|| ++|+.||||++.+..+...+. .++++|+.+|+++.||.||.+--.|+..+.+++|||.+ .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 4689999999998 579999999998766654333 78999999999999999999999999999999999999 6
Q ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC---CEEEeecccccccccCCCC
Q 018614 130 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 130 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~---~vkl~Dfg~a~~~~~~~~~ 204 (353)
|++.+.+. +.+++++.....++.||+.||+|||.++ |+|+||||+|||+.+.. .+||||||+|+.+.....
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 67777764 4567999999999999999999999999 99999999999998654 599999999999875433
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....||+.|+|||++.+..|+..-|+||.|+++|--++|..||.. .+++..++.+...+....++..++.+..+||
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHH
Confidence 3457799999999999999999999999999999999999999974 3456666766555555567788899999999
Q ss_pred HHHcccCCCCCCCHHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
..+|+..-.+|-+.++.+.|-+
T Consensus 800 n~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred HHHHHHHHHHhcchHhhccchh
Confidence 9999999999999999887753
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=283.22 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=196.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec--CceE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 121 (353)
.+|+..+.||+|+||.+|. +|..+|+|.+..... .......+.+|+.+++++ +|+||+++++++... ...|
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4688899999999998873 478899998854322 223345677899999999 999999999988643 3579
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
+||||++ ++|.+++... .+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999995 5999998765 6889999999999999999999999 999999999999999999999999999876443
Q ss_pred CCC----CcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-----------
Q 018614 202 EDR----PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----------- 265 (353)
Q Consensus 202 ~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----------- 265 (353)
... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 221 2223457888999998765 457889999999999999999999997655433322221111
Q ss_pred ----------------CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 ----------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 ----------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..........++.++.++|.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 011111112357889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=281.30 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=196.0
Q ss_pred Ccc-cceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHH-----------HHHHHHHHHHHHhcCCCCcccceeeE
Q 018614 51 DFT-NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD-----------RVRAFRDELALLQKIRHPNVVQFLGA 113 (353)
Q Consensus 51 ~~~-~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~ 113 (353)
+|. ..+.||.|+||.||. .|+.||||.+......... ....+.+|+.++++++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 454 457799999999873 5788999998654322100 01246789999999999999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 114 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 114 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
+......++|||++. ++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcc
Confidence 999999999999995 699999988777999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCC-------------CCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHH
Q 018614 194 VSKLLTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 259 (353)
Q Consensus 194 ~a~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 259 (353)
++....... ........++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 987654111 1111223356789999998764 46889999999999999999999998776544333
Q ss_pred HHHhcCCCCCC------------------------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 260 AYAARQRPPFK------------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 260 ~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+......+.. ......+.++.++|.+||..+|++||++++++.+
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 32221100000 0012346779999999999999999999999976
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=274.24 Aligned_cols=247 Identities=28% Similarity=0.481 Sum_probs=197.1
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|+..+.||.|++|.+|. +++.+|+|.+.... ........+..|+.+++.++|+|++++++++.+....++|+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 55677899999998873 58899999987653 2233345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 96 6999999876 46999999999999999999999999 99999999999999999999999999877643322 1
Q ss_pred cccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC------------------
Q 018614 206 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------------ 266 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------ 266 (353)
......+..|+|||.+.+. .++.++||||||++++++++|.+||......+....+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2223346679999998776 788999999999999999999999977654333222211100
Q ss_pred --CCCC-----CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 --PPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 --~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+... ......+..+.+++.+||..||++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 0011236789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.83 Aligned_cols=246 Identities=27% Similarity=0.446 Sum_probs=194.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
+|...+.||+|+||.||. .+..+++|+++..... .......+..|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 478889999999999883 2334555555432211 112223466789999999999999999999988999999
Q ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 124 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 345899999999999999999999999 999999999999986 579999999987764
Q ss_pred cCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+ ..+..++.+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP---SLPETYSRQ 232 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC---CCcchhcHH
Confidence 3322 122344677899999998888899999999999999999999999765443333333222222 234567889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.++|.+||..+|++||++.+++++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhC
Confidence 9999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=300.71 Aligned_cols=144 Identities=29% Similarity=0.516 Sum_probs=131.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|...+.||+|+||.||. .++.||||++.............+..|+.+++.++|+||+++++.+......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 4688899999999999873 47899999997655555566677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
||+.+++|.+++...+.+++..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999988777999999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=279.04 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=193.0
Q ss_pred CcccceeeecceEEEEEE-----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec----C
Q 018614 51 DFTNSVEITKGTFILAFW-----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----S 118 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~----~ 118 (353)
+|+..+.||+|+||.||. . +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 477889999999998872 3 6689999986532 2233345678899999999 599999999875322 4
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..++++|++ +++|.+++.....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 578999998 5799999987778999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCC---CcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC---------
Q 018614 199 TVKEDR---PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--------- 265 (353)
Q Consensus 199 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------- 265 (353)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+.......+....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432211 1123457888999998765 468899999999999999999999997655332222111100
Q ss_pred ------------------CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 ------------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 ------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...+.......+..+.+|+.+||+.||++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 001111112246789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=267.54 Aligned_cols=245 Identities=26% Similarity=0.400 Sum_probs=196.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
+.+....||.|.||.|. ..|...|||.++.... ....++++.|.....+- +.||||+++|+.-.++..||.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 45666789999999986 4789999999987654 33446677787765555 6899999999999999999999
Q ss_pred ecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 125 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 125 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
|+| ..+|+.+.+ .+..+++..+-.|....+.||.||...- .+||||+||+|||++..|.|||||||.+-.+.
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999 678887765 3456899999999999999999998754 29999999999999999999999999987664
Q ss_pred cCCCCCcccCCCCCcccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH---HhcCCCCCCCc--
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQRPPFKAP-- 272 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~~~~~~-- 272 (353)
..-. .+...|...|||||.+.. ..|+.++||||||++|||+.||+.||...+. +.+++ ..+..+.+...
T Consensus 220 ~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 220 DSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCccc
Confidence 3322 233446678999999853 3589999999999999999999999988764 33333 23333322222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.-.++..+..+|..||.+|-+.||.+.+|+++
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 23478899999999999999999999999876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=280.97 Aligned_cols=246 Identities=28% Similarity=0.391 Sum_probs=196.3
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc----
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 119 (353)
..+|+....||.|++|.+|. ++..||+|++..... .......+.+|+.+++.++|+||+++.+++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 34699999999999998873 478899999865422 23334567789999999999999999988765544
Q ss_pred --eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 120 --MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 120 --~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
.++|+|++ +++|.+++.. ..+++..++.++.|++.||.|||+.| ++|+||+|+||++++++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 7799999875 45999999999999999999999999 99999999999999999999999999877
Q ss_pred cccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC--------
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-------- 268 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------- 268 (353)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......+
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 5432 222346778999998865 367889999999999999999999998665443333322211100
Q ss_pred -------------------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+......++..+.+||.+||+.||++|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000112347889999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=278.03 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=193.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------ 117 (353)
..+|+..+.||+|+||.|+. +|..||+|++..... .......+.+|+.++++++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 35799999999999998862 578999999865421 223345677899999999999999999988643
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
...+++++++ +++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3468888887 78999888654 5899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC---------
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--------- 267 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------- 267 (353)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+......
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 4321 223456778999998866 46788999999999999999999999765543322222111100
Q ss_pred ------------------CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+.......++++.++|.+||..||++||++.+++.|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000011246778999999999999999999999988
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=291.23 Aligned_cols=254 Identities=24% Similarity=0.477 Sum_probs=220.1
Q ss_pred CcccceeeecceEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceE
Q 018614 51 DFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 121 (353)
.....+.||.|.||.||+. ..+||||++.... ..+.-.++..|+.++..++|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 4666789999999999842 3589999987653 3445578999999999999999999999998765 88
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 122 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
||++|+++|+|.|+++.. ..+-....+.|..||++||.|||.+. ++||||-+.|||+.....||+.|||+++....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999999864 45888999999999999999999998 99999999999999999999999999998865
Q ss_pred CCCCCc-ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 201 KEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 201 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
....-. .....++.|+|-|.+....|+.++||||+||++||++| |..||.+...+++...+..+.+.+ .+..++.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs---qPpiCti 927 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS---QPPICTI 927 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC---CCCCccH
Confidence 543322 23345678999999999999999999999999999998 999999999999999987777633 3456888
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
++..++.+||..|++.||+++++...+.++.....
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 89999999999999999999999999998866543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=278.76 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=194.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 118 (353)
.+|+..+.||+|+||.|+. +|..||||.+.... ........+.+|+.++++++||||+++++++....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 4699999999999998873 57899999986532 23334456789999999999999999999987543
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..++|||++ +++|.+++.. ..+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999999 7899988865 45899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC----------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP---------- 267 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------- 267 (353)
... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+......
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 169 DSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 322 123346778999999876 45788999999999999999999999865432222221111000
Q ss_pred -----------------CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 -----------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 -----------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+......++..+.++|.+||..||++||++.+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000112456779999999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=276.44 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=194.3
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-cCceE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMM 121 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 121 (353)
...+|+..+.||.|+||.|+. +|..||+|.+..... .......+..|+.+++.++||||+++.+++.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 345799999999999998873 578899998865432 22334567889999999999999999999865 56789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
+++||+ +++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 999999 67999888643 5888899999999999999999999 999999999999999999999999998754321
Q ss_pred CCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHh-----------------
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA----------------- 263 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~----------------- 263 (353)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+..
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 122345678999998765 5688999999999999999999999976543211111100
Q ss_pred -------cC---CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 264 -------RQ---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 264 -------~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.. ..+.......++.++.++|.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000112356889999999999999999999999977
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=274.95 Aligned_cols=251 Identities=28% Similarity=0.404 Sum_probs=192.0
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------ 117 (353)
..+|+..+.||.|+||.||. ++..+|+|.+......+ .....+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 35799999999999998873 57889999886543222 1123467899999999999999999987543
Q ss_pred --CceEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 118 --SPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 118 --~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
...++|+||+. ++|...+.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 34699999995 577777764 346999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC----------cccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHh
Q 018614 195 SKLLTVKEDRP----------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 263 (353)
Q Consensus 195 a~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 263 (353)
+.......... .....+++.|+|||.+.+. .++.++||||||+++|+|++|++||.+.........+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 97654332111 1123456779999987654 578899999999999999999999987655443333221
Q ss_pred cCCCC----------------------CCC----chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 264 RQRPP----------------------FKA----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 264 ~~~~~----------------------~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+ ... ....+++.+.+++.+||+.||++|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11000 000 001234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=267.93 Aligned_cols=245 Identities=24% Similarity=0.407 Sum_probs=192.4
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEEe
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e 125 (353)
|+..+.||.|++|.||. .++.|+||.+...... .+ .....+|+..++++. |+||+++++++.++...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 56778999999998873 4678999998654321 11 123456899999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+ +++|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 99 789999887654 6899999999999999999999999 9999999999999999999999999997664322
Q ss_pred CCcccCCCCCcccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC--------------
Q 018614 204 RPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-------------- 268 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------- 268 (353)
......++..|+|||.+. +..++.++|+||||+++++|++|++||......+....+......+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122344677899999874 4467899999999999999999999997665433322221110000
Q ss_pred ------------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 ------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
........+..+.+++++||..+|++||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000001225779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=244.91 Aligned_cols=249 Identities=24% Similarity=0.434 Sum_probs=202.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|...++||+|+||.|++ +++.||+|.++.+.- ++..-....+|+-+++.++|.||++++++...+..+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 3577788999999999984 478899999976532 2222245678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||| ..+|..+... ++.++...+..++.|++.||.++|+++ +.|||+||.|.+|+.+|.+|++|||+++.+..+..
T Consensus 81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 999 6799999876 556999999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCC-------------
Q 018614 204 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP------------- 268 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~------------- 268 (353)
.......|.+|.+|.++.+. .|+...|+||.||++.|+.. |++.|++.+.++....+-.....+
T Consensus 157 -cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred -eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 22234568899999998876 57899999999999999985 999999988777666553322111
Q ss_pred CCCc------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 FKAP------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ~~~~------------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+. ...++..-+++++++|.-+|..|.++++.++|
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1000 01223346789999999999999999998876
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.18 Aligned_cols=242 Identities=31% Similarity=0.493 Sum_probs=187.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe---------
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 116 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------- 116 (353)
+|+....||+||||.|+ .+|+.+|||++.... .......+.+|+.+|.+|+|||||+++..+.+
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 57788899999999987 479999999998764 45666788999999999999999999842200
Q ss_pred --------------------------------------------------------------------------------
Q 018614 117 -------------------------------------------------------------------------------- 116 (353)
Q Consensus 117 -------------------------------------------------------------------------------- 116 (353)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------c--------CceEEEEecCCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhcC
Q 018614 117 ----------------------S--------SPMMIVTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHENK 165 (353)
Q Consensus 117 ----------------------~--------~~~~iv~e~~~~~~L~~~l~~~~~~-~~~~~~~i~~qi~~al~~Lh~~~ 165 (353)
+ ..+||-||||+...|.+++.++... .....|+++++|+.||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 1258899999887788887765433 47889999999999999999999
Q ss_pred CCCEEecCCCCCCEEEcCCCCEEEeecccccccc-----------------cCCCCCcccCCCCCcccCccccCCCC---
Q 018614 166 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT-----------------VKEDRPLTCQDTSCRYVAPEVFKNEE--- 225 (353)
Q Consensus 166 ~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~~--- 225 (353)
+|||||||.|||++.++.|||+|||+|+... .......+...||.-|+|||++.+..
T Consensus 718 ---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 718 ---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred ---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999998721 01112335677999999999997765
Q ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCc----hhhhHHHHHHHHHHHcccCCCCCCCHHHH
Q 018614 226 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP----AKLYARGLKELIEECWNEKPAKRPTFRQI 301 (353)
Q Consensus 226 ~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~l 301 (353)
|+.|+|+||||++++||+. ||...- +....+..-....++.. .+.++. -..+|+.+++.||++||||.+|
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~LR~g~iP~~~~f~~~~~~~-e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTNLRKGSIPEPADFFDPEHPE-EASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHhcccCCCCCCcccccccchH-HHHHHHHHhcCCCccCCCHHHH
Confidence 9999999999999999985 564322 22222222222222222 223333 4579999999999999999999
Q ss_pred HH
Q 018614 302 IT 303 (353)
Q Consensus 302 l~ 303 (353)
|+
T Consensus 869 L~ 870 (1351)
T KOG1035|consen 869 LN 870 (1351)
T ss_pred hh
Confidence 85
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=265.03 Aligned_cols=250 Identities=25% Similarity=0.389 Sum_probs=191.0
Q ss_pred CcccceeeecceEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-cCce
Q 018614 51 DFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 120 (353)
.|+....||+|+||.||+. ...+|||.++.+.-.. ..-...-+|+.+++.++||||+.+..+|.. +..+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 5888899999999999852 3378999987652111 111344679999999999999999999877 7789
Q ss_pred EEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC----CCEEEee
Q 018614 121 MIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVAD 191 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~----~~vkl~D 191 (353)
++++||.+. +|.+++.- ...++...+..|++||+.|+.|||++. |+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 89998862 224899999999999999999999999 9999999999999977 8999999
Q ss_pred cccccccccCCCC--CcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------chHH
Q 018614 192 FGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------EVPK 259 (353)
Q Consensus 192 fg~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~---------~~~~ 259 (353)
+|+++.+...-.. .......|.+|.|||.+.|. .|+.+.|||+.||++.||++-.+.|.+.... ....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999988654322 22344578999999998876 5789999999999999999998888543210 0111
Q ss_pred HHHh-cCCCC------CCCch--------------------------hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 260 AYAA-RQRPP------FKAPA--------------------------KLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 260 ~~~~-~~~~~------~~~~~--------------------------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
.+.. .+.|. +...+ ..-++...+|+.++|..||-+|.|+++.+++.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111 11110 00000 00124477899999999999999999999884
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=278.45 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=194.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 118 (353)
.+|.....||+|+||.|+. +|..||+|.+..... .......+.+|+.+++.++|+||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 3688899999999998873 578999999865432 2233356788999999999999999999986543
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..++|+||+. .+|..+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 4699999994 57877653 35899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC-----------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----------- 266 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------- 266 (353)
... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.....
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 321 122345778999999876 4678899999999999999999999987654333222211100
Q ss_pred -----------CCCC-----CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHH
Q 018614 267 -----------PPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINN 310 (353)
Q Consensus 267 -----------~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--l~~~~~ 310 (353)
+... ......+..+.+||.+||+.||++||++.+++.| ++.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000 0012356778999999999999999999999977 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=284.92 Aligned_cols=237 Identities=27% Similarity=0.399 Sum_probs=195.3
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
..|+....+|.|+|+.+. .++...++|++..... ...+|+.++... +||||+++.+.+.++...|+|
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 357777789999998775 3577889999876521 234566555555 799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE-cCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill-~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||.+.|+-|.+.+.....+. ..+..|+.+|+.|+.|||++| ++||||||+|||+ ++.|+++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999998888887665555 788889999999999999999 9999999999999 69999999999999887544
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.....-|..|.|||++....++.++||||||++||+|++|+.||...... ++... .+.+.+. ..+|.+.+
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~---i~~~~~s---~~vS~~AK 540 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR---IQMPKFS---ECVSDEAK 540 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh---hcCCccc---cccCHHHH
Confidence 11223467899999999999999999999999999999999999887666 22222 2223222 56889999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
+||.+||+.||.+|+++.++..|-.-
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999988554
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=278.92 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=191.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------ 117 (353)
..+|+..+.||.|+||.||. +|..||+|.+..... +....+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 35799999999999999873 478999998865432 3446678899999999999999999876543
Q ss_pred --------CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-CCCEE
Q 018614 118 --------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLK 188 (353)
Q Consensus 118 --------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-~~~vk 188 (353)
...|+||||++ ++|.+++.. ..+++..++.++.|++.||.|||+.| ++|+||||+||+++. ++.++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34789999995 689888864 35899999999999999999999999 999999999999984 55789
Q ss_pred EeecccccccccCCCCC--cccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhc-
Q 018614 189 VADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR- 264 (353)
Q Consensus 189 l~Dfg~a~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~- 264 (353)
|+|||++.......... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999987653221111 112245778999998654 56788999999999999999999999765433322221110
Q ss_pred ----------------------CCCCCCC---chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 265 ----------------------QRPPFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 265 ----------------------~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
......+ ....++.++.+|+.+||+.||++||++.+++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000 012356789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=286.72 Aligned_cols=246 Identities=27% Similarity=0.432 Sum_probs=207.3
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEe-----cC
Q 018614 50 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-----SS 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-----~~ 118 (353)
.-|++.+.||+|++|.|| .+|+.+|+|++....-.+ +++..|.++++.+ .|||++.++|+|.. ++
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 357788999999999887 467889999987653222 3566788999988 59999999999853 46
Q ss_pred ceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
.+|+|||||.||+..|++++. ..+.+..+..|++.++.||.+||.+. ++|||||-.|||++.+|.|||+|||++.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 799999999999999999863 45889999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCcccCCCCCcccCccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 197 LLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
..+....+..+ ..||+.|||||++... .|+.++|+||||++..||..|.+|+.++........+..+-.+.+ .
T Consensus 172 QldsT~grRnT-~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL-k 249 (953)
T KOG0587|consen 172 QLDSTVGRRNT-FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL-K 249 (953)
T ss_pred eeecccccccC-cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc-c
Confidence 88876666555 5689999999998654 567799999999999999999999998887666555433322222 2
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+..+++++.+||..||.+|.++||+..++++|
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 367899999999999999999999999999976
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=258.37 Aligned_cols=221 Identities=19% Similarity=0.257 Sum_probs=176.1
Q ss_pred ceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCHHHH
Q 018614 61 GTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 135 (353)
Q Consensus 61 G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~ 135 (353)
|.|+.|+ .+|+.+|+|.+.... .+.+|...+....||||+++++++.+....+++|||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 6666665 367899999986542 123344555556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcc
Q 018614 136 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 215 (353)
Q Consensus 136 l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y 215 (353)
+.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+....... ....++..|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 987777999999999999999999999999 9999999999999999999999999876554321 122345679
Q ss_pred cCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCC
Q 018614 216 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295 (353)
Q Consensus 216 ~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 295 (353)
+|||.+.+..++.++|+||+|+++|+|++|..|+...... +..... . ..+..+++.++++|.+||+.||++|
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~--~-~~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTT--L-NIPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccc--c-CCcccCCHHHHHHHHHHccCCHHHh
Confidence 9999998888999999999999999999999887543211 000001 1 1224467889999999999999999
Q ss_pred CCH-----HHHHHH
Q 018614 296 PTF-----RQIITR 304 (353)
Q Consensus 296 ps~-----~~ll~~ 304 (353)
|++ +++++|
T Consensus 221 ~~~~~~~~~~~~~h 234 (237)
T cd05576 221 LGAGVAGVEDIKSH 234 (237)
T ss_pred cCCCccchHHHHcC
Confidence 996 555543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=278.68 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=200.6
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------
Q 018614 49 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------ 117 (353)
...|...+.||+|+||.|| ..|+.||||.++.... ....+...+|++++++++|+|||+++++=...
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 3457777899999999998 3689999999987542 23345678999999999999999999876543
Q ss_pred CceEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc--CCC--CEEEe
Q 018614 118 SPMMIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSG--NLKVA 190 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~--~~~--~vkl~ 190 (353)
....+|||||.||+|...+++ ...+++...+.++.+++.||.|||.+| |+||||||.||++- .+| ..||+
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeee
Confidence 346899999999999999974 345999999999999999999999999 99999999999975 333 47999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----hHHHHHhcC
Q 018614 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQ 265 (353)
Q Consensus 191 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~ 265 (353)
|||.|+.++... ...+..||..|.+||+... +.|+..+|.|||||++|+++||..||-...... +...+..++
T Consensus 167 DfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 167 DFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred cccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 999999887543 5677889999999999984 788999999999999999999999996554442 333332222
Q ss_pred CC------------------CCCCchhhhH----HHHHHHHHHHcccCCCCCC--CHHHHHHHHHHHHHH
Q 018614 266 RP------------------PFKAPAKLYA----RGLKELIEECWNEKPAKRP--TFRQIITRLESINNS 311 (353)
Q Consensus 266 ~~------------------~~~~~~~~~~----~~l~~li~~cl~~dp~~Rp--s~~~ll~~l~~~~~~ 311 (353)
.. .++. +...+ ..+-..+..+|..+|.+|. .+.+....+..+...
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred CCceeEeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11 1111 11222 3355678888999999999 888888777776543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.97 Aligned_cols=244 Identities=23% Similarity=0.372 Sum_probs=188.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.+.....||+|+||.||. +|..||||.+...... ...|+..+++++||||+++++++.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 456667899999999983 5789999988643211 1246788999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++|+|.+++.. +++..+..++.|++.||+|||...+.+++||||||+||+++.++..++. ||.+......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 9999999999963 7899999999999999999995433349999999999999998887775 6654432211
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--chHHHHHh---c-----C-CCCC---CC
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAA---R-----Q-RPPF---KA 271 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~--~~~~~~~~---~-----~-~~~~---~~ 271 (353)
....+++.|+|||++.+..++.++|||||||++|||++|+.||...... ........ . . .+.. ..
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 1224678999999999999999999999999999999999998543211 11111100 0 0 0111 01
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.......++.+++.+||+.||++||+++++++.|+++..
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 112334568899999999999999999999999998754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=254.93 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=193.4
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-------
Q 018614 49 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------- 116 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------- 116 (353)
...|+...+||+|+||.|+ ..|+.||+|++-.+.-.. ..-....+|+.+|..++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3468888899999999876 357788988764321111 111234679999999999999999887742
Q ss_pred -cCceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 117 -SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 117 -~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
...+|+||.+|+. +|.-++.+. .+++...+.+++.++..||.|+|+.. |+|||+||.|+||+.+|.++|+|||+
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 2458999999965 899888765 46999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCC---CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC---CC
Q 018614 195 SKLLTVKED---RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---RP 267 (353)
Q Consensus 195 a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~ 267 (353)
++.+..... ...+....|.+|.+||.+.|. .++++.|||+.||++.||++|.+.+.+.+.-.....+..-. .+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 976643322 223455678999999998765 78999999999999999999999988766544433332100 11
Q ss_pred CCCCch----------------h------------hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 268 PFKAPA----------------K------------LYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 268 ~~~~~~----------------~------------~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
..++.. . .-.++..+|++++|..||.+|+++.+++.|--
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 111000 0 01246779999999999999999999998743
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=263.07 Aligned_cols=244 Identities=26% Similarity=0.302 Sum_probs=193.7
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CC----cccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HP----NVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~----~i~~~~~~~~~~ 117 (353)
..+|++...+|+|+||.|. ..+..||||+++.- ....++.+-|+++++++. .| -++++.++|.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 4579999999999999876 24789999998753 344556678999999993 22 367888899999
Q ss_pred CceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC-----------
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----------- 184 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~----------- 184 (353)
++.|||+|.+ |-++.+++.++. +++..++..++.|++.++++||+.+ ++|.||||+|||+.++
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999 789999998755 4889999999999999999999999 9999999999997532
Q ss_pred ---------CCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 018614 185 ---------GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 255 (353)
Q Consensus 185 ---------~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 255 (353)
-.|+++|||.|++..... .....|..|.|||++.+-.++.++||||+||||+|+++|...|+..++.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 258999999998765433 3345688899999999999999999999999999999999999888765
Q ss_pred chH---HHHHh---------c--------CCCC----------------CCCc------hhhhHHHHHHHHHHHcccCCC
Q 018614 256 EVP---KAYAA---------R--------QRPP----------------FKAP------AKLYARGLKELIEECWNEKPA 293 (353)
Q Consensus 256 ~~~---~~~~~---------~--------~~~~----------------~~~~------~~~~~~~l~~li~~cl~~dp~ 293 (353)
+-. +.+.. . +... ..+. .+.--.+|.|||+.||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 522 11100 0 0000 0000 011124589999999999999
Q ss_pred CCCCHHHHHHH
Q 018614 294 KRPTFRQIITR 304 (353)
Q Consensus 294 ~Rps~~~ll~~ 304 (353)
+|+|+.|++.|
T Consensus 396 ~RiTl~EAL~H 406 (415)
T KOG0671|consen 396 RRITLREALSH 406 (415)
T ss_pred ccccHHHHhcC
Confidence 99999999987
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=256.87 Aligned_cols=254 Identities=30% Similarity=0.457 Sum_probs=199.5
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCcccceeeEEEecC----ce
Q 018614 50 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~~----~~ 120 (353)
...+....||+|.||.|+ ..++.||||+++. +..+.+.+|-++++.. +|+||+++++.-.... .+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 356667889999999998 4689999999853 4456788898888866 7999999999875444 78
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN------KPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~------~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
++|++|.+.|+|.+||..+ .+++....+++..++.||+|||+. .+.+|+|||||..||||.++++..|+|||+
T Consensus 284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999999876 489999999999999999999963 334699999999999999999999999999
Q ss_pred ccccccCCC-CCcccCCCCCcccCccccCCCC-CC-----CchhHHHHHHHHHHHHcCCC------------CCCC----
Q 018614 195 SKLLTVKED-RPLTCQDTSCRYVAPEVFKNEE-YD-----TKVDVFSFALILQEMIEGCP------------PFTM---- 251 (353)
Q Consensus 195 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~DvwslG~il~elltg~~------------pf~~---- 251 (353)
|..+..... .......||.+|||||++.+.. +. .+.||||+|.++||+++... ||..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 998864432 2334578999999999997652 22 37899999999999987532 3320
Q ss_pred -CCCCchHHHHHh-cCCCCCCCchh--hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 252 -KHDNEVPKAYAA-RQRPPFKAPAK--LYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 252 -~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
...+++...+.. +.+|.++.... .....+++.++.||..||+.|.|+.=+.+.+.++..
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 111233333333 33554443221 234568999999999999999999999999988844
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=246.25 Aligned_cols=229 Identities=34% Similarity=0.558 Sum_probs=188.3
Q ss_pred cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHH
Q 018614 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148 (353)
Q Consensus 69 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~ 148 (353)
+|..+++|++........ ...+.+|+..+++++|+||+++++.+......++++|++++++|.+++.....++...++
T Consensus 13 ~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~ 90 (244)
T smart00220 13 TGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEAR 90 (244)
T ss_pred CCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHH
Confidence 468999999876543221 467889999999999999999999999989999999999888999999876668999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCC
Q 018614 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 228 (353)
Q Consensus 149 ~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 228 (353)
.++.+++.++.+||..+ ++|+||+|+||++++++.++|+|||.+....... ......++..|++||.+.+..++.
T Consensus 91 ~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~ 165 (244)
T smart00220 91 FYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGK 165 (244)
T ss_pred HHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCc
Confidence 99999999999999999 9999999999999999999999999998775432 222344677899999999888999
Q ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 229 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 229 ~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++|||+||++++++++|..||..........................++.++.+++.+||..+|++||++.+++++
T Consensus 166 ~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 166 AVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 9999999999999999999997743333222222222222221112277889999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=256.66 Aligned_cols=253 Identities=31% Similarity=0.518 Sum_probs=197.5
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCcccceeeEEEec----CceE
Q 018614 51 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQS----SPMM 121 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~ 121 (353)
+.+..+.||+|.||.|+ |.|+.||||++... + + +...+|.++++.. +|+||+.|++.-..+ .++|
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr---d-E--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR---D-E--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEeccc---c-h--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 56677899999999887 78999999998643 1 2 3567788877764 899999999986543 3589
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-----NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-----~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
+|++|.+.|+|.|+|++. .++....++++..++.||++||. +|+-+|.|||||..|||+.++|..-|+|+|||-
T Consensus 286 LvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred EeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999999999874 58999999999999999999994 566679999999999999999999999999997
Q ss_pred ccccCCC---CCcccCCCCCcccCccccCCCC----C--CCchhHHHHHHHHHHHHc----C------CCCCCCCCCC--
Q 018614 197 LLTVKED---RPLTCQDTSCRYVAPEVFKNEE----Y--DTKVDVFSFALILQEMIE----G------CPPFTMKHDN-- 255 (353)
Q Consensus 197 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~----~--~~~~DvwslG~il~ellt----g------~~pf~~~~~~-- 255 (353)
....... .......||.+|||||++.... + -..+||||||.++||++- | ++||.+..+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 7654422 2234567999999999986542 2 136999999999999964 2 5788665432
Q ss_pred ---chHHHHH-hcCCCCCCCchhh--hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 256 ---EVPKAYA-ARQRPPFKAPAKL--YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 256 ---~~~~~~~-~~~~~~~~~~~~~--~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
++.+-+- ...+|.++..... .-..+..+|+.||..||..|.|+=.+.+.|.++.+
T Consensus 445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2222221 2224444443332 23568889999999999999999999999988865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=252.14 Aligned_cols=240 Identities=24% Similarity=0.410 Sum_probs=199.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
+|.....||+|+|..|. ++.+.+|+|+++++.+.+++.+.=.+.|-.++.+- +||.+|-+..+|+.+.++++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 68888999999997654 46788999999998888777777778888888887 6999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||++||+|--+++++.+++++.++.+...|+.||.|||++| ||+||||.+|||+|..|++||+|+|+.+.--.+...
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 99999999999998889999999999999999999999999 999999999999999999999999999865443333
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC--CC-----CCchHHHHHhcCCCCCCCchhhhH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM--KH-----DNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~--~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
...+-||+.|.|||++.+..|+...|+|+||++|+||+.|+.||.- ++ .++...++...+.-.+ +..++
T Consensus 408 -tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---prsls 483 (593)
T KOG0695|consen 408 -TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---PRSLS 483 (593)
T ss_pred -cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---cceee
Confidence 3346689999999999999999999999999999999999999953 11 1222222222221111 22344
Q ss_pred HHHHHHHHHHcccCCCCCCC
Q 018614 278 RGLKELIEECWNEKPAKRPT 297 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps 297 (353)
-....+++.-|++||.+|..
T Consensus 484 vkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcC
Confidence 44667899999999999953
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=269.34 Aligned_cols=241 Identities=24% Similarity=0.354 Sum_probs=200.7
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|..++.||-|.||.|.. +...+|+|.+++..+...........|-.+|..-+.+-||+++..|.+...+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 66788999999998752 3456899999887766777778889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC---
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--- 203 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~--- 203 (353)
++||++-.+|-+-+-|.+..++.++..+..|+++.|..| +|||||||+|||||.+|++||+||||+.-+.....
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999999999998888999999999999999999999999 99999999999999999999999999864321100
Q ss_pred ----------------------C----------------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcC
Q 018614 204 ----------------------R----------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 245 (353)
Q Consensus 204 ----------------------~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 245 (353)
. .-.+..||+.|+|||++....++..+|+||.|+|||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 0 00234689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCC
Q 018614 246 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 296 (353)
Q Consensus 246 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 296 (353)
++||......+....+.+.....--.....+++++.++|.++.. +++.|.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 99998887777665553333222223356788999999887653 356663
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.40 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=199.5
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCH----HHHHHHHHHHHHHhcCCCCcccceeeEEE-ecCc
Q 018614 50 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDD----DRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 119 (353)
.+|-....||+|+|..|| ...+.||||+-....-..+ .......+|..+.+.|+||.||+++++|. +...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 367788899999998876 3578899998654332222 23345568999999999999999999996 5567
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---CCCEEEeeccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSK 196 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~~~vkl~Dfg~a~ 196 (353)
+|-|+|||+|.+|+-||+....+++..++.|+.||+.||.||.... .+|||-||||.|||+-+ .|.+||+|||+++
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 8999999999999999999888999999999999999999999876 46999999999999864 4679999999999
Q ss_pred ccccCCCCCc------ccCCCCCcccCccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHH--HHh
Q 018614 197 LLTVKEDRPL------TCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKA--YAA 263 (353)
Q Consensus 197 ~~~~~~~~~~------~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~--~~~ 263 (353)
.++....... .-..||.+|++||.+.-+ +.+.+.||||+||++|+++.|+.||.....- ++... +.+
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 9876544321 234689999999987533 5678999999999999999999999754321 11111 111
Q ss_pred cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.....+++ .+.++.+.++||++||++--++|.+..+|..+
T Consensus 702 AtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 702 ATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 12222322 34578899999999999999999998888764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=247.40 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=211.4
Q ss_pred CcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-cCc
Q 018614 51 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSP 119 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 119 (353)
+++....+-+|+||.+|.. .+.|-+|.++... ++-....+..|.-.+..+.|||+.++.++... ...
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 4555667889999998732 3456677776543 34455678889999999999999999998865 456
Q ss_pred eEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 120 MMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
.++++.+..-|+|..++... ..++..+...++.|++.|++|||.++ +||.||.+.|.+||+.-.|||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEecc
Confidence 78999999889999999732 12667788899999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCC
Q 018614 192 FGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 269 (353)
Q Consensus 192 fg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 269 (353)
-.+++.+-...... ......+..||+||.+.+..|+..+|+||||++||||+| |+.||.+-++.++...+..+.+..
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla- 518 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA- 518 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec-
Confidence 99998765433322 223345778999999999999999999999999999998 999999999988887776655433
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
.+.++|.++..++.-||+..|++||+++|+..-|.++..++.
T Consensus 519 --QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 519 --QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred --CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 345789999999999999999999999999999999988765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=258.62 Aligned_cols=243 Identities=24% Similarity=0.358 Sum_probs=197.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC------CCcccceeeEEEecCc
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGAVTQSSP 119 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~ 119 (353)
+|.+....|+|.|+.|. ..|..||||+++...+.. ..=+.|+++|+.|+ -.++++++..|.+.++
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 67778889999999876 357899999998754332 23357999999995 2479999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEeecccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVS 195 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~Dfg~a 195 (353)
+|+|+|.+ ..+|.++|+..+. +....+..++.|++.||..|...| |+|+||||+|||++... .+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999998 7799999987553 788999999999999999999999 99999999999999654 5899999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC-CC------
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PP------ 268 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~------ 268 (353)
..... +..+.+..+..|.|||++.|-.|+...|+||+||+||||+||+..|++.++..+.......+. .+
T Consensus 585 ~~~~e---neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASE---NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccc---ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 77653 333445566789999999999999999999999999999999999999888776644322110 00
Q ss_pred -------------------------------------------------CCCchhhhHHHHHHHHHHHcccCCCCCCCHH
Q 018614 269 -------------------------------------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFR 299 (353)
Q Consensus 269 -------------------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 299 (353)
++......-..|++|+.+||..||++|.+..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 0000111235699999999999999999999
Q ss_pred HHHHH
Q 018614 300 QIITR 304 (353)
Q Consensus 300 ~ll~~ 304 (353)
+.|+|
T Consensus 742 qAL~H 746 (752)
T KOG0670|consen 742 QALKH 746 (752)
T ss_pred HHhcC
Confidence 99987
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=272.78 Aligned_cols=239 Identities=26% Similarity=0.390 Sum_probs=187.7
Q ss_pred cccceeeecceEEEE----EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILA----FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|...+.+|.|+-|.+ .+.|+.||||.+-.+. .....+|+..|+.- +||||+++++.-.+.+..||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 444556788776543 3678999999985432 23457899999998 599999999999999999999999
Q ss_pred CCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---C--CCEEEeecccccc
Q 018614 127 LPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---S--GNLKVADFGVSKL 197 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~--~~vkl~Dfg~a~~ 197 (353)
| ..+|.++++.... ......+.++.|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9 6799999987411 112456788999999999999999 999999999999986 3 3689999999999
Q ss_pred cccCCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCc-h
Q 018614 198 LTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP-A 273 (353)
Q Consensus 198 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~ 273 (353)
+...... ......||-+|+|||++.....+.++|||||||++|+.++ |..||.+.-..+. .|..+........ .
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPL 738 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccC
Confidence 8766543 2345678999999999999888889999999999999998 6999987654332 2333332211111 1
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..+ +..+||.+|++.+|..||++.+++.|
T Consensus 739 ~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 739 PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 112 78999999999999999999999854
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=256.44 Aligned_cols=250 Identities=18% Similarity=0.211 Sum_probs=177.6
Q ss_pred cCcCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHH--------------H
Q 018614 48 HELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRA--------------F 92 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~~~~~--------------~ 92 (353)
...+|...++||+|+||.||. .++.||||.+.... ....+. .
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~---~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR---QGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc---hhhHHHHHhhhhhhhcccchh
Confidence 345799999999999999983 24579999986432 111122 2
Q ss_pred HHHHHHHhcCCCCc-----ccceeeEEEe--------cCceEEEEecCCCCCHHHHHHhcC-------------------
Q 018614 93 RDELALLQKIRHPN-----VVQFLGAVTQ--------SSPMMIVTEYLPKGDLRAFLKRKG------------------- 140 (353)
Q Consensus 93 ~~E~~~l~~l~h~~-----i~~~~~~~~~--------~~~~~iv~e~~~~~~L~~~l~~~~------------------- 140 (353)
..|+..+.+++|.+ ++++++++.. .+..++||||+++++|.+++....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 34666667776554 3667777643 356899999999999999986421
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcc
Q 018614 141 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 215 (353)
Q Consensus 141 -----~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y 215 (353)
.+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++...............+++.|
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y 376 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence 1345678889999999999999999 99999999999999999999999999976543322222223347899
Q ss_pred cCccccCCCC--------------------C--CCchhHHHHHHHHHHHHcCCC-CCCCCCCC--------chHHHH--H
Q 018614 216 VAPEVFKNEE--------------------Y--DTKVDVFSFALILQEMIEGCP-PFTMKHDN--------EVPKAY--A 262 (353)
Q Consensus 216 ~aPE~~~~~~--------------------~--~~~~DvwslG~il~elltg~~-pf~~~~~~--------~~~~~~--~ 262 (353)
+|||.+.... + ..+.||||+||++++|++|.. ||...... .....+ .
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 9999875432 1 124699999999999999875 76532111 111111 1
Q ss_pred hcCCCCCCCchhhhHHHHHHHHHHHcccCC---CCCCCHHHHHHH
Q 018614 263 ARQRPPFKAPAKLYARGLKELIEECWNEKP---AKRPTFRQIITR 304 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~~ll~~ 304 (353)
......+. .....+....+|+.++|..+| .+|+|++++|+|
T Consensus 457 ~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11122222 234467889999999999876 689999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=224.89 Aligned_cols=196 Identities=26% Similarity=0.451 Sum_probs=161.3
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEe
Q 018614 52 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
......||+|+||.|. .+|...|+|.++... . .+...++.+|+.+..+. ..|++|.++|...+.+..||.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 4456789999999764 589999999998754 2 33345677788887766 69999999999999999999999
Q ss_pred cCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 126 YLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 126 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
.| ..+|+.+.. ..+.+++..+-+|+..++.||.|||++=+ +||||+||+|||++..|+||+||||.+-.+.+.
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 99 568877664 35568999999999999999999999752 999999999999999999999999998776543
Q ss_pred CCCCcccCCCCCcccCccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMKHD 254 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~~~ 254 (353)
-.. +...|...|+|||.+.. ..|+.++||||||++++||.+++.||+....
T Consensus 203 iAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 203 IAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred hHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 222 22345667999998743 3789999999999999999999999986643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=265.44 Aligned_cols=245 Identities=19% Similarity=0.227 Sum_probs=163.3
Q ss_pred CcCcccceeeecceEEEEEE-----c----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeE------
Q 018614 49 ELDFTNSVEITKGTFILAFW-----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA------ 113 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~------ 113 (353)
..+|+..+.||+|+||.||. + +..||+|.+.... .. +....+ .+++..+.++..++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AV---EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hh---HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 44799999999999999984 3 6889999875432 11 111111 1222222233222221
Q ss_pred EEecCceEEEEecCCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecC
Q 018614 114 VTQSSPMMIVTEYLPKGDLRAFLKRKGA--------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173 (353)
Q Consensus 114 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~d 173 (353)
...+...++|+||+++++|.+++..... .....+..++.|++.||.|||+.+ |+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCc
Confidence 2345678999999999999999875421 112346679999999999999999 99999
Q ss_pred CCCCCEEEcC-CCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCC----------------------CCCCch
Q 018614 174 LEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE----------------------EYDTKV 230 (353)
Q Consensus 174 lkp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~ 230 (353)
|||+|||++. ++.+||+|||+++..............+++.|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999995 67899999999987654333333345678899999965322 233467
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC----------CCCCCCc-------hhhhHHHHHHHHHHHcccCCC
Q 018614 231 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----------RPPFKAP-------AKLYARGLKELIEECWNEKPA 293 (353)
Q Consensus 231 DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----------~~~~~~~-------~~~~~~~l~~li~~cl~~dp~ 293 (353)
|||||||++|||+++..++.... ......+.... ....... .........+||.+||+.||+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999999776643210 00001110000 0000000 001123355899999999999
Q ss_pred CCCCHHHHHHH
Q 018614 294 KRPTFRQIITR 304 (353)
Q Consensus 294 ~Rps~~~ll~~ 304 (353)
+|||++++++|
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999987
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=237.35 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=194.6
Q ss_pred CcCcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------C
Q 018614 49 ELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 118 (353)
..+|...+-+|.|.-..+- ..+++||+|++..+. ......+...+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCceEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 3467777778877663222 368899999987763 3333334567899999999999999999998643 3
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|+|||++ ..+|.+.+.. .++-..+..++.|++.|+.|||+.| |+||||||+||++..+..+||.|||+|+..
T Consensus 95 e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 579999999 6799998873 3778899999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCC---------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF--------- 269 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------- 269 (353)
... -..+.+..+..|.|||++.+..+...+||||+||++.||++|...|++.+.-+...++......+-
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 543 344567788899999999999999999999999999999999999987766433322221110000
Q ss_pred ---------------------C-----C---chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 270 ---------------------K-----A---PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 270 ---------------------~-----~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+ . ....-+..+++++.+||..||++|.|++++|.|
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0 000112458899999999999999999999987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-33 Score=260.86 Aligned_cols=247 Identities=26% Similarity=0.418 Sum_probs=211.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+....+|.|+||-||+ +|+..|+|+++.+.. +....+++|+-+++..+||||+.++|.+......||.||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 588888999999999884 588999999977643 334567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
||.||+|.+...-.+++++.++..+.+..+++|+|||+.| -+|||||-.||++++.|.+|++|||.+-.+...-.+
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~K- 168 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK- 168 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhh-
Confidence 9999999999988889999999999999999999999999 899999999999999999999999998877644333
Q ss_pred cccCCCCCcccCcccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHHHHH
Q 018614 206 LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLK 281 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 281 (353)
..++.||+.|||||+- ..+.|...+|||++|++..|+-.-++|-....+........+.. .++.......+++.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 3457799999999975 45688999999999999999998888877666655555554444 3333334567889999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+|++.+|.++|.+||+++.+|.|
T Consensus 249 ~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHhcCCCccCCChhhheec
Confidence 99999999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=224.01 Aligned_cols=260 Identities=15% Similarity=0.268 Sum_probs=221.8
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEE
Q 018614 49 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~i 122 (353)
...|.++++||+|+||+.+ +++++||||.-.... ...++..|.+..+.|. .++|+.++.+...+..-.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 4579999999999999876 578999999865432 1246788999999985 7999999999988888899
Q ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-----CEEEeeccccc
Q 018614 123 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVSK 196 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-----~vkl~Dfg~a~ 196 (353)
|+|++ |.+|.|++.-++ .|+...+..+|.|++.-++|+|++. +|+|||||+|+||...+ .+.++|||+|+
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99999 899999998554 5999999999999999999999999 99999999999998654 59999999999
Q ss_pred ccccCCCCC------cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC----C
Q 018614 197 LLTVKEDRP------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----R 266 (353)
Q Consensus 197 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----~ 266 (353)
.+.++.... ..+..||.+||+--.+.|.+.+.+.|+-|||-++++++-|..||.+.........+.+.+ .
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 987654432 356779999999999999999999999999999999999999999988877766665433 3
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhccc
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 317 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 317 (353)
.++......+|.++...++-.-..+-.+-|+++.+...+.++.........
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D 308 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD 308 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence 344445667899999999999999999999999999999999887665544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=220.95 Aligned_cols=241 Identities=19% Similarity=0.365 Sum_probs=188.6
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEec--CceE
Q 018614 50 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~ 121 (353)
.+|+..+++|+|.|+.|+ .+++.++||++++-. ...+.+|+.+|+.|. ||||++++++..+. ....
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 479999999999998776 467889999986532 256889999999996 99999999998764 4578
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEeeccccccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTV 200 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~Dfg~a~~~~~ 200 (353)
+|+|++.+.+...+.. .++...+...+.++++||.|+|+.| |.|||+||.|++||... .++|+|+|+|.++..
T Consensus 112 LiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999998877777654 3788899999999999999999999 99999999999999654 599999999999875
Q ss_pred CCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCC-CCCCCchHHHHHhcC------------C
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQ------------R 266 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~-~~~~~~~~~~~~~~~------------~ 266 (353)
...... ...+..|-.||.+.. +.|+..-|+|||||++..|+..+.||- +.++.+....+.+.. .
T Consensus 186 ~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 GKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred Cceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 543322 334557889998854 568899999999999999999888874 444333222221100 0
Q ss_pred CCCCC---------------------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 PPFKA---------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ~~~~~---------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..+++ ....++++..||+.++|..|-++|+|++|.+.|
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00100 112346889999999999999999999999987
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=217.44 Aligned_cols=207 Identities=38% Similarity=0.660 Sum_probs=177.7
Q ss_pred eecceEEEEEE---c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCH
Q 018614 58 ITKGTFILAFW---R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132 (353)
Q Consensus 58 ig~G~~~~v~~---~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 132 (353)
||.|.+|.+|. . |..+++|++....... ....+.+|+..++.++|++|+++++++......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 57888887763 3 7899999987653211 346788999999999999999999999998999999999988999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-CCCEEEeecccccccccCCCCCcccCC
Q 018614 133 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQD 210 (353)
Q Consensus 133 ~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 210 (353)
.+++... ..++...++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 9999875 46899999999999999999999999 999999999999999 89999999999987654321 122234
Q ss_pred CCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcc
Q 018614 211 TSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 289 (353)
Q Consensus 211 ~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 289 (353)
+...|++||..... .++.++|+|++|++++++ ..+.+++..|+.
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence 56689999999887 888999999999999999 557899999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 018614 290 EKPAKRPTFRQIITRL 305 (353)
Q Consensus 290 ~dp~~Rps~~~ll~~l 305 (353)
.+|++||++.++++++
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 9999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=233.35 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=198.7
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec-----Cc
Q 018614 50 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 119 (353)
.+.+..+-||-|.||+|+ .+|+.||+|++..- +..-...+.+.+|+.+|..++|.|++..+++..-. ..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 455667889999999998 47999999988642 33344456788999999999999999988876543 23
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
+|+++|.+ ..+|..++-....++.+.+.-++.||+.||.|||+.+ |.||||||.|.|++.+-.+||||||+++...
T Consensus 132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 68889998 5689998887778999999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-------------
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------- 265 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------- 265 (353)
.......+....|-.|.|||++.|. .|+...||||.||++.||+..+..|.....-+..+.+....
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 6655555545567789999999775 68999999999999999999998887665544333332111
Q ss_pred ------------CCCCCC-----chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 266 ------------RPPFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 266 ------------~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
.+.+.. .+..-..+...++.++|..||++|.+..+.+.++
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 011110 1112335677889999999999999999998775
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=233.53 Aligned_cols=126 Identities=28% Similarity=0.376 Sum_probs=106.5
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----C---CcccceeeEEEe
Q 018614 50 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----H---PNVVQFLGAVTQ 116 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~i~~~~~~~~~ 116 (353)
.+|-+.++||+|-|..|+ ...+.||+|+.+.. +...+....|+.+|+++. | ..||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 579999999999998887 25789999998653 344456778999999883 3 369999999965
Q ss_pred ----cCceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc
Q 018614 117 ----SSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 182 (353)
Q Consensus 117 ----~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~ 182 (353)
+.++|+|+|++ |-+|..+|.... .++...+..|++||+.||.|||+.. +|||.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45799999999 889999997643 4999999999999999999999976 599999999999985
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=244.76 Aligned_cols=204 Identities=23% Similarity=0.373 Sum_probs=172.9
Q ss_pred CcccCccCc-CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHH-----HHHHHHHHhcCC---CCcc
Q 018614 42 EYEIDPHEL-DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRA-----FRDELALLQKIR---HPNV 107 (353)
Q Consensus 42 ~~~i~~~~~-~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~-----~~~E~~~l~~l~---h~~i 107 (353)
.|+..+... +|+....+|.|.||.|. .+...|+||.+.++.+.-+.+.+. +-.|+.+|..++ |+||
T Consensus 552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 344444443 68899999999999876 245679999988776544333222 346999999997 9999
Q ss_pred cceeeEEEecCceEEEEecC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC
Q 018614 108 VQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 108 ~~~~~~~~~~~~~~iv~e~~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
++++++|++++.+|++||.. +|.+|.+++..+..+++..+..|+.|++.|+++||++| |||||||-+||.++.+|.
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF 708 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence 99999999999999999975 45799999999888999999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCCCCcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 018614 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTM 251 (353)
Q Consensus 187 vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~ 251 (353)
+||+|||.+......+ ...+.||..|+|||++.|.+| +..-|||+||+++|.+.....||..
T Consensus 709 ~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999998765443 345679999999999999887 5678999999999999988888853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=219.32 Aligned_cols=242 Identities=18% Similarity=0.323 Sum_probs=186.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceee-EEEecCceEEE
Q 018614 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLG-AVTQSSPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~-~~~~~~~~~iv 123 (353)
.|.+.+.+|.|-||... .+.+.+++|.+..+. .....|.+|...--.|. |.||+..++ .|+..+.++++
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 69999999999999765 356789999987763 44568899988877775 899998766 46777888999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC--CCEEEeecccccccccC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVK 201 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~--~~vkl~Dfg~a~~~~~~ 201 (353)
+||++.|+|..-+...+ +-+....+++.|+++|+.|+|+++ +||||||.+||||-+. .+|||||||+.+..+..
T Consensus 101 qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999998886644 788888999999999999999999 9999999999998743 36999999998775433
Q ss_pred CCCCcccCCCCCcccCccccCC---C--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----hHHHHHhcCCCCCCCc
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKN---E--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKAP 272 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~---~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~ 272 (353)
... ...+..|.+||.... + ...+.+|+|.||+++|.++||++||....... ....+..+..+..+..
T Consensus 177 V~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 177 VKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred ehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 222 223456899997642 2 34678999999999999999999997432211 1223334444544445
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...+++.+..+.++-|..++++|--..+..+.
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 56778888999999999999999444444433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-29 Score=215.57 Aligned_cols=207 Identities=31% Similarity=0.547 Sum_probs=172.6
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
|...+.||.|+++.+|. .+..+++|.+...... .....+.+|+..++.++|+|++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 45678899999988763 3688999998765322 2456788999999999999999999999988999999999
Q ss_pred CCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+++++|.+++..... +++..++.++.+++.++.+||..+ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 998899999987766 899999999999999999999998 9999999999999999999999999998775443112
Q ss_pred cccCCCCCcccCcccc-CCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCCC-chHHHHHh
Q 018614 206 LTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDN-EVPKAYAA 263 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~~-~~~~-~~~~~~~~ 263 (353)
.....+...|++||.+ ....++.++|+|+||+++++|++|+.||.. .... ++.+.+..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 2233456789999998 667788899999999999999999999976 3333 44444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=206.53 Aligned_cols=260 Identities=17% Similarity=0.222 Sum_probs=215.9
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-CcccceeeEEEecCceEE
Q 018614 49 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~i 122 (353)
..+|...++||.|+||-.| .+|+.||||+-+...-. .++..|..+.+.|++ ..|+.+..++.+...-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3579999999999998766 47999999998765432 357789999999975 688888888888888899
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---CCCEEEeeccccccc
Q 018614 123 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLL 198 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~~~vkl~Dfg~a~~~ 198 (353)
||+.+ |.+|.++++-+ ..++..+++.++-|++.-++|+|.++ +|||||||+|+|..- ...+.|+|||+++.+
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999 89999999843 45999999999999999999999999 999999999999873 346999999999987
Q ss_pred ccCCCCC------cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC----CCC
Q 018614 199 TVKEDRP------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPP 268 (353)
Q Consensus 199 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----~~~ 268 (353)
.+..... .....||.+|++--.+.+...+.+.|+-|+|.++.++.-|..||.+.....-.+++.+.. ..+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 6543322 245668999999999999999999999999999999999999999887655444443222 233
Q ss_pred CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhccc
Q 018614 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 317 (353)
Q Consensus 269 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 317 (353)
.......+|.++.-.+.-|-..--++-|+...|.+.+.-++..++.+-.
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d 293 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYD 293 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCC
Confidence 3334567899999999999999999999999999999999888876655
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=203.16 Aligned_cols=164 Identities=18% Similarity=0.290 Sum_probs=131.0
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 018614 130 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208 (353)
Q Consensus 130 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 208 (353)
|+|.+++... ..+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999864 45999999999999999999999975 999999999999999 99987764322
Q ss_pred CCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHhcCCCC---CCCchhhhHH--HHHH
Q 018614 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPP---FKAPAKLYAR--GLKE 282 (353)
Q Consensus 209 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~--~l~~ 282 (353)
..+++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....... .......++. ++.+
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD 143 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence 24678999999999999999999999999999999999999765432 2222222222111 1112334444 6999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
++.+||..||++||++.++++++..+..
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 9999999999999999999999987744
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=254.22 Aligned_cols=195 Identities=16% Similarity=0.210 Sum_probs=140.4
Q ss_pred cCCC-CcccceeeEE-------EecCceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEe
Q 018614 101 KIRH-PNVVQFLGAV-------TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIH 171 (353)
Q Consensus 101 ~l~h-~~i~~~~~~~-------~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH 171 (353)
.++| +||..+++.| .+...++.++|++ +++|.+++... ..+++..++.++.||+.||.|||++| |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 3445 5777777776 2334577888988 67999999753 45899999999999999999999999 999
Q ss_pred cCCCCCCEEEcCCCC-------------------EEEeecccccccccCCC---------------CCcccCCCCCcccC
Q 018614 172 RDLEPSNILRDDSGN-------------------LKVADFGVSKLLTVKED---------------RPLTCQDTSCRYVA 217 (353)
Q Consensus 172 ~dlkp~Nill~~~~~-------------------vkl~Dfg~a~~~~~~~~---------------~~~~~~~~~~~y~a 217 (353)
|||||+||||+..|. +|++|||+++....... .......+|+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999965444 55556665543211000 00011346888999
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCC
Q 018614 218 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 297 (353)
Q Consensus 218 PE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 297 (353)
||++.+..++.++|||||||++|||++|.+|+.... .....+.....++. .........+++..||..+|.+||+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQ---ILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChh---hhhcCHHHHHHHHHhCCCChhhCcC
Confidence 999999999999999999999999999988875322 12222211111111 1111334668999999999999999
Q ss_pred HHHHHHH
Q 018614 298 FRQIITR 304 (353)
Q Consensus 298 ~~~ll~~ 304 (353)
+.++++|
T Consensus 259 ~~eil~h 265 (793)
T PLN00181 259 MSELLQS 265 (793)
T ss_pred hHHHhhc
Confidence 9999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=219.52 Aligned_cols=244 Identities=20% Similarity=0.350 Sum_probs=188.9
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCce
Q 018614 50 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 120 (353)
..|....+||.|+|+.|+. ..+.||+|.+..... . ..+.+|+++|..+ .+.||+++.+++..++..
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--P---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--c---hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 4588889999999998872 567899999876432 2 3578999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc-CCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~-~~~~vkl~Dfg~a~~~~ 199 (353)
.+|+||++.....++... ++...+..+++.++.||.++|.+| ||||||||+|+|.+ ..+.-.|+|||+|...+
T Consensus 111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999999998864 678999999999999999999999 99999999999998 45678999999997221
Q ss_pred cCC---------------------------------C----------CCcccCCCCCcccCccccCC-CCCCCchhHHHH
Q 018614 200 VKE---------------------------------D----------RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSF 235 (353)
Q Consensus 200 ~~~---------------------------------~----------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvwsl 235 (353)
... . .......||++|.|||++.. +..++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0 00012358999999999854 567889999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCc-hHHHHH--------------hcC--------------------C---C----------
Q 018614 236 ALILQEMIEGCPPFTMKHDNE-VPKAYA--------------ARQ--------------------R---P---------- 267 (353)
Q Consensus 236 G~il~elltg~~pf~~~~~~~-~~~~~~--------------~~~--------------------~---~---------- 267 (353)
|+++..+++++.||-...++. ....+. .+. . .
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999984433211 000000 000 0 0
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
......+.++..+.+|+++||..||.+|.|+++.|+|
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0000112345578999999999999999999999987
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=213.77 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=198.7
Q ss_pred CcccceeeecceEEEEEE----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC----CcccceeeEE-EecCc
Q 018614 51 DFTNSVEITKGTFILAFW----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH----PNVVQFLGAV-TQSSP 119 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~i~~~~~~~-~~~~~ 119 (353)
+|...+.||+|+||.||. . ...+|+|.......... ..+..|..++..++. +++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 799999999999999883 1 24788888765422111 146678888888862 5889999998 47778
Q ss_pred eEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC-----CCEEEeec
Q 018614 120 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-----GNLKVADF 192 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~-----~~vkl~Df 192 (353)
.||||+.+ |.+|.++.... +.++..+++.++.|++.+|++||+.| ++||||||+|+++... ..+.|.||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 89999999 89999998654 35999999999999999999999999 9999999999999865 35999999
Q ss_pred cccc--ccccCCC------CC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHh
Q 018614 193 GVSK--LLTVKED------RP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 263 (353)
Q Consensus 193 g~a~--~~~~~~~------~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 263 (353)
|+++ .+..... .. .....||.+|+++.++.+...+++.|+||++.++.+++.|..||...........+..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998 3321111 11 2245599999999999999999999999999999999999999977665433333322
Q ss_pred cCCCCCCC-chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 264 RQRPPFKA-PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 264 ~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
........ .....+.++..+...+-..+..++|++..+...+++....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 22111111 2233567788888888889999999999999999888665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-23 Score=189.13 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=199.7
Q ss_pred cccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC-cccceeeEEEecCceEEEEecCC
Q 018614 52 FTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
|.....||.|+|+.|+. ....+++|.+.............+.+|+.+++.+.|+ +++++.+.+......+++++++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 66778899999988773 2357899998876554444567889999999999988 79999999977777899999999
Q ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEeecccccccccCCCC
Q 018614 129 KGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 129 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~Dfg~a~~~~~~~~~ 204 (353)
++++.+++.... .+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||.+.........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999998887664 6899999999999999999999999 99999999999999988 6999999999865443322
Q ss_pred -----CcccCCCCCcccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CchHHHHHhcCCC-CCCC
Q 018614 205 -----PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAYAARQRP-PFKA 271 (353)
Q Consensus 205 -----~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~-~~~~ 271 (353)
......++..|++||.+.+ ...+...|+|++|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2345668899999999987 5788899999999999999999999876654 2333333333222 1111
Q ss_pred chhh----hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 PAKL----YARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 ~~~~----~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.... ....+.+++..++..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111 12568899999999999999999988876
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=196.43 Aligned_cols=176 Identities=21% Similarity=0.212 Sum_probs=131.7
Q ss_pred CCCCCCCcccCccCcCcccceeeecceEEEEEE------cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHhcCCCCcc
Q 018614 36 HAREVPEYEIDPHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNV 107 (353)
Q Consensus 36 ~~~~~~~~~i~~~~~~~~~~~~ig~G~~~~v~~------~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i 107 (353)
...++|.-.+.+...+|...+.||+|+||.||. +|+.||||+...... ........+.+|++++++++|+|+
T Consensus 4 ~~~~~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~i 83 (365)
T PRK09188 4 IDVPLPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGV 83 (365)
T ss_pred CCCCCcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCC
Confidence 334455555666777899999999999999983 466789998653211 123345678999999999999999
Q ss_pred cceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCC-CCCCEEEcCCCC
Q 018614 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGN 186 (353)
Q Consensus 108 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dl-kp~Nill~~~~~ 186 (353)
++.+.. .+..|+||||++|++|... .. .. ...++.|++.||.|||+.| ++|||| ||+|||++.++.
T Consensus 84 v~~l~~---~~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 84 VPQLLA---TGKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred CcEEEE---cCCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCC
Confidence 853322 2467999999999999732 11 11 1467899999999999999 999999 999999999999
Q ss_pred EEEeecccccccccCCCC-------CcccCCCCCcccCccccCCC
Q 018614 187 LKVADFGVSKLLTVKEDR-------PLTCQDTSCRYVAPEVFKNE 224 (353)
Q Consensus 187 vkl~Dfg~a~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~ 224 (353)
++|+|||+++.+...... ......+++.|+|||.+...
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999999976543211 11234567789999988643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-25 Score=214.51 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=184.0
Q ss_pred cceeeecceEEEEEE-----cCeEEEEEEcCc---ccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 54 NSVEITKGTFILAFW-----RGIQVAVKKLGE---EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 54 ~~~~ig~G~~~~v~~-----~g~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
....+|.|.+|.++. .....+.|.++. ......+....+..|+.+-..+.|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 356778888873331 122233333321 111122222336677888888899999887776665555445599
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~- 204 (353)
||++ +|..++...+.+....+-.++.|++.|+.|+|+.| +.|||+|++|++++..|.+||+|||.+.....+-..
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9998 99999988777999999999999999999999999 999999999999999999999999999876544332
Q ss_pred --CcccCCCCCcccCccccCCCCCCC-chhHHHHHHHHHHHHcCCCCCCCCCCCchHH-HHH-h---cCCCCCCCchhhh
Q 018614 205 --PLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVPK-AYA-A---RQRPPFKAPAKLY 276 (353)
Q Consensus 205 --~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~-~---~~~~~~~~~~~~~ 276 (353)
......|...|+|||.+.+..|.+ ..||||.|++++.|.+|+.||......+... ... . ............+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 224456788899999999999987 6899999999999999999997655443321 110 1 1112222234567
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+.+.+|.++|+.||.+|.|+++|++.
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhC
Confidence 8889999999999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=176.98 Aligned_cols=239 Identities=29% Similarity=0.483 Sum_probs=186.3
Q ss_pred ecceEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCHHHHHHh
Q 018614 59 TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 138 (353)
Q Consensus 59 g~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~ 138 (353)
-.|..+...|.|..+++|++...... ...-+.|..|.-.|+-+.||||+.++|.|.....+.++..|++.|+|..++..
T Consensus 202 hsgelwrgrwqgndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe 280 (448)
T KOG0195|consen 202 HSGELWRGRWQGNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE 280 (448)
T ss_pred CCcccccccccCcchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc
Confidence 35666777789999999998764432 22235688899999999999999999999999899999999999999999986
Q ss_pred cCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCccc
Q 018614 139 KGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 216 (353)
Q Consensus 139 ~~~--~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~ 216 (353)
... .+..++.+++.+++.|++|||+..+. +.---|....|+||++.+.+|.- +-+++.- ......-.+.|+
T Consensus 281 ~t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarism-ad~kfsf-----qe~gr~y~pawm 353 (448)
T KOG0195|consen 281 QTSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISM-ADTKFSF-----QEVGRAYSPAWM 353 (448)
T ss_pred CccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheec-ccceeee-----eccccccCcccC
Confidence 543 67889999999999999999998732 33346788899999988766531 2111110 001122356899
Q ss_pred CccccCCCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHHHHHHHHHHHcccCC
Q 018614 217 APEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKP 292 (353)
Q Consensus 217 aPE~~~~~~~~---~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp 292 (353)
+||.+...+.+ ..+|+|||++++|||-|...||.+..+.+.--++..++ +..+ +...+..+..|+.-|++.||
T Consensus 354 spealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i---ppgis~hm~klm~icmnedp 430 (448)
T KOG0195|consen 354 SPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI---PPGISRHMNKLMNICMNEDP 430 (448)
T ss_pred CHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC---CCCccHHHHHHHHHHhcCCC
Confidence 99999876544 47999999999999999999999988877666665444 3332 34567788999999999999
Q ss_pred CCCCCHHHHHHHHHHH
Q 018614 293 AKRPTFRQIITRLESI 308 (353)
Q Consensus 293 ~~Rps~~~ll~~l~~~ 308 (353)
.+||.+..++-.|+++
T Consensus 431 gkrpkfdmivpilekm 446 (448)
T KOG0195|consen 431 GKRPKFDMIVPILEKM 446 (448)
T ss_pred CcCCCcceehhhHHHh
Confidence 9999999999888875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-23 Score=176.30 Aligned_cols=170 Identities=10% Similarity=0.175 Sum_probs=132.8
Q ss_pred CcCcccceeeecceEEEEEE---cCeEEEEEEcCcccCCCHHHHHH------HHHHHHHHhcCCCCcccceeeEEEec--
Q 018614 49 ELDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRA------FRDELALLQKIRHPNVVQFLGAVTQS-- 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~---~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~~i~~~~~~~~~~-- 117 (353)
..+|...+.+|.|+||.|+. ++..+|||.+.......+...+. +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 45799999999999998873 46689999998766555544444 57899999999999999998886543
Q ss_pred ------CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 118 ------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 118 ------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
+..+++|||++|.+|.++.. +++ ....++..+|..+|+.| ++|||++|+||+++.+| ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEE
Confidence 35799999999999988742 333 34569999999999999 99999999999999988 99999
Q ss_pred cccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHH
Q 018614 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243 (353)
Q Consensus 192 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ell 243 (353)
||............ .......++.++|+|+||+++..+.
T Consensus 178 fg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 99876543211111 1233445668999999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=177.89 Aligned_cols=231 Identities=19% Similarity=0.300 Sum_probs=148.4
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC----------CcccceeeE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH----------PNVVQFLGA 113 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~~i~~~~~~ 113 (353)
...+..+..||.|+++.|+. +|+.+|+|++...........+++.+|.-....+.+ -.++..++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 34566788999999998873 579999999866543334456677777655555322 122222232
Q ss_pred EE---------ec---C-----ceEEEEecCCCCCHHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCE
Q 018614 114 VT---------QS---S-----PMMIVTEYLPKGDLRAFLKR---KGA----LKPSTAVRFALDIARGMNYLHENKPVPI 169 (353)
Q Consensus 114 ~~---------~~---~-----~~~iv~e~~~~~~L~~~l~~---~~~----~~~~~~~~i~~qi~~al~~Lh~~~~~~i 169 (353)
.. .. . ..+++|+.+ .++|.+++.. ... +.....+.+..|+++.+++||+.| +
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---L 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence 21 11 1 246788888 5689888752 221 222334556689999999999999 9
Q ss_pred EecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCC--------CCCCCchhHHHHHHHHHH
Q 018614 170 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--------EEYDTKVDVFSFALILQE 241 (353)
Q Consensus 170 iH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~e 241 (353)
+|+||+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|+||+++|.
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999997766543211 1234467899997643 246789999999999999
Q ss_pred HHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCC
Q 018614 242 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295 (353)
Q Consensus 242 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 295 (353)
|++|..||........... .+.... .+|+.+++||..+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999986644332211 223333 678899999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-23 Score=203.42 Aligned_cols=246 Identities=21% Similarity=0.290 Sum_probs=172.7
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCccc-CCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
++...+.+|.+.|-.+. .....|+||++.+.. ..+-....+-..|++ ...+++||++++.-.-..+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 56777889999996554 223348899986532 112222222233444 5666899999988877777778999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC-
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP- 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~- 205 (353)
. .-+|.|.+..++.+..-+...|+.|++.||.-+|..| |+|||||.+||||+.-+=+.|+||..-+..--+.+++
T Consensus 103 v-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred H-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 8 4599999988877888888999999999999999999 9999999999999988789999998665332222221
Q ss_pred -c-----ccCCCCCcccCccccCCC-----------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCC
Q 018614 206 -L-----TCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 267 (353)
Q Consensus 206 -~-----~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 267 (353)
. +....+ +|.|||.+-.. ..+++-||||+||+++||++ |++||.-. ..-.+..+...
T Consensus 179 df~fFFDTSrRRt-CYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~ 253 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRT-CYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNAD 253 (1431)
T ss_pred cceEEEecCCcee-eecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCcc
Confidence 1 111222 69999976431 15678899999999999998 99999421 11111111100
Q ss_pred CCC-CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 268 PFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 268 ~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
... ....--+..++.+|..|++.||++|.++++.|+.-.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 000 000111235889999999999999999999998743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-23 Score=194.71 Aligned_cols=222 Identities=22% Similarity=0.319 Sum_probs=183.2
Q ss_pred eecceEEEEE--------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEEecCC
Q 018614 58 ITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 58 ig~G~~~~v~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
+|+|.||.|+ ..|.-+|+|+..+........ .....|..++...+ ||.++++...+..+...++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 6888888765 246678888876644332222 14566888888886 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 018614 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208 (353)
Q Consensus 129 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 208 (353)
||.|...+.....+.+.....+...++-|++++|..+ ++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 9999999988777888999999999999999999999 999999999999999999999999999876433222
Q ss_pred CCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHc
Q 018614 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288 (353)
Q Consensus 209 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 288 (353)
-|+..|||||++. .+...+|.||+|+++++|++|..||.. ++...|.+...+ .+...+..+++++.+++
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~----~p~~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE----MPRELSAEARSLFRQLF 222 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC----CchhhhHHHHHHHHHHH
Confidence 4788999999998 577889999999999999999999987 444554333322 24567888999999999
Q ss_pred ccCCCCCCCH
Q 018614 289 NEKPAKRPTF 298 (353)
Q Consensus 289 ~~dp~~Rps~ 298 (353)
..+|..|.-.
T Consensus 223 ~r~p~nrLg~ 232 (612)
T KOG0603|consen 223 KRNPENRLGA 232 (612)
T ss_pred hhCHHHHhcc
Confidence 9999999665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=165.67 Aligned_cols=138 Identities=20% Similarity=0.244 Sum_probs=105.7
Q ss_pred ceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHH-----------------------HHHHHHHHHHHhcCCCCcc
Q 018614 55 SVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDR-----------------------VRAFRDELALLQKIRHPNV 107 (353)
Q Consensus 55 ~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~~i 107 (353)
...||+|+||.||. +|+.||||+++.......+. ......|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999873 58999999997643211110 1122459999999988777
Q ss_pred cceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCEEecCCCCCCEEEcCCCC
Q 018614 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL-HENKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 108 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~L-h~~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
......... ..+|||||++|+++.........++...+..++.|++.+|.++ |+.| ++||||||+||++++ +.
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~-~~ 155 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD-GK 155 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC-Cc
Confidence 543333222 2389999998877766544456789999999999999999999 6888 999999999999984 78
Q ss_pred EEEeeccccccc
Q 018614 187 LKVADFGVSKLL 198 (353)
Q Consensus 187 vkl~Dfg~a~~~ 198 (353)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=181.76 Aligned_cols=211 Identities=29% Similarity=0.489 Sum_probs=165.2
Q ss_pred HhcCCCCcccceeeEEEecCceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCC
Q 018614 99 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177 (353)
Q Consensus 99 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~ 177 (353)
|+++.|.|+.+++|.+.++...++|.+||..|+|.|.+.+. -.++......++++++.||.|||.... ..|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeeeccc
Confidence 46789999999999999999999999999999999999873 358888999999999999999999761 399999999
Q ss_pred CEEEcCCCCEEEeecccccccccCC-CCCcccCCCCCcccCccccCCCC-------CCCchhHHHHHHHHHHHHcCCCCC
Q 018614 178 NILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEE-------YDTKVDVFSFALILQEMIEGCPPF 249 (353)
Q Consensus 178 Nill~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~il~elltg~~pf 249 (353)
|.++|....+||.|||+........ ...........-|.|||.+.+.. .+.+.|+||+|++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999987764210 01111111234599999987641 456799999999999999999999
Q ss_pred CCCCCC----chHHHHHhcCCCCCCCch---hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 250 TMKHDN----EVPKAYAARQRPPFKAPA---KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 250 ~~~~~~----~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
...... ++...+...+..++.+.. ...++++..++++||..+|.+||+++++-..++.+...
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 874332 333444332433333221 14556789999999999999999999999998887553
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=169.81 Aligned_cols=196 Identities=21% Similarity=0.307 Sum_probs=146.2
Q ss_pred CCCcccceeeEEEe---------------------------cCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 018614 103 RHPNVVQFLGAVTQ---------------------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 155 (353)
Q Consensus 103 ~h~~i~~~~~~~~~---------------------------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~ 155 (353)
.|||||++.++|.+ +..+|+||..+ ..+|.+++..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999999887743 23579999998 569999997654 56777788999999
Q ss_pred HHHHHHHhcCCCCEEecCCCCCCEEEc--CCC--CEEEeecccccccccC-----CCCCcccCCCCCcccCccccCCCC-
Q 018614 156 RGMNYLHENKPVPIIHRDLEPSNILRD--DSG--NLKVADFGVSKLLTVK-----EDRPLTCQDTSCRYVAPEVFKNEE- 225 (353)
Q Consensus 156 ~al~~Lh~~~~~~iiH~dlkp~Nill~--~~~--~vkl~Dfg~a~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~- 225 (353)
+|+.|||.+| +.|||+|.+|||+. +++ .+.++|||.+-.-... ........+|....||||+.....
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999 99999999999975 444 3789999976433221 111123456777899999875432
Q ss_pred ----C-CCchhHHHHHHHHHHHHcCCCCCCCCCCCch-HHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHH
Q 018614 226 ----Y-DTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299 (353)
Q Consensus 226 ----~-~~~~DvwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 299 (353)
. -.++|.|+.|.+.||++....||......-. ...+...+ ++..+..+++.+++++..+|+.||++|++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q---LPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ---LPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh---CCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 1 1489999999999999999999976322111 11122333 3344677889999999999999999999987
Q ss_pred HHHHHHH
Q 018614 300 QIITRLE 306 (353)
Q Consensus 300 ~ll~~l~ 306 (353)
-....|.
T Consensus 506 iAANvl~ 512 (598)
T KOG4158|consen 506 IAANVLN 512 (598)
T ss_pred HHHhHHH
Confidence 7665553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-20 Score=156.46 Aligned_cols=139 Identities=19% Similarity=0.160 Sum_probs=107.0
Q ss_pred ceeeecceEEEEEE----cCeEEEEEEcCcccCCC---------------------H--HHHHHHHHHHHHHhcCCCCcc
Q 018614 55 SVEITKGTFILAFW----RGIQVAVKKLGEEVISD---------------------D--DRVRAFRDELALLQKIRHPNV 107 (353)
Q Consensus 55 ~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~---------------------~--~~~~~~~~E~~~l~~l~h~~i 107 (353)
...||+|++|.||. +|+.||||+++...... . .....+..|...+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999873 58999999987652110 0 001223578999999999987
Q ss_pred cceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCC
Q 018614 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 108 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
.....+... ..++||||++|+++.........++......++.|++.++.++|+ .| ++||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence 554444332 248999999887554433334557888999999999999999999 88 99999999999999 789
Q ss_pred EEEeecccccccc
Q 018614 187 LKVADFGVSKLLT 199 (353)
Q Consensus 187 vkl~Dfg~a~~~~ 199 (353)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999997754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=157.85 Aligned_cols=135 Identities=18% Similarity=0.269 Sum_probs=103.4
Q ss_pred CcccceeeecceEEEEEEc--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-----CCCcccceeeEEEecC---ce
Q 018614 51 DFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-----RHPNVVQFLGAVTQSS---PM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~---~~ 120 (353)
++.....||+|+|+.||.. ....+||++.... ......+.+|+.+++.+ .||||++++|++.++. ..
T Consensus 3 ~L~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 3 RLSEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred ecCCcceecCCCceEEEECCCCcCeEEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3556788999999999852 1223578775432 22335689999999999 5799999999998763 33
Q ss_pred -EEEEec--CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCEEecCCCCCCEEEcCC----CCEEEeec
Q 018614 121 -MIVTEY--LPKGDLRAFLKRKGALKPSTAVRFALDIARGM-NYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADF 192 (353)
Q Consensus 121 -~iv~e~--~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al-~~Lh~~~~~~iiH~dlkp~Nill~~~----~~vkl~Df 192 (353)
.+|+|| +.+++|.+++++. .+++. ..++.|++.++ +|||+++ |+||||||+|||++.. +.++|+||
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 378999 4468999999764 46655 35677888777 9999999 9999999999999843 37999994
Q ss_pred cc
Q 018614 193 GV 194 (353)
Q Consensus 193 g~ 194 (353)
+.
T Consensus 154 ~G 155 (210)
T PRK10345 154 IG 155 (210)
T ss_pred CC
Confidence 43
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-20 Score=154.38 Aligned_cols=183 Identities=14% Similarity=0.063 Sum_probs=132.4
Q ss_pred cceeeecceEEEEEE---cCeEEEEEEcCcccCCCH-HHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEEecCC
Q 018614 54 NSVEITKGTFILAFW---RGIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 54 ~~~~ig~G~~~~v~~---~g~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
....|++|+||.|+. .+.+++.+.+........ -....+.+|+++|++++ ++++++++++ ...+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 457899999999885 456676666554321111 11124789999999995 5789999886 34699999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCC-CCCCEEEcCCCCEEEeecccccccccCCCC---
Q 018614 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFGVSKLLTVKEDR--- 204 (353)
Q Consensus 129 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dl-kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~--- 204 (353)
|.+|...+.. ....++.|++.+|.++|+.| ++|||| ||+|||++.+|.++|+|||++.........
T Consensus 82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9888764421 12357789999999999999 999999 799999999999999999999865432210
Q ss_pred -C--------cccCCCCCcccCccccCCC-CCC-CchhHHHHHHHHHHHHcCCCCCC
Q 018614 205 -P--------LTCQDTSCRYVAPEVFKNE-EYD-TKVDVFSFALILQEMIEGCPPFT 250 (353)
Q Consensus 205 -~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~DvwslG~il~elltg~~pf~ 250 (353)
. ......++.+++|+...-- ..+ .+.++++.|+-+|.++|+..++-
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0111245567777754322 233 57899999999999999887764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-19 Score=179.77 Aligned_cols=254 Identities=20% Similarity=0.236 Sum_probs=184.2
Q ss_pred cCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCcccceeeEEEec
Q 018614 45 IDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQS 117 (353)
Q Consensus 45 i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~ 117 (353)
+......|.+.+.||+|+||.||+ +|+.||+|+-+.....+ |.==.+++.+|+ -+.|..+...+.-.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 334455788999999999999984 58999999987654321 111122333333 24455555555555
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-------CCCEEEe
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-------SGNLKVA 190 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-------~~~vkl~ 190 (353)
+..++|+||.+-|+|.++++..+..++..+..++.|++..++.||..+ |||+||||+|++|.. ..-++|+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 667899999999999999998778999999999999999999999999 999999999999863 2348999
Q ss_pred ecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCC
Q 018614 191 DFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 269 (353)
Q Consensus 191 Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 269 (353)
|||-+..+...... ......+|-.+-.+|+..|..++...|.|.|+.+++-|+.|+.-= ...+..-..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~ 912 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMV 912 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceec
Confidence 99998877654443 334445566788899999999999999999999999999985431 101110000
Q ss_pred CC-chhhhH-HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhcccc
Q 018614 270 KA-PAKLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRW 318 (353)
Q Consensus 270 ~~-~~~~~~-~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~ 318 (353)
.. ....+- .-..+|+..+|+.|-..=|...+|...|+.........-++
T Consensus 913 ~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~~~~~ 963 (974)
T KOG1166|consen 913 KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFTGLRE 963 (974)
T ss_pred cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHHHHHH
Confidence 00 011111 12456788888877777799999999999988776653333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-20 Score=182.75 Aligned_cols=213 Identities=26% Similarity=0.397 Sum_probs=157.2
Q ss_pred cccCccCcCcccceeeecceEEEEEEc-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec
Q 018614 43 YEIDPHELDFTNSVEITKGTFILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 117 (353)
Q Consensus 43 ~~i~~~~~~~~~~~~ig~G~~~~v~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 117 (353)
+...+.+.+|..++.|..|.||.||.. -+++|+|+ ++.. .+++. |..+-
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~--------------lilRn-----ilt~a------ 129 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN--------------LILRN-----ILTFA------ 129 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccc--------------hhhhc-----ccccc------
Confidence 455567778999999999999998843 34566633 2211 11211 11111
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
+..++| |+-..++++-+.++... +.+++|||+.| |+|||+||+|.+|+.-|++|+.|||+.+.
T Consensus 130 ~npfvv------gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 130 GNPFVV------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred CCccee------chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence 112222 45666666655555443 78899999999 99999999999999999999999999875
Q ss_pred cccCCCC-------------Cc-ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHh
Q 018614 198 LTVKEDR-------------PL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 263 (353)
Q Consensus 198 ~~~~~~~-------------~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 263 (353)
....... .. ....+|+.|.|||++....|+..+|+|++|+++|+++-|..||.+.+.++++..++.
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 4321110 00 123589999999999999999999999999999999999999999999888887766
Q ss_pred cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHH
Q 018614 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 299 (353)
......+. ...+++++++++.++|..+|..|--..
T Consensus 273 d~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 273 DDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 55444333 455788999999999999999995433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-19 Score=166.90 Aligned_cols=170 Identities=27% Similarity=0.409 Sum_probs=130.5
Q ss_pred ceEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
.+||.|++|...+|.+++..+. ..+....+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 4789999999999999997543 26778899999999999999 66 999999999999999999999999999
Q ss_pred cccccCC-----CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCC
Q 018614 196 KLLTVKE-----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 269 (353)
Q Consensus 196 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 269 (353)
....... ....+...||..||+||++.+..|+.++||||||++++||+. =..++.. ......+..+..++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChH
Confidence 8776554 234456779999999999999999999999999999999986 2222211 111222223333311
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHH
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 300 (353)
....+|. -.+|+.+++...|.+||++.+
T Consensus 481 --~~~d~p~-e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 481 --FLQDYPE-EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred --HhhcCcH-HHHHHHHhcCCCcccCchHHH
Confidence 1223333 347999999999999994433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-17 Score=143.96 Aligned_cols=134 Identities=23% Similarity=0.373 Sum_probs=111.1
Q ss_pred eeeecceEEEEE---EcCeEEEEEEcCcccCCCHH-----HHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecC
Q 018614 56 VEITKGTFILAF---WRGIQVAVKKLGEEVISDDD-----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127 (353)
Q Consensus 56 ~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 127 (353)
+.||+|++|.|| ..|..|++|..........+ ....+.+|+.++..+.|++++....++.+....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 468999999987 45789999986654332221 1235778999999999999887777777778889999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 128 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
+|++|.+++.... . ....++.+++.+|.++|+.+ ++|+|++|+||+++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999987543 2 78899999999999999999 99999999999999 78899999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=141.16 Aligned_cols=130 Identities=25% Similarity=0.364 Sum_probs=104.5
Q ss_pred eeecceEEEEE---EcCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCC
Q 018614 57 EITKGTFILAF---WRGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 57 ~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
.||+|+||.|| +.|..|++|.......... .....+.+|+.+++.+.|+++.....++.+....++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999887 4678999998654322221 123557789999999998876655555566677899999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 129 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
|++|.+++..... .++.|++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998765321 78999999999999999 99999999999999 78999999998755
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=144.99 Aligned_cols=144 Identities=19% Similarity=0.137 Sum_probs=108.8
Q ss_pred CcCcccceeeecceEEEEE------EcCeEEEEEEcCcccCCC---------------------HHHHHHHHHHHHHHhc
Q 018614 49 ELDFTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISD---------------------DDRVRAFRDELALLQK 101 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~------~~g~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~ 101 (353)
..-|...+.||+|+||.|| .+|+.||+|+++...... ......+..|+.++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3357788999999999876 257899999987542110 0112345689999999
Q ss_pred CCCCc--ccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCE
Q 018614 102 IRHPN--VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179 (353)
Q Consensus 102 l~h~~--i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Ni 179 (353)
+.+.+ ++++++. ...++||||++|.+|.........+....+..++.|++.++.+||..| .++|+||||+||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 97533 3444442 235899999988888776544445666778899999999999999987 399999999999
Q ss_pred EEcCCCCEEEeecccccccc
Q 018614 180 LRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 180 ll~~~~~vkl~Dfg~a~~~~ 199 (353)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 7899999999886543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.2e-17 Score=158.89 Aligned_cols=136 Identities=24% Similarity=0.224 Sum_probs=109.1
Q ss_pred CcccceeeecceEEEEEE---cCeEEEEEEcCcccCCC-----HHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISD-----DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~---~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
.|...+.||+|+||.||. .+..+++|+........ ....+.+.+|+++++.++|++++....++.+....++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 345678999999999985 45555555432221111 1223567899999999999999887777777778899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
||||++|++|.+++. ....++.|++.+|.+||+.+ ++||||||+||++ +++.++|+|||+++..
T Consensus 414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999999885 35678999999999999999 9999999999999 5778999999998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-18 Score=171.02 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=194.2
Q ss_pred CcCcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceE
Q 018614 49 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 121 (353)
...|...+.||+|.|+.+.. ....+|+|.+.... ...........|..+-+.+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 55688888899999986641 22345666554432 23344455667888888886 999999999999999999
Q ss_pred EEEecCCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCCCCEEecCCCCCCEEEcCCC-CEEEeecccccc
Q 018614 122 IVTEYLPKGDLRAFL-KRKG-ALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKL 197 (353)
Q Consensus 122 iv~e~~~~~~L~~~l-~~~~-~~~~~~~~~i~~qi~~al~~Lh-~~~~~~iiH~dlkp~Nill~~~~-~vkl~Dfg~a~~ 197 (353)
+++++..|+++.+.+ .... ..+...+-..+.|+..++.|+| ..+ +.|+|+||+|.+++.++ .+++.|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999999988 5443 4677888899999999999999 887 99999999999999999 999999999998
Q ss_pred ccc--CCCCCcccCCC-CCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHH-HHHhcCCCCCCCc
Q 018614 198 LTV--KEDRPLTCQDT-SCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK-AYAARQRPPFKAP 272 (353)
Q Consensus 198 ~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 272 (353)
+.. ..........| ++.|+|||...+. -..+..|+||.|+++..+++|..||.......... .............
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 766 22223333445 8899999999885 44678999999999999999999997665443221 1111111212333
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+....+++.+++..+|..|.+.+++...
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cccCChhhhhcccccccCCchhcccccccccc
Confidence 45567778899999999999999999888654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=136.70 Aligned_cols=136 Identities=21% Similarity=0.114 Sum_probs=103.8
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCH-------------------HHHHHHHHHHHHHhcCCCCc-
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD-------------------DRVRAFRDELALLQKIRHPN- 106 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~~- 106 (353)
.|...+.||+|+||.||. +|+.||||++........ ........|..++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 477778999999999872 588999998764321000 01123567888888887763
Q ss_pred -ccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC
Q 018614 107 -VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185 (353)
Q Consensus 107 -i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~ 185 (353)
++..++ ....++||||++|++|..+... .....++.+++.++.++|..| ++|+||+|+||+++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCC
Confidence 444443 2456899999999998775431 345678899999999999999 99999999999999999
Q ss_pred CEEEeecccccccc
Q 018614 186 NLKVADFGVSKLLT 199 (353)
Q Consensus 186 ~vkl~Dfg~a~~~~ 199 (353)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.9e-16 Score=136.05 Aligned_cols=139 Identities=19% Similarity=0.213 Sum_probs=106.4
Q ss_pred CcccceeeecceEEEEEEcCeEEEEEEcCcccC-----C-----CHHHHHHHHHHHHHHhcCCCCcc--cceeeEEEec-
Q 018614 51 DFTNSVEITKGTFILAFWRGIQVAVKKLGEEVI-----S-----DDDRVRAFRDELALLQKIRHPNV--VQFLGAVTQS- 117 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~g~~vavK~~~~~~~-----~-----~~~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~- 117 (353)
.+..++..|.|+++.|+..+..++||.+....+ . .......+.+|+.++.++.|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 455556778888888888899999998854221 0 11223567889999999998775 6677664332
Q ss_pred Cc---eEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 118 SP---MMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 118 ~~---~~iv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
.. .++|||+++| .+|.+++... .+++. .+.|++.+|.+||+.| ++|+||||.|||++.++.++|+|||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECC
Confidence 22 3599999987 6999988653 45544 3568999999999999 9999999999999998999999999
Q ss_pred cccc
Q 018614 194 VSKL 197 (353)
Q Consensus 194 ~a~~ 197 (353)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=127.30 Aligned_cols=135 Identities=23% Similarity=0.221 Sum_probs=93.5
Q ss_pred ceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHH---------------------HHHHHHHHhcCCCC--cc
Q 018614 55 SVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRA---------------------FRDELALLQKIRHP--NV 107 (353)
Q Consensus 55 ~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--~i 107 (353)
.+.||+|+||.||. +|+.||||++............. ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999874 58899999986543221111111 13455556665433 24
Q ss_pred cceeeEEEecCceEEEEecCCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCC
Q 018614 108 VQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG 185 (353)
Q Consensus 108 ~~~~~~~~~~~~~~iv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~ 185 (353)
++.++. ...++||||++++.+.. .+.... . ...+..++.+++.++.++|. .+ ++|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 444443 24689999998843321 111110 1 16678899999999999999 88 99999999999999 88
Q ss_pred CEEEeecccccccc
Q 018614 186 NLKVADFGVSKLLT 199 (353)
Q Consensus 186 ~vkl~Dfg~a~~~~ 199 (353)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.5e-15 Score=118.56 Aligned_cols=131 Identities=19% Similarity=0.182 Sum_probs=106.8
Q ss_pred ceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC--CcccceeeEEEecCceEEEEecCCC
Q 018614 55 SVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 55 ~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
.+.||.|.++.+| ..+..+++|....... ...+.+|+..++.+++ .++++++++....+..+++|||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4678999998776 3456899999865432 3467889999999976 5889999888877889999999988
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
+.+..+ +......++.+++.+++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 4566678899999999999985333499999999999999989999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5e-14 Score=123.74 Aligned_cols=198 Identities=23% Similarity=0.339 Sum_probs=138.8
Q ss_pred HHhcCCCCcccceeeEEEec-----CceEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 018614 98 LLQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVP 168 (353)
Q Consensus 98 ~l~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~Lh~~~~~~ 168 (353)
.+-++-|.||++++.++.+. ....++.||+..|+|..+|++- ..+......+|+.||+.||.|||+... +
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P-p 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP-P 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC-c
Confidence 34455799999999888654 3468899999999999999752 237788899999999999999999874 5
Q ss_pred EEecCCCCCCEEEcCCCCEEEeecccccccccCCCC----CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc
Q 018614 169 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 244 (353)
Q Consensus 169 iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 244 (353)
++|+++..+.|++..+|.+|+.- +........... ......+.++|.+||.-.....+..+|||++|+...+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999888752 211111111000 0011234568999998777777889999999999999987
Q ss_pred CCCC-CCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 245 GCPP-FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 245 g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
|..- -......+....+... ...+. . ..=++++..|++-.|..||+++.++-|
T Consensus 278 lEiq~tnseS~~~~ee~ia~~-i~~le---n---~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANV-IIGLE---N---GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhhhh-eeecc---C---ccccCcCcccccCCCCCCcchhhhhcC
Confidence 7543 2222222222222111 11111 1 112468999999999999999999854
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.1e-13 Score=127.16 Aligned_cols=168 Identities=17% Similarity=0.307 Sum_probs=128.7
Q ss_pred EEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCH
Q 018614 65 LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 144 (353)
Q Consensus 65 ~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~ 144 (353)
....++.+|.|...+... .+......+-+..|+.++||||+++++.+..++..|+|+|.+ ..|..++++.+ .
T Consensus 32 t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~---~ 103 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG---K 103 (690)
T ss_pred ceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH---H
Confidence 445577888888876543 234455677888999999999999999999999999999998 37888887754 5
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCC
Q 018614 145 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 224 (353)
Q Consensus 145 ~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 224 (353)
..+..-+.||+.||.|||..+ .++|++|.-+.|+++..|..||++|.++........ +.........|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 566667899999999999765 399999999999999999999999988765443221 11112222236666654332
Q ss_pred CCCCchhHHHHHHHHHHHHcC
Q 018614 225 EYDTKVDVFSFALILQEMIEG 245 (353)
Q Consensus 225 ~~~~~~DvwslG~il~elltg 245 (353)
. ...|.|.||+++++++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 457999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.9e-14 Score=132.65 Aligned_cols=247 Identities=21% Similarity=0.238 Sum_probs=179.6
Q ss_pred CcCcccceeeec--ceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecC
Q 018614 49 ELDFTNSVEITK--GTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 118 (353)
Q Consensus 49 ~~~~~~~~~ig~--G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 118 (353)
...+.....+|. |++|.++. ++..+|+|.-....-..... ..=.+|+...+.+ .|++.++....+...+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~-~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS-KRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc-ccccchhhcccccCccccccccCcccccCC
Confidence 345667778999 99988773 45678888754432211111 1224566666666 4999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhcCCCCEEecCCCCCCEEEcCC-CCEEEeec
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIAR----GMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADF 192 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~----al~~Lh~~~~~~iiH~dlkp~Nill~~~-~~vkl~Df 192 (353)
..|+-+|++ +.+|.++...... ++...++..+.+... ||.++|+.+ ++|-|+||.||++..+ ...+++||
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 999999999 6788888876555 788889999999888 999999999 9999999999999999 78999999
Q ss_pred ccccccccCCCCCc----ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC
Q 018614 193 GVSKLLTVKEDRPL----TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268 (353)
Q Consensus 193 g~a~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 268 (353)
|+...+........ ....+...|++||...+ .++..+|+|++|.++.+..+|..+........... + .....+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~-r~~~ip 344 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-L-RQGYIP 344 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-c-ccccCc
Confidence 99988876542221 12245668999998755 77889999999999999998866654432222211 1 111111
Q ss_pred CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.. .....+.++...+.+++..+|-.|++++.+..+
T Consensus 345 ~e-~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 345 LE-FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hh-hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 11 122334556679999999999999998877654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.7e-12 Score=121.51 Aligned_cols=139 Identities=22% Similarity=0.268 Sum_probs=92.9
Q ss_pred ceeeecceEEEEE----EcCeEEEEEEcCcccCCC---------------------------HHHH----------HHHH
Q 018614 55 SVEITKGTFILAF----WRGIQVAVKKLGEEVISD---------------------------DDRV----------RAFR 93 (353)
Q Consensus 55 ~~~ig~G~~~~v~----~~g~~vavK~~~~~~~~~---------------------------~~~~----------~~~~ 93 (353)
.+.||.|++|.|+ .+|+.||||+.+...... .+.. -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999887 479999999986542100 0000 0234
Q ss_pred HHHHHHhcCC----CCcccceeeEE-EecCceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 018614 94 DELALLQKIR----HPNVVQFLGAV-TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIAR-GMNYLHENKP 166 (353)
Q Consensus 94 ~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~-al~~Lh~~~~ 166 (353)
+|+..+.++. +.+-+.+-.++ ......++||||++|++|.++.... ... ....++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC-
Confidence 4555555552 22222222222 2234569999999999998876532 112 23456666665 467889998
Q ss_pred CCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 167 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 167 ~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++|+|++|.||+++.+|.++++|||++..++
T Consensus 278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999986653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.7e-12 Score=123.20 Aligned_cols=138 Identities=18% Similarity=0.258 Sum_probs=86.2
Q ss_pred CcccceeeecceEEEEE----Ec-CeEEEEEEcCcccCC---------------------------CH----HHHHH---
Q 018614 51 DFTNSVEITKGTFILAF----WR-GIQVAVKKLGEEVIS---------------------------DD----DRVRA--- 91 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~----~~-g~~vavK~~~~~~~~---------------------------~~----~~~~~--- 91 (353)
.|.. +-||.|++|.|+ .+ |+.||||+.++.... .. +....
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 689999999886 24 899999999754210 01 11111
Q ss_pred ---HHHHHHHHhcCC----CCcccceeeEEEe-cCceEEEEecCCCCCHHHHH--HhcCC----CCHHHHHHHHHHHHHH
Q 018614 92 ---FRDELALLQKIR----HPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARG 157 (353)
Q Consensus 92 ---~~~E~~~l~~l~----h~~i~~~~~~~~~-~~~~~iv~e~~~~~~L~~~l--~~~~~----~~~~~~~~i~~qi~~a 157 (353)
+.+|+..+.++. +.+.+.+-.++.+ ....++||||++|+.+.++- ...+. +.+..+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 334444444442 3323333333322 34568999999999998753 33321 2223333334443
Q ss_pred HHHHHhcCCCCEEecCCCCCCEEEcCCC----CEEEeecccccccc
Q 018614 158 MNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLLT 199 (353)
Q Consensus 158 l~~Lh~~~~~~iiH~dlkp~Nill~~~~----~vkl~Dfg~a~~~~ 199 (353)
...| ++|+|+||.||+++.+| .++++|||++..++
T Consensus 277 ----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3567 99999999999999888 99999999986653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-11 Score=111.11 Aligned_cols=250 Identities=14% Similarity=0.187 Sum_probs=168.0
Q ss_pred ccceeeecceEEEEEEcCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeE------EEecC-ceEE
Q 018614 53 TNSVEITKGTFILAFWRGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA------VTQSS-PMMI 122 (353)
Q Consensus 53 ~~~~~ig~G~~~~v~~~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~------~~~~~-~~~i 122 (353)
..+..||+|+-+.+|.-|+ ..+.|++..+..... . +-+..|... .||-+..-+.+ ..+.+ ...+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhchhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3467899999887774332 334588765432111 1 122223333 56644331110 11222 2678
Q ss_pred EEecCCCC-CHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 123 VTEYLPKG-DLRAFLK------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 123 v~e~~~~~-~L~~~l~------~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
+|+.+.|. ....+++ ....+.+...+++++.++.+.+.||..| .+-+|++++|+|+++++.|.|.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 88888764 3444443 1233788999999999999999999999 999999999999999999999986543
Q ss_pred cccccCCCCCcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCc----hHH-HHH--
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE----VPK-AYA-- 262 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~----~~~-~~~-- 262 (353)
..- .+.....+..|...|.+||.-. +..-+...|.|.||+++++++. |+.||.+-.... -.+ .|.
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 322 2344456677888999999643 4455678999999999999998 599997643211 001 111
Q ss_pred -----hcC-----CCCCCCchhhhHHHHHHHHHHHccc--CCCCCCCHHHHHHHHHHHHHHhh
Q 018614 263 -----ARQ-----RPPFKAPAKLYARGLKELIEECWNE--KPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 263 -----~~~-----~~~~~~~~~~~~~~l~~li~~cl~~--dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
... .++...+...+++.+..+..+|+.. ++.-||+++..+..|..+..++-
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 111 2233345567889999999999965 46789999999999998877653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2e-13 Score=135.78 Aligned_cols=201 Identities=25% Similarity=0.365 Sum_probs=160.2
Q ss_pred HHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCC
Q 018614 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 174 (353)
Q Consensus 95 E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dl 174 (353)
+-.++-...+|.++...-.+......+++++|+.+++|...+.+.+..+.......+..+.+++++||... +.|+|+
T Consensus 854 ~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~ 930 (1205)
T KOG0606|consen 854 KSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDL 930 (1205)
T ss_pred ccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccc
Confidence 33333334457677666566667788999999999999999988777788888888889999999999987 899999
Q ss_pred CCCCEEEcCCCCEEEeecccccccccC--------C-------------C---------CCcccCCCCCcccCccccCCC
Q 018614 175 EPSNILRDDSGNLKVADFGVSKLLTVK--------E-------------D---------RPLTCQDTSCRYVAPEVFKNE 224 (353)
Q Consensus 175 kp~Nill~~~~~vkl~Dfg~a~~~~~~--------~-------------~---------~~~~~~~~~~~y~aPE~~~~~ 224 (353)
+|.|.++..+|..++.|||........ . . .......+|+.|.+||.+.+.
T Consensus 931 ~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~ 1010 (1205)
T KOG0606|consen 931 KPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR 1010 (1205)
T ss_pred cccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc
Confidence 999999999999999999843322100 0 0 111234578899999999999
Q ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHH
Q 018614 225 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299 (353)
Q Consensus 225 ~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 299 (353)
.....+|+|++|+++++.++|.+||.......+...+.....+... .+...+.+.++++...+..+|.+|..+.
T Consensus 1011 ~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1011 RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999999999999999988888888777655544433 3445678899999999999999998776
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.5e-12 Score=105.45 Aligned_cols=127 Identities=17% Similarity=0.161 Sum_probs=90.1
Q ss_pred eeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc-cceeeEEEecCceEEEEecCCCCC
Q 018614 56 VEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV-VQFLGAVTQSSPMMIVTEYLPKGD 131 (353)
Q Consensus 56 ~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~~~~ 131 (353)
+.++.|.++.+| ..|..+++|....... ....+..|+.+++.+.+.++ ++++... ....++|||+++|.+
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 456777776555 4678999999755421 11245678999998865444 4555543 334589999999987
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 132 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENK--PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 132 L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~--~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
+.+.- .....++.+++.+|+.||..+ ...++|+|++|+||+++ ++.++++|||.+..
T Consensus 78 l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76430 112345678999999999987 12259999999999999 56899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=6.9e-11 Score=96.82 Aligned_cols=130 Identities=23% Similarity=0.318 Sum_probs=93.4
Q ss_pred eeecceEEEEE---EcCeEEEEEEcCcccCCCHHHH-----HHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCC
Q 018614 57 EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRV-----RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 57 ~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
.+++|.=..++ +-|.++++|.=.+.....++.. ....+|+.++..+.--.|...+=++.+.....|+|||.+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 35566555444 3477777775443333333332 345689999999876666555555556666789999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 129 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
|..|.+.+... . ..++..+=.-+.-||..| |+|+||.++||++...+ +.++|||++..
T Consensus 83 G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA---R----PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999998765 2 345555666677799999 99999999999999865 99999999865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.6e-12 Score=120.65 Aligned_cols=245 Identities=21% Similarity=0.236 Sum_probs=174.8
Q ss_pred cCcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEE
Q 018614 50 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~i 122 (353)
.+|.....||.|.|+.++. ++..+++|.+........+.+.. ..|+.+...+ .|.+++.++..+...+..|+
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 3678888999999876653 45678888776654433333222 3566777766 48888988888877788889
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC-CCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~-~~vkl~Dfg~a~~~~~~ 201 (353)
-.|||+++++...+.-...+.+...+++..|++.++.++|+.. ++|+|++|+||++..+ +.-++.|||.+..+...
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccccee
Confidence 9999999888776644445788889999999999999999998 9999999999999986 67899999988653221
Q ss_pred CCCCcccCCCCCcc-cCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 202 EDRPLTCQDTSCRY-VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 202 ~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
.. ........| .++.......+..+.|+++||..+.+.++|...-..... ...+..+..+.. .....++
T Consensus 421 ~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~----~~~~~~~ 490 (524)
T KOG0601|consen 421 SG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNL----PGLKLQL 490 (524)
T ss_pred cc---cccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCC----CchHHhh
Confidence 11 112223334 355556666788899999999999999987543222111 111112222221 2233678
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
..+.+.++..++..||.+.++..+...+
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhh
Confidence 8899999999999999999988776544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.4e-10 Score=96.51 Aligned_cols=97 Identities=20% Similarity=0.254 Sum_probs=74.2
Q ss_pred HHHHHHhcCCC--CcccceeeEEEecCceEEEEecCCCCCHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCE
Q 018614 94 DELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLPKGDLR-AFLKRKGALKPSTAVRFALDIARGMNYL-HENKPVPI 169 (353)
Q Consensus 94 ~E~~~l~~l~h--~~i~~~~~~~~~~~~~~iv~e~~~~~~L~-~~l~~~~~~~~~~~~~i~~qi~~al~~L-h~~~~~~i 169 (353)
+|+..|+++.. -++++++++ ..-++||||+.+..+. ..+++ ..++......+..+++.+|..+ |..| +
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~g---l 146 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECN---L 146 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 89999999953 456677765 3458999999654332 22322 2355666778889999999998 8888 9
Q ss_pred EecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 170 IHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 170 iH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
+|+||++.||++++ +.+.|+|||.+....
T Consensus 147 VHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 147 VHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred ecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999999974 679999999886654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.4e-10 Score=103.81 Aligned_cols=204 Identities=13% Similarity=0.213 Sum_probs=147.6
Q ss_pred EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEE----ecCceEEEEecCCC-CCHHHHHHhc---
Q 018614 68 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT----QSSPMMIVTEYLPK-GDLRAFLKRK--- 139 (353)
Q Consensus 68 ~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~~~~~~iv~e~~~~-~~L~~~l~~~--- 139 (353)
.+|..+++|++........ .....-++.++++.|.|||++.++|. ++..+++|++|+++ ++|.++.-..
T Consensus 299 ~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~ 375 (655)
T KOG3741|consen 299 VDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPF 375 (655)
T ss_pred cCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcc
Confidence 5789999999843322221 12234578899999999999999886 34568999999887 5888776421
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcc
Q 018614 140 ------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 207 (353)
Q Consensus 140 ------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 207 (353)
...++..+|.++.|+..||.++|+.| +.-+-|.|.+|+++.+.+++|...|..........
T Consensus 376 t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~---- 448 (655)
T KOG3741|consen 376 TKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT---- 448 (655)
T ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC----
Confidence 23678899999999999999999999 88899999999999999999998887655443220
Q ss_pred cCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHH
Q 018614 208 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 287 (353)
Q Consensus 208 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 287 (353)
+.+. --.+.|.-.||.+++.|.+|..--...+. ..... .......++.++++++.-.
T Consensus 449 -----------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~---~~~s~------~~~I~~~yS~D~rn~v~yl 505 (655)
T KOG3741|consen 449 -----------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDS---TQSSH------LTRITTTYSTDLRNVVEYL 505 (655)
T ss_pred -----------cchh---HHhhhhHHHHHHHHHHHhhcccccccccc---hHHHH------HHHhhhhhhHHHHHHHHHH
Confidence 1111 12357899999999999998543111111 11110 1112456889999999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 018614 288 WNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 288 l~~dp~~Rps~~~ll~~l 305 (353)
...++++ -+.++++.++
T Consensus 506 ~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 506 ESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HhcCccc-ccHHHHHHHH
Confidence 9999987 6888888544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.5e-09 Score=88.71 Aligned_cols=141 Identities=22% Similarity=0.236 Sum_probs=102.2
Q ss_pred cceeeecceEEEEE---EcCeEEEEEEcCcccCCCHH-----HHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 54 NSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDD-----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 54 ~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
....+-+|.-+.++ +.|+...||.=.......+. ......+|++.+.++.--.|.-..-++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 34567788776554 68888888854333322222 23456789999999875566555555666677789999
Q ss_pred cCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC---CEEEeecccccc
Q 018614 126 YLPK-GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKL 197 (353)
Q Consensus 126 ~~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~---~vkl~Dfg~a~~ 197 (353)
|++| .++.+++.... .........++.++=..+.-||..+ +||+||..+||++.+++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9966 48888887532 2333344788899999999999999 99999999999998665 368999999754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.5e-09 Score=95.19 Aligned_cols=127 Identities=16% Similarity=0.115 Sum_probs=93.7
Q ss_pred EEEEcCeEEEEEEcCcccCCCHHHHH----------HHHHHHHHHhcCCCCcc--cceeeEEEe-----cCceEEEEecC
Q 018614 65 LAFWRGIQVAVKKLGEEVISDDDRVR----------AFRDELALLQKIRHPNV--VQFLGAVTQ-----SSPMMIVTEYL 127 (353)
Q Consensus 65 ~v~~~g~~vavK~~~~~~~~~~~~~~----------~~~~E~~~l~~l~h~~i--~~~~~~~~~-----~~~~~iv~e~~ 127 (353)
.+...|+.+.||....... .+... .+.+|...+.++...+| ++.+++... ....++|+|++
T Consensus 40 r~~~~g~~~~vKr~~~~~~--~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l 117 (268)
T PRK15123 40 RFELAGKSYFLKWHRGTGW--GEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDL 117 (268)
T ss_pred EEEECCEEEEEEEecCCcH--HHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeC
Confidence 3456788999997643321 11111 36788888888854444 345555543 23478999999
Q ss_pred CCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-------CCCEEEeeccccc
Q 018614 128 PKG-DLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-------SGNLKVADFGVSK 196 (353)
Q Consensus 128 ~~~-~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-------~~~vkl~Dfg~a~ 196 (353)
++. +|.+++.. ....+......++.+++..+.-||..| ++|+|++++|||++. ++.+.|+||+.+.
T Consensus 118 ~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 118 APTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 875 89999864 234566778899999999999999999 999999999999985 4679999999764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=7.7e-11 Score=113.40 Aligned_cols=148 Identities=18% Similarity=0.306 Sum_probs=110.9
Q ss_pred HHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc--------ccCCCCCcccCccccCCC
Q 018614 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL--------TCQDTSCRYVAPEVFKNE 224 (353)
Q Consensus 153 qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~ 224 (353)
+++.|+.|+|...+ +||++|.|++|+++..|.+||+.|+++........... ....-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44599999999763 99999999999999999999999998765544222111 111233469999999998
Q ss_pred CCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHH
Q 018614 225 EYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302 (353)
Q Consensus 225 ~~~~~~DvwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll 302 (353)
..+.++|+||+|+++|.+. .|+..+...........-..............+|.++++=+.+++..++.-||++..++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 8889999999999999999 57777766655444433322222222223367889999999999999999999777765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=9.7e-10 Score=95.33 Aligned_cols=139 Identities=19% Similarity=0.251 Sum_probs=99.4
Q ss_pred eeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC--cccceeeEEEec---CceEEEEec
Q 018614 56 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP--NVVQFLGAVTQS---SPMMIVTEY 126 (353)
Q Consensus 56 ~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~---~~~~iv~e~ 126 (353)
+.|+.|....+|. +|..+++|........ .....+..|+.+++.+.+. ++++++.+.... +..++|||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 4577787766553 3478999997654321 1234678899999999653 457777776553 367899999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK----------------------------------------- 165 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~----------------------------------------- 165 (353)
++|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998888765532 34666777777778888887777421
Q ss_pred ------------CCCEEecCCCCCCEEEcC--CCCEEEeecccccc
Q 018614 166 ------------PVPIIHRDLEPSNILRDD--SGNLKVADFGVSKL 197 (353)
Q Consensus 166 ------------~~~iiH~dlkp~Nill~~--~~~vkl~Dfg~a~~ 197 (353)
...++|+|++|+||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234899999999999998 66789999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.8e-09 Score=87.75 Aligned_cols=99 Identities=25% Similarity=0.306 Sum_probs=66.6
Q ss_pred HHHHHHHHHHhcCCCC--cccceeeEEEecCceEEEEecCC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhc
Q 018614 90 RAFRDELALLQKIRHP--NVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFLKRKGALKPSTAVRFALDIARGMNY-LHEN 164 (353)
Q Consensus 90 ~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~iv~e~~~--~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~-Lh~~ 164 (353)
....+|.+.|.++..- ++++++++. .-.|||||++ |..+..+.... ++......++.+++..+.. +|..
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc
Confidence 4457899999999765 466776553 3479999997 55555544322 2234556677778775555 5788
Q ss_pred CCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 165 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 165 ~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
| ++|+|+.+.||+++++ .+.++|||.+...
T Consensus 127 g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 127 G---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp T---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred C---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 8 9999999999999987 8999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.2e-08 Score=87.82 Aligned_cols=105 Identities=29% Similarity=0.393 Sum_probs=84.4
Q ss_pred HHHHHHHHHHhcCCCCc--ccceeeEEEec----CceEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 018614 90 RAFRDELALLQKIRHPN--VVQFLGAVTQS----SPMMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLH 162 (353)
Q Consensus 90 ~~~~~E~~~l~~l~h~~--i~~~~~~~~~~----~~~~iv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh 162 (353)
....+|...+..+...+ +++.+++.... ...++|+|++++. +|.+++......+......++.+++..++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 35677888888775443 45566666542 2358999999874 89999987544677788899999999999999
Q ss_pred hcCCCCEEecCCCCCCEEEcCCC---CEEEeecccccc
Q 018614 163 ENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKL 197 (353)
Q Consensus 163 ~~~~~~iiH~dlkp~Nill~~~~---~vkl~Dfg~a~~ 197 (353)
..| ++|+|+++.|||++.++ .+.++||+-+..
T Consensus 136 ~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 99999999999999887 799999997655
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.2e-07 Score=76.61 Aligned_cols=132 Identities=12% Similarity=0.122 Sum_probs=91.5
Q ss_pred eEEEEEEcCeEEEEEEcCcccCCC---HHHHHHHHHHHHHHhcCCCCc--ccceeeEEEe----cCceEEEEecCCC-CC
Q 018614 62 TFILAFWRGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPN--VVQFLGAVTQ----SSPMMIVTEYLPK-GD 131 (353)
Q Consensus 62 ~~~~v~~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~----~~~~~iv~e~~~~-~~ 131 (353)
+...+...|..+-+|.-....... +--...|.+|...++++...+ +++.+..... ....+||+|-++| .+
T Consensus 33 gV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~ 112 (216)
T PRK09902 33 GVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFIS 112 (216)
T ss_pred eEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCcc
Confidence 333344566677788654111000 112356889999999885322 4554422111 1235899998854 59
Q ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC--EEEeeccccc
Q 018614 132 LRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGVSK 196 (353)
Q Consensus 132 L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~--vkl~Dfg~a~ 196 (353)
|.+++.+. .+.+......++.+++.+++-||+.| +.|+|+.+.||+++.+|. +.++||--++
T Consensus 113 L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 113 IADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred HHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 99998663 23577778899999999999999999 999999999999987777 9999997544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-06 Score=74.19 Aligned_cols=121 Identities=21% Similarity=0.322 Sum_probs=77.5
Q ss_pred EEEEEcCeEEEEEEcCcccCCCHHHHHHH------HHHHHHHhcCCC---CcccceeeEEEe-----cCceEEEEecCCC
Q 018614 64 ILAFWRGIQVAVKKLGEEVISDDDRVRAF------RDELALLQKIRH---PNVVQFLGAVTQ-----SSPMMIVTEYLPK 129 (353)
Q Consensus 64 ~~v~~~g~~vavK~~~~~~~~~~~~~~~~------~~E~~~l~~l~h---~~i~~~~~~~~~-----~~~~~iv~e~~~~ 129 (353)
..+..+|..+++|..+......+.....| .+++.....+.. .....++.+... ....+++|||++|
T Consensus 48 alIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG 127 (229)
T PF06176_consen 48 ALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEG 127 (229)
T ss_pred EEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecC
Confidence 33446889999999876543322222222 233333333322 223333333221 1234689999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
..|.++.. +++ .++..+.+++.-||..| +.|+|.+|+|+++++++ ++++||+..+
T Consensus 128 ~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 128 VELNDIED----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eecccchh----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcccc
Confidence 88877642 222 34566778899999999 99999999999999765 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.8e-06 Score=75.22 Aligned_cols=136 Identities=11% Similarity=0.140 Sum_probs=82.8
Q ss_pred eeeecceEEEEEE-cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc--ccceeeEEEecCceEEEEecCCCCC-
Q 018614 56 VEITKGTFILAFW-RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYLPKGD- 131 (353)
Q Consensus 56 ~~ig~G~~~~v~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~iv~e~~~~~~- 131 (353)
..||+|..+.+|. .|..+++|...... .. ....+|.++++.+..-+ +++.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~~--~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHKTGKWMLKLYNPGF--DK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEecCCCEEEEeCCCCC--CH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 5689998888885 35677788876532 11 34678999999886433 5678888877778899999998853
Q ss_pred HHHHH--------------Hh------c---CCCCHHHHH-HHHH----------HHHHH-HHHHHh-cCCCCEEecCCC
Q 018614 132 LRAFL--------------KR------K---GALKPSTAV-RFAL----------DIARG-MNYLHE-NKPVPIIHRDLE 175 (353)
Q Consensus 132 L~~~l--------------~~------~---~~~~~~~~~-~i~~----------qi~~a-l~~Lh~-~~~~~iiH~dlk 175 (353)
+...+ .+ . ......... .+.. .+... ..+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111 00 0 001111100 0100 01111 112221 112237999999
Q ss_pred CCCEEEcCCCCEEEeecccccc
Q 018614 176 PSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 176 p~Nill~~~~~vkl~Dfg~a~~ 197 (353)
|.||++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999988 99999997643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1e-06 Score=76.79 Aligned_cols=133 Identities=22% Similarity=0.175 Sum_probs=90.8
Q ss_pred cccceeeecceEEEEE----EcCeEEEEEEcCcccCC-----------------C--HHHHHHHHHHHHHHhcCCCC--c
Q 018614 52 FTNSVEITKGTFILAF----WRGIQVAVKKLGEEVIS-----------------D--DDRVRAFRDELALLQKIRHP--N 106 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~----~~g~~vavK~~~~~~~~-----------------~--~~~~~~~~~E~~~l~~l~h~--~ 106 (353)
...+..||-|-=+.|| .+|.++|||.=+..... + .-......+|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3355678888666555 35889999964321100 0 11223456899999999655 6
Q ss_pred ccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC
Q 018614 107 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 107 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
|++.+++ +.-.+|||+.+|..|...- ++....-.++..|+.-+..+-..| +||+|+++-||+++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence 7777764 4457999999886665432 234444455556666666656777 999999999999999999
Q ss_pred EEEeeccccc
Q 018614 187 LKVADFGVSK 196 (353)
Q Consensus 187 vkl~Dfg~a~ 196 (353)
+.++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999996543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.6e-06 Score=79.19 Aligned_cols=77 Identities=18% Similarity=0.323 Sum_probs=54.6
Q ss_pred cCceEEEEecCCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 117 SSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l--~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
.+.-.++|||++|..+.+.. +. ..++...+...+.++.- .-+-..| ++|+|.+|.||+++.+|.+.+.|||+
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi 311 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGI 311 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhcC---ccccCCCccceEEecCCcEEEEcCcc
Confidence 35568999999998888874 34 33554433333333222 2233456 99999999999999999999999998
Q ss_pred ccccc
Q 018614 195 SKLLT 199 (353)
Q Consensus 195 a~~~~ 199 (353)
...++
T Consensus 312 ~g~l~ 316 (517)
T COG0661 312 VGRLD 316 (517)
T ss_pred eecCC
Confidence 76543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.6e-06 Score=69.49 Aligned_cols=135 Identities=23% Similarity=0.341 Sum_probs=93.6
Q ss_pred ccceeeecceEEEEEE--cCeEEEEEEcCcccC-------------CCHHHHHHHHHHHHHHhcCC------CCccccee
Q 018614 53 TNSVEITKGTFILAFW--RGIQVAVKKLGEEVI-------------SDDDRVRAFRDELALLQKIR------HPNVVQFL 111 (353)
Q Consensus 53 ~~~~~ig~G~~~~v~~--~g~~vavK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~------h~~i~~~~ 111 (353)
.....||+|+.-.+|. .+...+||++..... .......+..+|+....++. +.+|.+++
T Consensus 4 ~~~~~i~~G~~R~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCCcccccCCCceEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 3456799999988885 456778999876540 00112345566777666665 78899999
Q ss_pred eEEEecCceEEEEecCCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC
Q 018614 112 GAVTQSSPMMIVTEYLPK------GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185 (353)
Q Consensus 112 ~~~~~~~~~~iv~e~~~~------~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~ 185 (353)
|+...+.-..+|+|.+.+ .+|.+++.+.. ++. .... .+-+-..||-..+ |+.+|++|.||++....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEEEEecC
Confidence 999999889999997532 37899986543 555 3333 3344455677777 99999999999997443
Q ss_pred ----CEEEee-cccc
Q 018614 186 ----NLKVAD-FGVS 195 (353)
Q Consensus 186 ----~vkl~D-fg~a 195 (353)
.+.|+| ||..
T Consensus 156 ~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEK 170 (199)
T ss_pred CCceEEEEEeCCCCc
Confidence 467777 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-05 Score=67.08 Aligned_cols=103 Identities=22% Similarity=0.254 Sum_probs=80.6
Q ss_pred HHHHHHHhcCCC-CcccceeeEEEecCceEEEEecCCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 018614 93 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVP 168 (353)
Q Consensus 93 ~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~---l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~ 168 (353)
..|.-+++.+++ +++++++|+|-+ +++.|+.+.+++... +..-...++..+.+++.++++.+.+|+..-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888875 699999999843 678899976655321 111113689999999999999999999843333
Q ss_pred EEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 169 IIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 169 iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
+..+|++++|+-++++|.+|++|.+.+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999999876654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.9e-08 Score=95.09 Aligned_cols=193 Identities=24% Similarity=0.220 Sum_probs=136.7
Q ss_pred ccCccCcCcccceeeecceEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc-ccceeeEEEecCceEE
Q 018614 44 EIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSSPMMI 122 (353)
Q Consensus 44 ~i~~~~~~~~~~~~ig~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~i 122 (353)
.++....-+..-..+++|+++.+++ .++.|-|.+....+... ....-++++|.+++||| .+..++-+..+...++
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpK-kRptaeklL~h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPK-KRPTAEKLLQHPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCc-cCCChhhheeceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 3344444456667788999987763 34556665554443332 34556889999999999 7777777777788899
Q ss_pred EEecCCCC-CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 123 VTEYLPKG-DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 123 v~e~~~~~-~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
+++++.++ +...... ....+...+...+...-+.+++++|+.. -+|+| ||+..+ +.++..||+....+..
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCc
Confidence 99999766 2222111 1112444455566777888899999975 58888 776665 6799999998877754
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 250 (353)
.. ......+++.++|||+.....+....|+|++|.-..++.-|.+|-.
T Consensus 384 ~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 384 TM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 43 2334567889999999999999999999999988777777776653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.22 E-value=8e-06 Score=83.69 Aligned_cols=199 Identities=22% Similarity=0.256 Sum_probs=140.5
Q ss_pred HHHHHHHHHHhcCCCCcccceeeEEEecCc----eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 018614 90 RAFRDELALLQKIRHPNVVQFLGAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 165 (353)
Q Consensus 90 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~ 165 (353)
.....|...+..+.|+|++.++.+...... ..+..+++...++...+..-+.++....+.+..++.+||+|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 334567778888899999999988765432 2345678888899999988888999999999999999999999986
Q ss_pred CCCEEecCCCCC---CEEEcCCCCEEEe--ecccccccccCCCCCcccCCCCCcccCccccCCCCCCC--chhHHHHHHH
Q 018614 166 PVPIIHRDLEPS---NILRDDSGNLKVA--DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT--KVDVFSFALI 238 (353)
Q Consensus 166 ~~~iiH~dlkp~---Nill~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~DvwslG~i 238 (353)
..|.-+..+ +.-.+..+.+.+. ||+............. ...+..+.++|......... ..|+|.+|..
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHH
Confidence 666655555 4555666667666 8888776654333222 22334578888877665544 5799999999
Q ss_pred HHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 239 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 239 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
...+..|..+-.... ....+ .......++.+.+.+|+..++++|+++.+++.+.-
T Consensus 382 ~~~~~~~~~i~~~~~---~~~~~----------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA---VPVSL----------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred HhhhhhcCccccccc---chhhh----------hccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 999988755422111 00110 01111125778999999999999999999998753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.15 E-value=3e-05 Score=68.38 Aligned_cols=61 Identities=11% Similarity=0.070 Sum_probs=43.4
Q ss_pred cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEEecCCCCCHHHH
Q 018614 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 135 (353)
Q Consensus 69 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~ 135 (353)
.+..+.+|...... ...+.+|+.+++.+. +-.+++++++...++..++|||+++|.+|.+.
T Consensus 21 ~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 21 KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 44578888875432 124567888888884 44466788887776778999999998777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.4e-05 Score=65.41 Aligned_cols=127 Identities=20% Similarity=0.272 Sum_probs=91.5
Q ss_pred cccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccc-ceeeEEEecCceEEEEecC
Q 018614 52 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV-QFLGAVTQSSPMMIVTEYL 127 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~iv~e~~ 127 (353)
.+....|++|+++.|| |.|..+|+|+-+.+. ....+..|+++|..++-.++. +++.+..+ ++.|||.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 3456789999999887 488899999876543 235788999999999877664 45555433 4569999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCC-CCCEEEcCCCCEEEeecccccc
Q 018614 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE-PSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 128 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlk-p~Nill~~~~~vkl~Dfg~a~~ 197 (353)
.|-.|.++.... +..+ +..++.+-.-|...| |-|+.|+ |...++..++.+.|+||..|+.
T Consensus 95 ~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 888888776421 2223 334555555677788 9999997 5556666666999999998874
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.1e-05 Score=68.05 Aligned_cols=133 Identities=21% Similarity=0.200 Sum_probs=85.3
Q ss_pred eecceEEEEEE----cCeEEEEEEcCcccCCCHH-------------------HH--HHHHHHHHHHhcCC--CCcccce
Q 018614 58 ITKGTFILAFW----RGIQVAVKKLGEEVISDDD-------------------RV--RAFRDELALLQKIR--HPNVVQF 110 (353)
Q Consensus 58 ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~-------------------~~--~~~~~E~~~l~~l~--h~~i~~~ 110 (353)
|..|-=..||+ ++..+|+|+++.....-.. .+ .=..+|...|+++. +=.+++.
T Consensus 56 istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~P 135 (268)
T COG1718 56 ISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEP 135 (268)
T ss_pred ecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCc
Confidence 33343345664 5789999998764321110 00 01235777777774 3345566
Q ss_pred eeEEEecCceEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEE
Q 018614 111 LGAVTQSSPMMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLK 188 (353)
Q Consensus 111 ~~~~~~~~~~~iv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vk 188 (353)
+++.. -.+||||+... .-.-.|+.- .+.......+..++++.+.-|-. .+ +||+||+.-|||+. ++.+.
T Consensus 136 i~~~~----nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 136 IAFRN----NVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred eeecC----CeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEE
Confidence 65543 36999998443 111122211 23334677888889999888877 66 99999999999999 78899
Q ss_pred Eeecccccccc
Q 018614 189 VADFGVSKLLT 199 (353)
Q Consensus 189 l~Dfg~a~~~~ 199 (353)
++|||-|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999876554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.7e-05 Score=66.21 Aligned_cols=137 Identities=21% Similarity=0.267 Sum_probs=75.2
Q ss_pred eeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC--cccceeeEEE---ecCceEEEEecC
Q 018614 56 VEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP--NVVQFLGAVT---QSSPMMIVTEYL 127 (353)
Q Consensus 56 ~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~---~~~~~~iv~e~~ 127 (353)
+.++.|....+| ..+..+++|..... .....+.+|..+++.+... .+++++.... .....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 567777665444 34568999986543 3445677899998888533 3567776443 234478999999
Q ss_pred CCCCHHH----------------HHH---hc----CCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 018614 128 PKGDLRA----------------FLK---RK----GALKPST---------AVRF------------ALDIAR-GMNYLH 162 (353)
Q Consensus 128 ~~~~L~~----------------~l~---~~----~~~~~~~---------~~~i------------~~qi~~-al~~Lh 162 (353)
+|..+.. .+. .. ..+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 8887777 111 11 0011000 0000 011222 233333
Q ss_pred h----cCCCCEEecCCCCCCEEEc-CCCCEEEeecccccc
Q 018614 163 E----NKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKL 197 (353)
Q Consensus 163 ~----~~~~~iiH~dlkp~Nill~-~~~~vkl~Dfg~a~~ 197 (353)
. .....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 1223499999999999999 556667999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.8e-05 Score=67.41 Aligned_cols=72 Identities=17% Similarity=0.094 Sum_probs=44.7
Q ss_pred eeeecceEE-EEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC---cccceeeEEEec---CceEEEEecCC
Q 018614 56 VEITKGTFI-LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP---NVVQFLGAVTQS---SPMMIVTEYLP 128 (353)
Q Consensus 56 ~~ig~G~~~-~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~~~---~~~~iv~e~~~ 128 (353)
+.|+.|+.. .||.-+..+++|...... ....+.+|+.+++.+... .++++++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRLGDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEcCCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 456666664 466556667788754321 223678899999888532 345555544332 23588999998
Q ss_pred CCCH
Q 018614 129 KGDL 132 (353)
Q Consensus 129 ~~~L 132 (353)
|.++
T Consensus 78 G~~l 81 (235)
T cd05155 78 GETA 81 (235)
T ss_pred CCCC
Confidence 8665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.7e-05 Score=76.64 Aligned_cols=77 Identities=14% Similarity=0.332 Sum_probs=53.2
Q ss_pred CceEEEEecCCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC----CCCEEEee
Q 018614 118 SPMMIVTEYLPKGDLRAF--LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD----SGNLKVAD 191 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~--l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~----~~~vkl~D 191 (353)
....++|||++|..+.|+ +.+. .++...+..-+.+...-+ +-..| ++|+|-+|.||+++. ++.+.+.|
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~q--If~~G---ffHaDPHPGNilv~~~~~~~~~ivllD 348 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQ--IFKTG---FFHADPHPGNILVRPNPEGDEEIVLLD 348 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHH--HHhcC---CccCCCCCCcEEEecCCCCCccEEEEc
Confidence 456899999999766544 3343 366664444444333322 22345 999999999999994 56799999
Q ss_pred ccccccccc
Q 018614 192 FGVSKLLTV 200 (353)
Q Consensus 192 fg~a~~~~~ 200 (353)
||+...+..
T Consensus 349 hGl~~~is~ 357 (538)
T KOG1235|consen 349 HGLYAVISH 357 (538)
T ss_pred ccccccccH
Confidence 999877653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00025 Score=73.54 Aligned_cols=75 Identities=16% Similarity=0.203 Sum_probs=48.4
Q ss_pred ceeeecceEEEEE---EcC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcc--cceeeEEEec---CceE
Q 018614 55 SVEITKGTFILAF---WRG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNV--VQFLGAVTQS---SPMM 121 (353)
Q Consensus 55 ~~~ig~G~~~~v~---~~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~---~~~~ 121 (353)
...++.|....+| ..+ ..+++|+......... ...+.+|+.+++.+. |.++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~--~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS--AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc--HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3567777665444 222 3677787654322111 135778999999995 6655 7778877654 4679
Q ss_pred EEEecCCCCC
Q 018614 122 IVTEYLPKGD 131 (353)
Q Consensus 122 iv~e~~~~~~ 131 (353)
+|||+++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00076 Score=61.37 Aligned_cols=75 Identities=11% Similarity=0.035 Sum_probs=52.0
Q ss_pred ccceeeecceEEEEEE---cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC---CcccceeeEEEe---cCceEEE
Q 018614 53 TNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH---PNVVQFLGAVTQ---SSPMMIV 123 (353)
Q Consensus 53 ~~~~~ig~G~~~~v~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~i~~~~~~~~~---~~~~~iv 123 (353)
.....||.|..+.||. .+..+.+|..+.. . .. ..+..|+..++.+.. -.++++++.+.+ .+..++|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~-~-~~---~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSF-S-TP---GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEeccc-c-cc---hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3456799999988874 3345667774321 1 11 367889999998853 367888887754 3668999
Q ss_pred EecCCCCCH
Q 018614 124 TEYLPKGDL 132 (353)
Q Consensus 124 ~e~~~~~~L 132 (353)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999988654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00048 Score=65.54 Aligned_cols=157 Identities=19% Similarity=0.268 Sum_probs=97.6
Q ss_pred HHHHHHHHHhcCCCCcccceeeEEEec-CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCE
Q 018614 91 AFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 169 (353)
Q Consensus 91 ~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~i 169 (353)
++.-....++.++|+|..+++++-... .+..+|+|++ +.+|.+++..+. +-..... .++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~---~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHG---V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccc---c
Confidence 456677889999999999999887532 4478999999 779999987653 2111111 222 3
Q ss_pred EecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 018614 170 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249 (353)
Q Consensus 170 iH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 249 (353)
.|-. .++.+| .++.. | |- ...+|+|||++|.++.++..|...+
T Consensus 89 ~~~~------------~~~~td-~~~t~-----------------~--~~-----~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 89 LHLN------------IIYITD-HFLTK-----------------Y--PS-----PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred ceeh------------hhhccc-ccccc-----------------C--CC-----CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 3221 122333 11000 0 00 0114999999999999999998887
Q ss_pred CCCCCCchHHHHHhcCCCCCCC--------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 018614 250 TMKHDNEVPKAYAARQRPPFKA--------PAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303 (353)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~ 303 (353)
......+....+.+-...+... ..-.+++.+.++...|+...|..||...++.+
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 7666555544443333222111 11234566788999999999999887666553
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0047 Score=52.32 Aligned_cols=127 Identities=22% Similarity=0.285 Sum_probs=86.1
Q ss_pred cCcCcccceeeecceE-EEEE---EcCeEEEEEEcCccc----------CCC-H-------HHHHHHHHHHHHHhcCC--
Q 018614 48 HELDFTNSVEITKGTF-ILAF---WRGIQVAVKKLGEEV----------ISD-D-------DRVRAFRDELALLQKIR-- 103 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~-~~v~---~~g~~vavK~~~~~~----------~~~-~-------~~~~~~~~E~~~l~~l~-- 103 (353)
...+++..+.||.|.- |.|+ ..|..+|+|++.... ... + ....-|..|.+...+|+
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 3467888899999988 7765 579999999932211 000 0 12235778988888885
Q ss_pred -CCcc--cceeeEEEec------------------CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 018614 104 -HPNV--VQFLGAVTQS------------------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 162 (353)
Q Consensus 104 -h~~i--~~~~~~~~~~------------------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh 162 (353)
+.++ ++.+|+..-. ....||.||.+... .+.. .-+.+|..-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4456 8888887322 12367888876543 1222 23455666677889
Q ss_pred hcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 163 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 163 ~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
..| |+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCC---eeeccCcccccc-----CCEEEecccC
Confidence 999 999999999986 2478999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0018 Score=56.63 Aligned_cols=30 Identities=23% Similarity=0.428 Sum_probs=26.1
Q ss_pred CEEecCCCCCCEEEcC-CCCEEEeecccccc
Q 018614 168 PIIHRDLEPSNILRDD-SGNLKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~-~~~vkl~Dfg~a~~ 197 (353)
.++|+|+.+.||++++ ++.+.++||..+..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 4999999999999998 57899999987643
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.16 E-value=3.1e-05 Score=81.45 Aligned_cols=158 Identities=15% Similarity=0.055 Sum_probs=110.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe--cCceEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 018614 92 FRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENK 165 (353)
Q Consensus 92 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~Lh~~~ 165 (353)
...|..-++...|+++.....-... +...+++++++.+|.+.+.+-+. .++....+...-.+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555666788887765554432 23468899999999999988643 22444444444444355555555432
Q ss_pred --CCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHH
Q 018614 166 --PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243 (353)
Q Consensus 166 --~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ell 243 (353)
..-.+|+++|+-|.+|..+..++++++|+.+..... ........+++.|+.|++...-.++.++|+|..|+-+|...
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 123689999999999999999999999999843222 12223345677788888888888888999999999999998
Q ss_pred cCCCCCC
Q 018614 244 EGCPPFT 250 (353)
Q Consensus 244 tg~~pf~ 250 (353)
.|..+|.
T Consensus 1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred cccHHHH
Confidence 8887763
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0026 Score=56.50 Aligned_cols=122 Identities=16% Similarity=0.176 Sum_probs=65.7
Q ss_pred EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc-cceeeEEEecCceEEEEecCCCCCHHH------------
Q 018614 68 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV-VQFLGAVTQSSPMMIVTEYLPKGDLRA------------ 134 (353)
Q Consensus 68 ~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~~~~L~~------------ 134 (353)
.+|..+++|....... ...-...+|..+++.+...++ ++++.... -++|+||++|..+..
T Consensus 17 ~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~l 89 (256)
T TIGR02721 17 HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLEL 89 (256)
T ss_pred eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHH
Confidence 4566788887543211 000123578888888864333 44554432 368999998865431
Q ss_pred --HHHh---c----CCCCHH-HHHHHHHH---------HHHHHHHHHhc-----CCCCEEecCCCCCCEEEcCCCCEEEe
Q 018614 135 --FLKR---K----GALKPS-TAVRFALD---------IARGMNYLHEN-----KPVPIIHRDLEPSNILRDDSGNLKVA 190 (353)
Q Consensus 135 --~l~~---~----~~~~~~-~~~~i~~q---------i~~al~~Lh~~-----~~~~iiH~dlkp~Nill~~~~~vkl~ 190 (353)
.+.+ . .+++.. .+.....+ +...+..+-.. .+..++|+|+.|.||++++++ +.|+
T Consensus 90 a~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lI 168 (256)
T TIGR02721 90 AALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLI 168 (256)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEE
Confidence 1111 0 011211 11111111 11112222221 112389999999999999877 7899
Q ss_pred ecccccc
Q 018614 191 DFGVSKL 197 (353)
Q Consensus 191 Dfg~a~~ 197 (353)
||..+..
T Consensus 169 DwE~a~~ 175 (256)
T TIGR02721 169 DWEYASD 175 (256)
T ss_pred eccccCc
Confidence 9987644
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.014 Score=53.33 Aligned_cols=30 Identities=20% Similarity=0.325 Sum_probs=26.9
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
+++|+|+.+.||+++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987644
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.026 Score=53.34 Aligned_cols=74 Identities=23% Similarity=0.135 Sum_probs=46.9
Q ss_pred ceeeecceEEEEEE----cC-eEEEEEEcCcccCC--C--HHHHHHHHHHHHHHhcCC---CCcccceeeEEEecCceEE
Q 018614 55 SVEITKGTFILAFW----RG-IQVAVKKLGEEVIS--D--DDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 55 ~~~ig~G~~~~v~~----~g-~~vavK~~~~~~~~--~--~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~i 122 (353)
.+.||.|.+..||. +| +.|+||.-...... + .-.......|.+.|+.+. ...+++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999877763 34 47999985421110 0 112345667888888763 2456777766 3455789
Q ss_pred EEecCCCC
Q 018614 123 VTEYLPKG 130 (353)
Q Consensus 123 v~e~~~~~ 130 (353)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.011 Score=53.69 Aligned_cols=136 Identities=16% Similarity=0.089 Sum_probs=73.5
Q ss_pred ceeeecceEE---EEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc--ccceeeE------EEecCceEEE
Q 018614 55 SVEITKGTFI---LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGA------VTQSSPMMIV 123 (353)
Q Consensus 55 ~~~ig~G~~~---~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~------~~~~~~~~iv 123 (353)
.+.+..|.-. .+...+..+++|+.... .. ..+..|+.+++.+.+.+ +++++.. ...++..+++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~---~~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV---SA---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC---Ch---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 3445555322 23335567888987541 12 24556777777774322 4444431 2334567899
Q ss_pred EecCCCCCHHH----HH----H------h-cCCC----------CHHHH--H--------HHHHHHHHHHHHHHh----c
Q 018614 124 TEYLPKGDLRA----FL----K------R-KGAL----------KPSTA--V--------RFALDIARGMNYLHE----N 164 (353)
Q Consensus 124 ~e~~~~~~L~~----~l----~------~-~~~~----------~~~~~--~--------~i~~qi~~al~~Lh~----~ 164 (353)
+++++|..+.. .. + . ...+ .+... . .....+..++.++.. .
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99998865421 11 0 0 0000 00000 0 011112334444443 1
Q ss_pred CCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 165 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 165 ~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
-...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 11249999999999999998777899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0071 Score=55.12 Aligned_cols=128 Identities=17% Similarity=0.245 Sum_probs=73.5
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC--CcccceeeEEEecC--ceEEEEecCCCCCH-------------
Q 018614 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSS--PMMIVTEYLPKGDL------------- 132 (353)
Q Consensus 70 g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~--~~~iv~e~~~~~~L------------- 132 (353)
++.+++. ... ............+|..+++.+.- --+...++.+.++. ..|.||+|++|..+
T Consensus 48 ~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~ 125 (321)
T COG3173 48 GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQF 125 (321)
T ss_pred CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHH
Confidence 6677777 321 12223334556778888888753 23455666666554 67999999987321
Q ss_pred -----HHHHHh-------c----CC---CCHHHHHHHHH--------------HHHHHHHHHHhc-----CCCCEEecCC
Q 018614 133 -----RAFLKR-------K----GA---LKPSTAVRFAL--------------DIARGMNYLHEN-----KPVPIIHRDL 174 (353)
Q Consensus 133 -----~~~l~~-------~----~~---~~~~~~~~i~~--------------qi~~al~~Lh~~-----~~~~iiH~dl 174 (353)
.+.|.. . +. ....++..+.. .+.....+|+.+ ++..++|+|+
T Consensus 126 ~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~ 205 (321)
T COG3173 126 ALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDY 205 (321)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCc
Confidence 112210 0 00 00011111111 122223444433 2335899999
Q ss_pred CCCCEEEcCCCCEEEeecccccccc
Q 018614 175 EPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 175 kp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++.|+++++.+-+=+.||+++..-+
T Consensus 206 ~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 206 RPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ccCCEEEeCCCeeEEEeccccccCC
Confidence 9999999999889999999986643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.015 Score=52.26 Aligned_cols=30 Identities=30% Similarity=0.575 Sum_probs=25.2
Q ss_pred CEEecCCCCCCEEEcCCCC-EEEeecccccc
Q 018614 168 PIIHRDLEPSNILRDDSGN-LKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~-vkl~Dfg~a~~ 197 (353)
.++|+|++|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997555 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.022 Score=52.27 Aligned_cols=30 Identities=27% Similarity=0.241 Sum_probs=25.5
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
++||+|+.|.||+++.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 499999999999999766568999997643
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.012 Score=54.00 Aligned_cols=73 Identities=23% Similarity=0.305 Sum_probs=58.1
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
...|++|++. |+++.-.- .....++..++++.+..++-+..+- +.-|||+...||||+ +|.|.|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is~ik----~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISIIK----ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeeeee----cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 3457888887 65654322 2457788899999998888887765 489999999999999 89999999999985
Q ss_pred c
Q 018614 198 L 198 (353)
Q Consensus 198 ~ 198 (353)
-
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0043 Score=56.10 Aligned_cols=92 Identities=22% Similarity=0.242 Sum_probs=64.7
Q ss_pred HHHHHHHHhcCCC--CcccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCE
Q 018614 92 FRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 169 (353)
Q Consensus 92 ~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~i 169 (353)
..+|...|+.|.. --|++.+++ .+-++|||++.|..|...-.- .+... +...+..-+.-|-.+| +
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d~~~---ly~~lm~~Iv~la~~G---l 223 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV---EDPPT---LYDDLMGLIVRLANHG---L 223 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec---CChHH---HHHHHHHHHHHHHHcC---c
Confidence 3578888888853 235666654 445899999988777654321 22333 3334444455667788 9
Q ss_pred EecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 170 IHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 170 iH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
||+|+.-=||++++++.++++||--..
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhh
Confidence 999999999999999999999996443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.093 Score=49.59 Aligned_cols=73 Identities=12% Similarity=0.055 Sum_probs=43.2
Q ss_pred ceeeecceEEEEE---EcCeEEEEEEcCcccCC-CH---HHHHHHHHHHHHHhcCC---CCcccceeeEEEecCceEEEE
Q 018614 55 SVEITKGTFILAF---WRGIQVAVKKLGEEVIS-DD---DRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 55 ~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~-~~---~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+.||.|.--.|| ..+..++||.-...... .. .....-..|+..|+.+. ...+++++.++. ...+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 4678888765544 34556888876522110 00 01223344566666653 247788888776 4467889
Q ss_pred ecCCC
Q 018614 125 EYLPK 129 (353)
Q Consensus 125 e~~~~ 129 (353)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99966
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.033 Score=51.36 Aligned_cols=100 Identities=23% Similarity=0.278 Sum_probs=67.9
Q ss_pred HHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEec
Q 018614 94 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD-LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 172 (353)
Q Consensus 94 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~-L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~ 172 (353)
+|++.|+++....|+-.--+... .-.+||+++.... ..-.|+ .-.++...+..+-.|++.-+.-|.... ++||.
T Consensus 215 KE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHA 289 (520)
T KOG2270|consen 215 KEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKC--RLVHA 289 (520)
T ss_pred HHHHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHh--ceecc
Confidence 57777777765554322211211 2368999984321 222222 224777788888889999999888876 39999
Q ss_pred CCCCCCEEEcCCCCEEEeecccccccc
Q 018614 173 DLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 173 dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
||.--|+|+-+ |.+.++|.+-+...+
T Consensus 290 DLSEfN~Lyhd-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 290 DLSEFNLLYHD-GKLYIIDVSQSVEHD 315 (520)
T ss_pred chhhhhheEEC-CEEEEEEccccccCC
Confidence 99999999977 679999988665443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.17 Score=47.03 Aligned_cols=28 Identities=25% Similarity=0.361 Sum_probs=23.4
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
.++|+|+.+.||++++++ ++++|+.++.
T Consensus 193 ~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred eeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 389999999999998764 7799987653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.24 Score=42.87 Aligned_cols=72 Identities=21% Similarity=0.194 Sum_probs=49.8
Q ss_pred eeeecceEE---EEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCcccceeeEEEecCceEEEEecCCC
Q 018614 56 VEITKGTFI---LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~---~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+.+..|..- .+.....++.||+-. .+..+.|..|+.-|+.+. .-.|++++.+.......|+||||++.
T Consensus 22 ~~v~gG~inea~~v~dg~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 22 EEVSGGDINEAWRLRDGTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred cccCCccccceeEeecCCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 445555442 233455678888743 344567788888887774 34678889888889999999999987
Q ss_pred CCHH
Q 018614 130 GDLR 133 (353)
Q Consensus 130 ~~L~ 133 (353)
+.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 5543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.082 Score=48.07 Aligned_cols=30 Identities=33% Similarity=0.449 Sum_probs=26.3
Q ss_pred CCEEecCCCCCCEEEcCC----CCEEEeeccccc
Q 018614 167 VPIIHRDLEPSNILRDDS----GNLKVADFGVSK 196 (353)
Q Consensus 167 ~~iiH~dlkp~Nill~~~----~~vkl~Dfg~a~ 196 (353)
..++|+|+.+.||+++++ +.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 358999999999999985 889999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.065 Score=48.95 Aligned_cols=29 Identities=38% Similarity=0.466 Sum_probs=25.8
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
+++|+|+++.||++++++.+.|+||+.+.
T Consensus 188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 188 GVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 49999999999999998877899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.26 Score=44.54 Aligned_cols=72 Identities=19% Similarity=0.125 Sum_probs=41.5
Q ss_pred ccceeeecceEEEE---EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCcccceeeEEEecCceEEEEec
Q 018614 53 TNSVEITKGTFILA---FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 53 ~~~~~ig~G~~~~v---~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+..+.++.|....+ ..++..+.||+-.... ...|..|+.-|+.|. .-.+++++++....+..++||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 34566776655433 3467889999875321 135677888888883 34678899988877778999999
Q ss_pred CCCC
Q 018614 127 LPKG 130 (353)
Q Consensus 127 ~~~~ 130 (353)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 8655
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.047 Score=45.84 Aligned_cols=28 Identities=25% Similarity=0.480 Sum_probs=25.1
Q ss_pred EEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 169 IIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 169 iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
.+|+|+.|+||+++++| ++|+||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 79999999999999887 88999998754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.93 E-value=0.15 Score=46.51 Aligned_cols=27 Identities=33% Similarity=0.450 Sum_probs=24.0
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 4999999999999998 67899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.61 E-value=0.14 Score=45.79 Aligned_cols=47 Identities=26% Similarity=0.438 Sum_probs=34.1
Q ss_pred HHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 150 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 150 i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
.+..+-.++.-++..- .-++|+|+.|+|++.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3444444444444431 1289999999999999999999999987754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.85 E-value=0.44 Score=44.96 Aligned_cols=27 Identities=30% Similarity=0.347 Sum_probs=22.9
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
..+|.|+.+.||+.++ +.+.++||..|
T Consensus 228 VfCHNDL~~gNIL~~~-~~l~lID~EYA 254 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN-QGIYFIDFDFA 254 (383)
T ss_pred eeeeccCCcccEEecC-CCEEEEEeccc
Confidence 4899999999999765 45999999765
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.81 E-value=0.28 Score=45.20 Aligned_cols=29 Identities=41% Similarity=0.620 Sum_probs=25.5
Q ss_pred EEecCCCCCCEEEcCCCC-EEEeecccccc
Q 018614 169 IIHRDLEPSNILRDDSGN-LKVADFGVSKL 197 (353)
Q Consensus 169 iiH~dlkp~Nill~~~~~-vkl~Dfg~a~~ 197 (353)
+||+|+.|.||+++.... +-++|||-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 899999999999998874 89999997643
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.33 E-value=0.089 Score=45.14 Aligned_cols=30 Identities=37% Similarity=0.644 Sum_probs=21.1
Q ss_pred CEEecCCCCCCEEE-cCCCCEEEeecccccc
Q 018614 168 PIIHRDLEPSNILR-DDSGNLKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill-~~~~~vkl~Dfg~a~~ 197 (353)
.++|+|+.+.||++ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 38999999999999 8889999999987754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.87 E-value=0.23 Score=45.27 Aligned_cols=41 Identities=29% Similarity=0.152 Sum_probs=27.0
Q ss_pred HHHHHHHHHHHHHHHHH-HhcCCCCEEecCCCCCCEEEcCCC
Q 018614 145 STAVRFALDIARGMNYL-HENKPVPIIHRDLEPSNILRDDSG 185 (353)
Q Consensus 145 ~~~~~i~~qi~~al~~L-h~~~~~~iiH~dlkp~Nill~~~~ 185 (353)
.-+..+..||+.-.-.+ .-.+-...+|-||||+|||+-++.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 34555677877655344 222223499999999999987654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=91.68 E-value=0.28 Score=45.66 Aligned_cols=29 Identities=24% Similarity=0.488 Sum_probs=25.2
Q ss_pred CEEecCCCCCCEEEcC-CCCEEEeeccccc
Q 018614 168 PIIHRDLEPSNILRDD-SGNLKVADFGVSK 196 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~-~~~vkl~Dfg~a~ 196 (353)
.++|+|+++.||++++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 4899999999999986 4679999998764
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=90.83 E-value=0.25 Score=41.95 Aligned_cols=30 Identities=27% Similarity=0.384 Sum_probs=24.7
Q ss_pred CEEecCCCCCCEEEcCCC-----CEEEeecccccc
Q 018614 168 PIIHRDLEPSNILRDDSG-----NLKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~-----~vkl~Dfg~a~~ 197 (353)
.++|||+.+.||++..++ .+.++||..+..
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 489999999999998543 589999987643
|
subfamily of choline kinases |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.61 E-value=0.28 Score=42.28 Aligned_cols=103 Identities=16% Similarity=0.210 Sum_probs=63.0
Q ss_pred EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHH
Q 018614 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 151 (353)
Q Consensus 72 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~ 151 (353)
+..+|+++.-...- ...-|..+..+++++. .|+++..- ++..+.++.|+|-... . .. ..++
T Consensus 87 ~L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~----------i--~~-~N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK----------I--NF-SNFI 147 (308)
T ss_pred hhhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc----------c--ch-hHHH
Confidence 44456655433320 1134567778877764 35555522 3445789999883211 0 01 1112
Q ss_pred HHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 152 ~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
.-=+++|.-+|+... +.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 148 ~agi~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAGIKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHhHHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhh
Confidence 222456778895432 499999999999999999999999663
|
The function of this family is unknown. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=90.15 E-value=0.33 Score=44.51 Aligned_cols=55 Identities=29% Similarity=0.238 Sum_probs=33.8
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCC------------------CEEEeecccccccc
Q 018614 145 STAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG------------------NLKVADFGVSKLLT 199 (353)
Q Consensus 145 ~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~------------------~vkl~Dfg~a~~~~ 199 (353)
.-+..+..||+.-.--+.. .+-...+|-||||+|||+-++. ..+|.||.++...+
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 3445566677654322211 1112389999999999986543 35677777776544
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 353 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-36 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-36 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-32 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-31 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-31 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-31 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-31 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-31 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-31 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-29 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-29 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-29 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-29 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-29 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-29 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-29 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-29 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-29 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-29 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-29 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-28 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-28 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-28 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-28 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-28 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-28 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-28 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-27 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-27 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-27 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-27 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-27 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-27 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-27 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-27 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-26 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-26 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-26 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-26 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-26 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-26 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-26 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-26 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-26 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-26 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-26 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-26 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-26 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-26 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-26 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-26 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-26 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-26 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-26 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-26 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-26 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-26 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-26 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-26 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-26 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-26 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-26 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-26 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-26 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-26 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-26 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-26 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-26 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-26 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-26 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-26 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-26 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-26 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-26 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-26 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-26 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-26 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-26 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-26 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-26 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-26 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-26 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-26 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-26 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-25 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-25 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-25 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-25 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-25 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-25 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-25 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-25 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-25 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-25 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-25 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-25 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-25 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-25 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-25 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-25 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-25 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-25 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-25 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-25 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-24 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-24 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-24 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-24 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-24 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-24 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-24 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-23 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-23 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-23 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-23 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-23 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-23 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-23 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-23 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-23 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-23 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-23 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-23 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-23 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-23 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-23 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-23 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-23 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-22 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-22 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-22 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-22 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-22 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-22 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-22 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-22 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-22 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-22 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-22 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-22 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-22 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-22 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-22 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-22 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-22 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-22 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-22 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-22 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-22 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-21 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-21 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-21 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-21 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-21 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-21 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-21 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-21 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-21 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-21 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-21 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-21 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-20 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-20 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-20 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-20 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-20 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-20 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-20 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-20 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-20 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-20 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-20 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-20 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-19 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-19 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-19 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-19 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-19 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-19 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-19 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-19 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-19 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-19 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-19 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-19 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-19 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-19 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-19 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-18 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-18 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-18 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-18 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-18 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-18 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-18 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-18 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-17 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-16 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-16 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-16 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-15 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-15 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-15 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-14 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-13 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-12 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-12 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-12 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-09 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 1e-94
Identities = 81/280 (28%), Positives = 132/280 (47%), Gaps = 25/280 (8%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 98
+ ID E++ + +G F A WR VA+K++ + +AF EL
Sbjct: 2 LHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQI-----ESESERKAFIVELRQ 54
Query: 99 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIA 155
L ++ HPN+V+ GA P+ +V EY G L L + + A+ + L +
Sbjct: 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 156 RGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKEDRPLTCQDTSCR 214
+G+ YLH +P +IHRDL+P N+L G LK+ DFG + + +T S
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAA 168
Query: 215 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAP 272
++APEVF+ Y K DVFS+ +IL E+I PF +A RPP
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--- 225
Query: 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312
K + ++ L+ CW++ P++RP+ +I+ + +
Sbjct: 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 3e-94
Identities = 97/282 (34%), Positives = 148/282 (52%), Gaps = 19/282 (6%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 95
+ + +I +L+ +I G+F A W G VAVK L E+ + RV F E
Sbjct: 28 DGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLRE 84
Query: 96 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFAL 152
+A+++++RHPN+V F+GAVTQ + IVTEYL +G L L + GA L + A
Sbjct: 85 VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 212
D+A+GMNYLH P PI+HR+L+ N+L D +KV DFG+S+L +
Sbjct: 145 DVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGT 202
Query: 213 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP--PF 269
++APEV ++E + K DV+SF +IL E+ P+ + +V A + +R P
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262
Query: 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311
+ + +IE CW +P KRP+F I+ L + S
Sbjct: 263 NLNPQ-----VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 7e-91
Identities = 87/280 (31%), Positives = 126/280 (45%), Gaps = 26/280 (9%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISD-DDRVRAFRDELALL 99
EID EL I G F AFW G +VAVK + D + R E L
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 100 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 159
++HPN++ G + + +V E+ G L L K + P V +A+ IARGMN
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSG--------NLKVADFGVSKLLTVKEDRPLTCQDT 211
YLH+ VPIIHRDL+ SNIL LK+ DFG+++
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAG 176
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP--P 268
+ ++APEV + + DV+S+ ++L E++ G PF V A + P
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
P +L+E+CWN P RP+F I+ +L +I
Sbjct: 237 STCPEPFA-----KLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 3e-87
Identities = 81/287 (28%), Positives = 130/287 (45%), Gaps = 32/287 (11%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFW--RGIQVAVKKLGEEVISDD----DRVRAF 92
+ +E+++ +I KG F VA+K L + ++ + F
Sbjct: 13 LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 93 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFA 151
+ E+ ++ + HPN+V+ G + P +V E++P GDL L + +K S +R
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVSKLLTVKEDRPL 206
LDIA G+ Y+ P PI+HRDL NI KVADFG+S+ +
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSV 183
Query: 207 TCQDTSCRYVAPEVF--KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 264
+ + +++APE + E Y K D +SFA+IL ++ G PF ++ R
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 265 Q---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ RP P R L+ +IE CW+ P KRP F I+ L +
Sbjct: 244 EEGLRPTI--PEDCPPR-LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 2e-85
Identities = 68/284 (23%), Positives = 127/284 (44%), Gaps = 27/284 (9%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 98
E++I +L+ I KG F W G +VA++ + E ++D+++AF+ E+
Sbjct: 27 EWDIPFEQLEIGE--LIGKGRFGQVYHGRWHG-EVAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 99 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 157
++ RH NVV F+GA + I+T L + + K L + + A +I +G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV----KEDRPLTCQDTSC 213
M YLH I+H+DL+ N+ D+ G + + DFG+ + V + + L Q+
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 214 RYVAPEVFKNEE---------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 264
++APE+ + + DVF+ I E+ PF + +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258
Query: 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+P + + +++ CW + +RPTF +++ LE +
Sbjct: 259 MKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 4e-85
Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 24/280 (8%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 98
ID +L+F ++ + W+G + VK L S + R F +E
Sbjct: 4 HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60
Query: 99 LQKIRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFALDI 154
L+ HPNV+ LGA + ++T ++P G L L + S AV+FALD+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 214
ARGM +LH +P I L +++ D+ +++ V +
Sbjct: 121 ARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM------YAPA 173
Query: 215 YVAPEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK 270
+VAPE + + DT D++SFA++L E++ PF + E+ A RP
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI- 232
Query: 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310
P + + + +L++ C NE PAKRP F I+ LE + +
Sbjct: 233 -PPGI-SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 6e-82
Identities = 85/299 (28%), Positives = 135/299 (45%), Gaps = 40/299 (13%)
Query: 40 VPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRD 94
+P P +L + KG F I R G + +K+L D++ R F
Sbjct: 2 MPHRIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLK 56
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALD 153
E+ +++ + HPNV++F+G + + + +TEY+ G LR +K S V FA D
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 211
IA GM YLH IIHRDL N L ++ N+ VADFG+++L+ ++ +P +
Sbjct: 117 IASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 212 -----------SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI------EGCPPFTMKHD 254
+ ++APE+ YD KVDVFSF ++L E+I P TM
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 255 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313
V + P P + + C + P KRP+F ++ LE++ +
Sbjct: 234 LNVRGFL--DRYCPPNCPPSFF-----PITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-81
Identities = 73/277 (26%), Positives = 137/277 (49%), Gaps = 18/277 (6%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 98
++EI ++ I G+F W G VAVK L +++AF++E+ +
Sbjct: 18 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGV 73
Query: 99 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 157
L+K RH N++ F+G T + IVT++ L L + + + A ARG
Sbjct: 74 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYV 216
M+YLH IIHRDL+ +NI + +K+ DFG++ + Q + S ++
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 217 APEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPFKAP 272
APEV + ++ Y + DV++F ++L E++ G P++ + + +++ + P +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 273 AKLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ + +K L+ EC +K +RP+F +I+ +E +
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 1e-78
Identities = 69/313 (22%), Positives = 123/313 (39%), Gaps = 46/313 (14%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 98
++ +I KG + + WRG +VAVK + ++ E+
Sbjct: 31 VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVF----FTTEEASWFRETEIYQ 84
Query: 99 LQKIRHPNVVQFLGAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 154
+RH N++ F+ A + + + ++T+Y G L +LK L + ++ A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143
Query: 155 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 209
G+ +LH I HRDL+ NIL +G +AD G++ +
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 210 DTSC---RYVAPEV------FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 260
+T RY+ PEV + + D++SF LIL E+ C + + ++P
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 261 YAA----------------RQRP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
+ RP P + + R + +L+ ECW PA R T ++
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 303 TRLESINNSINHK 315
L ++ S + K
Sbjct: 324 KTLAKMSESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 3e-74
Identities = 70/291 (24%), Positives = 116/291 (39%), Gaps = 44/291 (15%)
Query: 58 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 114
+ KG + W+G VAVK R EL +RH N++ F+ +
Sbjct: 16 VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRET----ELYNTVMLRHENILGFIASD 71
Query: 115 TQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV--- 167
S + ++T Y G L +L+ L + +R L IA G+ +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 168 --PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK 222
I HRDL+ NIL +G +AD G++ + + ++ + RY+APEV
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 223 NE------EYDTKVDVFSFALILQEMIEGCPPFTMKHD------NEVPKAYAA------- 263
+ +VD+++F L+L E+ + D + VP +
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250
Query: 264 ---RQRPPFKAPAKLYA--RGLKELIEECWNEKPAKRPTFRQIITRLESIN 309
+QRP L +L++ECW + P+ R T +I L I+
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-73
Identities = 71/331 (21%), Positives = 121/331 (36%), Gaps = 46/331 (13%)
Query: 24 ELIFQMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGE 80
+LI+ M + + I KG F WRG +VAVK
Sbjct: 18 DLIYDMTTSGSGSGLPLLVQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSS 75
Query: 81 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFL 136
R E+ +RH N++ F+ A + + + +V++Y G L +L
Sbjct: 76 REERSWFREA----EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 131
Query: 137 KRKGALKPSTAVRFALDIARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVAD 191
R + ++ AL A G+ +LH I HRDL+ NIL +G +AD
Sbjct: 132 NRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190
Query: 192 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNE------EYDTKVDVFSFALILQEM 242
G++ D + RY+APEV + E + D+++ L+ E+
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250
Query: 243 IEGC------PPFTMKHDNEVPKAYAA----------RQRPPFKAPAKL--YARGLKELI 284
C + + + + VP + + RP + R + +++
Sbjct: 251 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 310
Query: 285 EECWNEKPAKRPTFRQIITRLESINNSINHK 315
ECW A R T +I L ++ K
Sbjct: 311 RECWYANGAARLTALRIKKTLSQLSQQEGIK 341
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-69
Identities = 68/312 (21%), Positives = 116/312 (37%), Gaps = 46/312 (14%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 97
L +G F A VAVK + D + E+
Sbjct: 17 ENLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVY 70
Query: 98 LLQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 153
L ++H N++QF+GA + + + ++T + KG L FLK + + A
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129
Query: 154 IARGMNYLHENKPV-------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206
+ARG+ YLHE+ P I HRD++ N+L ++ +ADFG++ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 207 TCQDT-SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 260
T + RY+APEV + ++D+++ L+L E+ C D +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 261 YAA-----------------RQRPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQI 301
++RP + L E IEECW+ R + +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 302 ITRLESINNSIN 313
R+ + N
Sbjct: 310 GERITQMQRLTN 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-67
Identities = 79/328 (24%), Positives = 119/328 (36%), Gaps = 61/328 (18%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 95
E +D L I +G + VAVK S +R + F +E
Sbjct: 4 AASEPSLDLDNLKLLEL--IGRGRYGAVYKGSLDERPVAVKVF-----SFANR-QNFINE 55
Query: 96 LA--LLQKIRHPNVVQFLGA-----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148
+ + H N+ +F+ ++V EY P G L +L ++
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114
Query: 149 RFALDIARGMNYLHENKPV------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202
R A + RG+ YLH P I HRDL N+L + G ++DFG+S LT
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 203 DRPLTCQDTSC-------RYVAPEVFKN-------EEYDTKVDVFSFALILQEMIEGC-- 246
+D + RY+APEV + E +VD+++ LI E+ C
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 247 -------PPFTMKHDNEVPKAYAA----------RQRPPFK---APAKLYARGLKELIEE 286
P + M EV +QRP F L R LKE IE+
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 287 CWNEKPAKRPTFRQIITRLESINNSINH 314
CW++ R T + R+ +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-61
Identities = 76/291 (26%), Positives = 139/291 (47%), Gaps = 24/291 (8%)
Query: 28 QMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVAVKKLGEEV 82
+ P + ++E++ ++ + ++ G + W+ + VAVK L E+
Sbjct: 200 RNKPTIYGVSPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT 257
Query: 83 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKG 140
+ ++ F E A++++I+HPN+VQ LG T+ P I+TE++ G+L +L+ +
Sbjct: 258 MEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 313
Query: 141 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200
+ + A I+ M YL + IHR+L N L ++ +KVADFG+S+L+T
Sbjct: 314 EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370
Query: 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK 259
++ APE ++ K DV++F ++L E+ G P+ ++V +
Sbjct: 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430
Query: 260 AYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
R P P K+Y EL+ CW P+ RP+F +I E++
Sbjct: 431 LLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-60
Identities = 85/278 (30%), Positives = 145/278 (52%), Gaps = 28/278 (10%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 97
++ IDP EL F EI G F L +W +VA+K + E +S++D F +E
Sbjct: 2 KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 55
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 156
++ K+ HP +VQ G + +P+ +VTE++ G L +L+ ++G T + LD+
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 213
GM YL E +IHRDL N L ++ +KV+DFG+++ + D T +
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPV 169
Query: 214 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 270
++ +PEVF Y +K DV+SF +++ E+ EG P+ + ++EV + + R P
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 229
Query: 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
A +Y +++ CW E+P RP F +++ +L I
Sbjct: 230 ASTHVY-----QIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-60
Identities = 76/278 (27%), Positives = 136/278 (48%), Gaps = 24/278 (8%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVAVKKLGEEVISDDDRVRAFRDE 95
++E++ ++ + ++ G + W+ + VAVK L E+ + ++ F E
Sbjct: 6 DKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKE 59
Query: 96 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALD 153
A++++I+HPN+VQ LG T+ P I+TE++ G+L +L+ + + + A
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 213
I+ M YL + IHRDL N L ++ +KVADFG+S+L+T
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 214 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 270
++ APE ++ K DV++F ++L E+ G P+ ++V + R P
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
P K+Y EL+ CW P+ RP+F +I E++
Sbjct: 237 CPEKVY-----ELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-60
Identities = 82/286 (28%), Positives = 138/286 (48%), Gaps = 34/286 (11%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 97
+ ++ EL I KG F +L +RG +VAVK + + + F E +
Sbjct: 14 SGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-----FLAEAS 66
Query: 98 LLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 154
++ ++RH N+VQ LG + + + IVTEY+ KG L +L+ + L ++F+LD+
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---PLTCQDT 211
M YL N +HRDL N+L + KV+DFG++K + +D P+
Sbjct: 127 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV----- 178
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PP 268
++ APE + +++ TK DV+SF ++L E+ G P+ +V + P
Sbjct: 179 --KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 236
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314
P +Y E+++ CW+ A RP+F Q+ +LE I H
Sbjct: 237 DGCPPAVY-----EVMKNCWHLDAAMRPSFLQLREQLEHIKTHELH 277
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 1e-59
Identities = 78/281 (27%), Positives = 122/281 (43%), Gaps = 28/281 (9%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVAVKKLGEEVISDDDRVRAFRDE 95
++ ++ +L +I +G F R VAVK E + D F E
Sbjct: 107 DKWVLNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQE 162
Query: 96 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 154
+L++ HPN+V+ +G TQ P+ IV E + GD FL+ L+ T ++ D
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 213
A GM YL IHRDL N L + LK++DFG+S+ D
Sbjct: 223 AAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE---ADGVYAASGGLRQ 276
Query: 214 ---RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--P 267
++ APE Y ++ DV+SF ++L E G P+ + + + R
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336
Query: 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
P P ++ L+E+CW +P +RP+F I L+SI
Sbjct: 337 PELCPDAVF-----RLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-59
Identities = 83/276 (30%), Positives = 140/276 (50%), Gaps = 28/276 (10%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALL 99
E+ E+ E+ G F L W+G VAVK + E +S+D+ F E +
Sbjct: 4 ELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTM 57
Query: 100 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 158
K+ HP +V+F G ++ P+ IVTEY+ G L +L+ L+PS + D+ GM
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 159 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRY 215
+L ++ IHRDL N L D +KV+DFG+++ + D + ++
Sbjct: 118 AFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKW 171
Query: 216 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAP 272
APEVF +Y +K DV++F +++ E+ G P+ + ++EV + R P A
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLAS 231
Query: 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+Y +++ CW+E P KRPTF+Q+++ +E +
Sbjct: 232 DTIY-----QIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-59
Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 22/279 (7%)
Query: 42 EYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 95
EI+ + + E+ G + R + VA+K L + + R F E
Sbjct: 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSE 100
Query: 96 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 154
+++ + HPN+++ G VT+ MIVTEY+ G L FL+ G V +
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 213
GM YL + +HRDL N+L D + KV+DFG+S++L D T
Sbjct: 161 GAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 214 -RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPF 269
R+ APE + + DV+SF +++ E++ G P+ + +V + R P
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM 277
Query: 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
P L+ +L+ +CW++ A+RP F QI++ L+++
Sbjct: 278 GCPHALH-----QLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-59
Identities = 79/278 (28%), Positives = 136/278 (48%), Gaps = 28/278 (10%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 97
+EIDP +L F E+ G F WRG VA+K + E +S+D+ F +E
Sbjct: 18 SWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAK 71
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 156
++ + H +VQ G T+ P+ I+TEY+ G L +L+ + + + D+
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 213
M YL + +HRDL N L +D G +KV+DFG+S+ + D T S
Sbjct: 132 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPV 185
Query: 214 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 270
R+ PEV ++ +K D+++F +++ E+ G P+ ++E + A R P
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL 245
Query: 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
A K+Y ++ CW+EK +RPTF+ +++ + +
Sbjct: 246 ASEKVY-----TIMYSCWHEKADERPTFKILLSNILDV 278
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-58
Identities = 86/286 (30%), Positives = 141/286 (49%), Gaps = 34/286 (11%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 97
+ ++ EL I KG F +L +RG +VAVK I +D +AF E +
Sbjct: 186 SGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEAS 238
Query: 98 LLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDI 154
++ ++RH N+VQ LG + + + IVTEY+ KG L +L+ +G L ++F+LD+
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---PLTCQDT 211
M YL N +HRDL N+L + KV+DFG++K + +D P+
Sbjct: 299 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV----- 350
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PP 268
++ APE + +++ TK DV+SF ++L E+ G P+ +V + P
Sbjct: 351 --KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 408
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314
P +Y ++++ CW+ A RPTF Q+ +LE I H
Sbjct: 409 DGCPPAVY-----DVMKNCWHLDAATRPTFLQLREQLEHIRTHELH 449
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-58
Identities = 83/276 (30%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 97
+EI L ++ +G F + W G +VA+K L +S + F E
Sbjct: 178 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 231
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIA 155
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 232 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 156 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 215
GM Y+ +HRDL +NIL ++ KVADFG+++L+ E ++
Sbjct: 291 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 216 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAP 272
APE + K DV+SF ++L E+ +G P+ + EV R P + P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
L+ +L+ +CW ++P +RPTF + LE
Sbjct: 408 ESLH-----DLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-58
Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 37/295 (12%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRD 94
E +D L + E+ G F +++ VAVK L E +D
Sbjct: 10 EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLA 67
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 154
E ++Q++ +P +V+ +G M+V E G L +L++ +K + +
Sbjct: 68 EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---------P 205
+ GM YL E+ +HRDL N+L K++DFG+SK L E+ P
Sbjct: 127 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAAR 264
+ ++ APE ++ +K DV+SF +++ E G P+ +EV
Sbjct: 184 V-------KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
Query: 265 QR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 317
+R P P ++Y +L+ CW RP F + RL + + ++
Sbjct: 237 ERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-57
Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 27/282 (9%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 92
EI P + I G F + + VA+K L ++ R F
Sbjct: 38 TTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQR-VDF 93
Query: 93 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 151
E ++ + H N+++ G +++ PMMI+TEY+ G L FL+ + G V
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
IA GM YL +HRDL NIL + + KV+DFG+S++L + T
Sbjct: 154 RGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 212 SC--RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR-- 266
R+ APE ++ + DV+SF +++ E++ G P+ ++EV KA R
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270
Query: 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
P P+ +Y +L+ +CW ++ A+RP F I++ L+ +
Sbjct: 271 TPMDCPSAIY-----QLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-57
Identities = 72/304 (23%), Positives = 135/304 (44%), Gaps = 45/304 (14%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 92
+ + L F ++ KG F + + VAVKKL S ++ +R F
Sbjct: 4 PTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDF 58
Query: 93 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 149
E+ +L+ ++H N+V++ G + + ++ EYLP G LR +L++ K + ++
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 150 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLT 207
+ I +GM YL + IHRDL NIL ++ +K+ DFG++K+L ++ +
Sbjct: 119 YTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 208 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTM 251
++ + APE ++ DV+SF ++L E+ G
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235
Query: 252 KHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309
+ + R P P ++Y ++ ECWN +RP+FR + R++ I
Sbjct: 236 MIVFHLIELLKNNGRLPRPDGCPDEIY-----MIMTECWNNNVNQRPSFRDLALRVDQIR 290
Query: 310 NSIN 313
+++
Sbjct: 291 DNMA 294
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-57
Identities = 83/277 (29%), Positives = 133/277 (48%), Gaps = 22/277 (7%)
Query: 44 EIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 97
E+D + V E+ G L + I VA+K L + + R F E +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEAS 98
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIAR 156
++ + HPN+++ G VT+S P+MIVTEY+ G L +FL K V IA
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--R 214
GM YL + +HRDL NIL + + KV+DFG+ ++L + T + R
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 215 YVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKA 271
+ +PE ++ + DV+S+ ++L E++ G P+ + +V KA R PP
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275
Query: 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
PA LY +L+ +CW + RP F QI++ L+ +
Sbjct: 276 PAALY-----QLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-57
Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 26/285 (9%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVRAFR 93
I +L ++ G+F W + VAVK L +V+S + + F
Sbjct: 12 TCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 94 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL 152
E+ + + H N+++ G V PM +VTE P G L L+ +G T R+A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT- 211
+A GM YL + IHRDL N+L +K+ DFG+ + L +D + +
Sbjct: 129 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 212 -SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKA-YAARQR-- 266
+ APE K + D + F + L EM G P+ + +++ +R
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311
P P +Y ++ +CW KP RPTF + L +
Sbjct: 246 RPEDCPQDIY-----NVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-57
Identities = 83/276 (30%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 97
+EI L ++ +G F + W G +VA+K L +S + F E
Sbjct: 261 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 314
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIA 155
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 156 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 215
GM Y+ +HRDL +NIL ++ KVADFG+++L+ E ++
Sbjct: 374 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 216 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAP 272
APE + K DV+SF ++L E+ +G P+ + EV R P + P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 490
Query: 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
L+ +L+ +CW ++P +RPTF + LE
Sbjct: 491 ESLH-----DLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-57
Identities = 72/314 (22%), Positives = 135/314 (42%), Gaps = 45/314 (14%)
Query: 31 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEE 81
+ + + L F ++ KG F + + VAVKKL
Sbjct: 24 GAMGSAFEDRDPTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH- 80
Query: 82 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKR- 138
S ++ +R F E+ +L+ ++H N+V++ G + + ++ EYLP G LR +L++
Sbjct: 81 --STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 138
Query: 139 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198
K + +++ I +GM YL + IHRDL NIL ++ +K+ DFG++K+L
Sbjct: 139 KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195
Query: 199 TVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI------------- 243
++ + ++ + APE ++ DV+SF ++L E+
Sbjct: 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 255
Query: 244 ---EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTF 298
G + + R P P ++Y ++ ECWN +RP+F
Sbjct: 256 MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY-----MIMTECWNNNVNQRPSF 310
Query: 299 RQIITRLESINNSI 312
R + R++ I + +
Sbjct: 311 RDLALRVDQIRDQM 324
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-57
Identities = 86/280 (30%), Positives = 137/280 (48%), Gaps = 30/280 (10%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDEL 96
E+E+ L + G F + ++ G +VAVK L + +S D F E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 97 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 154
L+++++H +V+ VTQ P+ I+TEY+ G L FLK L + + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-- 212
A GM ++ E IHRDL +NIL D+ + K+ADFG+++L+ ED T ++ +
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKF 172
Query: 213 -CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PP 268
++ APE + K DV+SF ++L E++ G P+ + EV + R P
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
P +LY +L+ CW E+P RPTF + + LE
Sbjct: 233 DNCPEELY-----QLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 3e-56
Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 39/293 (13%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 93
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 2 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 58
Query: 94 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 152
E ++ ++ +P +V+ +G + +M+V E G L FL ++ + S
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-------- 204
++ GM YL E +HRDL N+L + K++DFG+SK L +
Sbjct: 118 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 205 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYA 262
PL ++ APE ++ ++ DV+S+ + + E + G P+ EV
Sbjct: 175 WPL-------KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
Query: 263 ARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313
+R P + P +LY L+ +CW K RP F + R+ + S+
Sbjct: 228 QGKRMECPPECPPELY-----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-56
Identities = 67/283 (23%), Positives = 133/283 (46%), Gaps = 27/283 (9%)
Query: 39 EVPEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAF 92
+YEI ++ + ++ +G ++ + VA+K + D F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKF 63
Query: 93 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 151
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL+ RK +L ++ + +A
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
++ + YL + +HRD+ N+L + +K+ DFG+S+ + ED
Sbjct: 123 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASK 176
Query: 212 S---CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR- 266
+++APE + + DV+ F + + E++ G PF +N+V +R
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236
Query: 267 -PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
P P LY L+ +CW P++RP F ++ +L +I
Sbjct: 237 PMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-56
Identities = 63/262 (24%), Positives = 122/262 (46%), Gaps = 31/262 (11%)
Query: 60 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118
KG +I + I VA+K+L E + + DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 119 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
+ ++T+ +P G L ++ + K + + + + IA+GMNYL + + ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146
Query: 178 NILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEYDTK 229
N+L ++K+ DFG++KLL +E P+ +++A E + Y +
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-------KWMALESILHRIYTHQ 199
Query: 230 VDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEE 286
DV+S+ + + E++ G P+ +E+ +R P +Y ++ +
Sbjct: 200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY-----MIMRK 254
Query: 287 CWNEKPAKRPTFRQIITRLESI 308
CW RP FR++I +
Sbjct: 255 CWMIDADSRPKFRELIIEFSKM 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-56
Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 27/281 (9%)
Query: 41 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 94
P+Y I ++ + E+ +G + I VAVK ++ D F
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMS 62
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 153
E +++ + HP++V+ +G + + P I+ E P G+L +L+R K +LK T V ++L
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS- 212
I + M YL +HRD+ NIL +K+ DFG+S+ + ED +
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTR 175
Query: 213 --CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--P 267
++++PE + T DV+ FA+ + E++ G PF + +V R
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 235
Query: 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
P P LY L+ CW+ P+ RP F +++ L +
Sbjct: 236 PDLCPPVLY-----TLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 7e-56
Identities = 70/302 (23%), Positives = 135/302 (44%), Gaps = 45/302 (14%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRV 89
EV + L ++ +G F L + G QVAVK L E S + +
Sbjct: 12 EVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHI 67
Query: 90 RAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKR-KGALKPST 146
+ E+ +L+ + H N+V++ G T+ + + ++ E+LP G L+ +L + K +
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 147 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 204
+++A+ I +GM+YL + +HRDL N+L + +K+ DFG++K + ++
Sbjct: 128 QLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 184
Query: 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPP 248
+D+ + APE ++ DV+SF + L E++ G
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
Query: 249 FTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306
M + +R P P ++Y +L+ +CW +P+ R +F+ +I E
Sbjct: 245 GQMTV-TRLVNTLKEGKRLPCPPNCPDEVY-----QLMRKCWEFQPSNRTSFQNLIEGFE 298
Query: 307 SI 308
++
Sbjct: 299 AL 300
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 8e-56
Identities = 78/299 (26%), Positives = 139/299 (46%), Gaps = 30/299 (10%)
Query: 28 QMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLG 79
++ ++ + + V I P L + I +G F I AVK L
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62
Query: 80 EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFL-K 137
I+D V F E +++ HPNV+ LG +S ++V Y+ GDLR F+
Sbjct: 63 R--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 138 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197
+ F L +A+GM YL K +HRDL N + D+ +KVADFG+++
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177
Query: 198 LTVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 251
+ + + + + +++A E + +++ TK DV+SF ++L E++ G PP+
Sbjct: 178 --MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235
Query: 252 KHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ ++ +R P P LY E++ +CW+ K RP+F ++++R+ +I
Sbjct: 236 VNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 5e-55
Identities = 76/299 (25%), Positives = 132/299 (44%), Gaps = 46/299 (15%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 92
+ L + + ++ KG F L + VAVK+L S D+ R F
Sbjct: 17 PTIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDF 71
Query: 93 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVR 149
+ E+ +L+ + +V++ G + +V EYLP G LR FL + + L S +
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 150 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLT 207
++ I +GM YL + +HRDL NIL + ++K+ADFG++KLL + +D
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 208 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTM 251
+ + APE + + + DV+SF ++L E+ GC
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
Query: 252 KHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ + + QR P PA+++ EL++ CW P RP+F + +L+ +
Sbjct: 249 AL-SRLLELLEEGQRLPAPPACPAEVH-----ELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 7e-55
Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 30/288 (10%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 90
EV + I + + I KG F + IQ A+K L I++ +V
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVE 67
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLK-RKGALKPSTAV 148
AF E L++ + HPNV+ +G + + ++ Y+ GDL F++ + +
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208
F L +ARGM YL E K +HRDL N + D+S +KVADFG+++ + + +
Sbjct: 128 SFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSV 182
Query: 209 QDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 262
Q ++ A E + + TK DV+SF ++L E++ G PP+ ++ A
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
Query: 263 ARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+R P P LY +++++CW PA RPTFR ++ +E I
Sbjct: 243 QGRRLPQPEYCPDSLY-----QVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 7e-55
Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 27/279 (9%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 94
EL + G F W I V +K + ++ S +A D
Sbjct: 9 IFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTD 64
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALD 153
+ + + H ++V+ LG S + +VT+YLP G L ++ +GAL P + + +
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTS 212
IA+GM YL E+ ++HR+L N+L ++VADFGV+ LL + + T
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 213 CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPF 269
+++A E +Y + DV+S+ + + E++ G P+ EVP +R P
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240
Query: 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+Y ++ +CW RPTF+++ +
Sbjct: 241 ICTIDVY-----MVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-55
Identities = 77/287 (26%), Positives = 129/287 (44%), Gaps = 24/287 (8%)
Query: 31 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDD 86
+ E +EI L ++ G F +A + +VAVK + +S +
Sbjct: 171 SSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE 228
Query: 87 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKP 144
F E +++ ++H +V+ VT+ P+ I+TE++ KG L FLK
Sbjct: 229 A----FLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPL 283
Query: 145 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204
+ F+ IA GM ++ + IHRDL +NIL S K+ADFG+++++ E
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340
Query: 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA 263
++ APE + K DV+SF ++L E++ G P+ + EV +A
Sbjct: 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
Query: 264 RQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
R P P +LY ++ CW +P +RPTF I + L+
Sbjct: 401 GYRMPRPENCPEELY-----NIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-54
Identities = 87/309 (28%), Positives = 133/309 (43%), Gaps = 60/309 (19%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 90
++E + L F + G F + A G+ VAVK L +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 91 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 139
A EL +L + H N+V LGA T P +++TEY GDL FL+RK
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 140 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
AL + F+ +A+GM +L IHRDL NIL K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 192 FGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
FG+++ + VK + P+ +++APE N Y + DV+S+ + L E+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPV-------KWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 244 E--GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299
P M D++ K R P APA++Y ++++ CW+ P KRPTF+
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY-----DIMKTCWDADPLKRPTFK 296
Query: 300 QIITRLESI 308
QI+ +E
Sbjct: 297 QIVQLIEKQ 305
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-54
Identities = 73/296 (24%), Positives = 125/296 (42%), Gaps = 40/296 (13%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 90
++ + ID + L + +G F + + ++VAVK + + S +
Sbjct: 25 KLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI-E 81
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTEYLPKGDLRAFLKR------K 139
F E A ++ HPNV++ LG + S M++ ++ GDL +L
Sbjct: 82 EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 140 GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199
+ T ++F +DIA GM YL +HRDL N + D + VADFG+SK +
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKI- 197
Query: 200 VKEDRPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 254
Q +++A E + Y +K DV++F + + E+ G P+ +
Sbjct: 198 --YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255
Query: 255 NEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+E+ R P +LY E++ CW P RPTF + +LE +
Sbjct: 256 HEMYDYLLHGHRLKQPEDCLDELY-----EIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-54
Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 30/288 (10%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 90
V I P L + I +G F I AVK L I+D V
Sbjct: 78 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVS 135
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFL-KRKGALKPSTAV 148
F E +++ HPNV+ LG +S ++V Y+ GDLR F+ +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 195
Query: 149 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208
F L +A+GM +L K +HRDL N + D+ +KVADFG+++ + + +
Sbjct: 196 GFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFDSV 250
Query: 209 QDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 262
+ + +++A E + +++ TK DV+SF ++L E++ G PP+ + ++
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
Query: 263 ARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+R P P LY E++ +CW+ K RP+F ++++R+ +I
Sbjct: 311 QGRRLLQPEYCPDPLY-----EVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-54
Identities = 71/296 (23%), Positives = 128/296 (43%), Gaps = 45/296 (15%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 94
L ++ +G F L + VAVK L + + ++
Sbjct: 27 VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQ 82
Query: 95 ELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 152
E+ +L+ + H +++++ G + + + +V EY+P G LR +L + ++ + + FA
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQ 141
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQD 210
I GM YLH IHRDL N+L D+ +K+ DFG++K + + R D
Sbjct: 142 QICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTMKHD 254
+ + APE K ++ DV+SF + L E++ G M
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV- 257
Query: 255 NEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ + +R P K PA++Y L++ CW + + RPTF +I L+++
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVY-----HLMKNCWETEASFRPTFENLIPILKTV 308
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-54
Identities = 68/310 (21%), Positives = 122/310 (39%), Gaps = 48/310 (15%)
Query: 43 YEIDPHELDFTNSVEITKGTF---ILAFWRG---------IQVAVKKLGEEVISDDDRVR 90
++I +L F + +GTF R +V +K L + + +
Sbjct: 3 HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK---AHRNYSE 57
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 149
+F + +++ K+ H ++V G ++V E++ G L +LK+ K + +
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117
Query: 150 FALDIARGMNYLHENKPVPIIHRDLEPSNIL--------RDDSGNLKVADFGVSKLLTVK 201
A +A M++L EN +IH ++ NIL + +K++D G+S + K
Sbjct: 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 202 E--DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV 257
+ + +V PE +N + + D +SF L E+ G P +
Sbjct: 175 DILQERI-------PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
Query: 258 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 317
+ Y R + P A+L LI C + +P RP+FR II L S+ R
Sbjct: 228 LQFYEDRHQLPAPKAAELA-----NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282
Query: 318 WKIRTMKCFH 327
H
Sbjct: 283 ---SHHHHHH 289
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 7e-54
Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 51/302 (16%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 90
++ + I + + KG F A + ++VAVK L ++I+ D
Sbjct: 14 KLEDVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI-E 70
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLKR------ 138
F E A +++ HP+V + +G +S M++ ++ GDL AFL
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 139 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198
L T VRF +DIA GM YL IHRDL N + + + VADFG+S
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS--- 184
Query: 199 TVKEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 248
R + D +++A E + Y DV++F + + E++ G P
Sbjct: 185 -----RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
Query: 249 FTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306
+ + E+ R P + ++Y +L+ +CW+ P +RP+F + LE
Sbjct: 240 YAGIENAEIYNYLIGGNRLKQPPECMEEVY-----DLMYQCWSADPKQRPSFTCLRMELE 294
Query: 307 SI 308
+I
Sbjct: 295 NI 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-53
Identities = 73/303 (24%), Positives = 135/303 (44%), Gaps = 58/303 (19%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 90
E+E+ ++ + E+ +G+F +G+ +VA+K + E S +R
Sbjct: 18 DEWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRER-I 73
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------G 140
F +E +++++ +VV+ LG V+Q P +++ E + +GDL+++L+
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 141 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200
S ++ A +IA GM YL+ NK +HRDL N + + +K+ DFG++
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT----- 185
Query: 201 KEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFALILQEMIE-GCP 247
R + D Y +PE K+ + T DV+SF ++L E+
Sbjct: 186 ---RDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239
Query: 248 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
P+ + +V + P P L+ EL+ CW P RP+F +II+ +
Sbjct: 240 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSI 294
Query: 306 ESI 308
+
Sbjct: 295 KEE 297
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-53
Identities = 62/259 (23%), Positives = 120/259 (46%), Gaps = 25/259 (9%)
Query: 60 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118
KG +I + I VA+K+L E + + DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 119 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
+ ++T+ +P G L ++ + K + + + + IA+GMNYL + + ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146
Query: 178 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKVDV 232
N+L ++K+ DFG++KLL +E +++A E + Y + DV
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDV 202
Query: 233 FSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWN 289
+S+ + + E++ G P+ +E+ +R P +Y ++ +CW
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY-----MIMVKCWM 257
Query: 290 EKPAKRPTFRQIITRLESI 308
RP FR++I +
Sbjct: 258 IDADSRPKFRELIIEFSKM 276
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 7e-53
Identities = 79/314 (25%), Positives = 131/314 (41%), Gaps = 59/314 (18%)
Query: 36 HAREVPEY-------EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKL 78
H E P+Y I ++ E+ +G F LA + VAVK L
Sbjct: 22 HIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79
Query: 79 GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 138
E S+ R + F+ E LL ++H ++V+F G T+ P+++V EY+ GDL FL+
Sbjct: 80 KEA--SESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRS 136
Query: 139 ---------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
G L + A +A GM YL +HRDL N L
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193
Query: 184 SGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 237
+K+ DFG+S+ + V L R++ PE ++ T+ DV+SF +
Sbjct: 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTML-----PIRWMPPESILYRKFTTESDVWSFGV 248
Query: 238 ILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAK 294
+L E+ G P+ + E + P P ++Y ++ CW +P +
Sbjct: 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVY-----AIMRGCWQREPQQ 303
Query: 295 RPTFRQIITRLESI 308
R + + + RL+++
Sbjct: 304 RHSIKDVHARLQAL 317
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 7e-53
Identities = 84/302 (27%), Positives = 132/302 (43%), Gaps = 52/302 (17%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 93
EI + F E+ + F G VA+K L ++ R FR
Sbjct: 5 EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLR-EEFR 60
Query: 94 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--------------- 138
E L +++HPNVV LG VT+ P+ ++ Y GDL FL
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 139 -KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197
K AL+P V IA GM YL + ++H+DL N+L D N+K++D G+ +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 198 L------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 250
+ + + L R++APE ++ D++S+ ++L E+ G P+
Sbjct: 178 VYAADYYKLLGNSLL-----PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 251 MKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ +V + RQ P PA +Y L+ ECWNE P++RP F+ I +RL +
Sbjct: 233 GYSNQDVVEMIRNRQVLPCPDDCPAWVY-----ALMIECWNEFPSRRPRFKDIHSRLRAW 287
Query: 309 NN 310
N
Sbjct: 288 GN 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 7e-53
Identities = 88/312 (28%), Positives = 143/312 (45%), Gaps = 55/312 (17%)
Query: 33 HVKHAREVPEY----EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEE 81
H H + P+ +D +++ F + I +G F + A + + A+K++ E
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 82 VISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK- 139
S DD R F EL +L K+ HPN++ LGA + + EY P G+L FL++
Sbjct: 64 A-SKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121
Query: 140 ---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
L + FA D+ARGM+YL + + IHRDL NIL ++
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 178
Query: 185 GNLKVADFGVSKLLTVKEDR-----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239
K+ADFG+S+ V + P+ R++A E Y T DV+S+ ++L
Sbjct: 179 YVAKIADFGLSRGQEVYVKKTMGRLPV-------RWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 240 QEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRP 296
E++ G P+ E+ + R P ++Y +L+ +CW EKP +RP
Sbjct: 232 WEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVY-----DLMRQCWREKPYERP 286
Query: 297 TFRQIITRLESI 308
+F QI+ L +
Sbjct: 287 SFAQILVSLNRM 298
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-52
Identities = 77/303 (25%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 90
++E + L F + G F + A G+ +VAVK L + D
Sbjct: 39 EKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKE 94
Query: 91 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 140
A EL ++ + +H N+V LGA T P++++TEY GDL FL+RK
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 141 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195
+ F+ +A+GM +L IHRD+ N+L + K+ DFG++
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 196 KLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCP 247
+ + VK + L +++APE + Y + DV+S+ ++L E+ P
Sbjct: 212 RDIMNDSNYIVKGNARLP-----VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 248 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
+ +++ K + P AP +Y +++ CW +P RPTF+QI + L
Sbjct: 267 YPGILVNSKFYKLVKDGYQMAQPAFAPKNIY-----SIMQACWALEPTHRPTFQQICSFL 321
Query: 306 ESI 308
+
Sbjct: 322 QEQ 324
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-52
Identities = 77/306 (25%), Positives = 124/306 (40%), Gaps = 65/306 (21%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 93
I ++ E+ +G F LA + VAVK L + + R + F+
Sbjct: 11 HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR-KDFQ 65
Query: 94 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---------------- 137
E LL ++H ++V+F G P+++V EY+ GDL FL+
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 138 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197
KG L S + A IA GM YL +HRDL N L + +K+ DFG+S
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS-- 180
Query: 198 LTVKEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFALILQEMI-E 244
R + D Y PE ++ T+ DV+SF +IL E+
Sbjct: 181 ------RDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231
Query: 245 GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
G P+ + EV + + P P ++Y +++ CW +P +R ++I
Sbjct: 232 GKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY-----DVMLGCWQREPQQRLNIKEIY 286
Query: 303 TRLESI 308
L ++
Sbjct: 287 KILHAL 292
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 81/314 (25%), Positives = 133/314 (42%), Gaps = 66/314 (21%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 90
P++E L + +G F + A + VAVK L E + +R
Sbjct: 16 PKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELR 71
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------- 139
E +L+++ HP+V++ GA +Q P++++ EY G LR FL+
Sbjct: 72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 140 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
AL + FA I++GM YL E K ++HRDL NIL +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRK 188
Query: 187 LKVADFGVSKLLTVKEDRPLTCQD----TSC-----RYVAPEVFKNEEYDTKVDVFSFAL 237
+K++DFG+S R + +D S +++A E + Y T+ DV+SF +
Sbjct: 189 MKISDFGLS--------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 238 ILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAK 294
+L E++ G P+ + R P ++Y L+ +CW ++P K
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY-----RLMLQCWKQEPDK 295
Query: 295 RPTFRQIITRLESI 308
RP F I LE +
Sbjct: 296 RPVFADISKDLEKM 309
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-52
Identities = 67/267 (25%), Positives = 128/267 (47%), Gaps = 17/267 (6%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 98
+ +EI +G+F ++VA +L + ++ +R + F++E +
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEM 78
Query: 99 LQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 154
L+ ++HPN+V+F + V +++VTE + G L+ +LKR +K + I
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 213
+G+ +LH P PIIHRDL+ NI +G++K+ D G++ L + T
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPE 195
Query: 214 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 273
++APE+++ E+YD VDV++F + + EM P++ + P +
Sbjct: 196 -FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFD 252
Query: 274 KLYARGLKELIEECWNEKPAKRPTFRQ 300
K+ +KE+IE C + +R + +
Sbjct: 253 KVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-52
Identities = 78/315 (24%), Positives = 126/315 (40%), Gaps = 67/315 (21%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 90
++E L+F + G F + A GI QVAVK L E+ +D
Sbjct: 38 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 93
Query: 91 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 139
A EL ++ ++ H N+V LGA T S P+ ++ EY GDL +L+ K
Sbjct: 94 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 140 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
L + FA +A+GM +L +HRDL N+L
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKV 210
Query: 187 LKVADFGVSKLLTVKEDRPLTCQD-----TSC----RYVAPEVFKNEEYDTKVDVFSFAL 237
+K+ DFG++ R + + +++APE Y K DV+S+ +
Sbjct: 211 VKICDFGLA--------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
Query: 238 ILQEMIE-GCPPF-TMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPA 293
+L E+ G P+ + D K + PF A ++Y +++ CW
Sbjct: 263 LLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY-----IIMQSCWAFDSR 317
Query: 294 KRPTFRQIITRLESI 308
KRP+F + + L
Sbjct: 318 KRPSFPNLTSFLGCQ 332
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 7e-52
Identities = 81/298 (27%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 91
E+ + + G F G+ QVAVK L E S+ D
Sbjct: 24 LKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-LD 79
Query: 92 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALKP 144
F E ++ K H N+V+ +G QS P I+ E + GDL++FL+ +L
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 145 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLL--- 198
+ A DIA G YL EN IHRD+ N L G K+ DFG+++ +
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 199 --TVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMK 252
K P+ +++ PE F + +K D +SF ++L E+ G P+ K
Sbjct: 197 SYYRKGGCAMLPV-------KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 253 HDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ EV + + R PP P +Y ++ +CW +P RP F I+ R+E
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-51
Identities = 79/308 (25%), Positives = 140/308 (45%), Gaps = 59/308 (19%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------QVAVKKLGEEVISDDDR 88
P++E +L + +G F ++A GI VAVK L ++ ++ D
Sbjct: 28 PKWEFPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDL 84
Query: 89 VRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-------- 139
E+ +++ I +H N++ LGA TQ P+ ++ EY KG+LR +L+ +
Sbjct: 85 -SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 140 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
+ V +ARGM YL K IHRDL N+L ++ +K+AD
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIAD 200
Query: 192 FGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
FG+++ + + P+ +++APE + Y + DV+SF +++ E+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 244 E-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
G P+ E+ K R P +LY ++ +CW+ P++RPTF+Q
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY-----MMMRDCWHAVPSQRPTFKQ 308
Query: 301 IITRLESI 308
++ L+ I
Sbjct: 309 LVEDLDRI 316
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-51
Identities = 84/330 (25%), Positives = 130/330 (39%), Gaps = 72/330 (21%)
Query: 28 QMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKK 77
M + ++ E + +++ +I +G F A G+ VAVK
Sbjct: 27 MYQRMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKM 84
Query: 78 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 137
L EE S D + F+ E AL+ + +PN+V+ LG PM ++ EY+ GDL FL+
Sbjct: 85 LKEEA-SADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 142
Query: 138 RK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173
L + + A +A GM YL E K +HRD
Sbjct: 143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199
Query: 174 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------------APEVF 221
L N L ++ +K+ADFG+S R + D Y PE
Sbjct: 200 LATRNCLVGENMVVKIADFGLS--------RNIYSADY---YKADGNDAIPIRWMPPESI 248
Query: 222 KNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYAR 278
Y T+ DV+++ ++L E+ G P+ EV P P +LY
Sbjct: 249 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELY-- 306
Query: 279 GLKELIEECWNEKPAKRPTFRQIITRLESI 308
L+ CW++ PA RP+F I L+ +
Sbjct: 307 ---NLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-51
Identities = 78/308 (25%), Positives = 140/308 (45%), Gaps = 59/308 (19%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------QVAVKKLGEEVISDDDR 88
P++E +L + +G F ++A GI VAVK L ++ + +
Sbjct: 74 PKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKD 129
Query: 89 VRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-------- 139
+ E+ +++ I +H N++ LGA TQ P+ ++ EY KG+LR +L+ +
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 140 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
+ V +ARGM YL K IHRDL N+L ++ +K+AD
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIAD 246
Query: 192 FGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
FG+++ + + P+ +++APE + Y + DV+SF +++ E+
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
Query: 244 E-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
G P+ E+ K R P +LY ++ +CW+ P++RPTF+Q
Sbjct: 300 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY-----MMMRDCWHAVPSQRPTFKQ 354
Query: 301 IITRLESI 308
++ L+ I
Sbjct: 355 LVEDLDRI 362
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-51
Identities = 67/285 (23%), Positives = 133/285 (46%), Gaps = 35/285 (12%)
Query: 41 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 94
+YEI ++ + ++ +G ++ + VA+K + D F
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQ 440
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 153
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL RK +L ++ + +A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL-------TVKEDRPL 206
++ + YL + +HRD+ N+L + +K+ DFG+S+ + K P+
Sbjct: 500 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 207 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQ 265
+++APE + + DV+ F + + E++ G PF +N+V +
Sbjct: 557 -------KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609
Query: 266 R--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
R P P LY L+ +CW P++RP F ++ +L +I
Sbjct: 610 RLPMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-51
Identities = 80/300 (26%), Positives = 122/300 (40%), Gaps = 52/300 (17%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 90
E+ + + G F G+ QVAVK L E S+ D
Sbjct: 64 DLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-L 119
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALK 143
F E ++ K H N+V+ +G QS P I+ E + GDL++FL+ +L
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 144 PSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV 200
+ A DIA G YL EN IHRD+ N L G K+ DFG++
Sbjct: 180 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA----- 231
Query: 201 KEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFT 250
R + +++ PE F + +K D +SF ++L E+ G P+
Sbjct: 232 ---RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 251 MKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
K + EV + + R PP P +Y ++ +CW +P RP F I+ R+E
Sbjct: 289 SKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-51
Identities = 83/307 (27%), Positives = 136/307 (44%), Gaps = 59/307 (19%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 91
++E L + +G F I A GI VAVK L E + RA
Sbjct: 21 KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 76
Query: 92 FRDELALLQKI-RHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKR----------- 138
EL +L I H NVV LGA T+ P+M++ E+ G+L +L+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 139 -----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
K L + ++ +A+GM +L K IHRDL NIL + +K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFG 193
Query: 194 VSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 244
+++ + K D PL +++APE + Y + DV+SF ++L E+
Sbjct: 194 LARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 245 GCPPF-TMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
G P+ +K D E + R P ++Y + + +CW+ +P++RPTF ++
Sbjct: 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-----QTMLDCWHGEPSQRPTFSEL 301
Query: 302 ITRLESI 308
+ L ++
Sbjct: 302 VEHLGNL 308
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-50
Identities = 82/308 (26%), Positives = 139/308 (45%), Gaps = 59/308 (19%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------QVAVKKLGEEVISDDDR 88
P +E+ L + +G F +LA G+ +VAVK L + ++ D
Sbjct: 62 PRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDL 118
Query: 89 VRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-------- 139
E+ +++ I +H N++ LGA TQ P+ ++ EY KG+LR +L+ +
Sbjct: 119 -SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 140 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
L V A +ARGM YL K IHRDL N+L + +K+AD
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIAD 234
Query: 192 FGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
FG+++ + + P+ +++APE + Y + DV+SF ++L E+
Sbjct: 235 FGLARDIHHIDYYKKTTNGRLPV-------KWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
Query: 244 E-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
G P+ E+ K R P +LY ++ +CW+ P++RPTF+Q
Sbjct: 288 TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELY-----MMMRDCWHAVPSQRPTFKQ 342
Query: 301 IITRLESI 308
++ L+ I
Sbjct: 343 LVEDLDRI 350
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 8e-50
Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 25/288 (8%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 93
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 328 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 384
Query: 94 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 152
E ++ ++ +P +V+ +G + +M+V E G L FL ++ + S
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 212
++ GM YL E +HR+L N+L + K++DFG+SK L +
Sbjct: 444 QVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 213 --CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--P 267
++ APE ++ ++ DV+S+ + + E + G P+ EV +R
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 560
Query: 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 315
P + P +LY L+ +CW K RP F + R+ + S+ K
Sbjct: 561 PPECPPELY-----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 8e-50
Identities = 60/288 (20%), Positives = 128/288 (44%), Gaps = 13/288 (4%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G Q +K++ +S +R + R E+A+L ++HPN+VQ+ + ++ + IV +Y
Sbjct: 49 GRQYVIKEINISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 130 GDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
GDL + + + + + I + ++H+ K I+HRD++ NI G +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTV 164
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 247
++ DFG++++L + C T Y++PE+ +N+ Y+ K D+++ +L E+
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTPY-YLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 248 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--- 304
F + + PP Y+ L+ L+ + + P RP+ I+ +
Sbjct: 224 AFEAGSMKNLVLKIISGSFPPV--SLH-YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280
Query: 305 LESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSSRSKSSCSTSS 352
+ I ++ + + +K F + S ++ S +
Sbjct: 281 AKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQ 328
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-49
Identities = 53/257 (20%), Positives = 90/257 (35%), Gaps = 18/257 (7%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
F + G++ + G AVK+ DR R + + + +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHEN 164
V+ A + + + TE L+ + GA L + + D + +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 165 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 224
++H D++P+NI G K+ DFG+ L + RY+APE+
Sbjct: 177 G---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGD-PRYMAPELL-QG 230
Query: 225 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284
Y T DVFS L + E+ + P F A + L+ ++
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELP--HGGEGWQQLRQGYLPPEFTAG---LSSELRSVL 285
Query: 285 EECWNEKPAKRPTFRQI 301
P R T +
Sbjct: 286 VMMLEPDPKLRATAEAL 302
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-48
Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 13/254 (5%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+I +G F A G+ VA+KK+ + D E+ LL+++ HPNV+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPV 167
+ + + + IV E GDL +K + T ++ + + + ++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 227
++HRD++P+N+ +G +K+ D G+ + + K + T Y++PE Y+
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERIHENGYN 214
Query: 228 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 287
K D++S +L EM PF N Q P+ Y+ L++L+ C
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274
Query: 288 WNEKPAKRPTFRQI 301
N P KRP +
Sbjct: 275 INPDPEKRPDVTYV 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 13/241 (5%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYL 127
G + K+L +++ ++ E+ LL++++HPN+V++ + ++ + IV EY
Sbjct: 31 GKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 128 PKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVP--IIHRDLEPSNILR 181
GDL + + + + L +R + + H ++HRDL+P+N+
Sbjct: 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 182 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 241
D N+K+ DFG++++L T T Y++PE Y+ K D++S +L E
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFVGTPY-YMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 242 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
+ PPFT E+ + P + Y+ L E+I N K RP+ +I
Sbjct: 209 LCALMPPFTAFSQKELAGKIREGKFRRI--PYR-YSDELNEIITRMLNLKDYHRPSVEEI 265
Query: 302 I 302
+
Sbjct: 266 L 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-47
Identities = 71/303 (23%), Positives = 127/303 (41%), Gaps = 50/303 (16%)
Query: 42 EYEIDPHEL-DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 95
+ +D DF I G F A R G +K++ + +A R E
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAER-E 54
Query: 96 LALLQKIRHPNVVQFLGA----------------VTQSSPMMIVTEYLPKGDLRAFLKRK 139
+ L K+ H N+V + G +++ + I E+ KG L +++++
Sbjct: 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 140 GA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197
L A+ I +G++Y+H K +I+RDL+PSNI D+ +K+ DFG+
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 198 LTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 254
L R S RY++PE +++Y +VD+++ LIL E++ C
Sbjct: 172 LKNDGKR-----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA----- 221
Query: 255 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314
E K + + ++ + K L+++ ++KP RP +I+ L S
Sbjct: 222 FETSKFFTDLRDGIIS---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278
Query: 315 KRR 317
R
Sbjct: 279 NER 281
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-46
Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 48/288 (16%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
DF + +G F + A A+KK+ +++ E+ LL + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILS-EVMLLASLNHQ 62
Query: 106 NVVQFLGA-------------VTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFA 151
VV++ A V + S + I EY G L + + + R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD- 210
I ++Y+H IIHRDL+P NI D+S N+K+ DFG++K + D
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 211 ---------TSC---RYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 257
++ YVA EV Y+ K+D++S +I EMI P T +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
Query: 258 PKAYAARQRPPFKAPAKL---YARGLKELIEECWNEKPAKRPTFRQII 302
+ + P + K++I + P KRP R ++
Sbjct: 238 ---LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 60/236 (25%), Positives = 110/236 (46%), Gaps = 16/236 (6%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
+A+K L + + R E+ + +RHPN+++ G ++ + ++ EY P
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G + L++ + ++A ++Y H + +IHRD++P N+L +G LK+
Sbjct: 94 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKI 150
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
ADFG S P + + C Y+ PE+ + +D KVD++S ++ E + G
Sbjct: 151 ADFGWSVHA------PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
Query: 247 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
PPF N + Y R F P + G ++LI P++RP R+++
Sbjct: 205 PPF---EANTYQETYKRISRVEFTFPDFV-TEGARDLISRLLKHNPSQRPMLREVL 256
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 20/275 (7%)
Query: 37 AREVPEYEIDPHEL-DFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVR 90
A+E+PE +DP + + KG F I A K + + ++ +
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 91 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 150
E+++ + + H +VV F G + + +V E + L KR+ AL A +
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210
I G YLH N+ +IHRDL+ N+ ++ +K+ DFG++ + +R +
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER----KK 173
Query: 211 TSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 267
C Y+APEV + + +VDV+S I+ ++ G PPF + + + Y ++
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKN 230
Query: 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
+ P + LI++ P RPT +++
Sbjct: 231 EYSIPKHI-NPVAASLIQKMLQTDPTARPTINELL 264
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 56/259 (21%), Positives = 99/259 (38%), Gaps = 36/259 (13%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA------------VTQS 117
A+K++ + R + R E+ L K+ HP +V++ A +
Sbjct: 30 DCNYAIKRIRLPN-RELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87
Query: 118 SPMMIVTEYLPKGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDL 174
+ I + K +L+ ++ + ++ S + L IA + +LH ++HRDL
Sbjct: 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDL 144
Query: 175 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----------CRYVAPEVFKN 223
+PSNI +KV DFG+ + E+ Y++PE
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204
Query: 224 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283
Y KVD+FS LIL E++ P T E + + F +
Sbjct: 205 NSYSHKVDIFSLGLILFELL--YPFST---QMERVRTLTDVRNLKFPPLFTQKYPCEYVM 259
Query: 284 IEECWNEKPAKRPTFRQII 302
+++ + P +RP II
Sbjct: 260 VQDMLSPSPMERPEAINII 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-45
Identities = 57/280 (20%), Positives = 105/280 (37%), Gaps = 43/280 (15%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
+F +I G F R G A+K+ + + D A R+ A +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYL 161
+VV++ A + M+I EY G L + K + L + RG+ Y+
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 162 HENKPVPIIHRDLEPSNILRDDSGNL-------------------KVADFGVSKLLTVKE 202
H ++H D++PSNI + K+ D G ++
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--- 185
Query: 203 DRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 261
P + R++A EV + N + K D+F+ AL + P ++ ++ +
Sbjct: 186 -SPQVEEGD-SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP--RNGDQW---H 238
Query: 262 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
RQ + P ++ EL++ + P +RP+ +
Sbjct: 239 EIRQGRLPRIPQV-LSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-45
Identities = 66/269 (24%), Positives = 107/269 (39%), Gaps = 26/269 (9%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 95
+YE T+ + +G+F + G Q AVKK+ EV + E
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------E 100
Query: 96 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 155
L + P +V GAV + + I E L G L +K+ G L A+ +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 156 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLTCQDTSCR 214
G+ YLH + I+H D++ N+L G+ + DFG + L
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 215 ----YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPP 268
++APEV + D KVD++S ++ M+ GC P+T P A+ P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT--QYFRGPLCLKIASEPPPI 275
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPT 297
+ P A + I+E ++P R +
Sbjct: 276 REIPPSC-APLTAQAIQEGLRKEPVHRAS 303
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-45
Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 14/236 (5%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
A K + + ++ + E+++ + + H +VV F G + + +V E +
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
L KR+ AL A + I G YLH N+ +IHRDL+ N+ ++ +K+
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKI 182
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
DFG++ + +R + C Y+APEV + + +VDV+S I+ ++ G
Sbjct: 183 GDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 247 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
PPF + + + Y ++ + P + LI++ P RPT +++
Sbjct: 239 PPF---ETSCLKETYLRIKKNEYSIPKHI-NPVAASLIQKMLQTDPTARPTINELL 290
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-44
Identities = 60/235 (25%), Positives = 108/235 (45%), Gaps = 16/235 (6%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
+A+K L + + + R E+ + +RHPN+++ + ++ E+ P+
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G+L L++ G + F ++A ++Y HE K +IHRD++P N+L G LK+
Sbjct: 99 GELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKI 155
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
ADFG S P + T C Y+ PE+ + + +D KVD++ ++ E + G
Sbjct: 156 ADFGWSVH------APSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
Query: 247 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
PPF + + K P L + G K+LI + P +R + +
Sbjct: 210 PPF---DSPSHTETHRRIVNVDLKFPPFL-SDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-44
Identities = 52/261 (19%), Positives = 102/261 (39%), Gaps = 26/261 (9%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----IVTE 125
G A+K++ + + + E + + HPN+++ + + ++
Sbjct: 54 GHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 126 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 181
+ +G L ++R L + L I RG+ +H HRDL+P+NIL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILL 167
Query: 182 DDSGNLKVADFGVSKLLTVKEDRPLTC--------QDTSCRYVAPEVFKNEEY---DTKV 230
D G + D G + + Q + Y APE+F + + D +
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 231 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 290
DV+S +L M+ G P+ M A A + + + ++ L +L+
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR-HSSALWQLLNSMMTV 286
Query: 291 KPAKRPTFRQIITRLESINNS 311
P +RP ++++LE++
Sbjct: 287 DPHQRPHIPLLLSQLEALQPP 307
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-44
Identities = 55/249 (22%), Positives = 113/249 (45%), Gaps = 27/249 (10%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 127
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 33 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 90
Query: 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 91 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 146
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 233
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 147 KLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 234 SFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKP 292
S IL M G PF + N++ K +A + P + L+++++ C P
Sbjct: 205 SLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQDVLKCCLKRDP 262
Query: 293 AKRPTFRQI 301
+R + ++
Sbjct: 263 KQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 55/249 (22%), Positives = 113/249 (45%), Gaps = 27/249 (10%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 127
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 52 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 109
Query: 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 110 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 165
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 233
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 166 KLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 234 SFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKP 292
S IL M G PF + N++ K +A + P + L+++++ C P
Sbjct: 224 SLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQDVLKCCLKRDP 281
Query: 293 AKRPTFRQI 301
+R + ++
Sbjct: 282 KQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 55/249 (22%), Positives = 113/249 (45%), Gaps = 27/249 (10%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 127
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 80 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137
Query: 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 138 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 193
Query: 188 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 233
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 194 KLIDFGIANQM--QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 234 SFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKP 292
S IL M G PF + N++ K +A + P + L+++++ C P
Sbjct: 252 SLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQDVLKCCLKRDP 309
Query: 293 AKRPTFRQI 301
+R + ++
Sbjct: 310 KQRISIPEL 318
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-43
Identities = 74/255 (29%), Positives = 118/255 (46%), Gaps = 27/255 (10%)
Query: 58 ITKGTF---ILAFWR--GIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+ KGT+ +++A+K E+ D + +E+AL + ++H N+VQ+L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIK----EIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAV--RFALDIARGMNYLHENKPVP 168
G+ +++ + I E +P G L A L+ K G LK + + I G+ YLH+N+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 169 IIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-- 225
I+HRD++ N+L + SG LK++DFG SK L T T Y+APE+
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ-YMAPEIIDKGPRG 201
Query: 226 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP---KAYAARQRPPFKAPAKLYARGLKE 282
Y D++S + EM G PPF + K + P P + A K
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFY-ELGEPQAAMFKVGMFKVHPEI--PESMSAEA-KA 257
Query: 283 LIEECWNEKPAKRPT 297
I +C+ P KR
Sbjct: 258 FILKCFEPDPDKRAC 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-43
Identities = 64/237 (27%), Positives = 113/237 (47%), Gaps = 17/237 (7%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G +VA+K + + ++ + FR E+ +++ + HPN+V+ + + ++ EY
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G++ +L G +K A I + Y H+ + I+HRDL+ N+L D N+K+
Sbjct: 99 GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKI 155
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 245
ADFG S L D C Y APE+F+ ++YD +VDV+S +IL ++ G
Sbjct: 156 ADFGFSNE--FTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 246 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
PF + + R ++ P + + + L++ P KR T QI+
Sbjct: 211 SLPF---DGQNLKELRERVLRGKYRIPFYM-STDCENLLKRFLVLNPIKRGTLEQIM 263
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 59/237 (24%), Positives = 115/237 (48%), Gaps = 15/237 (6%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G++VA+K + ++ + V+ ++E+ + +++HP++++ S+ + +V E
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 130 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
G++ +LK R + A F I GM YLH + I+HRDL SN+L + N+K
Sbjct: 96 GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIK 152
Query: 189 VADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 245
+ADFG++ L + ++ T C Y++PE+ + + DV+S + ++ G
Sbjct: 153 IADFGLATQLKMPHEK----HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
Query: 246 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
PPF + V ++ P+ L + K+LI + PA R + ++
Sbjct: 209 RPPF---DTDTVKNTLNKVVLADYEMPSFL-SIEAKDLIHQLLRRNPADRLSLSSVL 261
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 65/298 (21%), Positives = 119/298 (39%), Gaps = 40/298 (13%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--------M 120
G + A+K+L + +++++ RA E+ ++K+ HPN+VQF A +
Sbjct: 53 GREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 121 MIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 178
+++TE + K +G L T ++ R + ++H KP PIIHRDL+ N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVEN 168
Query: 179 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----------TSCRYVAPEVF---KNE 224
+L + G +K+ DFG + ++ D + Q T+ Y PE+ N
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 225 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284
K D+++ IL + PF D + + P LI
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPF---EDGAKLRIVNGKYSIPPHDT---QYTVFHSLI 282
Query: 285 EECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSS 342
P +R + +++ +L+ I + N + I + LE ++ S
Sbjct: 283 RAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL-----LEQNGGYGSATLSR 335
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-40
Identities = 54/303 (17%), Positives = 94/303 (31%), Gaps = 67/303 (22%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 127
G A+K V E +L+K+ H N+V+ +++ + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 128 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 181
P G L L+ L S + D+ GMN+L EN I+HR+++P NI+R
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148
Query: 182 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--------NEEYDTK 229
D K+ DFG ++ L +D + Y+ P++++ ++Y
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 230 VDVFSFALILQEMIEGCPPF----------------TMKHDNEVPKAYAARQRPPFKAPA 273
VD++S + G PF + + P
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263
Query: 274 KLYARG---------LKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMK 324
+ L ++ K F Q I
Sbjct: 264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF----------FAET--SDILHRG 311
Query: 325 CFH 327
H
Sbjct: 312 NSH 314
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 71/238 (29%), Positives = 116/238 (48%), Gaps = 18/238 (7%)
Query: 70 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
G +VAVK L +++ S D + R E+ L+ RHP++++ ++ + +V EY+
Sbjct: 36 GHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
G+L ++ + G ++ A R I ++Y H + ++HRDL+P N+L D N K
Sbjct: 95 GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAK 151
Query: 189 VADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIE 244
+ADFG+S ++ + L TSC Y APEV Y +VD++S +IL ++
Sbjct: 152 IADFGLSNMM--SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206
Query: 245 GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
G PF D VP + + F P L R + L+ P KR T + I
Sbjct: 207 GTLPF---DDEHVPTLFKKIRGGVFYIPEYL-NRSVATLLMHMLQVDPLKRATIKDIR 260
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 71/286 (24%), Positives = 115/286 (40%), Gaps = 32/286 (11%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL------GAVTQSSPMMIV 123
G QVA+K+ + +S +R R E+ +++K+ HPNVV + + ++
Sbjct: 39 GEQVAIKQC-RQELSPKNRERWCL-EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 124 TEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180
EY GDLR +L + LK DI+ + YLHEN+ IIHRDL+P NI+
Sbjct: 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 153
Query: 181 RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFS 234
K+ D G +K L + T +Y+APE+ + ++Y VD +S
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL--DQGELCT---EFVGTLQYLAPELLEQKKYTVTVDYWS 208
Query: 235 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 294
F + E I G PF N P + + R +Y + P
Sbjct: 209 FGTLAFECITGFRPF---LPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNH 265
Query: 295 RPTFRQI-ITRLESINNSINHKRRWK---IRTMKCFHNLEAMLKKD 336
+ R + ++R + CF L+++L
Sbjct: 266 LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 2e-39
Identities = 53/286 (18%), Positives = 93/286 (32%), Gaps = 55/286 (19%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 127
G A+K V E +L+K+ H N+V+ +++ + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 128 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 181
P G L L+ L S + D+ GMN+L EN I+HR+++P NI+R
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148
Query: 182 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--------NEEYDTK 229
D K+ DFG ++ L +D + Y+ P++++ ++Y
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 230 VDVFSFALILQEMIEGCPPFTMKHDNE----------------VPKAYAARQRPPFKAPA 273
VD++S + G PF + P
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263
Query: 274 KL---------YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310
+ L ++ K F Q I +
Sbjct: 264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 88/313 (28%), Positives = 142/313 (45%), Gaps = 36/313 (11%)
Query: 29 MAPMHVKHA-REVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV 82
MA V+ + + DP EL FT +I KG+F F VA+K + E
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE- 58
Query: 83 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 142
+D + + E+ +L + P V ++ G+ + + + I+ EYL G L+
Sbjct: 59 -EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 143 KPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200
+ A R L +G++YLH K IHRD++ +N+L + G +K+ADFGV+ LT
Sbjct: 118 ETQIATILREIL---KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171
Query: 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 260
+ + T T ++APEV K YD+K D++S + E+ G PP + H
Sbjct: 172 TQIKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------P 224
Query: 261 YAARQRPPFKAPAKL---YARGLKELIEECWNEKPAKRPT---------FRQIITRLESI 308
P P L Y++ LKE +E C N++P+ RPT + + +
Sbjct: 225 MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYL 284
Query: 309 NNSINHKRRWKIR 321
I+ +RWK
Sbjct: 285 TELIDRYKRWKAE 297
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 49/242 (20%), Positives = 90/242 (37%), Gaps = 22/242 (9%)
Query: 75 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 134
+ + +S + A ++ + N V L + + I + K +L+
Sbjct: 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150
Query: 135 FLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
++ R+ +L+ + + IA + +LH ++HRDL+PSNI +KV D
Sbjct: 151 WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 207
Query: 192 FGVSKLLTVKEDRPLTCQDTSCR-----------YVAPEVFKNEEYDTKVDVFSFALILQ 240
FG+ + E+ Y++PE Y KVD+FS LIL
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 241 EMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
E++ T E + + F ++++ + P +RP
Sbjct: 268 ELL--YSFST---QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322
Query: 301 II 302
II
Sbjct: 323 II 324
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-38
Identities = 66/287 (22%), Positives = 127/287 (44%), Gaps = 23/287 (8%)
Query: 46 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
DP + +T +I +G + G +VA++++ + + +E+ +++
Sbjct: 17 DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 160
+ ++PN+V +L + + +V EYL G L + + A + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131
Query: 161 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 220
LH N+ +IHRD++ NIL G++K+ DFG +T ++ + T T ++APEV
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEV 187
Query: 221 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280
+ Y KVD++S ++ EMIEG PP+ ++ A P + P K +
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK-LSAIF 246
Query: 281 KELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWK 319
++ + C KR + F +I L S+ I +
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 59/290 (20%), Positives = 107/290 (36%), Gaps = 58/290 (20%)
Query: 60 KGTF---ILAFWRGIQVAVKKL--------------GEEVISDDDRVRAFRDELALLQKI 102
+G F IL A+KK + IS + F++EL ++ I
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 103 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR------ 156
++ + G +T + I+ EY+ + F + L + + + +
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 157 --GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 213
+Y+H K I HRD++PSNIL D +G +K++DFG S+ + D+ + S
Sbjct: 161 LNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIK---GSRG 212
Query: 214 --RYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 269
++ PE F NE KVD++S + L M PF + + + +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF--SLKISLVELFNNIRTKNI 270
Query: 270 KAPAKLYAR------------------GLKELIEECWNEKPAKRPTFRQI 301
+ P + ++ + PA+R T
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 69/237 (29%), Positives = 118/237 (49%), Gaps = 17/237 (7%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
+VA+K + +++ D E++ L+ +RHP++++ +T + +++V EY
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G+L ++ K + RF I + Y H +K I+HRDL+P N+L DD+ N+K+
Sbjct: 93 GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKI 149
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 245
ADFG+S ++ + L TSC Y APEV + Y +VDV+S ++L M+ G
Sbjct: 150 ADFGLSNIM--TDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204
Query: 246 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
PF D +P + + P L + G + LI P +R T ++I
Sbjct: 205 RLPF---DDEFIPNLFKKVNSCVYVMPDFL-SPGAQSLIRRMIVADPMQRITIQEIR 257
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 18/240 (7%)
Query: 70 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
VAVK + + + + ++ + E+ + + + H NVV+F G + + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
G+L ++ + A RF + G+ YLH I HRD++P N+L D+ NLK
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145
Query: 189 VADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMI 243
++DFG++ + +R L + C YVAPE+ K E+ VDV+S ++L M+
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 244 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQII 302
G P+ D+ + Y+ + L+ + E P+ R T I
Sbjct: 203 AGELPWDQPSDS--CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 14/231 (6%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
+VA+K + ++ ++ F E+ ++ H N+V + + +V EY+
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 132 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
L +++ G L TA+ F I G+ + H+ + I+HRD++P NIL D + LK+ D
Sbjct: 98 LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154
Query: 192 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 248
FG++K L+ + LT + + +Y +PE K E D D++S ++L EM+ G PP
Sbjct: 155 FGIAKALS---ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
Query: 249 FTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECWNEKPAKRP 296
F + V A Q + L +I + A R
Sbjct: 212 FN--GETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 46/271 (16%)
Query: 70 GIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
VAVKKL V + + F E+ ++ K +H N+V+ LG + + +V Y+P
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113
Query: 129 KGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185
G L L P + A A G+N+LHEN IHRD++ +NIL D++
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF 170
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQDTSCR------YVAPEVFKNEEYDT-----KVDVFS 234
K++DFG+++ + R Y+AP E K D++S
Sbjct: 171 TAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAP------EALRGEITPKSDIYS 219
Query: 235 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-----------YARGLKEL 283
F ++L E+I G P + ++ + + ++ +
Sbjct: 220 FGVVLLEIITGLPAVDEHREPQLLLDIK---EEIEDEEKTIEDYIDKKMNDADSTSVEAM 276
Query: 284 IE---ECWNEKPAKRPTFRQIITRLESINNS 311
+C +EK KRP +++ L+ + S
Sbjct: 277 YSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 55/243 (22%), Positives = 99/243 (40%), Gaps = 28/243 (11%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124
+V VK K+ E+ +D ++ E+A+L ++ H N+++ L +V
Sbjct: 49 NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108
Query: 125 E-YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
E + DL AF+ R L A + + YL IIHRD++ NI+ +
Sbjct: 109 EKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAE 165
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 239
+K+ DFG + ++ + T C Y APEV Y +++++S + L
Sbjct: 166 DFTIKLIDFGSAAY--LERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
Query: 240 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299
++ PF E+ + A PP+ L L+ P +R T
Sbjct: 221 YTLVFEENPF-----CELEETVEAAIHPPYLVSK-----ELMSLVSGLLQPVPERRTTLE 270
Query: 300 QII 302
+++
Sbjct: 271 KLV 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-37
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 95 ELALLQKIRHPNVVQF---LGAVTQSSPMMIVTEYLPKGDLRAF-LKRKGALKPSTAVRF 150
E+A+L+K+ HPNVV+ L + + +V E + +G + + L A +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKPLSEDQARFY 142
Query: 151 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 210
D+ +G+ YLH K IIHRD++PSN+L + G++K+ADFGVS D L+
Sbjct: 143 FQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLS--- 195
Query: 211 TSC---RYVAPEVFKNE--EYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 264
+ ++APE + +DV++ + L + G PF D + ++
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF---MDERIMCLHSKI 252
Query: 265 QRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQI 301
+ + P + A LK+LI ++ P R +I
Sbjct: 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 65/287 (22%), Positives = 119/287 (41%), Gaps = 23/287 (8%)
Query: 46 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
DP L + V+I +G+ + G QVAVK + + R +E+ +++
Sbjct: 42 DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 97
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 160
+H NVV+ + + ++ E+L G L + + L + + + Y
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAY 156
Query: 161 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 220
LH +IHRD++ +IL G +K++DFG ++ + + T ++APEV
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAPEV 212
Query: 221 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280
Y T+VD++S +++ EM++G PP+ + K P K K + L
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHK-VSPVL 271
Query: 281 KELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWK 319
++ +E P +R T F E + I R+
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQT 318
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-37
Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 32/245 (13%)
Query: 70 GIQVAVKKLGEEVISD----DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIV 123
+ VA+K + ++ ISD + R E+ LL+K+ V++ L + +++
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126
Query: 124 TEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 182
E P DL F+ +GAL+ A F + + + H ++HRD++ NIL D
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 183
Query: 183 -DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFAL 237
+ G LK+ DFG LL D Y PE + Y V+S +
Sbjct: 184 LNRGELKLIDFGSGALLK---DTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 238 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 297
+L +M+ G PF +E + + + + + LI C +P+ RPT
Sbjct: 238 LLYDMVCGDIPF---EHDE--EIIRGQVFFRQRVSS-----ECQHLIRWCLALRPSDRPT 287
Query: 298 FRQII 302
F +I
Sbjct: 288 FEEIQ 292
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 26/282 (9%)
Query: 30 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 84
PM K + I + L T + GTF + G +VAVK L + I
Sbjct: 1 GPMAEKQKHDGRVK-IGHYILGDT----LGVGTFGKVKVGKHELTGHKVAVKILNRQKIR 55
Query: 85 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 144
D V R E+ L+ RHP++++ ++ S + +V EY+ G+L ++ + G L
Sbjct: 56 SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE 115
Query: 145 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204
+ R I G++Y H + ++HRDL+P N+L D N K+ADFG+S ++ +
Sbjct: 116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGE 170
Query: 205 PLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 260
L TSC Y APEV Y +VD++S +IL ++ G PF D+ VP
Sbjct: 171 FL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTL 224
Query: 261 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
+ F P L + L++ P KR T + I
Sbjct: 225 FKKICDGIFYTPQYL-NPSVISLLKHMLQVDPMKRATIKDIR 265
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 22/242 (9%)
Query: 70 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128
VAVK + + + + ++ + E+ + + + H NVV+F G + + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
G+L ++ + A RF + G+ YLH I HRD++P N+L D+ NLK
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145
Query: 189 VADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMI 243
++DFG++ + +R L + C YVAPE+ K E+ VDV+S ++L M+
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 244 EGCPPFTMKHDNEVP---KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
G P+ D+ P+K L+ + E P+ R T
Sbjct: 203 AGELPWDQPSDSCQEYSDWKEKKTYLNPWKK----IDSAPLALLHKILVENPSARITIPD 258
Query: 301 II 302
I
Sbjct: 259 IK 260
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 54/235 (22%), Positives = 86/235 (36%), Gaps = 24/235 (10%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 131
VA+K + E + SD + E +++ P+VV + + + D
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 132 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
L A L+R+G L P AV I ++ H HRD++P NIL + D
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD 177
Query: 192 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 248
FG++ T D LT + Y+APE F + D+++ +L E + G PP
Sbjct: 178 FGIASATT---DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
Query: 249 FT-------MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 296
+ H N+ P A +I + P R
Sbjct: 235 YQGDQLSVMGAHINQAIP--RPSTVRPGIPVA------FDAVIARGMAKNPEDRY 281
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 67/247 (27%), Positives = 101/247 (40%), Gaps = 34/247 (13%)
Query: 70 GIQVAVKKLG----EEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAVTQSSPMM 121
+QVA+K + D V E+ALL K+ HP V++ L M
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114
Query: 122 IVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180
+V E LP DL ++ KG L + F + + + H ++HRD++ NIL
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENIL 171
Query: 181 RD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSF 235
D G K+ DFG LL D P Y PE +Y V+S
Sbjct: 172 IDLRRGCAKLIDFGSGALL---HDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSL 225
Query: 236 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
++L +M+ G PF + D E+ +A PA + + LI C KP+ R
Sbjct: 226 GILLYDMVCGDIPF--ERDQEILEA-------ELHFPAHV-SPDCCALIRRCLAPKPSSR 275
Query: 296 PTFRQII 302
P+ +I+
Sbjct: 276 PSLEEIL 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 66/272 (24%), Positives = 110/272 (40%), Gaps = 31/272 (11%)
Query: 51 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
D+ I G + + +VA+K++ E + E+ + + HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHP 73
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA-LDIA-------RG 157
N+V + + + +V + L G + +K A + IA G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TS 212
+ YLH+N IHRD++ NIL + G++++ADFGVS L D T
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 213 CRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 271
C ++APEV + YD K D++SF + E+ G P+ +V P +
Sbjct: 191 C-WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 272 PA------KLYARGLKELIEECWNEKPAKRPT 297
K Y + +++I C + P KRPT
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 27/240 (11%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL--GAVTQSSPMM--IVTEYL 127
VAVK L ++ D FR E + HP +V G + + IV EY+
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 128 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187
LR + +G + P A+ D + +N+ H+N IIHRD++P+NI+ + +
Sbjct: 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155
Query: 188 KVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 244
KV DFG+++ + +T + +Y++PE + + D + DV+S +L E++
Sbjct: 156 KVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 245 GCPPFT--------MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 296
G PPFT +H E P P A + + L ++ + + P R
Sbjct: 215 GEPPFTGDSPVSVAYQHVREDP--------IPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 68/290 (23%), Positives = 129/290 (44%), Gaps = 25/290 (8%)
Query: 46 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
P E+ F ++ +G++ + G VA+K + + ++ E++++Q
Sbjct: 26 QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQ 79
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 159
+ P+VV++ G+ +++ + IV EY G + ++ R L +G+
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YLH + IHRD++ NIL + G+ K+ADFGV+ LT + T T ++APE
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPE 195
Query: 220 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279
V + Y+ D++S + EM EG PP+ H P F+ P ++
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL-WSDN 254
Query: 280 LKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWKIR 321
+ +++C + P +R T F + + + + IN K++
Sbjct: 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLK 304
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 74/290 (25%), Positives = 114/290 (39%), Gaps = 40/290 (13%)
Query: 28 QMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEV 82
P+ + + Y+ +I G F L + VAVK +
Sbjct: 7 TTGPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERGA 57
Query: 83 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 142
D+ V+ R E+ + +RHPN+V+F + + + I+ EY G+L + G
Sbjct: 58 A-IDENVQ--R-EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF 113
Query: 143 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTV 200
A F + G++Y H + I HRDL+ N L D S LK+ DFG SK
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-- 168
Query: 201 KEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNE 256
++ Y+APEV +EYD DV+S + L M+ G PF D E
Sbjct: 169 VLHSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF---EDPE 222
Query: 257 VPKAYAAR----QRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQI 301
P+ Y + P + + LI + PA R + +I
Sbjct: 223 EPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-35
Identities = 61/266 (22%), Positives = 107/266 (40%), Gaps = 42/266 (15%)
Query: 70 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127
G +VA+K+ + + + F E+ L RHP++V +G + + M+++ +Y+
Sbjct: 63 GAKVALKRR-----TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 128 PKGDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
G+L+ L + + ARG++YLH IIHRD++ NIL D+
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEYDTKVDVFSF 235
+ K+ DFG+SK T + T S Y+ PE F K DV+SF
Sbjct: 175 NFVPKITDFGISKKGTELD-------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 236 ALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKA------PAKLYARGLK---E 282
++L E++ E A + + K+ L+ +
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD 287
Query: 283 LIEECWNEKPAKRPTFRQIITRLESI 308
+C RP+ ++ +LE
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-35
Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 22/244 (9%)
Query: 70 GIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTE 125
+ AVK L ++ + + E+ LL+++RH NV+Q + + + V E
Sbjct: 30 LCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88
Query: 126 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
Y G + A + + G+ YLH I+H+D++P N+L
Sbjct: 89 YCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG 145
Query: 185 GNLKVADFGVSKLL-TVKEDRPLTCQDTSC---RYVAPEVFKNEE-YD-TKVDVFSFALI 238
G LK++ GV++ L D TS + PE+ + + KVD++S +
Sbjct: 146 GTLKISALGVAEALHPFAADDTC---RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVT 202
Query: 239 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 298
L + G PF + + K + + + P L +L++ +PAKR +
Sbjct: 203 LYNITTGLYPF---EGDNIYKLFENIGKGSYAIPGDC-GPPLSDLLKGMLEYEPAKRFSI 258
Query: 299 RQII 302
RQI
Sbjct: 259 RQIR 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-35
Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 28/249 (11%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124
+VA++ K + D E+ +L+K+ HP +++ + IV
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218
Query: 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 181
E + G+L + LK +T + + + YLHEN IIHRDL+P N+L +
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 275
Query: 182 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 235
++ +K+ DFG SK+ + E + T C Y+APEV + Y+ VD +S
Sbjct: 276 EEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 236 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECWNEKP 292
+IL + G PPF+ + +++A +L+++ P
Sbjct: 331 GVILFICLSGYPPFS--EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 388
Query: 293 AKRPTFRQI 301
R T +
Sbjct: 389 KARFTTEEA 397
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-35
Identities = 66/279 (23%), Positives = 111/279 (39%), Gaps = 63/279 (22%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G+ +A K + E I R + R EL +L + P +V F GA + I E++
Sbjct: 58 GLVMARKLIHLE-IKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
G L LK+ G + + ++ + +G+ YL E I+HRD++PSNIL + G +K+
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKL 173
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEM 242
DFGVS L D+ Y++PE + Y + D++S L L EM
Sbjct: 174 CDFGVSGQLI----------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
Query: 243 IEGCPPFTMKHDNEVPKAYAA--------------------------------------- 263
G P E+ +
Sbjct: 224 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283
Query: 264 --RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
+ PP K P+ +++ ++ + +C + PA+R +Q
Sbjct: 284 IVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 57/272 (20%), Positives = 115/272 (42%), Gaps = 24/272 (8%)
Query: 43 YEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 97
E+ +L+ E+ +G + + G +AVK++ V + ++ R D
Sbjct: 2 MEVKADDLEPIM--ELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDI 58
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFALDI 154
++ + P V F GA+ + + I E + + + + + + A+ I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 214
+ + +LH +IHRD++PSN+L + G +K+ DFG+S L + D C+
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 215 -YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPP 268
Y+APE E Y K D++S + + E+ P+ + + + P
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQVVEEPS 231
Query: 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
+ PA ++ + +C + +RPT+ +
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 60/270 (22%), Positives = 117/270 (43%), Gaps = 19/270 (7%)
Query: 42 EYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDEL 96
Y+ + ++L+ E+ GT + G +AVK++ + ++ R D
Sbjct: 19 RYQAEINDLENLG--EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLD 75
Query: 97 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 156
+L+ P +VQ G ++ + I E + + + +G + + + I +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-Y 215
+ YL E +IHRD++PSNIL D+ G +K+ DFG+S L + + + C Y
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAY 190
Query: 216 VAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 270
+APE + YD + DV+S + L E+ G P+ + ++ PP
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250
Query: 271 APAKLYARGLKELIEECWNEKPAKRPTFRQ 300
++ + +++C + KRP + +
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 63/258 (24%), Positives = 101/258 (39%), Gaps = 31/258 (12%)
Query: 61 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 118
GT + + VAVK++ E S DR E+ LL++ HPNV+++
Sbjct: 38 GTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQ 91
Query: 119 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
I E L+ ++++K A + G+ +LH I+HRDL+P
Sbjct: 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPH 147
Query: 178 NILRDDSGN-----LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK---NEEY 226
NIL ++DFG+ K L + + ++APE+ E
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLA-VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 227 DTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA--PAKLYARGLKEL 283
VD+FS + +I EG PF + +A P K +EL
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPF---GKSLQRQANILLGACSLDCLHPEKHEDVIAREL 263
Query: 284 IEECWNEKPAKRPTFRQI 301
IE+ P KRP+ + +
Sbjct: 264 IEKMIAMDPQKRPSAKHV 281
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 62/236 (26%), Positives = 112/236 (47%), Gaps = 11/236 (4%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G + AVK + + + + E+ LL+++ HPN+++ +V E
Sbjct: 51 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 186
G+L + + A R + G+ Y+H+NK I+HRDL+P N+L + N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 167
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
+++ DFG+S + + + + + Y+APEV YD K DV+S +IL ++ GC
Sbjct: 168 IRIIDFGLSTH--FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224
Query: 247 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 301
PPF ++ ++ K + + F+ P K + K+LI + P+ R + R
Sbjct: 225 PPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-34
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124
+VA+K K + D E+ +L+K+ HP +++ + IV
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93
Query: 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 181
E + G+L + LK +T + + + YLHEN IIHRDL+P N+L +
Sbjct: 94 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 150
Query: 182 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 235
++ +K+ DFG SK+ + E + T C Y+APEV + Y+ VD +S
Sbjct: 151 EEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205
Query: 236 ALILQEMIEGCPPF 249
+IL + G PPF
Sbjct: 206 GVILFICLSGYPPF 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 29/245 (11%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G++ A K + + +S D + E + +K++HPN+V+ ++ + S +V + +
Sbjct: 31 GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 186
G+L + + + A I + Y H N I+HR+L+P N+L +
Sbjct: 90 GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
+K+ADFG++ V + Y++PEV K + Y VD+++ +IL ++
Sbjct: 147 VKLADFGLAIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
Query: 244 EGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPAKRP 296
G PPF + + + A P + A K LI+ P KR
Sbjct: 202 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-------KSLIDSMLTVNPKKRI 254
Query: 297 TFRQI 301
T Q
Sbjct: 255 TADQA 259
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 59/236 (25%), Positives = 117/236 (49%), Gaps = 12/236 (5%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
++ A+K + + +S + +E+A+L+ + HPN+++ +V E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 186
G+L + + A + G+ YLH++ I+HRDL+P N+L ++
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDAL 177
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
+K+ DFG+S + + + + + + Y+APEV + ++YD K DV+S +IL ++ G
Sbjct: 178 IKIVDFGLSAV--FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234
Query: 247 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 301
PPF + D E+ + + + F +P K + G K+LI++ +R + +Q
Sbjct: 235 PPFGGQTDQEILRK-VEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 56/286 (19%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G VAVK+L EE + F+ E+ ++ H N+++ G + ++V Y+
Sbjct: 54 GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 130 GDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185
G + + L+ + +P R AL ARG+ YLH++ IIHRD++ +NIL D+
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEYDTKVDVFSFAL 237
V DFG++KL+ K DT + ++APE + K DVF + +
Sbjct: 172 EAVVGDFGLAKLMDYK--------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 223
Query: 238 ILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARG-LKELI--------- 284
+L E+I G F + + L L+ L+
Sbjct: 224 MLLELITGQRAFDLARLANDDDVMLLDWVK---------GLLKEKKLEALVDVDLQGNYK 274
Query: 285 -EE----------CWNEKPAKRPTFRQIITRLESINNSINHKRRWK 319
EE C P +RP +++ LE + W+
Sbjct: 275 DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG-DGLAERWEEWQ 319
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 37/263 (14%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+ G F L R G A+K + + D + +E+A+L+KI+H N+V
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
++ +V + + G+L + +G A + + YLHEN I+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 172 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 225
RDL+P N+L +++ + + DFG+SK+ ++ ++ T+C YVAPEV +
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMS---TACGTPGYVAPEVLAQKP 183
Query: 226 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYAR 278
Y VD +S +I ++ G PPF + ++++ + P + A
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA----- 238
Query: 279 GLKELIEECWNEKPAKRPTFRQI 301
K+ I + P +R T +
Sbjct: 239 --KDFICHLLEKDPNERYTCEKA 259
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 66/302 (21%), Positives = 125/302 (41%), Gaps = 40/302 (13%)
Query: 44 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELAL 98
++DP+E+ + E+ G F + G A K + ++ + + E+ +
Sbjct: 14 DLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEI 69
Query: 99 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARG 157
L HP +V+ LGA + I+ E+ P G + A + ++ +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV- 216
+N+LH + IIHRDL+ N+L G++++ADFGVS + + ++
Sbjct: 130 LNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-------FIG 179
Query: 217 -----APEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 266
APEV K+ YD K D++S + L EM + PP + V A
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239
Query: 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRW 318
P P+K ++ ++ ++ ++ P RP+ F IT +++ + +
Sbjct: 240 PTLLTPSK-WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAE 298
Query: 319 KI 320
+
Sbjct: 299 VM 300
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 57/239 (23%), Positives = 103/239 (43%), Gaps = 20/239 (8%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
I+ A KK+ + + D DR + E+ +++ + HPN+++ ++ + +V E
Sbjct: 34 RIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 186
G+L + K + S A R D+ + Y H+ + HRDL+P N L
Sbjct: 91 GELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSP 147
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
LK+ DFG++ K + + T YV+P+V + Y + D +S +++ ++
Sbjct: 148 LKLIDFGLAAR--FKPGKMMR---TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLL 201
Query: 244 EGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 301
G PPF+ D+EV F + + LI + P +R T Q
Sbjct: 202 CGYPPFSAPTDSEVMLK-IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 54/228 (23%), Positives = 107/228 (46%), Gaps = 15/228 (6%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K + ++ + + VR EL ++Q + HP +V + M +V + L GDLR
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
L++ K T F ++ ++YL + IIHRD++P NIL D+ G++ + DF
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160
Query: 194 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCP 247
++ + + + +T T Y+APE+F + + Y VD +S + E++ G
Sbjct: 161 IAAM--LPRETQIT---TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
Query: 248 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
P+ ++ + + P+ ++ + L+++ P +R
Sbjct: 216 PYHIRSSTSSKEIVHTFETTVVTYPSAW-SQEMVSLLKKLLEPNPDQR 262
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 12/236 (5%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
+ AVK + + + D E+ LL+K+ HPN+++ + SS IV E
Sbjct: 47 QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 186
G+L + ++ A R + G+ Y+H++ I+HRDL+P NIL ++ +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
+K+ DFG+S +++ + + + Y+APEV + YD K DV+S +IL ++ G
Sbjct: 163 IKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT 219
Query: 247 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 301
PPF K++ ++ K + F P + + K+LI + P+ R T Q
Sbjct: 220 PPFYGKNEYDILKR-VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 57/242 (23%), Positives = 106/242 (43%), Gaps = 22/242 (9%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G++ +K + ++ + E+ +L+ + HPN+++ M IV E
Sbjct: 47 GLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104
Query: 130 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RD 182
G+L + R AL + + Y H ++H+DL+P NIL
Sbjct: 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTS 161
Query: 183 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 239
+K+ DFG+++L K D T + Y+APEVFK + K D++S +++
Sbjct: 162 PHSPIKIIDFGLAEL--FKSDEHST---NAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
Query: 240 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299
++ GC PFT EV + A + P + + +L+++ + P +RP+
Sbjct: 216 YFLLTGCLPFTGTSLEEVQQK-ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAA 274
Query: 300 QI 301
Q+
Sbjct: 275 QV 276
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-32
Identities = 54/335 (16%), Positives = 104/335 (31%), Gaps = 68/335 (20%)
Query: 29 MAPMHVKHAREVPEYEI----DPHELDFTNSVEITKGTFILAF-WRGIQ------VAVKK 77
MA H H + + + I KG L V V++
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRR 59
Query: 78 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 137
+ E S++ V + EL + + HPN+V + + + +VT ++ G + +
Sbjct: 60 INLEACSNEM-VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 138 --RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195
+ + + ++Y+H +HR ++ S+IL G + ++ +
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 196 KLLTVKEDRPLTCQDTSCRYV------APEVFK--NEEYDTKVDVFSFALILQEMIEGCP 247
+ R D V +PEV + + YD K D++S + E+ G
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 248 PF---------TMKHDNEVPK---------------------------------AYAARQ 265
PF K + VP +
Sbjct: 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295
Query: 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
P + ++ +E+C P RP+
Sbjct: 296 DSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 28/271 (10%), Positives = 53/271 (19%), Gaps = 46/271 (16%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT----- 124
A+K + + + ++ + + P V
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 125 --------------------EYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARG 157
DL +G + R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 217
L ++H P N+ G L + D K Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL----WKVGTRGPASSVPVTYAP 259
Query: 218 PEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 275
E + ++ + L + + PF + R P
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAF 319
Query: 276 YAR-----GLKELIEECWNEKPAKRPTFRQI 301
+ +K LI N +R +
Sbjct: 320 GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 20/185 (10%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VA+KK E + A R E+ +L++++HPN+V L + + +V EY +
Sbjct: 31 VAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV 88
Query: 133 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
L R P V+ + +N+ H++ IHRD++P NIL +K+ D
Sbjct: 89 LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCD 145
Query: 192 FGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFALILQEMIE 244
FG ++LLT V +PE+ + +Y VDV++ + E++
Sbjct: 146 FGFARLLTG-PSDYYDD------EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198
Query: 245 GCPPF 249
G P +
Sbjct: 199 GVPLW 203
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 68/276 (24%), Positives = 119/276 (43%), Gaps = 26/276 (9%)
Query: 42 EYEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDEL 96
++ +L EI +G + ++ G +AVK++ V + ++ + D
Sbjct: 16 HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLD 72
Query: 97 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-----AVRFA 151
+++ P +VQF GA+ + I E + F K ++ +
Sbjct: 73 VVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
L + +N+L EN IIHRD++PSNIL D SGN+K+ DFG+S L D +D
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA 186
Query: 212 SCR-YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 266
CR Y+APE YD + DV+S + L E+ G P+ + +
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246
Query: 267 PP--FKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 300
PP + + ++ + C + +KRP +++
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-32
Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 50/278 (17%)
Query: 61 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 118
GT + ++G VAVK++ D E+ LL + HPNV+++ + T
Sbjct: 29 GTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82
Query: 119 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ I E +L+ ++ K K + IA G+ +LH K IIH
Sbjct: 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIH 138
Query: 172 RDLEPSNIL-------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RY 215
RDL+P NIL ++ + ++DFG+ K L + T + +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 216 VAPEVFKNEE-------YDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRP 267
APE+ + +D+FS + ++ +G PF D ++ R
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF---GDKYSRESNIIRGIF 255
Query: 268 PFKAPAKLYARGL----KELIEECWNEKPAKRPTFRQI 301
L+ R L +LI + + P KRPT ++
Sbjct: 256 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-32
Identities = 75/320 (23%), Positives = 130/320 (40%), Gaps = 53/320 (16%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G++ A K + + +S D + E + +K++HPN+V+ ++ + S +V + +
Sbjct: 54 GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 186
G+L + + + A I + Y H N I+HR+L+P N+L +
Sbjct: 113 GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 169
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
+K+ADFG++ V + Y++PEV K + Y VD+++ +IL ++
Sbjct: 170 VKLADFGLAIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
Query: 244 EGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPAKRP 296
G PPF + + + A P + A K LI+ P KR
Sbjct: 225 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-------KSLIDSMLTVNPKKRI 277
Query: 297 TFRQI-----ITRLESINNSI------------NHKRRWK---IRTMKCFHNLE----AM 332
T Q I E + ++I N +R+ K + TM NL +
Sbjct: 278 TADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNL 337
Query: 333 LKKDHSSPSSRSKSSCSTSS 352
L K P S K S +S
Sbjct: 338 LNKKEQGPPSTIKESSESSQ 357
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 52/226 (23%), Positives = 106/226 (46%), Gaps = 14/226 (6%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L + I +++V E ++ ++ HP V+ + Y G+L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 134 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
++++ G+ + RF +I + YLH IIHRDL+P NIL ++ ++++ DF
Sbjct: 119 KYIRKIGSFDETCT-RFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 174
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G +K+L+ + + + +YV+PE+ + D+++ I+ +++ G PPF
Sbjct: 175 GTAKVLSPESKQARAN--SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232
Query: 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
+ NE + + + P K + + ++L+E+ KR
Sbjct: 233 --RAGNEY-LIFQKIIKLEYDFPEKFFPKA-RDLVEKLLVLDATKR 274
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 66/246 (26%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
+ AVK + + + D E+ LL+K+ HPN+++ + SS IV E
Sbjct: 47 QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 186
G+L + ++ A R + G+ Y+H++ I+HRDL+P NIL ++ +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
+K+ DFG+S +++ + Y+APEV + YD K DV+S +IL ++
Sbjct: 163 IKIIDFGLSTC--FQQNTKMK---DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILL 216
Query: 244 EGCPPFTMKHDNEVPKAYAARQRPPFKAP--------AKLYARGLKELIEECWNEKPAKR 295
G PPF K++ ++ K + F P A K+LI + P+ R
Sbjct: 217 SGTPPFYGKNEYDILKR-VETGKYAFDLPQWRTISDDA-------KDLIRKMLTFHPSLR 268
Query: 296 PTFRQI 301
T Q
Sbjct: 269 ITATQC 274
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 58/181 (32%), Positives = 104/181 (57%), Gaps = 12/181 (6%)
Query: 73 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
VA+K++ + ++D+ + A R E++LL+++ HPN+V + + + +V E++ K
Sbjct: 48 VALKRIRLD--AEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 131 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
DL+ L K L+ S + + RG+ + H+++ I+HRDL+P N+L + G LK+
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKL 160
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 248
ADFG+++ + R T + + Y AP+V +++Y T VD++S I EMI G P
Sbjct: 161 ADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219
Query: 249 F 249
F
Sbjct: 220 F 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 56/181 (30%), Positives = 103/181 (56%), Gaps = 12/181 (6%)
Query: 73 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
A+KK+ E +D+ + R E+++L++++H N+V+ + +++V E+L +
Sbjct: 29 FALKKIRLE--KEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 131 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
DL+ L +G L+ TA F L + G+ Y H+ + ++HRDL+P N+L + G LK+
Sbjct: 85 DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKI 141
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 248
ADFG+++ + R T + + Y AP+V +++Y T +D++S I EM+ G P
Sbjct: 142 ADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
Query: 249 F 249
F
Sbjct: 201 F 201
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 4e-31
Identities = 46/334 (13%), Positives = 103/334 (30%), Gaps = 47/334 (14%)
Query: 33 HVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEV 82
+ + E+++ + + + +G F A + +K
Sbjct: 50 KLPAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107
Query: 83 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA- 141
+ + L+ ++F A + ++V E G L +
Sbjct: 108 PWEFYIGT---QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164
Query: 142 ----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----------RDDSGN 186
+ + FA+ + + +H+ + IIH D++P N + D S
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 187 LKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 245
L + D G S + + + T + + + E+ N+ ++ ++D F A + M+ G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 246 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305
E + F+ L E N ++ +
Sbjct: 282 TYMKVKNEGGEC------KPEGLFRRLPHLDM--WNEFFHVMLNIPDCHHLPSLDLLRQK 333
Query: 306 ESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSS 339
+ KIR ++ + L +L + S
Sbjct: 334 --LKKVFQQHYTNKIRALR--NRLIVLLLECKRS 363
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 61/182 (33%), Positives = 96/182 (52%), Gaps = 11/182 (6%)
Query: 73 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
VA+KK+ D A R E+ LLQ++ HPN++ L A S + +V +++
Sbjct: 38 VAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96
Query: 130 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
DL +K L PS + L +G+ YLH++ I+HRDL+P+N+L D++G LK
Sbjct: 97 -DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 152
Query: 189 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 247
+ADFG++K +R T Q + Y APE+ F Y VD+++ IL E++ P
Sbjct: 153 LADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211
Query: 248 PF 249
Sbjct: 212 FL 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 61/242 (25%), Positives = 104/242 (42%), Gaps = 23/242 (9%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
++ AVK I D + + LL+ +HPN++ + +VTE +
Sbjct: 47 NMEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSG 185
G+L + R+ A I + + YLH ++HRDL+PSNIL +
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 242
++++ DFG +K L E+ L T C +VAPEV + + YD D++S ++L M
Sbjct: 158 SIRICDFGFAKQLR-AENGLLM---TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 243 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECWNEKPAKRPTFR 299
+ G PF D+ + A F + K+L+ + + P +R T
Sbjct: 214 LTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273
Query: 300 QI 301
+
Sbjct: 274 LV 275
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 56/282 (19%), Positives = 109/282 (38%), Gaps = 41/282 (14%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124
G++ A K + E+++L+++ H NV+ + ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94
Query: 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 180
E + G+L FL +K +L A F I G+NYLH K I H DL+P NI+
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151
Query: 181 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFAL 237
++K+ DFG++ + ++ +VAPE+ E + D++S +
Sbjct: 152 NIPIPHIKLIDFGLAHEI--EDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 238 ILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNE 290
I ++ G PF E + F A K+ I + +
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA-------KDFIRKLLVK 259
Query: 291 KPAKRPTFRQI-----ITRLESINNSINHKRRWKIRTMKCFH 327
+ KR T ++ IT +++ + + + + +
Sbjct: 260 ETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQY 301
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-31
Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 38/255 (14%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVR-AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 122
+ AVK G + +R A E+ +L+K+ HPN++Q ++ +
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 182
V + + KG+L +L K L + + + LH+ I+HRDL+P NIL D
Sbjct: 102 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 158
Query: 183 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE------YDTKVDVF 233
D N+K+ DFG S + L C Y+APE+ + Y +VD++
Sbjct: 159 DDMNIKLTDFGFSCQ--LDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 234 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEE 286
S +I+ ++ G PPF + + + + P + K+L+
Sbjct: 214 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV-------KDLVSR 266
Query: 287 CWNEKPAKRPTFRQI 301
+P KR T +
Sbjct: 267 FLVVQPQKRYTAEEA 281
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 62/246 (25%), Positives = 114/246 (46%), Gaps = 21/246 (8%)
Query: 70 GIQVAVK----------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119
+ A+K + ++ + + +E++LL+ + HPN+++
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179
+VTE+ G+L + + A I G+ YLH++ I+HRD++P NI
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177
Query: 180 L---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 236
L ++ N+K+ DFG+S +D L + + Y+APEV K ++Y+ K DV+S
Sbjct: 178 LLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCG 234
Query: 237 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKR 295
+I+ ++ G PPF ++D ++ K + + F K + KELI+ KR
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKK-VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKR 293
Query: 296 PTFRQI 301
T +
Sbjct: 294 CTAEEA 299
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 57/250 (22%), Positives = 99/250 (39%), Gaps = 36/250 (14%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124
G + A K +L E+ +L++IRHPN++ + ++++
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVS--REEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87
Query: 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 180
E + G+L FL K +L A +F I G++YLH + I H DL+P NI+
Sbjct: 88 ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDK 144
Query: 181 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFAL 237
+ +K+ DFG++ + + +VAPE+ E + D++S +
Sbjct: 145 NVPNPRIKLIDFGIAHKI--EAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
Query: 238 ILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNE 290
I ++ G PF + E +A F A K+ I +
Sbjct: 200 ITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA-------KDFIRRLLVK 252
Query: 291 KPAKRPTFRQ 300
P +R T Q
Sbjct: 253 DPKRRMTIAQ 262
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-31
Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 8/179 (4%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
VA+KK E + A R E+ LL+++RH N+V L + +V E++ +
Sbjct: 53 VAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI 110
Query: 133 RAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
L+ L ++ I G+ + H + IIHRD++P NIL SG +K+ D
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCD 167
Query: 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 249
FG ++ L + + Y APE+ + +Y VDV++ ++ EM G P F
Sbjct: 168 FGFARTLAAP-GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 23/195 (11%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 123
G + AVK ++ A R E +L+++ HP+++ + + SS M +V
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
+ + KG+L +L K AL + +++LH N I+HRDL+P NIL DD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE------YDTKVDVFS 234
+ ++++DFG S ++ L C Y+APE+ K Y +VD+++
Sbjct: 236 NMQIRLSDFGFSCH--LEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA 290
Query: 235 FALILQEMIEGCPPF 249
+IL ++ G PPF
Sbjct: 291 CGVILFTLLAGSPPF 305
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 49/181 (27%), Positives = 93/181 (51%), Gaps = 12/181 (6%)
Query: 73 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
VA+K++ + DD+ V A R E+ LL++++H N+V+ + + +V E+ +
Sbjct: 30 VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85
Query: 131 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
DL+ + G L P F + +G+ + H ++HRDL+P N+L + +G LK+
Sbjct: 86 DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKL 142
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 248
A+FG+++ + R + + + Y P+V F + Y T +D++S I E+ P
Sbjct: 143 ANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
Query: 249 F 249
Sbjct: 202 L 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 64/288 (22%), Positives = 111/288 (38%), Gaps = 32/288 (11%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124
G+Q A K + E+++L++I+HPNV+ + ++++
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVS--REDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93
Query: 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 180
E + G+L FL K +L A F I G+ YLH + I H DL+P NI+
Sbjct: 94 ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDR 150
Query: 181 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 240
+K+ DFG++ + + +VAPE+ E + D++S +I
Sbjct: 151 NVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 241 EMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPA 293
++ G PF E +A F A A K+ I + P
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA-------KDFIRRLLVKDPK 261
Query: 294 KRPTFRQIITR--LESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSS 339
KR T + + ++ + R+ M+ F A K ++ S
Sbjct: 262 KRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGS 309
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 71/297 (23%), Positives = 116/297 (39%), Gaps = 37/297 (12%)
Query: 46 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
DP +L F++ EI G+F + VA+KK+ +++ + E+ LQ
Sbjct: 51 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 160
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 161 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED---RPLTCQDTSCRYVA 217
LH + +IHRD++ NIL + G +K+ DFG + ++ P ++A
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY--------WMA 218
Query: 218 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KA-YAARQRPPFKAP 272
PEV +YD KVDV+S + E+ E PP N A Y Q
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMSALYHIAQNESPALQ 274
Query: 273 AKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWKIR 321
+ ++ + ++ C + P RPT F I + I +
Sbjct: 275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE 331
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 57/257 (22%), Positives = 101/257 (39%), Gaps = 49/257 (19%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 128
AVK +IS + E+ L+ HPN+V+ +V E L
Sbjct: 36 NQAFAVK-----IISKRMEANTQK-EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89
Query: 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 185
G+L +K+K + A + ++++H+ ++HRDL+P N+L +D+
Sbjct: 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNL 146
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 242
+K+ DFG ++L +++PL T C Y APE+ YD D++S +IL M
Sbjct: 147 EIKIIDFGFARLKPP-DNQPLK---TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTM 202
Query: 243 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL------------------KELI 284
+ G PF + + + ++ + K+LI
Sbjct: 203 LSGQVPF-----------QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI 251
Query: 285 EECWNEKPAKRPTFRQI 301
+ P KR +
Sbjct: 252 QGLLTVDPNKRLKMSGL 268
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 44/235 (18%), Positives = 82/235 (34%), Gaps = 39/235 (16%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVTEY 126
V +K L D + E L ++ HP++VQ V + IV EY
Sbjct: 108 PVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165
Query: 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
+ L+ L + A+ + L+I ++YLH +++ DL+P NI+ +
Sbjct: 166 VGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEEQ- 219
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVDVFSFALILQE 241
LK+ D G + + + APE+ + D+++ L
Sbjct: 220 LKLIDLGAVSRIN----------SFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAA 268
Query: 242 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 296
+ P ++ + +P P K L+ + P +R
Sbjct: 269 LTLDLPTRNGRYVDGLP-----EDDPVLKTYDSYGR-----LLRRAIDPDPRQRF 313
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 53/182 (29%), Positives = 93/182 (51%), Gaps = 15/182 (8%)
Query: 73 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
VA+K++ EE A R E++LL+ ++H N+V + + +V EYL K
Sbjct: 30 VALKEIRLEHEEGAP----CTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 130 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188
DL+ +L G + F + RG+ Y H K ++HRDL+P N+L ++ G LK
Sbjct: 85 -DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELK 140
Query: 189 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 247
+ADFG+++ ++ + + + Y P++ + +Y T++D++ I EM G P
Sbjct: 141 LADFGLARAKSI-PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
Query: 248 PF 249
F
Sbjct: 200 LF 201
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 60/285 (21%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124
A+K K+ + D +R++ E+ L++K+ HPN+ + + +V
Sbjct: 51 RAIRAIKIMNKNKIRQINPKDVERIK---TEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107
Query: 125 EYLPKGDLRAFLKRKGALKPST-------------------------------------- 146
E G L L
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167
Query: 147 --AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 202
I ++YLH I HRD++P N L + S +K+ DFG+SK
Sbjct: 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224
Query: 203 DRPLTCQDTSC---RYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 257
+ T +VAPEV NE Y K D +S ++L ++ G PF +D +
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT 284
Query: 258 PKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 301
++ F+ P + + ++L+ N +R +
Sbjct: 285 ISQ-VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 66/324 (20%), Positives = 123/324 (37%), Gaps = 57/324 (17%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124
G++ A K + E+++L+++ HPN++ + ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVC--REEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94
Query: 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 180
E + G+L FL +K +L A F I G+NYLH K I H DL+P NI+
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151
Query: 181 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFAL 237
++K+ DFG++ +++ +VAPE+ E + D++S +
Sbjct: 152 NIPIPHIKLIDFGLAHE--IEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 238 ILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNE 290
I ++ G PF E A F A K+ I + +
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA-------KDFIRKLLVK 259
Query: 291 KPAKRPTFRQI-----ITRLESINNSINH--------------KRRWK--IRTMKCFHNL 329
+ KR T ++ IT +++ + +RRWK + ++L
Sbjct: 260 ETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHL 319
Query: 330 EAMLKKDHSSPSSRSKSSCSTSSI 353
L K +S +C + +
Sbjct: 320 TRSLMKKVHLRTSEDLRNCESDTE 343
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 29/229 (12%)
Query: 37 AREVPEYEIDPHELDFTNSV-----EITKGTF---ILAFWR--GIQVAVKKLGEEVISDD 86
A VP+Y ID D + E+ +G + A+K V+
Sbjct: 35 ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK-----VLKKT 89
Query: 87 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 146
+ R E+ +L ++ HPN+++ + + +V E + G+L + KG
Sbjct: 90 VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149
Query: 147 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKED 203
A I + YLHEN I+HRDL+P N+L LK+ADFG+SK+ V+
Sbjct: 150 AADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQ 204
Query: 204 RPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
+ T C Y APE+ + Y +VD++S +I ++ G PF
Sbjct: 205 VLMK---TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 53/264 (20%), Positives = 111/264 (42%), Gaps = 35/264 (13%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
E+ KG F G + A + + +S D + E + + ++HPN+V+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLH 76
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
++++ ++ + + G+L + + + A I + + H+ ++H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVH 133
Query: 172 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 225
R+L+P N+L + +K+ADFG++ + E + Y++PEV + +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWF---GFAGTPGYLSPEVLRKDP 189
Query: 226 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP--------AKLYA 277
Y VD+++ +IL ++ G PPF + + + + F +P A
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ-IKAGAYDFPSPEWDTVTPEA---- 244
Query: 278 RGLKELIEECWNEKPAKRPTFRQI 301
K+LI + P+KR T +
Sbjct: 245 ---KDLINKMLTINPSKRITAAEA 265
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 48/185 (25%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 73 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
VA+K++ E +++ V A R E++LL++++H N+++ + + + ++ EY
Sbjct: 62 VAIKRIRLE--HEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----RDDSG 185
DL+ ++ + + F + G+N+ H + +HRDL+P N+L ++
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP 174
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIE 244
LK+ DFG+++ + R T + + Y PE+ + Y T VD++S A I EM+
Sbjct: 175 VLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
Query: 245 GCPPF 249
P F
Sbjct: 234 KTPLF 238
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 34/240 (14%), Positives = 70/240 (29%), Gaps = 44/240 (18%)
Query: 67 FWRGI------QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120
FW+ + QVA+ + + + DD ++ L +I P V + L V +
Sbjct: 47 FWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106
Query: 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180
++V E++ G L+ + P A+R +A + H + PS +
Sbjct: 107 LVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVR 161
Query: 181 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 240
G++ +A + + + D+ L
Sbjct: 162 VSIDGDVVLAYPA---------------------TMPDA-------NPQDDIRGIGASLY 193
Query: 241 EMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKLYA---RGLKELIEECWNEKPAKRP 296
++ P + + A P PA + + + R
Sbjct: 194 ALLVNRWPLPEAGVRSGLAPAERDTAGQP-IEPADIDRDIPFQISAVAARSVQGDGGIRS 252
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 36/274 (13%)
Query: 46 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
DP + F + GT+ + G A+K + +V D++ + E+ +L+
Sbjct: 21 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEE--EIKQEINMLK 75
Query: 101 KI-RHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFA 151
K H N+ + GA + +P + +V E+ G + +K + LK
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
+I RG+++LH++K +IHRD++ N+L ++ +K+ DFGVS L R T T
Sbjct: 136 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 212 SCRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYA--A 263
++APEV +E YD K D++S + EM EG PP H P +A
Sbjct: 193 PY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----PMRALFLIP 247
Query: 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 297
R P K +++ + IE C + ++RP
Sbjct: 248 RNPAPRLKSKK-WSKKFQSFIESCLVKNHSQRPA 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 16/230 (6%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL- 132
A KKL ++ + + E +L K+ +V A + + +V + GD+
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 133 ---RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189
+ + A+ + I G+ +LH+ II+RDL+P N+L DD GN+++
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRI 330
Query: 190 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
+D G++ L + + ++APE+ EEYD VD F+ + L EMI
Sbjct: 331 SDLGLAVELKAGQTKT----KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
Query: 247 PPFTM-KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
PF E + P K + K+ E + P KR
Sbjct: 387 GPFRARGEKVENKELKQRVLEQAVTYPDKF-SPASKDFCEALLQKDPEKR 435
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 25/195 (12%)
Query: 70 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124
G Q AVK K + ++ E ++ ++HP++V+ L + + +V
Sbjct: 49 GQQFAVKIVDVAKFTSSPGLSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 125 EYLPKGDLRAFLKRKGALKPS----TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180
E++ DL + ++ A + I + Y H+N IIHRD++P +L
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVL 162
Query: 181 ---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFS 234
+++S +K+ FGV+ L + ++APEV K E Y VDV+
Sbjct: 163 LASKENSAPVKLGGFGVAIQLG-ESGLVAG---GRVGTPHFMAPEVVKREPYGKPVDVWG 218
Query: 235 FALILQEMIEGCPPF 249
+IL ++ GC PF
Sbjct: 219 CGVILFILLSGCLPF 233
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 53/187 (28%), Positives = 97/187 (51%), Gaps = 20/187 (10%)
Query: 73 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
VA+K++ EE A R E++L+++++H N+V+ + + + +V E++
Sbjct: 33 VALKEVKLDSEEGTP----STAIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87
Query: 130 GDLRAFLK------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
DL+ ++ L+ + F + +G+ + HENK I+HRDL+P N+L +
Sbjct: 88 -DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINK 143
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEM 242
G LK+ DFG+++ + + + + Y AP+V + Y T +D++S IL EM
Sbjct: 144 RGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202
Query: 243 IEGCPPF 249
I G P F
Sbjct: 203 ITGKPLF 209
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 51/280 (18%), Positives = 104/280 (37%), Gaps = 35/280 (12%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
K + + + E+++L RH N++ + ++++ E++
Sbjct: 30 KKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85
Query: 130 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 184
D+ F L V + + + +LH + I H D+ P NI+ S
Sbjct: 86 LDI--FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRS 140
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 244
+K+ +FG ++ L K T+ Y APEV +++ T D++S ++ ++
Sbjct: 141 STIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 245 GCPPFTMKHDNE----VPKAYAARQRPPFK---APAKLYARGLKELIEECWNEKPAKRPT 297
G PF + + + + A FK A + ++ ++ R T
Sbjct: 199 GINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA-------MDFVDRLLVKERKSRMT 251
Query: 298 FRQIITRLES--INNSINHKRRWKIRTMKCFHNLEAMLKK 335
+ L+ + I IRT+K ++KK
Sbjct: 252 ASEA---LQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 56/304 (18%)
Query: 31 PMHVKHAREVPEYEIDPHELDFTNSVEITK-----GTF---ILAFWR--GIQVAVKKLGE 80
H EV +P + T+ +++K G + F R G + A+K L
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-- 62
Query: 81 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFL 136
D +A ++ Q P++V L ++I+ E + G+L + +
Sbjct: 63 -----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117
Query: 137 KRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVAD 191
+ +G + A DI + +LH + I HRD++P N+L ++ LK+ D
Sbjct: 118 QERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD 174
Query: 192 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 248
FG +K L T C YVAPEV E+YD D++S +I+ ++ G PP
Sbjct: 175 FGFAKET---TQNALQ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
Query: 249 FTMKHDNEVPKAYAARQR---PPFKAP--------AKLYARGLKELIEECWNEKPAKRPT 297
F + R R F P A K+LI P +R T
Sbjct: 229 FYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA-------KQLIRLLLKTDPTERLT 281
Query: 298 FRQI 301
Q
Sbjct: 282 ITQF 285
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 32/247 (12%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 128
G + A K L + D R E+A+L+ + P V+ +S ++++ EY
Sbjct: 54 GQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112
Query: 129 KGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 183
G++ + + + +R I G+ YLH+N I+H DL+P NIL
Sbjct: 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQ 240
G++K+ DFG+S+ + L Y+APE+ + T D+++ +I
Sbjct: 170 LGDIKIVDFGMSRKI--GHACELR---EIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224
Query: 241 EMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPA 293
++ PF + + E + F A + I+ + P
Sbjct: 225 MLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA-------TDFIQSLLVKNPE 277
Query: 294 KRPTFRQ 300
KRPT
Sbjct: 278 KRPTAEI 284
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 52/229 (22%), Positives = 98/229 (42%), Gaps = 17/229 (7%)
Query: 74 AVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 130
A+K L ++ I +E L+L+ P +V A + + + + G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
DL L + G + +A +I G+ ++H +++RDL+P+NIL D+ G+++++
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334
Query: 191 DFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGC 246
D G++ + +P S Y+APEV K YD+ D FS +L +++ G
Sbjct: 335 DLGLACD--FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
Query: 247 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
PF + + + P + L+ L+E +R
Sbjct: 389 SPFRQHKTKDKHEIDRMTLTMAVELPDSF-SPELRSLLEGLLQRDVNRR 436
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 62/253 (24%), Positives = 113/253 (44%), Gaps = 22/253 (8%)
Query: 51 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
F + G+F +L + A+K L ++ + ++ +E +LQ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 165
+V+ + +S + +V EY+ G++ + L+R G A +A I YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 166 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK 222
+I+RDL+P N+L D G ++V DFG + K + T T C +APE+
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRT--WTLCGTPEALAPEIIL 211
Query: 223 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282
++ Y+ VD ++ +++ EM G PPF ++ + Y + P+ + LK+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF---FADQPIQIYEKIVSGKVRFPSHF-SSDLKD 267
Query: 283 LIEECWNEKPAKR 295
L+ KR
Sbjct: 268 LLRNLLQVDLTKR 280
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 39/193 (20%), Positives = 85/193 (44%), Gaps = 15/193 (7%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G K + D V+ +E++++ ++ HP ++ A M+++ E+L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 130 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 184
G+L F + + + + G+ ++HE+ I+H D++P NI+ +
Sbjct: 133 GEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKA 187
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 244
++K+ DFG++ L D + + + APE+ E D+++ ++ ++
Sbjct: 188 SSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
Query: 245 GCPPFTMKHDNEV 257
G PF + D E
Sbjct: 246 GLSPFAGEDDLET 258
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 10/187 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L +EVI D V E +LQ RHP + A + V EY G+L
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
L R+ A + +I + YLH +++RD++ N++ D G++K+ DFG
Sbjct: 94 FHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150
Query: 194 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
+ K T C Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 151 LCKEGISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
Query: 251 MKHDNEV 257
+ +
Sbjct: 207 NQDHERL 213
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A KKL ++ I +E +L+K+ VV A + +V + GDL+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 134 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
+ G + AV +A +I G+ LH + I++RDL+P NIL DD G+++++D
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329
Query: 192 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 248
G++ V E + + Y+APEV KNE Y D ++ +L EMI G P
Sbjct: 330 LGLAV--HVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
Query: 249 FT-MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
F K + + + P + + + + L + + PA+R
Sbjct: 385 FQQRKKKIKREEVERLVKEVPEEYSERF-SPQARSLCSQLLCKDPAER 431
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 13/225 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
L R+ A + +I ++YLH K +++RDL+ N++ D G++K+ DFG
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFG 294
Query: 194 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
+ K T C Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 295 LCKEGIKDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350
Query: 251 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
+ ++ + + P L K L+ + P +R
Sbjct: 351 NQDHEKL---FELILMEEIRFPRTL-GPEAKSLLSGLLKKDPKQR 391
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 9e-28
Identities = 58/312 (18%), Positives = 107/312 (34%), Gaps = 45/312 (14%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G A K + SD + VR E+ + +RHP +V A + M+++ E++
Sbjct: 182 GNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 130 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 184
G+L F + AV + + +G+ ++HEN +H DL+P NI+ S
Sbjct: 239 GEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRS 293
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 244
LK+ DFG++ L + + + + APEV + + D++S ++ ++
Sbjct: 294 NELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
Query: 245 GCPPFTMKHDNE----VPKAYAARQRPPFK---APAKLYARGLKELIEECWNEKPAKRPT 297
G PF ++D+E V F K+ I + P R T
Sbjct: 352 GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG-------KDFIRKLLLADPNTRMT 404
Query: 298 FRQ----------------IITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPS 341
Q + + + L +
Sbjct: 405 IHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 464
Query: 342 SRSKSSCSTSSI 353
+ S +
Sbjct: 465 RPQEYSIRDAFW 476
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 32/271 (11%), Positives = 74/271 (27%), Gaps = 49/271 (18%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----------------------HPNV 107
G V + ++ ++E+ L+ +R P
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 108 VQFLGAVTQSSPMMIVTEYL----PKGD-------LRAFLKRKGALKPSTAVRFALDIAR 156
+ + M +++ + + + L + +L ++ L + R
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 216
+ LH ++H L P +I+ D G + + F P+
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETT 279
Query: 217 APEVFKNEEYDTK-----VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 271
A + ++ D ++ L + + P D+ R
Sbjct: 280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN---TDDAALGGSEWIFRSCKNI 336
Query: 272 PAKLYARGLKELIEECWNEKPAKRPTFRQII 302
P + ++ L+E R Q +
Sbjct: 337 P-----QPVRALLEGFLRYPKEDRLLPLQAM 362
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 55/265 (20%), Positives = 99/265 (37%), Gaps = 42/265 (15%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 128
+ AVK + ++ RV E+ +L + + H NV++ + + +V E +
Sbjct: 38 SQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 185
G + + + ++ A D+A +++LH I HRDL+P NIL +
Sbjct: 95 GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVS 151
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQD---TSC---RYVAPEVFK-----NEEYDTKVDVFS 234
+K+ DF + + + D T C Y+APEV + YD + D++S
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211
Query: 235 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL-------------- 280
+IL ++ G PPF R L+
Sbjct: 212 LGVILYILLSGYPPF---VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI 268
Query: 281 ----KELIEECWNEKPAKRPTFRQI 301
K+LI + +R + Q+
Sbjct: 269 SCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 47/191 (24%), Positives = 93/191 (48%), Gaps = 11/191 (5%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129
G+++A K + + D + V+ +E++++ ++ H N++Q A + +++V EY+
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170
Query: 130 GDL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGN 186
G+L + L + F I G+ ++H+ I+H DL+P NIL D+
Sbjct: 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQ 227
Query: 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 246
+K+ DFG+++ K L + ++APEV + D++S +I ++ G
Sbjct: 228 IKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285
Query: 247 PPFTMKHDNEV 257
PF +D E
Sbjct: 286 SPFLGDNDAET 296
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 25/190 (13%)
Query: 72 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTE 125
+VA+KK + D R R EL +++ ++HPNVV + +V E
Sbjct: 66 EVAIKK-----VLQDKR-FKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118
Query: 126 YLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 181
Y+P+ + R + K K + + + R + Y+H I HRD++P N+L
Sbjct: 119 YVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLL 174
Query: 182 D-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALIL 239
D SG LK+ DFG +K+L P S Y APE+ F Y T +D++S ++
Sbjct: 175 DPPSGVLKLIDFGSAKILI--AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232
Query: 240 QEMIEGCPPF 249
E+++G P F
Sbjct: 233 AELMQGQPLF 242
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-27
Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 23/181 (12%)
Query: 138 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197
K L + ++ +A+GM +L K IHRDL NIL + +K+ DFG+++
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 198 L------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF- 249
+ K D L +++APE + Y + DV+SF ++L E+ G P+
Sbjct: 243 IYKDPDYVRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297
Query: 250 TMKHDNEVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 307
+K D E + R R P ++Y + + +CW+ +P++RPTF +++ L +
Sbjct: 298 GVKIDEEFCRRLKEGTRMRAPDYTTPEMY-----QTMLDCWHGEPSQRPTFSELVEHLGN 352
Query: 308 I 308
+
Sbjct: 353 L 353
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 60/225 (26%), Positives = 109/225 (48%), Gaps = 17/225 (7%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L +E++ +V DE +L + HP +++ G + + ++ +Y+ G+L
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
+ L++ A +A ++ + YLH II+RDL+P NIL D +G++K+ DFG
Sbjct: 95 SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151
Query: 194 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
+ K +T T C Y+APEV + Y+ +D +SF +++ EM+ G PF
Sbjct: 152 FA-----KYVPDVT--YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF- 203
Query: 251 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
+D+ K Y + P +K+L+ ++R
Sbjct: 204 --YDSNTMKTYEKILNAELRFPPFF-NEDVKDLLSRLITRDLSQR 245
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 56/192 (29%), Positives = 89/192 (46%), Gaps = 25/192 (13%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 123
G VA+KK + D R R EL +++K+ H N+V+ S +V
Sbjct: 79 GELVAIKK-----VLQDKR-FKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 124 TEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179
+Y+P+ + R + + K L + + R + Y+H I HRD++P N+
Sbjct: 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNL 187
Query: 180 LRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFAL 237
L D D+ LK+ DFG +K L P S Y APE+ F +Y + +DV+S
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245
Query: 238 ILQEMIEGCPPF 249
+L E++ G P F
Sbjct: 246 VLAELLLGQPIF 257
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-27
Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 11/188 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
AVK L ++V+ DD V E +L + P + Q + V EY+ GDL
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
+++ G K AV +A +IA G+ +L II+RDL+ N++ D G++K+ADF
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 165
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K T C Y+APE+ + Y VD ++F ++L EM+ G PF
Sbjct: 166 GMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221
Query: 250 TMKHDNEV 257
+ ++E+
Sbjct: 222 EGEDEDEL 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 17/188 (9%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K + + + V FR+E +L + Q A + + +V EY GDL
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 134 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
L + G P+ RF +I ++ +H +HRD++P NIL D G++++ADF
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-------YDTKVDVFSFALILQEM 242
G L + Y++PE+ + Y + D ++ + EM
Sbjct: 207 GSCLKLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
Query: 243 IEGCPPFT 250
G PF
Sbjct: 264 FYGQTPFY 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 32/277 (11%), Positives = 73/277 (26%), Gaps = 60/277 (21%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-------------------------H 104
G V + ++ ++E+ L+ +R
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 105 PNVVQFLGAVTQSSPMMIVTEY-LPKGD-------LRAFLKRKGALKPSTAVRFALDIAR 156
+++ + Y + + L + +L ++ L + R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 216
+ LH ++H L P +I+ D G + + F V++ + S +
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL----VRDGARVVS-SVSRGFE 269
Query: 217 APEVFKNEE-----------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 265
PE+ D ++ L++ + P +
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI---TKDAALGGSEWIF 326
Query: 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
R P ++ L+E R Q +
Sbjct: 327 RSCKNIPQ-----PVRALLEGFLRYPKEDRLLPLQAM 358
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 56/191 (29%), Positives = 100/191 (52%), Gaps = 11/191 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A+K + +E+++DD+ + + E + ++ HP +V S + V EY+ GDL
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 98 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K D T T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 155 GMCKEGLRPGDT--T--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210
Query: 250 TMKHDNEVPKA 260
+ ++ P
Sbjct: 211 DIVGSSDNPDQ 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A+K L ++V+ DD V E +L HP + + V EYL GDL
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
++ S A +A +I G+ +LH I++RDL+ NIL D G++K+ADF
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF 162
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K + + + +T C Y+APE+ ++Y+ VD +SF ++L EM+ G PF
Sbjct: 163 GMCKENMLGDAKT----NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218
Query: 250 TMKHDNEV 257
+ + E+
Sbjct: 219 HGQDEEEL 226
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 55/191 (28%), Positives = 100/191 (52%), Gaps = 11/191 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A++ + +E+++DD+ + + E + ++ HP +V S + V EY+ GDL
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K D T T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 198 GMCKEGLRPGDT--T--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253
Query: 250 TMKHDNEVPKA 260
+ ++ P
Sbjct: 254 DIVGSSDNPDQ 264
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 59/190 (31%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 73 VAVKKL---GEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MM 121
VA+K + + R E+ALL+++ HPNVV+ + S +
Sbjct: 37 VALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95
Query: 122 IVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179
+V E++ + DLR +L + L T RG+++LH N I+HRDL+P NI
Sbjct: 96 LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENI 151
Query: 180 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239
L G +K+ADFG++++ + LT + Y APEV Y T VD++S I
Sbjct: 152 LVTSGGTVKLADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 209
Query: 240 QEMIEGCPPF 249
EM P F
Sbjct: 210 AEMFRRKPLF 219
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 58/188 (30%), Positives = 92/188 (48%), Gaps = 11/188 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
AVK L ++V+ DD V E L + P + Q + V EY+ GDL
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
+++ G K AV +A +IA G+ +L II+RDL+ N++ D G++K+ADF
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 486
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K T C Y+APE+ + Y VD ++F ++L EM+ G PF
Sbjct: 487 GMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542
Query: 250 TMKHDNEV 257
+ ++E+
Sbjct: 543 EGEDEDEL 550
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 11/188 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
AVK L ++VI DD V E +L HP + Q + V E++ GDL
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
+++ + A +A +I + +LH+ II+RDL+ N+L D G+ K+ADF
Sbjct: 112 MFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K T T C Y+APE+ + Y VD ++ ++L EM+ G PF
Sbjct: 169 GMCKEGICNGVT--T--ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF 224
Query: 250 TMKHDNEV 257
++++++
Sbjct: 225 EAENEDDL 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 65/256 (25%), Positives = 100/256 (39%), Gaps = 47/256 (18%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 124
+ A+K ++ D + R E+ L + + P++V+ + ++IV
Sbjct: 87 QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138
Query: 125 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 180
E L G+L R + A A I + YLH I HRD++P N+L
Sbjct: 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 195
Query: 181 -RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFA 236
+ + LK+ DFG +K LT T C YVAPEV E+YD D++S
Sbjct: 196 SKRPNAILKLTDFGFAKE--TTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250
Query: 237 LILQEMIEGCPPFTMKHDNEVPKAYAARQR---PPFKAP--------AKLYARGLKELIE 285
+I+ ++ G PPF H + R R F P K LI
Sbjct: 251 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV-------KMLIR 303
Query: 286 ECWNEKPAKRPTFRQI 301
+P +R T +
Sbjct: 304 NLLKTEPTQRMTITEF 319
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 11/187 (5%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L + + DRVR + E +L ++ HP +V+ A + ++ ++L GDL
Sbjct: 56 AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
L ++ + ++A +++LH II+RDL+P NIL D+ G++K+ DFG
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171
Query: 194 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
+SK E + + C Y+APEV + D +SF +++ EM+ G PF
Sbjct: 172 LSKESIDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227
Query: 251 MKHDNEV 257
K E
Sbjct: 228 GKDRKET 234
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 21/189 (11%)
Query: 73 VAVKKLGEEVISDDDRV--RAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MMI 122
VA+K++ + + ++ + R E+A+L+ + HPNVV+ T S + +
Sbjct: 40 VALKRVRVQ--TGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 123 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180
V E++ + DL +L + + T + RG+++LH ++ ++HRDL+P NIL
Sbjct: 97 VFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 152
Query: 181 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 240
SG +K+ADFG++++ + LT + Y APEV Y T VD++S I
Sbjct: 153 VTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 241 EMIEGCPPF 249
EM P F
Sbjct: 211 EMFRRKPLF 219
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 44/186 (23%), Positives = 79/186 (42%), Gaps = 15/186 (8%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L + + FR+E +L + A + + +V +Y GDL
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162
Query: 134 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
L + P RF ++ ++ +H+ +HRD++P NIL D +G++++ADF
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-----YDTKVDVFSFALILQEMIE 244
G L + Y++PE+ + E Y + D +S + + EM+
Sbjct: 220 GSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 245 GCPPFT 250
G PF
Sbjct: 277 GETPFY 282
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 11/188 (5%)
Query: 74 AVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
A+K L ++ + + E +L++++HP +V + A + ++ EYL G+L
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
L+R+G TA + +I+ + +LH+ II+RDL+P NI+ + G++K+ DF
Sbjct: 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF 165
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K T C Y+APE+ ++ VD +S ++ +M+ G PPF
Sbjct: 166 GLCKESIHDGTV----THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221
Query: 250 TMKHDNEV 257
T ++ +
Sbjct: 222 TGENRKKT 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 15/226 (6%)
Query: 74 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 132
AVK L ++ I + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 133 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192
L+R+ A +A +IA + YLH I++RDL+P NIL D G++ + DF
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183
Query: 193 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249
G+ K T T C Y+APEV + YD VD + +L EM+ G PPF
Sbjct: 184 GLCKENIEHNST--T--STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239
Query: 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
++ E+ Y P + + + L+E + KR
Sbjct: 240 YSRNTAEM---YDNILNKPLQLKPNI-TNSARHLLEGLLQKDRTKR 281
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 15/186 (8%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 123
VA+KKL + RA+R EL L++ + H N++ L T + IV
Sbjct: 50 ERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
E + +L ++ + L + G+ +LH IIHRDL+PSNI+
Sbjct: 109 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
LK+ DFG+++ T +T + Y APEV Y VD++S I+ EMI
Sbjct: 163 DCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220
Query: 244 EGCPPF 249
+G F
Sbjct: 221 KGGVLF 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 48/192 (25%), Positives = 86/192 (44%), Gaps = 22/192 (11%)
Query: 73 VAVKKLGEEVISDDDRVR--AFRDELALLQKIRHPNVVQFLGAVTQSSP--------MMI 122
VA+KK+ E ++ + A R E+ +LQ ++H NVV + + + +
Sbjct: 45 VALKKVLME--NEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101
Query: 123 VTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 181
V ++ DL L S R + G+ Y+H NK I+HRD++ +N+L
Sbjct: 102 VFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLI 157
Query: 182 DDSGNLKVADFGVSKLLTV---KEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFAL 237
G LK+ADFG+++ ++ + T + + Y PE+ +Y +D++
Sbjct: 158 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 217
Query: 238 ILQEMIEGCPPF 249
I+ EM P
Sbjct: 218 IMAEMWTRSPIM 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 33/198 (16%)
Query: 73 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKG 130
A+K++ IS A R E+ALL++++HPNV+ + + + +Y
Sbjct: 51 YALKQIEGTGISMS----ACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104
Query: 131 DLRAFLK---------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 180
DL +K + L I G++YLH N ++HRDL+P+NIL
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILV 161
Query: 181 ---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-----YVAPEV-FKNEEYDTKVD 231
+ G +K+AD G ++L +PL D Y APE+ Y +D
Sbjct: 162 MGEGPERGRVKIADMGFARLFNS-PLKPLA--DLDPVVVTFWYRAPELLLGARHYTKAID 218
Query: 232 VFSFALILQEMIEGCPPF 249
+++ I E++ P F
Sbjct: 219 IWAIGCIFAELLTSEPIF 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 14/183 (7%)
Query: 74 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 133
A+K L + + F +E ++ P VVQ A + +V EY+P GDL
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156
Query: 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193
L + A + ++ ++ +H IHRD++P N+L D SG+LK+ADFG
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213
Query: 194 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGC 246
+ + DT+ Y++PEV K++ Y + D +S + L EM+ G
Sbjct: 214 TCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
Query: 247 PPF 249
PF
Sbjct: 271 TPF 273
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 68/231 (29%), Positives = 99/231 (42%), Gaps = 31/231 (13%)
Query: 40 VPEYEIDPHELD-FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 93
E E+D F +GTF L + G+ VA+KK+ D R
Sbjct: 12 AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNR 65
Query: 94 D--ELALLQKIRHPNVVQFLGAVTQSSP-------MMIVTEYLPKGDL----RAFLKRKG 140
+ + L + HPN+VQ + +V EY+P L R + +R+
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV 124
Query: 141 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLT 199
A P F + R + LH V + HRD++P N+L + G LK+ DFG +K L+
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 200 VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 249
P S Y APE+ F N+ Y T VD++S I EM+ G P F
Sbjct: 184 --PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 30/193 (15%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 123
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T +S + +V
Sbjct: 49 GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
++ DL+ + K + +G+ Y+H ++HRDL+P N+ ++
Sbjct: 108 MPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNE 161
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFA 236
LK+ DFG+++ D +T YV APEV Y+ VD++S
Sbjct: 162 DCELKILDFGLAR----HADAEMT------GYVVTRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 237 LILQEMIEGCPPF 249
I+ EM+ G F
Sbjct: 212 CIMAEMLTGKTLF 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 35/203 (17%)
Query: 69 RGIQVAVKKLGEEVISDDDRV---------RAFRDELALLQKIRHPNVVQFLGAVTQSSP 119
GI VA+K++ V R R E+ LL HPN++
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLRDIFVHFEE 103
Query: 120 MM-----IVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173
+VTE + DL + ++ + P F I G++ LHE ++HRD
Sbjct: 104 PAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159
Query: 174 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEY 226
L P NIL D+ ++ + DF +++ D T YV APE+ + + +
Sbjct: 160 LHPGNILLADNNDITICDFNLAR--EDTADANKT------HYVTHRWYRAPELVMQFKGF 211
Query: 227 DTKVDVFSFALILQEMIEGCPPF 249
VD++S ++ EM F
Sbjct: 212 TKLVDMWSAGCVMAEMFNRKALF 234
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 53/192 (27%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 123
VA+KKL + RA+R EL L++ + H N++ L T + +V
Sbjct: 87 DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
E + +L ++ + L + G+ +LH IIHRDL+PSNI+
Sbjct: 146 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 199
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEVFKNEEYDTKVDVFSFAL 237
LK+ DFG+++ T +T YV APEV Y VD++S
Sbjct: 200 DCTLKILDFGLAR--TAGTSFMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 238 ILQEMIEGCPPF 249
I+ EM+ F
Sbjct: 252 IMGEMVRHKILF 263
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 29/193 (15%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 123
G +VA+KKL S+ RA+R EL LL+ +RH NV+ L T + +V
Sbjct: 50 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
++ DL +K + L + +G+ Y+H IIHRDL+P N+ ++
Sbjct: 109 MPFMGT-DLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNE 163
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFA 236
LK+ DFG+++ + D +T YV APEV Y VD++S
Sbjct: 164 DCELKILDFGLAR----QADSEMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVG 213
Query: 237 LILQEMIEGCPPF 249
I+ EMI G F
Sbjct: 214 CIMAEMITGKTLF 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 41/246 (16%)
Query: 29 MAPMHVKHAREVPEY---EIDPHELDFTNSVEITK-------GTFILAFWR--GIQVAVK 76
MA H H++E P + E++ + + G+ AF G++VAVK
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 77 KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPKG 130
KL S R +R EL LL+ ++H NV+ L T + + +VT +
Sbjct: 61 KLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA- 118
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190
DL +K + L I RG+ Y+H IIHRDL+PSN+ ++ LK+
Sbjct: 119 DLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 174
Query: 191 DFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFALILQEMI 243
DFG++ R + T YV APE+ Y+ VD++S I+ E++
Sbjct: 175 DFGLA--------RHTADEMTG--YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 244 EGCPPF 249
G F
Sbjct: 225 TGRTLF 230
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 32/216 (14%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 124
VA+KK+ D R R E+ +L +++ +++ + + IV
Sbjct: 51 EKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
E DL+ K L ++ G N++HE+ IIHRDL+P+N L +
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQD 165
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------------YV------APEV-FK 222
++KV DFG+++ + ++D + +V APE+
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225
Query: 223 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 258
E Y +D++S I E++ N P
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 37/221 (16%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 124
VA+KK+ D R R E+A+L ++ H +VV+ L V +V
Sbjct: 78 KRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
E D + + L ++ G+ Y+H I+HRDL+P+N L +
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQD 192
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------------YV------AP 218
++KV DFG+++ + E+ + +V AP
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252
Query: 219 EV-FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 258
E+ E Y +DV+S I E++ H + P
Sbjct: 253 ELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-22
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 19/191 (9%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI--VTEY 126
+V VK + + + R E+ +L+ +R PN++ V V E+
Sbjct: 61 NEKVVVKI-----LKPVKKKKIKR-EIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114
Query: 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSG 185
+ D + + L + +I + ++Y H I+HRD++P N++ D +
Sbjct: 115 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 168
Query: 186 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIE 244
L++ D+G+++ + + S + PE+ + + YD +D++S +L MI
Sbjct: 169 KLRLIDWGLAE--FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
Query: 245 GCPPFTMKHDN 255
PF HDN
Sbjct: 227 RKEPFFHGHDN 237
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-22
Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 24/196 (12%)
Query: 70 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IV 123
G VA+KK+ E +R R E+ +L+ +H N++ S I+
Sbjct: 36 GEIVAIKKI--EPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
E + DL + + L F R + LH + +IHRDL+PSN+L +
Sbjct: 93 QELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINS 147
Query: 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YV------APEV-FKNEEYDTKVDVF 233
+ +LKV DFG+++++ +V APEV + +Y +DV+
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVW 207
Query: 234 SFALILQEMIEGCPPF 249
S IL E+ P F
Sbjct: 208 SCGCILAELFLRRPIF 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 31/196 (15%)
Query: 70 GIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----I 122
++VA+KK+ E R R E+ +L + RH N++ + + I
Sbjct: 52 KVRVAIKKISPFEHQT---YCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107
Query: 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 182
V + + DL L + L F I RG+ Y+H ++HRDL+PSN+L +
Sbjct: 108 VQDLMET-DLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162
Query: 183 DSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEV-FKNEEYDTKVDVF 233
+ +LK+ DFG++++ D LT YV APE+ ++ Y +D++
Sbjct: 163 TTCDLKICDFGLARVADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSIDIW 216
Query: 234 SFALILQEMIEGCPPF 249
S IL EM+ P F
Sbjct: 217 SVGCILAEMLSNRPIF 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 54/230 (23%), Positives = 105/230 (45%), Gaps = 15/230 (6%)
Query: 74 AVKKLG-EEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGD 131
A+K L ++ R E +L+ IR P +V A + + ++ +Y+ G+
Sbjct: 86 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145
Query: 132 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
L L ++ + +I + +LH+ II+RD++ NIL D +G++ + D
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 202
Query: 192 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGC 246
FG+SK V ++ C Y+AP++ + + +D VD +S +++ E++ G
Sbjct: 203 FGLSK-EFVADETERA--YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
Query: 247 PPFTMK-HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
PFT+ N + + P ++ + K+LI+ + P KR
Sbjct: 260 SPFTVDGEKNSQAEISRRILKSEPPYPQEM-SALAKDLIQRLLMKDPKKR 308
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 57/224 (25%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-------- 121
G + A+KK + D R R EL +++ + H N+++ + +
Sbjct: 32 GKRFALKK-----VLQDPR-YKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84
Query: 122 ------------------------------IVTEYLPKGDL----RAFLKRKGALKPSTA 147
++ EY+P L ++F++ ++ +
Sbjct: 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLI 143
Query: 148 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPL 206
+ + R + ++H I HRD++P N+L + LK+ DFG +K L P
Sbjct: 144 SIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI--PSEPS 198
Query: 207 TCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 249
S Y APE+ EY +D++S + E+I G P F
Sbjct: 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 62/298 (20%), Positives = 102/298 (34%), Gaps = 84/298 (28%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 124
+ A+K ++ D + R E+ L + + P++V+ + ++IV
Sbjct: 43 QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94
Query: 125 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 180
E L G+L R + A A I + YLH I HRD++P N+L
Sbjct: 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 151
Query: 181 -RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 239
+ + LK+ DFG A E E+YD D++S +I+
Sbjct: 152 SKRPNAILKLTDFG----------------------FAKETTG-EKYDKSCDMWSLGVIM 188
Query: 240 QEMIEGCPPFTMKHDNEVPKAYAAR---QRPPFKAP--------AKLYARGLKELIEECW 288
++ G PPF H + R + F P K LI
Sbjct: 189 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV-------KMLIRNLL 241
Query: 289 NEKPAKRPTFRQII-------------TRLESINNSINHKRRWK---------IRTMK 324
+P +R T + + T L + K RW+ + TM+
Sbjct: 242 KTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 299
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 40/205 (19%)
Query: 70 GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----- 121
+VA+KK I D A R E+ +++++ H N+V+ + S +
Sbjct: 36 DKRVAIKK-----IVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89
Query: 122 ---------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 172
IV EY+ DL L +G L A F + RG+ Y+H ++HR
Sbjct: 90 SLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHR 144
Query: 173 DLEPSNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNE 224
DL+P+N+ + LK+ DFG+++ + + + +P +
Sbjct: 145 DLKPANLFINTEDLVLKIGDFGLAR--IMDPHYSHKGHLSE--GLVTKWYRSPRLLLSPN 200
Query: 225 EYDTKVDVFSFALILQEMIEGCPPF 249
Y +D+++ I EM+ G F
Sbjct: 201 NYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM----IVT 124
G VAVKK+ + + D R FR E+ +L ++ H N+V L + + +V
Sbjct: 34 GEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLR--ADNDRDVYLVF 90
Query: 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
+Y+ DL A + R L+P + + + YLH ++HRD++PSNIL +
Sbjct: 91 DYMET-DLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAE 145
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------YV------APEV-FKN 223
++KVADFG+S+ + YV APE+ +
Sbjct: 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS 205
Query: 224 EEYDTKVDVFSFALILQEMIEGCPPF 249
+Y +D++S IL E++ G P F
Sbjct: 206 TKYTKGIDMWSLGCILGEILCGKPIF 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 68/319 (21%), Positives = 115/319 (36%), Gaps = 57/319 (17%)
Query: 60 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIR---------- 103
G F LA VA+K ++ D A DE+ LLQ++
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 104 -HPNVVQFLGAVTQSSPMM----IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIAR 156
++++ L P +V E L +L A +K+ P V+ + +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLLTVKEDRPLTCQD 210
G++Y+H IIH D++P N+L + +K+AD G + D T
Sbjct: 143 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196
Query: 211 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK-----AYAARQ 265
+ Y +PEV + D++S A ++ E+I G F + K A
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256
Query: 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKC 325
P+ L G + +N + R + LE + + K ++ K
Sbjct: 257 LGEL--PSYLLRNG--KYTRTFFNSRGLLRNISKLKFWPLEDV---LTEKYKFSKDEAKE 309
Query: 326 FHN-LEAMLKKDHSSPSSR 343
+ L ML+ D P R
Sbjct: 310 ISDFLSPMLQLD---PRKR 325
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 60 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH------PNV 107
KG+F + A+ VA+K ++ ++ R R +E+ +L+ +R NV
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP--STAVR-FALDIARGMNYLHEN 164
+ L T + + + E L +L +K K + VR FA I + ++ LH+N
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIK-KNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 165 KPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 222
+ IIH DL+P NIL + +KV DFG S E + + S Y APEV
Sbjct: 220 R---IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRFYRAPEVIL 272
Query: 223 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 256
Y +D++S IL E++ G P + + +
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 22/199 (11%)
Query: 69 RGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMM 121
VA+K +I + + E+ LL+ + +V + +
Sbjct: 78 EQEWVAIK-----IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132
Query: 122 IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 179
+V E L +L L+ R FA + + +L + + IIH DL+P NI
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENI 190
Query: 180 L--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 237
L +K+ DFG S + + + S Y +PEV YD +D++S
Sbjct: 191 LLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246
Query: 238 ILQEMIEGCPPFTMKHDNE 256
IL EM G P F+ ++ +
Sbjct: 247 ILVEMHTGEPLFSGANEVD 265
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 68/323 (21%), Positives = 122/323 (37%), Gaps = 59/323 (18%)
Query: 60 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRH-----PNVV 108
GTF +L AVK V+ + + + + E +L+KI++ N+V
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 109 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKP 166
++ G M ++ E L L + R ++ + ++I + +NYL +
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS- 157
Query: 167 VPIIHRDLEPSNIL-------------------------RDDSGNLKVADFGVSKLLTVK 201
+ H DL+P NIL R S +K+ DFG +
Sbjct: 158 --LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----TF 211
Query: 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 261
+ + +Y APEV N +D D++SF +L E+ G F H++ A
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR-THEHMEHLAM 270
Query: 262 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIR 321
P P + K + N K + + + + + SI + +KI
Sbjct: 271 MESIIQPI--PKNMLYEATKTNGSKYVN-KDELKLAWPENASSINSIKHVKKCLPLYKII 327
Query: 322 TMKCFHN-LEAMLKKDHSSPSSR 343
+ F + L ++L+ D P+ R
Sbjct: 328 KHELFCDFLYSILQID---PTLR 347
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 55/213 (25%), Positives = 80/213 (37%), Gaps = 41/213 (19%)
Query: 72 QVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVT 124
QVA+K +I + + R A R E+ +L+KI+ V M I
Sbjct: 47 QVALK-----IIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101
Query: 125 EYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 180
E L K + FLK P VR A + + +LHEN+ + H DL+P NIL
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFV 157
Query: 181 -----------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 223
+ +++VADFG + + T + Y PEV
Sbjct: 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTTIVATRHYRPPEVILE 213
Query: 224 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 256
+ DV+S IL E G F + E
Sbjct: 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 8e-12
Identities = 52/256 (20%), Positives = 83/256 (32%), Gaps = 76/256 (29%)
Query: 59 TKGTFILA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPN---VV 108
T L+ VA+K V S + DE+ LL+ +R PN VV
Sbjct: 49 HFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 109 QFLGAVTQSSP----MMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLH 162
Q L S + +V E L L ++ + L + + +G++YLH
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163
Query: 163 ENKPVPIIHRDLEPSNIL------------------------------------------ 180
IIH D++P NIL
Sbjct: 164 TK--CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 181 -------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 233
+ +K+AD G + + T + +Y + EV Y+T D++
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277
Query: 234 SFALILQEMIEGCPPF 249
S A + E+ G F
Sbjct: 278 STACMAFELATGDYLF 293
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 52/207 (25%), Positives = 77/207 (37%), Gaps = 34/207 (16%)
Query: 73 VAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVTE 125
VAVK ++ + DR A R E+ +L+ + VQ L + IV E
Sbjct: 43 VAVK-----IVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97
Query: 126 YLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183
L F+K G L +R A I + +N+LH NK + H DL+P NIL
Sbjct: 98 LLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQ 153
Query: 184 SGNLKVADFGVSKLLTVKEDRPL-------TC--QDTSCRYV------APEVFKNEEYDT 228
S + + + + + + + V APEV +
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQ 213
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDN 255
DV+S IL E G F HD+
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFP-THDS 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 1e-05
Identities = 51/365 (13%), Positives = 103/365 (28%), Gaps = 87/365 (23%)
Query: 27 FQMAPMHVKHAREVPEYEID-PHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD 85
F+ ++ + +E D + ++ K K+ + +I
Sbjct: 9 FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSIL-----------SKEEIDHIIMS 57
Query: 86 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--------------SPMMIVTEYLPK-- 129
D V L + V +F+ V + P M+ Y+ +
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117
Query: 130 ---GDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 182
D + F K R +P +R AL R + +I
Sbjct: 118 RLYNDNQVFAKYNVSRL---QPYLKLRQALLELRPAKNV-------LID----------- 156
Query: 183 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP-EVF--KNEEYDTKVDVFSFALIL 239
G V G + + + C + ++F + ++ V L
Sbjct: 157 --G---VLGSGKTWV--ALD----VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 240 QEMIEGCPPFTMKHDNEVP---KAYAARQRPPFKAPAKLYARGLKELI-EECWNEKPAKR 295
I+ P +T + D+ + ++ + +K Y L L+ N K
Sbjct: 206 LYQID--PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWNA 261
Query: 296 PTFR-QII--TRLESINNSINHKRRWKIR---TMKCFHNLEAM---LKKDHSSPSSRSKS 346
+I+ TR + + + ++ I E LK P +
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE 321
Query: 347 SCSTS 351
+T+
Sbjct: 322 VLTTN 326
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 21/77 (27%), Positives = 41/77 (53%), Gaps = 6/77 (7%)
Query: 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 180
+V E L DL+ + G K ST ++ + + + Y+HEN+ +H D++ +N+L
Sbjct: 129 MVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184
Query: 181 -RDDSGNLKVADFGVSK 196
+ + +AD+G+S
Sbjct: 185 GYKNPDQVYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 30/135 (22%), Positives = 50/135 (37%), Gaps = 18/135 (13%)
Query: 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 128
VA+K + R E +++ + Q +V E L
Sbjct: 34 NEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLG 88
Query: 129 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 184
DL R +LK T + A+ + M Y+H +I+RD++P N L R +
Sbjct: 89 PSLEDLFDLCDRTFSLK--TVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGN 143
Query: 185 GNLKVA---DFGVSK 196
+V DF ++K
Sbjct: 144 KTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 8/69 (11%)
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNL 187
DL F RK +LK T + A + + Y+H IHRD++P N L +
Sbjct: 93 DLFNFCSRKFSLK--TVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 147
Query: 188 KVADFGVSK 196
+ DFG++K
Sbjct: 148 YIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 22/80 (27%), Positives = 38/80 (47%), Gaps = 10/80 (12%)
Query: 122 IVTEYLPK--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179
+V + L DL F RK +LK T + A + + ++H +HRD++P N
Sbjct: 80 LVMDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHSKS---FLHRDIKPDNF 134
Query: 180 L---RDDSGNLKVADFGVSK 196
L + + + DFG++K
Sbjct: 135 LMGLGRRANQVYIIDFGLAK 154
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 12/82 (14%)
Query: 122 IVTEYLPK--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179
+V + L DL RK ++K T A + + +HE +++RD++P N
Sbjct: 83 LVIDLLGPSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIHEKS---LVYRDIKPDNF 137
Query: 180 L-----RDDSGNLKVADFGVSK 196
L ++ + V DFG+ K
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVK 159
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 3e-04
Identities = 26/202 (12%), Positives = 49/202 (24%), Gaps = 52/202 (25%)
Query: 47 PHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDD-----RVRAFRDELAL 98
+I +G F VA+K + E + E+ +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 99 LQKI---------RHPNVVQFLGAVTQSSP------------------------------ 119
+++ R +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 120 MMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 178
+ IV E+ G DL + +TA + + + + HRDL N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGN 192
Query: 179 ILRDDSGNLKVADFGVSKLLTV 200
+L + K+ K T+
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 6/68 (8%)
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 188
+ L + ++ A + + +LHEN+ +H ++ NI +D +
Sbjct: 146 SALDVSPKH-VLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVT 201
Query: 189 VADFGVSK 196
+A +G +
Sbjct: 202 LAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 14/68 (20%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 188
+ ++ + K T ++ +L I + Y+HE++ +H D++ SN+L + +
Sbjct: 140 KIYEANAKRFSRK--TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY 194
Query: 189 VADFGVSK 196
+ D+G++
Sbjct: 195 LVDYGLAY 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 353 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.06 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.61 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.06 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.01 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.51 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.47 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.02 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.81 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.42 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.33 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.1 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.76 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 88.74 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.07 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=413.12 Aligned_cols=251 Identities=28% Similarity=0.488 Sum_probs=218.4
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
+|...++||+|+||.||. +|..||||+++.. ..+..+.|.+|+.++++++|||||+++|++.+++.+
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 578889999999999984 3678999999753 456667899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCE
Q 018614 121 MIVTEYLPKGDLRAFLKRK-------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 187 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~v 187 (353)
|||||||++|+|.+++... ..+++..++.++.|++.||.|||+++ ||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence 9999999999999999753 25899999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcC
Q 018614 188 KVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 265 (353)
Q Consensus 188 kl~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 265 (353)
||+|||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..++...+..+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998765433222 223457899999999999999999999999999999999 999999988878877777666
Q ss_pred CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 266 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.++. +..+|+++.+||.+||+.||++|||++++++.|+++.+
T Consensus 248 ~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 248 VLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 5443 35688999999999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-57 Score=407.59 Aligned_cols=264 Identities=28% Similarity=0.470 Sum_probs=216.2
Q ss_pred CCcccCccCcCcccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
..|+|+.++ ++..++||+|+||.||. ....||||+++... ...+..+.|.+|+.++++++|||||+++|++.+ +
T Consensus 29 ~~Wei~~~~--l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 29 YYWEIEASE--VMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCCBCCTTS--CCEEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred cCcEEcHHH--eEEeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 358887665 56678999999999984 34579999987643 345667889999999999999999999998865 5
Q ss_pred ceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
.+|||||||++|+|.+++... ..+++..++.++.||+.||.|||+++ ||||||||+|||+++++.+||+|||+|+.
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 689999999999999999764 46999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCC-CCcccCCCCCcccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC--CCCCCC
Q 018614 198 LTVKED-RPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKA 271 (353)
Q Consensus 198 ~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~ 271 (353)
...... .......||+.|+|||++.+ +.++.++|||||||++|||+||+.||...+............ .+....
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 654322 22344578999999999864 458999999999999999999999998876655444443333 233334
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
.+..+++++.+||.+||+.||++|||+.+++++|+.+..+
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 4567889999999999999999999999999999988544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-57 Score=413.42 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=217.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..|+..++||+|+||.||. +|+.||||+++.... ..+|+.++++++|||||++++++.++..+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3577788999999999984 488999999976543 246999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+||+|.+++++.+.+++..++.++.||+.||.|||+++ ||||||||+||||+.+| .+||+|||+|+.......
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999999998888999999999999999999999999 99999999999999988 599999999987754322
Q ss_pred C----CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 204 R----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 204 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
. ......||+.|+|||++.+..++.++|||||||++|||++|++||......++...+..... +....+..++++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP-PIREIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-GGGGSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-CchhcCccCCHH
Confidence 1 11234689999999999999999999999999999999999999998888888777765443 222234568899
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhh
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~ 314 (353)
+.+||.+||++||++|||+.|++++|.........
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 99999999999999999999999999988766553
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=419.39 Aligned_cols=247 Identities=22% Similarity=0.447 Sum_probs=211.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++..... .....+.+.+|+.++++++|||||++++++.+++.+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 3799999999999999984 589999999977654 3455678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 125 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||+||+|.+++...+ .+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999997543 4789999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
. ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..++...+.....++. +..+++++++
T Consensus 180 ~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~ 255 (350)
T 4b9d_A 180 E-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---SLHYSYDLRS 255 (350)
T ss_dssp H-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSCHHHHH
T ss_pred c-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---CccCCHHHHH
Confidence 1 12234589999999999999999999999999999999999999998877777777766655443 4568899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||+.||++|||++++++|
T Consensus 256 li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-57 Score=412.60 Aligned_cols=251 Identities=27% Similarity=0.483 Sum_probs=213.0
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
++...++||+|+||.||. ++..||||+++.. ..+..+.|.+|+.++++++|||||+++|++.+...+
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 567788999999999984 3678999999753 456667899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC
Q 018614 121 MIVTEYLPKGDLRAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~ 185 (353)
|||||||++|+|.+++... +++++..++.++.|++.||.|||+++ ||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 9999999999999999753 34899999999999999999999999 99999999999999999
Q ss_pred CEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHh
Q 018614 186 NLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 263 (353)
Q Consensus 186 ~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 263 (353)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......++...+..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999999876543322 2234568999999999999999999999999999999999 9999998887777777766
Q ss_pred cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
+..++. +..+++++.+||.+||+.||++|||+++|+++|+.+..
T Consensus 276 g~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 276 GRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp TCCCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 655443 35688999999999999999999999999999998854
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-58 Score=414.11 Aligned_cols=247 Identities=21% Similarity=0.405 Sum_probs=217.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++.+....+....+.+.+|+.++++++||||++++++|.+++.+|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 699999999999999984 588999999976433233345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC-C
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~ 204 (353)
||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|+.+..... .
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999998754332 2
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......||+.|+|||++.+..++.++|||||||++|+|++|++||...+..++...+..... .+ +..+++++++||
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~---p~~~s~~~~dli 265 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DF---PEKFFPKARDLV 265 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CC---CTTCCHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CC---CcccCHHHHHHH
Confidence 33456799999999999999999999999999999999999999988777777776655442 22 345788999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+||+.||++|||++|++.+
T Consensus 266 ~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHSCSSGGGSTTSGGGTCH
T ss_pred HHHccCCHhHCcChHHHcCC
Confidence 99999999999999998655
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-57 Score=412.39 Aligned_cols=246 Identities=22% Similarity=0.385 Sum_probs=215.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..|+..++||+|+||.||. +|+.||||++....... .+.+.+|+.++++++|||||+++++|.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3599999999999999984 58899999997654332 245789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|||+||+|.+++.+ +.+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999999999976 46999999999999999999999999 99999999999999999999999999987754332
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+.....+.+. ....+++++++||
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~-~~~~~s~~~~dli 304 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK-NLHKVSPSLKGFL 304 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCS-CGGGSCHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC-ccccCCHHHHHHH
Confidence 233467999999999999999999999999999999999999999887766666666554433333 3467899999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+||+.||++|||++|+++|
T Consensus 305 ~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 305 DRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-57 Score=402.31 Aligned_cols=245 Identities=27% Similarity=0.445 Sum_probs=200.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++......+.+....+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 3799999999999999984 58999999998765555555677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+ +|+|.+++.+.+.+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 999 7899999998889999999999999999999999999 9999999999999999999999999998765332
Q ss_pred CcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....+.... ..+ +..+++++++|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~---p~~~s~~~~~l 242 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTL---PKFLSPGAAGL 242 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCC---CTTSCHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCC---CCCCCHHHHHH
Confidence 2234568999999999998886 579999999999999999999998876666666654443 222 34578999999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~ 304 (353)
|.+||+.||++|||++++++|
T Consensus 243 i~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHccCChhHCcCHHHHHcC
Confidence 999999999999999999987
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-57 Score=410.19 Aligned_cols=249 Identities=30% Similarity=0.518 Sum_probs=215.8
Q ss_pred cccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceE
Q 018614 52 FTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 121 (353)
++..++||+|+||.||+ +++.||||+++... .....+.|.+|+.++++++|||||+++|++.+++.++
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45567899999999984 35789999997543 2334467999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC
Q 018614 122 IVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~ 185 (353)
||||||++|+|.+++... ..+++..++.++.||+.||.|||+++ +|||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 999999999999999643 34889999999999999999999999 99999999999999999
Q ss_pred CEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHh
Q 018614 186 NLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 263 (353)
Q Consensus 186 ~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 263 (353)
.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+....++...+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999999999876543322 2334568899999999999999999999999999999998 8999999888787777766
Q ss_pred cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+..++. +..+|+++.+|+.+||+.||++|||+.+|+++|+.+
T Consensus 263 ~~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 263 RQVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 655543 456889999999999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=414.01 Aligned_cols=246 Identities=22% Similarity=0.387 Sum_probs=215.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..|+..++||+|+||.||. +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 3599999999999999984 58999999997543322 246789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|||+||+|.+++... .+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 228 Ey~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 228 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp ECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred eCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 999999999999754 5999999999999999999999999 99999999999999999999999999987754332
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+....+.....+.+. ....+++++++||
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~-~~~~~s~~~~dli 381 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK-NLHKVSPSLKGFL 381 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-CTTSSCHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCc-ccccCCHHHHHHH
Confidence 223456899999999999999999999999999999999999999887776776666555433332 3456889999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+||..||++|||+.|+++|
T Consensus 382 ~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-55 Score=394.53 Aligned_cols=246 Identities=26% Similarity=0.496 Sum_probs=204.4
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe----cCceEE
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMI 122 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~i 122 (353)
|+..++||+|+||.||. +|..||+|++..... .....+.+.+|+.++++++|||||++++++.+ +..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 35667899999999984 478999999976544 34556789999999999999999999999865 345899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-CCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~ 201 (353)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+++. +|+||||||+|||++. +|.+||+|||+|+....
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 99999999999999988889999999999999999999999863 3999999999999984 78999999999986432
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.......||+.|+|||++.+ .++.++|||||||++|||+||+.||.+................+. ..+..++++++
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~ 260 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-SFDKVAIPEVK 260 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-GGGGCCCHHHH
T ss_pred --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC-CCCccCCHHHH
Confidence 22334679999999999865 699999999999999999999999986654433333323222221 22345678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+||.+||+.||++|||++++++|
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=404.51 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=205.1
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
+|+..+.||+|+||.||. .++.||||+++.......+ ...+.+|+.++++++||||+++++++.+++.+|+
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 699999999999999983 3678999998764332211 2357789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||||+||+|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999999888999999999999999999999999 9999999999999999999999999998754332
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+..... .+ +..+|+++++
T Consensus 181 ~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~---p~~~s~~~~~ 255 (304)
T 3ubd_A 181 K-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GM---PQFLSPEAQS 255 (304)
T ss_dssp C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CC---CTTSCHHHHH
T ss_pred c-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CC---CCcCCHHHHH
Confidence 2 22345689999999999999999999999999999999999999998877777766655432 22 3457899999
Q ss_pred HHHHHcccCCCCCCCH-----HHHHHH
Q 018614 283 LIEECWNEKPAKRPTF-----RQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~-----~~ll~~ 304 (353)
||.+||+.||++|||+ +++++|
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 9999999999999985 677765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=401.58 Aligned_cols=260 Identities=27% Similarity=0.481 Sum_probs=217.6
Q ss_pred CcccCccCcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-Ccccce
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 110 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~ 110 (353)
.|+|+.+ +|+..+.||+|+||.||.. ++.||||.+.... .....+.+.+|+.+++++.| ||||++
T Consensus 58 ~wEi~~~--~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCGG--GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecHH--HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3666543 5888899999999999842 3579999997643 34556789999999999975 899999
Q ss_pred eeEEEec-CceEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecC
Q 018614 111 LGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173 (353)
Q Consensus 111 ~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~d 173 (353)
+|+|.+. ..++||||||++|+|.+++... ..+++..++.++.||+.||.|||+++ +||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 5689999999999999999753 23789999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 018614 174 LEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 251 (353)
Q Consensus 174 lkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~ 251 (353)
|||+|||+++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876543332 2234557899999999999999999999999999999998 9999998
Q ss_pred CCCCchHH-HHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 252 KHDNEVPK-AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 252 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
....+... .+..+..+.. +..+++++.+||.+||+.||++|||+.+|+++|+++..+
T Consensus 291 ~~~~~~~~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 77655443 4434444433 345789999999999999999999999999999998654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=380.91 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=190.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC-------
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 118 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------- 118 (353)
+|+..+.||+|+||.||. +|+.||||++.... .....+.+.+|+.++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 588899999999999984 48899999986543 4555677899999999999999999999987654
Q ss_pred -----ceEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEe
Q 018614 119 -----PMMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190 (353)
Q Consensus 119 -----~~~iv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~ 190 (353)
.+|+|||||++|+|.+++..... .++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 36999999999999999987654 455678899999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCC-----------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHH
Q 018614 191 DFGVSKLLTVKEDR-----------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 259 (353)
Q Consensus 191 Dfg~a~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 259 (353)
|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++ ||.... +...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 99999887543221 1123468999999999999999999999999999999996 775321 1122
Q ss_pred HHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 260 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+.......+++.....++.+.+||.+||+.||++|||+.++++|
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 222222223333345566778899999999999999999999885
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=376.99 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=196.0
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC----ceEEE
Q 018614 51 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~iv 123 (353)
+|...++||+|+||.|| ++|+.||||++.... ........|+..+.+++||||+++++++.+++ .+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 47778999999999988 579999999986542 21122334666677889999999999998654 47999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-----PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~-----~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
|||+++|+|.+++... .+++..+++++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999999765 5899999999999999999999871 112999999999999999999999999999876
Q ss_pred ccCCCC---CcccCCCCCcccCccccCCC------CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--------------
Q 018614 199 TVKEDR---PLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------------- 255 (353)
Q Consensus 199 ~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~-------------- 255 (353)
...... ......||+.|+|||++.+. .++.++|||||||++|||+||.+||......
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543322 12234689999999998764 3677999999999999999998766432211
Q ss_pred -chHHHHHhcC-CCCCCCc--hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 256 -EVPKAYAARQ-RPPFKAP--AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 256 -~~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.....+.... ++.++.. ....+..+.+|+.+||+.||++|||+.++++.|+++..
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1112222222 2333221 12356789999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=386.33 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=206.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe------cCc
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SSP 119 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~ 119 (353)
+|+..+.||+|+||.||. +|+.||||+++... ......+.+.+|+.+|++++||||+++++++.. .+.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 699999999999999984 58999999997653 234555678899999999999999999998754 367
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
+||||||| +|+|.+++...+.+++..+..++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~-~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECC-SEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 89999999 4689999988888999999999999999999999999 9999999999999999999999999998764
Q ss_pred cCC---CCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCC------
Q 018614 200 VKE---DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF------ 269 (353)
Q Consensus 200 ~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------ 269 (353)
... ........||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+..+....+......+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 332 2223456799999999998875 568999999999999999999999988776665555533221110
Q ss_pred ----------------CC-----chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 270 ----------------KA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 270 ----------------~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.. ....+++++.+||.+||..||++|||++++|+|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 012357889999999999999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=393.61 Aligned_cols=246 Identities=22% Similarity=0.377 Sum_probs=215.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.|+. +|+.||||++... .....+.+.+|+.+|+.++||||++++++|.+...+|||||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 799999999999999984 5899999998654 34445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC--CCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~--~~vkl~Dfg~a~~~~~~~ 202 (353)
||+||+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999964 456999999999999999999999999 9999999999999854 89999999999887533
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............+++++++
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2233456899999999999999999999999999999999999999988777777776555433333344668899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||..||++|||+.++++|
T Consensus 390 li~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=395.67 Aligned_cols=246 Identities=22% Similarity=0.359 Sum_probs=204.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 121 (353)
.+|+..+.||+|+||.||. +|+.||||++.+..+. ..........++.+++.++||||++++++|.+...+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 4799999999999999984 5899999998654321 2222233344567778889999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999999999999889999999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHH--hcCCCCCCCchhhhHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA--ARQRPPFKAPAKLYAR 278 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 278 (353)
. .....||+.|+|||++.+ ..|+.++|||||||++|||++|++||............. ......+ +..+++
T Consensus 346 ~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~---p~~~S~ 419 (689)
T 3v5w_A 346 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---PDSFSP 419 (689)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC---CTTSCH
T ss_pred C---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC---CccCCH
Confidence 2 233569999999999964 579999999999999999999999997655443322221 1222222 346889
Q ss_pred HHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPT-----FRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps-----~~~ll~~ 304 (353)
++++||.+||..||++|++ ++++++|
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 9999999999999999998 7888877
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=367.61 Aligned_cols=244 Identities=20% Similarity=0.286 Sum_probs=194.7
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCce
Q 018614 50 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 120 (353)
.+|+..+.||+|+||.||. .++.||||.+.... . ...+.+|+++++.+ +||||+++++++.+.+.+
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4699999999999999983 25789999886542 1 23577899999998 699999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC-CCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~-~~vkl~Dfg~a~~~~ 199 (353)
|+||||++|++|.++++ .+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999999984 4899999999999999999999999 9999999999999876 799999999998654
Q ss_pred cCCC---------------------------CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 018614 200 VKED---------------------------RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTM 251 (353)
Q Consensus 200 ~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~ 251 (353)
.... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 3211 111234689999999999775 589999999999999999999999965
Q ss_pred CCCC-chHHHHHh-----------------------------------cC-----CCC----------CCCchhhhHHHH
Q 018614 252 KHDN-EVPKAYAA-----------------------------------RQ-----RPP----------FKAPAKLYARGL 280 (353)
Q Consensus 252 ~~~~-~~~~~~~~-----------------------------------~~-----~~~----------~~~~~~~~~~~l 280 (353)
...+ +....+.. .. .+. .......+++++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 4432 11111110 00 000 001123467889
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+||.+||..||++|||++|+++|
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHCcCChhHCcCHHHHhcC
Confidence 999999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=353.19 Aligned_cols=257 Identities=28% Similarity=0.524 Sum_probs=220.9
Q ss_pred CcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 115 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 115 (353)
..+|+..+.||+|+||.||. .+..||||++.... .......+.+|+.+++++ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 34789999999999999983 23579999997652 455667899999999999 8999999999999
Q ss_pred ecCceEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCE
Q 018614 116 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179 (353)
Q Consensus 116 ~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Ni 179 (353)
+.+..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence 9999999999999999999998643 3788999999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCch
Q 018614 180 LRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 257 (353)
Q Consensus 180 ll~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 257 (353)
|++.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999987654322 22233456788999999999999999999999999999999 9999998887777
Q ss_pred HHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 258 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
...+........ +..++.++.+||.+||+.||++||++.+++++|+++.....
T Consensus 315 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 315 FKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 766655544433 34578899999999999999999999999999999876544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=351.31 Aligned_cols=247 Identities=27% Similarity=0.456 Sum_probs=215.4
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
...+|+..+.||+|+||.|+. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 345799999999999999983 688999999976543 44556778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 9999999999999988888999999999999999999999999 999999999999999999999999999876433
Q ss_pred CCCcccCCCCCcccCccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+....... +..+++++.
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~ 242 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI----PFYMSTDCE 242 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHH
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----CCCCCHHHH
Confidence 223345689999999999888775 79999999999999999999999877666666665543221 234678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+|+.+||..||.+|||++++++|
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999987
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=346.39 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=215.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. .|..||+|.+........+..+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 34799999999999999983 4789999998766556677778899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999999998888999999999999999999999999 99999999999999999999999999987654433
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCC-CCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF-KAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 282 (353)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.................+.. ......+++.+.+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 333445689999999999999999999999999999999999999987665444433333332221 1112457889999
Q ss_pred HHHHHcccCCCCCC-CHHHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRP-TFRQIITRLESINN 310 (353)
Q Consensus 283 li~~cl~~dp~~Rp-s~~~ll~~l~~~~~ 310 (353)
+|.+||+.||++|| +++++.+.|+.+..
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 99999999999998 89999999887643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=342.83 Aligned_cols=248 Identities=22% Similarity=0.437 Sum_probs=213.9
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
...+|+..+.||+|+||.||. +|+.||||++....... .+.+.+|+.++++++||||+++++++...+..++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 345799999999999999984 47899999987654333 2467899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||||+++++|.+++... .+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999999999765 5999999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.....+.... +..++..+.+
T Consensus 171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 248 (297)
T 3fxz_A 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSAIFRD 248 (297)
T ss_dssp CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSC-GGGSCHHHHH
T ss_pred cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC-ccccCHHHHH
Confidence 22 234568899999999999999999999999999999999999998776555555554444443333 4568899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||+.||++|||+.++++|
T Consensus 249 li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHccCChhHCcCHHHHhhC
Confidence 9999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=343.24 Aligned_cols=258 Identities=36% Similarity=0.608 Sum_probs=210.3
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 49 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
..+|+..+.||+|+||.|| ..|..||||++..... ..+..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 4478999999999999987 4689999999876543 45566788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|+++++|.+++...+. +++..++.++.|++.||.|||+.|. +++||||||+||+++.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999986543 8999999999999999999999862 39999999999999999999999999997654322
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+....... ..+..+++++.+
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 270 (309)
T 3p86_A 194 -LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--EIPRNLNPQVAA 270 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--CCCTTSCHHHHH
T ss_pred -cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCccCCHHHHH
Confidence 12234568899999999999999999999999999999999999998876655554443222211 123567889999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
||.+||+.||++|||+.++++.|+.+...
T Consensus 271 li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=347.65 Aligned_cols=247 Identities=16% Similarity=0.295 Sum_probs=212.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|..||+|.+... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 4799999999999999984 4889999998643 233456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC--CCCEEEeecccccccccC
Q 018614 125 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~--~~~vkl~Dfg~a~~~~~~ 201 (353)
||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++||||||+|||++. ++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999997654 6999999999999999999999999 999999999999997 789999999999876532
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
. ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+..............++.++.
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 2 22335578899999999998899999999999999999999999988776666666655443332222346788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+||.+||..||++|||+.++++|-
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHcCCChhHCcCHHHHhcCh
Confidence 999999999999999999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=351.93 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=213.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
..+|+..+.||+|+||.||. +|..||+|++........ ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 45799999999999999984 488999999876543211 1235688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC----CEEEeeccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSK 196 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~----~vkl~Dfg~a~ 196 (353)
++||||++|++|.+++...+.+++..++.++.||+.||.|||+.| ++||||||+|||+++++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 999999999999999988888999999999999999999999999 99999999999999877 79999999998
Q ss_pred ccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 197 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+..............+
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred EcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence 765432 223456899999999999999999999999999999999999999887666666665444322221223467
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++++++||.+||..||++|||+.++++|
T Consensus 246 s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 246 SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 8899999999999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=351.11 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=212.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.|+. +|+.||+|++........+....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 3688999999999999984 58899999987543222223456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||++||+|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||+++...... .
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC-C
Confidence 99999999999998888999999999999999999999999 9999999999999999999999999998643222 2
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+..... .+ +..+++++.+||
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~---p~~~s~~~~~li 236 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RF---PRTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CC---CTTSCHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC---CCCCCHHHHHHH
Confidence 22345578999999999999999999999999999999999999988766666555544332 22 345788999999
Q ss_pred HHHcccCCCCCC-----CHHHHHHH
Q 018614 285 EECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
.+||+.||++|| +++++++|
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999999 89999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.62 Aligned_cols=250 Identities=19% Similarity=0.323 Sum_probs=216.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|..||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4689999999999999984 588999999876543 3344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc---CCCCEEEeecccccccccC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~---~~~~vkl~Dfg~a~~~~~~ 201 (353)
||++||+|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++ .++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999999998888999999999999999999999999 99999999999998 4678999999999876543
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+..............+++++.
T Consensus 167 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 167 QQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245 (444)
T ss_dssp CC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred Cc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 22 22345689999999999999999999999999999999999999988777777777665554433334456889999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+||.+||+.||++|||+.++++|
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=344.67 Aligned_cols=257 Identities=29% Similarity=0.491 Sum_probs=218.0
Q ss_pred CcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 49 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
..+|+..+.||+|+||.||. .+..||||++.... .....+.+.+|+.++++++||||+++++++.+....
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 45799999999999999983 24469999997542 355567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++||||+++++|.+++... +.+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999754 46999999999999999999999999 9999999999999999999999999998775
Q ss_pred cCCCCCc--ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 200 VKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 200 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
....... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+......+. +..+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 279 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA---PMGC 279 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC---CCCc
Confidence 4332221 22345678999999998899999999999999999999 9999988877777666655544332 3467
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
++++.+||..||..||++|||+.++++.|+.+.....
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 8899999999999999999999999999999976544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=336.66 Aligned_cols=256 Identities=30% Similarity=0.581 Sum_probs=218.2
Q ss_pred cccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 43 YEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 43 ~~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
|.++. .+|+..+.||+|+||.||. ++..||+|++....... +.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~i~~--~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 5 WVIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp CBCCG--GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred EEeCh--hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 55443 3688899999999999884 67889999997654322 46889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccc
Confidence 999999999999999999764 45899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
.............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+....... .+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 232 (269)
T 4hcu_A 156 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLA 232 (269)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTS
T ss_pred ccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC---CCCcC
Confidence 65433223334456778999999998899999999999999999999 999998877666666665543332 23456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
++++.+++.+||+.||++||++.+++++|+++..
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 8889999999999999999999999999999865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=349.07 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=216.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|..||+|++..... .....+.+.+|+.++++++||||+++++++.+....|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3699999999999999984 488999999976543 3455677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC---CEEEeecccccccccC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVK 201 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~---~vkl~Dfg~a~~~~~~ 201 (353)
||+++++|.+++.....+++..++.++.||+.||.|||++| ++||||||+|||++.++ .+||+|||++......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999999999988778999999999999999999999999 99999999999998654 5999999999876533
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..............+++++.
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 185 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp C--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred c--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 2 22345689999999999999999999999999999999999999988776666666655543333334456889999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+||.+||..||++||++.++++|
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=337.96 Aligned_cols=259 Identities=27% Similarity=0.514 Sum_probs=217.0
Q ss_pred CCcccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 116 (353)
..|++. ..+|+..+.||+|+||.||. ++..||+|++....... +.+.+|+.++++++||||+++++++.+
T Consensus 17 ~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 17 GSWEID--PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CTTBCC--GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCccCC--HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 356554 34689999999999999883 45689999997654322 467899999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccc
Confidence 9999999999999999999986 456999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchh
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
...............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+........ +.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 244 (283)
T 3gen_A 168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PH 244 (283)
T ss_dssp GGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CT
T ss_pred ccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CC
Confidence 8764433222333456778999999998899999999999999999998 9999988777666666655443332 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
.+++.+.+|+.+||+.||++|||+.+++++|+++...
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 5678899999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=335.46 Aligned_cols=253 Identities=30% Similarity=0.551 Sum_probs=215.9
Q ss_pred cCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 48 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
...+|+..+.||+|+||.||. ++..||+|++....... ..+.+|+.++++++||||+++++++.+....++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 355799999999999999883 45689999997654322 4678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999998754 4999999999999999999999999 9999999999999999999999999998765443
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+........ +..+++++.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 235 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---PHLASDTIY 235 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTSCHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC---CCcChHHHH
Confidence 333334456678999999998889999999999999999999 9999988776666555544443322 344678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
+++.+||+.||++|||+.+++++|+.+..
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 99999999999999999999999998843
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=353.10 Aligned_cols=260 Identities=30% Similarity=0.522 Sum_probs=219.3
Q ss_pred CcccCccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 116 (353)
.|.+.. .+|+..+.||+|+||.||. +|+.||||++.... ..+....+.+|+.++++++||||+++++++.+
T Consensus 108 ~~~~~~--~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 108 KWVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp TTBCCG--GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccEEch--HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 455443 3688899999999999983 58899999987542 34555678899999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
.+..++||||+++++|.+++...+ .+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 999999999999999999998654 5999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCc-ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCch
Q 018614 196 KLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 273 (353)
Q Consensus 196 ~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 273 (353)
+.......... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+......+. +
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 337 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC---P 337 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC---C
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 86543211111 11224567999999998889999999999999999998 9999998877666666655544443 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
..+++++.+||.+||+.||++|||+.++++.|+++.+.
T Consensus 338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 45788999999999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=352.86 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=209.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||||++.............+.+|..+++.+ +||||+++++++.+....|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 4799999999999999983 4789999998764333333446678899999988 799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||++||+|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||+++......
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 999999999999998888999999999999999999999999 9999999999999999999999999998643222
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...... + +..+++++.+|
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~---p~~~~~~~~~l 254 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-Y---PTWLHEDATGI 254 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-C---CTTSCHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-C---CCCCCHHHHHH
Confidence 2223456899999999999989999999999999999999999999988777777666554422 2 23477889999
Q ss_pred HHHHcccCCCCCCCH------HHHHHH
Q 018614 284 IEECWNEKPAKRPTF------RQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~------~~ll~~ 304 (353)
|++||..||++||++ +++++|
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 999999999999999 888876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=335.12 Aligned_cols=254 Identities=24% Similarity=0.467 Sum_probs=206.6
Q ss_pred CcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 49 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
..+|+..+.||+|+||.||. .+..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 45799999999999999873 2457999998754 24556678999999999999999999999985 4678
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999998654 5899999999999999999999999 9999999999999999999999999998775
Q ss_pred cCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
...........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......+. +..+++
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~~ 244 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PPNCPP 244 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTTCCH
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC---CCCCCH
Confidence 443333333456778999999998899999999999999999997 9999998877777776655544333 346788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
++.+++.+||..||++|||+.+++++|+++...
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999998664
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=339.98 Aligned_cols=255 Identities=30% Similarity=0.489 Sum_probs=213.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|..||+|.+... +.+..+.+.+|+.++++++||||+++++++.++...++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 34688999999999999984 4889999988543 456677899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999987 456999999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCC-------------cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch-----HHHHHhc
Q 018614 203 DRP-------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-----PKAYAAR 264 (353)
Q Consensus 203 ~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~ 264 (353)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........ .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 211 1134688999999999999999999999999999999999999876443221 1111111
Q ss_pred CCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhc
Q 018614 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 315 (353)
Q Consensus 265 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~ 315 (353)
.. +..+++++.+|+.+||+.||++|||+.++++.|+.+...+...
T Consensus 243 ~~------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 243 YC------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp TC------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred cC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence 11 2345677999999999999999999999999999998776643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=346.43 Aligned_cols=265 Identities=28% Similarity=0.528 Sum_probs=224.1
Q ss_pred CCcccCccCcCcccceeeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcc
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV 107 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 107 (353)
+.|++. ..+|+..+.||+|+||.||.. +..||||++.... .......+.+|+.+++++ +||||
T Consensus 62 ~~~~i~--~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnI 137 (382)
T 3tt0_A 62 PRWELP--RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNI 137 (382)
T ss_dssp TTTBCC--GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccccc--hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchh
Confidence 344443 347999999999999999842 2579999987652 455667889999999999 89999
Q ss_pred cceeeEEEecCceEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEe
Q 018614 108 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 171 (353)
Q Consensus 108 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH 171 (353)
+++++++.+.+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++|
T Consensus 138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 214 (382)
T 3tt0_A 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 214 (382)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred hhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 999999999999999999999999999998753 4899999999999999999999999 999
Q ss_pred cCCCCCCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 018614 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 249 (353)
Q Consensus 172 ~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf 249 (353)
|||||+|||++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654322 22233456778999999999999999999999999999999 99999
Q ss_pred CCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhc
Q 018614 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 315 (353)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~ 315 (353)
......+....+........ +..+++++.+||.+||+.||++|||+.+++++|+++.......
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 295 PGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp TTCCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred CCCCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 98877666666655544333 3457889999999999999999999999999999997665433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=352.85 Aligned_cols=247 Identities=30% Similarity=0.554 Sum_probs=214.0
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC-ceEEEEe
Q 018614 50 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-PMMIVTE 125 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~iv~e 125 (353)
.+|+..+.||+|+||.|| ..|+.||||+++... ..+.+.+|+.++++++||||+++++++.... ..++|||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 368888999999999987 468999999997643 2357889999999999999999999987665 7899999
Q ss_pred cCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+++|+|.+++...+. +++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 9999999999987554 799999999999999999999999 9999999999999999999999999998643221
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+..+..... +..+++++.+
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~ 417 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDGCPPAVYD 417 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC---CTTCCHHHHH
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHH
Confidence 12346788999999999999999999999999999998 9999999888888777766554433 3567899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
||.+||..||++|||+.++++.|+++...
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=342.18 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=211.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCcccceeeEEEecCceE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 121 (353)
.+|+..+.||+|+||.||. +|..||+|++........ ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4699999999999999984 488999999876432211 12356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC----CEEEeecccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL 197 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~----~vkl~Dfg~a~~ 197 (353)
+||||+++++|.+++.....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999999999988778999999999999999999999999 99999999999999887 799999999987
Q ss_pred cccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......+....+..............++
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 65332 2233568899999999999999999999999999999999999998766555555554433222212234578
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..+.+||.+||..||++|||+.++++|
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 889999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=337.49 Aligned_cols=260 Identities=28% Similarity=0.515 Sum_probs=221.5
Q ss_pred CCcccCccCcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccce
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF 110 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 110 (353)
+.|++. ..+|...+.||+|+||.||.. +..||||++.... .....+.+.+|+.++++++||||+++
T Consensus 16 ~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~ 91 (314)
T 2ivs_A 16 PKWEFP--RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKL 91 (314)
T ss_dssp TTTBCC--GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccccc--hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeE
Confidence 445443 457999999999999998742 3789999997542 45666789999999999999999999
Q ss_pred eeEEEecCceEEEEecCCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCC
Q 018614 111 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA------------------------LKPSTAVRFALDIARGMNYLHENKP 166 (353)
Q Consensus 111 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~al~~Lh~~~~ 166 (353)
++++.+.+..++||||+++++|.+++..... +++..++.++.||+.||.|||+++
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~- 170 (314)
T 2ivs_A 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK- 170 (314)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 9999999999999999999999999986533 789999999999999999999999
Q ss_pred CCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-
Q 018614 167 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 244 (353)
Q Consensus 167 ~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt- 244 (353)
++||||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 171 --ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp --EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred --CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999876443221 1223446778999999998889999999999999999999
Q ss_pred CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 245 GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 245 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
|..||...........+........ +..+++++.+|+.+||+.||++||++.+++++|+++..
T Consensus 249 g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLLKTGHRMER---PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHhhcCCcCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999998887777766655443332 34678899999999999999999999999999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=343.46 Aligned_cols=244 Identities=24% Similarity=0.454 Sum_probs=211.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||+|++...........+.+.+|..+++.++||||+++++++.+....|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 3689999999999999984 58899999987543222223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||++|++|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999875432
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..... .+ +..++.++.+||
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~---p~~~~~~~~~li 234 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RF---PPFFNEDVKDLL 234 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CC---CTTSCHHHHHHH
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC---CCCCCHHHHHHH
Confidence 2234588999999999999999999999999999999999999988766666555544432 22 245788999999
Q ss_pred HHHcccCCCCCC-----CHHHHHHH
Q 018614 285 EECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
.+||..||++|| +++++++|
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcC
Confidence 999999999999 89999976
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=342.22 Aligned_cols=247 Identities=24% Similarity=0.407 Sum_probs=209.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||+|++........+....+.+|..+++++ +||||+++++++.+....|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 3689999999999999984 4889999999877666777778889999999988 899999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++++|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 999999999999998888999999999999999999999999 9999999999999999999999999998643222
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------chHHHHHhcCCCCCCCchh
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------EVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~---------~~~~~~~~~~~~~~~~~~~ 274 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.. ....+ +.
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~---p~ 240 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRI---PR 240 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CCCCC---CT
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CCCCC---CC
Confidence 2233456899999999999999999999999999999999999999753211 12222222 22222 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCH------HHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTF------RQIITR 304 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~ 304 (353)
.++.++.+||.+||+.||++||++ .++++|
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 578899999999999999999996 677765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=349.81 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=211.1
Q ss_pred ccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCce
Q 018614 47 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 120 (353)
....+|+..+.||+|+||.||. +|+.||||++........+....+..|..++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3445799999999999999883 4889999998764321122335677899999877 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... +.+ +..+++++
T Consensus 171 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~s~~~ 245 (345)
T 1xjd_A 171 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFY---PRWLEKEA 245 (345)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CTTSCHHH
T ss_pred CCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCC---CcccCHHH
Confidence 222 2334568999999999999999999999999999999999999998877666666664433 222 34578899
Q ss_pred HHHHHHHcccCCCCCCCHH-HHHHH
Q 018614 281 KELIEECWNEKPAKRPTFR-QIITR 304 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~-~ll~~ 304 (353)
.+||.+||..||++||++. ++++|
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcC
Confidence 9999999999999999998 77755
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=349.07 Aligned_cols=247 Identities=23% Similarity=0.415 Sum_probs=205.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.|+. +|+.||+|+++.......+....+.+|..++.++ +||||+++++++.+...+|+|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 4799999999999999984 4789999999876655555556788899999887 899999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++......
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 207 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 207 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence 999999999999998888999999999999999999999999 9999999999999999999999999998643222
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--------c-hHHHHHhcCCCCCCCchh
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--------E-VPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~--------~-~~~~~~~~~~~~~~~~~~ 274 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... . ....+ ......+ +.
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~---p~ 283 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRI---PR 283 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH-HHCCCCC---CT
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH-hccccCC---CC
Confidence 2233456899999999999999999999999999999999999999643221 1 22222 2222222 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCH------HHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTF------RQIITR 304 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~ 304 (353)
.++.++.+||.+||+.||++||++ .++++|
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 578899999999999999999995 677765
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=343.53 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=206.6
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc----
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 119 (353)
..+|+..+.||+|+||.||. +|+.||||++........+....+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 34799999999999999983 578999999987766667777889999999999999999999999876654
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
.|+||||+++++|.+++...+.+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 3999999999999999998888999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 200 VKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 200 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+...........+.......++
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 43221 1223457899999999999999999999999999999999999998776555544444443322212224578
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.++.+||.+||+.||++||++.+++.+
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 899999999999999999977776654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=347.19 Aligned_cols=245 Identities=24% Similarity=0.396 Sum_probs=212.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++.............+.+|+.+++.++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4799999999999999883 58899999986543222223456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||++|++|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999876432
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..... .+ +..++.++.+||
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~---p~~~~~~~~~li 269 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RF---PSHFSSDLKDLL 269 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CC---CTTCCHHHHHHH
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-CC---CCCCCHHHHHHH
Confidence 2234578999999999999999999999999999999999999988766666666655432 22 345788999999
Q ss_pred HHHcccCCCCCCC-----HHHHHHHH
Q 018614 285 EECWNEKPAKRPT-----FRQIITRL 305 (353)
Q Consensus 285 ~~cl~~dp~~Rps-----~~~ll~~l 305 (353)
.+||+.||++||+ ++++++|-
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCc
Confidence 9999999999998 89998763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=333.30 Aligned_cols=262 Identities=25% Similarity=0.399 Sum_probs=218.1
Q ss_pred ccCcCcccce-eeecceEEEEEEc-------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 47 PHELDFTNSV-EITKGTFILAFWR-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 47 ~~~~~~~~~~-~ig~G~~~~v~~~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
....+|+..+ .||+|+||.||.. +..||||++..... .....+.+.+|+.+++.++||||+++++++ ...
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 3345788877 9999999999842 57899999976532 334457789999999999999999999999 567
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..++||||+++++|.+++.....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 88999999999999999998888999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhh
Q 018614 199 TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 275 (353)
Q Consensus 199 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (353)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.....+.. +..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 244 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAG 244 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTT
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCC
Confidence 543221 1122345678999999988889999999999999999999 9999998776666666555444333 346
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 018614 276 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 316 (353)
Q Consensus 276 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 316 (353)
+++++.++|.+||+.||++||++.++++.|+++........
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 78899999999999999999999999999999987765443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=345.58 Aligned_cols=247 Identities=27% Similarity=0.407 Sum_probs=210.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||||++.............+..|..++..+ +||+|+++++++.+....|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 4799999999999999984 4678999998764322223345678899999988 799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||++||+|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||+++......
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 999999999999998888999999999999999999999999 9999999999999999999999999998643222
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..... .+ +..+++++.+|
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~---p~~~s~~~~~l 251 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AY---PKSMSKEAVAI 251 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CC---CTTSCHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CC---CCCCCHHHHHH
Confidence 223345689999999999999999999999999999999999999988776666666655432 22 24578899999
Q ss_pred HHHHcccCCCCCCC-----HHHHHHH
Q 018614 284 IEECWNEKPAKRPT-----FRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps-----~~~ll~~ 304 (353)
|.+||..||++||+ ++++++|
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999995 5888876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=338.24 Aligned_cols=263 Identities=20% Similarity=0.268 Sum_probs=208.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
-.+|+..+.||+|+||.||. +|+.||+|++......+....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 35799999999999999883 5789999999876555566667899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++++|.+++...+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999999999998888999999999999999999999999 99999999999999999999999999987654433
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ....+........++.++.++
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHHHHHH
Confidence 3333456888999999999999999999999999999999999999876543332222 222222222345678889999
Q ss_pred HHHHcccCCCCCC-CHHHHHHHHHHHHHHhhhc
Q 018614 284 IEECWNEKPAKRP-TFRQIITRLESINNSINHK 315 (353)
Q Consensus 284 i~~cl~~dp~~Rp-s~~~ll~~l~~~~~~~~~~ 315 (353)
|.+||+.||++|| +++++++.|+++.......
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred HHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 9999999999999 9999999999876554433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=341.68 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=218.0
Q ss_pred ccCcCcccceeeecceEEEEEE---c-------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe
Q 018614 47 PHELDFTNSVEITKGTFILAFW---R-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~---~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 116 (353)
....+|+..+.||+|+||.||. . +..||||++.... ..+....+.+|+.++++++||||+++++++.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3345799999999999999883 2 2789999997643 45566789999999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEec
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHR 172 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~ 172 (353)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ ++||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 99999999999999999999863 45899999999999999999999999 9999
Q ss_pred CCCCCCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 018614 173 DLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 250 (353)
Q Consensus 173 dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~ 250 (353)
||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643322 12233456788999999998899999999999999999999 999998
Q ss_pred CCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 251 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
.....+....+........ +..++.++.+|+.+||+.||++||++.+++++|+++....
T Consensus 279 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 8776666666655443332 3467889999999999999999999999999999986543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.62 Aligned_cols=264 Identities=25% Similarity=0.418 Sum_probs=220.5
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 49 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
..+|+..+.||+|+||.||. .+..||||.+.... .......+.+|+.++++++||||+++++++.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 45799999999999999883 36789999987542 3455567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEE
Q 018614 119 PMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vk 188 (353)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++| ++||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 999999999999999999752 34689999999999999999999999 99999999999999999999
Q ss_pred EeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCC
Q 018614 189 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 189 l~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 266 (353)
|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 9999999866433221 1223345778999999998899999999999999999999 8999988776666665554443
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhccccce
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKI 320 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~ 320 (353)
.. .+..++.++.+||.+||..||++|||+.+++++|+++.....+...+.+
T Consensus 259 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~ 309 (322)
T 1p4o_A 259 LD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 309 (322)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTT
T ss_pred CC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccccc
Confidence 33 2356788999999999999999999999999999988665544444444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=337.14 Aligned_cols=265 Identities=28% Similarity=0.523 Sum_probs=221.7
Q ss_pred CCCcccCccCcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCc
Q 018614 40 VPEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN 106 (353)
Q Consensus 40 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 106 (353)
.+.|++. ..+|+..+.||+|+||.||. ++..||||++.... .......+.+|+.+++++ +|||
T Consensus 27 ~~~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 27 DPKWEFP--RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp CTTTBCC--GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CccccCC--HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCC
Confidence 3455543 45799999999999999883 35689999997643 455667889999999999 8999
Q ss_pred ccceeeEEEecCceEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEE
Q 018614 107 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPII 170 (353)
Q Consensus 107 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~ii 170 (353)
|+++++++.+.+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 179 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CI 179 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999999999999998643 3889999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCC
Q 018614 171 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 248 (353)
Q Consensus 171 H~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 248 (353)
||||||+||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 180 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999876543221 1223446778999999988889999999999999999999 9999
Q ss_pred CCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhh
Q 018614 249 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314 (353)
Q Consensus 249 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~ 314 (353)
|......+....+........ +..++.++.+++.+||..||++||++.+++++|+++......
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 260 YPGIPVEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp STTCCHHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cCcCCHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 988776666665555443332 345788999999999999999999999999999999775543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=338.05 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=206.6
Q ss_pred CccCcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc---
Q 018614 46 DPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--- 119 (353)
Q Consensus 46 ~~~~~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 119 (353)
.....+|+..+.||+|+||.|| ..|+.||||++... .........|+.++++++||||+++++++.+...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 3445689999999999999887 46899999998654 2233455679999999999999999999987554
Q ss_pred -eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCEEecCCCCCCEEEcCCCCEE
Q 018614 120 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN----------KPVPIIHRDLEPSNILRDDSGNLK 188 (353)
Q Consensus 120 -~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~----------~~~~iiH~dlkp~Nill~~~~~vk 188 (353)
+++||||+++|+|.+++... .+++..++.++.|++.||.|||+. + ++||||||+|||++.++.+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 69999999999999999765 499999999999999999999998 8 99999999999999999999
Q ss_pred EeecccccccccCCCC-CcccCCCCCcccCccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch-----
Q 018614 189 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV----- 257 (353)
Q Consensus 189 l~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~----- 257 (353)
|+|||+++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999876543322 22335689999999999873 455688999999999999999999976543211
Q ss_pred -----------HHHHHhcC-CCCCCC--chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 258 -----------PKAYAARQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 258 -----------~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
...+.... .+.... .....++++.+||.+||+.||++|||+.++++.|+++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 122111 1223567799999999999999999999999999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=327.78 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=216.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|..||+|++..... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 35799999999999999984 478999999876543 345567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC---EEEeeccccccccc
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV 200 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~---vkl~Dfg~a~~~~~ 200 (353)
|||+++++|.+++.....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. ++|+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999988888999999999999999999999999 999999999999986655 99999999977653
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+..............+++++
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 161 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp SC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred Cc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 32 2233568899999999999999999999999999999999999998877666666665554433333345678999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+||.+||+.||++|||+.++++|
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHcccChhhCCCHHHHhcC
Confidence 999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=336.69 Aligned_cols=265 Identities=25% Similarity=0.413 Sum_probs=217.3
Q ss_pred CCCcccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEE
Q 018614 40 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 115 (353)
Q Consensus 40 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 115 (353)
.+..++.....+|+..+.||+|+||.||. +|..||||.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 44555666677999999999999999984 48899999986542 234567889999999999999999999999
Q ss_pred ecCceEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 116 QSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 116 ~~~~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
+.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999986543 4899999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH-------Hh
Q 018614 192 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-------AA 263 (353)
Q Consensus 192 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-------~~ 263 (353)
||++......... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+..... ..
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 9999875433222 223344788999999998889999999999999999999999999765543322111 01
Q ss_pred cCC-----CC-CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 264 RQR-----PP-FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 264 ~~~-----~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
... +. .......++..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 110 11 112245678899999999999999999999999999998865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=343.78 Aligned_cols=257 Identities=28% Similarity=0.500 Sum_probs=207.9
Q ss_pred CcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 49 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
..+|+..+.||+|+||.||. .+..||||.+.... .....+.+.+|+.++++++||||+++++++.+....
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34799999999999999984 35679999997542 455567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999998654 5999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCc--ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 200 VKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 200 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
....... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+......+. +..+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~ 275 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---PMDC 275 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---CTTC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Cccc
Confidence 4322211 22234678999999999999999999999999999998 9999988776666665544433322 3457
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
+.++.+|+.+||+.||++||++.++++.|+++.....
T Consensus 276 ~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp BHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred cHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 8889999999999999999999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=333.82 Aligned_cols=261 Identities=28% Similarity=0.501 Sum_probs=223.4
Q ss_pred CCcccCccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEE
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 115 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 115 (353)
..|++. ..+|+..+.||+|+||.||. .+..||+|.+.... ...+.+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~~~--~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 6 DKWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp CTTBCC--GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hccccc--ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 455543 45799999999999998874 37899999987542 23467889999999999999999999999
Q ss_pred ecCceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 116 QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 116 ~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
+....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCc
Confidence 9999999999999999999998643 4899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCc
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 272 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 233 (288)
T 3kfa_A 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER--- 233 (288)
T ss_dssp GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC---
T ss_pred cceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC---
Confidence 998776444333334456778999999998899999999999999999999 9999998887777766655443332
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
+..+++++.+|+.+||..||++|||+.++++.|+.+.....
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 34578899999999999999999999999999999877544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=328.04 Aligned_cols=256 Identities=30% Similarity=0.578 Sum_probs=217.0
Q ss_pred cccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 43 YEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 43 ~~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
|.++. .+|+..+.||+|+||.||. ++..||+|++...... .+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~i~~--~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 76 (267)
T 3t9t_A 3 WVIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 76 (267)
T ss_dssp CBCCG--GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred eEEch--hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 44443 3688899999999999884 5778999999765432 246889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccc
Confidence 999999999999999999865 45899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
.............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+........ +..+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~ 230 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLA 230 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTS
T ss_pred cccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccC
Confidence 64332222233456778999999998899999999999999999999 9999988776666665554433322 3456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
+.++.+++.+||..||++||++.+++++|+++..
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 7889999999999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=356.07 Aligned_cols=257 Identities=28% Similarity=0.505 Sum_probs=217.0
Q ss_pred CcccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 117 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 117 (353)
.|++. ..+|+..+.||+|+||.||. .+..||||++..... ..+.+.+|+.++++++||||+++++++. .
T Consensus 182 ~~~i~--~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 182 AWEIP--RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp CSBCC--GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred ceeec--hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 34443 33688889999999999984 377899999976432 2357899999999999999999999986 5
Q ss_pred CceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
...++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 6789999999999999999753 25899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchh
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
+..............+++.|+|||++.+..++.++||||||+++|||++ |+.||.+....+....+..+...+. +.
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~ 408 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---PE 408 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---CT
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 8764332222233446778999999998899999999999999999999 9999998877777766665544432 35
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
.+++++.+||.+||..||++|||+++|++.|+++...
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 6788999999999999999999999999999988553
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=345.88 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=216.2
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.+|+..+.||+|+||.||. .+..||||++.... .......+.+|+.++++++||||+++++++.+...
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4688999999999998873 34689999986432 34555678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC---CEEE
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV 189 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~---~vkl 189 (353)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||++| ++||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999998643 4899999999999999999999999 99999999999999555 5999
Q ss_pred eecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCC
Q 018614 190 ADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 267 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 267 (353)
+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986543222 22233456889999999999999999999999999999998 99999988777766666555443
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
.. +..++.++.+|+.+||+.||++||++.+++++|+.+....
T Consensus 306 ~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 306 DP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 32 3457888999999999999999999999999999986644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=329.25 Aligned_cols=254 Identities=31% Similarity=0.534 Sum_probs=201.1
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCC-HHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 49 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISD-DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..+|+..+.||+|+||.|| ..|..||||++....... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 3478999999999999987 468999999987643222 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC--------CCCEEEeeccccc
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--------SGNLKVADFGVSK 196 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~--------~~~vkl~Dfg~a~ 196 (353)
||+++++|.+++.. ..+++..++.++.|++.||.|||+++..+++||||||+||+++. ++.++|+|||++.
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 99999999999854 46999999999999999999999988545889999999999986 6789999999998
Q ss_pred ccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 197 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
....... ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+....... ..+..+
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 239 (271)
T 3dtc_A 165 EWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL--PIPSTC 239 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC--CCCTTC
T ss_pred ccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC--CCCccc
Confidence 6643322 23457889999999999899999999999999999999999998776555544443333221 223567
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
++++.+++.+||+.||++|||+.+++++|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 88999999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=342.51 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=214.2
Q ss_pred CcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 117 (353)
..+|+..+.||+|+||.||.. ++.||||++.... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 457999999999999999842 3789999997542 345567789999999999 789999999999875
Q ss_pred C-ceEEEEecCCCCCHHHHHHhcCC-------------------------------------------------------
Q 018614 118 S-PMMIVTEYLPKGDLRAFLKRKGA------------------------------------------------------- 141 (353)
Q Consensus 118 ~-~~~iv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 141 (353)
+ ..++||||+++|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4 48999999999999999986432
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccC
Q 018614 142 -----------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQ 209 (353)
Q Consensus 142 -----------~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~ 209 (353)
+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++......... .....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 889999999999999999999999 999999999999999999999999999876433221 22334
Q ss_pred CCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHHHHHHHHHHH
Q 018614 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEEC 287 (353)
Q Consensus 210 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 287 (353)
.+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+......... .... +..+++++.+++.+|
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDC 332 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHH
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHH
Confidence 56788999999999999999999999999999998 999998877655544443333 2222 345788999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 288 WNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 288 l~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
|+.||++|||+.+++++|+.+..+.
T Consensus 333 l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccCChhhCCCHHHHHHHHHHHHHHh
Confidence 9999999999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=330.80 Aligned_cols=259 Identities=24% Similarity=0.384 Sum_probs=220.5
Q ss_pred CCCCcccCcc-CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceee
Q 018614 39 EVPEYEIDPH-ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 112 (353)
Q Consensus 39 ~~~~~~i~~~-~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 112 (353)
.+|++.+++. ..+|+..+.||+|+||.||. .++.||+|++...........+.+.+|+.+++.++||||+++++
T Consensus 3 ~~p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 82 (294)
T 2rku_A 3 EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82 (294)
T ss_dssp CCCSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCcceeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence 4556555543 34799999999999999984 47899999997766556677788999999999999999999999
Q ss_pred EEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeec
Q 018614 113 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192 (353)
Q Consensus 113 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Df 192 (353)
++.+.+..++||||+++++|.+++.....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred eeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEec
Confidence 99999999999999999999999988888999999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCc
Q 018614 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 272 (353)
Q Consensus 193 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
|++........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+..... . .
T Consensus 160 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~---~ 234 (294)
T 2rku_A 160 GLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-S---I 234 (294)
T ss_dssp TTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-C---C
T ss_pred cCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC-C---C
Confidence 99987643322 22335578899999999998899999999999999999999999987665444444433321 1 1
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+..++..+.+++.+||..||++|||+.+++++-
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 345778899999999999999999999999873
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.47 Aligned_cols=255 Identities=26% Similarity=0.511 Sum_probs=206.5
Q ss_pred CcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe--c
Q 018614 49 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--S 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 117 (353)
..+|+..+.||+|+||.||. +|+.||||++... ..+..+.+.+|+.++++++||||+++++++.. .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 45799999999999999873 5789999998754 45666789999999999999999999999854 3
Q ss_pred CceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 56899999999999999998754 4999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC----------------chH
Q 018614 197 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN----------------EVP 258 (353)
Q Consensus 197 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~----------------~~~ 258 (353)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76543221 122344667799999999999999999999999999999999998643211 111
Q ss_pred HHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 259 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
..+......+ .+..+++++.+||.+||+.||++|||+.++++.|+++...+
T Consensus 243 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 ELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1122222222 24567899999999999999999999999999999997654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=338.55 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=201.1
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 50 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
.+|+..+.||+|+||.||. +|+.||+|++...... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4699999999999999983 5789999999765332 223345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
|+||||+++++|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++.++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999876433
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+..... .+ +..++.++
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~---p~~~~~~~ 248 (327)
T 3a62_A 174 DGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NL---PPYLTQEA 248 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CC---CTTSCHHH
T ss_pred CCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CC---CCCCCHHH
Confidence 221 22335678999999999999999999999999999999999999987766555555544332 22 24578899
Q ss_pred HHHHHHHcccCCCCCC-----CHHHHHHH
Q 018614 281 KELIEECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
.+||.+||..||++|| ++.++++|
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 9999999999999999 78898886
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=356.47 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=210.5
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
...+|+..+.||+|+||.||. +|+.||+|++.............+.+|+.+++.++||||+++++++.+...+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 345799999999999999983 478999999865321111112347789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||||++||+|.+++.+. .+++..++.++.||+.||.|||+.| ++||||||+|||++.+|.+||+|||+++......
T Consensus 147 V~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 99999999999999764 5999999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCCcccCCCCCcccCccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+.........+....+++
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence 22233456899999999997665 78899999999999999999999988776666666654321111112235788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAK--RPTFRQIITRL 305 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~--Rps~~~ll~~l 305 (353)
++++||.+||..+|.+ ||+++++++|-
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 9999999999999988 99999999883
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=346.88 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=207.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|...+.||+|+||.||. +|+.||||++........+....+.+|+.+++.++||||+++++++.+....++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4799999999999999983 57899999986532211222346889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+ +|+|.+++...+.+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++........
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~- 163 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF- 163 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT-
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc-
Confidence 999 7899999988888999999999999999999999999 99999999999999999999999999987654322
Q ss_pred CcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
.....|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+.. .....+..+++++.+|
T Consensus 164 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 164 -LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS----CVYVMPDFLSPGAQSL 238 (336)
T ss_dssp -TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS----SCCCCCTTSCHHHHHH
T ss_pred -cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----CCCCCcccCCHHHHHH
Confidence 233458899999999988776 6899999999999999999999987655444322211 1112245578899999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
|.+||..||.+|||++++++|-.
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHH
T ss_pred HHHHcCCChhHCcCHHHHHhChh
Confidence 99999999999999999998743
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=346.63 Aligned_cols=249 Identities=23% Similarity=0.418 Sum_probs=207.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||+|++.............+.+|+.+++.++||||+++++++.+....|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4699999999999999883 47889999986543222233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+.||+|.+++.....+++..++.++.||+.||.|||+.| ++||||||+|||++.+|.+||+|||++...... .
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999876432 2
Q ss_pred CcccCCCCCcccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....... ...+..++.++.
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~p~~~s~~~~ 248 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-VTYPSAWSQEMV 248 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-CCCCTTSCHHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-cCCCCcCCHHHH
Confidence 2344568999999999864 458899999999999999999999998665544433332211111 112345788999
Q ss_pred HHHHHHcccCCCCCCC-HHHHHHH
Q 018614 282 ELIEECWNEKPAKRPT-FRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps-~~~ll~~ 304 (353)
+||.+||+.||++||+ ++++++|
T Consensus 249 ~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 249 SLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHHhcCCHhHhcccHHHHHcC
Confidence 9999999999999999 7777654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=356.60 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=203.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++........+....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 4699999999999999983 57899999997654444455567789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||+++++|.+++.....+++..++.++.||+.||.|||+ .| ++||||||+|||++.++.+||+|||+++......
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 999999999999988889999999999999999999998 88 9999999999999999999999999998643322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...... + +..+++++.+|
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~---p~~~~~~~~~l 379 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-F---PRTLGPEAKSL 379 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-C---CTTSCHHHHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-C---CccCCHHHHHH
Confidence 2223456899999999999999999999999999999999999999887766666665444322 2 24578899999
Q ss_pred HHHHcccCCCCCC-----CHHHHHHH
Q 018614 284 IEECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
|.+||+.||++|| +++++++|
T Consensus 380 i~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 380 LSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 9999999999999 99999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=357.19 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=212.3
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
...+|+..+.||+|+||.||. +|+.||+|++.............+.+|..++..++||||+++++++.+...+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 345799999999999999984 478999999865321111112347889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999999987 467999999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCCcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCchhh
Q 018614 202 EDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKL 275 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 275 (353)
.........||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+.... ...++.....
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 308 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence 333334456899999999986 5678999999999999999999999999877666666664432 2233333345
Q ss_pred hHHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 018614 276 YARGLKELIEECWNEKPAK--RPTFRQIITR 304 (353)
Q Consensus 276 ~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 304 (353)
+++++++||++||..+|++ ||+++++++|
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 7889999999999988888 9999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=343.34 Aligned_cols=272 Identities=28% Similarity=0.483 Sum_probs=217.3
Q ss_pred CCCcccCccCcCcccceeeecceEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccccee
Q 018614 40 VPEYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111 (353)
Q Consensus 40 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 111 (353)
.+.+.+......|+..+.||+|+||.||.. +..||+|.+... ......+.+.+|+.++++++||||++++
T Consensus 79 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~ 156 (373)
T 3c1x_A 79 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLL 156 (373)
T ss_dssp TTTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCC
T ss_pred ccccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 345566677778899999999999999831 246899998653 2345567899999999999999999999
Q ss_pred eEEE-ecCceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEE
Q 018614 112 GAVT-QSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189 (353)
Q Consensus 112 ~~~~-~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl 189 (353)
+++. .++..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||
T Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp EEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred EEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEE
Confidence 9875 4567899999999999999998654 4889999999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCCC---CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcC
Q 018614 190 ADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 265 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 265 (353)
+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+....
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~ 313 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC
Confidence 999999866433211 1233456778999999999999999999999999999999 789998888777776665554
Q ss_pred CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhccccc
Q 018614 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWK 319 (353)
Q Consensus 266 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~ 319 (353)
.... +..++..+.+++.+||..||++||++.+++++|+++...+.......
T Consensus 314 ~~~~---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~~ 364 (373)
T 3c1x_A 314 RLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 364 (373)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCC
T ss_pred CCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccceee
Confidence 3332 34578899999999999999999999999999999988777554333
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=341.92 Aligned_cols=256 Identities=17% Similarity=0.340 Sum_probs=209.6
Q ss_pred cCccCcCcccceeeecc--eEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec
Q 018614 45 IDPHELDFTNSVEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 117 (353)
Q Consensus 45 i~~~~~~~~~~~~ig~G--~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 117 (353)
+.+...+|+..+.||+| +||.||. +|+.||||++..... ..+..+.+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 44556689999999999 9998883 588999999976543 355667888999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccc
Confidence 9999999999999999999875 56999999999999999999999999 999999999999999999999999988
Q ss_pred cccccCCC------CCcccCCCCCcccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC
Q 018614 196 KLLTVKED------RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 267 (353)
Q Consensus 196 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 267 (353)
........ .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 65432211 11122357888999999987 57899999999999999999999999887665554332221111
Q ss_pred C------------------------------------------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 P------------------------------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ~------------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
. .......+++++.+||.+||+.||++|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 001234567889999999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=335.24 Aligned_cols=258 Identities=28% Similarity=0.475 Sum_probs=203.3
Q ss_pred CcCcccceeeecceEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
..+|+..+.||+|+||.||. .+ ..||||++....... ...+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45799999999999999983 22 279999997654333 4457789999999999999999999999876654
Q ss_pred ------EEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEE
Q 018614 121 ------MIVTEYLPKGDLRAFLKRKG------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188 (353)
Q Consensus 121 ------~iv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vk 188 (353)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999996532 4899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCC
Q 018614 189 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 189 l~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 266 (353)
|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 9999999876443222 2233446778999999999999999999999999999999 9999998888777777655554
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
... +..+++++.+|+.+||+.||++|||+.++++.|+++.....
T Consensus 258 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 258 LKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp CCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred CCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 333 34577899999999999999999999999999999976543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=330.16 Aligned_cols=265 Identities=28% Similarity=0.502 Sum_probs=221.3
Q ss_pred CCcccCccCcCcccceeeecceEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceee
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 112 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 112 (353)
+.+.+.+...+|+..+.||+|+||.||.. +..||+|.+... ......+.+.+|+.++++++||||+++++
T Consensus 16 ~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 93 (298)
T 3f66_A 16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 93 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred hheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence 35667788889999999999999999831 235899998753 34566678999999999999999999999
Q ss_pred EEE-ecCceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEe
Q 018614 113 AVT-QSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190 (353)
Q Consensus 113 ~~~-~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~ 190 (353)
++. .++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 94 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 170 (298)
T 3f66_A 94 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVA 170 (298)
T ss_dssp EECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEEC
Confidence 864 556789999999999999999764 45899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCC---CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCC
Q 018614 191 DFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 191 Dfg~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 266 (353)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+.....
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 250 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence 9999987643321 12233456778999999999999999999999999999999 7788888777777666655543
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
... +..++..+.+++.+||+.||++|||+.++++.|+++...+.
T Consensus 251 ~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 251 LLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 332 34567889999999999999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=327.57 Aligned_cols=269 Identities=29% Similarity=0.521 Sum_probs=223.3
Q ss_pred CCCcccCccCcCcccceeeecceEEEEEE-----c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccccee
Q 018614 40 VPEYEIDPHELDFTNSVEITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111 (353)
Q Consensus 40 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~-----~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 111 (353)
..++.++.....|...+.||+|+||.||. + +..||+|.+... ......+.+.+|+.+++.++||||++++
T Consensus 11 ~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 88 (298)
T 3pls_A 11 VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALI 88 (298)
T ss_dssp TGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 34566777777899999999999999984 2 237999998753 3456667899999999999999999999
Q ss_pred eEEEecCce-EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEE
Q 018614 112 GAVTQSSPM-MIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189 (353)
Q Consensus 112 ~~~~~~~~~-~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl 189 (353)
+++.+.... ++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp EEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred EEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEe
Confidence 999866555 999999999999999986 345899999999999999999999999 999999999999999999999
Q ss_pred eecccccccccCC---CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcC
Q 018614 190 ADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 265 (353)
Q Consensus 190 ~Dfg~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 265 (353)
+|||++....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+....
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC
Confidence 9999998654322 122233456788999999999999999999999999999999 566666666666665555444
Q ss_pred CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 018614 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 316 (353)
Q Consensus 266 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 316 (353)
.... +..++.++.+|+.+||+.||++|||++++++.|+++..++....
T Consensus 246 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 246 RLPQ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CCCC---CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 3332 34578889999999999999999999999999999988765443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=342.38 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=207.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|+.||||++..... .+..+.+.+|+.+++.++||||+++++++.++...|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 34799999999999999984 588999999865432 22335688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++++|.+++.....+++..++.++.|++.||.|||+.| ++||||||+|||++.++.+||+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999999987777999999999999999999999999 99999999999999999999999999987643322
Q ss_pred -CCcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 204 -RPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 204 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.......|++.|+|||++.+..+ +.++||||||+++|+|++|+.||................... ......++.++.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPL 239 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-STTGGGSCHHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-CCccccCCHHHH
Confidence 22234568899999999987765 778999999999999999999998766554333332222222 223456889999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+||.+||..||++|||+.+++++
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhhCcCHHHHhhC
Confidence 99999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=328.51 Aligned_cols=262 Identities=27% Similarity=0.493 Sum_probs=205.2
Q ss_pred CCcccCccCcCcccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
+.++|. ..+|+..+.||+|+||.||. ....||+|++.... ......+.+.+|+.++++++||||++++++. ...
T Consensus 17 ~~~ei~--~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 17 DDWEIP--DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp -CCBCC--TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCCccC--ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 344444 55799999999999999984 45679999997654 3456667899999999999999999999965 556
Q ss_pred ceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccc
Confidence 789999999999999999643 45999999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCC-CCcccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC--CCCCCC
Q 018614 198 LTVKED-RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKA 271 (353)
Q Consensus 198 ~~~~~~-~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~ 271 (353)
...... .......+++.|+|||.+. +..++.++||||||+++|+|++|+.||................ .+....
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 543221 2223456789999999986 5678889999999999999999999998766554443333322 223333
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
....+++++.+||.+||+.||++|||+.++++.|+++.
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 34567899999999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=354.39 Aligned_cols=250 Identities=29% Similarity=0.506 Sum_probs=216.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. .+..||||++..... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 3588889999999998873 378999999976532 2357889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 125 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 125 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||+++|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999864 34899999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
........+++.|+|||++.+..++.++||||||+++|||++ |..||...+..++...+........ +..+++++.
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 449 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---PEGCPEKVY 449 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC---CTTCCHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHH
Confidence 223333446778999999998899999999999999999999 9999998887777776655444332 346788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
+||.+||+.||++|||+.+|++.|+.+.
T Consensus 450 ~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 450 ELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=329.11 Aligned_cols=258 Identities=24% Similarity=0.470 Sum_probs=205.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|..||||++......+......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4799999999999999884 58899999998755556677788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 125 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 125 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999974 345899999999999999999999999 99999999999999999999999999887643
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc--hHHHHHhcCCCCCCCchhhhHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--VPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ....+.....+.. ....++.
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 265 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSE 265 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC--CTTTSCH
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC--cccccCH
Confidence 322 1223457889999999999999999999999999999999999997654332 2233333222222 2356788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
++.+||.+||..||++|||+.++++.|+++.....
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999999966543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=326.66 Aligned_cols=259 Identities=24% Similarity=0.412 Sum_probs=218.6
Q ss_pred CcCcccce-eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 49 ELDFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 49 ~~~~~~~~-~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
..+|.... .||+|+||.||. .+..||||++... ......+.+.+|+.++++++||||+++++++ ..+..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 34566655 999999999873 4778999999764 2455667899999999999999999999999 55679
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++|||++++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999999654 45999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 200 VKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 200 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.....+.. +..+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~ 238 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPEC 238 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTTC
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC---CCCc
Confidence 33221 1223345788999999988889999999999999999998 9999998877776666655544433 3467
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 316 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 316 (353)
++++.++|.+||..||++||++.+++++|+.+..+.....
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 8899999999999999999999999999999987765443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=336.59 Aligned_cols=254 Identities=16% Similarity=0.232 Sum_probs=211.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||||++...... ..+.+|+.+++++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 4799999999999998873 5889999998654321 2577899999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC-----EEEeecccccc
Q 018614 124 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSKL 197 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~-----vkl~Dfg~a~~ 197 (353)
|||+ +++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999 99999999863 56999999999999999999999999 999999999999998887 99999999987
Q ss_pred cccCCCC------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhc---CC-C
Q 018614 198 LTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR-P 267 (353)
Q Consensus 198 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~---~~-~ 267 (353)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... .. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6543321 123456899999999999999999999999999999999999999987666554333221 11 1
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
+.......++ ++.+|+..||+.||.+||++.+|++.|+++.....
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1111112355 89999999999999999999999999999877654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=330.52 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=217.1
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 117 (353)
..+|+..+.||+|+||.||. .+..||||++.... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 45799999999999999873 24789999997543 344557889999999999 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCE
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Ni 179 (353)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 99999999999999999998653 3899999999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCch
Q 018614 180 LRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 257 (353)
Q Consensus 180 ll~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 257 (353)
+++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 99999999999999998765443221 223345678999999998899999999999999999999 9999988776655
Q ss_pred HHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 258 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
............ .+..++.++.+|+.+||+.||++|||+.+++++|+++....
T Consensus 257 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 FYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 544444332222 23457889999999999999999999999999999986643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=342.43 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=204.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
.+|+..+.||+|+||.||. +|+.||||++...... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3699999999999999984 4889999998543211 01123568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC---EEEeecccc
Q 018614 123 VTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVS 195 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~---vkl~Dfg~a 195 (353)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998888642 24899999999999999999999999 999999999999987654 999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhh
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 275 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (353)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .+....+..............
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence 87654322 2233568999999999999999999999999999999999999998743 233334433332222122345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 276 YARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 276 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.++.+||.+||..||++|||+.++++|
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 78899999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=333.12 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=204.4
Q ss_pred cCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 48 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
...+|+..+.||+|+||.||. +|+.||+|++..... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 345799999999999999883 578999999876432 233346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||++ ++|.+++.... .+++..++.++.|++.||.|||+.| ++||||||+|||++.++.+||+|||++.......
T Consensus 98 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 98 FEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99996 58888887644 4999999999999999999999999 9999999999999999999999999998765332
Q ss_pred CCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCC----------
Q 018614 203 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA---------- 271 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 271 (353)
. ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+......+...
T Consensus 174 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 R-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred c-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 2 2233457889999999876 568999999999999999999999999887777665554321111100
Q ss_pred ----------------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 ----------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 ----------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+++++.+||.+||+.||++|||++++++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 012356789999999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=330.04 Aligned_cols=247 Identities=25% Similarity=0.470 Sum_probs=208.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. ++..||+|++.............+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 34799999999999999984 4678999998654322222345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++++|.+++.....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 999999999999998888999999999999999999999999 9999999999999999999999999986654322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+...... + +..++.++.+|
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~l 237 (279)
T 3fdn_A 164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-F---PDFVTEGARDL 237 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-C---CTTSCHHHHHH
T ss_pred --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC-C---CCcCCHHHHHH
Confidence 23345788999999999999999999999999999999999999877655555555433322 1 34577889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~l 305 (353)
|.+||+.||++|||+.++++|-
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCH
T ss_pred HHHHhccChhhCCCHHHHhhCc
Confidence 9999999999999999999983
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=327.08 Aligned_cols=255 Identities=26% Similarity=0.489 Sum_probs=213.1
Q ss_pred cCcCcccceeeecceEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 48 HELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
...+|+..+.||+|+||.||.. +..||+|.+.... ..+..+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 3457999999999999998841 2359999987643 34556789999999999999999999999865 45
Q ss_pred eEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 789999999999999997654 4999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+......+. +..++
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 240 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDLCP 240 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTTCC
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCCCC
Confidence 5443333344556788999999998899999999999999999998 9999988777777666655544332 34578
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
+.+.+++.+||..||++||++.+++++|+++...
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 8899999999999999999999999999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=332.10 Aligned_cols=246 Identities=23% Similarity=0.391 Sum_probs=209.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|...+.||+|+||.||. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++......++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 366778999999999983 5899999998654322 23567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++........ .
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 197 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence 9999999999865 45999999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....+... ....+++++.+||.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~ 276 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK-NSHKVSPVLRDFLE 276 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT-TGGGSCHHHHHHHH
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC-ccccCCHHHHHHHH
Confidence 23456889999999999999999999999999999999999999877655555555444333332 34567889999999
Q ss_pred HHcccCCCCCCCHHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~l 305 (353)
+||+.||++|||+.+++++-
T Consensus 277 ~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 277 RMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHSCSSTTTSCCHHHHHTSG
T ss_pred HHccCChhhCcCHHHHhcCh
Confidence 99999999999999999873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=342.06 Aligned_cols=247 Identities=18% Similarity=0.353 Sum_probs=211.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 4799999999999999984 57899999986542 334457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC--CCCEEEeecccccccccC
Q 018614 125 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~--~~~vkl~Dfg~a~~~~~~ 201 (353)
||+++++|.+++.... .+++..++.++.||+.||.|||+.| ++||||||+|||++. .+.+||+|||++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999997654 5999999999999999999999999 999999999999984 567999999999876533
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
. ......+|+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..............+++++.
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 205 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred c--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 2 22334688999999999999999999999999999999999999988766555555544443322233456789999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+||.+||..||++|||+.++++|
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=335.21 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=212.0
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
..+|+..+.||+|+||.||. +|..||+|++........ ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 44699999999999999984 488999999876432211 1235688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC----CEEEeeccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSK 196 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~----~vkl~Dfg~a~ 196 (353)
++||||+++++|.+++.....+++..++.++.|++.||.|||+.| ++||||||+||+++.++ .++|+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999998878999999999999999999999999 99999999999999888 79999999998
Q ss_pred ccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 197 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+..............+
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence 765432 223345788999999999999999999999999999999999999877655555555433322211122457
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+..+.+||.+||..||++|||+.++++|
T Consensus 246 ~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 246 SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 7889999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=327.50 Aligned_cols=260 Identities=30% Similarity=0.505 Sum_probs=216.6
Q ss_pred CcccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 117 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 117 (353)
+|++. ..+|+..+.||+|+||.||. ++..||+|.+...... .+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~v~--~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 7 EWEVP--RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp TTBCC--GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hcccC--HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 45544 34689999999999999884 3678999998764321 2468899999999999999999999864
Q ss_pred CceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccc
Confidence 56899999999999999997532 5899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchh
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
...............++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+....... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 233 (279)
T 1qpc_A 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPD 233 (279)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCT
T ss_pred ccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---Ccc
Confidence 8765443333334456778999999988889999999999999999999 999998876666655554443322 234
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhh
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~ 314 (353)
.++.++.+|+.+||..||++|||+.++++.|+++......
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 6788999999999999999999999999999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=335.48 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=220.1
Q ss_pred CCCCCCcccCcc-CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccce
Q 018614 37 AREVPEYEIDPH-ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF 110 (353)
Q Consensus 37 ~~~~~~~~i~~~-~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 110 (353)
....++..+++. ..+|...+.||+|+||.||. +++.||+|++...........+.+.+|+.+++.++||||+++
T Consensus 27 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 106 (335)
T 2owb_A 27 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106 (335)
T ss_dssp CCCCCSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccCcceecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 333444444333 34799999999999999984 478999999987666666777889999999999999999999
Q ss_pred eeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEe
Q 018614 111 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190 (353)
Q Consensus 111 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~ 190 (353)
++++.+.+..++||||+++++|.+++.....+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~ 183 (335)
T 2owb_A 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIG 183 (335)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEe
Confidence 9999999999999999999999999988888999999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCC
Q 018614 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 270 (353)
Q Consensus 191 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 270 (353)
|||++........ ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+..... .+
T Consensus 184 Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~- 260 (335)
T 2owb_A 184 DFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SI- 260 (335)
T ss_dssp CCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CC-
T ss_pred eccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-CC-
Confidence 9999987653322 22335578899999999998999999999999999999999999987665554444433322 11
Q ss_pred CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 271 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+..++.++.+||.+||+.||++||++.+++++
T Consensus 261 --~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 --PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 34567889999999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=353.43 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=209.5
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
...+|+..+.||+|+||.||. +|+.||||++.............+.+|..++..++||||+++++++.+...+|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 345799999999999999873 588999999865322222223457889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||||++||+|.+++.+.+ .+++..++.++.||+.||.|||+.+ ++||||||+|||++.+|.+||+|||+++.....
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999999999998754 6999999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccCCCCCcccCccccC-------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCch
Q 018614 202 EDRPLTCQDTSCRYVAPEVFK-------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPA 273 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 273 (353)
.........||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+.... ...++...
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 332233456899999999987 4578999999999999999999999998877666666655432 12222223
Q ss_pred hhhHHHHHHHHHHHcccCCCCC---CCHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKR---PTFRQIITR 304 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~R---ps~~~ll~~ 304 (353)
..+++++++||.+||. +|.+| |+++++++|
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 5678999999999999 99998 599999887
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=337.07 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=211.1
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 117 (353)
..+|+..+.||+|+||.||. .+..||||++.... .......+.+|+.+++++ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34789999999999999873 24579999987542 233446788999999999 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCC
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 174 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dl 174 (353)
+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.| ++||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 99999999999999999998643 2789999999999999999999999 999999
Q ss_pred CCCCEEEcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 018614 175 EPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMK 252 (353)
Q Consensus 175 kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 252 (353)
||+||+++.++.++|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999998765433221 223446778999999998899999999999999999998 99999887
Q ss_pred CCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 253 HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
................ ..+..+++++.+||.+||..||++|||+.+++++|+.+....
T Consensus 279 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKM--DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCSHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CcHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 7665554444333221 123456889999999999999999999999999999985543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=327.73 Aligned_cols=257 Identities=16% Similarity=0.244 Sum_probs=213.4
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~i 122 (353)
..+|+..+.||+|+||.||. +|+.||||++...... ..+.+|+.+++.+ +|++++++++++.+....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 44799999999999999883 5889999998654321 3477899999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC-----EEEeeccccc
Q 018614 123 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSK 196 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~-----vkl~Dfg~a~ 196 (353)
||||+ +++|.+++...+ .+++..++.++.|++.||.|||++| ++||||||+||+++.++. ++|+|||++.
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999 999999998754 4999999999999999999999999 999999999999987775 9999999998
Q ss_pred ccccCCCC------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHH---hcC-C
Q 018614 197 LLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---ARQ-R 266 (353)
Q Consensus 197 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~---~~~-~ 266 (353)
........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+. ... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 77544321 2234568899999999999999999999999999999999999998865543332221 111 1
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhh
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~ 314 (353)
.+.......+++++.+|+.+||+.||++||+++++++.|+++......
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 121112235788999999999999999999999999999999887654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=342.35 Aligned_cols=243 Identities=26% Similarity=0.410 Sum_probs=199.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HhcCCCCcccceeeEEEecCceEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
..+|+..+.||+|+||.||. ++..||||++.............+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 34799999999999999984 478999999987665555555566777776 577899999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||||++||+|.+++...+.+++..++.++.||+.||+|||++| ++||||||+|||++.+|.+||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 9999999999999998888999999999999999999999999 9999999999999999999999999998643322
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..... .+ +..++.++.+
T Consensus 194 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~---~~~~~~~~~~ 268 (373)
T 2r5t_A 194 S-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QL---KPNITNSARH 268 (373)
T ss_dssp C-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-CC---CSSSCHHHHH
T ss_pred C-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-CC---CCCCCHHHHH
Confidence 2 23345689999999999999999999999999999999999999988776666666654432 22 2357888999
Q ss_pred HHHHHcccCCCCCCCHH
Q 018614 283 LIEECWNEKPAKRPTFR 299 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~ 299 (353)
||.+||+.||++||++.
T Consensus 269 li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHTCSSGGGSTTTT
T ss_pred HHHHHcccCHHhCCCCC
Confidence 99999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=324.45 Aligned_cols=246 Identities=23% Similarity=0.368 Sum_probs=210.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. ++..||+|++....... .+.+.+|+.++++++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 4689999999999999984 36789999987654333 356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE---cCCCCEEEeecccccccccC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill---~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||+++++|.+++.....+++..++.++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999999988888999999999999999999999999 9999999999999 78889999999999876533
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
. ......+++.|+|||.+.+. ++.++||||||+++|+|++|+.||......+....+..............+++++.
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred c--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 2 22335578899999998764 89999999999999999999999988776666666555443332222235788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+||.+||+.||++||++.++++|
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=335.04 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=210.5
Q ss_pred ccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 44 EIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 44 ~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
++.....+|+..+.||+|+||.||. +|+.||||++...... .....+.+|+.+++.++||||+++++++.+...
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 3445566899999999999999984 5788999998764321 112357899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhc---CCCCEEecCCCCCCEEEcCCCCEEEeec
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHEN---KPVPIIHRDLEPSNILRDDSGNLKVADF 192 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~Lh~~---~~~~iiH~dlkp~Nill~~~~~vkl~Df 192 (353)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+. + ++||||||+|||++.++.++|+||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999998643 389999999999999999999999 8 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-----CCCCchHHHHHhcCCC
Q 018614 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-----KHDNEVPKAYAARQRP 267 (353)
Q Consensus 193 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~-----~~~~~~~~~~~~~~~~ 267 (353)
|++...............||+.|+|||.+.+..++.++||||||+++|+|++|+.||.. .........+......
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 99987765444444455689999999999888899999999999999999999999952 1111111111110000
Q ss_pred ----------CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 268 ----------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 268 ----------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.........+..+.+++..||+.||++|||+.+++++|+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 00112345678899999999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=354.03 Aligned_cols=247 Identities=29% Similarity=0.442 Sum_probs=212.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|...+.||+|+||.||. +|+.||||++........+....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34799999999999998883 5889999998654322222345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++++|.+++...+.+++..++.++.||+.||.|||+.| ++||||||+|||++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 999999999999988778999999999999999999999999 9999999999999999999999999998765332
Q ss_pred CCcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
......|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+...... .+..+++++.+
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~ 245 (476)
T 2y94_A 171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY----TPQYLNPSVIS 245 (476)
T ss_dssp -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC----CCTTCCHHHHH
T ss_pred -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC----CCccCCHHHHH
Confidence 2233468899999999988765 67999999999999999999999887766666665444321 13457788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||..||++|||+.++++|
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHcCCCchhCcCHHHHHhC
Confidence 9999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=331.19 Aligned_cols=258 Identities=29% Similarity=0.499 Sum_probs=212.0
Q ss_pred cCcCcccceeeecceEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 48 HELDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
...+|+..+.||+|+||.||.. +..||||.+.... .......+.+|+.++++++||||+++++++.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3457888999999999998841 2359999987543 3455567899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999864 46999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCC--cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchh
Q 018614 198 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 198 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+. +.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---~~ 273 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---PM 273 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC---cc
Confidence 65432211 122345678999999999999999999999999999999 9999988776666666655443332 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
.++.++.+++.+||+.||++||++.++++.|+++.....
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 578899999999999999999999999999999876544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=339.72 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=197.9
Q ss_pred CccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 46 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 46 ~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
.....+|+..+.||+|+||.||. +|+.||||++....... ..+.+|+.+++.++||||+++++++.+....
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 34456899999999999998873 58899999987654322 3577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC--EEEeeccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGVSKLL 198 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~--vkl~Dfg~a~~~ 198 (353)
++||||+++++|.+++...+.+++..++.++.|++.||.|||++| ++||||||+||+++.++. +||+|||+++..
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999999999988888999999999999999999999999 999999999999987765 999999998754
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhc-CCCCC-CCchhh
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPF-KAPAKL 275 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~-~~~~~~ 275 (353)
.... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............... ..... .+....
T Consensus 169 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (361)
T 3uc3_A 169 VLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred cccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence 3221 2233458899999999988888665 89999999999999999999876654433332211 11111 112235
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 276 YARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 276 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+++++.+||.+||..||++|||+.++++|-
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 688899999999999999999999999883
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=339.93 Aligned_cols=243 Identities=21% Similarity=0.337 Sum_probs=202.6
Q ss_pred cceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCC
Q 018614 54 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 54 ~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
..+.||+|+||.||. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 356899999999984 48899999987542 3455678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE--cCCCCEEEeecccccccccCCCCC
Q 018614 129 KGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--DDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 129 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill--~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+++|.+++... ..+++..++.++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||++....... .
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 99999988754 35999999999999999999999999 9999999999999 567789999999998765332 2
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..............+++++.+||.
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence 23345889999999999999999999999999999999999999887766666666554433333334567899999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~ 304 (353)
+||+.||++||++.++++|
T Consensus 325 ~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHcCCChhhCCCHHHHhcC
Confidence 9999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=329.08 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=208.2
Q ss_pred cCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC-
Q 018614 48 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 118 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 118 (353)
...+|...+.||+|+||.||. .+..||+|.+..... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345799999999999998873 245899999876533 4555677899999999999999999999997654
Q ss_pred ----ceEEEEecCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEE
Q 018614 119 ----PMMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 188 (353)
Q Consensus 119 ----~~~iv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vk 188 (353)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 35999999999999999953 245899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCC
Q 018614 189 VADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 189 l~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 266 (353)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+.....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 999999987643322 12233456778999999999999999999999999999999 9999998887777766655544
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
... +..+++++.+||.+||..||++|||+.+++++|+++...+.
T Consensus 268 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 268 LKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp CCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 332 35678899999999999999999999999999999977653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=356.02 Aligned_cols=250 Identities=25% Similarity=0.441 Sum_probs=217.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++.............+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4699999999999999983 58899999987654443344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE---cCCCCEEEeecccccccccC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill---~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||+.+++|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||+ +.++.+||+|||++......
T Consensus 106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999999998888999999999999999999999999 9999999999999 56789999999999876533
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||......+....+.........+....+++++.
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 183 K--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp C--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred c--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 2 2233458899999999876 689999999999999999999999998877777777766554433344567889999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+||.+||+.||++|||+.++++|-
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred HHHHHHCCCChhHCcCHHHHhhCh
Confidence 999999999999999999999873
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=328.35 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=206.6
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC--ceE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 121 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 121 (353)
..+|+..+.||+|+||.||. +|+.||||++...... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 45799999999999999984 3889999998754322 22356789999999999999999999998665 779
Q ss_pred EEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE----cCCCCEEEeeccc
Q 018614 122 IVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGV 194 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill----~~~~~vkl~Dfg~ 194 (353)
+||||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999986433 899999999999999999999999 9999999999999 7778899999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccC--------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----hHHHHH
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFK--------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYA 262 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~----~~~~~~ 262 (353)
++...... ......+++.|+|||++. +..++.++|||||||++|+|++|+.||....... ....+.
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred ceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 98765432 223355889999999886 5678999999999999999999999997554322 222222
Q ss_pred hcCC---------------------CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 263 ARQR---------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 263 ~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
.... +........++..+.+||++||+.||++|||+++++++.++-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2211 111122356788999999999999999999999999998864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=327.74 Aligned_cols=248 Identities=21% Similarity=0.416 Sum_probs=200.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++..... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 689999999999999883 478999999976543 33444678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+++ +|.+.+.. .+.+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-S
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-c
Confidence 9965 66665554 567999999999999999999999999 9999999999999999999999999998765332 2
Q ss_pred CcccCCCCCcccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCC-CCCCCCchHHHHHhcCCCC--------------
Q 018614 205 PLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPP-------------- 268 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf-~~~~~~~~~~~~~~~~~~~-------------- 268 (353)
......+|+.|+|||++.+.. ++.++||||||+++|+|++|..|| ...+..+....+......+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 223356788999999998765 799999999999999999877774 4443333333332211000
Q ss_pred -----------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -----------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.......++.++++||.+||+.||++|||++++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 001123467889999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=333.54 Aligned_cols=255 Identities=24% Similarity=0.487 Sum_probs=209.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
..+|+..+.||+|+||.||. +|+ .||+|.+.... .......+.+|+.++++++||||+++++++.++ .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-S
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-C
Confidence 45799999999999999984 233 46888876432 233446788999999999999999999999875 4
Q ss_pred eEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.++|+|++++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 78999999999999999874 45999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 199 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 199 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+. +..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 244 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPIC 244 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTTB
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC---CccC
Confidence 543322 2233446778999999999999999999999999999999 9999998877777666655544332 3457
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
+.++.+|+.+||+.||++||++.+++++|+.+....
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 788999999999999999999999999999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=336.61 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=195.3
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 34699999999999999984 47789999987542 224678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---CCCEEEeeccccccccc
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV 200 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~~~vkl~Dfg~a~~~~~ 200 (353)
|||+++++|.+++...+.+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||++.....
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999988878999999999999999999999999 999999999999975 88999999999987643
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-hHHHHHhcCCCCCCCchhhhHHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ....+..............++.+
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 22 1233557899999999999999999999999999999999999998766544 33344333333333334567889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.+||.+||..||++|||+.++++|
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=350.07 Aligned_cols=257 Identities=32% Similarity=0.512 Sum_probs=211.0
Q ss_pred CcccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 117 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 117 (353)
.|++. ..+|+..+.||+|+||.||. .+..||||++...... .+.+.+|+.++++++||||+++++++.+
T Consensus 178 ~~~i~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 178 AWEIP--RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp CSBCC--GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccccC--hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 35443 33588889999999999884 3467999999765422 2468899999999999999999999876
Q ss_pred CceEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
+..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccc
Confidence 678999999999999999964 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchh
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
+..............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+....+..+...+. +.
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~ 404 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PP 404 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CT
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 8765433333334456788999999998899999999999999999999 9999998877777666655544433 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
.+++.+.+||.+||+.||++|||++++++.|+++...
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 6788999999999999999999999999999988543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=327.26 Aligned_cols=252 Identities=25% Similarity=0.514 Sum_probs=204.5
Q ss_pred cCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--C
Q 018614 50 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--S 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 118 (353)
.+|+..+.||+|+||.||. .|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+. .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 4589999999999999873 57899999987543 223346788999999999999999999999876 6
Q ss_pred ceEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 68999999999999999954 456999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCC--CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-----------CC----chHHH
Q 018614 198 LTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH-----------DN----EVPKA 260 (353)
Q Consensus 198 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~-----------~~----~~~~~ 260 (353)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|..|+.... .. .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 654332 12233457778999999999899999999999999999999998864221 01 11111
Q ss_pred HHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 261 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
+....... .+..+++++.+||.+||+.||++|||+.++++.|+++.
T Consensus 256 ~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22222222 23467889999999999999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=332.87 Aligned_cols=246 Identities=26% Similarity=0.456 Sum_probs=209.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..|+..+.||+|+||.||. +|+.||||++........+..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3588899999999999983 58899999997655445566678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||+. |+|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9996 688888864 456999999999999999999999999 999999999999999999999999999775432
Q ss_pred CCcccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
....+++.|+|||++. +..++.++||||||+++|+|++|+.||...........+.....+.. ....+++.+
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 282 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYF 282 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHHH
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCHHH
Confidence 2345789999999984 56789999999999999999999999987765555555544444333 234578899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.+||.+||+.||++|||+++++++..
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHHHcccChhhCcCHHHHhhChh
Confidence 99999999999999999999997743
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=322.82 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=209.5
Q ss_pred cccceeeecceEEEEEE---cCeEEEEEEcCccc-CCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecC
Q 018614 52 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 127 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~---~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 127 (353)
|..++.||+|+||.||. ++..||||++.... ....+..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 45568999999999885 68899999986532 223445677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 128 PKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 128 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999999974 345899999999999999999999999 999999999999999999999999999876543222
Q ss_pred -CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHh----c-------CCCCCCCc
Q 018614 205 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA----R-------QRPPFKAP 272 (353)
Q Consensus 205 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~----~-------~~~~~~~~ 272 (353)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.. . ....+...
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 1223457889999998875 578999999999999999999999987665443222211 1 01122233
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
...++..+.+++.+||..||++|||+.+++++|+++.
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 4567889999999999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=330.55 Aligned_cols=255 Identities=25% Similarity=0.489 Sum_probs=210.7
Q ss_pred cccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--Cce
Q 018614 52 FTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 120 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 120 (353)
|+..+.||+|+||.||. +|+.||||++.... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 48999999999999952 67899999997652 455567899999999999999999999999874 568
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
++||||+++++|.+++... .+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999999765 4999999999999999999999999 99999999999999999999999999987754
Q ss_pred CCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------------chHHHHHh
Q 018614 201 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------------EVPKAYAA 263 (353)
Q Consensus 201 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~---------------~~~~~~~~ 263 (353)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 3221 123345777899999999988999999999999999999999998653211 01111112
Q ss_pred cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhc
Q 018614 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 315 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~ 315 (353)
.... ..+..++.++.+||.+||+.||++|||+.++++.|+.+...+...
T Consensus 267 ~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 267 GERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 2222 224567889999999999999999999999999999998877643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=348.37 Aligned_cols=247 Identities=23% Similarity=0.421 Sum_probs=208.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|..||+|++....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 599999999999999983 57899999987643221 223568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC---CCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~---~~vkl~Dfg~a~~~~~~~ 202 (353)
|+++|+|.+++.....+++..++.++.||+.||.|||+.| ++||||||+|||++.. +.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999999999988888999999999999999999999999 9999999999999764 459999999998765432
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+..............+++++.+
T Consensus 194 --~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred --cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 2234568999999999864 6899999999999999999999999988777777777665544433444568899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||+.||++|||+.++++|
T Consensus 271 li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHCCCChhhCccHHHHhcC
Confidence 9999999999999999999987
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=339.22 Aligned_cols=254 Identities=21% Similarity=0.321 Sum_probs=208.1
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
...+|+..+.||+|+||.||. ++..||+|++...... ..+..+.+.+|+.++++++||||+++++++.+....
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 345799999999999999883 4778999998654211 233456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHH
Q 018614 121 MIVTEYLPKGDLRAFLKR----------------------------------------KGALKPSTAVRFALDIARGMNY 160 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~al~~ 160 (353)
++||||+++++|.+++.. ...+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999999842 0013577888999999999999
Q ss_pred HHhcCCCCEEecCCCCCCEEEcCCC--CEEEeecccccccccCCCC---CcccCCCCCcccCccccCC--CCCCCchhHH
Q 018614 161 LHENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN--EEYDTKVDVF 233 (353)
Q Consensus 161 Lh~~~~~~iiH~dlkp~Nill~~~~--~vkl~Dfg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dvw 233 (353)
||+.+ ++||||||+||+++.++ .+||+|||++......... ......+++.|+|||++.+ ..++.++|||
T Consensus 184 LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 184 LHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 99999 99999999999998776 8999999999876432221 2234568899999999865 6788999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 234 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 234 slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
|||+++|+|++|+.||......+....+..............+++++.+||.+||+.||++||++.++++|
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999998887766666665555444334445678999999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=350.84 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=209.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH----------HHHHHHHHHHHHHhcCCCCcccceeeEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD----------DRVRAFRDELALLQKIRHPNVVQFLGAV 114 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 114 (353)
.+|+..+.||+|+||.||. ++..||||++........ ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4799999999999999983 578999999876443211 2245788999999999999999999999
Q ss_pred EecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC---CEEEee
Q 018614 115 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVAD 191 (353)
Q Consensus 115 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~---~vkl~D 191 (353)
.+....|+||||+++++|.+++.....+++..++.++.||+.||.|||+.| ++||||||+|||++.++ .+||+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999988888999999999999999999999999 99999999999999876 699999
Q ss_pred cccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 192 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+..........
T Consensus 193 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 193 FGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred CCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99998765432 2234568999999999874 68999999999999999999999999887777776665554332222
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+++++.+||.+||..||.+|||+.++++|
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 335678999999999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=328.28 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=209.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|...+.||+|+||.||. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 3688999999999999983 58899999987542 222356789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE---cCCCCEEEeecccccccccC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill---~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999999988888999999999999999999999999 9999999999999 78889999999998764322
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+..............++.++.
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 12223478899999999999999999999999999999999999988766666666655443322233456789999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+||.+||..||++||++.++++|-
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHcCCChhHCcCHHHHhcCc
Confidence 999999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=327.58 Aligned_cols=245 Identities=25% Similarity=0.466 Sum_probs=209.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. ++..||+|++.............+.+|+.++++++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999984 47889999986532211222356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 99999999999998888999999999999999999999999 9999999999999999999999999987654322
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+..... .+ +..++.++.+||
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~li 243 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KF---PPFLSDGSKDLI 243 (284)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CC---CTTSCHHHHHHH
T ss_pred -cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-CC---CCcCCHHHHHHH
Confidence 2234578899999999999999999999999999999999999987665555444433221 21 245778899999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+||..||++||++.++++|
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTC
T ss_pred HHHhhcCHhhCCCHHHHhhC
Confidence 99999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=327.94 Aligned_cols=247 Identities=23% Similarity=0.442 Sum_probs=185.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++........+..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4699999999999999883 57899999986542212222467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999875 46999999999999999999999999 99999999999999999999999999987653322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+... .. ..+..++.++.+|
T Consensus 168 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~l 242 (278)
T 3cok_A 168 K-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA---DY-EMPSFLSIEAKDL 242 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS---CC-CCCTTSCHHHHHH
T ss_pred c-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc---cc-CCccccCHHHHHH
Confidence 2 22345788999999999989999999999999999999999999876655443332111 11 1234578899999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~ 304 (353)
|.+||..||++|||+.++++|
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHcccCHhhCCCHHHHhcC
Confidence 999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=330.10 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=199.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC-----------------------HHHHHHHHHHHHHHhc
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----------------------DDRVRAFRDELALLQK 101 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~ 101 (353)
.+|+..+.||+|+||.||. +|+.||||++....... ....+.+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 4799999999999999984 48899999986543211 1223568899999999
Q ss_pred CCCCcccceeeEEEe--cCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCE
Q 018614 102 IRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179 (353)
Q Consensus 102 l~h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Ni 179 (353)
++||||+++++++.+ ....++||||+++++|.+++. ...+++..++.++.|++.||.|||+++ ++||||||+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 168 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL 168 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 999999999999986 567899999999999988654 346999999999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 018614 180 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE 256 (353)
Q Consensus 180 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~ 256 (353)
+++.++.+||+|||++........ ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.......
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 999999999999999987654322 123356889999999998765 3678999999999999999999998765544
Q ss_pred hHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 257 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+..... .++ ....+++++.+||.+||+.||++||++.++++|
T Consensus 248 ~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 248 LHSKIKSQAL-EFP-DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHCCC-CCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHhcccC-CCC-CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 4444433322 221 124578889999999999999999999999876
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=334.47 Aligned_cols=246 Identities=24% Similarity=0.404 Sum_probs=204.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||||++...... ..+|+.++.++ +||||+++++++.+....|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3689999999999999884 5889999998765322 34677888887 799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC----CCEEEeecccccccc
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLLT 199 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~----~~vkl~Dfg~a~~~~ 199 (353)
|||++||+|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||+.+. +.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999999998888999999999999999999999999 9999999999998543 249999999998765
Q ss_pred cCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---chHHHHHhcCCCCCCCchhhh
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---EVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 276 (353)
..... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ++...+..............+
T Consensus 172 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 172 AENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp CTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred CCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 43322 23355789999999998888899999999999999999999999864332 333444343333222234568
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
++++.+||.+||..||++||++.++++|-.
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 899999999999999999999999998743
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=330.64 Aligned_cols=248 Identities=25% Similarity=0.483 Sum_probs=190.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||+|++..... ......+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 4689999999999999984 488999999865432 122246778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 125 EYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 125 e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
||++ ++|.+++... ..+++..++.++.||+.||.|||+.| ++||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9996 6999999753 34899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC-CC--------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PP-------- 268 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~-------- 268 (353)
..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+..... +.
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 43322 22334578899999999764 689999999999999999999999987765554444432110 00
Q ss_pred ----CC-----------------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 ----FK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ----~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+. .....++.++.+||.+||+.||++|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 0012467789999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=322.62 Aligned_cols=251 Identities=30% Similarity=0.504 Sum_probs=204.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHH----HHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRV----RAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
..+|+..+.||+|+||.||. +++.||+|++........... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 45799999999999998883 578999999876443322221 57889999999999999999999986544
Q ss_pred eEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC-----EEEeecc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFG 193 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~-----vkl~Dfg 193 (353)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ .+++||||||+||+++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 79999999999999887543 5999999999999999999999986 23999999999999988776 9999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchH--HHHHhcCCCCC
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP--KAYAARQRPPF 269 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~ 269 (353)
++..... ......+++.|+|||++. ...++.++||||||+++|+|++|+.||......... ..+......
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 248 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR-- 248 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC--
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC--
Confidence 9975432 233456889999999984 456788999999999999999999999877665542 222222211
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
...+..+++++.+||.+||+.||++|||+.++++.|+++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 123456788999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=324.22 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=207.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
+|+..+.||+|+||.||. +|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 588899999999999984 488999999876433211 124578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC----CEEEeeccccccc
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLL 198 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~----~vkl~Dfg~a~~~ 198 (353)
||||+++++|.+++.....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++...
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999988778999999999999999999999999 99999999999999877 7999999999876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+..............++.
T Consensus 163 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 163 EAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 4332 22334578899999999999999999999999999999999999987765555544433332221122345678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+.+|+.+||..||++||++.++++|
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 89999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=351.30 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=212.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|+.||||++....... .....+.+|+.++++++||||+++++++.+....|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 34799999999999999984 58899999986432211 1235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc---CCCCEEEeeccccccccc
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~---~~~~vkl~Dfg~a~~~~~ 200 (353)
|||+++++|.+++.....+++..++.++.||+.||.|||++| ++||||||+|||++ .++.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999999988888999999999999999999999999 99999999999995 456799999999987643
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+.........+....+++++
T Consensus 177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 32 2234568899999999876 58999999999999999999999999887777777766655444334456788999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 018614 281 KELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+||.+||..||++|||+.++++|
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=329.13 Aligned_cols=258 Identities=26% Similarity=0.456 Sum_probs=215.8
Q ss_pred CcCcccceeeecceEEEEEEc-----C-----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFWR-----G-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~~-----g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 117 (353)
..+|+..+.||+|+||.||.. | ..||+|.+.... ..+..+.+.+|+.+++++ +||||+++++++.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 457899999999999999842 2 379999987543 345567889999999999 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 183 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~ 183 (353)
+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 9999999999999999999753 34799999999999999999999999 999999999999999
Q ss_pred CCCEEEeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHH
Q 018614 184 SGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY 261 (353)
Q Consensus 184 ~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~ 261 (353)
++.++|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 9999999999998765433221 223345778999999998899999999999999999998 99999887766555444
Q ss_pred HhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 262 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
........ .+..+++++.+|+.+||+.||++|||+.+++++|+++.....
T Consensus 280 ~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 280 VKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 44332221 234467889999999999999999999999999999876544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=331.03 Aligned_cols=254 Identities=24% Similarity=0.495 Sum_probs=207.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
..+|+..+.||+|+||.||. +|+ .||+|.+..... ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 45799999999999999984 333 467787754322 223457889999999999999999999998754
Q ss_pred eEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.++|+|++.+++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 88999999999999999864 45999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 199 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 199 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......+. +..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 244 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPIC 244 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTTB
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CccC
Confidence 543222 2233446778999999999999999999999999999999 9999998887777776655544433 3457
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
+.++.+||.+||..||++||++.++++.|+.+...
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 88899999999999999999999999999998654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=357.32 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=211.1
Q ss_pred eeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCC
Q 018614 56 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 56 ~~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
+.||+|+||.||. .+..||||+++.... +....+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999984 357899999976532 33445678999999999999999999999964 56899999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC--CCc
Q 018614 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPL 206 (353)
Q Consensus 129 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~--~~~ 206 (353)
+|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999998888999999999999999999999999 99999999999999999999999999987654322 122
Q ss_pred ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......++...+........ +..+++++.+||.
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~ 606 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDLMN 606 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHH
Confidence 33446778999999999999999999999999999998 9999998887777777766554443 3457899999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 286 ECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
.||..||++||++.++++.|+++...+
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999987655
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=327.66 Aligned_cols=250 Identities=23% Similarity=0.373 Sum_probs=203.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++.... ........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3689999999999999983 48899999986653 34455677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++++|.+++.....+++..++.++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999999988778999999999999999999999999 999999999999999999999999999876533222
Q ss_pred CcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC----------------
Q 018614 205 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP---------------- 267 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------------- 267 (353)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+......
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 223457889999999876 56799999999999999999999999877655444333221100
Q ss_pred --CCCC---------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 --PFKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 --~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.... ....++.++.+||.+||+.||++|||++++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 013467889999999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=333.39 Aligned_cols=240 Identities=24% Similarity=0.387 Sum_probs=181.7
Q ss_pred ceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEEecCC
Q 018614 55 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 55 ~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
.+.||+|+||.||. +|+.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 47899999999984 4789999998643 1245678999999997 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC---CEEEeecccccccccCCCCC
Q 018614 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 129 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~---~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+++|.+++...+.+++..++.++.|++.||.|||+++ ++||||||+|||++.++ .+||+|||++........ .
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 9999999998888999999999999999999999999 99999999999998766 799999999986543322 2
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-------chHHHHHhcCCCCCCCchhhhHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------EVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
.....+|+.|+|||++.+..++.++||||||+++|+|++|+.||...... +....+..............+++
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence 23345788999999999999999999999999999999999999865432 22223322222221122346789
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.+||.+||..||++|||+.++++|
T Consensus 246 ~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 246 EAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 99999999999999999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=323.01 Aligned_cols=248 Identities=30% Similarity=0.552 Sum_probs=205.7
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec-CceEEEE
Q 018614 49 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVT 124 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~ 124 (353)
..+|+..+.||+|+||.|| ..|+.||||++.... ..+.+.+|+.++++++||||+++++++... +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 4479999999999999887 478999999987542 235788999999999999999999997544 5789999
Q ss_pred ecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 125 EYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||+++++|.+++...+. +++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999999986543 899999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+....... .+..+++++.
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 244 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPAVY 244 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---CCTTCCHHHH
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CcccCCHHHH
Confidence 22346778999999998899999999999999999998 999998877766666654443332 2356788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
++|.+||..||++||++.++++.|+++...
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=329.16 Aligned_cols=244 Identities=24% Similarity=0.393 Sum_probs=197.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc------
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP------ 119 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------ 119 (353)
+|+..+.||+|+||.||. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 688899999999999883 58899999987543 23345678999999999999999999999865432
Q ss_pred ---------------------------------------------------eEEEEecCCCCCHHHHHHhcCC---CCHH
Q 018614 120 ---------------------------------------------------MMIVTEYLPKGDLRAFLKRKGA---LKPS 145 (353)
Q Consensus 120 ---------------------------------------------------~~iv~e~~~~~~L~~~l~~~~~---~~~~ 145 (353)
.++||||+++++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 7999999999999999987543 5666
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC-----------CCcccCCCCCc
Q 018614 146 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-----------RPLTCQDTSCR 214 (353)
Q Consensus 146 ~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-----------~~~~~~~~~~~ 214 (353)
.++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++........ .......+|+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999999 99999999999999999999999999987754321 12233468999
Q ss_pred ccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCC
Q 018614 215 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 294 (353)
Q Consensus 215 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 294 (353)
|+|||++.+..++.++||||||+++|+|++|..|+.. .............+......++++.+||.+||+.||++
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence 9999999999999999999999999999998776521 11111112222333334566788999999999999999
Q ss_pred CCCHHHHHHH
Q 018614 295 RPTFRQIITR 304 (353)
Q Consensus 295 Rps~~~ll~~ 304 (353)
|||+.++++|
T Consensus 317 Rps~~~~l~~ 326 (332)
T 3qd2_B 317 RPEATDIIEN 326 (332)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhhc
Confidence 9999999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=354.66 Aligned_cols=248 Identities=24% Similarity=0.426 Sum_probs=208.6
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCCC
Q 018614 57 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 57 ~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
.||+|+||.||. .+..||||+++... .....+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 799999999873 35679999997643 22334678999999999999999999999976 569999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC--Cc
Q 018614 130 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL 206 (353)
Q Consensus 130 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~--~~ 206 (353)
|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++........ ..
T Consensus 420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999999754 34999999999999999999999999 999999999999999999999999999876533221 11
Q ss_pred ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||......++...+..+..... +..+++++.+||.
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~ 573 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECPPELYALMS 573 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHHHHH
Confidence 22335678999999998999999999999999999998 9999999888887777766654443 3457899999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 286 ECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
+||..||++||++.++++.|+.+.....
T Consensus 574 ~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 574 DCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp HTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred HHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 9999999999999999999999877655
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=355.35 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=207.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|+.||||++.............+.+|+.++++++||||+++++++.+....|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 34689999999999999984 5889999998654322222335678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 124 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
|||++||+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999986543 999999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----hHHHHHhcCCCCCCCchhhhH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 277 (353)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... +...+ ......+ +..++
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i-~~~~~~~---p~~~s 413 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVPEEY---SERFS 413 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH-HHCCCCC---CTTSC
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh-hcccccC---CccCC
Confidence 2 2234568999999999999999999999999999999999999998765432 22222 2222222 35678
Q ss_pred HHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
+++.+||.+||..||++|| +++++++|
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 9999999999999999999 78999977
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=319.29 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=210.4
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec--CceEEEE
Q 018614 50 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~ 124 (353)
.+|+..+.||+|+||.|| ..|..||||++..... .....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 368899999999999887 4689999999976533 345557799999999999999999999999877 7789999
Q ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 125 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+. +++|+||||+||+++.++.++|.|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 9999999999998765 48999999999999999999999762 399999999999999999999999988755322
Q ss_pred CCCcccCCCCCcccCccccCCCCCCC---chhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||...........+......+ ..+..++++
T Consensus 166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 239 (271)
T 3kmu_A 166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--TIPPGISPH 239 (271)
T ss_dssp ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--CCCTTCCHH
T ss_pred ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--CCCCCCCHH
Confidence 2235688999999998765554 7999999999999999999998876655555444433222 123467889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
+.+++.+||+.||++|||++++++.|+++.
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 999999999999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=339.36 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=194.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecC--ceE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS--PMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~--~~~ 121 (353)
.+|+..+.||+|+||.|+. +|+.||||++... .........+.+|+.+++++. ||||+++++++...+ .+|
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 4799999999999999884 4889999998654 334555677889999999997 999999999997544 689
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
+||||++ ++|.+++... .+++..+..++.||+.||.|||+.| ++||||||+|||++.++.+||+|||+++.....
T Consensus 88 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999995 6999999764 6999999999999999999999999 999999999999999999999999999865321
Q ss_pred C--------------------CCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHH
Q 018614 202 E--------------------DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 260 (353)
Q Consensus 202 ~--------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 260 (353)
. ........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1 111233568999999999976 6789999999999999999999999988765554444
Q ss_pred HHhcCCCCC------------------------------CCc-------------hhhhHHHHHHHHHHHcccCCCCCCC
Q 018614 261 YAARQRPPF------------------------------KAP-------------AKLYARGLKELIEECWNEKPAKRPT 297 (353)
Q Consensus 261 ~~~~~~~~~------------------------------~~~-------------~~~~~~~l~~li~~cl~~dp~~Rps 297 (353)
+......+. ... ...+++++.+||.+||..||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 432111110 000 0145778999999999999999999
Q ss_pred HHHHHHH
Q 018614 298 FRQIITR 304 (353)
Q Consensus 298 ~~~ll~~ 304 (353)
++++++|
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=326.48 Aligned_cols=248 Identities=27% Similarity=0.461 Sum_probs=199.4
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|+..+.||+|+||.||. .|+.||+|++..... .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 688999999999999984 478999999865432 122235678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
++ ++|.+++... +.+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 96 5999999864 56999999999999999999999999 99999999999999999999999999987643222 2
Q ss_pred cccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCC---------------
Q 018614 206 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP--------------- 268 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~--------------- 268 (353)
.....+|+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+.... .+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 2334578899999998764 58999999999999999999999998766544443332211 000
Q ss_pred -CC--------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -FK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+. .....+++++.+||.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 0113467889999999999999999999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=330.02 Aligned_cols=254 Identities=31% Similarity=0.534 Sum_probs=209.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeE--EEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 121 (353)
.+|+..+.||+|+||.||. +|.. ||+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 4789999999999999873 4554 4899886432 234456788999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC
Q 018614 122 IVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~ 185 (353)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++| ++||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence 9999999999999997653 5899999999999999999999999 99999999999999999
Q ss_pred CEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhc
Q 018614 186 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 264 (353)
Q Consensus 186 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 264 (353)
.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+...
T Consensus 180 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred eEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 99999999987543221 1223446778999999988889999999999999999998 99999887665555554443
Q ss_pred CCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 265 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
.... .+..+++++.+||.+||..||++|||+.+++++|+++.....
T Consensus 258 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 258 YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp CCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 3222 234578899999999999999999999999999999876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=326.89 Aligned_cols=257 Identities=27% Similarity=0.467 Sum_probs=214.0
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 117 (353)
..+|+..+.||+|+||.||. +++.||||++.... .......+.+|+.+++++ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 45799999999999999984 24789999997643 345556789999999999 699999999998765
Q ss_pred C-ceEEEEecCCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEE
Q 018614 118 S-PMMIVTEYLPKGDLRAFLKRKGA----------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 180 (353)
Q Consensus 118 ~-~~~iv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nil 180 (353)
+ ..++||||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence 4 58999999999999999986543 789999999999999999999999 999999999999
Q ss_pred EcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchH
Q 018614 181 RDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 258 (353)
Q Consensus 181 l~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 258 (353)
++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 999999999999999876443222 1223446778999999999999999999999999999998 99999887655444
Q ss_pred HHHH-hcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 259 KAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 259 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
.... ....... +..+++++.+++.+||+.||++|||+.+++++|+.+..+-.
T Consensus 261 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 261 CRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHhccCccCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 3332 3322222 34578889999999999999999999999999999876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=337.74 Aligned_cols=264 Identities=14% Similarity=0.214 Sum_probs=205.6
Q ss_pred CcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHH--------HHHHHHHHHHHhcCCCCcccce
Q 018614 49 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDR--------VRAFRDELALLQKIRHPNVVQF 110 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~ 110 (353)
..+|+..+.||+|+||.||.. +..||||++.......... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 447999999999999999842 5789999986542100000 0123345667778889999999
Q ss_pred eeEEEec----CceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc--C
Q 018614 111 LGAVTQS----SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--D 183 (353)
Q Consensus 111 ~~~~~~~----~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~--~ 183 (353)
++++... ...++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.+ ++||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 9998765 4489999999 99999999875 56999999999999999999999999 99999999999999 8
Q ss_pred CCCEEEeecccccccccCCCC------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch
Q 018614 184 SGNLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 257 (353)
Q Consensus 184 ~~~vkl~Dfg~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 257 (353)
++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 899999999999876533221 11234589999999999999999999999999999999999999986444332
Q ss_pred HHHHHhcC-CCCCCC------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 018614 258 PKAYAARQ-RPPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 316 (353)
Q Consensus 258 ~~~~~~~~-~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 316 (353)
........ ...... ....+++++.+|+..||..||++||++.+|++.|+++........
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 22211111 111100 013457889999999999999999999999999999988765443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=332.29 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=200.9
Q ss_pred ccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC--CcccceeeEEEecCce
Q 018614 47 PHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPM 120 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~ 120 (353)
....+|+..+.||+|+||.||. +++.||||++..... .......+.+|+.++++++| +||+++++++.+....
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3455799999999999999984 478899999876543 45566788999999999976 9999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
++|||+. +++|.+++.....+++..++.++.||+.||.|||+.+ ++||||||+|||++ ++.+||+|||++.....
T Consensus 85 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCC-SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9999954 8899999999888999999999999999999999999 99999999999997 57899999999987654
Q ss_pred CCCC-CcccCCCCCcccCccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch-HHHHHhcCCC
Q 018614 201 KEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRP 267 (353)
Q Consensus 201 ~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~ 267 (353)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+.... .
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~ 238 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN-H 238 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT-S
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC-c
Confidence 3322 2234568999999999864 6788899999999999999999999976543211 11111111 1
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
. ...+...+.++.+||.+||+.||++|||+.++++|..
T Consensus 239 ~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 239 E-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp C-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred c-cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 1 1122345678999999999999999999999998743
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=333.98 Aligned_cols=254 Identities=25% Similarity=0.491 Sum_probs=210.3
Q ss_pred CcCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
..+|+..+.||+|+||.||. +|. .||+|.+..... ......+.+|+.++++++||||+++++++. +..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 44799999999999999984 233 388888754321 122235678999999999999999999886 467
Q ss_pred eEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.++||||+++++|.+++... +.+++..++.++.|++.||.|||+.| ++||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 89999999999999999864 46899999999999999999999999 999999999999999999999999999887
Q ss_pred ccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 199 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 199 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
...... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+........ +..+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 242 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---PQIC 242 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---CTTB
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---CCcC
Confidence 544322 2234557789999999998899999999999999999999 9999998887777777665543332 2346
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
+.++.+++.+||..||++||++.+++++|+.+...
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 77789999999999999999999999999998554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=333.71 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=208.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-C----HHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCc
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-D----DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~-~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 119 (353)
+|+..+.||+|+||.||. +|+.||||++...... . .+..+.+.+|+.+++++ +||||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 588889999999999984 4889999998654311 1 22345678999999999 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
.++||||+++++|.+++.....+++..++.++.||+.||.|||+.| ++|+||||+||+++.+|.++|+|||++....
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999998878999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCcccCCCCCcccCccccCC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCch
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 273 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 273 (353)
... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.........+..
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 252 PGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 332 2234568899999999853 35788999999999999999999999876655555555444333222223
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 274 KLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 274 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..++.++.+||.+||..||++|||+.++++|
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 4567889999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=335.46 Aligned_cols=243 Identities=26% Similarity=0.369 Sum_probs=194.6
Q ss_pred Ccccc-eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh-cCCCCcccceeeEEEe----cCc
Q 018614 51 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQ----SSP 119 (353)
Q Consensus 51 ~~~~~-~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~----~~~ 119 (353)
+|... +.||+|+||.||. +|+.||||++... ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 56665 6899999999984 4789999998532 24567888874 4589999999999875 567
Q ss_pred eEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---CCCEEEeeccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 194 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~~~vkl~Dfg~ 194 (353)
+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||+.| ++||||||+|||++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998653 4999999999999999999999999 999999999999997 78899999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----hHHHHHhcCCCCCC
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFK 270 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~~~ 270 (353)
++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.........
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 98754322 2234557889999999999999999999999999999999999997765432 33444433332222
Q ss_pred CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 271 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
.....++.++.+||.+||..||++|||+.++++|-.
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 233567899999999999999999999999999843
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=322.55 Aligned_cols=250 Identities=29% Similarity=0.480 Sum_probs=198.0
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc--CCCCcccceeeEEEec----Cc
Q 018614 49 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQS----SP 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~----~~ 119 (353)
..+|+..+.||+|+||.|| .+|+.||||++.... ...+..|.+++.. ++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 3479999999999999987 478999999986531 1345566666666 7899999999987543 45
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh--------~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
.++||||+++++|.++++. ..+++..++.++.|++.||.||| +.+ ++||||||+|||++.++.+||+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 8999999999999999954 46999999999999999999999 777 99999999999999999999999
Q ss_pred cccccccccCCCCC---cccCCCCCcccCccccCCC------CCCCchhHHHHHHHHHHHHcC----------CCCCCCC
Q 018614 192 FGVSKLLTVKEDRP---LTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEG----------CPPFTMK 252 (353)
Q Consensus 192 fg~a~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~pf~~~ 252 (353)
||++.......... .....||+.|+|||++.+. .++.++||||||+++|+|++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997765432221 2234689999999999876 445789999999999999999 8888664
Q ss_pred CCCch----HHHHHh-cC-CCCCCC--chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 253 HDNEV----PKAYAA-RQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 253 ~~~~~----~~~~~~-~~-~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
..... ...... .. .+..+. ....+++++.+|+.+||+.||++|||+.++++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 33221 111111 11 222211 1234678899999999999999999999999999876
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=325.11 Aligned_cols=250 Identities=21% Similarity=0.330 Sum_probs=198.8
Q ss_pred CcCcccc-eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceE
Q 018614 49 ELDFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 49 ~~~~~~~-~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 121 (353)
...|+.. +.||+|+||.||. +|+.||||++..... .....+.+|+.++.++ +||||+++++++.+.+..|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3457774 7899999999984 588999999865432 2235678999999985 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC---EEEeeccccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLL 198 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~---vkl~Dfg~a~~~ 198 (353)
+||||+++++|.+++.....+++..++.++.|++.||.|||+++ ++||||||+||+++.++. +||+|||++...
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999998888999999999999999999999999 999999999999998776 999999998765
Q ss_pred ccCCC------CCcccCCCCCcccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-----------
Q 018614 199 TVKED------RPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----------- 256 (353)
Q Consensus 199 ~~~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~----------- 256 (353)
..... .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11123448899999999875 467899999999999999999999998765432
Q ss_pred ----hHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 257 ----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 257 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+..............++.++.+||.+||..||++|||+.++++|
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 223332222211111123578899999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=319.46 Aligned_cols=256 Identities=16% Similarity=0.227 Sum_probs=208.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEE-EecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||||++...... ..+.+|+.+++.++|++++..++.+ ......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 4799999999999999883 5889999998654322 2578899999999988876666555 566778999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE---cCCCCEEEeecccccccc
Q 018614 124 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill---~~~~~vkl~Dfg~a~~~~ 199 (353)
|||+ +++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999 8999999974 446999999999999999999999999 9999999999999 488899999999998765
Q ss_pred cCCCC------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---chHHHHHhcC-CCCC
Q 018614 200 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---EVPKAYAARQ-RPPF 269 (353)
Q Consensus 200 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~-~~~~ 269 (353)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... +....+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 44321 123456889999999999999999999999999999999999999875432 2333322221 1111
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhh
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~ 314 (353)
......+++++.+|+.+||+.||++|||+.++++.|+++......
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 111245678899999999999999999999999999999877654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=346.14 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=196.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 118 (353)
.+|+..+.||+|+||.|+. +|+.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4799999999999999974 48899999997653 34555677889999999999999999999996553
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|+||||++ ++|.+.+.. .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~-~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCS-EEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCC-CCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 4699999995 467777743 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC----------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP---------- 268 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---------- 268 (353)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 532 22334568999999999999999999999999999999999999998876544444332211110
Q ss_pred -----------CCC-----------------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -----------FKA-----------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -----------~~~-----------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
... .....++++.+||.+||..||++|||++++++|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 011226789999999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=319.16 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=212.6
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--C----HHHHHHHHHHHHHHhcCC-CCcccceeeEEE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--D----DDRVRAFRDELALLQKIR-HPNVVQFLGAVT 115 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~--~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 115 (353)
...+|+..+.||+|+||.||. +|+.||||++...... . ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 345799999999999999984 5789999998654311 1 233466789999999995 999999999999
Q ss_pred ecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 116 QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 116 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
+....++||||+++++|.+++.....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999998878999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCC
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 269 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 269 (353)
....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||...........+........
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred hhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 8765332 223345788999999884 45678899999999999999999999987766555555555443333
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
......++.++.+||.+||+.||++|||+.++++|
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 33345788999999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=327.18 Aligned_cols=256 Identities=29% Similarity=0.514 Sum_probs=209.0
Q ss_pred cCcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEE--e
Q 018614 48 HELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--Q 116 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~ 116 (353)
...+|+..+.||+|+||.||. .|..||||++... .....+.+.+|+.++++++||||+++++++. +
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 345799999999999999873 4789999998754 3555677899999999999999999999886 4
Q ss_pred cCceEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccc
Confidence 5568999999999999999986 345999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------------chH
Q 018614 196 KLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------------EVP 258 (353)
Q Consensus 196 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~---------------~~~ 258 (353)
......... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 876543221 123345777899999999888999999999999999999999998543221 111
Q ss_pred HHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 259 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
..+....... .+..+++++.+||.+||+.||++|||+.+++++|+.+....
T Consensus 255 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 255 ELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1222222222 24567889999999999999999999999999999885544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=322.61 Aligned_cols=246 Identities=28% Similarity=0.438 Sum_probs=201.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++........+....+.+|+.+++.++||||+++++++.+....++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 4799999999999999883 48899999986542222223457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++++|.+++...+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 99999999999988888999999999999999999999999 9999999999999999999999999998765332
Q ss_pred CcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+..... . .+..++.++.++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~---~~~~~~~~l~~l 241 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-Y---IPEYLNRSVATL 241 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C---CCTTSCHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c---CchhcCHHHHHH
Confidence 1223457889999999988765 5799999999999999999999987665555555443322 1 134567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 018614 284 IEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~~~ll~~ 304 (353)
|.+||+.||++|||+.++++|
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=338.97 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=204.9
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 119 (353)
.+|+..+.||+|+||.||. +|+.||||++...... .......+.+|+.+++++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4799999999999999983 5789999998753211 111223466799999999 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
.++||||+++++|.+++.....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999998888999999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCCCcccCCCCCcccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHh---cCCCCCCCchh
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---RQRPPFKAPAK 274 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~ 274 (353)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.. ...+. .+.
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~ 287 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---YPQ 287 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC---CCT
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC---CCc
Confidence 4333333345689999999999863 478899999999999999999999976544333222221 12222 234
Q ss_pred hhHHHHHHHHHHHcccCCCCCC-----CHHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRP-----TFRQIITRL 305 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~l 305 (353)
.++..+.+||.+||..||++|| +++++++|.
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 5778899999999999999999 999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=352.55 Aligned_cols=257 Identities=32% Similarity=0.512 Sum_probs=215.9
Q ss_pred CcccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 117 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 117 (353)
.|++. ..+|+..+.||+|+||.||. .+..||||++...... .+.+.+|+.++++++||||+++++++.+
T Consensus 261 ~~~i~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 261 AWEIP--RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp CSBCC--GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ceecc--hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 45544 33588889999999999984 3467999999765422 2468899999999999999999999876
Q ss_pred CceEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
+..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 678999999999999999964 245899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchh
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
+..............++..|+|||++.+..++.++||||||+++|||++ |+.||......++...+..+...+. +.
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~ 487 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PP 487 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC---CT
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 8764322122223446778999999998899999999999999999999 9999998877777766655544432 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
.++.++.+||.+||..||++|||+++|++.|+++...
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 6788999999999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=350.27 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=206.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||+|++.............+.+|+.++++++||||+++++++.+...+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 4688899999999999984 58899999987543322233456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 125 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 125 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
||++||+|.+++... ..+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999763 35999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----hHHHHHhcCCCCCCCchhhh
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 276 (353)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... +...+... ...+ +..+
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~~~---p~~~ 416 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AVTY---PDKF 416 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CCCC---CTTS
T ss_pred CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-ccCC---Cccc
Confidence 3222 233468999999999999999999999999999999999999998764322 22222222 2222 3467
Q ss_pred HHHHHHHHHHHcccCCCCCCCH-----HHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTF-----RQIITR 304 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~-----~~ll~~ 304 (353)
++++.+||.+||+.||++||++ +++++|
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 8899999999999999999964 777765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=360.97 Aligned_cols=247 Identities=27% Similarity=0.411 Sum_probs=212.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||||++........+..+.+..|..++..+ +||+|+++++++.+...+|+|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 4688999999999999883 4778999998754322223345678899999988 699999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++|+|.+++...+.+++..++.++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+++......
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 496 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 496 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence 999999999999998888999999999999999999999999 9999999999999999999999999998643322
Q ss_pred CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 283 (353)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+..... .+ +..+++++.+|
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~---p~~~s~~~~~l 572 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AY---PKSMSKEAVAI 572 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-CC---CTTSCHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CC---CccCCHHHHHH
Confidence 223345689999999999999999999999999999999999999998877777766655432 22 34578999999
Q ss_pred HHHHcccCCCCCCCH-----HHHHHH
Q 018614 284 IEECWNEKPAKRPTF-----RQIITR 304 (353)
Q Consensus 284 i~~cl~~dp~~Rps~-----~~ll~~ 304 (353)
|++||+.||++||++ ++|++|
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 999999999999998 778765
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=320.82 Aligned_cols=246 Identities=23% Similarity=0.440 Sum_probs=200.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|...+.||+|+||.||. +|..||+|++...... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4699999999999999983 5789999998765422 22357889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE---cCCCCEEEeecccccc
Q 018614 125 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKL 197 (353)
Q Consensus 125 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill---~~~~~vkl~Dfg~a~~ 197 (353)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++||||||+||++ +.++.++|+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999999864 356999999999999999999999999 9999999999999 4567899999999987
Q ss_pred cccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
..... ......+++.|+|||++. ..++.++||||||+++|+|++|+.||......+........ .+........++
T Consensus 177 ~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 252 (285)
T 3is5_A 177 FKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-EPNYAVECRPLT 252 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCC--CCCC
T ss_pred cCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-CcccccccCcCC
Confidence 64332 223355788999999986 46889999999999999999999999887655554444332 233333334467
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++.+||.+||+.||++|||+.++++|
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 889999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=328.28 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=201.9
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----CCcccceeeEEEecC
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPNVVQFLGAVTQSS 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~ 118 (353)
..+|+..+.||+|+||.||. +|+.||||++... ......+..|+.+++.+. ||||+++++++....
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 35799999999999999984 5789999998642 344566778999999986 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-------------
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------- 183 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~------------- 183 (353)
..++|||++ +++|.+++.... .+++..++.++.||+.||.|||+.| ++||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence 999999999 899999998754 4899999999999999999999999 999999999999975
Q ss_pred ------------CCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 018614 184 ------------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 251 (353)
Q Consensus 184 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 251 (353)
++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 788999999999865432 2234578999999999999999999999999999999999999987
Q ss_pred CCCCchHHHHHhcCCCCCC------------------------------------------CchhhhHHHHHHHHHHHcc
Q 018614 252 KHDNEVPKAYAARQRPPFK------------------------------------------APAKLYARGLKELIEECWN 289 (353)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~cl~ 289 (353)
....+....+.....+... ......++.+.+||.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 6654444433322111100 0001123678899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 018614 290 EKPAKRPTFRQIITR 304 (353)
Q Consensus 290 ~dp~~Rps~~~ll~~ 304 (353)
.||++|||+.++++|
T Consensus 342 ~dP~~Rpta~elL~h 356 (360)
T 3llt_A 342 IDPTLRPSPAELLKH 356 (360)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=331.78 Aligned_cols=247 Identities=27% Similarity=0.477 Sum_probs=207.6
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|..||+|++.... .......+.+|+.++++++||||+++++++.+++..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 34799999999999999984 48899999987642 455667889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~-~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||+++++|.+++...+.+++..++.++.|++.||.|||+. + ++||||||+||+++.++.++|+|||++.......
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999999999888899999999999999999999996 8 9999999999999999999999999997654322
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHH----------------------
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA---------------------- 260 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~---------------------- 260 (353)
.....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....
T Consensus 187 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 187 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred ---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2234578899999999999999999999999999999999999976543322111
Q ss_pred --------------------HHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 261 --------------------YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 261 --------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+.....+ ......++.++.+||.+||+.||++|||++++++|-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred ccccccCCCCcccchhhhhHHhccCCC--CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 1111111 112344688899999999999999999999999883
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.86 Aligned_cols=247 Identities=31% Similarity=0.590 Sum_probs=200.6
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 50 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
.+|+..+.||+|+||.|| ..+..||||.+... ...+.+.+|+.++++++||||+++++++. +..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 368889999999999887 46889999998643 23467889999999999999999999886 358999999
Q ss_pred CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHh---cCCCCEEecCCCCCCEEEcCCCC-EEEeecccccccc
Q 018614 127 LPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHE---NKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLT 199 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~Lh~---~~~~~iiH~dlkp~Nill~~~~~-vkl~Dfg~a~~~~ 199 (353)
+++++|.+++..... ++...++.++.|++.||.|||+ ++ ++||||||+||+++.++. +||+|||++....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999986543 7889999999999999999999 66 999999999999998887 7999999997654
Q ss_pred cCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchH--HHHHhcCCCCCCCchhhhH
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP--KAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 277 (353)
.. .....+++.|+|||++.+..++.++||||||+++|+|++|+.||......... ........+. ....++
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 230 (307)
T 2eva_A 158 TH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP---LIKNLP 230 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC---CBTTCC
T ss_pred cc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC---cccccC
Confidence 32 12245788999999999999999999999999999999999999865544322 2222222222 245678
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
..+.+|+.+||+.||++|||+.++++.|+.+.....
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 899999999999999999999999999999865443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.54 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=198.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 118 (353)
.+|+..+.||+|+||.||. +|+.||||++.... ........+.+|+.++++++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4799999999999999883 48899999986643 34555677899999999999999999999997653
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.| ++||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 8899999976 46999999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC-----------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----------- 266 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------- 266 (353)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 179 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 179 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 432 234567899999999877 6789999999999999999999999987765444333322110
Q ss_pred ----------------CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 ----------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..+......+++++.+||.+||..||++|||+.++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 01111123457889999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=343.90 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=187.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec-----Cc
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 119 (353)
.+|+..+.||+|+||.||. +|+.||||++... ..+....+.+.+|+.++++++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4799999999999999873 5789999998654 33455667889999999999999999999998543 56
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
+|+|||++ +++|.+++.....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 89999998 6799999988888999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCC--------------------------CCcccCCCCCcccCcccc-CCCCCCCchhHHHHHHHHHHHHc--------
Q 018614 200 VKED--------------------------RPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIE-------- 244 (353)
Q Consensus 200 ~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt-------- 244 (353)
.... .......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 3221 112345679999999976 56679999999999999999998
Q ss_pred ---CCCCCCCCCCCc--------------------hHHHHHh-----------------------cC----CCCCCCchh
Q 018614 245 ---GCPPFTMKHDNE--------------------VPKAYAA-----------------------RQ----RPPFKAPAK 274 (353)
Q Consensus 245 ---g~~pf~~~~~~~--------------------~~~~~~~-----------------------~~----~~~~~~~~~ 274 (353)
|+++|.+..... ....+.. .. ...+.....
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 677776543210 0000000 00 000111123
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
..++++.+||.+||..||++|||++++++|
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 457889999999999999999999999997
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=330.92 Aligned_cols=249 Identities=21% Similarity=0.376 Sum_probs=196.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++..... .......+.+|+.++++++||||+++++++.++...++||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 4799999999999999884 588999999976532 2333456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc-----CCCCEEEeecccccccc
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-----DSGNLKVADFGVSKLLT 199 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~-----~~~~vkl~Dfg~a~~~~ 199 (353)
||++ ++|.+++.....+++..++.++.||+.||.|||+.+ ++||||||+|||++ ..+.+||+|||++....
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9996 599999998888999999999999999999999999 99999999999995 44559999999998765
Q ss_pred cCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC-CCCCC------
Q 018614 200 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PPFKA------ 271 (353)
Q Consensus 200 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~------ 271 (353)
.... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+..... +....
T Consensus 189 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Cccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 3322 22334568899999999875 479999999999999999999999987665544444432211 11000
Q ss_pred -------------------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 -------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 -------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+++++.+||.+||+.||++|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 012267889999999999999999999999976
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=325.97 Aligned_cols=250 Identities=27% Similarity=0.385 Sum_probs=199.9
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHhcC---CCCcccceeeEEEecC
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSS 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~ 118 (353)
..+|+..+.||+|+||.||. +|+.||||++....... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 44799999999999999883 57899999986432111 11112455677776666 4999999999998765
Q ss_pred -----ceEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 119 -----PMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 119 -----~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
..++|||++. ++|.+++..... +++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence 4799999995 699999987654 899999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 192 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+......+...
T Consensus 164 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 164 FGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp CSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99998764322 2234567899999999999999999999999999999999999998876655555443321110000
Q ss_pred -----------------------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 -----------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 -----------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+++++.+||.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 012467889999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=324.13 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=201.5
Q ss_pred CcCcccceeeecceEEEEEE-----cC-------eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RG-------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 116 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 116 (353)
..+|+..+.||+|+||.||. .+ ..||+|++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 44789999999999999883 22 579999986542 3344678899999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC--------E
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------L 187 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~--------v 187 (353)
....++||||+++++|.+++..... +++..++.++.|++.||.|||+++ ++||||||+|||++.++. +
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999987654 999999999999999999999999 999999999999998887 9
Q ss_pred EEeecccccccccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCchHHHHHhcC
Q 018614 188 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQ 265 (353)
Q Consensus 188 kl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~ 265 (353)
+|+|||++...... ....+++.|+|||++.+ ..++.++||||||+++|+|++| .+||..............
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-- 233 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-- 233 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--
Confidence 99999998654321 22335778999999987 6789999999999999999995 555555443333222222
Q ss_pred CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 266 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
.... +...++++.+|+.+||+.||++|||+.+++++|+++..+
T Consensus 234 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 234 RHQL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp TCCC---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred cCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1111 123456788999999999999999999999999998554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=342.17 Aligned_cols=239 Identities=13% Similarity=0.140 Sum_probs=191.6
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH---HHhcCCCCccccee-------eE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA---LLQKIRHPNVVQFL-------GA 113 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~~i~~~~-------~~ 113 (353)
..+|+..+.||+|+||.||. +|+.||||++...........+.+.+|+. .+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788999999999999983 48899999997654444556678899995 55555799999998 66
Q ss_pred EEecC-----------------ceEEEEecCCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhcCCCCE
Q 018614 114 VTQSS-----------------PMMIVTEYLPKGDLRAFLKRKGALKP-------STAVRFALDIARGMNYLHENKPVPI 169 (353)
Q Consensus 114 ~~~~~-----------------~~~iv~e~~~~~~L~~~l~~~~~~~~-------~~~~~i~~qi~~al~~Lh~~~~~~i 169 (353)
+.+.+ ..|+||||+ +|+|.+++...+.+++ ..++.++.||+.||.|||++| +
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 389999999 6899999986544554 788889999999999999999 9
Q ss_pred EecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCC-----------CCCCchhHHHHHHH
Q 018614 170 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALI 238 (353)
Q Consensus 170 iH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~i 238 (353)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2233445 899999999887 89999999999999
Q ss_pred HHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 239 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 239 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+|+|++|+.||...........+... ...+++++.+||.+||+.||++||++.++++|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CCSGGGGSS--------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccchhhhhhh--------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999776544433222111 13567889999999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=327.30 Aligned_cols=257 Identities=29% Similarity=0.471 Sum_probs=212.0
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 49 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
..+|+..+.||+|+||.||. ++..||||.+... ........+.+|+.++++++||||+++++++.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 45799999999999998873 3457999998643 23555567899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---CCCEE
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLK 188 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~~~vk 188 (353)
..|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++||||||+||+++. +..++
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999998653 3889999999999999999999999 999999999999994 44699
Q ss_pred EeecccccccccCCC-CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCC
Q 018614 189 VADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 189 l~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 266 (353)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 999999976543322 12233456789999999988899999999999999999998 9999988766666665555443
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
... +..++..+.+||.+||+.||++||++.+++++|+.+.....
T Consensus 264 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 264 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 332 34578899999999999999999999999999998866443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=320.00 Aligned_cols=253 Identities=26% Similarity=0.473 Sum_probs=200.1
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCcccceeeEEEec----Cce
Q 018614 50 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQS----SPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~ 120 (353)
.+|+..+.||+|+||.|| ..|+.||||++.... . ..+..|.+++... +||||+++++++.+. ...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE----E--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG----H--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc----c--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 479999999999999987 478999999985431 1 2344556665554 899999999999877 678
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCEEecCCCCCCEEEcCCCCEEEeec
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN--------KPVPIIHRDLEPSNILRDDSGNLKVADF 192 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~--------~~~~iiH~dlkp~Nill~~~~~vkl~Df 192 (353)
++||||+++++|.+++... .+++..++.++.|++.||.|||+. + ++||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeC
Confidence 9999999999999999765 599999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccccCCCCC---cccCCCCCcccCccccCCCCCCCc------hhHHHHHHHHHHHHcC----------CCCCCCCC
Q 018614 193 GVSKLLTVKEDRP---LTCQDTSCRYVAPEVFKNEEYDTK------VDVFSFALILQEMIEG----------CPPFTMKH 253 (353)
Q Consensus 193 g~a~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg----------~~pf~~~~ 253 (353)
|++.......... .....||+.|+|||++.+...... +|||||||++|+|++| ..||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9997664332221 123468899999999988776665 9999999999999999 77776543
Q ss_pred CCch----HHHHHh-cC-CCCCCC--chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 254 DNEV----PKAYAA-RQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 254 ~~~~----~~~~~~-~~-~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
.... ...... .. .+.+.. ....+++++.+||.+||+.||++|||+.+++++|+++....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 3221 111111 11 222211 12367889999999999999999999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=319.13 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=207.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++..... .+..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3688999999999999884 488999999865433 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC-
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~- 203 (353)
||+++++|.+++.....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999987777999999999999999999999999 99999999999999999999999999987643321
Q ss_pred CCcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||................... ......++..+.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPLA 240 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-STTGGGSCHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-cCchhhcCHHHHH
Confidence 12233557889999999987765 678999999999999999999998766543332222222222 2234567899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||+.||++|||+.++++|
T Consensus 241 li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHCCCCchhCCCHHHHhcC
Confidence 9999999999999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=322.66 Aligned_cols=257 Identities=26% Similarity=0.468 Sum_probs=203.6
Q ss_pred cCcCcccceeeecceEEEEEE------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 48 HELDFTNSVEITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
...+|+..+.||+|+||.||. ++ ..||||++........+..+.+.+|+.++++++||||+++++++.+..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 345799999999999998873 12 268999987665445566778999999999999999999999998754
Q ss_pred eEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.++|||++++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999999764 45999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhh
Q 018614 199 TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 275 (353)
Q Consensus 199 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (353)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+....... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--CCCTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC--CCCcC
Confidence 543221 1223456778999999988888999999999999999999 999998877666555554433221 12346
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 276 YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 276 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
++.++.+++.+||..||++|||+.+++++|+++..
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 78899999999999999999999999999998744
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=332.24 Aligned_cols=240 Identities=23% Similarity=0.393 Sum_probs=202.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.+|+..+.||+|+||.||. +|+.||||++........ .....+.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 4799999999999998884 588999999876543221 122356789999999999999999999999999
Q ss_pred eEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 120 MMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 120 ~~iv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.++|||++.+| +|.+++.....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999998666 99999998888999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
.... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... . . .....+..++
T Consensus 181 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~-~----~~~~~~~~~~ 248 (335)
T 3dls_A 181 ERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----V-E----AAIHPPYLVS 248 (335)
T ss_dssp CTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----T-T----TCCCCSSCCC
T ss_pred CCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----H-h----hccCCCcccC
Confidence 5432 2233457899999999988876 78999999999999999999999753210 0 1 1111233478
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++.+||.+||+.||++|||+.+++++
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 889999999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=329.63 Aligned_cols=247 Identities=23% Similarity=0.401 Sum_probs=196.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++..... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 688999999999999984 578999999865421 1111234579999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|++ ++|.+++...+ .+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 995 69999988654 4899999999999999999999999 99999999999999999999999999986543322
Q ss_pred CcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCC------------
Q 018614 205 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA------------ 271 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------------ 271 (353)
......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+......+...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2233457889999999876 568999999999999999999999998876655554443321111100
Q ss_pred --------------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 --------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 --------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+++++.+||.+||+.||++|||++++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 012357789999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.97 Aligned_cols=256 Identities=16% Similarity=0.230 Sum_probs=205.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEE-EecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||||++...... ..+.+|+.+++.++|++++..++.+ ......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 4799999999999999883 5789999986543222 3477899999999988777666655 666778999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE---cCCCCEEEeecccccccc
Q 018614 124 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill---~~~~~vkl~Dfg~a~~~~ 199 (353)
|||+ +++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 9999999985 446999999999999999999999999 9999999999999 788999999999998765
Q ss_pred cCCC------CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc---hHHHHHhcC-CCCC
Q 018614 200 VKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAYAARQ-RPPF 269 (353)
Q Consensus 200 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~---~~~~~~~~~-~~~~ 269 (353)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 4332 12234568899999999999999999999999999999999999998755432 222221111 1111
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhh
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~ 314 (353)
......+++++.+|+.+||+.||++|||+.++++.|+++......
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 111244678999999999999999999999999999999876653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=325.01 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=191.6
Q ss_pred ccCccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEe-
Q 018614 44 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ- 116 (353)
Q Consensus 44 ~i~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~- 116 (353)
.+.....+|+..+.||+|+||.||. +|+.||||++... .......+.+|+.+++++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 4445566899999999999999883 5789999988543 3555677899999999996 9999999999943
Q ss_pred -------cCceEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC
Q 018614 117 -------SSPMMIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 117 -------~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
....++||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||+.+. +++||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSC
T ss_pred ccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCC
Confidence 33479999999 5799998865 4569999999999999999999999752 3999999999999999999
Q ss_pred EEEeecccccccccCCCCC-----------cccCCCCCcccCcccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 018614 187 LKVADFGVSKLLTVKEDRP-----------LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMK 252 (353)
Q Consensus 187 vkl~Dfg~a~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~ 252 (353)
+||+|||++.......... .....+++.|+|||++ .+..++.++||||||+++|+|++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998765432211 1134478899999998 5667889999999999999999999999765
Q ss_pred CCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 253 HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
......... ... ......+..+.+||.+||+.||++||++.+++++|+.+.....
T Consensus 257 ~~~~~~~~~---~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 257 AKLRIVNGK---YSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hHHHhhcCc---ccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 443322211 111 1123345668899999999999999999999999999977554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=316.16 Aligned_cols=251 Identities=25% Similarity=0.477 Sum_probs=205.8
Q ss_pred ccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe----c
Q 018614 47 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S 117 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~ 117 (353)
.....|...+.||+|+||.||. ++..||+|.+..... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 3344588889999999999984 467899999876543 34556788999999999999999999999875 3
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc-CCCCEEEeeccccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSK 196 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~-~~~~vkl~Dfg~a~ 196 (353)
...++||||+++++|.+++.....+++..++.++.|++.||.|||+.+. +++|+||||+||+++ .++.++|+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 4589999999999999999987889999999999999999999999752 399999999999998 78999999999997
Q ss_pred ccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 197 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
..... ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||..................+ .......
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 255 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFDKVA 255 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-GGGGGCC
T ss_pred ccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-cccCCCC
Confidence 64322 2233557889999998875 58999999999999999999999998755443333322222221 1223456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++++.+||.+||..||++|||+.++++|
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 6889999999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=319.27 Aligned_cols=246 Identities=25% Similarity=0.444 Sum_probs=204.0
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|+.||||.+..... ...+.+|+.++++++||||+++++++......++|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 45799999999999999884 388999999865421 24678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999999974 456999999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.....+.+ ..+..++..+.+
T Consensus 180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 257 (314)
T 3com_A 180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF-RKPELWSDNFTD 257 (314)
T ss_dssp S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSCHHHHH
T ss_pred c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-CCcccCCHHHHH
Confidence 2 22334578899999999999999999999999999999999999987654444333333333222 234567899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||..||++|||+.++++|
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHccCChhhCcCHHHHHhC
Confidence 9999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=331.76 Aligned_cols=248 Identities=22% Similarity=0.381 Sum_probs=200.2
Q ss_pred CcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CCcccceeeEEEecCceEE
Q 018614 49 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~i 122 (353)
..+|+..+.||+|+||.||. .|+.||||++..... ..+....+.+|+.++++++ ||||+++++++.....+|+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34599999999999999984 378999999876543 4556678999999999996 5999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||| +.+++|.+++.....+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++.......
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999 458899999998888999999999999999999999999 99999999999996 5899999999998765432
Q ss_pred CC-CcccCCCCCcccCccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHhcC-CCC
Q 018614 203 DR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQ-RPP 268 (353)
Q Consensus 203 ~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~-~~~ 268 (353)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.... ...
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 22 2234568999999999865 36888999999999999999999999765432 1222222211 111
Q ss_pred CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 269 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 269 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+ +...+.++.+||.+||..||++||++.++++|-
T Consensus 289 ~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 289 F---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp C---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred C---CccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1 233467899999999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=328.84 Aligned_cols=248 Identities=22% Similarity=0.366 Sum_probs=206.6
Q ss_pred Ccccc-eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEE
Q 018614 51 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 51 ~~~~~-~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv 123 (353)
+|... +.||+|+||.||. +|+.||+|++...... ......+.+|+.+++.+. ||||+++++++.+....++|
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 46665 7899999999984 4889999998764332 223457889999999995 69999999999999999999
Q ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---CCCEEEeeccccccc
Q 018614 124 TEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLL 198 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~~~vkl~Dfg~a~~~ 198 (353)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.| ++||||||+||+++. ++.+||+|||++...
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999998543 56999999999999999999999999 999999999999998 789999999999876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
.... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+..............+++
T Consensus 185 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 262 (327)
T 3lm5_A 185 GHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence 5332 22334688999999999999999999999999999999999999988776666555554443333334456789
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+.+||.+||+.||++|||++++++|
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 99999999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=321.03 Aligned_cols=248 Identities=30% Similarity=0.505 Sum_probs=211.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
..|+..+.||+|+||.||. +|+.||||++..... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4699999999999999884 478999999876532 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++++|.+++.. +.+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.........
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999865 46999999999999999999999999 999999999999999999999999999876543222
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.....+.. ...++..+.+||
T Consensus 176 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li 251 (303)
T 3a7i_A 176 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL---EGNYSKPLKEFV 251 (303)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CSSCCHHHHHHH
T ss_pred -cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC---ccccCHHHHHHH
Confidence 2335578899999999999999999999999999999999999987765555555444433332 345788899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
.+||..||++|||+.+++++..-
T Consensus 252 ~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 252 EACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp HHHCCSSGGGSCCHHHHTTCHHH
T ss_pred HHHcCCChhhCcCHHHHhhChhh
Confidence 99999999999999999998543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.80 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=196.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec-----Cc
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 119 (353)
.+|+..+.||+|+||.|+. +|+.||||++... .........+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4799999999999999984 4789999999764 33455667889999999999999999999999766 56
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
.|+|||++ +++|.+++.....+++..++.++.||+.||.|||+.| ++||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecC-CcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 89999999 5699999998878999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCC---------------------CcccCCCCCcccCcccc-CCCCCCCchhHHHHHHHHHHHHcC-----------C
Q 018614 200 VKEDR---------------------PLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEG-----------C 246 (353)
Q Consensus 200 ~~~~~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg-----------~ 246 (353)
..... ......+|+.|+|||++ .+..++.++|||||||++|||++| .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 43211 12456789999999986 566799999999999999999984 4
Q ss_pred CCCCCCCCC-----------------chH-----------------------HHHHhcCCCCCCC----chhhhHHHHHH
Q 018614 247 PPFTMKHDN-----------------EVP-----------------------KAYAARQRPPFKA----PAKLYARGLKE 282 (353)
Q Consensus 247 ~pf~~~~~~-----------------~~~-----------------------~~~~~~~~~~~~~----~~~~~~~~l~~ 282 (353)
++|.+.+.. ... ............. ....+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 444433210 000 0000000000000 01346788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||..||++|||++++++|
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=319.12 Aligned_cols=242 Identities=21% Similarity=0.264 Sum_probs=193.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||||++...... .........|+..+..+ +||||+++++++.+++..++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 4689999999999999984 5889999998665433 33334445555555555 899999999999999999999
Q ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||+ +++|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999 779999887644 5999999999999999999999999 9999999999999999999999999988764332
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
......||+.|+|||++.+ .++.++||||||+++|+|++|..|+... .....+.....+ ......+++++.+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLP--PEFTAGLSSELRS 283 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCC--HHHHTTSCHHHHH
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCC--cccccCCCHHHHH
Confidence 2233458899999999876 7899999999999999999997665432 222222221111 1123457889999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||+.||++|||+.+++++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCChhhCcCHHHHHhC
Confidence 9999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=330.40 Aligned_cols=255 Identities=15% Similarity=0.214 Sum_probs=206.8
Q ss_pred cCcCcccceeeecceEEEEEE-------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccc-----
Q 018614 48 HELDFTNSVEITKGTFILAFW-------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ----- 109 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~----- 109 (353)
...+|+..+.||+|+||.||. .++.||||++... ..+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhh
Confidence 346899999999999999883 2788999998654 25778999999999999987
Q ss_pred ----------eeeEEEe-cCceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCC
Q 018614 110 ----------FLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176 (353)
Q Consensus 110 ----------~~~~~~~-~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp 176 (353)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp 187 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTA 187 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCG
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCH
Confidence 5677766 67789999999 99999999875 67999999999999999999999999 99999999
Q ss_pred CCEEEcCCC--CEEEeecccccccccCCCC------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCC
Q 018614 177 SNILRDDSG--NLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 248 (353)
Q Consensus 177 ~Nill~~~~--~vkl~Dfg~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 248 (353)
+|||++.++ .++|+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 8999999999876543221 11334688999999999999999999999999999999999999
Q ss_pred CCCCCCCc--hHHHHH--hcCCCCCCC---chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhh
Q 018614 249 FTMKHDNE--VPKAYA--ARQRPPFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 314 (353)
Q Consensus 249 f~~~~~~~--~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~ 314 (353)
|....... ...... ......+.. ....+++++.+||.+||..||++||++.++++.|+++......
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 98764222 111111 111111111 1134678999999999999999999999999999999877653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=338.21 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=197.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.+|...+.||+|+||.||. +|+.||||++...... ..+....+.+|+.++++++||||+++++++.. ..
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 4689999999999999984 4789999998754322 12223357899999999999999999999854 55
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC---CEEEeeccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSK 196 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~---~vkl~Dfg~a~ 196 (353)
.++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ ++||||||+|||++.++ .+||+|||+++
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccce
Confidence 8999999999999999988788999999999999999999999999 99999999999997544 59999999998
Q ss_pred ccccCCCCCcccCCCCCcccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-hHHHHHhcCCCCCCCc
Q 018614 197 LLTVKEDRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAP 272 (353)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 272 (353)
...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ....+...........
T Consensus 291 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 291 ILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred ecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 765322 2233568899999999863 567889999999999999999999998765543 3344433333332223
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...+++++.+||.+||+.||++||++.++++|
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 34578899999999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=322.18 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=208.3
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe--cCceE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMM 121 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 121 (353)
..+|+..+.||+|+||.||. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+ ....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 34799999999999998874 588999999976543 34556789999999999999999999998854 56789
Q ss_pred EEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCC--CCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 122 IVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKP--VPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~Lh~~~~--~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+.+. .+++|+||||+||+++.++.++|+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999753 248999999999999999999999761 23999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhh
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 275 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (353)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.....+.+ +..
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~ 239 (279)
T 2w5a_A 164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---PYR 239 (279)
T ss_dssp HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---CTT
T ss_pred eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---Ccc
Confidence 77643211 11223478899999999998999999999999999999999999988766566566655544333 345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 276 YARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 276 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
++.++.++|.+||+.||++||++.++++++.
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 7889999999999999999999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=323.32 Aligned_cols=256 Identities=26% Similarity=0.514 Sum_probs=209.7
Q ss_pred CcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC-
Q 018614 49 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 118 (353)
..+|+..+.||+|+||.||. +|+.||||++... ..+..+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 45689999999999999873 4789999998754 3455678899999999999999999999986543
Q ss_pred -ceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 119 -PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 119 -~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 7899999999999999998753 5999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC----------CC-c-----hH
Q 018614 197 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH----------DN-E-----VP 258 (353)
Q Consensus 197 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~----------~~-~-----~~ 258 (353)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||.... .. . ..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 76543221 1223446778999999988889999999999999999999999885321 00 0 11
Q ss_pred HHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 259 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
..+......+ .+..++.++.+||.+||+.||++|||+.++++.|+++...+.
T Consensus 274 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 274 ELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1122222222 235678899999999999999999999999999999977653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=325.06 Aligned_cols=253 Identities=22% Similarity=0.382 Sum_probs=203.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe----cCc
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSP 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~ 119 (353)
..+|+..+.||+|+||.||. +|+.||||++... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 45799999999999999873 5789999988543 35566788999999999999999999999863 346
Q ss_pred eEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 120 MMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999999975 356999999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCC--------cccCCCCCcccCccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCC--CCCchHHHHH
Q 018614 196 KLLTVKEDRP--------LTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMK--HDNEVPKAYA 262 (353)
Q Consensus 196 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~--~~~~~~~~~~ 262 (353)
.......... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||... ........+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 7653211110 11234688999999987654 688999999999999999999999642 1222333332
Q ss_pred hcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 263 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.....+ ....++.++.+||.+||+.||++||++.+++++|+.+..
T Consensus 262 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 NQLSIP---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp CC--CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ccCCCC---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 221111 234578899999999999999999999999999998743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=313.41 Aligned_cols=240 Identities=21% Similarity=0.361 Sum_probs=200.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||||++....... .....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4688999999999999984 58999999987654333 3446778899999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC---------------
Q 018614 124 TEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--------------- 184 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~--------------- 184 (353)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999764 56999999999999999999999999 9999999999999844
Q ss_pred ----CCEEEeecccccccccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHH
Q 018614 185 ----GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 259 (353)
Q Consensus 185 ----~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 259 (353)
..++|+|||++....... ...+++.|+|||.+.+. .++.++||||||+++|+|++|.+|+... ....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~ 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWH 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHH
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHH
Confidence 479999999998765332 23478899999999876 5667999999999999999998876433 3334
Q ss_pred HHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 260 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+.....+.. +..+++++.+||.+||..||++|||+.++++|
T Consensus 239 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 EIRQGRLPRI---PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHTTCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHcCCCCCC---CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 4444433332 34578899999999999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=328.00 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=199.1
Q ss_pred CccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 46 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 46 ~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
.....+|+..+.||+|+||.||. +|+.||||++....... ......+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 33456899999999999999984 47899999987543221 112246789999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
..++||||+++ +|.+++.... .+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 99999999965 8999887643 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCC-----
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK----- 270 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~----- 270 (353)
...... ......+|+.|+|||++.+. .++.++||||||+++|+|++|.+||......+....+.... .+...
T Consensus 162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 653322 22345678999999998764 57899999999999999999999998776555544443321 11000
Q ss_pred -------------C-----chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 271 -------------A-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 271 -------------~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
. ....++.++.+||.+||..||++|||+.++++|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 0134568899999999999999999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=323.31 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=200.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
.+|+..+.||+|+||.||. +|+.||||++...... .......+.+|+.++++++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 3689999999999999984 4789999998754321 1223345789999999999999999999987654
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC---EEEeeccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSK 196 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~---vkl~Dfg~a~ 196 (353)
.++||||+++++|.+++.....+++..++.++.||+.||.|||++| ++||||||+||+++.++. +||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 8999999999999999988778999999999999999999999999 999999999999987664 9999999998
Q ss_pred ccccCCCCCcccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHhcCCCCCCCc
Q 018614 197 LLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAP 272 (353)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 272 (353)
...... ......+++.|+|||++. +..++.++||||||+++|+|++|..||...... .....+...........
T Consensus 166 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 166 ILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp ECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred eccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 764221 112345788999999973 567889999999999999999999999876554 33344433333322222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...++.++.+||.+||..||++||++.++++|
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 34578899999999999999999999999976
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=328.05 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=202.9
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|+.||||++.... ........+.+|+.++++++||||+++++++.+....++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 34799999999999998873 37899999986543 3445556788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++++|.+++.....+++..++.++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++........
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999999999998877778999999999999999999999999 99999999999999999999999999987643322
Q ss_pred CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC----------------
Q 018614 204 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---------------- 266 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------- 266 (353)
......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+.....
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 22334578899999999875 789999999999999999999999987765444333321100
Q ss_pred -----CCCCC------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 -----PPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 -----~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.... ....+++++.+||.+||+.||++|||+.++++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 012467889999999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=329.50 Aligned_cols=257 Identities=16% Similarity=0.218 Sum_probs=199.2
Q ss_pred CcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHH--------HHHHHHHHHHHHhcCCCCcccceee
Q 018614 49 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDD--------RVRAFRDELALLQKIRHPNVVQFLG 112 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~ 112 (353)
..+|+..+.||+|+||.||. .+..||||++......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 45799999999999999883 5678999998654211000 1123567888999999999999999
Q ss_pred EEEe----cCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC--C
Q 018614 113 AVTQ----SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--N 186 (353)
Q Consensus 113 ~~~~----~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~--~ 186 (353)
++.. ....|+||||+ +++|.+++...+.+++..++.++.||+.||.|||+.+ ++||||||+|||++.++ .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence 9987 67899999999 9999999987778999999999999999999999999 99999999999999877 9
Q ss_pred EEEeecccccccccCCC------CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchH-H
Q 018614 187 LKVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-K 259 (353)
Q Consensus 187 vkl~Dfg~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~ 259 (353)
+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|+|++|+.||......... .
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 99999999987643321 1113456899999999999999999999999999999999999999653332221 1
Q ss_pred HHHhcCCCCCCCc------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 260 AYAARQRPPFKAP------AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 260 ~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
............. ...+++++.+||.+||..||++||+++++++.|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111111110 1157789999999999999999999999999998863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=328.77 Aligned_cols=247 Identities=25% Similarity=0.346 Sum_probs=195.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 118 (353)
.+|+..+.||+|+||.||. +|+.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4799999999999999974 48899999987643 34555677889999999999999999999997654
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|+||||++ ++|.+++.. .+++..++.++.||+.||.|||++| ++||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCC-CCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 6799999995 589888863 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC----------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP---------- 268 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---------- 268 (353)
.... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 178 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 178 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred cccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 4321 2233567889999999999999999999999999999999999998766544444333221111
Q ss_pred -----------CC-----------------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 269 -----------FK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 269 -----------~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
+. ......+.++.+||.+||..||++|||++++++|-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00 00122367899999999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=325.05 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=205.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec-----C
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----S 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 118 (353)
..+|+..+.||+|+||.||. +|..||||++... ......+.+.+|+.++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 45799999999999999984 5789999998753 2455567889999999999999999999999654 4
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|+|||+++ ++|.+++... .+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++...
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 6899999995 6999999764 5999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCC--cccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCC------
Q 018614 199 TVKEDRP--LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF------ 269 (353)
Q Consensus 199 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------ 269 (353)
....... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+......+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 5432221 234568999999998654 4589999999999999999999999988776666555432111110
Q ss_pred -----------------C----CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 270 -----------------K----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 270 -----------------~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
. .....++.++.+||.+||+.||++|||+.++++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0013457889999999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=323.88 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=196.7
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHH--HhcCCCCcccceeeEEEe-----cC
Q 018614 49 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELAL--LQKIRHPNVVQFLGAVTQ-----SS 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~i~~~~~~~~~-----~~ 118 (353)
..+|+..+.||+|+||.|| .+|+.||||++.... . ..+..|.++ +..++||||+++++.+.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---R---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---H---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---h---hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3479999999999999988 468999999986432 1 233344444 455899999999986543 22
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCEEecCCCCCCEEEcCCCCEEE
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN---------KPVPIIHRDLEPSNILRDDSGNLKV 189 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~---------~~~~iiH~dlkp~Nill~~~~~vkl 189 (353)
.+++||||+++|+|.+++.... .++..++.++.||+.||.|||+. + ++||||||+|||++.++.+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 5689999999999999997654 68999999999999999999999 8 999999999999999999999
Q ss_pred eecccccccccCCC-------CCcccCCCCCcccCccccCC-------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-
Q 018614 190 ADFGVSKLLTVKED-------RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIEGCPPFTMKHD- 254 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~pf~~~~~- 254 (353)
+|||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987653221 11223458999999999987 4566789999999999999999666533221
Q ss_pred Cch----------------HHH-HHh-cCCCCCCC---chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 255 NEV----------------PKA-YAA-RQRPPFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 255 ~~~----------------~~~-~~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
... ... ... ...+.++. ....+++++.+||.+||+.||++|||+.++++.|+++...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 110 011 111 11222211 223467789999999999999999999999999999988776
Q ss_pred hccc
Q 018614 314 HKRR 317 (353)
Q Consensus 314 ~~~~ 317 (353)
+.+.
T Consensus 322 ~~~~ 325 (336)
T 3g2f_A 322 RNKS 325 (336)
T ss_dssp C---
T ss_pred hccc
Confidence 5544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=321.16 Aligned_cols=251 Identities=26% Similarity=0.469 Sum_probs=190.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|+.||||.+..... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 45799999999999998873 578999999865432 23446788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 124 TEYLPKGDLRAFLKR--------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999974 345899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCC----CCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCC
Q 018614 196 KLLTVKED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 270 (353)
Q Consensus 196 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 270 (353)
........ .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.................+...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 76643221 11233457889999999876 56899999999999999999999999887665555444333322221
Q ss_pred C------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 271 A------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 271 ~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
. ....++.++.+||.+||+.||++||++.++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1 123567889999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=326.80 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=200.9
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe------
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------ 116 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------ 116 (353)
...+|+..+.||+|+||.||. +|+.||||++...... ......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 345799999999999998873 5789999998665332 2223457789999999999999999999976
Q ss_pred --cCceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 117 --SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 117 --~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
.+..++||||++ ++|.+.+... ..+++..++.++.|++.||.|||+.| ++||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 94 RCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp ---CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred cCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 346899999996 5887777654 46999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCC---CCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC-
Q 018614 194 VSKLLTVKED---RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP- 268 (353)
Q Consensus 194 ~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~- 268 (353)
++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987653222 22234567889999999876 457999999999999999999999998876555544443321111
Q ss_pred --CCCchh-------------------------hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 --FKAPAK-------------------------LYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 --~~~~~~-------------------------~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...... ..++++.+||.+||+.||++|||+.++++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 100000 125679999999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.27 Aligned_cols=244 Identities=25% Similarity=0.347 Sum_probs=200.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC------CCCcccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI------RHPNVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~ 117 (353)
..+|+..+.||+|+||.||. .|+.||||++... ......+.+|+.+++.+ +|+||+++++.+...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 34799999999999999984 4789999998653 34445677788888776 577999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC--EEEeecc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFG 193 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~--vkl~Dfg 193 (353)
...++|||++ +++|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+|||++.++. +||+|||
T Consensus 172 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 9999999999 569999998654 3899999999999999999999999 999999999999999887 9999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCC----
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF---- 269 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---- 269 (353)
++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+......+.
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 99765422 2234678899999999999999999999999999999999999987765444433322110000
Q ss_pred ----------------------------------------------CC-----chhhhHHHHHHHHHHHcccCCCCCCCH
Q 018614 270 ----------------------------------------------KA-----PAKLYARGLKELIEECWNEKPAKRPTF 298 (353)
Q Consensus 270 ----------------------------------------------~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~ 298 (353)
.. .....++++.+||.+||+.||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 00 001236779999999999999999999
Q ss_pred HHHHHH
Q 018614 299 RQIITR 304 (353)
Q Consensus 299 ~~ll~~ 304 (353)
.++++|
T Consensus 404 ~e~L~H 409 (429)
T 3kvw_A 404 GQALRH 409 (429)
T ss_dssp HHHHTS
T ss_pred HHHhCC
Confidence 999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=348.03 Aligned_cols=253 Identities=24% Similarity=0.468 Sum_probs=212.5
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceE
Q 018614 50 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 121 (353)
.+|+..+.||+|+||.||. .+..||||.+... ......+.+.+|+.++++++||||+++++++. ++..+
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 4688889999999999873 2457999998653 24556678999999999999999999999985 45689
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
+||||+++|+|.+++...+ .+++..++.++.|++.||.|||++| ++||||||+|||++.++.+||+|||++.....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 9999999999999998654 5899999999999999999999999 99999999999999999999999999987754
Q ss_pred CCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+......+. +..+++.
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~ 620 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PPNCPPT 620 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC---CTTCCHH
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---CccccHH
Confidence 43333333456778999999998899999999999999999997 9999998777676666665554443 3457889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
+.+||.+||..||++|||+.++++.|+++...
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=314.05 Aligned_cols=248 Identities=23% Similarity=0.406 Sum_probs=190.1
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
...+|+..+.||+|+||.||. +|+.||+|++.... ........+.++...++.++||||+++++++.+.+..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 345799999999999999974 68899999987643 223334445566666888899999999999999999999
Q ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 123 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~-~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
||||++ ++|.+++.. ...+++..++.++.|++.||.|||++ | ++||||||+||+++.++.+||+|||++..
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999996 588887753 45699999999999999999999998 8 99999999999999999999999999987
Q ss_pred cccCCCCCcccCCCCCcccCcccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-hHHHHHhcCCCCCCCc
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAP 272 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 272 (353)
...... .....+++.|+|||.+ .+..++.++||||||+++|+|++|+.||....... ..........+. ..
T Consensus 160 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 235 (290)
T 3fme_A 160 LVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ--LP 235 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC--CC
T ss_pred cccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC--cc
Confidence 654322 2234578899999996 56678899999999999999999999998643322 222222222222 22
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...+++++.+|+.+||+.||++|||+.++++|
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 34678899999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=315.54 Aligned_cols=248 Identities=26% Similarity=0.433 Sum_probs=208.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++...... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 3799999999999999884 5889999998654332 223457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC---CCEEEeecccccccccC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVK 201 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~---~~vkl~Dfg~a~~~~~~ 201 (353)
|++++++|.+++.....+++..++.++.|++.||.|||+.| ++|+||||+||+++.+ +.++|+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999999988778999999999999999999999999 9999999999999764 46999999999876433
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.. .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+..............++.++.
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 22 122336778999999876 489999999999999999999999988766666555555443322223356789999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+||.+||..||++|||+.+++++
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHcccChhhCcCHHHHhcC
Confidence 99999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=318.58 Aligned_cols=249 Identities=25% Similarity=0.418 Sum_probs=199.9
Q ss_pred CccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEe---
Q 018614 46 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ--- 116 (353)
Q Consensus 46 ~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--- 116 (353)
.....+|+..+.||+|+||.||. +|+.||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 34456899999999999999884 5889999998654322 24678899999999 79999999999976
Q ss_pred ---cCceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 117 ---SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 117 ---~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||+.| ++|+||||+||+++.++.++|+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999999864 45899999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC
Q 018614 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 192 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 266 (353)
||++........ ......+++.|+|||++. +..++.++||||||+++|+|++|..||...........+.....
T Consensus 173 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (326)
T 2x7f_A 173 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251 (326)
T ss_dssp CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred CcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence 999887643221 122345788999999987 56788999999999999999999999987665444444433333
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.. ....++..+.+||.+||..||++||++.++++|
T Consensus 252 ~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 252 PRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 222 234578899999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=319.37 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=204.0
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc--CCCCcccceeeEEEecC----ce
Q 018614 50 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQSS----PM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~ 120 (353)
.+|+..+.||+|+||.|| .+|+.||||++.... ...+.+|+++++. ++||||+++++++.... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 479999999999999887 468999999986431 2456788888887 68999999999998775 78
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCEEecCCCCCCEEEcCCCCEEEeec
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVADF 192 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh--------~~~~~~iiH~dlkp~Nill~~~~~vkl~Df 192 (353)
++||||+++++|.+++.+. .+++..++.++.|++.||.||| +.+ ++||||||+||+++.++.+||+||
T Consensus 116 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999999764 5899999999999999999999 777 999999999999999999999999
Q ss_pred ccccccccCCCC---CcccCCCCCcccCccccCCCC------CCCchhHHHHHHHHHHHHcC----------CCCCCCCC
Q 018614 193 GVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEG----------CPPFTMKH 253 (353)
Q Consensus 193 g~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg----------~~pf~~~~ 253 (353)
|++......... ......+++.|+|||++.+.. ++.++||||||+++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999876543321 123346889999999997763 33689999999999999999 78887654
Q ss_pred CCc-----hHHHHHhcC-CCCCCC--chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 254 DNE-----VPKAYAARQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 254 ~~~-----~~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
... ....+.... .+.+.. ....++..+.+|+.+||+.||++|||+.+++++|+++..+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 321 122221222 222211 12356678999999999999999999999999999987653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=320.36 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=202.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|..||+|++.... .+....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 4699999999999998873 47899999986543 223457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 125 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 125 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++........
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999999999876 456999999999999999999999999 99999999999999999999999998764322111
Q ss_pred CCcccCCCCCcccCcccc-----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 204 RPLTCQDTSCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
......+++.|+|||.+ .+..++.++||||||+++|+|++|..||...........+.....+. ...+..++.
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 250 (302)
T 2j7t_A 173 -KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTPSKWSV 250 (302)
T ss_dssp -C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGSCH
T ss_pred -ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCccccCH
Confidence 11234578899999998 46678999999999999999999999998776555554444443332 233566889
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++.+||.+||..||++|||+.++++|
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=329.85 Aligned_cols=247 Identities=12% Similarity=0.109 Sum_probs=184.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCccccee-------eEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFL-------GAVT 115 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~-------~~~~ 115 (353)
.+|+..+.||+|+||.||. +|+.||||++...........+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999983 5789999999876554556667788885544444 699987754 5554
Q ss_pred ecC-----------------ceEEEEecCCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhcCCCCEEe
Q 018614 116 QSS-----------------PMMIVTEYLPKGDLRAFLKRK-GALKPSTA------VRFALDIARGMNYLHENKPVPIIH 171 (353)
Q Consensus 116 ~~~-----------------~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~------~~i~~qi~~al~~Lh~~~~~~iiH 171 (353)
..+ ..|+||||++ ++|.+++... ..+....+ +.++.||+.||+|||++| ++|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 433 2799999997 8999999863 23455555 678899999999999999 999
Q ss_pred cCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCC
Q 018614 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPF 249 (353)
Q Consensus 172 ~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf 249 (353)
|||||+|||++.++.+||+|||+++...... ....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998764221 12345689999999987 68999999999999999999999999
Q ss_pred CCCCCCchHHH-----HHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 250 TMKHDNEVPKA-----YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 250 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
........... ...............+++++.+||.+||+.||++|||+.++++|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 87643321100 00001111111224678999999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=329.83 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=207.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC--ceE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 121 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 121 (353)
..+|+..+.||+|+||.||. +|+.||||++...... ...+.+.+|+.++++++||||+++++++.+.. ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 45799999999999999984 3889999998754322 22356778999999999999999999998765 679
Q ss_pred EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE----cCCCCEEEeeccc
Q 018614 122 IVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGV 194 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill----~~~~~vkl~Dfg~ 194 (353)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++||||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999997543 2899999999999999999999999 9999999999999 7777899999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCC--------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC----chHHHHH
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN--------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN----EVPKAYA 262 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~pf~~~~~~----~~~~~~~ 262 (353)
++...... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... +....+.
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 98765432 2233558899999999865 46778999999999999999999999754332 2222332
Q ss_pred hcCCC---------------------CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 263 ARQRP---------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 263 ~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
..... ........++..+.+++.+||+.||++||++.++++.++++...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 22211 01112356788999999999999999999999999999888654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=314.92 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=200.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCCCcccceeeEEE--ecCceE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~ 121 (353)
.+|+..+.||+|+||.||. +|..||+|++...... .......+.+|+.++++++||||+++++++. +....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 4799999999999999983 5789999998754211 1223467889999999999999999999984 456789
Q ss_pred EEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 122 IVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
+||||++++ |.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999665 8888875 345999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCC-CCcccCCCCCcccCccccCCCCC--CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 200 VKED-RPLTCQDTSCRYVAPEVFKNEEY--DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 200 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~--~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
.... .......+++.|+|||++.+... +.++||||||+++|+|++|+.||......+....+..... .. +..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~---~~~~ 236 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-AI---PGDC 236 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CC---CSSS
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-CC---CCcc
Confidence 3222 22234557889999999976543 7799999999999999999999987665555555544332 21 3457
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
++++.+||.+||..||++|||+.++++|
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 7889999999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=321.43 Aligned_cols=252 Identities=15% Similarity=0.208 Sum_probs=205.5
Q ss_pred cCccCcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCccccee
Q 018614 45 IDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFL 111 (353)
Q Consensus 45 i~~~~~~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~ 111 (353)
+.....+|...+.||+|+||.||.. ++.||||++.... . ..+..|+.+++.+. |+||++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~---~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---P---WEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---H---HHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---h---hHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 3344567999999999999998843 6789999987542 2 35667777777775 99999999
Q ss_pred eEEEecCceEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---
Q 018614 112 GAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--- 183 (353)
Q Consensus 112 ~~~~~~~~~~iv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~--- 183 (353)
+++...+..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence 999999999999999999999999974 345999999999999999999999999 999999999999998
Q ss_pred --------CCCEEEeecccccccccCC-CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 018614 184 --------SGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 254 (353)
Q Consensus 184 --------~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~ 254 (353)
++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999997654322 2223445689999999999999999999999999999999999999965433
Q ss_pred CchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCC-CCHHHHHHHHHHHHHHhh
Q 018614 255 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR-PTFRQIITRLESINNSIN 313 (353)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-ps~~~ll~~l~~~~~~~~ 313 (353)
.... ....+... ..++.+.+++..||+.+|.+| |+++++.+.|+++.....
T Consensus 291 ~~~~------~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 291 GECK------PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp TEEE------ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred Ccee------echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 2211 01111111 236678899999999999998 678888999998877644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=314.12 Aligned_cols=247 Identities=26% Similarity=0.459 Sum_probs=201.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe--------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-------- 116 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------- 116 (353)
.+|+..+.||+|+||.||. +|+.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3689999999999998873 48899999986542 246789999999999999999998854
Q ss_pred --------cCceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC
Q 018614 117 --------SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 117 --------~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34589999999999999999754 46999999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC
Q 018614 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 187 vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 266 (353)
++|+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++|..|+.... .....+....
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~~- 235 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGI- 235 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHTTC-
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhccc-
Confidence 99999999987654322 233457889999999999999999999999999999999998874321 1122221211
Q ss_pred CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 018614 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 316 (353)
Q Consensus 267 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 316 (353)
....++.++.+||.+||..||++||++.+++++|+.+.......+
T Consensus 236 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 236 -----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred -----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 123467889999999999999999999999999999876655433
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=327.57 Aligned_cols=245 Identities=26% Similarity=0.367 Sum_probs=185.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------C
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 118 (353)
.+|+..+.||+|+||.||. +|+.||||++.... ........+.+|+.++++++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4799999999999999884 48899999987643 3455567788999999999999999999998654 5
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..|+|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+.| ++||||||+|||++.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 679999999 7899999876 46999999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC----------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP---------- 267 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------- 267 (353)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 432 233567899999999877 67899999999999999999999999887654444333221100
Q ss_pred ------------CCC--C---chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ------------PFK--A---PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ------------~~~--~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
... . .....++++.+||.+||..||++|||+.++++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0 012346789999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=326.16 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=195.2
Q ss_pred ccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-----
Q 018614 47 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----- 116 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 116 (353)
....+|+..+.||+|+||.||. +|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3456899999999999999984 578999998865421 22469999999999999999999843
Q ss_pred ---------------------------------cCceEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 018614 117 ---------------------------------SSPMMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMN 159 (353)
Q Consensus 117 ---------------------------------~~~~~iv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~ 159 (353)
....++||||++ ++|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 234889999996 58777765 3456999999999999999999
Q ss_pred HHHhcCCCCEEecCCCCCCEEEc-CCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHH
Q 018614 160 YLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFAL 237 (353)
Q Consensus 160 ~Lh~~~~~~iiH~dlkp~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~ 237 (353)
|||+.| ++||||||+||+++ .++.+||+|||+++...... ......+++.|+|||.+.+. .++.++|||||||
T Consensus 156 ~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999 99999999999998 68899999999998764332 22345578899999998775 4899999999999
Q ss_pred HHHHHHcCCCCCCCCCCCchHHHHHhcCCCC-------------------CCC------chhhhHHHHHHHHHHHcccCC
Q 018614 238 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-------------------FKA------PAKLYARGLKELIEECWNEKP 292 (353)
Q Consensus 238 il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------------~~~------~~~~~~~~l~~li~~cl~~dp 292 (353)
++|+|++|+.||.+....+....+......+ ... .+..+++++.+||.+||..||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999998876555444443211100 000 123467889999999999999
Q ss_pred CCCCCHHHHHHH
Q 018614 293 AKRPTFRQIITR 304 (353)
Q Consensus 293 ~~Rps~~~ll~~ 304 (353)
++|||+.++++|
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=330.94 Aligned_cols=255 Identities=15% Similarity=0.224 Sum_probs=209.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-CcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~iv 123 (353)
.+|+..+.||+|+||.||. +|+.||||++...... ..+.+|+.+++.++| +++..+..++......++|
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 4799999999999999984 3889999987654322 246789999999986 5556666666778888999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE---cCCCCEEEeecccccccc
Q 018614 124 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill---~~~~~vkl~Dfg~a~~~~ 199 (353)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++...
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999 9999999985 456999999999999999999999999 9999999999999 688999999999998775
Q ss_pred cCCCC------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC----CCCC
Q 018614 200 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPF 269 (353)
Q Consensus 200 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----~~~~ 269 (353)
..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 44321 1224568999999999999999999999999999999999999998876654443332211 1111
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
......++.++.+||..||..||++||++.+|++.|+++.....
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 11234568899999999999999999999999999999977544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=326.03 Aligned_cols=248 Identities=23% Similarity=0.418 Sum_probs=205.3
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCH--------------HHHHHHHHHHHHHhcCCCCcccceee
Q 018614 50 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDD--------------DRVRAFRDELALLQKIRHPNVVQFLG 112 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i~~~~~ 112 (353)
.+|+..+.||+|+||.|| .+|+.||||.+........ .....+.+|+.++++++||||+++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred CceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 489999999999998877 3789999999865432211 11157889999999999999999999
Q ss_pred EEEecCceEEEEecCCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcC
Q 018614 113 AVTQSSPMMIVTEYLPKGDLRAF------LKR--KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDD 183 (353)
Q Consensus 113 ~~~~~~~~~iv~e~~~~~~L~~~------l~~--~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~ 183 (353)
++.+.+..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .| ++|+||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence 99999999999999999999998 655 4569999999999999999999999 88 999999999999999
Q ss_pred CCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCC-CCCC-chhHHHHHHHHHHHHcCCCCCCCCCC-CchHHH
Q 018614 184 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDT-KVDVFSFALILQEMIEGCPPFTMKHD-NEVPKA 260 (353)
Q Consensus 184 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~pf~~~~~-~~~~~~ 260 (353)
++.++|+|||++...... ......+++.|+|||.+.+. .++. ++||||||+++|+|++|+.||..... .+....
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 999999999999876433 22345678899999999887 5666 99999999999999999999988766 344444
Q ss_pred HHhcCCCCCCC----------------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 261 YAARQRPPFKA----------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 261 ~~~~~~~~~~~----------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+... ...++. ....++.++.+||.+||+.||++||++.++++|
T Consensus 265 i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 265 IRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred Hhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 4322 222211 014578899999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=312.47 Aligned_cols=244 Identities=27% Similarity=0.486 Sum_probs=197.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|.....||+|+||.||. ++..||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 456667899999999883 47899999986542 3344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-CCCEEEeecccccccccC
Q 018614 126 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~ 201 (353)
|+++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||+++. ++.++|+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999998652 3678999999999999999999999 999999999999997 899999999999876432
Q ss_pred CCCCcccCCCCCcccCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH--HhcCCCCCCCchhhhH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYA 277 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 277 (353)
.. ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||............ .....+. .+..++
T Consensus 177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 252 (295)
T 2clq_A 177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE---IPESMS 252 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC---CCTTSC
T ss_pred CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc---ccccCC
Confidence 21 123345788999999987643 788999999999999999999999765433221111 1122222 234578
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.++.+||.+||+.||++||++.+++++
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 899999999999999999999999876
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=313.99 Aligned_cols=244 Identities=27% Similarity=0.368 Sum_probs=201.5
Q ss_pred CcCcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC------cccceeeEEEe
Q 018614 49 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP------NVVQFLGAVTQ 116 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~ 116 (353)
..+|+..+.||+|+||.||. +|+.||||++... ......+.+|+.+++.++|+ +++++++++.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 34799999999999999883 4789999998643 34456788999999988765 49999999999
Q ss_pred cCceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-----------
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD----------- 183 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~----------- 183 (353)
.+..++||||+ +++|.+++...+ .+++..++.++.|++.||.|||++| ++||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999 889999998765 5889999999999999999999999 999999999999987
Q ss_pred --------CCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 018614 184 --------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 255 (353)
Q Consensus 184 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 255 (353)
++.++|+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999875432 22345788999999999999999999999999999999999999876654
Q ss_pred chHHHHHhcCCCC----------------------------------------CCCchhhhHHHHHHHHHHHcccCCCCC
Q 018614 256 EVPKAYAARQRPP----------------------------------------FKAPAKLYARGLKELIEECWNEKPAKR 295 (353)
Q Consensus 256 ~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~R 295 (353)
+....+.....+. ........++++.+||.+||..||++|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 4333322111100 001123457889999999999999999
Q ss_pred CCHHHHHHH
Q 018614 296 PTFRQIITR 304 (353)
Q Consensus 296 ps~~~ll~~ 304 (353)
||+.++++|
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=316.98 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=200.0
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec-----C
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----S 118 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 118 (353)
..+|+..+.||+|+||.||. +|+.||||++... ........+.+|+.++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 45799999999999999884 4889999998643 2455566788999999999999999999988654 6
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..++|||++. ++|.+++... .+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7899999995 6999999764 5999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCC---------CcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CC
Q 018614 199 TVKEDR---------PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP 267 (353)
Q Consensus 199 ~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~ 267 (353)
...... ......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.......+.... .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 533211 1122457889999998754 678999999999999999999999998765433322221110 00
Q ss_pred ----------------------CCC--C---chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ----------------------PFK--A---PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ----------------------~~~--~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
... . ....+++++.+||.+||..||++|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0 113567889999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=323.49 Aligned_cols=262 Identities=24% Similarity=0.434 Sum_probs=208.2
Q ss_pred CCcccCccCcCcccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 118 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 118 (353)
.+|++. ..+|+..+.||+|+||.||. .+..||+|++...... .+..+.+.+|+.++++++||||+++++++.+..
T Consensus 26 ~~~~i~--~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 26 QEWDIP--FEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGSSSC--CSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccCC--HHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 445544 34689999999999999883 3456999998754322 222245678999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.| ++||||||+||+++ ++.++|+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999997654 5899999999999999999999999 99999999999998 67999999999876
Q ss_pred cccCC----CCCcccCCCCCcccCccccCC---------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhc
Q 018614 198 LTVKE----DRPLTCQDTSCRYVAPEVFKN---------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 264 (353)
Q Consensus 198 ~~~~~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 264 (353)
..... ........+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 53221 112233457889999999875 35788999999999999999999999887766666555554
Q ss_pred CCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 265 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 265 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
..+... ...++.++.+|+.+||..||++|||+.++++.|+++...
T Consensus 259 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 259 MKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 443332 234677899999999999999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=320.38 Aligned_cols=244 Identities=24% Similarity=0.380 Sum_probs=198.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce----
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM---- 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~---- 120 (353)
.+|...+.||+|+||.||. +|+.||||++.... ........+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4799999999999999984 48999999997653 3455567888999999999999999999999877654
Q ss_pred --EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 121 --MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 121 --~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
++||||+. ++|.+++.. .+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999995 689888743 4999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC---------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP--------- 268 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------- 268 (353)
... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+......+
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 432 223457889999999887 678999999999999999999999998766544443332211100
Q ss_pred ---------------CC---CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 ---------------FK---APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ---------------~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.. .....+++++.+||.+||+.||++|||+.++++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 0112457889999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=311.56 Aligned_cols=244 Identities=27% Similarity=0.421 Sum_probs=191.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe---------
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 116 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------- 116 (353)
+|+..+.||+|+||.||. +|+.||||.+... ......+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 588899999999999883 5889999998543 4556778999999999999999999998865
Q ss_pred ----cCceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 117 ----SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 117 ----~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 356799999999999999998654 4788999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCC-------------CCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC-CCc
Q 018614 192 FGVSKLLTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKH-DNE 256 (353)
Q Consensus 192 fg~a~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~-~~~ 256 (353)
||++....... ........+++.|+|||.+.+. .++.++||||||+++|+|++ ||.... ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99998764321 1112334578899999999765 68999999999999999998 554221 112
Q ss_pred hHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 257 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+...............+..+.+||.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 222232222211122234567789999999999999999999999976
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=326.01 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=179.3
Q ss_pred ccc-ceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe--cCceE
Q 018614 52 FTN-SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMM 121 (353)
Q Consensus 52 ~~~-~~~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 121 (353)
|+. +++||+|+||.||. .+..||||++...... ..+.+|+.++++++||||+++++++.. ....+
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 554 56899999999983 3678999999765332 357789999999999999999999954 66789
Q ss_pred EEEecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE----cCCCCEE
Q 018614 122 IVTEYLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLK 188 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill----~~~~~vk 188 (353)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999995 6888888632 13899999999999999999999999 9999999999999 6778999
Q ss_pred EeecccccccccCCC--CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------c
Q 018614 189 VADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------E 256 (353)
Q Consensus 189 l~Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~---------~ 256 (353)
|+|||+++....... .......+|+.|+|||++.+. .++.++|||||||++|+|++|++||...... +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987653321 222345679999999999874 5899999999999999999999999765432 1
Q ss_pred hHHHHHh-cCCCCCCCch---------------------------------hhhHHHHHHHHHHHcccCCCCCCCHHHHH
Q 018614 257 VPKAYAA-RQRPPFKAPA---------------------------------KLYARGLKELIEECWNEKPAKRPTFRQII 302 (353)
Q Consensus 257 ~~~~~~~-~~~~~~~~~~---------------------------------~~~~~~l~~li~~cl~~dp~~Rps~~~ll 302 (353)
....+.. ...+...... ...+.++.+||.+||..||++|||+++++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1111111 1111100000 01156788999999999999999999999
Q ss_pred HHH
Q 018614 303 TRL 305 (353)
Q Consensus 303 ~~l 305 (353)
+|-
T Consensus 333 ~hp 335 (405)
T 3rgf_A 333 QDP 335 (405)
T ss_dssp TSG
T ss_pred cCh
Confidence 983
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=311.38 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=200.3
Q ss_pred cCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CCcccceeeEEEecC
Q 018614 45 IDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSS 118 (353)
Q Consensus 45 i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~ 118 (353)
+.....+|+..+.||+|+||.||. +|+.||||++..... .......+.+|+.++++++ |+||+++++++.+..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 344456799999999999999984 478899999876433 4556678899999999997 599999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
..++|||+ .+++|.+++.....+++..++.++.|++.||.|||+.+ ++||||||+||++++ +.+||+|||++...
T Consensus 102 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 102 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 99999995 48899999998888999999999999999999999999 999999999999975 88999999999876
Q ss_pred ccCCCC-CcccCCCCCcccCccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch-HHHHHhcC
Q 018614 199 TVKEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQ 265 (353)
Q Consensus 199 ~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~ 265 (353)
...... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...+....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 543221 1223457899999999875 4678899999999999999999999976543221 11121111
Q ss_pred -CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 266 -RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 266 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
... .+...+.++.+||.+||..||++||++.+++++-
T Consensus 257 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 257 HEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp SCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cccC---CcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 111 1234577899999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=327.35 Aligned_cols=245 Identities=25% Similarity=0.352 Sum_probs=193.3
Q ss_pred ccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec----
Q 018614 47 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS---- 117 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 117 (353)
+...+|+..+.||+|+||.||. +|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 3445799999999999999983 488999999865321 234699999999999999999988542
Q ss_pred --CceEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC-CCEEEe
Q 018614 118 --SPMMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVA 190 (353)
Q Consensus 118 --~~~~iv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~-~~vkl~ 190 (353)
..+++||||+++ +|.+++. ....+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||+
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEec
Confidence 236799999964 7766664 2456999999999999999999999999 9999999999999955 568999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-C--
Q 018614 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R-- 266 (353)
Q Consensus 191 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~-- 266 (353)
|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+.... .
T Consensus 200 DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 200 DFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp CCTTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred cchhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999998764332 22335678999999998765 78999999999999999999999998766444333332210 0
Q ss_pred -----------CC--CCC---------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 -----------PP--FKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 -----------~~--~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.. +.. ....+++++.+||.+||..||++||++.++++|
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 000 012457889999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.69 Aligned_cols=244 Identities=23% Similarity=0.317 Sum_probs=197.4
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--------CCcccceeeEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--------HPNVVQFLGAVT 115 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~ 115 (353)
..+|+..+.||+|+||.||. +|+.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 35799999999999999984 4889999998643 445567889999999885 788999999987
Q ss_pred ----ecCceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCCCEEecCCCCCCEEEcCCC---
Q 018614 116 ----QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSG--- 185 (353)
Q Consensus 116 ----~~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~-~~~~iiH~dlkp~Nill~~~~--- 185 (353)
+....++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ | ++||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 456789999999 66777777654 4599999999999999999999998 8 99999999999999775
Q ss_pred ----------------------------------------------CEEEeecccccccccCCCCCcccCCCCCcccCcc
Q 018614 186 ----------------------------------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219 (353)
Q Consensus 186 ----------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE 219 (353)
.+||+|||++...... .....+|+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 7999999999876432 23345789999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHH------HHHh-cCCCC------------------------
Q 018614 220 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK------AYAA-RQRPP------------------------ 268 (353)
Q Consensus 220 ~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~------~~~~-~~~~~------------------------ 268 (353)
++.+..++.++|||||||++|+|++|+.||.......... .+.. ....+
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999998765433211 1100 00000
Q ss_pred -------------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
........+.++.+||.+||+.||++|||+.++++|
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 001124567889999999999999999999999976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=313.27 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=200.5
Q ss_pred ccCcCcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeeEEE--
Q 018614 47 PHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT-- 115 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~-- 115 (353)
....+|+..+.||+|+||.||. +|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 3456899999999999999883 36889999986543211 1112355677777666 8999999999987
Q ss_pred ---ecCceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEe
Q 018614 116 ---QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 190 (353)
Q Consensus 116 ---~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~ 190 (353)
.....++||||++ ++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999996 69999998753 3899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC---
Q 018614 191 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--- 267 (353)
Q Consensus 191 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--- 267 (353)
|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||...........+......
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 999998764322 223356788999999999999999999999999999999999999877655444444321100
Q ss_pred --------------------CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 --------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
........++..+.+||.+||..||++||++.++++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0001123467889999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=317.23 Aligned_cols=244 Identities=24% Similarity=0.385 Sum_probs=198.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc-----
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----- 119 (353)
.+|...+.||+|+||.||. +|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4699999999999999984 48899999997643 345556778899999999999999999999987654
Q ss_pred -eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 120 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 120 -~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999995 688887743 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC------------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------ 265 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------ 265 (353)
... .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 432 223457889999999877 678999999999999999999999998765443333322110
Q ss_pred ---------------CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 ---------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 ---------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...+......+++++.+||.+||..||++|||+.++++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111222234568899999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=311.35 Aligned_cols=241 Identities=21% Similarity=0.369 Sum_probs=195.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEe--cCceE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~ 121 (353)
.+|+..+.||+|+||.||. +|+.||||++.... ...+.+|+.++++++ ||||+++++++.+ ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 4699999999999999984 57899999986432 246789999999997 9999999999987 66789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEeeccccccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTV 200 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~Dfg~a~~~~~ 200 (353)
+||||+++++|.+++.. +++..++.++.|++.||.|||++| ++||||||+|||++.++ .++|+|||++.....
T Consensus 110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999998853 899999999999999999999999 99999999999999777 799999999987653
Q ss_pred CCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-hHHHHH------------hcCC
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYA------------ARQR 266 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~~~------------~~~~ 266 (353)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....+. ....
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 322 233467889999999877 678999999999999999999999995443211 111100 0000
Q ss_pred CCC---------------------CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 PPF---------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ~~~---------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
... ......+++++.+||.+||+.||++|||++++++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 01123368899999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=312.70 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=193.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEE---------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--------- 115 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--------- 115 (353)
.+|+..+.||+|+||.||. +|+.||||++... +.+..+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 4799999999999999884 3889999998643 4566678899999999999999999999873
Q ss_pred -----ecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc-CCCCEEE
Q 018614 116 -----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKV 189 (353)
Q Consensus 116 -----~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~-~~~~vkl 189 (353)
+....++||||++ ++|.+++.. +.+++..++.++.|++.||.|||++| ++||||||+||+++ +++.+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3457899999996 699999865 46999999999999999999999999 99999999999997 5678999
Q ss_pred eecccccccccCCC--CCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC
Q 018614 190 ADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 266 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 266 (353)
+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999987643221 11223446888999998865 6789999999999999999999999987765444433322211
Q ss_pred C-----------------------CCCC---chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 P-----------------------PFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ~-----------------------~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
. +... ....++.++.+||.+||+.||++|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 0000 113467889999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=321.48 Aligned_cols=243 Identities=26% Similarity=0.402 Sum_probs=192.4
Q ss_pred CcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc-----
Q 018614 49 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----- 119 (353)
..+|+..+.||+|+||.||. .+..||+|++..... ...+|+.+++.++||||+++++++...+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 44799999999999999983 355689988754321 12369999999999999999999965443
Q ss_pred -eEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc-CCCCEEEeecc
Q 018614 120 -MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG 193 (353)
Q Consensus 120 -~~iv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~-~~~~vkl~Dfg 193 (353)
.++||||+++ ++.+.+. ....+++..++.++.||+.||.|||+.| ++||||||+|||++ .++.+||+|||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 7899999966 4444433 2456999999999999999999999999 99999999999999 78999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC------
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------ 266 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------ 266 (353)
+++...... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 188 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 188 SAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp TCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 998764332 22345678899999998765 589999999999999999999999988765444443332110
Q ss_pred -------------CCCCC------chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 -------------PPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 -------------~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.... ....+++++.+||.+||..||++|||+.++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000 012367889999999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=314.94 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=172.2
Q ss_pred CcCcccce-eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe----cC
Q 018614 49 ELDFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SS 118 (353)
Q Consensus 49 ~~~~~~~~-~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~ 118 (353)
..+|+..+ .||+|+||.||. +|+.||||++... ... ..+....++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 45788854 699999999984 4889999998543 222 2223334566799999999999976 44
Q ss_pred ceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---CCCEEEeecc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFG 193 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~~~vkl~Dfg 193 (353)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++||||||+||+++. ++.+||+|||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 5899999999999999998754 5999999999999999999999999 999999999999986 4559999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHH----HHhcCCCCC
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA----YAARQRPPF 269 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~----~~~~~~~~~ 269 (353)
++....... .....+++.|+|||++.+..++.++||||||+++|+|++|..||........... +........
T Consensus 177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 998654322 2234568899999999888899999999999999999999999977654433211 111111111
Q ss_pred CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 270 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
......+++++.+||.+||..||++|||+.++++|-
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 122346788999999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=311.92 Aligned_cols=251 Identities=26% Similarity=0.447 Sum_probs=180.7
Q ss_pred ccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeeEEEecCce
Q 018614 47 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
....+|+..+.||+|+||.||. +|+.||||++.... .......+..|+. +++.++||||+++++++.+.+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 3345799999999999999983 48899999987542 2333445555655 77778999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCEEecCCCCCCEEEcCCCCEEEeeccc
Q 018614 121 MIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGV 194 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~Lh~~-~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~ 194 (353)
++||||++ ++|.+++.. ...+++..++.++.|++.||.|||+. | ++||||||+||+++.++.+||+|||+
T Consensus 97 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 97 WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence 99999996 588888863 45689999999999999999999998 8 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCcccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHhcCCCCC
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPF 269 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~ 269 (353)
+........ .....+++.|+|||++ .+..++.++||||||+++|+|++|+.||...... +....+.....+.+
T Consensus 173 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 173 SGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred ceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 987643321 2223578899999998 4667899999999999999999999999764321 11111111111211
Q ss_pred C-CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 270 K-APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 270 ~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
. .....+++++.+||.+||..||++||++.+++++-
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 1 11235788999999999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=309.35 Aligned_cols=248 Identities=25% Similarity=0.441 Sum_probs=185.9
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|+.||||++..... .....+.+.++..+++.++||||+++++++.+....++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 44788999999999998884 488999999876432 233334455566678888999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 124 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~-~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
|||+ ++.+..+... ...+++..++.++.|++.||.|||+. | ++|+||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999 6677777654 45699999999999999999999995 8 999999999999999999999999999766433
Q ss_pred CCCCcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHhcCCCCCCCchhh
Q 018614 202 EDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKL 275 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 275 (353)
. ......+++.|+|||.+. +..++.++||||||+++|+|++|+.||...... +....+.....+.. +....
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 255 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHMG 255 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSSC
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccCC
Confidence 2 122345788999999984 557888999999999999999999999864432 33333333333222 22345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 276 YARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 276 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++++.+||.+||..||++||++.++++|
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 78899999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=319.57 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=195.4
Q ss_pred cCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccC--------CCHHHHHHHHHHHHHHhcCCCCcccceeeEEE
Q 018614 48 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVI--------SDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 115 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 115 (353)
...+|+..+.||+|+||.||. .|..||||++..... .+....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 345799999999999999984 488999999865322 23344578899999999999999999999985
Q ss_pred ec-----CceEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEE
Q 018614 116 QS-----SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 189 (353)
Q Consensus 116 ~~-----~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl 189 (353)
.. ...|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.| ++||||||+||+++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEE
Confidence 43 35799999996 68888887543 5999999999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC-
Q 018614 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP- 267 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 267 (353)
+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+......
T Consensus 176 ~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 176 CDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp CCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999997544322 2233457889999999877 67899999999999999999999999876654444433221110
Q ss_pred ----------------------CCCC-----chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 ----------------------PFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 ----------------------~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.... ....+++.+.+||.+||+.||++|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000 112346789999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=317.47 Aligned_cols=244 Identities=24% Similarity=0.274 Sum_probs=196.9
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CC-----cccceeeEEEec
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HP-----NVVQFLGAVTQS 117 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~ 117 (353)
..+|+..+.||+|+||.||. +|+.||||++... ......+..|+.+++.++ |+ +|+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34799999999999999984 4789999998643 344566778888888874 44 599999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCCCEEecCCCCCCEEEc--CCCCEEEee
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHE--NKPVPIIHRDLEPSNILRD--DSGNLKVAD 191 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~--~~~~~iiH~dlkp~Nill~--~~~~vkl~D 191 (353)
...++|||+++ ++|.+++... ..+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999995 6999999865 358999999999999999999995 56 99999999999995 477899999
Q ss_pred cccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCC--
Q 018614 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF-- 269 (353)
Q Consensus 192 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-- 269 (353)
||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+.
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999876432 2235678899999999999999999999999999999999999987765554444332111000
Q ss_pred --------------------------------CC--------------------------chhhhHHHHHHHHHHHcccC
Q 018614 270 --------------------------------KA--------------------------PAKLYARGLKELIEECWNEK 291 (353)
Q Consensus 270 --------------------------------~~--------------------------~~~~~~~~l~~li~~cl~~d 291 (353)
.. ......+++.+||.+||+.|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 00 00011247899999999999
Q ss_pred CCCCCCHHHHHHH
Q 018614 292 PAKRPTFRQIITR 304 (353)
Q Consensus 292 p~~Rps~~~ll~~ 304 (353)
|++|||++++++|
T Consensus 361 P~~Rpta~e~L~h 373 (382)
T 2vx3_A 361 PKTRIQPYYALQH 373 (382)
T ss_dssp TTTSCCHHHHTTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=311.03 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=198.7
Q ss_pred CcCcccceeeecceEEEEEE-----c-CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc------ccceeeEEEe
Q 018614 49 ELDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN------VVQFLGAVTQ 116 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~~~~ 116 (353)
..+|+..+.||+|+||.||. . +..||+|++... ....+.+.+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 45799999999999999983 2 378999998643 344567888999999997665 8999999999
Q ss_pred cCceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE-------------
Q 018614 117 SSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR------------- 181 (353)
Q Consensus 117 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill------------- 181 (353)
.+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++| ++||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 99999999999 677877776543 5999999999999999999999999 9999999999999
Q ss_pred ------cCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 018614 182 ------DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 255 (353)
Q Consensus 182 ------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 255 (353)
+.++.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999865432 23346789999999999999999999999999999999999999876654
Q ss_pred chHHHHHhcCCCC----------------------------------------CCCchhhhHHHHHHHHHHHcccCCCCC
Q 018614 256 EVPKAYAARQRPP----------------------------------------FKAPAKLYARGLKELIEECWNEKPAKR 295 (353)
Q Consensus 256 ~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~R 295 (353)
+....+.....+. ........+.++.+||.+||..||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 4333322211100 001112346689999999999999999
Q ss_pred CCHHHHHHH
Q 018614 296 PTFRQIITR 304 (353)
Q Consensus 296 ps~~~ll~~ 304 (353)
||+.++++|
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=316.49 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=185.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc----
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 119 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 119 (353)
..+|+..+.||+|+||.||. +|..||||++....... ....+++..++.++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 44799999999999999883 47899999885543222 245677888888999999999999976443
Q ss_pred ---eEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCEEecCCCCCCEEEcC-CCCEEE
Q 018614 120 ---MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDD-SGNLKV 189 (353)
Q Consensus 120 ---~~iv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~Lh--~~~~~~iiH~dlkp~Nill~~-~~~vkl 189 (353)
.++||||+++ +|.+.+. ....+++..++.++.|++.||.||| +.| ++||||||+|||++. ++.+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence 7899999965 6655443 3456899999999999999999999 888 999999999999996 899999
Q ss_pred eecccccccccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC
Q 018614 190 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 268 (353)
Q Consensus 190 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 268 (353)
+|||++....... ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+......+
T Consensus 174 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 174 CDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999998765432 22334578899999998665 48999999999999999999999998876555544443211110
Q ss_pred ----------------------------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 ----------------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 ----------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+......+++++.+||.+||+.||++|||+.++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000111257889999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.68 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=189.1
Q ss_pred CCcccCccCcCcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEE
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 115 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 115 (353)
|+++.... ..|...+.||+|+||.|+ .+|+.||||++.... ...+.+|+.+++++ +||||+++++++.
T Consensus 7 p~~~~~l~-~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 79 (434)
T 2rio_A 7 PNFEQSLK-NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSET 79 (434)
T ss_dssp -CCSCSCS-SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cchhhhhh-heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 44443322 346667889999999875 358899999986532 23567899999886 8999999999999
Q ss_pred ecCceEEEEecCCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC----
Q 018614 116 QSSPMMIVTEYLPKGDLRAFLKRKGAL-------KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---- 184 (353)
Q Consensus 116 ~~~~~~iv~e~~~~~~L~~~l~~~~~~-------~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~---- 184 (353)
+....|+||||++ |+|.+++...... ++..++.++.||+.||.|||+++ ++||||||+|||++.+
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~ 155 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFT 155 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHH
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccc
Confidence 9999999999994 6999999865432 22345789999999999999999 9999999999999754
Q ss_pred ---------CCEEEeecccccccccCCCC---CcccCCCCCcccCccccCC-------CCCCCchhHHHHHHHHHHHHc-
Q 018614 185 ---------GNLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE- 244 (353)
Q Consensus 185 ---------~~vkl~Dfg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt- 244 (353)
+.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 156 ~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~ 235 (434)
T 2rio_A 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235 (434)
T ss_dssp SCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence 47999999999877543221 1223468999999999876 578899999999999999999
Q ss_pred CCCCCCCCCCCchHHHHHhcCC--CCC-CCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 245 GCPPFTMKHDNEVPKAYAARQR--PPF-KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 245 g~~pf~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
|..||....... ..+..... +.. ......++.++.+||.+||+.||++|||+.++++|
T Consensus 236 g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 236 GKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp SCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 999997654332 22222221 111 11234678899999999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=323.13 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=190.0
Q ss_pred CcCcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|...+.||+|+||.|+ .+|+.||||++...... .+.+|+.+++.+ +||||+++++++.+....|+|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 4569999999999998754 36889999998654321 245799999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-----CCCEEEeecccccc
Q 018614 124 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVSKL 197 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-----~~~vkl~Dfg~a~~ 197 (353)
||+++ ++|.+++.... .+.+..++.++.||+.||.|||+.+ ++||||||+|||++. ...++|+|||+++.
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99994 69999998654 3555677899999999999999999 999999999999953 23588999999987
Q ss_pred cccCCC--CCcccCCCCCcccCccccC---CCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 198 LTVKED--RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 198 ~~~~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
...... .......||+.|+|||++. +..++.++|||||||++|+|++ |..||......... ............
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 251 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLGACSLDCLH 251 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTTCCCCTTSC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhccCCccccC
Confidence 654322 1223456899999999997 4567889999999999999999 99999655433322 222222222222
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.....+..+.+||.+||+.||++|||+.++++|
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 334567789999999999999999999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=313.96 Aligned_cols=244 Identities=20% Similarity=0.320 Sum_probs=193.9
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----------CCcccceee
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLG 112 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~ 112 (353)
..+|+..+.||+|+||.||. +|+.||||++... ......+.+|+.+++++. |+||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 45799999999999999983 5889999998643 334466788999998886 789999999
Q ss_pred EEEecC----ceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCCCEEecCCCCCCEEEc---
Q 018614 113 AVTQSS----PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRD--- 182 (353)
Q Consensus 113 ~~~~~~----~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~-~~~~iiH~dlkp~Nill~--- 182 (353)
++...+ ..++|||++ +++|.+++... ..+++..++.++.||+.||.|||++ | ++||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence 997654 689999999 89999999863 3499999999999999999999998 8 99999999999995
Q ss_pred ---CCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch--
Q 018614 183 ---DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-- 257 (353)
Q Consensus 183 ---~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-- 257 (353)
..+.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 3447999999999876432 2234578899999999999999999999999999999999999976542211
Q ss_pred ----HHHHHh-cCCCC-------------------------------------CCCchhhhHHHHHHHHHHHcccCCCCC
Q 018614 258 ----PKAYAA-RQRPP-------------------------------------FKAPAKLYARGLKELIEECWNEKPAKR 295 (353)
Q Consensus 258 ----~~~~~~-~~~~~-------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~R 295 (353)
...+.. ....+ ....+..++.++.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111110 00000 001124578899999999999999999
Q ss_pred CCHHHHHHH
Q 018614 296 PTFRQIITR 304 (353)
Q Consensus 296 ps~~~ll~~ 304 (353)
||+.++++|
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=312.90 Aligned_cols=243 Identities=26% Similarity=0.410 Sum_probs=200.6
Q ss_pred CccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCC--CCcccceeeEEE
Q 018614 46 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIR--HPNVVQFLGAVT 115 (353)
Q Consensus 46 ~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~ 115 (353)
+....+|+..+.||+|+||.||. +|+.||||++........ .....+.+|+.+++++. |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34456899999999999999984 588999999876543221 11134567999999996 599999999999
Q ss_pred ecCceEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc-CCCCEEEeecc
Q 018614 116 QSSPMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG 193 (353)
Q Consensus 116 ~~~~~~iv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~-~~~~vkl~Dfg 193 (353)
+....++|||++.+ ++|.+++...+.+++..++.++.|++.||.|||+.+ ++||||||+|||++ +++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999976 899999998888999999999999999999999999 99999999999999 78899999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCc
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 272 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
++...... ......+++.|+|||++.+..+ +.++||||||+++|+|++|+.||.... .+..... . .
T Consensus 196 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~-~---~ 262 (320)
T 3a99_A 196 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV-F---F 262 (320)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC-C---C
T ss_pred cccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccc-c---c
Confidence 99876532 2233458889999999877665 678999999999999999999996431 2222221 1 1
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...+++++.+||.+||+.||++|||+.+++++
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 24567889999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=306.67 Aligned_cols=241 Identities=27% Similarity=0.418 Sum_probs=192.5
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcC----CCCcccceeeEEE
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKI----RHPNVVQFLGAVT 115 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~i~~~~~~~~ 115 (353)
...+|+..+.||+|+||.||. +|+.||||++........ .....+.+|+.+++++ +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 345799999999999999984 478999999976543221 1223356788998888 8999999999999
Q ss_pred ecCceEEEEec-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc-CCCCEEEeecc
Q 018614 116 QSSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG 193 (353)
Q Consensus 116 ~~~~~~iv~e~-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~-~~~~vkl~Dfg 193 (353)
+.+..++|||+ +.+++|.+++...+.+++..++.++.|++.||.|||+.+ ++||||||+||+++ .++.++|+|||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCS
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcc
Confidence 98999999999 788999999998888999999999999999999999999 99999999999999 88999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCc
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 272 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
++....... .....++..|+|||++.+..+. .++||||||+++|+|++|+.||... ..+... ...+
T Consensus 186 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~-~~~~--- 252 (312)
T 2iwi_A 186 SGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEA-ELHF--- 252 (312)
T ss_dssp SCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHT-CCCC---
T ss_pred hhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhh-ccCC---
Confidence 998765332 2334578899999998776664 4899999999999999999999643 112121 1111
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+..++.++.+||.+||+.||++|||+.+++++
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 24577889999999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=299.34 Aligned_cols=230 Identities=13% Similarity=0.100 Sum_probs=189.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. .|+.||||++........+..+.+.+|+..+++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 5799999999999999883 38899999998776666677788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||++|++|.++++.. .....+..++.|++.||.|||++| ++||||||+|||++.+|.++|+++|
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999543 466678999999999999999999 9999999999999999999998443
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH---HhcCCCCCCCchhhhHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~ 281 (353)
|++ .++.++||||||+++|+|++|+.||......+..... ..............+++++.
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 333 3688999999999999999999999876543321100 01111111111245788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 282 ELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
+||.+||+.||++| |+.++++.|+++.....
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 99999999999999 99999999999865433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=294.41 Aligned_cols=222 Identities=25% Similarity=0.407 Sum_probs=177.2
Q ss_pred cCcccc-eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH-hcCCCCcccceeeEEEe----cC
Q 018614 50 LDFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQ----SS 118 (353)
Q Consensus 50 ~~~~~~-~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~----~~ 118 (353)
.+|... +.||+|+||.||. +|+.||+|++... ..+.+|+.++ +..+||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 467776 7799999999883 5789999998542 2456788887 55689999999999987 67
Q ss_pred ceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---CCCEEEeecc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFG 193 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~~~vkl~Dfg 193 (353)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.++|+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 7899999999999999998754 5999999999999999999999999 999999999999998 7889999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCCCCCc
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAP 272 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~ 272 (353)
++.... +..++.++||||||+++|+|++|+.||................ .......
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 222 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence 886532 2346789999999999999999999997654433221111111 1111111
Q ss_pred ---hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 018614 273 ---AKLYARGLKELIEECWNEKPAKRPTFRQIITRL 305 (353)
Q Consensus 273 ---~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l 305 (353)
...+++++.+||.+||+.||++|||+.++++|-
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 145788999999999999999999999999873
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=325.60 Aligned_cols=246 Identities=27% Similarity=0.370 Sum_probs=195.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe------cC
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SS 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 118 (353)
.+|+..+.||+|+||.||. +|..||||++.... .......+.+|+.++++++||||+++++++.. ++
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 4799999999999999873 58899999987642 45566788999999999999999999998755 67
Q ss_pred ceEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC---EEEeec
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADF 192 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~---vkl~Df 192 (353)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++||||||+||+++.++. ++|+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 7899999999999999998644 5899999999999999999999999 999999999999997765 999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCch---------HHHHH-
Q 018614 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------PKAYA- 262 (353)
Q Consensus 193 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~---------~~~~~- 262 (353)
|++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||........ .....
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9998765432 22345688999999999999999999999999999999999999965321000 00000
Q ss_pred ----hc------CCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHH
Q 018614 263 ----AR------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302 (353)
Q Consensus 263 ----~~------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll 302 (353)
.+ ..+........+++.+.+||..||..||++|||+.+++
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00 00111112345789999999999999999999999855
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=309.65 Aligned_cols=245 Identities=13% Similarity=0.124 Sum_probs=184.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-Ccccc--------------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQ-------------- 109 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~-------------- 109 (353)
.+|...+.||+|+||.||. +|+.||||++...........+.+.+|+.+++.+.| ++...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3577888999999999983 488999999875443334445678999999999976 22111
Q ss_pred -------eeeEEEe-----cCceEEEEecCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEE
Q 018614 110 -------FLGAVTQ-----SSPMMIVTEYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARGMNYLHENKPVPII 170 (353)
Q Consensus 110 -------~~~~~~~-----~~~~~iv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~ii 170 (353)
++.++.. ....+++|+.+ +++|.++++. ...+++..++.++.|++.||.|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 22467888877 7899999852 123677889999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCcccc----------CCCCCCCchhHHHHHHHHH
Q 018614 171 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----------KNEEYDTKVDVFSFALILQ 240 (353)
Q Consensus 171 H~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslG~il~ 240 (353)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998875433 223345 899999999 5667888999999999999
Q ss_pred HHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHHH
Q 018614 241 EMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINNS 311 (353)
Q Consensus 241 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--l~~~~~~ 311 (353)
+|++|+.||......+....+... ...+++++.+||.+||+.||++||++.+++++ ++.+...
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGGSS--------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred HHHHCCCCCCCcchhhhHHHHHhh--------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHH
Confidence 999999999876544333222111 12456889999999999999999999999876 4444443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=320.87 Aligned_cols=237 Identities=20% Similarity=0.306 Sum_probs=193.9
Q ss_pred cCcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc----
Q 018614 50 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 119 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 119 (353)
.+|+..+.||+|+||.||. +|+.||||++... ...+....+.+|+.++++++||||+++++++.+.+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 5799999999999999983 4789999998653 245566778999999999999999999999987766
Q ss_pred -eEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 120 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 120 -~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+||+|||+++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999998765 6999999999999999999999999 9999999999999985 8999999999876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||........ + ........++
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------~-~~~~~~~~~~ 295 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------P-EDDPVLKTYD 295 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------C-TTCHHHHHCH
T ss_pred ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------c-ccccccccCH
Confidence 432 334588999999998765 48899999999999999999999875322211 1 1112234567
Q ss_pred HHHHHHHHHcccCCCCCCC-HHHHHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRPT-FRQIITRLESINN 310 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps-~~~ll~~l~~~~~ 310 (353)
.+.+||.+||..||++||+ ++++...|..+..
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 8999999999999999995 6666666666543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=302.16 Aligned_cols=240 Identities=13% Similarity=0.148 Sum_probs=182.5
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCC---------CCccccee
Q 018614 49 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIR---------HPNVVQFL 111 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~i~~~~ 111 (353)
..+|+..+.||+|+||.|| .+|+.||||++...... .....+.+.+|+.+++.++ ||||+++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 3479999999999999987 46899999999765321 1222356778888888875 55665555
Q ss_pred eE-----------------EEe-------------cCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 018614 112 GA-----------------VTQ-------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 161 (353)
Q Consensus 112 ~~-----------------~~~-------------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~L 161 (353)
++ +.+ ....|+||||+++|++.+.+.+ ..+++..++.++.||+.||.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence 54 333 6789999999999876665543 4589999999999999999999
Q ss_pred H-hcCCCCEEecCCCCCCEEEcCCC--------------------CEEEeecccccccccCCCCCcccCCCCCcccCccc
Q 018614 162 H-ENKPVPIIHRDLEPSNILRDDSG--------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 220 (353)
Q Consensus 162 h-~~~~~~iiH~dlkp~Nill~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~ 220 (353)
| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||+
T Consensus 178 H~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 178 EASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred HHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence 9 899 99999999999999887 8999999999876532 2357899999999
Q ss_pred cCCCCCCCchhHHHHHHH-HHHHHcCCCCCCCCCC-CchHHHHHhc-C--CCCCCCchhhhHHHHHHHHHHHcccCCCCC
Q 018614 221 FKNEEYDTKVDVFSFALI-LQEMIEGCPPFTMKHD-NEVPKAYAAR-Q--RPPFKAPAKLYARGLKELIEECWNEKPAKR 295 (353)
Q Consensus 221 ~~~~~~~~~~DvwslG~i-l~elltg~~pf~~~~~-~~~~~~~~~~-~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 295 (353)
+.+.. +.++||||||++ .+++++|..||..... ......+... . ..........+++++.+||++||+.|
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 98766 889999998777 6777889999843210 0111222211 1 11122234578999999999999987
Q ss_pred CCHHHHH-HH
Q 018614 296 PTFRQII-TR 304 (353)
Q Consensus 296 ps~~~ll-~~ 304 (353)
|+++++ +|
T Consensus 324 -sa~e~l~~H 332 (336)
T 2vuw_A 324 -SATDLLCQH 332 (336)
T ss_dssp -SHHHHHHHC
T ss_pred -CHHHHHhcC
Confidence 899998 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=269.23 Aligned_cols=171 Identities=15% Similarity=0.126 Sum_probs=129.7
Q ss_pred EEcCeEEEEEEcCcccCC-------CHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEEEEecCCCCCHHHHHHh
Q 018614 67 FWRGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 138 (353)
Q Consensus 67 ~~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~ 138 (353)
++.|+.+++|.+...... .+...+++.+|+++|+++ .|+||+++++++.+++..||||||++|++|.+++..
T Consensus 256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~ 335 (569)
T 4azs_A 256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA 335 (569)
T ss_dssp EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence 467899999998764321 123346799999999999 699999999999999999999999999999999998
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCc
Q 018614 139 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 218 (353)
Q Consensus 139 ~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aP 218 (353)
.+++++. .|+.||+.||+|+|++| ||||||||+|||++++|.+||+|||+|+........ .....||+.|+||
T Consensus 336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~-~~t~vGTp~YmAP 408 (569)
T 4azs_A 336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW-PTNLVQSFFVFVN 408 (569)
T ss_dssp TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---CC-SHHHHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc-ccCceechhhccH
Confidence 8888765 57899999999999999 999999999999999999999999999876543322 2334588999999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHcC
Q 018614 219 EVFKNEEYDTKVDVFSFALILQEMIEG 245 (353)
Q Consensus 219 E~~~~~~~~~~~DvwslG~il~elltg 245 (353)
|++.+ .+..++|+|++|++++++.++
T Consensus 409 E~l~g-~~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 409 ELFAE-NKSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp HHC------------------CCCCTT
T ss_pred HHhCC-CCCCcccccccccchhhhccc
Confidence 99976 466789999999998877554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=232.91 Aligned_cols=184 Identities=20% Similarity=0.240 Sum_probs=144.3
Q ss_pred cceeeecceEEEEEE---cCeEEEEEEcCcccCCCHH-----HHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 54 NSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDD-----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 54 ~~~~ig~G~~~~v~~---~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
..+.||+|+||.||. .+..+++|........... ..+.+.+|+.++++++||||+++..++......|+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 456899999999983 6788999987554433222 23557899999999999999976666667788899999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++++|.+++.. +..++.|++.||.|||+++ ++||||||+|||++. .+||+|||+++.........
T Consensus 420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999865 5689999999999999999 999999999999999 99999999998875432211
Q ss_pred ------cccCCCCCcccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 018614 206 ------LTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFT 250 (353)
Q Consensus 206 ------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~ 250 (353)
.....||+.|+|||++.+ ..|+...|+|+..+-..+-..++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 124567899999999987 567788899999988888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-23 Score=185.58 Aligned_cols=144 Identities=17% Similarity=0.106 Sum_probs=112.8
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCH---------------HHHHHHHHHHHHHhcCCCCccccee
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD---------------DRVRAFRDELALLQKIRHPNVVQFL 111 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~i~~~~ 111 (353)
.|...+.||+|+||.||. +|+.||||+++....... .....+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 455679999999999884 588999999865321110 23467889999999999 5 6666
Q ss_pred eEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEee
Q 018614 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191 (353)
Q Consensus 112 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~D 191 (353)
+++.. +..|+||||++|++|.+ +. . .....++.|++.||.|||+.| ++||||||+|||++ ++.++|+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~----~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR----V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc----h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence 65544 55699999999999988 42 1 234579999999999999999 99999999999999 99999999
Q ss_pred cccccccccCCCCCcccCCCCCcccCccccCC
Q 018614 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 223 (353)
Q Consensus 192 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 223 (353)
||++... ..+.|||.+.+
T Consensus 236 FG~a~~~--------------~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVEV--------------GEEGWREILER 253 (282)
T ss_dssp CTTCEET--------------TSTTHHHHHHH
T ss_pred CCCCeEC--------------CCCCHHHHHHH
Confidence 9998643 24678887643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.7e-19 Score=156.82 Aligned_cols=135 Identities=21% Similarity=0.215 Sum_probs=103.1
Q ss_pred cccceeeecceEEEEEE-----cCeE--EEEEEcCcccCCC---------------------HHHHHHHHHHHHHHhcCC
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQ--VAVKKLGEEVISD---------------------DDRVRAFRDELALLQKIR 103 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 103 (353)
|+....||+|+||.||. +|+. ||||+++...... ......+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66778999999999872 6888 9999875432110 111235788999999998
Q ss_pred CCcc--cceeeEEEecCceEEEEecCCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCEEecCCC
Q 018614 104 HPNV--VQFLGAVTQSSPMMIVTEYLPK-G----DLRAFLKRKGALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLE 175 (353)
Q Consensus 104 h~~i--~~~~~~~~~~~~~~iv~e~~~~-~----~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh-~~~~~~iiH~dlk 175 (353)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.| ++|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 8764 444432 356899999932 3 78776532 234567889999999999999 898 9999999
Q ss_pred CCCEEEcCCCCEEEeeccccccc
Q 018614 176 PSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 176 p~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
|+|||++. .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 8999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.2e-17 Score=151.54 Aligned_cols=135 Identities=17% Similarity=0.138 Sum_probs=95.2
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCC------------C---HHH----HHHHHHHHHHHhcCCCCcc
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS------------D---DDR----VRAFRDELALLQKIRHPNV 107 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~------------~---~~~----~~~~~~E~~~l~~l~h~~i 107 (353)
-|++...||.|+++.||. +|+.||||+++..... . ... .....+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388899999999999984 5889999987642110 0 000 0112346666666644433
Q ss_pred c--ceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC
Q 018614 108 V--QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 185 (353)
Q Consensus 108 ~--~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~ 185 (353)
. ..++. ...++||||++|++|..+. .......++.|++.+|.+||..| +|||||||.|||++++|
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence 2 22222 2237999999888876543 22345678899999999999999 99999999999999877
Q ss_pred C----------EEEeeccccccc
Q 018614 186 N----------LKVADFGVSKLL 198 (353)
Q Consensus 186 ~----------vkl~Dfg~a~~~ 198 (353)
. +.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3 889999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=5e-12 Score=111.56 Aligned_cols=138 Identities=12% Similarity=0.032 Sum_probs=102.4
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
.|+....++.|+...|| ..|..+++|+......... ..+.+|+.+++.+. +..++++++++.+.+..|+|||+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~---~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH---HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 46665666666655554 3578999999865321111 24778999999884 66788999999988899999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN------------------------------------------ 164 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~------------------------------------------ 164 (353)
++|.+|.+.+. +......++.++..+|..||+.
T Consensus 92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99999987631 1223457888999999999981
Q ss_pred --------------CCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 165 --------------KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 165 --------------~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
....++|+|++|.||++++.+.+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01238999999999999876666799998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.06 E-value=5.9e-11 Score=107.11 Aligned_cols=185 Identities=17% Similarity=0.133 Sum_probs=121.8
Q ss_pred eeeecceEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCc--ccceeeEEEecC---ceEEEEecCCC
Q 018614 56 VEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPN--VVQFLGAVTQSS---PMMIVTEYLPK 129 (353)
Q Consensus 56 ~~ig~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--i~~~~~~~~~~~---~~~iv~e~~~~ 129 (353)
+.++.|....+|.-+..+++|..... .....+.+|+.+++.+. +.. +++++....... ..|+||++++|
T Consensus 26 ~~~~~G~~n~v~~v~~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEINRDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEESTTSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEECCEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 45888888888877778889986432 34467889999998883 333 445555443333 35899999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 018614 130 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-------------------------------------------- 165 (353)
Q Consensus 130 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~-------------------------------------------- 165 (353)
.+|.+.... .++......++.|++..|..||+..
T Consensus 101 ~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 101 VPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp EECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred eECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 888654332 3677788888888888888888611
Q ss_pred -----------CCCEEecCCCCCCEEEcC--CCCEEEeecccccccccCCCCCcccCCCCCcccCccccCC-----CCC-
Q 018614 166 -----------PVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEY- 226 (353)
Q Consensus 166 -----------~~~iiH~dlkp~Nill~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~- 226 (353)
...++|+|++|.||++++ .+.+.|+||+.+...+.... .........-..|+.... +..
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D--l~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND--FISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH--HHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH--HHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 123899999999999998 45688999998865432110 000000000012221110 011
Q ss_pred --------CCchhHHHHHHHHHHHHcCCCCC
Q 018614 227 --------DTKVDVFSFALILQEMIEGCPPF 249 (353)
Q Consensus 227 --------~~~~DvwslG~il~elltg~~pf 249 (353)
....+.|+++.++|.+.+|..+|
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12368999999999999998775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=3.6e-10 Score=104.32 Aligned_cols=140 Identities=14% Similarity=0.193 Sum_probs=99.8
Q ss_pred ceeeecceEEEEE---EcCeEEEEEEcC--cccCCCHHHHHHHHHHHHHHhcCC--CCcccceeeEEEec---CceEEEE
Q 018614 55 SVEITKGTFILAF---WRGIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQS---SPMMIVT 124 (353)
Q Consensus 55 ~~~ig~G~~~~v~---~~g~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~---~~~~iv~ 124 (353)
.+.++.|.+..+| ..+..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. +..|+||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4667878765554 346788889876 32211 11245778999999996 45578889888776 4589999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK--------------------------------------- 165 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~--------------------------------------- 165 (353)
|+++|..+.+.. -..++......++.+++.+|..||+..
T Consensus 121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999887764311 123678888899999999999999730
Q ss_pred ----------------CCCEEecCCCCCCEEEcCCCC--EEEeeccccccc
Q 018614 166 ----------------PVPIIHRDLEPSNILRDDSGN--LKVADFGVSKLL 198 (353)
Q Consensus 166 ----------------~~~iiH~dlkp~Nill~~~~~--vkl~Dfg~a~~~ 198 (353)
...++|+|+++.||+++.++. +.|+||+.+...
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 234999999999999997653 689999988653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=4e-10 Score=98.75 Aligned_cols=124 Identities=19% Similarity=0.147 Sum_probs=87.5
Q ss_pred cceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc--ccceeeEEEecCceEEEEecCCCCCHH
Q 018614 60 KGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYLPKGDLR 133 (353)
Q Consensus 60 ~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~iv~e~~~~~~L~ 133 (353)
.|..+.||. +|..+++|....... ..+..|+.+++.+.+.+ +++++++...++..++|||+++|.+|.
T Consensus 30 gg~~~~v~~~~~~~g~~~vlK~~~~~~~------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 30 GCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp TTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCCCceEEEEecCCCCeEEEEeCCcccc------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 444455552 356799999765311 24678999998885444 567888888888899999999998874
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 018614 134 AFLKRKGALKPSTAVRFALDIARGMNYLHENK------------------------------------------------ 165 (353)
Q Consensus 134 ~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~------------------------------------------------ 165 (353)
.. ... ...++.+++..|..||+..
T Consensus 104 --~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 --SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp --TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred --cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 21 122 2256677777777777642
Q ss_pred -------CCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 166 -------PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 166 -------~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999997643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=3.5e-07 Score=82.34 Aligned_cols=136 Identities=18% Similarity=0.144 Sum_probs=92.1
Q ss_pred ceeeecceEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC---cccceeeEEE-ecCceEEEEecCCCC
Q 018614 55 SVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP---NVVQFLGAVT-QSSPMMIVTEYLPKG 130 (353)
Q Consensus 55 ~~~ig~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~-~~~~~~iv~e~~~~~ 130 (353)
...++.|....+|.-|..+++|+... ......+.+|+.+++.+.+. .+++++.+.. ..+..++|||+++|.
T Consensus 24 v~~l~~G~~n~v~~vg~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILVNGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEETTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEECCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 35577777777776678888998532 34456788999999999642 3567777664 455678999999998
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 018614 131 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN---------------------------------------------- 164 (353)
Q Consensus 131 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~---------------------------------------------- 164 (353)
+|.+..-. .++......++.++...|..||+.
T Consensus 99 ~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 176 (306)
T 3tdw_A 99 ILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF 176 (306)
T ss_dssp ECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred ECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence 87663211 134444444555555555544432
Q ss_pred -----------CCCCEEecCCCCCCEEEcC---CCC-EEEeecccccc
Q 018614 165 -----------KPVPIIHRDLEPSNILRDD---SGN-LKVADFGVSKL 197 (353)
Q Consensus 165 -----------~~~~iiH~dlkp~Nill~~---~~~-vkl~Dfg~a~~ 197 (353)
.+..++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2223799999999999997 455 48999997754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=3e-06 Score=74.46 Aligned_cols=118 Identities=14% Similarity=0.160 Sum_probs=84.6
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHH
Q 018614 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 148 (353)
Q Consensus 70 g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~ 148 (353)
+..+.+|+.... ....+..|+..|+.+. +-.++++++++.+.+..++|||+++|.++.+..... .....
T Consensus 50 ~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~ 119 (272)
T 4gkh_A 50 APELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGE 119 (272)
T ss_dssp CCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHH
T ss_pred CeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHH
Confidence 557889986432 2346778999998884 334778999999999999999999998887765432 12233
Q ss_pred HHHHHHHHHHHHHHhc-------------------------------------------------------CCCCEEecC
Q 018614 149 RFALDIARGMNYLHEN-------------------------------------------------------KPVPIIHRD 173 (353)
Q Consensus 149 ~i~~qi~~al~~Lh~~-------------------------------------------------------~~~~iiH~d 173 (353)
.+..++...|..||+. ....++|+|
T Consensus 120 ~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGD 199 (272)
T 4gkh_A 120 NIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGD 199 (272)
T ss_dssp HHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSC
T ss_pred HHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCC
Confidence 4555666666666631 011279999
Q ss_pred CCCCCEEEcCCCCEEEeecccccc
Q 018614 174 LEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 174 lkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
+.+.||++++.+.+-|+||+.+..
T Consensus 200 l~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 200 FSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCeEEEECCeEEEEEECccccc
Confidence 999999999877777999997643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=7.4e-06 Score=75.08 Aligned_cols=74 Identities=7% Similarity=0.033 Sum_probs=47.1
Q ss_pred eee-ecceEEEEE---Ec--------CeEEEEEEcCccc---CCCHHHHHHHHHHHHHHhcCC-C--CcccceeeEEEec
Q 018614 56 VEI-TKGTFILAF---WR--------GIQVAVKKLGEEV---ISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQS 117 (353)
Q Consensus 56 ~~i-g~G~~~~v~---~~--------g~~vavK~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~ 117 (353)
+.| +.|....+| .. |..+++|...... .... ..+.+|+.+++.+. + -.+++++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~---~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT---YRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC---CCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch---hHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 456 666555444 22 6678899875432 1011 24567888888884 3 3467788877655
Q ss_pred ---CceEEEEecCCCCCH
Q 018614 118 ---SPMMIVTEYLPKGDL 132 (353)
Q Consensus 118 ---~~~~iv~e~~~~~~L 132 (353)
+..++|||+++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 357899999987554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=0.00014 Score=65.84 Aligned_cols=29 Identities=21% Similarity=0.336 Sum_probs=26.0
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 49999999999999888899999999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=6.1e-05 Score=70.06 Aligned_cols=74 Identities=18% Similarity=0.133 Sum_probs=43.6
Q ss_pred ceeeecceEEEEEE-----cCeEEEEEEcCcccC-CCH---HHHHHHHHHHHHHhcCCC--C-cccceeeEEEecCceEE
Q 018614 55 SVEITKGTFILAFW-----RGIQVAVKKLGEEVI-SDD---DRVRAFRDELALLQKIRH--P-NVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 55 ~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-~i~~~~~~~~~~~~~~i 122 (353)
.+.+|.|..+.+|. .+..++||....... ... .....+..|..+++.+.. + .+++++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 35788888777662 357899998653211 000 011345678888887742 3 34455543 3456789
Q ss_pred EEecCCCC
Q 018614 123 VTEYLPKG 130 (353)
Q Consensus 123 v~e~~~~~ 130 (353)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00063 Score=57.09 Aligned_cols=138 Identities=14% Similarity=0.128 Sum_probs=90.5
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 018614 130 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 208 (353)
Q Consensus 130 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 208 (353)
.+|.++|+. ..+++++++|.++.|.+.+|.-+-... . -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc------------
Confidence 489999986 456999999999999999987763211 0 11333457889999999988763 1110
Q ss_pred CCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHH
Q 018614 209 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 287 (353)
Q Consensus 209 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 287 (353)
.....+.|||... ...+.+.=|||||+++|.-+- |-.+- .+..+++.|.+||..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~----------------------eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN----------------------EERELSPPLEQLIDHM 153 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT----------------------EEECCCHHHHHHHHHH
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc----------------------cchhhCHHHHHHHHHH
Confidence 0122466888763 345678899999999999985 32221 1334677888899888
Q ss_pred ccc-------------------------CCCCCCCHHHHHHHHH
Q 018614 288 WNE-------------------------KPAKRPTFRQIITRLE 306 (353)
Q Consensus 288 l~~-------------------------dp~~Rps~~~ll~~l~ 306 (353)
... .+..|++++++++.=.
T Consensus 154 t~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 154 ANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp TTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred HhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 755 2468889998886543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00066 Score=63.59 Aligned_cols=77 Identities=14% Similarity=0.087 Sum_probs=44.4
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCC---CCCchhHHHHHHHHHHHHc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIE 244 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~ellt 244 (353)
.++|+|++|.||+++.++ +.++||+.+........-..........|++|+...... .....++..+...+|+.+.
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 311 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLFN 311 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHHH
Confidence 499999999999999876 999999988654321110000000012355555443111 1123455577777777765
Q ss_pred C
Q 018614 245 G 245 (353)
Q Consensus 245 g 245 (353)
+
T Consensus 312 ~ 312 (420)
T 2pyw_A 312 K 312 (420)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00042 Score=62.21 Aligned_cols=72 Identities=19% Similarity=0.105 Sum_probs=52.3
Q ss_pred ceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCcccceeeEEEecCceEEEEecCC
Q 018614 55 SVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 55 ~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
.+.|+.|....+| .++..+++|+.... ....+..|+..|+.+. ...+++++.+....+..++|||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 4567777654443 35678889987543 1346788999998884 3568889988887788999999998
Q ss_pred CCCH
Q 018614 129 KGDL 132 (353)
Q Consensus 129 ~~~L 132 (353)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0016 Score=58.75 Aligned_cols=31 Identities=32% Similarity=0.441 Sum_probs=26.8
Q ss_pred CEEecCCCCCCEEEcCC----CCEEEeeccccccc
Q 018614 168 PIIHRDLEPSNILRDDS----GNLKVADFGVSKLL 198 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~----~~vkl~Dfg~a~~~ 198 (353)
.++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 49999999999999874 67999999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00056 Score=60.91 Aligned_cols=71 Identities=15% Similarity=0.183 Sum_probs=41.1
Q ss_pred ceeeecceEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc-cceeeEEEecCceEEEEecC-CCCCH
Q 018614 55 SVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV-VQFLGAVTQSSPMMIVTEYL-PKGDL 132 (353)
Q Consensus 55 ~~~ig~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~-~~~~L 132 (353)
.+.|+.|....+|.- ..+++|+..... .......+|+.+++.+...++ +++++.. ...-++++||+ +|.++
T Consensus 23 i~~l~gG~tN~~~~~-~~~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-GDLCLRIPGKGT----EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-eeEEEECCCCCc----cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 567877776666544 567888875421 100112457777777743233 4566543 33457899999 66443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.015 Score=51.17 Aligned_cols=72 Identities=19% Similarity=0.147 Sum_probs=46.4
Q ss_pred ccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-C--CcccceeeEEEecCceEEEEe
Q 018614 53 TNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 53 ~~~~~ig~G~~~~v~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~~~~~iv~e 125 (353)
...+.+|.|....|| .+|+.|.+|+......... ..+..|+..|+.+. . -.++++++.. ..++|||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~---~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD---GLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT---THHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh---hHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 345678888766665 3689999998754432221 24678999998884 2 1345555542 3478999
Q ss_pred cCCCCC
Q 018614 126 YLPKGD 131 (353)
Q Consensus 126 ~~~~~~ 131 (353)
+++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0051 Score=54.99 Aligned_cols=30 Identities=23% Similarity=0.173 Sum_probs=25.4
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
.++|+|+++.||++++++.+.|+||+.+..
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 499999999999999876668999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0031 Score=58.09 Aligned_cols=120 Identities=21% Similarity=0.288 Sum_probs=69.9
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEEecCCCCCHH--------------H
Q 018614 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLR--------------A 134 (353)
Q Consensus 70 g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~--------------~ 134 (353)
+..+.+|+.... ... ...+.+|..+++.+. +.-.+++++.+.+ .+||||++|.+|. +
T Consensus 82 ~~~~vlR~~g~~-~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~ 153 (379)
T 3feg_A 82 PREVLLRLYGAI-LQG---VDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIAT 153 (379)
T ss_dssp CSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHH
T ss_pred CCeEEEEECCCc-cch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHH
Confidence 367888986432 111 234568999998885 3223667776654 2899999874432 1
Q ss_pred HHHh---c----C-CCC--HHHHHHHHHHHHH-------------------HHHH----HHhc-CCCCEEecCCCCCCEE
Q 018614 135 FLKR---K----G-ALK--PSTAVRFALDIAR-------------------GMNY----LHEN-KPVPIIHRDLEPSNIL 180 (353)
Q Consensus 135 ~l~~---~----~-~~~--~~~~~~i~~qi~~-------------------al~~----Lh~~-~~~~iiH~dlkp~Nil 180 (353)
.+.+ - + ... ..++.++..++.. .+.. |... ....++|+|+.+.||+
T Consensus 154 ~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil 233 (379)
T 3feg_A 154 KMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNIL 233 (379)
T ss_dssp HHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEE
T ss_pred HHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEE
Confidence 1111 0 0 111 2344445444322 1222 2222 2234899999999999
Q ss_pred EcCC----CCEEEeecccccc
Q 018614 181 RDDS----GNLKVADFGVSKL 197 (353)
Q Consensus 181 l~~~----~~vkl~Dfg~a~~ 197 (353)
++.+ +.+.++||..+..
T Consensus 234 ~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 234 LLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EESCC---CCEEECCCTTCEE
T ss_pred EcCCCCccCcEEEEecccCCc
Confidence 9876 7899999987643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0036 Score=58.71 Aligned_cols=51 Identities=12% Similarity=0.225 Sum_probs=32.8
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc-cceeeEEEecCceEEEEecCCC
Q 018614 70 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV-VQFLGAVTQSSPMMIVTEYLPK 129 (353)
Q Consensus 70 g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~~ 129 (353)
+..+.+|+.... ... ..+..|..+++.+...++ +++++.+.+ .+|+||++|
T Consensus 105 ~~~~vlRi~~~~--~~~---~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G 156 (429)
T 1nw1_A 105 PNKVLLRVYFNP--ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPS 156 (429)
T ss_dssp CSEEEEEEECSC--CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCE
T ss_pred CceEEEEEeCCC--CcH---HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCC
Confidence 468889987432 111 234578888888853334 567776543 389999976
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.33 E-value=0.014 Score=52.25 Aligned_cols=28 Identities=21% Similarity=0.233 Sum_probs=24.3
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
.++|+|+++.||+++ + .+.|+||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 489999999999999 4 899999987654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.51 E-value=0.3 Score=40.74 Aligned_cols=115 Identities=11% Similarity=0.132 Sum_probs=79.1
Q ss_pred CCCcccceeeEEEecCceEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEE
Q 018614 103 RHPNVVQFLGAVTQSSPMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 181 (353)
Q Consensus 103 ~h~~i~~~~~~~~~~~~~~iv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill 181 (353)
.||+++.. .+-.+++.+.+.++.-+. .++.. ++ ..+....++++.+|+....++++ -+|--++|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 47777765 455566666676765542 23333 22 37889999999999998855544 4788999999999
Q ss_pred cCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 018614 182 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250 (353)
Q Consensus 182 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 250 (353)
+.++.+++.-.|+-.. ++|. ..+...=+-.+=+++..+++++..|.
T Consensus 113 ~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999987775322 2222 22333344467788889999988873
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.76 E-value=0.17 Score=45.61 Aligned_cols=31 Identities=19% Similarity=0.400 Sum_probs=27.2
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 4999999999999998888999999876543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.37 E-value=0.7 Score=38.66 Aligned_cols=113 Identities=12% Similarity=0.127 Sum_probs=77.5
Q ss_pred CCCcccceeeEEEecCceEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCEEecCCCCCCEE
Q 018614 103 RHPNVVQFLGAVTQSSPMMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMN-YLHENKPVPIIHRDLEPSNIL 180 (353)
Q Consensus 103 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~-~Lh~~~~~~iiH~dlkp~Nil 180 (353)
.||++ -..+-.+++.+.+.++.-+++ ++..+ + ..+....++++.+|+.... +++. -+|--++|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~---~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-R---KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-H---TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-H---hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 46777 344446667777777765443 55543 3 3789999999999999776 5544 578899999999
Q ss_pred EcCCCCEEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 018614 181 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 249 (353)
Q Consensus 181 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 249 (353)
++.++.+++.-.|+-. -++|.. .+...=+-.+=+++..++.++..|
T Consensus 117 f~~~~~p~i~hRGi~~------------------~lpP~e-----~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 117 FNRALEPFFLHVGVKE------------------SLPPDE-----WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp ECTTCCEEESCCEETT------------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred EeCCCcEEEEEcCCcc------------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999998777532 223321 222233446677888888887776
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.33 E-value=0.16 Score=46.12 Aligned_cols=29 Identities=31% Similarity=0.541 Sum_probs=24.1
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
.++|+|+++.||++++++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 489999999999998655 89999987643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=88.74 E-value=0.33 Score=45.66 Aligned_cols=65 Identities=12% Similarity=0.076 Sum_probs=38.0
Q ss_pred eeeecceEEEEE---EcC--eEEEEEEcCccc--CCCHHHHHHHHHHHHHHhcCCCCcc-cceeeEEEecCceEEEEecC
Q 018614 56 VEITKGTFILAF---WRG--IQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNV-VQFLGAVTQSSPMMIVTEYL 127 (353)
Q Consensus 56 ~~ig~G~~~~v~---~~g--~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~ 127 (353)
+.|+.|-...+| ..+ ..+++|+..... +.+ ...|..+++.+...++ +++++.+. + .+|+||+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id------R~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I 183 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN------REREKKISCILYNKNIAKKIYVFFT-N---GRIEEFM 183 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC------HHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC------HHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEee
Confidence 456555443333 344 788899875321 111 1478888888864444 56777763 2 3599999
Q ss_pred CCC
Q 018614 128 PKG 130 (353)
Q Consensus 128 ~~~ 130 (353)
+|.
T Consensus 184 ~G~ 186 (458)
T 2qg7_A 184 DGY 186 (458)
T ss_dssp CSE
T ss_pred CCc
Confidence 763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.07 E-value=0.58 Score=43.11 Aligned_cols=29 Identities=31% Similarity=0.454 Sum_probs=24.5
Q ss_pred EEecCCCCCCEEE------cCCCCEEEeecccccc
Q 018614 169 IIHRDLEPSNILR------DDSGNLKVADFGVSKL 197 (353)
Q Consensus 169 iiH~dlkp~Nill------~~~~~vkl~Dfg~a~~ 197 (353)
++|+|+.+.||++ ++++.+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4566799999987754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 353 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-63 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-11 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-64
Identities = 75/281 (26%), Positives = 134/281 (47%), Gaps = 18/281 (6%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 98
++EI ++ I G+F W G VAVK L + +AF++E+ +
Sbjct: 2 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQL-QAFKNEVGV 57
Query: 99 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 157
L+K RH N++ F+G T + IVT++ L L + + + A A+G
Sbjct: 58 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYV 216
M+YLH IIHRDL+ +NI + +K+ DFG++ + + Q + S ++
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 217 APEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKA 271
APEV + ++ Y + DV++F ++L E++ G P++ ++ + R P
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312
+ +K L+ EC +K +RP F QI+ +E + S+
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-63
Identities = 80/275 (29%), Positives = 134/275 (48%), Gaps = 24/275 (8%)
Query: 43 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 99
+ ++ EL I KG F +L +RG +VAVK I +D +AF E +++
Sbjct: 2 WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVM 54
Query: 100 QKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIAR 156
++RH N+VQ LG + + + IVTEY+ KG L +L+ +G L ++F+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 216
M YL N +HRDL N+L + KV+DFG++K + + ++
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWT 167
Query: 217 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 275
APE + +++ TK DV+SF ++L E+ G P+ +V +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDG 224
Query: 276 YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310
+ E+++ CW+ A RP+F Q+ +LE I
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-60
Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 19/266 (7%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDEL 96
++ ++ DF + KG F LA + +A+K L + + R E+
Sbjct: 2 QWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 97 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 156
+ +RHPN+++ G ++ + ++ EY P G + L++ + ++A
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117
Query: 157 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 216
++Y H + +IHRD++P N+L +G LK+ADFG S T + Y+
Sbjct: 118 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYL 171
Query: 217 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276
PE+ + +D KVD++S ++ E + G PPF E Y R F P
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRISRVEFTFP-DFV 227
Query: 277 ARGLKELIEECWNEKPAKRPTFRQII 302
G ++LI P++RP R+++
Sbjct: 228 TEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-59
Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 18/270 (6%)
Query: 45 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
IDP +L F E+ G F WR VA+K + E +S+D+ F +E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 159
+ H +VQ G T+ P+ I+TEY+ G L +L+ + + + D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YL +HRDL N L +D G +KV+DFG+S+ + E R+ PE
Sbjct: 115 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 220 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278
V ++ +K D+++F +++ E+ G P+ ++E + A R L +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASE 228
Query: 279 GLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ ++ CW+EK +RPTF+ +++ + +
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-59
Identities = 82/273 (30%), Positives = 141/273 (51%), Gaps = 18/273 (6%)
Query: 45 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 100
IDP EL F EI G F L +W +VA+K + E +S++D F +E ++
Sbjct: 2 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 55
Query: 101 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIARGMN 159
K+ HP +VQ G + +P+ +V E++ G L +L+ + L T + LD+ GM
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 160 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 219
YL E +IHRDL N L ++ +KV+DFG+++ + + T ++ +PE
Sbjct: 116 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 220 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278
VF Y +K DV+SF +++ E+ EG P+ + ++EV + + R +L +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLAST 229
Query: 279 GLKELIEECWNEKPAKRPTFRQIITRLESINNS 311
+ +++ CW E+P RP F +++ +L I S
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-59
Identities = 80/278 (28%), Positives = 129/278 (46%), Gaps = 20/278 (7%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDEL 96
E+E+ L + G F + ++ +VAVK L + +S D F E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 97 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS--TAVRFALDI 154
L+++++H +V+ VTQ P+ I+TEY+ G L FLK +K + + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 214
A GM ++ E IHRDL +NIL D+ + K+ADFG+++L+ E +
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 215 YVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPA 273
+ APE + K DV+SF ++L E++ G P+ + EV + R
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP--- 232
Query: 274 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311
L +L+ CW E+P RPTF + + LE +
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 9e-59
Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 24/290 (8%)
Query: 43 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 97
++ DP +L F++ EI G+F A VA+KK+ +++ + E+
Sbjct: 9 FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 157
LQK+RHPN +Q+ G + +V EY K L+ +G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 217
+ YLH + +IHRD++ NIL + G +K+ DFG + ++ P + ++A
Sbjct: 128 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMA 179
Query: 218 PEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274
PEV +YD KVDV+S + E+ E PP + A + P +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSG 237
Query: 275 LYARGLKELIEECWNEKPAKRPTFRQI-----ITRLESINNSINHKRRWK 319
++ + ++ C + P RPT + + R ++ +R K
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 287
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-58
Identities = 60/265 (22%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
D+ I G++ + G + K+L +++ ++ + E+ LL++++HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63
Query: 106 NVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMN 159
N+V++ + ++ + IV EY GDL + + + + L +R + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 160 YLHENKPV--PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 217
H ++HRDL+P+N+ D N+K+ DFG++++L T Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT-PYYMS 182
Query: 218 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277
PE Y+ K D++S +L E+ PPFT E+ + Y+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR---YS 239
Query: 278 RGLKELIEECWNEKPAKRPTFRQII 302
L E+I N K RP+ +I+
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-58
Identities = 71/270 (26%), Positives = 124/270 (45%), Gaps = 20/270 (7%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 98
+++P + + E+ G F A + + A K + + ++ + + E+ +
Sbjct: 7 DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDI 62
Query: 99 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 157
L HPN+V+ L A + + I+ E+ G + A + + + L S
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 217
+NYLH+NK IIHRDL+ NIL G++K+ADFGVS T + + + ++A
Sbjct: 123 LNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMA 178
Query: 218 PEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 272
PEV K+ YD K DV+S + L EM E PP + V A + P P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 273 AKLYARGLKELIEECWNEKPAKRPTFRQII 302
++ ++ K+ +++C + R T Q++
Sbjct: 239 SR-WSSNFKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-57
Identities = 67/256 (26%), Positives = 126/256 (49%), Gaps = 17/256 (6%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
EI +G+F ++VA +L + ++ +R R F++E +L+ ++HPN+V+F
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIVRFY 74
Query: 112 GA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 167
+ V +++VTE + G L+ +LKR +K + I +G+ +LH P
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 168 PIIHRDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 226
PIIHRDL+ NI +G++K+ D G++ L K + ++APE+++ +Y
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYEE-KY 189
Query: 227 DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 286
D VDV++F + + EM P++ + P K+ +KE+IE
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-KVAIPEVKEIIEG 248
Query: 287 CWNEKPAKRPTFRQII 302
C + +R + + ++
Sbjct: 249 CIRQNKDERYSIKDLL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-56
Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 19/278 (6%)
Query: 45 IDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELA 97
+D L + E+ G F +++ VAVK L E +D E
Sbjct: 3 LDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEAN 60
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 157
++Q++ +P +V+ +G + ++ M+V E G L +L++ +K + ++ G
Sbjct: 61 VMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 158 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRY 215
M YL E+ +HRDL N+L K++DFG+SK L E+ ++
Sbjct: 120 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 216 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274
APE ++ +K DV+SF +++ E G P+ +EV +R A
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG-- 234
Query: 275 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312
R + +L+ CW RP F + RL + +
Sbjct: 235 -CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-56
Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 52/296 (17%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
DF E+ G + G+ +A K + E EL +L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 165
+V F GA + I E++ G L LK+ G + + ++ + +G+ YL E
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 166 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 225
I+HRD++PSNIL + G +K+ DFGVS L D + Y++PE +
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 179
Query: 226 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------------- 266
Y + D++S L L EM G P E+ + +
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 267 ---------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
PP K P+ +++ ++ + +C + PA+R +Q+
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-56
Identities = 64/282 (22%), Positives = 117/282 (41%), Gaps = 21/282 (7%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRD 94
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 2 KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 58
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 153
E ++ ++ +P +V+ +G V Q+ +M+V E G L FL ++ + S
Sbjct: 59 EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDT 211
++ GM YL E +HRDL N+L + K++DFG+SK L + +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFK 270
++ APE ++ ++ DV+S+ + + E + G P+ EV +R
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC- 233
Query: 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312
L L+ +CW K RP F + R+ + S+
Sbjct: 234 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-55
Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 20/283 (7%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELA 97
+EI L ++ +G F + W +VA+K L +S + F E
Sbjct: 11 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 64
Query: 98 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIA 155
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 65 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123
Query: 156 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 215
GM Y+ +HRDL +NIL ++ KVADFG+++L+ E ++
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 216 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274
APE + K DV+SF ++L E+ +G P+ + EV R P
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-- 238
Query: 275 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 317
L +L+ +CW ++P +RPTF + LE S + +
Sbjct: 239 -CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-55
Identities = 57/251 (22%), Positives = 118/251 (47%), Gaps = 14/251 (5%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+I +G A G +VA++++ + + +E+ ++++ ++PN+V +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ + +V EYL G L + + + + +LH N+ +IH
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 231
RD++ NIL G++K+ DFG +T ++ + + + ++APEV + Y KVD
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 232 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 291
++S ++ EMIEG PP+ ++ A P + P KL + ++ + C +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL-SAIFRDFLNRCLDMD 257
Query: 292 PAKRPTFRQII 302
KR + ++++
Sbjct: 258 VEKRGSAKELL 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-55
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 44/298 (14%)
Query: 57 EITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 113
I KG F WRG +VAVK S ++R E+ +RH N++ F+ A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 114 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV-- 167
+ + + +V++Y G L +L R + ++ AL A G+ +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 168 ---PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF 221
I HRDL+ NIL +G +AD G++ D + RY+APEV
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 222 ------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP----------------- 258
K+ E + D+++ L+ E+ C + D ++P
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 259 -KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 315
R P + + R + +++ ECW A R T +I L ++ K
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (452), Expect = 2e-54
Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 93
++E++ ++ + ++ G + W+ + VAVK L E D V F
Sbjct: 8 NYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFL 61
Query: 94 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFA 151
E A++++I+HPN+VQ LG T+ P I+TE++ G+L +L + + + A
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121
Query: 152 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
I+ M YL + IHRDL N L ++ +KVADFG+S+L+T
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFK 270
++ APE ++ K DV++F ++L E+ G P+ ++V + R
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238
Query: 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ + EL+ CW P+ RP+F +I E++
Sbjct: 239 ---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-54
Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 13/262 (4%)
Query: 47 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 101
P D+ + +G + LA R VAVK + + D + E+ + +
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKM 59
Query: 102 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 161
+ H NVV+F G + + + EY G+L ++ + A RF + G+ YL
Sbjct: 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 162 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEV 220
H I HRD++P N+L D+ NLK++DFG++ + +R L + YVAPE+
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 221 FKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279
K E+ VDV+S ++L M+ G P+ D+ + +++ + P K
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYLNPWKKIDSA 235
Query: 280 LKELIEECWNEKPAKRPTFRQI 301
L+ + E P+ R T I
Sbjct: 236 PLALLHKILVENPSARITIPDI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-54
Identities = 65/277 (23%), Positives = 128/277 (46%), Gaps = 21/277 (7%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFR 93
+YEI ++ I +G F + + VA+K + + D F
Sbjct: 1 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFL 56
Query: 94 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 152
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL RK +L ++ + +A
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 212
++ + YL + +HRD+ N+L + +K+ DFG+S+ + +
Sbjct: 116 QLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 213 CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA 271
+++APE + + DV+ F + + E++ G PF +N+V +R P
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP- 231
Query: 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
L L+ +CW P++RP F ++ +L +I
Sbjct: 232 --PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 8e-54
Identities = 73/304 (24%), Positives = 122/304 (40%), Gaps = 47/304 (15%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-------IQVAVKKLGEEVISDDDRVR 90
++E L+F + G F + A G IQVAVK L E+ +D
Sbjct: 30 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 85
Query: 91 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 139
A EL ++ ++ H N+V LGA T S P+ ++ EY GDL +L+ K
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 140 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186
L + FA +A+GM +L +HRDL N+L
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 202
Query: 187 LKVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-E 244
+K+ DFG+++ + + + +++APE Y K DV+S+ ++L E+
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
Query: 245 GCPPFT-MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 303
G P+ + D K + + +++ CW KRP+F + +
Sbjct: 263 GVNPYPGIPVDANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 304 RLES 307
L
Sbjct: 320 FLGC 323
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (448), Expect = 4e-53
Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 25/280 (8%)
Query: 31 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISD 85
P+ +KH + Y+I E+ G F R G A K + SD
Sbjct: 16 PVEIKHDHVLDHYDIHE---------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 86 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKP 144
+ R E+ + +RHP +V A + M+++ E++ G+L + +
Sbjct: 67 KET---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123
Query: 145 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 202
AV + + +G+ ++HEN +H DL+P NI+ S LK+ DFG++ L K+
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180
Query: 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 262
+T + APEV + + D++S ++ ++ G PF ++D+E +
Sbjct: 181 SVKVTTGT--AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238
Query: 263 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
+ + + K+ I + P R T Q +
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 6e-53
Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 24/279 (8%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDE 95
EID + I G F + I VA+K L + + R F E
Sbjct: 22 EIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSE 77
Query: 96 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDI 154
+++ + HPNV+ G VT+S+P+MI+TE++ G L +FL++ G V I
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137
Query: 155 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 213
A GM YL + +HRDL NIL + + KV+DFG+S+ L P
Sbjct: 138 AAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 214 ---RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 269
R+ APE + ++ + DV+S+ +++ E++ G P+ + +V A R P
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP- 253
Query: 270 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
P L +L+ +CW + RP F QI+ L+ +
Sbjct: 254 --PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 9e-53
Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 10/253 (3%)
Query: 60 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119
+G + + + VAVK L +V+S + + F E+ + + H N+++ G V + P
Sbjct: 26 RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPP 84
Query: 120 MMIVTEYLPKGDLRAF-LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 178
M +VTE P G L K +G T R+A+ +A GM YL IHRDL N
Sbjct: 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARN 141
Query: 179 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFA 236
+L +K+ DFG+ + L +D + + + APE K + D + F
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 237 LILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
+ L EM G P+ + +++ ++ P + + ++ +CW KP R
Sbjct: 202 VTLWEMFTYGQEPWIGLNGSQILHKI-DKEGERLPRPEDC-PQDIYNVMVQCWAHKPEDR 259
Query: 296 PTFRQIITRLESI 308
PTF + L
Sbjct: 260 PTFVALRDFLLEA 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-52
Identities = 54/257 (21%), Positives = 116/257 (45%), Gaps = 13/257 (5%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
DF + +G+F +LA + A+K L + I +++V E ++ ++ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 165
V+ + Y G+L ++++ G+ + + +I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK- 127
Query: 166 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKNE 224
IIHRDL+P NIL ++ ++++ DFG +K+L+ + + YV+PE+ +
Sbjct: 128 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 225 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284
D+++ I+ +++ G PPF ++ + + + + P K + + ++L+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKIIKLEYDFPEKFFPK-ARDLV 241
Query: 285 EECWNEKPAKRPTFRQI 301
E+ KR ++
Sbjct: 242 EKLLVLDATKRLGCEEM 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-52
Identities = 54/304 (17%), Positives = 121/304 (39%), Gaps = 18/304 (5%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
++ +G F K + + D+V + E+++L RH N++
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVL-VKKEISILNIARHRNILHLH 67
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 170
+ ++++ E++ D+ + L V + + + +LH + I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124
Query: 171 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 228
H D+ P NI+ S +K+ +FG ++ L K T+ Y APEV +++ T
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288
D++S ++ ++ G PF + + ++ + + + K + + ++
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242
Query: 289 NEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSSRSKSSC 348
++ R T + + + + I IRT+K ++KKD + S ++ SC
Sbjct: 243 VKERKSRMTASEAL-QHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISC 301
Query: 349 STSS 352
+
Sbjct: 302 GGAI 305
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 6e-52
Identities = 77/304 (25%), Positives = 125/304 (41%), Gaps = 39/304 (12%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEVISDDDRVR 90
++E + L F + G F + A + VAVK L +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 91 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 140
A EL +L + H N+V LGA T P +++TEY GDL FL+RK
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 141 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
AL + F+ +A+GM +L IHRDL NIL K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 192 FGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
FG+++ + + + +++APE N Y + DV+S+ + L E+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 251 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES-IN 309
+ ++ +P + ++++ CW+ P KRPTF+QI+ +E I+
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHA-PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 310 NSIN 313
S N
Sbjct: 308 ESTN 311
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 1e-51
Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 15/254 (5%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+ G F ILA + VA+K + ++ + + + + +E+A+L KI+HPN+V
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ ++ + + G+L + KG A R + + YLH+ I+H
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVH 130
Query: 172 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 228
RDL+P N+L D+ + ++DFG+SK+ L+ + YVAPEV + Y
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288
VD +S +I ++ G PPF ++D ++ + + + K+ I
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248
Query: 289 NEKPAKRPTFRQII 302
+ P KR T Q +
Sbjct: 249 EKDPEKRFTCEQAL 262
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (437), Expect = 2e-51
Identities = 46/254 (18%), Positives = 104/254 (40%), Gaps = 16/254 (6%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
E+ G F + G K + D ++E++++ ++ HP ++
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLH 92
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 170
A M+++ E+L G+L + + + + + + G+ ++HE+ I+
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IV 149
Query: 171 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 228
H D++P NI+ + ++K+ DFG++ L D + + + APE+ E
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGF 207
Query: 229 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 288
D+++ ++ ++ G PF + D E + + + K+ I+
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267
Query: 289 NEKPAKRPTFRQII 302
++P KR T +
Sbjct: 268 QKEPRKRLTVHDAL 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-51
Identities = 76/288 (26%), Positives = 137/288 (47%), Gaps = 22/288 (7%)
Query: 38 REVPEYEIDPHELDFTNSVEITKGTF---ILAFW-----RGIQVAVKKLGEEVISDDDRV 89
+ V I P L + I +G F + I AVK L I+D V
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEV 72
Query: 90 RAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLK-RKGALKPSTA 147
F E +++ HPNV+ LG +S ++V Y+ GDLR F++
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 148 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 207
+ F L +A+GM +L K +HRDL N + D+ +KVADFG+++ + KE +
Sbjct: 133 IGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 208 CQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA 263
+ + +++A E + +++ TK DV+SF ++L E++ G PP+ + ++
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 264 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311
+R + L E++ +CW+ K RP+F ++++R+ +I ++
Sbjct: 250 GRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (430), Expect = 4e-51
Identities = 77/306 (25%), Positives = 127/306 (41%), Gaps = 46/306 (15%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTF----------ILAFWRGIQVAVKKLGEEVISDDDR 88
++ E + +++ +I +G F +L + VAVK L EE + D
Sbjct: 4 KLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADM 59
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------- 140
F+ E AL+ + +PN+V+ LG PM ++ EY+ GDL FL+
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 141 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 184
L + + A +A GM YL E K +HRDL N L ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 176
Query: 185 GNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 243
+K+ADFG+S+ + + D R++ PE Y T+ DV+++ ++L E+
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 244 E-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
G P+ EV + L L+ CW++ PA RP+F I
Sbjct: 237 SYGLQPYYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 303 TRLESI 308
L+ +
Sbjct: 294 RILQRM 299
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (421), Expect = 6e-50
Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 15/266 (5%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+ G LA VAVK L ++ D FR E + HP +V
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 112 GAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 167
+P IV EY+ LR + +G + P A+ D + +N+ H+N
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG-- 131
Query: 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEE 225
IIHRD++P+NI+ + +KV DFG+++ + + + +Y++PE + +
Sbjct: 132 -IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 226 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285
D + DV+S +L E++ G PPFT V + P A + + L ++
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 250
Query: 286 ECWNEKPAKRP-TFRQIITRLESINN 310
+ + P R T ++ L ++N
Sbjct: 251 KALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 9e-50
Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 14/258 (5%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRH 104
DF + KG+F LA ++ A+K L ++V+ DD V E +L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 105 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 164
P + + V EYL GDL ++ S A +A +I G+ +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 165 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 224
I++RDL+ NIL D G++K+ADFG+ K + + + T T Y+APE+ +
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT-PDYIAPEILLGQ 178
Query: 225 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284
+Y+ VD +SF ++L EM+ G PF + + E+ + + + P L + K+L+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSIRMDNPFYPRWL-EKEAKDLL 234
Query: 285 EECWNEKPAKRPTFRQII 302
+ + +P KR R I
Sbjct: 235 VKLFVREPEKRLGVRGDI 252
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-49
Identities = 60/269 (22%), Positives = 114/269 (42%), Gaps = 19/269 (7%)
Query: 51 DFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 101
+F + G F W I VA+K+L E + + DE ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 67
Query: 102 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 161
+ +P+V + LG S+ +I L + K + + + + IA+GMNYL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 162 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEV 220
+ + ++HRDL N+L ++K+ DFG++KLL +E +++A E
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 221 FKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279
+ Y + DV+S+ + + E++ G P+ +E+ +R P +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PICTID 241
Query: 280 LKELIEECWNEKPAKRPTFRQIITRLESI 308
+ ++ +CW RP FR++I +
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 3e-49
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 23/278 (8%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 94
EI P + I G F + + VA+K L + + F
Sbjct: 3 EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLG 58
Query: 95 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD-LRAFLKRKGALKPSTAVRFALD 153
E ++ + H N+++ G +++ PMMI+TEY+ G + ++ G V
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 211
IA GM YL +HRDL NIL + + KV+DFG+S++L + T
Sbjct: 119 IAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFK 270
R+ APE ++ + DV+SF +++ E++ G P+ ++EV KA R P
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235
Query: 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ +L+ +CW ++ A+RP F I++ L+ +
Sbjct: 236 MD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 163 bits (413), Expect = 9e-49
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 23/264 (8%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-H 104
+ +G + + AVK + + A E+ +L+K+ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 105 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 164
PN++Q ++ +V + + KG+L +L K L + + + LH+
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129
Query: 165 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 224
I+HRDL+P NIL DD N+K+ DFG S L L + Y+APE+ +
Sbjct: 130 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEIIECS 184
Query: 225 E------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278
Y +VD++S +I+ ++ G PPF + + + + Y+
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244
Query: 279 GLKELIEECWNEKPAKRPTFRQII 302
+K+L+ +P KR T + +
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEAL 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-48
Identities = 78/299 (26%), Positives = 131/299 (43%), Gaps = 41/299 (13%)
Query: 41 PEYEIDPHELDFTNSVEITKGTF---ILAFWR---------GIQVAVKKLGEEVISDDDR 88
P +E+ L + +G F +LA +VAVK L + D
Sbjct: 6 PRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 61
Query: 89 VRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------- 140
+ E+ +++ I +H N++ LGA TQ P+ ++ EY KG+LR +L+ +
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 141 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
L V A +ARGM YL IHRDL N+L + +K+AD
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIAD 178
Query: 192 FGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPF 249
FG+++ + + T +++APE + Y + DV+SF ++L E+ G P+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 250 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
E+ K R L ++ +CW+ P++RPTF+Q++ L+ I
Sbjct: 239 PGVPVEELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 3e-48
Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 44 EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRDEL 96
+D +++ F + I +G F + A + + A+K++ + + D R F EL
Sbjct: 6 VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGEL 61
Query: 97 ALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------------- 139
+L K+ HPN++ LGA + + EY P G+L FL++
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 140 GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199
L + FA D+ARGM+YL + IHRDL NIL ++ K+ADFG+S+
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-- 176
Query: 200 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 258
+ T R++A E Y T DV+S+ ++L E++ G P+ E+
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
Query: 259 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ R + +L+ +CW EKP +RP+F QI+ L +
Sbjct: 237 EKLPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 7e-47
Identities = 67/289 (23%), Positives = 132/289 (45%), Gaps = 32/289 (11%)
Query: 42 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 91
E+E+ ++ + E+ +G+F +G+ +VA+K + E +
Sbjct: 14 EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIE 69
Query: 92 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------A 141
F +E +++++ +VV+ LG V+Q P +++ E + +GDL+++L+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 142 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201
S ++ A +IA GM YL+ N +HRDL N + + +K+ DFG+++ +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 202 ED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPK 259
+ R R+++PE K+ + T DV+SF ++L E+ P+ + +V +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246
Query: 260 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
L EL+ CW P RP+F +II+ ++
Sbjct: 247 FVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-45
Identities = 60/258 (23%), Positives = 103/258 (39%), Gaps = 17/258 (6%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDR---VRAFRDELALLQKIRHPNVV 108
E+ G F + G+Q A K + + R E+++L++I+HPNV+
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 109 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 168
+ ++++ E + G+L FL K +L A F I G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---Q 133
Query: 169 IIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 224
I H DL+P NI+ D +K+ DFG++ + + +VAPE+ E
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 225 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284
+ D++S +I ++ G PF E +A + K+ I
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 285 EECWNEKPAKRPTFRQII 302
+ P KR T + +
Sbjct: 252 RRLLVKDPKKRMTIQDSL 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (398), Expect = 1e-45
Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 16/259 (6%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE---LALLQKI 102
DF+ I +G F G A+K L ++ I +E L+L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 103 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 162
P +V A + + + + GDL L + G + +A +I G+ ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 163 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF- 221
+++RDL+P+NIL D+ G+++++D G++ + + Y+APEV
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHGYMAPEVLQ 178
Query: 222 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281
K YD+ D FS +L +++ G PF + + + P ++ L+
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS-FSPELR 237
Query: 282 ELIEECWNEKPAKRPTFRQ 300
L+E +R
Sbjct: 238 SLLEGLLQRDVNRRLGCLG 256
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 2e-44
Identities = 61/249 (24%), Positives = 113/249 (45%), Gaps = 16/249 (6%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+ G+F L R G A+K L +E++ +V DE +L + HP +++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
G + + ++ +Y+ G+L + L++ A +A ++ + YLH II+
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIY 127
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 231
RDL+P NIL D +G++K+ DFG +K + + Y+APEV + Y+ +D
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYNKSID 183
Query: 232 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 291
+SF +++ EM+ G PF + + Y + P +K+L+
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKT---YEKILNAELRFPPFF-NEDVKDLLSRLITRD 239
Query: 292 PAKRPTFRQ 300
++R Q
Sbjct: 240 LSQRLGNLQ 248
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-44
Identities = 64/263 (24%), Positives = 110/263 (41%), Gaps = 30/263 (11%)
Query: 58 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 112
+ G + F + + A+K L D +A R+ + + P++V+ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72
Query: 113 A----VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKP 166
++IV E L G+L + ++ +G A A I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 167 VPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 223
I HRD++P N+L + LK+ DFG +K T LT + YVAPEV
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGP 187
Query: 224 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYAR---G 279
E+YD D++S +I+ ++ G PPF H + P + ++ P ++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 280 LKELIEECWNEKPAKRPTFRQII 302
+K LI +P +R T + +
Sbjct: 248 VKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-43
Identities = 70/298 (23%), Positives = 125/298 (41%), Gaps = 35/298 (11%)
Query: 39 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDR 88
+ ++E L + +G F I A GI VAVK L E + R
Sbjct: 4 DASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 61
Query: 89 VRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRKG------- 140
+ L+ H NVV LGA T+ P+M++ E+ G+L +L+ K
Sbjct: 62 -ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 141 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 191
L + ++ +A+GM +L K IHRDL NIL + +K+ D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICD 177
Query: 192 FGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 250
FG+++ + D +++APE + Y + DV+SF ++L E+
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 251 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 308
+ ++ +AP + + + +CW+ +P++RPTF +++ L ++
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAPDY-TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 3e-43
Identities = 41/278 (14%), Positives = 85/278 (30%), Gaps = 27/278 (9%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+I G+F L G +VA+K + + E + + ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 112 GAV-TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 170
+ ++V E L F T + A + + Y+H I
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FI 125
Query: 171 HRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRPLTCQDT------SCRYVAPEVF 221
HRD++P N L + + DFG++K + RY +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 222 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG-- 279
E + D+ S +L G P+ + Y P ++ +G
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 280 --LKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 315
+ C + + +P + + ++ +
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-42
Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 29/259 (11%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIR--HPN 106
+ G F + VA+K + ++ ISD + E+ LL+K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 107 VVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 165
V++ L + +++ E P DL F+ +GAL+ A F + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 166 PVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 224
++HRD++ NIL D + G LK+ DFG LL +D T D + Y PE +
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 225 EYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 283
Y + V+S ++L +M+ G PF +HD E+ R + F+ + + L
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-----IRGQVFFRQR---VSSECQHL 234
Query: 284 IEECWNEKPAKRPTFRQII 302
I C +P+ RPTF +I
Sbjct: 235 IRWCLALRPSDRPTFEEIQ 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-41
Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 13/255 (5%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
DF + KGTF IL + G A+K L +EVI D V E +LQ RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 165
+ A + V EY G+L L R+ A + +I + YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 166 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 225
+++RD++ N++ D G++K+ DFG+ K + + + Y+APEV ++ +
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDND 181
Query: 226 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285
Y VD + +++ EM+ G PF + + + + P L + K L+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILMEEIRFPRTL-SPEAKSLLA 237
Query: 286 ECWNEKPAKRPTFRQ 300
+ P +R
Sbjct: 238 GLLKKDPKQRLGGGP 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 8e-41
Identities = 64/276 (23%), Positives = 107/276 (38%), Gaps = 34/276 (12%)
Query: 58 ITKGTF---ILAFWR--GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQF 110
+ +G F A + VA+KK+ G + D R E+ LLQ++ HPN++
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 111 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 170
L A S + +V +++ L PS + L +G+ YLH++ I+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WIL 122
Query: 171 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 230
HRDL+P+N+L D++G LK+ADFG++K T +F Y V
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 231 DVFSFALILQEMIEGCPPFTMKHDNEVPKA------------------------YAARQR 266
D+++ IL E++ P D + + +
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
P L +LI+ + P R T Q +
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (354), Expect = 7e-40
Identities = 42/279 (15%), Positives = 84/279 (30%), Gaps = 27/279 (9%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
I +G+F QVA+K SD ++R LL V +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
G + ++V + L T A + + +HE +++
Sbjct: 70 G--QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 124
Query: 172 RDLEPSNIL-----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT------SCRYVAPEV 220
RD++P N L ++ + V DFG+ K + + RY++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 221 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA----ARQRPPFKAPAKLY 276
E + D+ + + + G P+ + Y +Q P + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 244
Query: 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 315
+ + N P + + + +N
Sbjct: 245 PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-38
Identities = 55/245 (22%), Positives = 104/245 (42%), Gaps = 7/245 (2%)
Query: 60 KGTFILAFWRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH-PNVVQFLGAVTQS 117
I G A+K L + I + R E +L+ IR P +V A
Sbjct: 42 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101
Query: 118 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 177
+ + ++ +Y+ G+L L ++ + +I + +LH+ II+RD++
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE 158
Query: 178 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSF 235
NIL D +G++ + DFG+SK E + Y+AP++ + + +D VD +S
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218
Query: 236 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 295
+++ E++ G PFT+ + + R + + K+LI+ + P KR
Sbjct: 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 278
Query: 296 PTFRQ 300
Sbjct: 279 LGCGP 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 1e-38
Identities = 59/249 (23%), Positives = 112/249 (44%), Gaps = 16/249 (6%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+ G+F +L + G A+K L ++ + ++ +E +LQ + P +V+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ +S + +V EY+ G++ + L+R G A +A I YLH +I+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 231
RDL+P N+L D G ++V DFG +K + + +APE+ ++ Y+ VD
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 232 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 291
++ +++ EM G PPF ++ Y + P+ ++ LK+L+
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQI---YEKIVSGKVRFPSH-FSSDLKDLLRNLLQVD 276
Query: 292 PAKRPTFRQ 300
KR +
Sbjct: 277 LTKRFGNLK 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (344), Expect = 2e-38
Identities = 59/275 (21%), Positives = 119/275 (43%), Gaps = 33/275 (12%)
Query: 57 EITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 112
+I +GT+ A G A+KK+ E + R E+++L++++H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYD 67
Query: 113 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 172
+ +++V E+L + + +G L+ TA F L + G+ Y H+ + ++HR
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124
Query: 173 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 232
DL+P N+L + G LK+ADFG+++ + + T + +++Y T +D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 233 FSFALILQEMIEGCPPFTMKHDNEV-------------------------PKAYAARQRP 267
+S I EM+ G P F + + + +
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
P+++ K +L+ + P +R T +Q +
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-37
Identities = 58/290 (20%), Positives = 109/290 (37%), Gaps = 49/290 (16%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+I +GTF A R G +VA+KK+ E + + A R E+ +LQ ++H NVV +
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 75
Query: 112 GAVTQSSP--------MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 163
+ + +V ++ S R + G+ Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 164 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEV 220
NK I+HRD++ +N+L G LK+ADFG+++ ++ ++ Y PE+
Sbjct: 136 NK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 221 FKNE-EYDTKVDVFSFALILQEMIEGCPPFT----------------------------M 251
E +Y +D++ I+ EM P
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 252 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 301
+ ++ +++ + A + +LI++ PA+R
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-36
Identities = 61/300 (20%), Positives = 123/300 (41%), Gaps = 39/300 (13%)
Query: 51 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 105
+F +I +GT+ A + G VA+KK+ + ++ A R E++LL+++ HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 106 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN 164
N+V+ L + + + +V E+L + + + + + +G+ + H +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 165 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 224
++HRDL+P N+L + G +K+ADFG+++ R T + + Y APE+
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGC 177
Query: 225 EY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEV-------------------------P 258
+Y T VD++S I EM+ F + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 259 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINNSINHKR 316
++ R F + L+ + + P KR + + + + + + H R
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-36
Identities = 65/296 (21%), Positives = 112/296 (37%), Gaps = 51/296 (17%)
Query: 47 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 101
P E+ +T++ I G+F A G VA+KK+ R EL +++K
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRK 69
Query: 102 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFAL 152
+ H N+V+ S + +V +Y+P+ R + + K L +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 153 DIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 211
+ R + Y+H I HRD++P N+ L D+ LK+ DFG +K L V+ + ++ +
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICS 185
Query: 212 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF-------------------TMK 252
+F +Y + +DV+S +L E++ G P F T +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 253 HDNEVPKAYAARQRPPFKAPAKLYARG------LKELIEECWNEKPAKRPTFRQII 302
E+ Y + P KA L P R T +
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-36
Identities = 63/299 (21%), Positives = 118/299 (39%), Gaps = 48/299 (16%)
Query: 43 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 97
+++ P +TN I +G + A+ ++VA+KK+ + E+
Sbjct: 4 FDVGPR---YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIK 58
Query: 98 LLQKIRHPNVVQFLGAV----TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 153
+L + RH N++ + + + + +L DL LK + L F
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117
Query: 154 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--T 211
I RG+ Y+H ++HRDL+PSN+L + + +LK+ DFG++++ D +
Sbjct: 118 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 212 SCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV------------- 257
+ Y APE+ N + T +D++S IL EM+ P F KH +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 258 --------------PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
+ + + P+ +L+++ P KR Q +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 7e-36
Identities = 66/283 (23%), Positives = 113/283 (39%), Gaps = 42/283 (14%)
Query: 57 EITKGTF---ILAFWR---GIQVAVKKLGEEVISDDDRVRAFR--DELALLQKIRHPNVV 108
EI +G + A G VA+K++ + + + R L L+ HPNVV
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 109 QFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLH 162
+ T S + +V E++ + K + T + RG+++LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 163 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 222
++ ++HRDL+P NIL SG +K+ADFG++++ + + + Y APEV
Sbjct: 134 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL 188
Query: 223 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-----------------------PK 259
Y T VD++S I EM P F D + +
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 260 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 302
A+ ++ P + K+L+ +C PAKR + +
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-34
Identities = 55/276 (19%), Positives = 110/276 (39%), Gaps = 35/276 (12%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+I +GT+ A R VA+K++ + + A R E+ LL++++H N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLH 67
Query: 112 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 171
+ + +V E+ + + F G L P F + +G+ + H ++H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124
Query: 172 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 231
RDL+P N+L + +G LK+A+FG+++ + T +F + Y T +D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 232 VFSFALILQEMIEGCPPFTMKHDNE--------------------VPKAYAARQRPPFKA 271
++S I E+ P +D + + K + P + A
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 272 PAKLYARG------LKELIEECWNEKPAKRPTFRQI 301
L ++L++ P +R + +
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 9e-32
Identities = 66/302 (21%), Positives = 109/302 (36%), Gaps = 53/302 (17%)
Query: 43 YEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 93
E+ + + G + A G +VA+KKL S+ RA+R
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66
Query: 94 DELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEYLPKGDLRAFLKRKGALKPSTA 147
EL LL+ +RH NV+ L T + +V ++ G L + L
Sbjct: 67 -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI 123
Query: 148 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 207
+ +G+ Y+H IHRDL+P N+ ++ LK+ DFG+++ + D +T
Sbjct: 124 QFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMT 176
Query: 208 CQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA--- 263
+ Y APEV N Y VD++S I+ EMI G F + K
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 264 ------------------------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 299
++ F + + L+E+ +R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 300 QI 301
+
Sbjct: 297 EA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (292), Expect = 1e-30
Identities = 53/319 (16%), Positives = 113/319 (35%), Gaps = 62/319 (19%)
Query: 32 MHVKHAREVPEYEIDPHELDFTNS------VEITKGTF---ILAFWR--GIQVAVKKLGE 80
V R ++ + H +++ N ++ +G + A +V VK L
Sbjct: 11 TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-- 68
Query: 81 EVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLK 137
+ + + E+ +L+ +R PN++ V S +V E++ D + +
Sbjct: 69 ----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 138 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSK 196
L + +I + ++Y H I+HRD++P N++ D + L++ D+G+++
Sbjct: 125 T---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178
Query: 197 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN- 255
++ + + + + YD +D++S +L MI PF HDN
Sbjct: 179 FYHPGQEYNVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
Query: 256 ----------------EVPKAYAARQRPPFKAPAKLYARG-----------------LKE 282
+ Y P F ++R +
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297
Query: 283 LIEECWNEKPAKRPTFRQI 301
+++ R T R+
Sbjct: 298 FLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 5e-28
Identities = 65/298 (21%), Positives = 105/298 (35%), Gaps = 30/298 (10%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
I G A+ VA+KKL + RA+R EL L++ + H N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLL 82
Query: 112 GAVTQSSPMM------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 165
T + +V E + + + G+ +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSA- 138
Query: 166 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 225
IIHRDL+PSNI+ LK+ DFG+++ T +T + Y APEV
Sbjct: 139 --GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 226 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285
Y VD++S I+ EM+ F + + + P K ++ +E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 286 ECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSSR 343
P +L + K++ + L ML D P+ R
Sbjct: 255 NRPKYAGLTFP-------KLFPDSLFPADSEHNKLKASQARDLLSKMLVID---PAKR 302
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 6e-27
Identities = 62/281 (22%), Positives = 99/281 (35%), Gaps = 43/281 (15%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 111
+ G + AF G++VAVKKL S R +R EL LL+ ++H NV+ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 112 GAVTQSSPMMIVTEYL----PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 167
T + + + G + + L I RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 141
Query: 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 227
IIHRDL+PSN+ ++ LK+ DFG+++ +D T + Y+
Sbjct: 142 -IIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 228 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG-------- 279
VD++S I+ E++ G F + K P K +
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 280 -------------------LKELIEECWNEKPAKRPTFRQI 301
+L+E+ KR T Q
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.7 bits (208), Expect = 6e-19
Identities = 64/317 (20%), Positives = 111/317 (35%), Gaps = 47/317 (14%)
Query: 57 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ-- 109
++ G F LA VA+K + D A DE+ LLQ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 110 -------------FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIA 155
F +++V E L + L K + P + + +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 156 RGMNYLHENKPVPIIHRDLEPSNILRDDSG------NLKVADFGVSKLLTVKEDRPLTCQ 209
G++Y+H IIH D++P N+L + +K+AD G + D T
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHYTNS 189
Query: 210 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQR 266
+ Y +PEV + D++S A ++ E+I G F + K A
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 267 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCF 326
+ P+ L G +N + R + LE + + + + + F
Sbjct: 250 LLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 327 HNLEAMLKKDHSSPSSR 343
L ML+ D P R
Sbjct: 308 --LSPMLQLD---PRKR 319
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 59.4 bits (143), Expect = 3e-11
Identities = 29/191 (15%), Positives = 61/191 (31%), Gaps = 37/191 (19%)
Query: 69 RGIQVAVKKLGEEVISDDD---------------RVRAFRDELALLQKIRHPNVVQFLGA 113
+ + VK S +R+ R+E LQK++ V +
Sbjct: 23 KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82
Query: 114 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173
++ E + +L + I + + I+H D
Sbjct: 83 ----EGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHR---GIVHGD 128
Query: 174 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 233
L N+L + G + + DF S + + R + +D + + Y T+ D+
Sbjct: 129 LSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN----IITYFSRTYRTEKDIN 183
Query: 234 SFALILQEMIE 244
S + +++
Sbjct: 184 S---AIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 353 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.78 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=397.68 Aligned_cols=244 Identities=25% Similarity=0.488 Sum_probs=213.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||+|++......+......+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 689999999999999984 578999999865433223334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+++|+|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++.++.+||+|||++...... .
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---C
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---c
Confidence 9999999999998888999999999999999999999999 999999999999999999999999999876532 2
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..+ +..+++++++||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTF---PDFVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCC---CTTSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC---CccCCHHHHHHHH
Confidence 234568999999999999999999999999999999999999998876666655554433 222 3457899999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~ 304 (353)
+||+.||++|||++++++|
T Consensus 237 ~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTC
T ss_pred HHccCCHhHCcCHHHHHcC
Confidence 9999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=392.58 Aligned_cols=264 Identities=28% Similarity=0.472 Sum_probs=214.7
Q ss_pred CcccCccCcCcccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 119 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 119 (353)
+|+|+.. +|+..+.||+|+||.||. .+..||||+++..... .+..+.|.+|+.++++++||||+++++++.+ ..
T Consensus 2 dwei~~~--~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 77 (276)
T d1uwha_ 2 DWEIPDG--QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ 77 (276)
T ss_dssp CCBCCTT--CCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred Ccccccc--cEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence 5777644 578889999999999984 3457999999765433 3456789999999999999999999998754 56
Q ss_pred eEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
+++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 89999999999999999754 45999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCC-CCcccCCCCCcccCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-C-CCCCCc
Q 018614 199 TVKED-RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R-PPFKAP 272 (353)
Q Consensus 199 ~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~-~~~~~~ 272 (353)
..... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.............. . +.....
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 54322 223445789999999998643 57889999999999999999999998876655444443333 2 222333
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
...+++++.+||.+||+.||++|||+++++++|+.+..++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 4568899999999999999999999999999999887643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-55 Score=391.61 Aligned_cols=246 Identities=22% Similarity=0.437 Sum_probs=214.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++....... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4699999999999999984 58999999987654333 356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||++||+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++.......
T Consensus 97 Ey~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 999999999988764 5999999999999999999999999 99999999999999999999999999987654322
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....+.+. .+..+++++++||
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li 250 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIFRDFL 250 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-SGGGSCHHHHHHH
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC-CcccCCHHHHHHH
Confidence 234456899999999999999999999999999999999999999877666655555555544443 3466899999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+||+.||++|||++++++|
T Consensus 251 ~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 251 NRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHTCSSTTTSCCHHHHTTC
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999876
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=393.04 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=209.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
..+|+..+.||+|+||.||. +|+.||||++..... .+..+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 34699999999999999983 588999999876432 23345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||+++++.+||+|||+|+.......
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999999987778999999999999999999999999 99999999999999999999999999988754332
Q ss_pred -CCcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 204 -RPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 204 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|++||................ .........+++++.
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSAPL 237 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-CTTSTTGGGSCHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCCccccCCHHHH
Confidence 22344678999999999988776 568999999999999999999998766544433332322 223334567889999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+||.+||+.||++|||++++++|
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-55 Score=387.25 Aligned_cols=250 Identities=29% Similarity=0.564 Sum_probs=205.8
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|+..+.||+|+||.||. +++.||||+++..... .+.+.+|+.++++++||||++++|++.+++..++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 578889999999999884 4778999999765432 24688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++.........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999998764 45899999999999999999999999 9999999999999999999999999998876544444
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....||+.|+|||++.+..++.++|||||||++|||+| |.+||......+....+..+..+.. +..+++++.+|+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li 235 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIM 235 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHHHHH
Confidence 445668899999999999999999999999999999999 6777777666666666655544433 345788999999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.+||+.||++|||+++++++|+++..
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999854
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-55 Score=390.81 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=212.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|+..+.||+|+||.||. +|+.||||++.... .+..+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 489899999999999984 57899999986542 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 126 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
|+++|+|.+++.+ .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++.......
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 9999999999865 456999999999999999999999999 99999999999999999999999999976543211
Q ss_pred CcccCCCCCcccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHH
Q 018614 205 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 279 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+..+....+.....+.+. .+..++++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~s~~ 244 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSSN 244 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGGGSCHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-ccccCCHH
Confidence 122356899999999984 456889999999999999999999999988887877777666544433 34578999
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 280 LKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 280 l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++||.+||+.||++|||++++++|
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999886
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=385.59 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=202.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe--cCceEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 123 (353)
+|+..+.||+|+||.||. +|+.||||.+..... .+...+.+.+|+.++++++||||+++++++.+ +..+|+|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 588899999999999984 488999999977654 34556788999999999999999999999865 4568999
Q ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 124 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP--VPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~Lh~~~~--~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999863 4569999999999999999999998641 1399999999999999999999999999988
Q ss_pred cccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+.....+.. +..++
T Consensus 164 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s 239 (269)
T d2java1 164 LNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---PYRYS 239 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSC
T ss_pred cccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---CcccC
Confidence 7543222 2345689999999999999999999999999999999999999988777666666655554433 45688
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++.+||.+||+.||++|||+.++++|
T Consensus 240 ~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 240 DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=386.02 Aligned_cols=259 Identities=31% Similarity=0.499 Sum_probs=217.8
Q ss_pred CCCcccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEE
Q 018614 40 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 115 (353)
Q Consensus 40 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 115 (353)
-.+|+|+.+ +|+..+.||+|+||.||. ++..||||+++..... .+.+.+|+.++++++||||++++|++.
T Consensus 5 ~~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 5 EDEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TCTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 346777654 688889999999999983 4678999999765322 246899999999999999999999876
Q ss_pred ecCceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 116 QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 116 ~~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
+ +..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||||++++.+||+|||
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecccc
Confidence 4 5679999999999999987532 35899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCc
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 272 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
+|+..............+++.|+|||++.+..++.++|||||||++|||+| |.+||......+....+.....+..
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~--- 231 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR--- 231 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---
Confidence 999876544334445668889999999998899999999999999999999 5666666665566666655544443
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
+..+++++.+|+.+||+.||++|||++++++.|++++.+
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 356788999999999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-54 Score=388.23 Aligned_cols=254 Identities=30% Similarity=0.520 Sum_probs=208.4
Q ss_pred CcccceeeecceEEEEEEc-----C---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFWR-----G---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~-----g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
+|+..+.||+|+||.||.. | ..||||.+.... ..+..+.|.+|+.++++++||||++++|++.+++..++
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 5778899999999999831 2 358999886543 35556789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||||+++|+|.+++... +.+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999998864 45999999999999999999999999 999999999999999999999999999877543
Q ss_pred CCCC----cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhh
Q 018614 202 EDRP----LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 276 (353)
Q Consensus 202 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
.... .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....++...+..+..++. +..+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~ 258 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP---PMDC 258 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Cccc
Confidence 2221 122457889999999999999999999999999999998 8999998887777777766555443 3457
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 277 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 277 ~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
++++.+|+.+||+.||++|||+.++++.|+++....
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 889999999999999999999999999999886543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=394.59 Aligned_cols=247 Identities=21% Similarity=0.403 Sum_probs=211.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++...........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 599999999999999983 488999999875433223334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC-C
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 204 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~ 204 (353)
|++||+|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++++|.+||+|||+|+....... .
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999988754332 2
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..+ +..+++++++||
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~s~~~~~li 241 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDF---PEKFFPKARDLV 241 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCC---CTTCCHHHHHHH
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCC---CccCCHHHHHHH
Confidence 2334568999999999999999999999999999999999999999877666666665443 222 345788999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+||+.||++|||++|++++
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCH
T ss_pred HHHccCCHhHCcCHHHHcCC
Confidence 99999999999999998765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=384.51 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=210.8
Q ss_pred eeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEecCC
Q 018614 56 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 128 (353)
Q Consensus 56 ~~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 128 (353)
++||+|+||.||. .++.||||+++.... +....+.+.+|+.++++++||||++++|++.+ +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 5799999999984 246799999976543 34455789999999999999999999999865 56799999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC--Cc
Q 018614 129 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL 206 (353)
Q Consensus 129 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~--~~ 206 (353)
+|+|.+++.....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++........ ..
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999999998888999999999999999999999999 999999999999999999999999999876543222 22
Q ss_pred ccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 207 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+....++...+..+..++. +..+|+++.+||.
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~ 244 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDLMN 244 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHHHH
Confidence 34568899999999999999999999999999999998 9999998877777777766555544 3467899999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 286 ECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 286 ~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
+||+.||++|||++++++.|+.+...
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999999999887544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=380.67 Aligned_cols=247 Identities=27% Similarity=0.518 Sum_probs=217.9
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|+..++||+|+||.||. ++..||||+++..... + +++.+|+.++++++||||++++|++.+++.+++||||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-E---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-H---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-H---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 678888999999999984 5778999999765432 2 4688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 127 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 127 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
+++|+|.+++.. ...+++..++.++.|++.||.|||+.| ++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999765 445899999999999999999999999 9999999999999999999999999998776554444
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......++...+........ +..+++++.+||
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li 234 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYTIM 234 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccHHHHHHH
Confidence 455678999999999999999999999999999999998 8999999888887777766544432 456788999999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHH
Q 018614 285 EECWNEKPAKRPTFRQIITRLES 307 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~~ll~~l~~ 307 (353)
.+||+.||++|||+++++++|.+
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999999865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-54 Score=391.33 Aligned_cols=244 Identities=25% Similarity=0.449 Sum_probs=214.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|+..+.||+|+||.||. +|+.||||++........+..+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 489999999999999984 588999999987665566667789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
||++|+|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 9999999888887788999999999999999999999999 999999999999999999999999999875432
Q ss_pred cccCCCCCcccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....+... ...+++++.+
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~ 245 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRN 245 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHHHH
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHHHH
Confidence 23568999999999864 45889999999999999999999999887666666565555544432 3467899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||+.||++|||++++++|
T Consensus 246 li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHCcCChhHCcCHHHHHhC
Confidence 9999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-54 Score=389.72 Aligned_cols=257 Identities=28% Similarity=0.485 Sum_probs=217.0
Q ss_pred CCcccCccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEE
Q 018614 41 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 115 (353)
Q Consensus 41 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 115 (353)
..|+|+.. +|+..+.||+|+||.||. +|+.||||+++.... ..+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 10 DKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 35887755 578889999999999884 488999999876532 2356889999999999999999999999
Q ss_pred ecCceEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 116 QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 116 ~~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
+++..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccc
Confidence 999999999999999999999764 45899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCCCchHHHHHhcCCCCCCCc
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAP 272 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
+++..............+++.|+|||++.+..++.++|||||||++|||++|..| |...+.......+.....+..
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~--- 237 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER--- 237 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC---
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC---
Confidence 9988765444434445578899999999999999999999999999999996555 555554454455544444333
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
+..+++++.+||.+||+.||++|||++++++.|+.+.
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 3467899999999999999999999999999888763
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-54 Score=391.71 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=200.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
.|+..+.||+|+||.||. +|+.||||++....... ....+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 499999999999999884 48899999997654322 23567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc---CCCCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~---~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|++||+|.+++...+.+++..+..++.||+.||.|||++| ++||||||+||++. +++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999999998888999999999999999999999999 99999999999995 57899999999998765332
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.........+....+|+++.+
T Consensus 165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 223456899999999999999999999999999999999999999887766666666655544433445678899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||+.||++|||++|+++|
T Consensus 243 li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCHhHCcCHHHHhcC
Confidence 9999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=382.11 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=216.9
Q ss_pred Ccccce-eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEE
Q 018614 51 DFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~-~ig~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~i 122 (353)
+|.... +||+|+||.||. ++..||||+++... .....+.|.+|+.++++++||||++++|++.+ +.+|+
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 455555 599999999984 24579999987542 45566789999999999999999999999865 56899
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999998653 56999999999999999999999999 999999999999999999999999999877543
Q ss_pred CCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 202 EDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 202 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....++...+..+..+.. +..+|+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~ 239 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECPP 239 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTTCCH
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCH
Confidence 321 2233457889999999999999999999999999999998 9999999887777777766665544 346889
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhh
Q 018614 279 GLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 313 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~ 313 (353)
++.+||.+||+.||++|||+.++++.|+....++.
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999988765443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=380.51 Aligned_cols=259 Identities=24% Similarity=0.481 Sum_probs=212.0
Q ss_pred CcccCccCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeE
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 113 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 113 (353)
+|+|+.+ +|+..+.||+|+||.||. .+..||||.+... ......+.+.+|+.++++++||||++++|+
T Consensus 1 ~~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 1 DYEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CCBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4777654 588899999999999883 1356889988643 345666789999999999999999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeec
Q 018614 114 VTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 192 (353)
Q Consensus 114 ~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Df 192 (353)
+. ++..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccc
Confidence 96 46789999999999999987654 45899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 193 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 193 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
|+++..............+|+.|+|||.+.+..++.++|||||||++|||++ |.+||......++...+..+..++.
T Consensus 153 G~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~-- 230 (273)
T d1mp8a_ 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-- 230 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC--
T ss_pred hhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 9998876544444455668899999999999999999999999999999998 8999999888888888776665544
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
+..+|+++.+||.+||+.||++|||+.+|+++|+.+...
T Consensus 231 -~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 231 -PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 356789999999999999999999999999999988654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-54 Score=391.97 Aligned_cols=248 Identities=27% Similarity=0.493 Sum_probs=207.4
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEE
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv 123 (353)
+.+|+..+.||+|+||.||. +|+.||+|+++... .......+.+|+.++++++||||++++++|.+...+|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45799999999999999984 58999999987643 233446788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCC
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||+ +| |+||||||+|||++++|.+||+|||+|+......
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999999988889999999999999999999997 48 9999999999999999999999999998765432
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHh-------------------
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA------------------- 263 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~------------------- 263 (353)
. ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.......
T Consensus 160 ~---~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 A---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp C------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred c---ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2 235689999999999999999999999999999999999999977554322111000
Q ss_pred ---------------------cCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 264 ---------------------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 264 ---------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+.......++.++.+||.+||..||++|||++++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00001111123467889999999999999999999999997
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-53 Score=391.19 Aligned_cols=246 Identities=22% Similarity=0.380 Sum_probs=215.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 799999999999999984 4899999998654 34445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc--CCCCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~--~~~~vkl~Dfg~a~~~~~~~ 202 (353)
|++||+|.+++.+ .+.+++..++.++.||+.||.|||++| ++||||||+|||++ .++.+||+|||+++.....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999999999954 456999999999999999999999999 99999999999996 4678999999999876533
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............+++++++
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2233456899999999999999999999999999999999999999887777777766555543333344678899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||+.||++|||++++++|
T Consensus 259 li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-53 Score=376.45 Aligned_cols=246 Identities=26% Similarity=0.495 Sum_probs=203.3
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe----cCceEE
Q 018614 52 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMI 122 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~i 122 (353)
|+..++||+|+||.||. +|+.||+|.+..... .....+.+.+|++++++++||||+++++++.+ +..+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 35667899999999984 478999999876544 34556789999999999999999999999865 345799
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc-CCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~-~~~~vkl~Dfg~a~~~~~~ 201 (353)
||||+++|+|.+++.+...+++..++.++.||+.||.|||+++. +|+||||||+|||++ +++.+||+|||+++.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999999988889999999999999999999999762 399999999999997 5789999999999864322
Q ss_pred CCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 281 (353)
......||+.|+|||++.+ .++.++|||||||++|||++|+.||..................+. .....+++++.
T Consensus 169 ---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~ 243 (270)
T d1t4ha_ 169 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-SFDKVAIPEVK 243 (270)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-GGGGCCCHHHH
T ss_pred ---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc-ccCccCCHHHH
Confidence 2234568999999999876 599999999999999999999999986654433322222222221 22345678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 018614 282 ELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 282 ~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+||.+||+.||++|||++|+++|
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHccCCHhHCcCHHHHhCC
Confidence 99999999999999999999876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=384.31 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=215.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC---HHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 121 (353)
.+|+..+.||+|+||.||. +|+.||||++....... ....+.+.+|+.++++++||||+++++++.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3699999999999999984 48899999986543322 123467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC----CEEEeecccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL 197 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~----~vkl~Dfg~a~~ 197 (353)
+|||||++|+|.+++...+.+++..++.++.|++.||.|||+++ ++||||||+||+++.++ .+||+|||++..
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999998888999999999999999999999999 99999999999999777 499999999987
Q ss_pred cccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............+|
T Consensus 167 ~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp CTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred cCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 65432 2234567889999999999999999999999999999999999999877666666665544333222345678
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+++++||++||+.||++|||++++++|
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 899999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=389.73 Aligned_cols=246 Identities=25% Similarity=0.403 Sum_probs=215.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||+++.......+....+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 699999999999999983 589999999976433223334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|++||+|.+++...+.+++..++.++.||+.||+|||++| ++||||||+|||++.+|.+||+|||+|+....... .
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~ 161 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc-c
Confidence 9999999999999888999999999999999999999999 99999999999999999999999999987653322 2
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
.....||+.|+|||++.+..++.++|||||||++|||++|++||...+..++...+.... ..+ +..+++++++||.
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~---p~~~s~~~~dli~ 237 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRF---PRTLSPEAKSLLA 237 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CTTSCHHHHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCC---CccCCHHHHHHHH
Confidence 334568999999999999999999999999999999999999999887776666665443 222 3468899999999
Q ss_pred HHcccCCCCCCC-----HHHHHHH
Q 018614 286 ECWNEKPAKRPT-----FRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rps-----~~~ll~~ 304 (353)
+||++||++|++ ++++++|
T Consensus 238 ~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 238 GLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hhccCCchhhcccccccHHHHHcC
Confidence 999999999995 8899886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-53 Score=378.09 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=215.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCc----e
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----M 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~ 120 (353)
.+|+..+.||+|+||.||. +|+.||||+++.....+.+....+.+|+.+++.++||||+++++++..... +
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 3599999999999999984 589999999988777677777889999999999999999999999976543 7
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++| ++||||||+|||++.++.++++|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999876543
Q ss_pred CCC--CCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 201 KED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 201 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
... .......||+.|+|||++.+..++.++|||||||++|+|++|++||...+..+....+......+.......+|+
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 322 223345689999999999999999999999999999999999999988766666555555443333233456889
Q ss_pred HHHHHHHHHcccCCCCCC-CHHHHHHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRP-TFRQIITRLESIN 309 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rp-s~~~ll~~l~~~~ 309 (353)
++.+||.+||+.||++|| |++++++.|.++.
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 999999999999999999 8999999888764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.7e-53 Score=388.86 Aligned_cols=246 Identities=18% Similarity=0.357 Sum_probs=214.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++.... ......+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 699999999999999984 58899999987543 3344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEc--CCCCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~--~~~~vkl~Dfg~a~~~~~~~ 202 (353)
||+||+|.+++...+ ++++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|......
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 999999999876544 5999999999999999999999999 99999999999998 6789999999999887543
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............+++++.+
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2233456789999999999999999999999999999999999999887776766666555543333344578899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||+.||++|||+.++++|
T Consensus 262 li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-53 Score=384.96 Aligned_cols=255 Identities=26% Similarity=0.442 Sum_probs=211.8
Q ss_pred CcccCccCcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccce
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 110 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~ 110 (353)
.|+++.+ +|+..+.||+|+||.||.. +..||+|.+.... .......+.+|+.++.++ +||||+++
T Consensus 31 kwei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 31 KWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGBCCGG--GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHH--HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 3666544 5788899999999999841 1369999986543 233446788999999998 89999999
Q ss_pred eeEEEecCceEEEEecCCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 018614 111 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPV 167 (353)
Q Consensus 111 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~al~~Lh~~~~~ 167 (353)
++++.+.+..|+|||||++|+|.+++.... .+++..++.++.|++.||.|||+++
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-- 184 (325)
T d1rjba_ 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184 (325)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 999999999999999999999999997542 3788999999999999999999999
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-C
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 245 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g 245 (353)
|+||||||+|||++.++.+||+|||+|+......... .....+|+.|+|||++.+..++.++|||||||++|||+| |
T Consensus 185 -IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 185 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp -EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred -eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 9999999999999999999999999998765543322 223456889999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCchHHHHHhcC-CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 018614 246 CPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 306 (353)
Q Consensus 246 ~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~ 306 (353)
+.||.+.........+.... .++. +..+|+++++||.+||+.||++|||+++|+++|.
T Consensus 264 ~~Pf~~~~~~~~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 264 VNPYPGIPVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99999877766655554443 3322 3467899999999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=373.21 Aligned_cols=259 Identities=29% Similarity=0.498 Sum_probs=209.9
Q ss_pred ccCccCcCcccceeeecceEEEEEEc-----C----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEE
Q 018614 44 EIDPHELDFTNSVEITKGTFILAFWR-----G----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 114 (353)
Q Consensus 44 ~i~~~~~~~~~~~~ig~G~~~~v~~~-----g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 114 (353)
||+++ .|+..+.||+|+||.||.. + ..||||++.... ..+....|.+|+.++++++||||++++|++
T Consensus 3 ei~~~--~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 3 EIHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp BCCTT--TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHH--HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence 34444 4778899999999999841 1 469999987543 345556789999999999999999999999
Q ss_pred EecCceEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 115 TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 115 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
.+....++||||+.++++.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||||+.++.+||+|||
T Consensus 79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 9999999999999999999988764 46999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCchHHHHHhcCCCCCC
Q 018614 194 VSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQRPPFK 270 (353)
Q Consensus 194 ~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~ 270 (353)
+++........ ......||+.|+|||++.+..++.++|||||||++|||++| .+|+......++...+..+..++.
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~- 234 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT- 234 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC-
Confidence 99876543322 22334578899999999999999999999999999999995 555666555566666655555443
Q ss_pred CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 271 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
+..++.++.+||.+||+.||++|||+.++++.|+++....
T Consensus 235 --~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 235 --PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp --CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 3457889999999999999999999999999999886643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-52 Score=371.05 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=216.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC------HHHHHHHHHHHHHHhcCC-CCcccceeeEEEec
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS 117 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 117 (353)
.+|+..+.||+|+||.||. +|+.||||++....... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 4799999999999999984 68899999987654322 223456889999999997 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 118 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 118 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
+.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999999999998888999999999999999999999999 99999999999999999999999999988
Q ss_pred cccCCCCCcccCCCCCcccCccccCC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 198 LTVKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
..... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.......+..+.......
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 75432 2334668999999998853 356889999999999999999999999887666666666555443334
Q ss_pred chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
....+|+++++||.+||+.||++|||++++++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 456789999999999999999999999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=381.59 Aligned_cols=245 Identities=16% Similarity=0.293 Sum_probs=211.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||+++... .....+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 599999999999999984 58899999997642 223467899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCC--CCEEEeecccccccccCC
Q 018614 126 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 202 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~--~~vkl~Dfg~a~~~~~~~ 202 (353)
||+||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.++|+|||++......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 999999999998655 6999999999999999999999999 9999999999999854 47999999999876432
Q ss_pred CCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHH
Q 018614 203 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 282 (353)
Q Consensus 203 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 282 (353)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+..............+++++++
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 2223355788999999999999999999999999999999999999988777777776555433322233467899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 018614 283 LIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 283 li~~cl~~dp~~Rps~~~ll~~ 304 (353)
||.+||..||++|||++++++|
T Consensus 237 li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999987
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-52 Score=381.82 Aligned_cols=244 Identities=24% Similarity=0.454 Sum_probs=213.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
.+|+..+.||+|+||.||. +|+.||||++...........+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 3699999999999999983 48899999987543322333467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||++||+|..++.....+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999999999999888999999999999999999999999 999999999999999999999999999886533
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...... + +..+++++.++|
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-~---p~~~s~~~~~li 232 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-F---PPFFNEDVKDLL 232 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC-C---CTTSCHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-C---CCCCCHHHHHHH
Confidence 23356899999999999999999999999999999999999999987776666666554322 2 345788999999
Q ss_pred HHHcccCCCCCC-----CHHHHHHH
Q 018614 285 EECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
.+||..||.+|+ |++++++|
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhhhCHHhccccchhhHHHHHcC
Confidence 999999999996 99999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=370.18 Aligned_cols=251 Identities=30% Similarity=0.559 Sum_probs=210.9
Q ss_pred cccCccCcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-cC
Q 018614 43 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS 118 (353)
Q Consensus 43 ~~i~~~~~~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 118 (353)
|+|+..+ |+..+.||+|+||.|| ..|..||||+++.+. ..+.+.+|+.++++++||||++++|++.+ .+
T Consensus 2 w~i~~~~--~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKE--LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGG--EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHH--eEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 7777664 6778899999999987 579999999996542 23568899999999999999999999865 46
Q ss_pred ceEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 196 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~ 196 (353)
.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccce
Confidence 6899999999999999996543 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhh
Q 018614 197 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 275 (353)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (353)
...... ....++..|+|||.+.+..++.++||||||+++|||+| |++||...+..++...+..+..+++ +..
T Consensus 152 ~~~~~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~---~~~ 224 (262)
T d1byga_ 152 EASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDG 224 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC---CTT
T ss_pred ecCCCC----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence 754322 22346789999999999999999999999999999998 8999998888888888766666654 345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 276 YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 276 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
+++++.+||.+||..||++|||+.+++++|+++..
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 78899999999999999999999999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=373.42 Aligned_cols=259 Identities=31% Similarity=0.495 Sum_probs=210.6
Q ss_pred CCCcccCccCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEE
Q 018614 40 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 115 (353)
Q Consensus 40 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 115 (353)
..+|+|+.+ +|+..+.||+|+||.||. ++..||||++..... . .+.|.+|+.++++++||||++++|++.
T Consensus 9 ~~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~---~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 9 KDAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp TTCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-C---HHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 346888754 699999999999999984 456899999976543 2 246899999999999999999999985
Q ss_pred ecCceEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 116 QSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 116 ~~~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
+ +..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ ++||||||+||||++++.+||+|||
T Consensus 83 ~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 83 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccc
Confidence 4 568999999999999998854 346999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCchHHHHHhcCCCCCCCc
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQRPPFKAP 272 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
+++..............+|+.|+|||++.++.++.++|||||||++|||++| ++|+......+....+..+...+.
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~--- 235 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--- 235 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---
Confidence 9987754444444456689999999999999999999999999999999995 555666555556666655544443
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 273 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 273 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
+..+++++.+||.+||+.||++||++++|++.|+.+...
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 356789999999999999999999999999998887543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-52 Score=384.50 Aligned_cols=243 Identities=24% Similarity=0.395 Sum_probs=212.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++......+....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 699999999999999984 589999999865433223334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
|+.+|+|.+++...+.+++..++.++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+++......
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--- 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--- 195 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccccc---
Confidence 9999999999998888999999999999999999999999 9999999999999999999999999998865322
Q ss_pred cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHH
Q 018614 206 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 285 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (353)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....... +..+++++.+||+
T Consensus 196 -~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 196 -WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLR 270 (350)
T ss_dssp -CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTCCHHHHHHHH
T ss_pred -ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC----CccCCHHHHHHHH
Confidence 23568999999999999999999999999999999999999998876666666654443222 3467889999999
Q ss_pred HHcccCCCCCC-----CHHHHHHH
Q 018614 286 ECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 286 ~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
+||..||.+|+ |++++++|
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccccccHHHHHcC
Confidence 99999999994 89999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-51 Score=381.29 Aligned_cols=248 Identities=22% Similarity=0.347 Sum_probs=206.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC---HHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 121 (353)
.+|+..+.||+|+||.||. +|+.||||++....... .........++.+++.++||||+++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 3689999999999999983 58899999986433211 122222344577788889999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
+||||++||+|.+++.+...+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999998888999999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHH
Q 018614 202 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 280 (353)
Q Consensus 202 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (353)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................... ..+..+++++
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~ 236 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPEL 236 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC-CCCSSSCHHH
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-CCCCCCCHHH
Confidence 2 233568999999999865 5689999999999999999999999988766655444333332222 2245688999
Q ss_pred HHHHHHHcccCCCCCCC-----HHHHHHH
Q 018614 281 KELIEECWNEKPAKRPT-----FRQIITR 304 (353)
Q Consensus 281 ~~li~~cl~~dp~~Rps-----~~~ll~~ 304 (353)
++||.+||+.||++||| ++++++|
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999999999999 7999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=369.18 Aligned_cols=261 Identities=29% Similarity=0.530 Sum_probs=218.3
Q ss_pred CCCcccCccCcCcccceeeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCc
Q 018614 40 VPEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN 106 (353)
Q Consensus 40 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 106 (353)
.|.|+|+.+ +|+..+.||+|+||.||.. +..||||++.... .......+.+|+..+.++ +|||
T Consensus 5 ~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 5 DPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp CTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCe
Confidence 355777655 6888899999999998841 2479999997653 345567788899999888 7999
Q ss_pred ccceeeEEEecCceEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEE
Q 018614 107 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPII 170 (353)
Q Consensus 107 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~ii 170 (353)
|+++++++.+++..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ ++
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---iv 157 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CI 157 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EE
Confidence 999999999999999999999999999999744 24899999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCC
Q 018614 171 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 248 (353)
Q Consensus 171 H~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 248 (353)
||||||+|||++.++.+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |.+|
T Consensus 158 HrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp CSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred eeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence 9999999999999999999999999987654333 2344567889999999999999999999999999999998 7999
Q ss_pred CCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 249 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 249 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
|.......+...+..+..+.. +..+++++.+||.+||+.||++|||+.++++.|+++..
T Consensus 238 ~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 238 YPGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp STTCCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 988877777666655544443 34578899999999999999999999999999998854
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-52 Score=368.76 Aligned_cols=253 Identities=26% Similarity=0.472 Sum_probs=204.2
Q ss_pred cCcccceeeecceEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceE
Q 018614 50 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 121 (353)
.+|+..+.||+|+||.||.. +..||||++......+.+..+.|.+|+.++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45889999999999998731 24799999987666566777889999999999999999999999975 4678
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 122 IVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
+||||+++++|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 99999999999988765 345999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCC--CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 201 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 201 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
.... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.+.+..+....+......+ +.+..+|
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~ 241 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPEDCP 241 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--CCCTTCC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--CCccccc
Confidence 4322 2233457889999999999999999999999999999998 899999887777777665544222 2235678
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESI 308 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~ 308 (353)
+++.+||.+||..||++|||+.+|++.|++.
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8999999999999999999999999988764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=378.40 Aligned_cols=246 Identities=28% Similarity=0.456 Sum_probs=209.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh-cCCCCcccceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~iv~ 124 (353)
+|+..+.||+|+||.||. +|+.||||++........+..+.+..|..++. .++||||+++++++.+++..|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 688999999999999984 58999999986543222222345566666654 689999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 018614 125 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 204 (353)
Q Consensus 125 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 204 (353)
||+++|+|.+++.....+++..++.++.||+.||.|||+++ ++||||||+|||+++++.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~- 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc-
Confidence 99999999999998888999999999999999999999999 99999999999999999999999999987654322
Q ss_pred CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHH
Q 018614 205 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 284 (353)
Q Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 284 (353)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+.... +.+ +..+++++.+||
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~---p~~~s~~~~dli 234 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFY---PRWLEKEAKDLL 234 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CTTSCHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCC---CccCCHHHHHHH
Confidence 2334568999999999999999999999999999999999999999887777666664433 322 345789999999
Q ss_pred HHHcccCCCCCCCHH-HHHHH
Q 018614 285 EECWNEKPAKRPTFR-QIITR 304 (353)
Q Consensus 285 ~~cl~~dp~~Rps~~-~ll~~ 304 (353)
.+||..||++||++. ++++|
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGGS
T ss_pred HHhcccCCCCCcCHHHHHHhC
Confidence 999999999999995 78764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=370.37 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=205.4
Q ss_pred CcccCccCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccce
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 110 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~ 110 (353)
.|+|..+ +|+..+.||+|+||.||. .++.||||++.... .....+.+.+|...+.++ +|+||+++
T Consensus 7 ~wei~~~--~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGG--GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHH--HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 4666543 588899999999999984 24689999987543 344556778888888877 68899999
Q ss_pred eeEEEec-CceEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecC
Q 018614 111 LGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 173 (353)
Q Consensus 111 ~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~d 173 (353)
++++... ..+++|||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9988654 4689999999999999999753 23789999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCC
Q 018614 174 LEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTM 251 (353)
Q Consensus 174 lkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~ 251 (353)
|||+|||+++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++| .+||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 23345689999999999999999999999999999999985 678887
Q ss_pred CCCCchHHHHH-hcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 252 KHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 252 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
....+...... .+..+.. +..+++++.+||.+||+.||++|||+++++++|+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 240 VKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 76655544433 3333332 34578899999999999999999999999999999854
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=371.53 Aligned_cols=254 Identities=24% Similarity=0.482 Sum_probs=211.6
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
.+|+..+.||+|+||.||. +|+ .||+|.+.... ..+..+.+.+|+.++++++||||++++|++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 3699999999999999984 232 68999886532 233456789999999999999999999999864 57
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 199 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~ 199 (353)
++++|++.+++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 7888999899999988764 45999999999999999999999999 9999999999999999999999999998875
Q ss_pred cCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 200 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 200 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
...... .....||+.|+|||.+.++.++.++|||||||++|||+| |.+||.+....++...+..+..++. +..++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---p~~~~ 239 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICT 239 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC---CTTBC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccC
Confidence 443322 233457899999999999999999999999999999998 8999998888887777766655543 34678
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHh
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 312 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~ 312 (353)
+++.+|+.+||+.||++|||+.+++++|+.+....
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 89999999999999999999999999999886543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-51 Score=370.32 Aligned_cols=251 Identities=29% Similarity=0.458 Sum_probs=215.8
Q ss_pred CcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 120 (353)
+|+..+.||+|+||.||.. +..||||++.... ..+....+.+|+.++++++||||+++++++......
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 6899999999999999832 3689999987543 455567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCC
Q 018614 121 MIVTEYLPKGDLRAFLKRKG------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 176 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp 176 (353)
+++|||+++|+|.+++.... .+++..++.++.|++.||+|||+++ +|||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999996432 3788899999999999999999999 99999999
Q ss_pred CCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCC
Q 018614 177 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHD 254 (353)
Q Consensus 177 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~ 254 (353)
+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++| .+||...+.
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9999999999999999999876443322 22345678899999999999999999999999999999997 578888877
Q ss_pred CchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 018614 255 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 309 (353)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~ 309 (353)
.+....+..+..++. +..+++++.+||.+||+.||++|||+.+|++.|+++.
T Consensus 249 ~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 EEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 777777766655443 4567889999999999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=364.98 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=223.0
Q ss_pred CCCcccCccCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccc
Q 018614 40 VPEYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 109 (353)
Q Consensus 40 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 109 (353)
..+|+|++. +|+..+.||+|+||.||. .+..||||+++... ..+....+.+|+.++++++||||++
T Consensus 12 ~~~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~ 87 (308)
T d1p4oa_ 12 PDEWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVR 87 (308)
T ss_dssp CCTTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred ccceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEee
Confidence 346888865 578889999999999973 25689999997543 4455567899999999999999999
Q ss_pred eeeEEEecCceEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCE
Q 018614 110 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 179 (353)
Q Consensus 110 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Ni 179 (353)
+++++..+...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||
T Consensus 88 ~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~Ni 164 (308)
T d1p4oa_ 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC 164 (308)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred eeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCce
Confidence 999999999999999999999999998642 23688999999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCch
Q 018614 180 LRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEV 257 (353)
Q Consensus 180 ll~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~ 257 (353)
|++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||+|| .+||......+.
T Consensus 165 Lld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~ 244 (308)
T d1p4oa_ 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244 (308)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred eecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998765443322 2334578999999999999999999999999999999997 688988887777
Q ss_pred HHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 258 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
...+..+..++. +..+++.+.+||.+||+.||++|||+.+|+++|++....
T Consensus 245 ~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 245 LRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 777766555443 356788999999999999999999999999999876443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=366.15 Aligned_cols=250 Identities=32% Similarity=0.539 Sum_probs=208.3
Q ss_pred CcccceeeecceEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEecCceEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 122 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~i 122 (353)
+|+..+.||+|+||.||. +|. .||||.+.... ..+..+.+.+|+.+++++ +||||++++|++.+++..++
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 577788999999999973 333 57788775332 334456799999999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCC
Q 018614 123 VTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 186 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~ 186 (353)
||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999999643 45899999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCchHHHHHhcC
Q 018614 187 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQ 265 (353)
Q Consensus 187 vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~ 265 (353)
+||+|||+++........ ....+|..|+|||.+.+..++.++|||||||++|||++| .+||...+..++...+..+.
T Consensus 166 ~kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EEECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred eEEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 999999999865433222 234578899999999999999999999999999999996 56788877777666665554
Q ss_pred CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 266 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 266 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.+.. +..+++++.+||.+||+.||++|||+++++++|+++..
T Consensus 244 ~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 244 RLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp CCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 4443 34578999999999999999999999999999999854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=362.72 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=219.6
Q ss_pred CcccCccCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccce
Q 018614 42 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 110 (353)
Q Consensus 42 ~~~i~~~~~~~~~~~~ig~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~ 110 (353)
.|+++.+ +|+..+.||+|+||.||. .+..||||+++... .......+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 17 KWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 4777654 677789999999999984 24589999997643 345566789999999999 69999999
Q ss_pred eeEEEecCceEEEEecCCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEec
Q 018614 111 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 172 (353)
Q Consensus 111 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~ 172 (353)
++++.+....++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ ++||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr 169 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR 169 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 999999999999999999999999997532 4889999999999999999999999 9999
Q ss_pred CCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 018614 173 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 250 (353)
Q Consensus 173 dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~ 250 (353)
||||+||+++.++.++++|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||.
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999877544332 2234567899999999999999999999999999999998 777787
Q ss_pred CCCCCchHHHHHhcCCCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 251 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.....+....+......+. .+..+++++.+||.+||+.||++|||+.+|++.|++...
T Consensus 250 ~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 7777666555544443322 234578899999999999999999999999999988644
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-51 Score=366.92 Aligned_cols=247 Identities=28% Similarity=0.383 Sum_probs=198.3
Q ss_pred cceeeecceEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 54 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 54 ~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
..+.||+|+||.||. +|+.||||+++...... +...+.+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 457899999999984 58899999987643322 12234688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 206 (353)
+.++++..+......+++..+..++.||+.||+|||++| ++||||||+|||++.++.+||+|||+++........ .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~ 157 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-Y 157 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-C
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc-c
Confidence 988777777666667999999999999999999999999 999999999999999999999999999876544322 2
Q ss_pred ccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC-----------------
Q 018614 207 TCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP----------------- 268 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----------------- 268 (353)
....+|+.|+|||++.+. .++.++|||||||++|||++|++||......+....+......+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 335688999999998654 57999999999999999999999998776655554443211000
Q ss_pred --CCC-----chhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 --FKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 --~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
... .....++++.+||.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 012457889999999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=367.12 Aligned_cols=241 Identities=27% Similarity=0.415 Sum_probs=197.4
Q ss_pred Ccccce-eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeeEEEe----cCc
Q 018614 51 DFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----SSP 119 (353)
Q Consensus 51 ~~~~~~-~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~ 119 (353)
+|++.. .||+|+||.||. +|+.||||+++.. ..+.+|+.++.++ +||||++++++|.+ +..
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 688764 599999999984 5789999998643 2467899886554 89999999999875 456
Q ss_pred eEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---CCCEEEeeccc
Q 018614 120 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 194 (353)
Q Consensus 120 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~~~vkl~Dfg~ 194 (353)
+|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++| ++||||||+|||+++ .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 899999999999999998743 5999999999999999999999999 999999999999985 55799999999
Q ss_pred ccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC---CCCCC-
Q 018614 195 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---RPPFK- 270 (353)
Q Consensus 195 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~- 270 (353)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.... ...++
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 98765432 2334568999999999999999999999999999999999999998776555444332221 11121
Q ss_pred CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 271 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.....+++++.+||.+||+.||++|||+.++++|
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2335688999999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=359.54 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=209.2
Q ss_pred cccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-cCceEE
Q 018614 52 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMI 122 (353)
Q Consensus 52 ~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~i 122 (353)
+...+.||+|+||.||. ....||||.++.. .+....+.|.+|+.++++++||||++++|++.. ++..++
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 33357899999999983 1236899998643 356667889999999999999999999999875 457899
Q ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccC
Q 018614 123 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 201 (353)
Q Consensus 123 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 201 (353)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.....
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999999999998544 4778899999999999999999999 999999999999999999999999999876544
Q ss_pred CCC---CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC-CCCCCchHHHHHhcCCCCCCCchhhhH
Q 018614 202 EDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPFKAPAKLYA 277 (353)
Q Consensus 202 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
... ......+|+.|+|||.+.+..++.++||||||+++|||++|..||. .....+....+..+..+.. +..++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~~ 260 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCP 260 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTTCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---cccCc
Confidence 322 2233568899999999999999999999999999999999666554 4444455566655554443 34578
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhc
Q 018614 278 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 315 (353)
Q Consensus 278 ~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~ 315 (353)
+++.+||.+||..||++||++.+++++|+++......+
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 89999999999999999999999999999997765443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=357.51 Aligned_cols=241 Identities=27% Similarity=0.408 Sum_probs=200.2
Q ss_pred cCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHH---HHHHHHHHHHHHhcCC--CCcccceeeEEEec
Q 018614 48 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD---RVRAFRDELALLQKIR--HPNVVQFLGAVTQS 117 (353)
Q Consensus 48 ~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~ 117 (353)
.+.+|+..+.||+|+||.||. +|+.||||++......+.. ....+.+|+.++++++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 356799999999999999983 5889999998754332211 1123568999999986 89999999999999
Q ss_pred CceEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-CCCEEEeecccc
Q 018614 118 SPMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVS 195 (353)
Q Consensus 118 ~~~~iv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-~~~vkl~Dfg~a 195 (353)
+..++|||++.+ +++.+++.....+++..++.++.||+.||.|||++| ++||||||+|||++. ++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence 999999999975 688999988888999999999999999999999999 999999999999985 578999999999
Q ss_pred cccccCCCCCcccCCCCCcccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchh
Q 018614 196 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 274 (353)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
+..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||... ..+.... ..+ +.
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~-~~~---~~ 225 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQ-VFF---RQ 225 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCC-CCC---SS
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcc-cCC---CC
Confidence 875432 2334568999999999987665 56789999999999999999999642 2232222 111 24
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 275 LYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 275 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+|+++++||.+||+.||++|||++++++|
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 578899999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=358.47 Aligned_cols=248 Identities=24% Similarity=0.434 Sum_probs=198.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||++..... .+.....+.+|++++++++||||+++++++.++..+|+|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 689999999999999984 488999999976432 22334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 018614 126 YLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 203 (353)
Q Consensus 126 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 203 (353)
|+.+ .+.+++.. ...+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9954 55555543 345999999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCcccCCCCCcccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCC------------
Q 018614 204 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK------------ 270 (353)
Q Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------------ 270 (353)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..+....+......+..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2333456889999999877665 478999999999999999999999876544433333221100000
Q ss_pred -------------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 271 -------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 271 -------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.....+++++.+||.+||..||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0012456889999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.6e-49 Score=353.66 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=201.2
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEec
Q 018614 51 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 126 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 126 (353)
+|+..+.||+|+||.||. +|+.||||++..... +......+.+|+.++++++||||+++++++.+++..+++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999984 478999999976532 223346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 018614 127 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 206 (353)
Q Consensus 127 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 206 (353)
+.++.+..+....+.+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......... .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-Y 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccc-c
Confidence 977766776666777999999999999999999999999 999999999999999999999999999876543322 2
Q ss_pred ccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-CCC----------------
Q 018614 207 TCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP---------------- 268 (353)
Q Consensus 207 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~---------------- 268 (353)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+.... .+.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 334578899999998765 56899999999999999999999998765544433332111 000
Q ss_pred --------CCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 --------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 --------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.......+++++.+||++||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000123457889999999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=353.25 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=197.6
Q ss_pred CcCcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeeEEEe---
Q 018614 49 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ--- 116 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~--- 116 (353)
+.+|++.+.||+|+||.||. +++.||||+++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 45899999999999999984 25679999986543221 1112355677777665 79999999999853
Q ss_pred --cCceEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 117 --SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 117 --~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
....+++||+++++.+...... ...+++..++.++.|++.||+|||+++ |+||||||+|||++..+.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 3468999999977666544443 345899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCC------
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP------ 267 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------ 267 (353)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|++||...+..+....+......
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 98865433 2234467899999999999999999999999999999999999999877655554444321100
Q ss_pred -----------------CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 268 -----------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 268 -----------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
+.......+++++.+||.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0001123467889999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=358.74 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=210.7
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCC-CcccceeeEEEecCce
Q 018614 51 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 120 (353)
+|+..+.||+|+||.||. +|+.||||+++..... +....+.+.+|+.++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 599999999999999984 3789999998754321 11223457789999999976 8999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
+++|||+.+++|.+++...+.+++..++.++.||+.||.|||+.+ ++||||||+||+++.+|.+||+|||+++....
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999987755
Q ss_pred CCCCCcccCCCCCcccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCCchhhhHH
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 278 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
..........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+...........+..+++
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 261 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence 444444456788999999998765 467899999999999999999999988777766665544332222223456889
Q ss_pred HHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 018614 279 GLKELIEECWNEKPAKRP-----TFRQIITR 304 (353)
Q Consensus 279 ~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 304 (353)
++.+||.+||..||++|| |++|+++|
T Consensus 262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 999999999999999999 47888865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=344.92 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=195.6
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC----ceEEE
Q 018614 51 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV 123 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~iv 123 (353)
+|...+.||+|+||.|| .+|+.||||++.... ........|+..+.+++||||+++++++.+.+ ..|+|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 46778899999999887 578999999986542 21122234555666789999999999998654 47999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 124 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-----PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~-----~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
|||+++|+|.+++++. .+++..++.++.|++.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999999875 5899999999999999999999741 123999999999999999999999999999877
Q ss_pred ccCCCC---CcccCCCCCcccCccccCCCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-------------
Q 018614 199 TVKEDR---PLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDNE------------- 256 (353)
Q Consensus 199 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~pf~~~~~~~------------- 256 (353)
...... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||.......
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 543321 223456899999999987653 5678999999999999999988874322111
Q ss_pred --hHHHHHhcC-CCCCCCc--hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHH
Q 018614 257 --VPKAYAARQ-RPPFKAP--AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 311 (353)
Q Consensus 257 --~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~ 311 (353)
......... .+.++.. ....+..+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 111111111 2232221 223456799999999999999999999999999988653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=348.00 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=196.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC------
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 118 (353)
.+|+..+.||+|+||.||. +|+.||||+++... ......+.+.+|+.+|++++||||++++++|...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4799999999999999984 48999999997654 34556678899999999999999999999997654
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.+|+||||+ +.+|..+++. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence 479999999 7788887765 46999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC------------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------ 265 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------ 265 (353)
... .....+|+.|+|||.+.+. .++.++|||||||++|+|++|++||...+.......+....
T Consensus 172 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 172 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred CCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 432 2345688999999998764 56889999999999999999999998765443332222111
Q ss_pred ---------------CCCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 ---------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 ---------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
...+.......++++.+||.+||..||++|||++++++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 011111123457889999999999999999999999997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=346.46 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=197.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEe-------
Q 018614 49 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------- 116 (353)
Q Consensus 49 ~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------- 116 (353)
-.+|+..+.||+|+||.||. +|+.||||++...... +.....+.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 35799999999999999984 5889999998665332 2334567899999999999999999998854
Q ss_pred -cCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccc
Q 018614 117 -SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 195 (353)
Q Consensus 117 -~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a 195 (353)
.+..|+|||++.++.+..+......+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 3468999999977666655555567999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC---CCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 018614 196 KLLTVKED---RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 271 (353)
Q Consensus 196 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 87653322 222335689999999998765 68999999999999999999999998766544444332211110000
Q ss_pred -----------------------c-----hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 272 -----------------------P-----AKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 272 -----------------------~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
. ....++++.+||.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 01235678899999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-46 Score=337.38 Aligned_cols=257 Identities=16% Similarity=0.242 Sum_probs=210.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-CcccceeeEEEecCceEEE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIV 123 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~iv 123 (353)
.+|++.+.||+|+||.||. +|+.||||++...... ..+.+|++.++.++| +|++.+++++..+...++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 4799999999999999984 5889999988654221 246788999999975 8999999999999999999
Q ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC-----CCCEEEeecccccc
Q 018614 124 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVSKL 197 (353)
Q Consensus 124 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~-----~~~vkl~Dfg~a~~ 197 (353)
||++ +++|.+++...+ .++...+..++.|++.||+|||++| ++||||||+|||++. .+.+||+|||+|+.
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999 789999997654 5999999999999999999999999 999999999999974 57899999999988
Q ss_pred cccCCCC------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHH---hcC-CC
Q 018614 198 LTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---ARQ-RP 267 (353)
Q Consensus 198 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~---~~~-~~ 267 (353)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+. ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7543221 2234568999999999999999999999999999999999999998766554433221 111 11
Q ss_pred CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHHHhhhc
Q 018614 268 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 315 (353)
Q Consensus 268 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~ 315 (353)
+.......+|+++.+|+..|+..+|++||+++.+.+.|+++.......
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 111122457889999999999999999999999999999987665433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=339.40 Aligned_cols=251 Identities=16% Similarity=0.228 Sum_probs=198.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccc-ceeeEEEecCceEEEE
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV-QFLGAVTQSSPMMIVT 124 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~iv~ 124 (353)
+|+..+.||+|+||.||. +|+.||||++...... ..+..|+++++.++|++++ .+.+++.++...++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 599999999999999984 4889999987654322 2467899999999877655 5556667778889999
Q ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcC---CCCEEEeeccccccccc
Q 018614 125 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV 200 (353)
Q Consensus 125 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~---~~~vkl~Dfg~a~~~~~ 200 (353)
||+ +++|.+.+.. ...+++..+..++.|++.||+|||++| |+||||||+|||++. +..++|+|||+|+....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999 6677776654 456999999999999999999999999 999999999999864 45799999999998754
Q ss_pred CCCC------CcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC----CCCCC
Q 018614 201 KEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK 270 (353)
Q Consensus 201 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----~~~~~ 270 (353)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.... ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3321 2234568999999999999999999999999999999999999998766544433322111 11211
Q ss_pred CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHH
Q 018614 271 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 310 (353)
Q Consensus 271 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~ 310 (353)
.....+|+++.+||..||+.||++||++.++.+.|+.+..
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 1234578999999999999999999999999998888754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=345.93 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=195.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecC-----ce
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 120 (353)
+|+..+.||+|+||.||. +|+.||||++.... .....+.+.+|+.+|++++||||+++++++.... ..
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 599999999999999984 58999999987542 4555678899999999999999999999997543 24
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
|+++ ++.+++|.+++... .+++..++.++.|++.||+|||++| ||||||||+|||++.++.+||+|||++.....
T Consensus 87 ~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 5554 55589999999765 5999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCC--CcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC-----------
Q 018614 201 KEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----------- 266 (353)
Q Consensus 201 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------- 266 (353)
.... ......|++.|+|||++.. ..++.++||||+||++|+|++|+.||.................
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 3222 2234568899999999854 4678899999999999999999999987654333222211100
Q ss_pred -------------CCCC---CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 -------------PPFK---APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 -------------~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.... .....+++++.+||.+||..||++|||++++++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0112456789999999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=349.63 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=194.1
Q ss_pred ccCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec----
Q 018614 47 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS---- 117 (353)
Q Consensus 47 ~~~~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 117 (353)
+.+.+|+..+.||+|+||.||. +|+.||||++..... ...+|+.++++++||||++++++|...
T Consensus 17 ~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp CEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred cccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence 4455799999999999999984 588999999866432 234799999999999999999998543
Q ss_pred --CceEEEEecCCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEee
Q 018614 118 --SPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVAD 191 (353)
Q Consensus 118 --~~~~iv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~D 191 (353)
..+|+||||++++.+..+. .....+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECC
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEec
Confidence 3478999999665333332 23456999999999999999999999999 99999999999999775 899999
Q ss_pred cccccccccCCCCCcccCCCCCcccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcC-----
Q 018614 192 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----- 265 (353)
Q Consensus 192 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----- 265 (353)
||++....... ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....
T Consensus 167 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 167 FGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CTTCEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccchhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 99998765332 2233567889999998765 578999999999999999999999998766544433332110
Q ss_pred --------------CCCCC------CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 --------------RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 --------------~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.+... ......++++.+||.+||..||++|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 1123467889999999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=336.26 Aligned_cols=249 Identities=20% Similarity=0.375 Sum_probs=205.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEecCceEEEEe
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 125 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 125 (353)
+|+..+.||+|+||.||. +|+.||||+++.... .......+.+|+.++++++||||+++++++.+....++|+|
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 699999999999999984 578999999976543 34556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 018614 126 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 205 (353)
Q Consensus 126 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 205 (353)
++.+++|..++...+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++....... .
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence 9999999998888888999999999999999999999999 99999999999999999999999999988754332 3
Q ss_pred cccCCCCCcccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCC-CchHHHHHhcCC-----------------
Q 018614 206 LTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQR----------------- 266 (353)
Q Consensus 206 ~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~----------------- 266 (353)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||..... .+....+.....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 33445678899999987665 68999999999999999999998754333 222222211111
Q ss_pred --------CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 --------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.........+++++.+||++||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111223567889999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=337.72 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=191.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec------C
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 118 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 118 (353)
.+|++.+.||+|+||.|+. +|+.||||++..... .......+.+|+.++++++||||++++++|... .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3699999999999999984 589999999976543 455567789999999999999999999999643 5
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccc
Q 018614 119 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 198 (353)
Q Consensus 119 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~ 198 (353)
.+|+||||+.+ ++.+.+. ..+++..++.++.||+.||.|||+.| ++||||||+|||++.++.++++|||+++..
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence 78999999965 5555543 45899999999999999999999999 999999999999999999999999998876
Q ss_pred ccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCC------------
Q 018614 199 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------ 266 (353)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------ 266 (353)
.... ......+|+.|+|||++.+..++.++||||+||++++|++|++||.+.+.......+.....
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 5432 22345578899999999999999999999999999999999999987654333322211100
Q ss_pred ---------C-----------------CCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 267 ---------P-----------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 267 ---------~-----------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
. .........++++.+||++||..||++|||++|+|+|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000123457889999999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.8e-45 Score=333.70 Aligned_cols=241 Identities=21% Similarity=0.344 Sum_probs=194.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEe--cCceE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMM 121 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~ 121 (353)
.+|+..++||+|+||.||. +|+.||||+++... .+.+.+|+.+|++++ ||||+++++++.. ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 3699999999999999984 48899999986532 246788999999995 9999999999974 35689
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCC-CEEEeeccccccccc
Q 018614 122 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTV 200 (353)
Q Consensus 122 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~-~vkl~Dfg~a~~~~~ 200 (353)
+||||+++++|..+. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++.....
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999987764 35999999999999999999999999 99999999999999765 599999999987654
Q ss_pred CCCCCcccCCCCCcccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchH-HHHH-------------hcC
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYA-------------ARQ 265 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~-------------~~~ 265 (353)
.. ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||......... ..+. ...
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 23345678899999998765 4799999999999999999999999765432211 1000 000
Q ss_pred C--------------------CCCCCchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 266 R--------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 266 ~--------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
. .........+++++.+||++||..||++|||++|+|+|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00111224567899999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=340.07 Aligned_cols=245 Identities=26% Similarity=0.349 Sum_probs=195.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeeEEEec-----Cce
Q 018614 51 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 120 (353)
Q Consensus 51 ~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 120 (353)
+|+..+.||+|+||.||. +|+.||||++.... .+....+.+.+|+.++++++||||+++++++... ...
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 699999999999999884 58999999998654 3445556788999999999999999999998643 234
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeeccccccccc
Q 018614 121 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 200 (353)
Q Consensus 121 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 200 (353)
+++++++.+|+|.+++.. +++++..++.++.||+.||.|||++| |+||||||+|||++.+|.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence 556666779999999865 46999999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHhcCCCC-----------
Q 018614 201 KEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP----------- 268 (353)
Q Consensus 201 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----------- 268 (353)
. .....|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 174 ~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp G----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred c----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 2 23355778899999877654 5889999999999999999999998766544443332211110
Q ss_pred -----------CC-----CchhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 018614 269 -----------FK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 304 (353)
Q Consensus 269 -----------~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 304 (353)
.. ......++++.+||.+||..||++|||++|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00 0012457889999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-38 Score=293.85 Aligned_cols=244 Identities=20% Similarity=0.314 Sum_probs=181.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----------CCcccceeeE
Q 018614 50 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLGA 113 (353)
Q Consensus 50 ~~~~~~~~ig~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~ 113 (353)
.+|+..++||+|+||.||. +|+.||||+++.. ....+.+.+|+.+++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 4699999999999999983 5899999998754 233456778888888775 5789999998
Q ss_pred EEec--CceEEEEecCCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCEEecCCCCCCEEEcCCCC-
Q 018614 114 VTQS--SPMMIVTEYLPKG-DLRAFLKR--KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN- 186 (353)
Q Consensus 114 ~~~~--~~~~iv~e~~~~~-~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~Lh~-~~~~~iiH~dlkp~Nill~~~~~- 186 (353)
+... ...+++++++..+ ........ ...+++..+..++.||+.||+|||+ .| |+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcc
Confidence 8643 3455666655443 33333332 3458999999999999999999998 77 999999999999986654
Q ss_pred -----EEEeecccccccccCCCCCcccCCCCCcccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCchH---
Q 018614 187 -----LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP--- 258 (353)
Q Consensus 187 -----vkl~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~--- 258 (353)
++++|||.+....... ....+++.|+|||++.+..++.++||||+||++++|++|+.||.........
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cccceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 9999999997654322 3355888999999999999999999999999999999999999754321100
Q ss_pred ---HHH-Hh-c------------------------CCCCC------------CCchhhhHHHHHHHHHHHcccCCCCCCC
Q 018614 259 ---KAY-AA-R------------------------QRPPF------------KAPAKLYARGLKELIEECWNEKPAKRPT 297 (353)
Q Consensus 259 ---~~~-~~-~------------------------~~~~~------------~~~~~~~~~~l~~li~~cl~~dp~~Rps 297 (353)
... .. + ..... .......++++.+||.+||..||++|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 000 00 0 00000 0012356788999999999999999999
Q ss_pred HHHHHHH
Q 018614 298 FRQIITR 304 (353)
Q Consensus 298 ~~~ll~~ 304 (353)
++|+|+|
T Consensus 322 a~e~L~H 328 (362)
T d1q8ya_ 322 AGGLVNH 328 (362)
T ss_dssp HHHHHTC
T ss_pred HHHHhcC
Confidence 9999876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=3.1e-23 Score=173.45 Aligned_cols=163 Identities=18% Similarity=0.152 Sum_probs=117.2
Q ss_pred ccceeeecceEEEEEE----cCeEEEEEEcCcccCC---------------CHHHHHHHHHHHHHHhcCCCCcccceeeE
Q 018614 53 TNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---------------DDDRVRAFRDELALLQKIRHPNVVQFLGA 113 (353)
Q Consensus 53 ~~~~~ig~G~~~~v~~----~g~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 113 (353)
.+++.||+|+||.||. +|+.||||+++..... .........+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999984 5889999987542111 01122345578889999999999988765
Q ss_pred EEecCceEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCEEecCCCCCCEEEcCCCCEEEeecc
Q 018614 114 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 193 (353)
Q Consensus 114 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~Lh~~~~~~iiH~dlkp~Nill~~~~~vkl~Dfg 193 (353)
. ..+++||++++..+.+ ++...+..++.|++.+|.|||++| ++||||||+|||+++++ ++|+|||
T Consensus 83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCT
T ss_pred c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECC
Confidence 3 2379999997755432 455567789999999999999999 99999999999999765 8999999
Q ss_pred cccccccCCCCCcccCCCCCcccCcc-----ccCCCCCCCchhHHHHHHHH
Q 018614 194 VSKLLTVKEDRPLTCQDTSCRYVAPE-----VFKNEEYDTKVDVFSFALIL 239 (353)
Q Consensus 194 ~a~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~~DvwslG~il 239 (353)
+|......... .|.... .+....|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 98765422111 111110 01235678899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.27 E-value=1.6e-06 Score=73.79 Aligned_cols=126 Identities=13% Similarity=0.026 Sum_probs=81.8
Q ss_pred EEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeeEEEecCceEEEEecCCCCCHHHHHHhcCCC
Q 018614 64 ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 142 (353)
Q Consensus 64 ~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~ 142 (353)
..+..++..+.+|.......... ..+.+|...++.+. +--+++++.+..+++..++||++++|.++.+.....
T Consensus 31 ~rv~~~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--- 104 (263)
T d1j7la_ 31 YKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--- 104 (263)
T ss_dssp EEEECSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---
T ss_pred EEEEeCCCeEEEEEcCCCcccch---hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc---
Confidence 34445677888998765432211 23567888888774 334678888888888999999999988776543211
Q ss_pred CHHHHHHHHHHHHHHHHHHHhc--------------------------------------------------------CC
Q 018614 143 KPSTAVRFALDIARGMNYLHEN--------------------------------------------------------KP 166 (353)
Q Consensus 143 ~~~~~~~i~~qi~~al~~Lh~~--------------------------------------------------------~~ 166 (353)
.....++.++...++.||+. ..
T Consensus 105 --~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 182 (263)
T d1j7la_ 105 --QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEE 182 (263)
T ss_dssp --SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCC
T ss_pred --ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCC
Confidence 11222334444444444421 11
Q ss_pred CCEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 167 VPIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 167 ~~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
..++|+|+.|.||++++++.+-|+||+.+..
T Consensus 183 ~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999876667999987643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.70 E-value=2.5e-05 Score=65.67 Aligned_cols=58 Identities=21% Similarity=0.170 Sum_probs=40.9
Q ss_pred cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC--CcccceeeEEEecCceEEEEecCCCCCH
Q 018614 69 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLPKGDL 132 (353)
Q Consensus 69 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~iv~e~~~~~~L 132 (353)
.+..+.+|....... ..+..|+..++.+.. -.+++++.+..+.+..++||++++|.++
T Consensus 34 ~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 34 GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 355678888655432 235678888877743 2367788888888889999999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.62 E-value=9.8e-05 Score=66.42 Aligned_cols=29 Identities=28% Similarity=0.375 Sum_probs=24.8
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
.++|+|++|.|||+++++ ++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 399999999999999764 89999987644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.37 E-value=0.0029 Score=54.84 Aligned_cols=124 Identities=12% Similarity=0.086 Sum_probs=67.5
Q ss_pred EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc--ccee-----eEEEecCceEEEEecCCCCC-----HHHH
Q 018614 68 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV--VQFL-----GAVTQSSPMMIVTEYLPKGD-----LRAF 135 (353)
Q Consensus 68 ~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--~~~~-----~~~~~~~~~~iv~e~~~~~~-----L~~~ 135 (353)
.+|..+++|+.+...- .. +++..|...+..|...++ +..+ ..+...+..+.++++++|.. ...+
T Consensus 44 ~dg~~~VlK~~rp~~~-s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~ 119 (325)
T d1zyla1 44 EDRRRFVVKFYRPERW-TA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQM 119 (325)
T ss_dssp TTCCCEEEEEECTTTS-CH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHH
T ss_pred CCCCEEEEEEeCCCCC-CH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHH
Confidence 3678899999876432 22 356678888887743222 1111 12344567888999987632 1111
Q ss_pred HH---------h----c-----CCCCH----------------------HHHHHHHHHHHHHHHHH-HhcCCCCEEecCC
Q 018614 136 LK---------R----K-----GALKP----------------------STAVRFALDIARGMNYL-HENKPVPIIHRDL 174 (353)
Q Consensus 136 l~---------~----~-----~~~~~----------------------~~~~~i~~qi~~al~~L-h~~~~~~iiH~dl 174 (353)
-. . . ...+. ......+.++...+.-. ......++||+|+
T Consensus 120 ~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDl 199 (325)
T d1zyla1 120 EAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDC 199 (325)
T ss_dssp HHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSC
T ss_pred HHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCC
Confidence 10 0 0 01111 11122233333333322 1222335899999
Q ss_pred CCCCEEEcCCCCEEEeecccccc
Q 018614 175 EPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 175 kp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
.+.|||++++ ..++||+.+..
T Consensus 200 h~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 200 HAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SGGGEEESSS--EEECCCTTCCE
T ss_pred CcccEEEeCC--ceEEechhccc
Confidence 9999999753 56899997754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.90 E-value=0.0069 Score=53.82 Aligned_cols=52 Identities=12% Similarity=0.187 Sum_probs=32.8
Q ss_pred eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc-ccceeeEEEecCceEEEEecCCCCC
Q 018614 71 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSSPMMIVTEYLPKGD 131 (353)
Q Consensus 71 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~iv~e~~~~~~ 131 (353)
..|.+++.... ... ....+|..+++.+.-.+ .+++++++.+ .+|+||++|.+
T Consensus 75 ~~vllRi~g~~--~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~ 127 (395)
T d1nw1a_ 75 NKVLLRVYFNP--ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 127 (395)
T ss_dssp SEEEEEEECSC--CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred CcEEEEecCCc--chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEecccc
Confidence 45777776522 111 23457888888885334 4577877753 68999997643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.78 E-value=0.0076 Score=51.61 Aligned_cols=30 Identities=23% Similarity=0.173 Sum_probs=26.4
Q ss_pred CEEecCCCCCCEEEcCCCCEEEeecccccc
Q 018614 168 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 197 (353)
Q Consensus 168 ~iiH~dlkp~Nill~~~~~vkl~Dfg~a~~ 197 (353)
++||+|+.++||+++.+...-++||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 499999999999999987778999997743
|